0001493152-23-010183.txt : 20230331 0001493152-23-010183.hdr.sgml : 20230331 20230331153836 ACCESSION NUMBER: 0001493152-23-010183 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 127 CONFORMED PERIOD OF REPORT: 20221231 FILED AS OF DATE: 20230331 DATE AS OF CHANGE: 20230331 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Vislink Technologies, Inc. CENTRAL INDEX KEY: 0001565228 STANDARD INDUSTRIAL CLASSIFICATION: COMMUNICATIONS EQUIPMENT, NEC [3669] IRS NUMBER: 205856795 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35988 FILM NUMBER: 23787159 BUSINESS ADDRESS: STREET 1: 350 CLARK DRIVE STREET 2: SUITE 125 CITY: MT. OLIVE STATE: NJ ZIP: 07828 BUSINESS PHONE: 941 953 9035 MAIL ADDRESS: STREET 1: 350 CLARK DRIVE STREET 2: SUITE 125 CITY: MT. OLIVE STATE: NJ ZIP: 07828 FORMER COMPANY: FORMER CONFORMED NAME: xG TECHNOLOGY, INC. DATE OF NAME CHANGE: 20121220 10-K 1 form10-k.htm
0001565228 false FY P5Y P5Y P3Y P3Y 0001565228 2022-01-01 2022-12-31 0001565228 2022-06-30 0001565228 2023-03-16 0001565228 2022-12-31 0001565228 2021-12-31 0001565228 us-gaap:SeriesAPreferredStockMember 2022-12-31 0001565228 us-gaap:SeriesAPreferredStockMember 2021-12-31 0001565228 2021-01-01 2021-12-31 0001565228 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2020-12-31 0001565228 us-gaap:CommonStockMember 2020-12-31 0001565228 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001565228 us-gaap:TreasuryStockMember 2020-12-31 0001565228 us-gaap:RetainedEarningsMember 2020-12-31 0001565228 2020-12-31 0001565228 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2021-12-31 0001565228 us-gaap:CommonStockMember 2021-12-31 0001565228 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001565228 us-gaap:TreasuryStockMember 2021-12-31 0001565228 us-gaap:RetainedEarningsMember 2021-12-31 0001565228 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2021-01-01 2021-12-31 0001565228 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001565228 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001565228 us-gaap:TreasuryStockMember 2021-01-01 2021-12-31 0001565228 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001565228 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-01-01 2022-12-31 0001565228 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001565228 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001565228 us-gaap:TreasuryStockMember 2022-01-01 2022-12-31 0001565228 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001565228 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-12-31 0001565228 us-gaap:CommonStockMember 2022-12-31 0001565228 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001565228 us-gaap:TreasuryStockMember 2022-12-31 0001565228 us-gaap:RetainedEarningsMember 2022-12-31 0001565228 us-gaap:SubsequentEventMember 2023-03-15 2023-03-16 0001565228 us-gaap:CommonStockMember 2021-02-07 2021-02-08 0001565228 us-gaap:CommonStockMember 2021-02-08 0001565228 srt:MinimumMember 2022-12-31 0001565228 srt:MinimumMember 2021-12-31 0001565228 VISL:SingleCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001565228 VISL:SingleCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001565228 VISL:SingleCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-12-31 0001565228 VISL:SingleCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001565228 VISL:SingleCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-12-31 0001565228 VISL:SingleCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001565228 srt:MinimumMember 2022-01-01 2022-12-31 0001565228 srt:MaximumMember 2022-01-01 2022-12-31 0001565228 srt:MinimumMember VISL:PatentsAndLicensesMember 2022-01-01 2022-12-31 0001565228 srt:MaximumMember VISL:PatentsAndLicensesMember 2022-01-01 2022-12-31 0001565228 VISL:PatentsAndLicensesMember 2022-01-01 2022-12-31 0001565228 VISL:PatentsAndLicensesMember 2021-01-01 2021-12-31 0001565228 us-gaap:OtherIntangibleAssetsMember srt:MinimumMember 2022-01-01 2022-12-31 0001565228 us-gaap:OtherIntangibleAssetsMember srt:MaximumMember 2022-01-01 2022-12-31 0001565228 us-gaap:OtherIntangibleAssetsMember 2022-01-01 2022-12-31 0001565228 us-gaap:OtherIntangibleAssetsMember 2021-01-01 2021-12-31 0001565228 VISL:GBPMember VISL:GBPToUSDMember 2022-12-31 0001565228 VISL:GBPToUSDMember 2022-12-31 0001565228 VISL:EuroMember VISL:EuroToGBPMember 2022-12-31 0001565228 VISL:GBPMember VISL:EuroToGBPMember 2022-12-31 0001565228 VISL:GBPMember VISL:GBPToUSDMember 2021-12-31 0001565228 VISL:GBPToUSDMember 2021-12-31 0001565228 VISL:EuroMember VISL:EuroToGBPMember 2021-12-31 0001565228 VISL:GBPMember VISL:EuroToGBPMember 2021-12-31 0001565228 2022-11-01 2022-11-30 0001565228 us-gaap:SeriesAPreferredStockMember 2022-11-30 0001565228 us-gaap:StockOptionMember 2022-01-01 2022-12-31 0001565228 us-gaap:StockOptionMember 2021-01-01 2021-12-31 0001565228 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001565228 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001565228 us-gaap:FairValueInputsLevel1Member VISL:AbandonmentOfRightofuseOperatingLeasesMember 2022-12-31 0001565228 us-gaap:FairValueInputsLevel2Member VISL:AbandonmentOfRightofuseOperatingLeasesMember 2022-12-31 0001565228 us-gaap:FairValueInputsLevel3Member VISL:AbandonmentOfRightofuseOperatingLeasesMember 2022-12-31 0001565228 VISL:AbandonmentOfRightofuseOperatingLeasesMember 2022-12-31 0001565228 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001565228 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001565228 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001565228 us-gaap:FairValueInputsLevel1Member VISL:OtherMember 2022-12-31 0001565228 us-gaap:FairValueInputsLevel2Member VISL:OtherMember 2022-12-31 0001565228 us-gaap:FairValueInputsLevel3Member VISL:OtherMember 2022-12-31 0001565228 VISL:OtherMember 2022-12-31 0001565228 VISL:MobileViewpointCorporateBVMember srt:MaximumMember 2021-08-16 0001565228 VISL:MobileViewpointCorporateBVMember 2021-08-15 2021-08-16 0001565228 VISL:MobileViewpointCorporateBVMember 2021-08-13 0001565228 VISL:MobileViewpointCorporateBVMember 2022-01-01 2022-12-31 0001565228 2021-08-16 0001565228 us-gaap:TradeNamesMember 2021-08-15 2021-08-16 0001565228 VISL:ProprietaryTechnologyMember 2021-08-15 2021-08-16 0001565228 us-gaap:GoodwillMember 2021-08-15 2021-08-16 0001565228 us-gaap:CustomerRelationshipsMember 2021-08-15 2021-08-16 0001565228 2021-08-15 2021-08-16 0001565228 VISL:InternalRateOfReturnMember 2021-08-16 0001565228 VISL:WorkingCapitalMember 2021-08-16 0001565228 VISL:IntangibleAssetsMember 2021-08-16 0001565228 us-gaap:GoodwillMember 2021-08-16 0001565228 srt:ScenarioPreviouslyReportedMember 2021-08-16 0001565228 srt:RestatementAdjustmentMember 2021-08-16 0001565228 srt:ScenarioPreviouslyReportedMember us-gaap:TradeNamesMember 2021-08-16 0001565228 srt:RestatementAdjustmentMember us-gaap:TradeNamesMember 2021-08-16 0001565228 us-gaap:TradeNamesMember 2021-08-16 0001565228 srt:ScenarioPreviouslyReportedMember VISL:ProprietaryTechnologyMember 2021-08-16 0001565228 srt:RestatementAdjustmentMember VISL:ProprietaryTechnologyMember 2021-08-16 0001565228 VISL:ProprietaryTechnologyMember 2021-08-16 0001565228 srt:ScenarioPreviouslyReportedMember us-gaap:CustomerRelationshipsMember 2021-08-16 0001565228 srt:RestatementAdjustmentMember us-gaap:CustomerRelationshipsMember 2021-08-16 0001565228 us-gaap:CustomerRelationshipsMember 2021-08-16 0001565228 srt:ScenarioPreviouslyReportedMember us-gaap:GoodwillMember 2021-08-16 0001565228 srt:RestatementAdjustmentMember us-gaap:GoodwillMember 2021-08-16 0001565228 VISL:TradeNameMember 2022-01-01 2022-12-31 0001565228 VISL:ProprietaryTechnologiesMember 2022-01-01 2022-12-31 0001565228 VISL:CustomerRelationshipMember 2022-01-01 2022-12-31 0001565228 VISL:GoodwillIntangiblesMember 2022-01-01 2022-12-31 0001565228 VISL:ProductRationalizationProgramMember 2022-01-01 2022-12-31 0001565228 VISL:ProductRationalizationProgramMember 2021-01-01 2021-12-31 0001565228 us-gaap:FurnitureAndFixturesMember srt:MinimumMember 2022-01-01 2022-12-31 0001565228 us-gaap:FurnitureAndFixturesMember srt:MaximumMember 2022-01-01 2022-12-31 0001565228 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001565228 us-gaap:FurnitureAndFixturesMember 2021-12-31 0001565228 us-gaap:LeaseholdImprovementsMember srt:MinimumMember 2022-01-01 2022-12-31 0001565228 us-gaap:LeaseholdImprovementsMember srt:MaximumMember 2022-01-01 2022-12-31 0001565228 us-gaap:LeaseholdImprovementsMember 2022-12-31 0001565228 us-gaap:LeaseholdImprovementsMember 2021-12-31 0001565228 us-gaap:ComputerEquipmentMember srt:MinimumMember 2022-01-01 2022-12-31 0001565228 us-gaap:ComputerEquipmentMember srt:MaximumMember 2022-01-01 2022-12-31 0001565228 us-gaap:ComputerEquipmentMember 2022-12-31 0001565228 us-gaap:ComputerEquipmentMember 2021-12-31 0001565228 VISL:ProprietaryTechnologyMember 2020-12-31 0001565228 VISL:PatentsAndLicensesMember 2020-12-31 0001565228 VISL:TradeNamesAndTechnologyMember 2020-12-31 0001565228 us-gaap:CustomerRelationshipsMember 2020-12-31 0001565228 VISL:ProprietaryTechnologyMember 2021-01-01 2021-12-31 0001565228 VISL:PatentsAndLicensesMember 2021-01-01 2021-12-31 0001565228 VISL:TradeNamesAndTechnologyMember 2021-01-01 2021-12-31 0001565228 us-gaap:CustomerRelationshipsMember 2021-01-01 2021-12-31 0001565228 VISL:ProprietaryTechnologyMember 2021-12-31 0001565228 VISL:PatentsAndLicensesMember 2021-12-31 0001565228 VISL:TradeNamesAndTechnologyMember 2021-12-31 0001565228 us-gaap:CustomerRelationshipsMember 2021-12-31 0001565228 VISL:ProprietaryTechnologyMember 2022-01-01 2022-12-31 0001565228 VISL:PatentsAndLicensesMember 2022-01-01 2022-12-31 0001565228 VISL:TradeNamesAndTechnologyMember 2022-01-01 2022-12-31 0001565228 us-gaap:CustomerRelationshipsMember 2022-01-01 2022-12-31 0001565228 VISL:ProprietaryTechnologyMember 2022-12-31 0001565228 VISL:PatentsAndLicensesMember 2022-12-31 0001565228 VISL:TradeNamesAndTechnologyMember 2022-12-31 0001565228 us-gaap:CustomerRelationshipsMember 2022-12-31 0001565228 VISL:ProprietaryTechnologyMember srt:MinimumMember 2022-01-01 2022-12-31 0001565228 VISL:ProprietaryTechnologyMember srt:MaximumMember 2022-01-01 2022-12-31 0001565228 VISL:PatentsAndLicensesMember srt:MinimumMember 2022-01-01 2022-12-31 0001565228 VISL:PatentsAndLicensesMember srt:MaximumMember 2022-01-01 2022-12-31 0001565228 VISL:TradeNamesAndTechnologyMember srt:MinimumMember 2022-01-01 2022-12-31 0001565228 VISL:TradeNamesAndTechnologyMember srt:MaximumMember 2022-01-01 2022-12-31 0001565228 VISL:NotesPayableOneMember 2022-12-31 0001565228 VISL:NotesPayableOneMember 2021-12-31 0001565228 VISL:NotesPayableTwoMember 2022-12-31 0001565228 VISL:NotesPayableTwoMember 2021-12-31 0001565228 VISL:DAndOInsurancePolicyRenewedMember VISL:NotesPayableOneMember 2021-04-05 0001565228 VISL:DAndOInsurancePolicyRenewedMember VISL:NotesPayableOneMember 2021-04-04 2021-04-05 0001565228 VISL:DAndOInsurancePolicyRenewedMember VISL:NotesPayableOneMember 2022-01-01 2022-12-31 0001565228 VISL:DAndOInsurancePolicyRenewedMember VISL:NotesPayableOneMember 2021-01-01 2021-12-31 0001565228 VISL:DAndOInsurancePolicyRenewedMember VISL:NotesPayableTwoMember 2022-04-05 0001565228 VISL:DAndOInsurancePolicyRenewedMember VISL:NotesPayableTwoMember 2022-04-04 2022-04-05 0001565228 VISL:DAndOInsurancePolicyRenewedMember VISL:NotesPayableTwoMember 2022-01-01 2022-12-31 0001565228 VISL:DAndOInsurancePolicyRenewedMember VISL:NotesPayableTwoMember 2021-01-01 2021-12-31 0001565228 VISL:LuttonUKMember 2022-01-01 2022-12-31 0001565228 VISL:LuttonUKMember 2022-04-28 0001565228 VISL:LuttonUKMember 2022-04-27 2022-04-28 0001565228 VISL:DubaiUAEMember 2022-01-01 2022-12-31 0001565228 VISL:DubaiUAEMember 2022-07-03 0001565228 VISL:DubaiUAEMember 2022-07-01 2022-07-03 0001565228 VISL:BillericaMaMember 2022-10-01 2022-12-31 0001565228 VISL:LuttonUKMember 2021-01-01 2021-12-31 0001565228 VISL:LuttonUKMember 2021-02-01 0001565228 VISL:LuttonUKMember 2021-01-31 2021-02-01 0001565228 VISL:DubaiUAEMember 2021-01-01 2021-12-31 0001565228 VISL:DubaiUAEMember 2021-05-23 2021-05-24 0001565228 VISL:DubaiUAEMember 2021-05-24 0001565228 VISL:MountOliveNJMember 2021-11-01 0001565228 VISL:MountOliveNJMember 2021-11-01 2021-11-01 0001565228 VISL:ColchesterUKWatersideHouseMember 2022-12-31 0001565228 VISL:ColchesterUKWatersideHouseMember 2022-01-01 2022-12-31 0001565228 country:SG 2022-12-31 0001565228 country:SG 2022-01-01 2022-12-31 0001565228 VISL:BillericaMaMember 2022-12-31 0001565228 VISL:BillericaMaMember 2022-01-01 2022-12-31 0001565228 VISL:HemelUKMember 2022-12-31 0001565228 VISL:HemelUKMember 2022-01-01 2022-12-31 0001565228 VISL:MountOliveNJMember 2022-12-31 0001565228 VISL:MountOliveNJMember 2022-01-01 2022-12-31 0001565228 us-gaap:MeasurementInputSharePriceMember 2022-12-31 0001565228 us-gaap:MeasurementInputSharePriceMember 2021-12-31 0001565228 us-gaap:MeasurementInputExercisePriceMember srt:MinimumMember 2022-12-31 0001565228 us-gaap:MeasurementInputExercisePriceMember srt:MaximumMember 2022-12-31 0001565228 us-gaap:MeasurementInputExercisePriceMember srt:MinimumMember 2021-12-31 0001565228 us-gaap:MeasurementInputExercisePriceMember srt:MaximumMember 2021-12-31 0001565228 us-gaap:MeasurementInputPriceVolatilityMember srt:MinimumMember 2022-12-31 0001565228 us-gaap:MeasurementInputPriceVolatilityMember srt:MaximumMember 2022-12-31 0001565228 us-gaap:MeasurementInputPriceVolatilityMember srt:MinimumMember 2021-12-31 0001565228 us-gaap:MeasurementInputPriceVolatilityMember srt:MaximumMember 2021-12-31 0001565228 us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MinimumMember 2022-12-31 0001565228 us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MaximumMember 2022-12-31 0001565228 us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MinimumMember 2021-12-31 0001565228 us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MaximumMember 2021-12-31 0001565228 us-gaap:MeasurementInputExpectedDividendRateMember 2022-12-31 0001565228 us-gaap:MeasurementInputExpectedDividendRateMember 2021-12-31 0001565228 srt:MaximumMember 2022-12-31 0001565228 srt:MaximumMember 2021-12-31 0001565228 2013-03-31 0001565228 us-gaap:SeriesBPreferredStockMember 2016-02-05 0001565228 us-gaap:SeriesDPreferredStockMember 2016-04-25 0001565228 us-gaap:SeriesEPreferredStockMember 2016-12-21 0001565228 us-gaap:SeriesAPreferredStockMember 2022-11-09 0001565228 us-gaap:SeriesAPreferredStockMember 2022-11-08 2022-11-09 0001565228 us-gaap:SeriesAPreferredStockMember us-gaap:SubsequentEventMember 2023-01-10 2023-01-23 0001565228 VISL:SeriesDConvertiblePreferredStockMember 2016-04-25 0001565228 VISL:SeriesEConvertiblePreferredStockMember 2016-12-21 0001565228 VISL:SeriesDPreferredStockAndSeriesEPreferredStockMember 2016-12-21 0001565228 us-gaap:SeriesAPreferredStockMember us-gaap:SubsequentEventMember 2023-03-24 0001565228 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001565228 us-gaap:RestrictedStockUnitsRSUMember us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001565228 VISL:ConsultingAgreementMember 2022-01-01 2022-12-31 0001565228 VISL:ConsultingAgreementMember 2022-05-04 2022-05-04 0001565228 VISL:ConsultingAgreementMember 2022-05-04 0001565228 VISL:ConsultingAgreementMember 2022-07-19 2022-07-19 0001565228 VISL:ConsultingAgreementMember 2022-07-19 0001565228 VISL:FebruaryTwoThousandAndTwentyOneFinancingMember 2021-01-01 2021-12-31 0001565228 VISL:FebruaryTwoThousandAndTwentyOneFinancingMember 2021-12-31 0001565228 VISL:FebruaryTwoThousandAndTwentyOneFinancingMember 2021-02-07 2021-02-08 0001565228 VISL:FebruaryTwoThousandAndTwentyOneFinancingMember 2021-02-08 0001565228 VISL:WarrantHoldersMember 2021-01-01 2021-12-31 0001565228 VISL:WarrantHoldersOneMember 2021-01-01 2021-12-31 0001565228 VISL:CommonStockWarrantsMember 2021-12-31 0001565228 VISL:CommonStockWarrantsMember 2021-01-01 2021-12-31 0001565228 us-gaap:MeasurementInputSharePriceMember VISL:CommonStockWarrantsMember 2021-12-31 0001565228 us-gaap:MeasurementInputExercisePriceMember VISL:CommonStockWarrantsMember 2021-12-31 0001565228 us-gaap:MeasurementInputPriceVolatilityMember VISL:CommonStockWarrantsMember 2021-12-31 0001565228 us-gaap:MeasurementInputRiskFreeInterestRateMember VISL:CommonStockWarrantsMember 2021-12-31 0001565228 us-gaap:MeasurementInputExpectedDividendRateMember VISL:CommonStockWarrantsMember 2021-12-31 0001565228 VISL:SpecificBoardMembersMember 2021-01-01 2021-12-31 0001565228 VISL:CommonStockWarrantsMember 2022-01-01 2022-12-31 0001565228 VISL:CommonStockWarrantsMember 2022-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeOneMember 2022-01-01 2022-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeOneMember 2022-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeOneMember 2021-01-01 2021-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeOneMember 2021-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeTwoMember 2022-01-01 2022-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeTwoMember 2022-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeTwoMember 2021-01-01 2021-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeTwoMember 2021-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeThreeMember 2022-01-01 2022-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeThreeMember 2022-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeThreeMember 2021-01-01 2021-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeThreeMember 2021-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeFourMember 2022-01-01 2022-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeFourMember 2022-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeFourMember 2021-01-01 2021-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeFourMember 2021-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeFiveMember 2022-01-01 2022-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeFiveMember 2022-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeFiveMember 2021-01-01 2021-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeFiveMember 2021-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeSixMember 2022-01-01 2022-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeSixMember 2022-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeSixMember 2021-01-01 2021-12-31 0001565228 VISL:WarrantsMember VISL:ExercisePriceRangeSixMember 2021-12-31 0001565228 VISL:WarrantsMember 2022-01-01 2022-12-31 0001565228 VISL:WarrantsMember 2022-12-31 0001565228 VISL:WarrantsMember 2021-01-01 2021-12-31 0001565228 VISL:WarrantsMember 2021-12-31 0001565228 VISL:TwoThousandThirteenLongTermStockIncentivePlanMember 2022-01-01 2022-12-31 0001565228 VISL:TimeVestedOptionMember 2022-01-01 2022-12-31 0001565228 VISL:PerformanceBasedOptionMember 2022-01-01 2022-12-31 0001565228 us-gaap:RestrictedStockMember 2022-01-01 2022-12-31 0001565228 VISL:TwoThousandThirteenLongTermStockIncentivePlanMember 2021-01-01 2021-12-31 0001565228 srt:MinimumMember VISL:TwoThousandThirteenLongTermStockIncentivePlanMember 2022-01-01 2022-12-31 0001565228 srt:MaximumMember VISL:TwoThousandThirteenLongTermStockIncentivePlanMember 2022-01-01 2022-12-31 0001565228 srt:MinimumMember VISL:TwoThousandThirteenLongTermStockIncentivePlanMember 2021-01-01 2021-12-31 0001565228 srt:MaximumMember VISL:TwoThousandThirteenLongTermStockIncentivePlanMember 2021-01-01 2021-12-31 0001565228 VISL:TwoThousandThirteenLongTermStockIncentivePlanMember 2021-12-31 0001565228 VISL:TwoThousandThirteenLongTermStockIncentivePlanMember 2020-12-31 0001565228 VISL:TwoThousandThirteenLongTermStockIncentivePlanMember 2022-12-31 0001565228 VISL:TimeVestedOptionMember 2021-01-01 2021-12-31 0001565228 VISL:TimeVestedOptionMember srt:MinimumMember 2022-01-01 2022-12-31 0001565228 VISL:TimeVestedOptionMember srt:MaximumMember 2022-01-01 2022-12-31 0001565228 VISL:TimeVestedOptionMember srt:MinimumMember 2021-01-01 2021-12-31 0001565228 VISL:TimeVestedOptionMember srt:MaximumMember 2021-01-01 2021-12-31 0001565228 VISL:TimeVestedOptionMember 2021-12-31 0001565228 VISL:TimeVestedOptionMember 2020-12-31 0001565228 VISL:TimeVestedOptionMember 2022-12-31 0001565228 VISL:PerformanceBasedOptionMember 2021-01-01 2021-12-31 0001565228 VISL:PerformanceBasedOptionMember 2021-12-31 0001565228 VISL:PerformanceBasedOptionMember 2020-12-31 0001565228 VISL:PerformanceBasedOptionMember 2022-12-31 0001565228 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0001565228 us-gaap:RestrictedStockUnitsRSUMember srt:MinimumMember 2022-01-01 2022-12-31 0001565228 us-gaap:RestrictedStockUnitsRSUMember srt:MaximumMember 2022-01-01 2022-12-31 0001565228 us-gaap:RestrictedStockUnitsRSUMember srt:MinimumMember 2021-01-01 2021-12-31 0001565228 us-gaap:RestrictedStockUnitsRSUMember srt:MaximumMember 2021-01-01 2021-12-31 0001565228 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001565228 us-gaap:RestrictedStockUnitsRSUMember 2020-12-31 0001565228 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001565228 VISL:PerformanceBasedOptionMember us-gaap:RestrictedStockMember 2022-01-01 2022-12-31 0001565228 VISL:PerformanceBasedOptionMember us-gaap:RestrictedStockMember 2021-01-01 2021-12-31 0001565228 us-gaap:RestrictedStockMember VISL:PerformanceBasedOptionMember srt:MinimumMember 2021-01-01 2021-12-31 0001565228 us-gaap:RestrictedStockMember VISL:PerformanceBasedOptionMember srt:MaximumMember 2021-01-01 2021-12-31 0001565228 us-gaap:RestrictedStockMember VISL:PerformanceBasedOptionMember 2021-12-31 0001565228 us-gaap:RestrictedStockMember VISL:PerformanceBasedOptionMember 2020-12-31 0001565228 us-gaap:RestrictedStockMember VISL:PerformanceBasedOptionMember 2022-12-31 0001565228 srt:ChiefExecutiveOfficerMember VISL:TimeVestedOptionMember 2022-01-01 2022-12-31 0001565228 srt:ChiefExecutiveOfficerMember VISL:TimeVestedOptionMember 2022-12-31 0001565228 srt:ChiefFinancialOfficerMember VISL:TimeVestedOptionMember 2022-01-01 2022-12-31 0001565228 srt:ChiefFinancialOfficerMember VISL:TimeVestedOptionMember 2022-12-31 0001565228 srt:ChiefExecutiveOfficerMember 2022-01-01 2022-12-31 0001565228 srt:ChiefExecutiveOfficerMember VISL:PerformanceBasedStockOptionMember 2022-01-01 2022-12-31 0001565228 srt:ChiefExecutiveOfficerMember VISL:PerformanceBasedStockOptionMember 2022-12-31 0001565228 VISL:PerformanceBasedStockOptionMember 2022-01-01 2022-12-31 0001565228 us-gaap:ShareBasedCompensationAwardTrancheOneMember VISL:PerformanceBasedStockOptionMember 2022-01-01 2022-12-31 0001565228 us-gaap:ShareBasedCompensationAwardTrancheTwoMember VISL:PerformanceBasedStockOptionMember 2022-01-01 2022-12-31 0001565228 us-gaap:ShareBasedCompensationAwardTrancheThreeMember VISL:PerformanceBasedStockOptionMember 2022-01-01 2022-12-31 0001565228 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001565228 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001565228 srt:DirectorMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001565228 srt:DirectorMember us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001565228 VISL:VpGlobalOperationsMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001565228 VISL:VpGlobalOperationsMember us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001565228 VISL:GroupOfTwentyTwoEmployeesMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001565228 VISL:GroupOfTwentyTwoEmployeesMember us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001565228 VISL:CarletonMMillerMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001565228 VISL:CarletonMMillerMember us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001565228 VISL:MikeBondMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001565228 VISL:MikeBondMember us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001565228 srt:ChiefExecutiveOfficerMember VISL:PerformanceBasedOptionMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001565228 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember VISL:PerformanceBasedOptionMember 2022-12-31 0001565228 us-gaap:ShareBasedCompensationAwardTrancheOneMember us-gaap:RestrictedStockUnitsRSUMember srt:ChiefExecutiveOfficerMember VISL:PerformanceBasedOptionMember 2022-01-01 2022-12-31 0001565228 us-gaap:ShareBasedCompensationAwardTrancheTwoMember us-gaap:RestrictedStockUnitsRSUMember srt:ChiefExecutiveOfficerMember VISL:PerformanceBasedOptionMember 2022-01-01 2022-12-31 0001565228 us-gaap:ShareBasedCompensationAwardTrancheThreeMember us-gaap:RestrictedStockUnitsRSUMember srt:ChiefExecutiveOfficerMember VISL:PerformanceBasedOptionMember 2022-01-01 2022-12-31 0001565228 srt:ChiefFinancialOfficerMember VISL:PerformanceBasedOptionMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001565228 srt:ChiefFinancialOfficerMember us-gaap:RestrictedStockUnitsRSUMember VISL:PerformanceBasedOptionMember 2022-12-31 0001565228 us-gaap:ShareBasedCompensationAwardTrancheOneMember us-gaap:RestrictedStockUnitsRSUMember srt:ChiefFinancialOfficerMember VISL:PerformanceBasedOptionMember 2022-01-01 2022-12-31 0001565228 us-gaap:ShareBasedCompensationAwardTrancheTwoMember us-gaap:RestrictedStockUnitsRSUMember srt:ChiefFinancialOfficerMember VISL:PerformanceBasedOptionMember 2022-01-01 2022-12-31 0001565228 us-gaap:ShareBasedCompensationAwardTrancheThreeMember us-gaap:RestrictedStockUnitsRSUMember srt:ChiefFinancialOfficerMember VISL:PerformanceBasedOptionMember 2022-01-01 2022-12-31 0001565228 VISL:PerformanceBasedOptionMember srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0001565228 srt:ChiefExecutiveOfficerMember VISL:PerformanceBasedOptionMember us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001565228 us-gaap:ShareBasedCompensationAwardTrancheOneMember srt:ChiefExecutiveOfficerMember VISL:PerformanceBasedOptionMember us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0001565228 us-gaap:ShareBasedCompensationAwardTrancheTwoMember srt:ChiefExecutiveOfficerMember VISL:PerformanceBasedOptionMember us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0001565228 us-gaap:ShareBasedCompensationAwardTrancheThreeMember srt:ChiefExecutiveOfficerMember VISL:PerformanceBasedOptionMember us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0001565228 srt:ChiefFinancialOfficerMember VISL:PerformanceBasedOptionMember us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0001565228 srt:ChiefFinancialOfficerMember VISL:PerformanceBasedOptionMember us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001565228 us-gaap:ShareBasedCompensationAwardTrancheOneMember srt:ChiefFinancialOfficerMember VISL:PerformanceBasedOptionMember us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0001565228 us-gaap:ShareBasedCompensationAwardTrancheTwoMember VISL:PerformanceBasedRestrictedStockUnitsMember srt:ChiefFinancialOfficerMember 2021-01-01 2021-12-31 0001565228 us-gaap:ShareBasedCompensationAwardTrancheThreeMember srt:ChiefFinancialOfficerMember VISL:PerformanceBasedOptionMember us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0001565228 us-gaap:ShareBasedCompensationAwardTrancheOneMember srt:ChiefExecutiveOfficerMember VISL:PerformanceBasedOptionMember 2022-01-01 2022-12-31 0001565228 us-gaap:ShareBasedCompensationAwardTrancheTwoMember srt:ChiefExecutiveOfficerMember VISL:PerformanceBasedOptionMember 2022-01-01 2022-12-31 0001565228 us-gaap:ShareBasedCompensationAwardTrancheThreeMember srt:ChiefExecutiveOfficerMember VISL:PerformanceBasedOptionMember 2022-01-01 2022-12-31 0001565228 us-gaap:RestrictedStockUnitsRSUMember srt:ChiefExecutiveOfficerMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2021-01-01 2021-12-31 0001565228 us-gaap:RestrictedStockUnitsRSUMember srt:ChiefExecutiveOfficerMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2021-01-01 2021-12-31 0001565228 us-gaap:RestrictedStockUnitsRSUMember srt:ChiefExecutiveOfficerMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2021-01-01 2021-12-31 0001565228 VISL:GroupPersonalPensionPlanUKMember 2022-01-01 2022-12-31 0001565228 VISL:GroupPersonalPensionPlanUKMember 2021-01-01 2021-12-31 0001565228 2022-05-20 0001565228 us-gaap:SubsequentEventMember 2023-01-11 0001565228 us-gaap:SubsequentEventMember 2023-01-10 2023-01-10 0001565228 us-gaap:SubsequentEventMember 2023-01-11 2023-01-11 0001565228 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember VISL:CustomerOneMember 2021-01-01 2021-12-31 0001565228 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember VISL:OneVendorMember 2022-12-31 0001565228 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember VISL:OneVendorMember 2022-01-01 2022-12-31 0001565228 us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember VISL:OneVendorMember 2021-12-31 0001565228 srt:NorthAmericaMember 2022-01-01 2022-12-31 0001565228 srt:NorthAmericaMember 2021-01-01 2021-12-31 0001565228 srt:SouthAmericaMember 2022-01-01 2022-12-31 0001565228 srt:SouthAmericaMember 2021-01-01 2021-12-31 0001565228 srt:EuropeMember 2022-01-01 2022-12-31 0001565228 srt:EuropeMember 2021-01-01 2021-12-31 0001565228 srt:AsiaMember 2022-01-01 2022-12-31 0001565228 srt:AsiaMember 2021-01-01 2021-12-31 0001565228 VISL:RestOfWorldMember 2022-01-01 2022-12-31 0001565228 VISL:RestOfWorldMember 2021-01-01 2021-12-31 0001565228 VISL:EquipmentSalesMember 2022-01-01 2022-12-31 0001565228 VISL:EquipmentSalesMember 2021-01-01 2021-12-31 0001565228 VISL:InstallationIntegrationAndRepairsMember 2022-01-01 2022-12-31 0001565228 VISL:InstallationIntegrationAndRepairsMember 2021-01-01 2021-12-31 0001565228 VISL:WarrantiesMember 2022-01-01 2022-12-31 0001565228 VISL:WarrantiesMember 2021-01-01 2021-12-31 0001565228 VISL:OtherMember 2022-01-01 2022-12-31 0001565228 VISL:OtherMember 2021-01-01 2021-12-31 0001565228 country:US 2022-12-31 0001565228 country:US 2021-12-31 0001565228 country:NL 2022-12-31 0001565228 country:NL 2021-12-31 0001565228 country:GB 2022-12-31 0001565228 country:GB 2021-12-31 0001565228 VISL:VendorMember 2022-01-01 2022-12-31 0001565228 VISL:VendorMember 2021-01-01 2021-12-31 0001565228 VISL:PayrollProtectionProgramMember 2022-01-01 2022-12-31 0001565228 VISL:PayrollProtectionProgramMember 2021-01-01 2021-12-31 0001565228 VISL:ConsultingAgreementMember 2021-01-01 2021-12-31 0001565228 VISL:DividendsPayableMember 2022-01-01 2022-12-31 0001565228 VISL:DividendsPayableMember 2021-01-01 2021-12-31 0001565228 VISL:VendorMember 2021-03-10 0001565228 VISL:VendorMember 2021-03-10 2021-03-10 0001565228 VISL:PayrollProtectionProgramMember 2021-07-26 2021-07-26 0001565228 us-gaap:CommonStockMember 2022-05-04 2022-05-04 0001565228 us-gaap:CommonStockMember 2022-07-19 2022-07-19 0001565228 us-gaap:CommonStockMember 2022-07-19 0001565228 us-gaap:CommonStockMember 2022-05-04 0001565228 2022-11-21 0001565228 us-gaap:SeriesAPreferredStockMember 2022-11-21 2022-11-21 0001565228 us-gaap:DomesticCountryMember 2021-12-31 0001565228 us-gaap:DomesticCountryMember VISL:CarriedForwardIndefinitelyMember 2020-12-31 0001565228 us-gaap:StateAndLocalJurisdictionMember 2020-12-31 0001565228 us-gaap:ForeignCountryMember 2020-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:GBP utr:sqft iso4217:AED iso4217:EUR

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

(Mark One)

 

  ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended December 31, 2022

or

 

  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from__________ to__________

 

Commission File Number: 001-35988

 

Vislink Technologies, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   20-5856795
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)

 

350 Clark Drive, Suite 125,

Mt. Olive, NJ 07828

(Address of principal executive offices) (Zip Code)

 

(Registrant’s telephone number, including area code): (908) 852-3700

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class:   Name of each exchange on which registered:
Common Stock, par value $0.00001   The Nasdaq Capital Market

 

Securities registered pursuant to Section 12(g) of the Act:

 

None

(Title of class)

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Act. Yes ☐ No

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter periods that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically on its corporate Web site, if any, every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for a such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of the registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer Smaller reporting company
  Emerging growth company

 

If an emerging growth company, indicate by a check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No

 

As of June 30, 2022, the last business day of the registrant’s most recently completed second fiscal quarter, the aggregate market value of the common stock held by non-affiliates of the registrant was approximately $28.4 million based on the closing price of $0.60 for the registrant’s common stock as quoted on the Nasdaq Capital Market on that date. Shares of common stock held by each director, each officer, and each person who owns 10% or more of the outstanding common stock have been excluded from this calculation in that such persons may be deemed affiliates. The determination of affiliate status is not necessarily conclusive.

 

The registrant had 47,619,317 shares of its common stock outstanding as of March 16, 2023.

 

 

 

 
 

 

VISLINK TECHNOLOGIES, INC.

FORM 10-K

ANNUAL REPORT

For the Fiscal Year Ended December 31, 2022

 

TABLE OF CONTENTS

 

      Page
PART I    
  Item 1. Business 4
  Item 1A. Risk Factors 14
  Item 1B. Unresolved Staff Comments 31
  Item 2. Properties 31
  Item 3. Legal Proceedings 31
  Item 4. Mine Safety Disclosures 31
PART II    
  Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities 32
  Item 6. Reserved 32
  Item 7. Management’s Discussion and Analysis of Financial Conditions and Results of Operations 33
  Item 7A. Quantitative and Qualitative Disclosures About Market Risk 44
  Item 8. Financial Statements and Supplementary Data 44
  Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure 44
  Item 9A. Controls and Procedures 44
  Item 9B. Other Information 45
  Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 45
PART III    
  Item 10. Directors, Executive Officers, and Corporate Governance 46
  Item 11. Executive Compensation 46
  Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 46
  Item 13. Certain Relationships and Related Transactions, and Director Independence 46
  Item 14. Principal Accountant Fees and Services 46
PART IV    
  Item 15. Exhibits, Financial Statement Schedules 47
SIGNATURES 51
FINANCIAL STATEMENTS F-1

 

2
 

 

FORWARD-LOOKING INFORMATION

 

This Annual Report on Form 10-K (including the section regarding Management’s Discussion and Analysis of Financial Condition and Results of Operations) (the “Report”) contains forward-looking statements regarding our business, financial condition, results of operations, and prospects. Words such as “expects,” “anticipates,” “intends,” “plans,” “believes,” “seeks,” “estimates,” and similar words and phrases are intended to identify forward-looking statements. However, this is not an all-inclusive list of words or phrases identifying forward-looking statements in this Report. Also, all information concerning future matters is forward-looking statements.

 

Although forward-looking statements in this Report reflect our management’s good faith judgment, such information can only be based on facts and circumstances currently known by us. Forward-looking statements are inherently subject to risks and uncertainties, and actual results and outcomes may differ materially from those discussed or anticipated by the forward-looking statements. Without limitation, factors that could cause or contribute to such differences in results and outcomes include those discussed elsewhere in this Report.

 

We file reports with the Securities and Exchange Commission (“SEC”), and those reports are available free of charge on our website (www.vislinktechnologies.com) under “About/Investor Information/SEC Filings.” The reports available include our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports, which are available as soon as reasonably practicable after we electronically file such materials or furnish them to the SEC. You can also read and copy any materials we file with the SEC at the SEC’s Public Reference Room at 100 F Street, N.E., Washington, DC 20549. You can obtain additional information about the Public Reference Room’s operation by calling the SEC at 1-800-SEC-0330. The SEC also maintains an Internet site (www.sec.gov) containing reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC, including us.

 

We undertake no obligation to revise or update any forward-looking statements to reflect any event or circumstance that may arise after the date of this Report. We urge you to carefully review and consider all the disclosures made in this Report.

 

3
 

 

PART I

 

Item 1. Business

 

Overview

 

Vislink, incorporated in Delaware in 2006, is a global technology business specializing in collecting, delivering, and managing high-quality, live video and associated data from the action scene to the viewing screen. Vislink provides solutions for collecting live news, sports, entertainment, and news events for the broadcast markets. Vislink also furnishes the surveillance and defense markets with real-time video intelligence solutions using various tailored transmission products. The Vislink team also provides professional and technical services utilizing a staff of technology experts with decades of applied knowledge and real-world experience in the terrestrial microwave, satellite, fiber optic, surveillance, and wireless communications systems delivering a broad spectrum of customer solutions.

 

Live Broadcast:

 

Vislink delivers an extensive portfolio of solutions for live news, sports, and entertainment industries. These solutions include video collection, transmission, management, and distribution via microwave, satellite, cellular, I.P. (Internet Protocol), MESH, and bonded cellular/5G networks. We also provide solutions utilizing A.I. (Artificial Intelligence) technologies to provide automated news and sporting events coverage. With over 50 years in operation, Vislink has the expertise and technology portfolio to deliver fully integrated, seamless, end-to-end solutions.

 

Industry-wide contributors acknowledge Vislink’s live broadcast solutions. The transmission of most of all outside wireless broadcast video content uses our equipment, with over 200,000 systems installed worldwide. We work closely with the majority of the world’s broadcasters. Vislink wireless cameras and ultra-compact encoders help bring many of the world’s most prestigious sporting and entertainment events to life. Recent examples include globally watched international sporting contests, award shows, racing events, and annual music and cultural events.

 

Military And Government:

 

Vislink has developed high-quality solutions to meet surveillance and defense markets’ operational and industry challenges based on our knowledge of live video delivery. Vislink solutions are specifically designed with interagency cooperation, utilizing the internationally-recognized I.P. platform and a web interface for video delivery. Vislink provides comprehensive video, audio, and data communications solutions to law enforcement and the public safety community, including Airborne, Unmanned Systems, Maritime, and Tactical Mobile Command Posts. These solutions may include:

 

integrated suites of airborne downlink transmitters, receivers, and antenna systems
data and video connectivity for airborne, marine, and ground assets
UAV video distribution
flexible support for COFDM and bonded cellular/5G Networks
terrestrial point-to-point
tactical mobile command
IP-based, high-end encryption, full-duplex, real-time connectivity at extended operating ranges
high-throughput air/marine/ground-to-anywhere uplink and downlink systems
secure live streaming platforms for use in mobile and fixed assets
personal portable products

 

Vislink public safety and surveillance solutions are deployed worldwide, including throughout the U.S., Europe, and the Middle East, at the local, regional, and federal levels of operation, criminal investigation, crisis management, mobile command posts, and field operations. These solutions are designed to meet the demands of field operations, command centers, and central receiving sites. Short-range and long-range solutions are available in areas including established infrastructure and exceptionally remote regions, making valuable video intelligence available regardless of location.

 

Satellite Communications:

 

Over 30 years of technical expertise support Vislink’s satellite solutions. These solutions ensure robust, secure communications while delivering low transmission costs for any organization that needs high-quality, reliable satellite transmission. We offer turnkey solutions that begin with state-of-the-art coding, compression, and engine modulation and end with our robust, lightweight antenna systems. Vislink Satellite solutions focus heavily on being the smallest, lightest, and most efficient in their categories, making transportation and ease of use a key driver in the customer experience. Vislink offers an extensive range of satellite designs that allow customers to optimize bit rate, size, weight, and total cost. Our satellite systems are used extensively globally, with over 2,000 systems deployed by governments, militaries, and broadcasters. While we continue offering satellite solutions, we no longer invest in the engineering and product development necessary to stay relevant in the sector. We will continue to market and sell our current solutions but do not anticipate introducing further upgrades or features to our satellite product line.

 

4
 

 

Connected Edge Solutions:

 

Vislink offers the hardware and software solutions needed to acquire, produce, contribute, and deliver video over all private and public networks with the Mobile Viewpoint acquisition. Connected edge solutions aid the video transport concept of ubiquitous IP networks and cloud-scale computing across 5G, WiFi6, Mesh, and COFDM-enabled networks. These solutions include:

 

  Live video encoding, stream adaptation, decoding, and production solutions
  Remote production workflows
  Wireless cameras
  AI-driven automated production
  Ability to contribute video over:
    Bonded cellular (3G and 4G)
    Satellite
    Fiber
    Emerging networks, including 5G and Starlink

 

Our Strategy

 

Our participation in the Live Production, Mil/Gov, and Satellite sectors allows us to offer various end-to-end, high-reliability, high-data-rate, long-range wireless video transmission solutions.

 

We use our solutions for applications in growing market segments, including in-game sports, mobile video feeds, real-time capture and display footage from drones and other aerial platforms, and rapid-response electronic newsgathering operations.

 

The acquisition of Mobile Viewpoint (“MVP”) in August 2021 is a component of our strategy to provide an industry-leading portfolio of live video acquisition, contribution, and distribution solutions that meet the demanding needs of media, enterprise, defense, and government organizations. Vislink and its customers will benefit from the ability to address the most transformative trends in today’s live video market, such as:

 

  Live internet video traffic is growing fast: from 2016 to 2021, there was a 15-fold increase in live video internet traffic (71.9% CAGR);
  The acceleration towards cloud-based remote production;
  The increasing demand for enhanced video content formats such as 4K, 8K, and 360-degree video; and
  The proliferation of new video transport capable networks such as 5G and Starlink.

 

The acquisition will permit the Company to expand its offerings, which serve the most of these transformative live video trends and bring high-quality live production economically to the previously challenging presentation of historical events involving amateur and semi-pro athletics. MVP’s technology enhances our go-to-market strategy as we seek to take advantage of new technologies such as 5G and other new networks and machine learning, which we believe are revolutionizing how video is generated and transported.

 

5
 

 

Market

 

Our services and product offerings broadly address Live Production, Mil/Gov, and Satellite markets.

 

Among the new subsections of the sports and entertainment market, the Company has identified the burgeoning e-sports live-streaming applications markets as those where our solutions have applicability. The Live Production market is focused on applying more agile wireless video systems for live production and broadcast of sports, entertainment, and news events. Drivers in this market include small, lightweight, easy-to-use equipment, low-latency video systems, reliability of the wireless links, and the ability to use licensed and unlicensed bands. Current trends within the market reduce the size of these products further and improve the wireless video systems’ agility as users demand higher link reliabilities at longer ranges. There is also an increased desire to provide audiences with new views and camera angles to enhance the viewing experience. We address this need by incorporating 4K, HDR, and other emerging video technologies.

 

The Live Production market’s broadcast news sector looks to improve operational efficiencies in gathering, producing, and transmitting wireless content. Recent trends in the market include a movement towards I.P. connectivity over point-to-point links for infrastructure, high-definition upgrades of remote newsgathering vehicles, and continued pressure to reduce expenses by improving operational efficiencies. Vislink focuses on the specific ways these customers create and gather content wirelessly. As the wireless communications industry begins transitioning to fifth-generation (5G) networks, the speed increases they will usher in expect to augment the availability of on-demand live streaming, where Vislink equipment is already in use.

 

The Mil/Gov market comprises vital segments, including state and local law enforcement agencies, federal agencies, and military system integrators. The market looks to improve video content’s reliability and quality without adding complexity and omitting technical intervention while operating video systems. State and local agencies benefit from the Department of Homeland Security grant programs to improve overall security. Recent trends within these segments include improved interoperability within agencies and demand for fully integrated systems, including robust microwave combined with ubiquitous I.P. networks; as the wireless video systems become more reliable and straightforward to deploy, the wireless systems’ option rate increases. Customers within this market include state police forces, sheriff’s departments, fire departments, first responders, the Department of Justice, and Homeland Security.

 

The drive to experience more and better visual communication systems impacts the Satellite market. Live T.V. broadcasting over satellite, and other connectivity types continues to be driven by cost-per-bit economics. Uplink operators are keen to reduce their OPEX costs by investing in greater transmission efficiency via compression and modulation approaches. There is also an interest in high-rate I.P. connectivity products and the desire for fully integrated solutions that enable remote live content capture, production, broadcast, and distribution. While we continue offering satellite solutions, we no longer invest in the engineering and product development necessary to stay relevant in the sector. We will continue to market and sell our current solutions but do not anticipate introducing further upgrades or features to our satellite product line.

 

6
 

 

Our Products and Solutions: Overview

 

We offer a full spectrum of wireless video products built around providing complete solutions. We have traditionally focused on developing core product technologies in final assembled products that cross-market segments. Such technology focus areas include R.F., Live Streaming, and microwave component development spanning the frequency range from D.C. to 18GHz, waveform modulation, advanced video encoding (HEVC) and decoding, 4K UHD (Ultra High Definition) camera systems, and digital signal processing. Through these products, we are positioned with significant technology I.P. and an established reputation for rapidly and economically delivering complex, bespoke engineering products and solutions to customers that are expertly managed to tight deadlines. Production of these products can quickly be scaled to respond to changes in market demand.

 

Live Production Products and Solutions

 

Vislink Live Production Solutions include high-definition communication links that reliably capture, transmit and manage live event footage. We offer a line of high-margin wireless camera transmitter and receiver products that may be interconnected over I.P. networks, expanding and simplifying their widespread use and significantly reducing deployment costs. HCAM is a 4K Ultra HD-capable on-camera wireless system designed to cover significant events among our transmitter products. Our flagship receiver product is the Quantum Receiver. The Quantum is an ultra-low latency, waveform agnostic central receiver representing the Vislink premier receiver in all market verticals, including MilGov. Features include HEVC quad signal decode, seamless geographical coverage, and an I.P. stream engine with cloud integration possibilities, OTT, and social media platforms. IP Link 3.0 is a studio-transmitter link system that enables broadcasting service platforms to access new monetization opportunities. Other essential receiver products include the ViewBack, CRx6, and CIRAS-X6. ViewBack is a lightweight, low-power, low latency, dual-channel diversity receiver-decoder that enables quicker production, more efficient editing, and more effective collaboration between camera operators and studio teams. We also offer ultra-compact onboard solutions integrating our MDR (Multi-Channel Diversity Receive System) technology with ruggedized support components designed to capture video from high-speed motorsports.

 

7
 

 

As a result of our acquisition of Mobile Viewpoint, we also offer a portfolio of products that includes the WMT line of mobile encoders and TerraLink rack encoders for live streaming over 4G and 5G, and systems developed using AI technologies for the automated coverage of news and sports productions., The TrolleyLive RemotePro is an all-in-one production unit for remote live broadcasts. LinkMatrix is a central platform for managing all devices and synchronizing all data sources.

 

 

Quantum

 

 

IP Link 3.0

 

 

WMT BaseLink Encoder

 

 

TerraLink 4CM Rack Encoder

 

 

TrolleyLive Remote Pro

 

8
 

 

Mil/Gov Products and Solutions

 

In the Mil/Gov sector, Vislink has focused on supplying miniature transmitters and handheld receivers for tactical surveillance and benefits from limited competition in this area. The HHT3 and Mobil Commanders are handheld receivers/monitors designed for tactical situations.

 

The Airborne Video Downlink System (AVDS) is a comprehensive aerial-based video transmission solution that delivers real-time surveillance to enhance law enforcement, emergency, and critical infrastructure operations. It includes an integrated suite of downlink transmitters, receivers, and antennas that capture real-time, reliable high-definition video from drones, helicopters, and other aircraft for display at command centers, mobile units, and video management systems. AVDS allows an unlimited number of observers to view the video over any network connection, including wired Ethernet, Wi-Fi, I.P. satellite, and I.P. cellular. AeroLink is an aircraft-based transmitter unit that provides bi-directional data transmission and is tightly integrated with other elements of the Vislink AVDS, including the Quantum and other Vislink central receivers. In addition to supporting Mil/Gov applications, AeroLink supports broadcast/ENG applications for transmitting air-based feeds from breaking news and sporting events.

 

 

HHT3

 

 

Mobil Commander

 

 

AeroLink

 

9
 

 

Satellite Products and Solutions

 

Our top satellite product has historically been MSAT, a highly portable tri-band satellite antenna system designed for rapid deployment in challenging environments. The Vislink Satellite product line features terminals ranging from 65cm man-portable systems to 2.4m flyaway and driveaway systems, all available in multiple satellite band configurations. Other Vislink Satellite products include the DVE6100 encoder and IRD6200 decoder electronics units complementing our satellite terminals. They support 4k UHD transmissions and deliver significant bandwidth efficiencies to satellite communications.

 

 

MSAT

 

 

 

DVE6100

 

10
 

 

Competition and Competitive Positioning

 

Vislink believes its primary competitors are Domo Tactical Communications (formerly a division of Cobham), Silvus Technologies, Persistent Systems, Troll Systems, and several smaller market-specific businesses.

 

We believe that Vislink represents one of the market share leaders in the professional broadcast and media video transmission sector. We have successfully leveraged our history of broadcast industry leadership, reputation for advanced technology, and the ability to provide end-to-end solutions to maintain and increase our customer base and continue delivering highly competitive offerings. Our products solve a growing market need for regular, high-definition, wireless video communications. Many of our product offerings address applications in growing market segments, including in-game sports-video mobile feeds, real-time capture and display footage from drones and other aerial platforms, and rapid-response electronic newsgathering operations.

 

Since completing the global rebranding of our solutions under the single Vislink entity in 2018 and the acquisition of MVP in 2021, we believe we can now offer an expanded range of product offerings, additional services, and enhanced capabilities. We believe this expansion of product offerings will position us for continued growth in Live Production and Mil/Gov markets. We continue to market and sell satellite solutions but do not anticipate investing in the engineering and development necessary to offer additional upgrades or features to our current products. We seek to improve margins and control product quality and competitive agility as we refine our production processes.

 

Sales and Marketing

 

Our sales team comprises sales managers responsible for defined regional areas, inside sales personnel, and business development representatives focused on targeted sectors and regions, supported by solution engineers trained in technical sales with a given market focus. The sales team focuses on helping current customers and nurturing relationships with prospective customers in key domestic and international markets. We employ a combination of sales channels, including direct-to-end customer sales, network group sales, reseller/integrators, and Original Equipment Manufacturer (“OEM”) sales channels to use the most efficient means of reaching customers depending on the market segment. Marketing and public relations activities, digital and print marketing initiatives, the creation of support materials, trade shows, and other event appearances support our sales efforts.

 

As of December 31, 2022, our business development, sales, and marketing team comprised 22 full-time employees and 4 contractors.

 

Customers

 

Vislink has developed a significant following based on our product offerings’ reputation for performance, reliability, and advanced technology use. We believe we have developed a diverse and stable customer base among blue-chip, tier-1 clients in Live Production markets and high-profile agencies and organizations in Mil/Gov and Satellite markets.

 

Manufacturing and Suppliers

 

We utilize a combination of external contract manufacturers and internal resources to manufacture, test, assure the quality of, and ship our products, allowing us to develop optimal supply chains tailored to our needs on a per-product and per-solution basis. As we advance, we anticipate focusing on our core strengths: innovation and technology design and developing, creating, and exploiting our intellectual property.

 

We may continue to rely upon third-party components and technology to build our products, particularly in the short term, as we procure components, subassemblies, and products necessary to manufacture our products based on our design, development, and production needs. While parts and supplies are generally available from various sources, we currently depend on a single or limited number of suppliers for several components for our products. We rely on purchase orders rather than long-term contracts with our suppliers. A delay in production could result if a supply disruption of critical components required us to re-engineer our products to incorporate alternate features.

 

11
 

 

Intellectual Property

 

We have developed a broad intellectual property portfolio covering wired and wireless communications systems. As of December 31, 2022, we have 17 patents granted in the United States, no patent applications pending, no provisional applications pending, and one disclosure. Internationally, we have two patents granted, no patent applications pending, and no Patent Cooperation Treaty (PCT) applications.

 

Areas of our development activities that have culminated in filings and/or awarded patents include:

 

  Self-Organizing Networks;
  R.F. Modulation;
  Compression (protocols, payload, signaling, etc.);
  Modulators/Demodulators;
  Antennas/Shielding;
  Wired and Wireless Networks;
  Media Access Control Protocols; and
  Interference Mitigation.

 

We protect our intellectual property rights by relying on federal, state, and common law rights and contractual restrictions. We control access to our proprietary technology by entering confidentiality and invention assignment agreements with our employees and contractors and confidentiality agreements with third parties. We also actively monitor activities concerning infringing uses of our intellectual property by third parties.

 

In addition to these contractual arrangements, we rely on a combination of the trade secret, copyright, trademark, trade dress, domain name, and patents to protect our products and other intellectual property. We own a substantial portion of the copyright interests in the software code used in connection with our products and the brand or title name trademark under our marketed products. We pursue our domain names, trademarks, and service marks in the United States and locations outside the United States. Our registered trademarks in the United States include “xG,” “IMT,” “Vislink,” “Mobile Viewpoint,” and the names of our products, among others.

 

Circumstances outside our control could pose a threat to our intellectual property rights. For example, adequate intellectual property protection may not be available in the United States or other countries where our products are sold or distributed. Also, our efforts to protect our proprietary rights may not be adequate. Any significant impairment of our intellectual property rights could harm our business or our ability to compete. Also, protecting our intellectual property rights is costly and time-consuming. Any unauthorized disclosure or use of our intellectual property could make it more expensive to do business, harming our operating results.

 

Mobile wireless communications technology and other industries may own many patents, copyrights, and trademarks. They may frequently request license agreements, threaten litigation, or file a suit against us based on infringement allegations or other violations of intellectual property rights. We may face third-party claims that our competitors and non-practicing entities infringe on their trademarks, copyrights, patents, and other intellectual property rights. As our business grows, we might face more claims of infringement.

 

12
 

 

Company Information

 

Effective February 11, 2019, xG Technology, Inc. changed its name to Vislink Technologies, Inc. Our predecessor company was initially incorporated in Delaware in 2006. Our executive offices are at 350 Clark Dr., Suite 125, Mt. Olive, NJ 07828, and (908) 852-3700 is the telephone number. Our website address is www.vislink.com. Our website’s information is not part of the report and is only for informational purposes.

 

Human Capital

 

Overall

 

Our business results depend partly on our ability to successfully manage our human capital resources, including attracting, identifying, and retaining key talent. As of December 31, 2022, we employed 109 full-time employees and 4 independent contractors, including 23 in development, two officers, 13 in general and administrative, one in business development, 44 in operations, and 22 in sales and marketing. As a global industrial technology company, many of our employees are engineers or trained trade or technical workers focusing on advanced manufacturing, and many possess advanced college degrees. No labor union represented our employees at any of our worldwide facilities as of December 31, 2022.

 

The Company emphasizes several measures and objectives in managing its human capital assets, including, among others, employee safety and wellness, talent acquisition and retention, employee engagement, development and training, diversity and inclusion, and compensation. These targeted ideals vary by country/region and may include annual bonuses, stock-based compensation awards, a 401(k) plan with employee matching opportunities, healthcare, and insurance benefits, health savings and flexible spending accounts, paid time off, family leaves, family care resources, employee assistance programs, and tuition assistance. We also provide our employees access to various innovative, flexible, and convenient health and wellness programs. We designed these programs to support employees’ physical and mental health by providing tools and resources to improve or maintain their health status and encourage engagement in healthy behaviors. We consider our employee relations generally to be good.

 

Covid-19

 

During the COVID-19 pandemic, our employees’ safety remained vital to us. Our response to the global pandemic efforts included implementing health-related protocols that we consider prudent. The Company continues to maintain policies relating to housekeeping, [visitation restrictions, social distancing], sanitization, hygiene, and respiratory etiquette. We retain employee leave policies and accommodations, remote working opportunities and infrastructure, and protocols for not reporting to work and/or when to return to work upon potential and/or confirmed COVID-19 exposure or infection. The use of personal protective equipment is an employee choice and optional for visitors to Company facilities. We support employees’ physical and mental health by providing tools and resources to improve or maintain their health status and encourage engagement in healthy behaviors.

 

13
 

 

Item 1A. Risk Factors

 

In addition to the other information in this Form 10-K, readers should consider the following essential factors carefully. These factors, among others, in some cases, have affected, and in the future could affect, our financial condition and results of operations and could cause our future results to differ materially from those expressed or implied in any forward-looking statements that appear in this Form 10-K or that we have made or will make elsewhere.

 

Risk Factor Summary

 

The following summarizes certain factors that may make our company’s investment speculative or risky. You should carefully consider the entire risk factor disclosure outlined in this Annual Report, in addition to the other information herein, including the section of this Report titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and our financial statements and related notes.

 

  We have incurred losses in the past and may be unable to achieve or sustain profitability in the future.
  We may need to raise additional capital to fund our existing commercial operations, develop and commercialize new products and expand our operations.
  If we cannot regain or maintain compliance with Nasdaq’s applicable continued listing requirements or standards, Nasdaq could delist our Common Stock.
  We face risks related to COVID-19, which could significantly disrupt our operations and adversely impact us and our business.
  We may require additional capital to develop and market new products. If we do not obtain additional financing, our business prospects, financial condition, and results of operations will be adversely affected if required.
  Our industry is highly competitive, and we may not compete effectively.
  Defects or errors in our products and services or products made by our suppliers could harm our brand and relations with our customers and expose us to liability. If we experience product recalls, we may incur significant expenses and experience decreased demand for our products.
  We acknowledge material weaknesses in the controls and procedures of our financial reporting. In the future, we may identify additional material weaknesses that may cause us to fail to meet our reporting obligations, including timeliness, or result in material misstatements of our financial statements.
  We rely on key executive officers, and their knowledge of our business and technical expertise would be difficult to replace.
  We purchase some components, subassemblies, and products from a limited number of suppliers. The loss of these suppliers may substantially disrupt our ability to obtain orders and fulfill sales as we design and qualify new components.
  Our intellectual property protections may be insufficient to safeguard our technology adequately.
  We may be subject to claims of intellectual property infringement or invalidity. Expenses incurred for monitoring, protecting, and defending our intellectual property rights could adversely affect our business.
  Enforcement of our intellectual property rights abroad, particularly in China, is limited, and it is often difficult to protect and enforce such rights.
  The intellectual property rights of others may prevent us from developing new products or entering new markets.
  We may be subject to infringement claims in the future.
  If our technology did not work as planned or was unsuccessful in developing and selling new products or penetrating new markets, our business and operating results would suffer.
  Demand for our defense-related products and products for emergency response services depends on government spending.
  Regulation of the telecommunications industry could harm our operating results and prospects.
  New regulations or standards or changes in existing laws or standards in the United States or internationally related to our products may result in unanticipated costs or liabilities, which could have a material adverse effect on our business, results of operations, and future sales, and could place additional burdens on the operations of our business.
  Our industry is subject to rapid technological change, and we must make substantial investments in new products, services, and technologies to compete successfully.
  At several of our annual stockholder meetings, including our 2019 Annual Meeting of Stockholders, we failed to obtain ratification by our stockholders of specific proposals submitted for approval of our stockholders at prior annual meetings, which could be deemed defective corporate acts.

 

14
 

 

Risks Related to the COVID-19 Pandemic

 

The COVID-19 pandemic has unfavorably affected the Company’s business, financial condition, and operating results and could affect the Company’s liquidity. We cannot predict, with any certainty, how future events may affect our operations in the near and long-term in the COVID-19 pandemic environment.

 

The COVID-19 pandemic and the continued measures to reduce its spread have negatively impacted the global economy, disrupted consumer/customer demand and supply chains, and created significant volatility and financial market disruption. These measures and the continued volatility of the worldwide economy adversely affected our results of operations for 2022.

 

The extent to which COVID-19 will impact our business remains uncertain and will depend on various changing factors on a day-to-day basis. We may not be able to predict such items accurately as:

 

  the duration and scope of the pandemic,
  the disruption of the national and global economy,
  the span of the economic downturn,
  the laws, programs, actions, and vaccine mandates that federal, state, and local governments will enact or take,
  the possibility to which our clients’ businesses contract or fail,
  the applicability to which new regulations intended to help small and medium-sized businesses,
  the extent to which our operations are impacted by facility closures, remote work, and/or infections,
  and how quickly and to what time normal economic and operating conditions can resume.

 

These factors could exacerbate the risks and uncertainties related to the COVID-19 pandemic.

 

Risks Related to the Company and Our Business

 

We have incurred losses in the past and may be unable to achieve or sustain profitability in the future.

 

We have incurred net losses since inception, including net losses of $13.6 million and $16.4 million for the years ended December 31, 2022, and 2021, respectively. As a result of ongoing losses, as of December 31, 2022, we had an accumulated deficit of $300.1 million and $25.6 million of cash. We expect to continue to incur significant sales and marketing, product development, regulatory and other expenses as we seek to expand existing relationships with our customers, obtain new customers, reach new markets, and develop new products or add new features to our existing products. Our net income (loss) may fluctuate significantly from fiscal period to period. We will need to generate significant additional revenues and/or cost-cutting to achieve and sustain profitability, and even if we achieve profitability, we cannot be sure that we will remain profitable for any substantial period of time. Our failure to achieve or maintain profitability could negatively impact the value of our common stock.

 

15
 

 

We may need to raise additional capital to fund our existing commercial operations, develop and commercialize new products and expand our operations.

 

Suppose our available cash balances, potential borrowing capacity, and anticipated cash flow from operations are insufficient to satisfy our liquidity requirements, including because of lower demand for our products, whether as a result of the risks described in this Annual Report on Form 10-K or otherwise, we may seek to sell common or preferred equity or debt securities, other forms of third-party funding or seek debt financing. Our current and future funding requirements will depend on many different factors, including:

 

our ability to achieve revenue growth and improve operating margin;

 

the cost of expanding our operations and offerings, including our sales and marketing efforts;
our rate of progress in, and cost of the sales and marketing activities associated with, establishing adoption of our products and maintaining or improving our sales to our current customers;
the cost of research and development activities, including research and development relating to new products and technologies or features for existing products;
the effect of competing technological and market developments;
costs related to international expansion; and
the potential cost and delays resulting from regulatory oversight of our business and products.

 

We may also consider raising additional capital in the future to expand our business, pursue strategic investments, take advantage of financing opportunities, or for other reasons, including:

 

expand our sales and marketing efforts to increase market adoption of our products and address competitive developments;
fund development and marketing efforts of any future products or additional features to then-current products;
acquire, license, or invest in new technologies;
provide for supply and inventory costs associated with plans to accommodate potential increases in demand for our products;
acquire or invest in complementary businesses or assets; and
finance capital expenditures and general and administrative expenses.

 

Additional capital may not be available to us at such times or in needed amounts. Even if capital is available, it might be available only on unfavorable terms. Any issuance of additional equity or equity-linked securities could be dilutive to our existing stockholders, and any new equity securities could have rights, preferences, and privileges superior to those of holders of our common stock. Debt financing, if available, may involve covenants restricting our operations or our ability to incur additional debt, pay dividends, repurchase our stock, make investments, and engage in merger, consolidation, or asset sale transactions. If we raise additional funds through collaboration and licensing arrangements with third parties, it may be necessary to relinquish or license some rights to our technologies or products on terms that are not favorable to us. If access to sufficient capital is not available as and when needed, our business will be materially impaired, and we may be required to cease operations, curtail one or more product development or expansion programs, significantly reduce expenses, sell assets, seek a merger or joint venture partner, file for protection from creditors or liquidate all our assets.

 

We face risks related to COVID-19, which could significantly disrupt our operations and adversely impact us and our business.

 

The enduring effect of the COVID-19 pandemic, including the advent of Delta and Omicron variants, plus the uncertainty of possible future variants, may subject the Company to particular challenges in its business, financial condition, results of operations, and cash flows. The timing and efficacy of the vaccination programs in the jurisdictions in which the Company operates and the actions implemented to contain the impact of COVID-19 by Federal and local governments limit determining the foreseeable resulting economic effects with any level of predictability.

 

We may require additional capital to develop and market new products. If we do not obtain additional financing, our business prospects, financial condition, and results of operations will be adversely affected if required.

 

We may require additional capital to develop new products in the future, and we may not be able to secure adequate additional financing when needed on acceptable terms or at all. To execute our business strategy, we may issue additional equity securities in public or private offerings, potentially at discounts to the current or future market price of our Common Stock. If we cannot secure additional funding, we may be forced to forego strategic opportunities or delay, scale back, and eliminate future product development.

 

Our industry is highly competitive, and we may not compete effectively.

 

The communications industry is highly competitive, rapidly evolving, and constantly technological change. We expect that new competitors are likely to join existing competitors. Many of our competitors may be larger and have more excellent financial, technical, operational, marketing, and other resources and experience than we do. If a competitor expends significant resources, we may not compete successfully. Also, the pace of technological change makes it impossible for us to predict whether we will face new competitors using different technologies to provide products. If our competitors were to offer better and more cost-effective products than our products, we might not be able to capture any significant market share.

 

16
 

 

Defects or errors in our products and services or products made by our suppliers could harm our brand and relations with our customers and expose us to liability. If we experience product recalls, we may incur significant expenses and experience decreased demand for our products.

 

Our products are inherently complex and may contain defects and errors that are only detectable when the products are in use. Because our products are used for personal and business purposes, such faults or errors could severely impact our end customers, damaging our reputation and customer relationships and exposing us to liability. Defects or impurities in our components, materials, or software, equipment failures, or other difficulties could adversely affect our customers’ ability to ship products on a timely basis and customer or licensee demand for our products. Any shipment delays or declines in demand could reduce our revenues and harm our ability to achieve or sustain desired levels of profitability. Our customers may also experience component or software failures or defects requiring significant product recalls, rework, and/or repairs not covered by warranty reserves.

 

We acknowledge material weaknesses in the controls and procedures of our financial reporting. In the future, we may identify additional material weaknesses that may cause us to fail to meet our reporting obligations, including timeliness, or result in material misstatements of our financial statements. If we continue to remediate our material weaknesses or implement effective controls and procedures for our financial reporting, our ability to accurately and timely report our financial results could be adversely affected, which would likely adversely affect the value of our Common Stock.

 

The Company’s management is responsible for establishing and maintaining internal controls over financial reporting. Internal Control Over Financial Reporting is a process designed by and under the supervision of the Company’s principal executive and principal financial officers, or persons performing similar functions, and effected by the Company’s Board, management, and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes under generally accepted accounting principles and includes those policies and procedures that:

 

  Pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company;
     
  Provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements following generally accepted accounting principles and that receipts and expenditures of the Company are being made only by authorizations of its management and Board; and
     
  Provide reasonable assurance regarding the prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on its financial statements.

 

Because of its inherent limitations, internal control over financial reporting is not intended to provide absolute assurance that a misstatement of our consolidated financial statements would be prevented or detected. Also, projections of any effectiveness evaluation to future periods are subject to the risks that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.

 

Our management evaluated the effectiveness of our internal control over financial reporting as of December 31, 2022, using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control-Integrated Framework (2013). In their assessment of the effectiveness of internal control over financial reporting as of December 31, 2022, management concluded that such control was ineffective and that there were control deficiencies that constituted material weaknesses because (i) we currently do not employ the appropriate number of accounting personnel to ensure (a) we maintain proper segregation of duties, (b) conduct a tolerable risk assessment, and (ii) we have not adequately documented a complete assessment of the effectiveness of the design and operation of our internal control over financial reporting.

 

We are designing and implementing measures to improve our internal control over financial reporting to remediate the material weaknesses related to our financial reporting as of December 31, 2022. Management has engaged a third-party consultant to identify and document our internal control deficiencies and provide an assessment of current controls and recommendations regarding remediation efforts to eliminate or mitigate the control deficiencies. Until we can remediate this situation, there are no assurances that the material weaknesses in our disclosure controls and procedures and internal control over financial reporting will not result in errors in our financial statements, which could lead to a restatement of those financial statements.

 

17
 

 

The Company is in the process of affecting the following:

 

  additional review procedures within our accounting and finance department,
  Implement application controls in our accounting system, and
  Implementing suitable accounting controls and processes.

 

If we cannot conclude on an ongoing basis that we have effective internal control over financial reporting under Section 404 of the Sarbanes Oxley Act of 2002, in that case, our independent registered public accounting firm may not issue an unqualified opinion or cause us to be untimely concerning our reporting obligations. If we cannot conclude that we have effective internal control over financial reporting, investors could lose confidence in our reported financial information, which could have a material adverse effect on the trading price of our common stock. Failure to remedy any material weakness in our internal control over financial reporting, or to implement or maintain other effective control systems required of public companies, could also restrict our future access to the capital markets. We will not fully correct the identified material weaknesses until the ongoing steps described above are effectively attained and operating efficiently for an appropriate time.

 

Our charter documents and Delaware law could prevent a takeover that stockholders consider favorable and reduce our Common Stock’s market price.

 

Our amended and restated certificate of incorporation (“Certificate of Incorporation”) and our Bylaws contain provisions that could delay or prevent a change in our Company’s control. These provisions could also make it more difficult for stockholders to elect directors and take other corporate actions. These provisions include:

 

  authorizing the Board to issue, without stockholder approval, preferred stock with rights senior to those of our Common Stock;
  limiting the persons who may call special meetings of stockholders; and
  they require advance notification of stockholder nominations and proposals.

 

Also, the provisions of Section 203 of the DGCL govern us. These provisions may prohibit large stockholders, particularly those owning 15% or more of our outstanding voting stock, from merging or combining with us for a specific time without our Board’s consent. These and other provisions in our Certificate of Incorporation and our Bylaws and under Delaware law could discourage potential takeover attempts, reduce the price that investors might be willing to pay in the future for shares of our Common Stock and result in the market price of our Common Stock being lower than it would be without these provisions.

 

Although our products may not cause users technical issues, our business and reputation may be harmed if users perceive our solutions to cause a slow or unreliable network connection or a high-profile network failure.

 

We expect our products to be in many different locations and user environments and can provide transmission of video, mobile broadband connectivity, and interference mitigation, among other applications. Our products’ ability to operate effectively can be negatively impacted by many different elements unrelated to our products. Although our products may not cause technical issues, users often may perceive the underlying cause of our technology’s poor performance. This perception, even if incorrect, could harm our business and reputation. Similarly, a high-profile network failure may be caused by improper operation or failure of a network component we did not supply. Still, other service providers may perceive that our products were implicated, which, even if incorrect, could harm our business, operating results, and financial condition.

 

18
 

 

Our ability to sell our products will be highly dependent on the quality of our support and service offerings, and our failure to offer high-quality support and services would adversely affect our sales and the results of operations.

 

Once our products are deployed, our channel partners and end customers will depend on our support organization to resolve any issues relating to our products. A high level of support will be necessary for our products’ successful marketing and sale. In many cases, our channel partners will likely provide support directly to our end customers, and we will not have complete control over the quality of the support supplied by our channel partners. These channel partners may also support other third-party products, potentially distracting resources from support for our products. Suppose our channel partners do not effectively assist our end customers in deploying our products, succeed in helping our end customers quickly, resolve post-deployment issues, or provide adequate ongoing support. In that case, our ability to sell our products to existing end customers could be adversely affected, and our reputation with potential end customers could be harmed. We sometimes guarantee a certain performance level to our channel partners and end customers, which could prove resource-intensive and expensive if unforeseen technical problems arise.

 

We are subject to increasing operating costs and inflation risks, which may adversely affect our performance.

 

While we attempt to offset increases in operating costs through various measures focused on increasing revenues, there is no assurance that we will do so. Therefore, operating expenses may rise faster than associated revenues resulting in a material adverse impact on our cash flow and margins.

 

We are also impacted by inflationary increases in wages and benefits, whether driven by competition for talent or ordinary course pay increases and other rising costs. Increases in the rate of inflation could also significantly impact our cost base. In all countries in which we operate, wage inflation, whether driven by competition for talent or ordinary course pay increases, may also increase our cost of providing services and reduce our profitability if we are not able to pass those costs on to our clients or charge premium prices when justified by market demand.

 

We are subject to increasing operating costs and inflation risks, which may adversely affect our performance.

 

While we attempt to offset increases in operating costs through various measures focused on increasing revenues, there is no assurance that we will do so. Therefore, operating expenses may rise faster than associated revenues resulting in a material adverse impact on our cash flow and margins.

 

We are also impacted by inflationary increases in wages and benefits, whether driven by competition for talent or ordinary course pay increases and other rising costs. Increases in the rate of inflation could also significantly impact our cost base. In all countries in which we operate, wage inflation, whether driven by competition for talent or ordinary course pay increases, may also increase our cost of providing services and reduce our profitability if we are not able to pass those costs on to our clients or charge premium prices when justified by market demand.

 

We may fail to recruit and retain qualified personnel.

 

We expect to rapidly expand our operations and grow our sales, development, and administrative functions. This expansion is expected to significantly strain our management and require hiring a considerable quantity of qualified personnel. Accordingly, recruiting and retaining such personnel in the future will be critical to our success. There is intense competition from other companies for qualified personnel in our activities. Suppose we fail to identify, attract, retain, and motivate this highly skilled personnel. In that case, we may be unable to continue our marketing and development activities, which could adversely affect our business, financial condition, results of operations, and prospects.

 

We rely on key executive officers, and their knowledge of our business and technical expertise would be difficult to replace.

 

We depend highly on our executive officers because of their expertise and experience in the telecommunications industry. We have agreements with our executive officers containing customary non-disclosure, non-compete, confidentiality, and assignment of inventions provisions. Our officers do not have “key person” life insurance policies. The loss of our key personnel’s technical knowledge, management, and industry expertise could result in delays in product development, loss of customers and sales, and diversion of management resources, adversely affecting our operating results.

 

19
 

 

We purchase some components, subassemblies, and products from a limited number of suppliers. The loss of these suppliers may substantially disrupt our ability to obtain orders and fulfill sales as we design and qualify new components.

 

We sometimes rely on third-party components and technology to build and operate our products, and until full integration with IMT and VCS, we may rely on our contract manufacturers to obtain the parts, subassemblies, and products necessary for the manufacture of our products. Shortages in components we use in our products are possible, and our ability to predict such components’ availability is limited. While parts and supplies are generally available from various sources, our contract manufacturers currently depend on a single or limited number of suppliers for several of our products. If our suppliers of these components or technology were to enter into exclusive relationships with other providers of wireless networking equipment or were to discontinue providing such components and technology to us, and we could not replace them cost-effectively or at all, our ability to provide our products would be impaired. Our contract manufacturers generally rely on purchase orders rather than long-term contracts with these suppliers.

 

Specific supply chains disruptions, such as the armed conflict between Russia and Ukraine, trade sanctions, and similar events, may also arise. It may be difficult for us to assess the ability of our suppliers to timely meet our demand in the future based on past performance. As a result, even if available, our contract manufacturers and we may not secure sufficient components at reasonable prices or acceptable quality to build our products on time. Therefore, we may be unable to meet customer demand for our products, adversely affecting our business, operating results, and financial condition.

 

We do not have long-term contracts with our existing contract manufacturers. The loss of any of our current contract manufacturers could adversely affect our business, operating results, and financial condition.

 

We do not have long-term contracts with our existing contract manufacturers. If any of our current contract manufacturers are unable or unwilling to manufacture our products in the future, the loss of such contract manufacturers could adversely affect our business, operating results, and financial condition.

 

Our intellectual property protections may be insufficient to safeguard our technology adequately.

 

Given the rapid pace of innovation and technological change within the wireless and broadband industries, our personnel, consultants, and contractors’ technical and creative skill and ability to develop, enhance, and market new products and upgrades to existing products are critical to continued success. Our success and ability to compete effectively depend on the proprietary technology we have developed internally. We rely primarily on patent laws to protect our proprietary rights. As of December 31, 2021, in the United States, we have 17 patents granted, no patent applications pending, and no provisional applications pending. Internationally, we have 2 patents granted and no patent applications pending. There can be no assurance that patents awaiting or future patent applications will be issued or that we would have the resources to protect any such issued patent from infringement if issued.

 

Further, we cannot patent much critical technology to our business. To date, we have relied on copyright, trademark, and trade secret laws, as well as confidentiality procedures, non-compete and/or work-for-hire invention assignment agreements, and licensing arrangements with our employees, consultants, contractors, customers, and vendors, to establish and protect our rights to this technology and, to the best extent possible, control the access to and distribution of our technology, software, documentation, and other proprietary information. Despite these precautions, it may be possible for a third party to copy or otherwise obtain and use this technology without authorization. Policing unauthorized use of this technology is challenging. There can be no assurance that our steps will prevent the misappropriation of or prevent unauthorized third parties from obtaining or using the technology we rely on. Also, adequate protection may be unavailable or limited in some jurisdictions. Litigation may be necessary in the future to enforce or protect our rights.

 

We may be subject to claims of intellectual property infringement or invalidity. Expenses incurred for monitoring, protecting, and defending our intellectual property rights could adversely affect our business.

 

Competitors and others may infringe on our intellectual property rights or allege we have violated theirs. If we are found to infringe on others’ rights, we could be required to discontinue offering certain products or systems, pay damages, or purchase a license to use the intellectual property in question from its owner. Monitoring infringement and misappropriation of intellectual property can be difficult and expensive, and we may be unable to detect infringement or misappropriation of our proprietary rights. We may also incur significant litigation expenses in protecting our intellectual property or defending our use of intellectual property, reducing our ability to fund product initiatives. These expenses could hurt our future cash flows and the results of operations. Litigation can also distract management from the day-to-day operations of the business.

 

20
 

 

Enforcement of our intellectual property rights abroad, particularly in China, is limited, and it is often difficult to protect and enforce such rights.

 

Many companies have encountered substantial intellectual property infringement in countries where we sell, or intend to sell, products or have our products manufactured. Patent protection outside the United States is generally not as comprehensive as in the United States and may not protect our intellectual property in some countries where our products are sold or may be sold in the future. Even if patents are granted outside the United States, effective enforcement may not be available in those countries.

 

In particular, the legal regime relating to China’s intellectual property rights is limited, and it is often difficult to protect and enforce such rights. The regulatory scheme for implementing China’s intellectual property laws may not be as developed as other countries’ regulatory schemes. Any advancement of an intellectual property enforcement claim through China’s regulatory system may require extensive time, allowing intellectual property infringers to continue mostly unimpeded, to our commercial detriment in the Chinese and other export markets. Also, rules of evidence may be unclear, inconsistent, or difficult to comply with, making it difficult to prove infringement of our intellectual property rights. As a result, enforcement cases involving technology, such as copyright infringement of software code or unauthorized manufacture or sale of products containing patented inventions, may be difficult or impossible to sustain.

 

These factors may make it increasingly complicated for us to enforce our intellectual property rights against parties misappropriating or copying our technology or products without our authorization, allowing competing enterprises to harm our business in the Chinese or other export markets by affecting the pricing for our products, reducing our sales and diluting our brand or product quality reputation.

 

The intellectual property rights of others may prevent us from developing new products or entering new markets.

 

The telecommunications industry is characterized by the rapid development of new technologies, which requires us to continuously introduce new products and expand into new markets that may be created. Therefore, our success depends on adapting our products and systems, incorporating new technologies, and growing into markets that new technologies may design. If technologies are protected by others’ intellectual property rights, including our competitors, we may be prevented from introducing new products or expanding into new markets created by these technologies. If others’ intellectual property rights prevent us from using innovative technologies, our financial condition, operating results, or prospects may be harmed.

 

We may be subject to infringement claims in the future.

 

We may be unaware of filed patent applications and issued patents that could include claims covering our products. Parties making claims of infringement may be able to obtain injunctive or other equitable relief that could effectively block our ability to sell or supply our products or license our technology and cause us to pay substantial royalties, licensing fees, or damages. The defense of any lawsuit could divert management’s efforts and attention from ordinary business operations and result in time-consuming and expensive litigation, regardless of the merits of such claims. These outcomes may (i) require us to stop selling products or using technology that contains the allegedly infringing intellectual property; (ii) need us to redesign those products that have the allegedly infringing intellectual property; (iii) require us to pay substantial damages to the party whose intellectual property rights we may be found to be infringing; (iv) result in the loss of existing customers or prohibit the acquisition of new customers; (v) cause us to attempt to obtain a license to the relevant intellectual property from third parties, which may not be available on reasonable terms or at all; (vi) materially and adversely affect our brand in the market place and cause a substantial loss of goodwill; (vii) cause our stock price to decline significantly; (viii) materially and adversely affect our liquidity, including our ability to pay debts and other obligations as they become due; or (ix) lead to our bankruptcy or liquidation.

 

We rely on the availability of third-party licenses. If these licenses are available only on less favorable terms or not in the future, our business and operating results will be harmed.

 

We have incorporated third-party licensed technology into our products. It may be necessary to renew licenses relating to these products or seek additional licenses for existing or new products. There can be no assurance that the required licenses will be available on acceptable terms or at all. The inability to obtain specific licenses or other rights, or to obtain those licenses or rights on favorable terms, or the need to engage in litigation regarding these matters could result in delays in product releases until such time, if ever, as equivalent technology could be identified, licensed or developed and integrated into our products and might have a material adverse effect on our business, operating results and financial condition. Moreover, the inclusion in our products of intellectual property licensed from third parties on a nonexclusive basis could limit our ability to protect our proprietary rights.

 

21
 

 

We expect to base our inventory purchasing decisions on our forecasts of customers’ demand, and if our forecasts are inaccurate, our operating results could be materially harmed.

 

As our customer base increases, we expect to place orders based on customer demand forecasts with our contract manufacturers. Our forecasts will be based on multiple assumptions, each of which may cause our estimates to be inaccurate, affecting our ability to provide products to our customers. When demand for our products increases significantly, we may not be able to meet demand on a timely basis, and we may need to expend a significant amount of time working with our customers to allocate limited supply and maintain positive customer relations, or we may incur additional costs to rush the manufacture and delivery of other products. If we underestimate customers’ demand, we may forego revenue opportunities, lose market share, and damage customer relationships. Conversely, if we overestimate customer demand, we may purchase more inventory than we can sell at any given time or at all. Also, we grant our distributors stock rotation rights, which require us to accept stock back from a distributor’s inventory, including obsolete inventory. As a result of our failure to correctly estimate the demand for our products, we could have excess or obsolete inventory, resulting in a decline in our inventory value, which would increase our costs of revenues and reduce our liquidity. Our failure to accurately manage inventory relative to demand would adversely affect our operating results.

 

If our technology did not work as planned or was unsuccessful in developing and selling new products or penetrating new markets, our business and operating results would suffer.

 

Our ability to compete successfully depends on our ability to design, develop, manufacture, assemble, test, market, and support new products and enhancements on a timely and cost-effective basis to keep pace with market needs and satisfy customers’ demands. Our success and ability to compete depend on the technology we have developed or may develop in the future. There is a risk that the technology we have developed or may develop may not work as intended or that the technology marketing may not be as successful as anticipated. Further, the markets in which our customers and we compete or plan to compete are characterized by regularly and rapidly changing technologies and technological obsolescence. A fundamental technological shift in our target markets could harm our competitive position. Our failure to anticipate these shifts, develop new technologies, or react to changes in existing technologies could materially delay our development of new products, resulting in product obsolescence, decreased revenue, and a loss of customer wins to our competitors. New technologies and products require substantial investment and long development and testing periods before being commercially viable. We intend to continue to make significant investments in developing new technologies and products, and it is possible that we may not successfully be able to build or acquire new products or product enhancements that compete effectively within our target markets or differentiate our products based on functionality, performance or cost and that our latest technologies and products will not result in meaningful revenue. Any delays in developing and releasing new or enhanced products could cause us to lose revenue opportunities and customers. Any technical flaws in product releases could diminish our products’ innovative impact and harm customer adoption and reputation. If we fail to introduce new products that meet our customers’ demands or target markets, do not achieve market acceptance, or fail to penetrate new markets, our revenue will not increase over time, and our operating results and competitive position will suffer.

 

We rely extensively on information technology systems and could face cybersecurity risks.

 

We rely extensively and increasingly on information technologies and infrastructure to manage our business, including developing new business opportunities and digital streaming products and services. Our business operations depend on secure transmission and other data and video processing over the internet and interconnected systems. Malicious technology-related events, such as cyberattacks, computer hacking, computer viruses, ransomware, worms, and other destructive or disruptive software and other attempts to gain access to confidential or personal data, denial of service attacks, and other malicious activities are becoming increasingly diverse and sophisticated, and the incidence of these events is on the rise worldwide and highlights the need for continual and effective cybersecurity awareness and education. Our business, which involves the collection, use, transmission, and other distribution of data and video, may make us and our clients and business partners attractive targets of hackers, denial of service attacks, malicious code, phishing attacks, ransomware attacks, and other threat actors, including malicious insiders (such as employees and prior employees), which may result in security incidents, including the unauthorized access, misuse, loss, corruption, inaccessibility, or destruction of this data (including personal, confidential and sensitive information), unavailability of services, or other adverse events. We have in the past faced cyber-attacks of this nature, and we expect to continue to face such attacks in the future. Some of these attacks have been successful, although none to date have been material. We cannot guarantee that our defensive measures will prevent such attacks in the future. These types of cyber-attacks and incidents can give rise to various losses and costs, including legal exposure and regulatory fines, damages to reputation, and others. If successful, these incidents could also materially disrupt operational systems and result in the loss of intellectual property, trade secrets, other proprietary or competitively sensitive information, and general data (including personal information).

 

Data breaches and improper use of social media by employees and others may risk sensitive data, such as personal information, strategic plans, and trade secrets, being exposed to third parties or the general public. Any such breaches or breakdowns could expose us to legal liability, be expensive to remedy, result in a loss of our or our clients’ or vendors’ proprietary information, and damage our reputation. Efforts to develop, implement and maintain security measures are costly, may not successfully prevent these events from occurring, and may require ongoing monitoring and updating as technologies and cyberattack techniques change frequently or are not recognized until successful.

 

Furthermore, computer malware, viruses, hacking, and phishing attacks have become more prevalent in our industry and may occur in future systems. Though it is difficult to determine what, if any, harm may directly result from any specific interruption or attack, any failure to maintain performance, reliability, security, and availability of our products and technical infrastructure to the satisfaction of our users may harm our reputation and our ability to attract and retain customers.

 

22
 

 

Regulation of the telecommunications industry could harm our operating results and prospects.

 

The traditional telecommunications industry is highly regulated, and our business and financial condition could be adversely affected by changes in regulations relating to the Internet telecommunications industry. Currently, few laws or regulations apply directly to access to or commerce on intellectual property networks, but future regulations could include sales taxes and tariffs in previously unregulated areas and provider access charges. We could be adversely affected by the regulation of intellectual property networks and commerce in any country where we market equipment and services to service or content providers. Rules governing the range of services and business models that service providers or content providers can offer could adversely affect those customers’ needs for products designed to enable a wide range of such services or business models. For instance, the U.S. Federal Communications Commission (“FCC”) has issued regulations governing aspects of fixed broadband networks and wireless networks. These regulations might impact service provider and content provider business models and providers’ needs for Internet telecommunications equipment and services. Also, many jurisdictions are evaluating or implementing cybersecurity, privacy, and data protection regulations, which could affect the market and networking and security equipment requirements.

 

Environmental regulations concerning electronic equipment manufacturing or operations may adversely impact our business and financial condition. For instance, the European Union has adopted electronic waste, e-waste, e-scrap, or electrical and electronic equipment waste, Restriction of the Use of Certain Hazardous Substances, Registration, Evaluation, Authorization, and Restriction of Chemicals. Furthermore, some governments have regulations prohibiting government entities from purchasing security products that do not meet specified indigenous certification criteria, even though those criteria may conflict with accepted international standards. Similar regulations are in effect or under consideration in several jurisdictions where we do business.

 

Adopting and implementing such regulations could decrease demand for our products, increase the cost of building and selling our products, impact our ability to ship products into affected areas, and recognize revenue on time. Any of these impacts could have a material adverse effect on our business, financial condition, and the results of operations.

 

At several of our annual stockholder meetings, including our 2019 Annual Meeting of Stockholders, we failed to obtain ratification by our stockholders of specific proposals submitted for approval of our stockholders at prior annual meetings, which could be deemed defective corporate acts.

 

At our 2015 Annual Meeting of Stockholders, our Board submitted to our stockholders for their approval (i) a proposal to approve our 2015 Employee Stock Purchase Plan and (ii) a proposal to approve our 2015 Incentive Compensation Plan. At our 2016 Annual Meeting of Stockholders, our Board submitted to our stockholders for their approval (i) a proposal to approve our 2016 Employee Stock Purchase Plan and (ii) a proposal to approve our 2016 Incentive Compensation Plan. At our 2017 Annual Meeting of Stockholders, our Board submitted to our stockholders, for their approval, (i) a proposal to approve an amendment to our 2016 Employee Stock Purchase Plan to increase the number of shares of Common Stock available for sale under such plan; (ii) a proposal to approve an amendment to our 2016 Incentive Compensation Plan to increase the number of shares of Common Stock available for sale under such plan; and (iii) a proposal to approve our 2017 Incentive Compensation Plan.

 

At each of these annual meetings, our inspector of elections determined that the applicable proposal received the requisite stockholder approval under our amended and restated bylaws (“Bylaws”) and certified that the proposal passed, which was subsequently disclosed in an applicable Current Report on Form 8-K. Questions have been raised about whether the votes on such proposals were tabulated following our Bylaws’ provisions and whether the requisite votes were obtained to approve each of these proposals.

 

According to the provisions of Section 204 of the General Corporation Law of the State of Delaware (“DGCL”) and to continue to remain in compliance with Nasdaq’s Listing Rules, we submitted all of these proposals, again, to our stockholders at our 2019 Annual Meeting of Stockholders for ratification to resolve any defects in the corporate acts relating to the approval of these proposals by our stockholders at the prior meetings. We could not obtain ratification by our stockholders for any proposals submitted to them at the 2019 Annual Meeting of Stockholders. Although we intend to resubmit these proposals to our stockholders for ratification, there can be no assurance that any of these proposals will be ratified. Suppose we cannot secure such ratifications or are deemed inadequate, among other consequences. In that case, this could result in a determination that none of the shares issued by us under these plans were duly authorized and validly issued, which could create accounting issues, affect our liquidity and capital structure, and expose us to claims from recipients of any stock awards granted according to such plans, any of which could have a material adverse effect on our business and results of operations.

 

23
 

 

Demand for our military and government-related products and products for emergency response services depends on government spending.

 

A portion of our business is derived from military and government markets. The military and government market largely depends on government budgets and is subject to governmental appropriations. Although multi-year contracts may be authorized with major procurements, funds are generally appropriated on a fiscal-year basis, even though a program may be expected to continue for several years. Consequently, programs are often only partially funded, and additional funds are committed if further appropriations are made. We cannot assure you that maintenance of or increases in military and government spending will be allocated to programs that would benefit our business. A decrease in levels of military and government spending or the government’s termination of, or failure to fully fund, one or more of the contracts for the programs in which we participate could have a material adverse effect on our financial position and the results of operations. Moreover, we cannot assure you that the new military and government-related communication and broadcasting programs we participate in will enter full-scale production as expected.

 

Our potential customers for our communication, surveillance and satellite products and solutions will likely include U.S. Government or Government-related entities that are subject to appropriations by Congress. Reduced funding for military and government procurement and research and development programs would likely adversely impact our ability to generate revenues.

 

We anticipate that a portion of our revenue will be derived from our communication, surveillance, and satellite products and solutions, at least in the foreseeable future, from U.S. Government and Government-related entities, including the U.S. Department of Defense and other departments and agencies. Government programs in which we may seek to participate, and contracts for our products, must compete with other programs for consideration during Congress’ budget and appropriations hearings and may be affected by changes in political power and appointments and general economic conditions, and other factors beyond our control. A government closure based on a failure of Congress to agree on federal appropriations or the uncertainty surrounding a continuing resolution may result in the termination or delay of federal funding opportunities we are pursuing. Reductions, extensions, or terminations in a program in which we seek to participate, or overall defense or another spending could adversely affect our ability to generate revenues and realize profits. We cannot predict whether potential changes in security, military, communications, and intelligence priorities will afford opportunities for our business regarding research and development or product contracts. Still, a possible reduction in government spending on such programs could negatively impact our ability to generate revenues. In addition, our ability to participate in U.S. Government programs may be affected by the adoption of new laws or regulations relating to government contracting or changes in existing laws or regulations, changes in political or public support for security, military and government programs, and uncertainties associated with the current global threat environment and other geo-political matters.

 

Contracting with government entities can be complex, expensive, and time-consuming.

 

The procurement process for government entities is, in many ways, more challenging than contracting in the private sector. We must comply with laws and regulations relating to the formation, administration, performance, and pricing of contracts with government entities, including U.S. federal, state, and local governmental bodies.

 

Government entities often require highly specialized contract terms that may differ from our standard arrangements. Government entities often impose complicated compliance requirements, require preferential pricing or “most favored nation” terms and conditions, or are otherwise time-consuming and expensive. Compliance with these exceptional standards or satisfaction with such requirements could complicate our efforts to obtain business or increase costs. Even if we meet these particular standards or conditions, the increased costs of providing our solutions to government customers could harm our margins.

 

Adverse developments affecting the financial services industry, including events or concerns involving liquidity, defaults, or non-performance by financial institutions or transactional counterparties, could adversely affect our business, financial condition, or results of operations.

 

Events involving limited liquidity, defaults, non-performance, or other adverse developments that affect financial institutions, transactional counterparties, or other companies in the financial services industry or the financial services industry generally, or concerns or rumors about any events of these kinds or other similar risks, have in the past and may in the future lead to market-wide liquidity problems. Most recently, on March 10, 2023, Silicon Valley Bank (“SVB”) was closed by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation (“FDIC”) as a receiver. Similarly, on March 12, 2023, Signature Bank and Silvergate Capital Corp. were each swept into receivership. Although we assess our banking and customer relationships as we believe necessary or appropriate, our access to funding sources and other credit arrangements in amounts adequate to finance or capitalize our current and projected future business operations and product development could be significantly impaired by factors that affect us, the financial services industry or economy in general. These factors could include, among others, events such as liquidity constraints or failures, the ability to perform obligations under various types of financial, credit, or liquidity agreements or arrangements, disruptions or instability in the financial services industry or financial markets, or concerns or negative expectations about the prospects for companies in the financial services industry.

 

24
 

 

Any decline in available funding or access to our cash and liquidity resources could, among other risks, adversely impact our ability to develop and commercialize new products and meet our operating expenses and financial obligations or fulfill our other commitments, resulting in breaches of our contractual obligations or result in violations of federal or state wage and hour laws. In addition, investor concerns regarding the U.S. or international financial systems could result in less favorable commercial financing terms, including higher interest rates or costs and tighter financial and operating covenants or systemic limitations on access to credit and liquidity sources, thereby making it more difficult for us to acquire financing on acceptable terms or at all. Any of these impacts, or any other consequences resulting from the factors described above or other related or similar factors not described above, could have material adverse effects on our liquidity and our business, financial condition, or results of operations.

 

Risks Related to Our Industry and its Regulatory Context

 

Our industry is subject to rapid technological change, and we must make substantial investments in new products, services, and technologies to compete successfully.

 

New technological innovations generally require a substantial investment before they are commercially viable. We intend to continue to make significant investments in developing new products and technologies, and it is possible that our development efforts will not be successful and that our new technologies will not result in meaningful revenues. Our future success will depend on our ability to quickly develop and introduce new products, technologies, and enhancements. Our future success will also depend on our ability to keep pace with technological developments, protect our intellectual property, satisfy customer requirements, meet customer expectations, price our products and services competitively, and achieve market acceptance. The introduction of products embodying new technologies and the emergence of new industry standards could render our existing products and technologies and products and technologies currently under development obsolete and unmarketable. If we fail to anticipate or respond adequately to technological developments or customer requirements or experience any significant delays in the development, introduction, or shipment of our products and technologies in commercial quantities, demand for our products and our customers’ and licensees’ products that use our technologies could decrease, and our competitive position could be damaged.

 

New regulations or standards or changes in existing laws or standards in the United States or internationally related to our products may result in unanticipated costs or liabilities, which could have a material adverse effect on our business, results of operations, and future sales, and could place additional burdens on the operations of our business.

 

Our products may be subject to governmental regulations in a variety of jurisdictions. Our technology and products must comply with these regulations and many industry standards to achieve and maintain market acceptance. In the United States, our technology and products must comply with various FCC rules and others. We may also have to comply with similar international regulations. For example, our wireless communication products operate through the transmission of radio signals, and radio emissions are subject to regulation in the United States and other countries in which we intend to do business. In the United States, various federal agencies, including the Center for Devices and Radiological Health of the Food and Drug Administration, the FCC, the Occupational Safety and Health Administration, and various state agencies, have promulgated regulations that concern the use of radio/electromagnetic emissions standards. Member countries of the European Union have enacted similar standards relating to electrical safety, electromagnetic compatibility and emissions, and chemical substances and use standards.

 

As these regulations and standards evolve, and if new rules or standards are implemented, we may be required to modify our technology or products or develop and support new versions. Our compliance with these regulations and standards may become more burdensome. The failure of technology or our products to comply, or delays in compliance with the various existing and evolving industry regulations and standards, could prevent or delay the introduction of our technology or products, harming our business. End-customer uncertainty regarding future policies may also affect demand for communications products, including our products. Moreover, channel partners or end-customers may require us, or we may otherwise deem it necessary or advisable, to alter our technology or products to address actual or anticipated changes in the regulatory environment. Our inability to change our technology or products to address these requirements and any regulatory changes may adversely affect our business, operating results, and financial condition.

 

Compliance with environmental, health, and safety laws and regulations, including new regulations requiring higher standards, may increase costs, limit our ability to utilize supply chains, and force product design changes.

 

Our operations are subject to various environmental, health, and safety laws and regulations and equivalent local, state, and regulatory agencies in each jurisdiction we operate or may operate in the future. Our products manufacturing uses substances regulated under various federal, state, and local laws governing the environment and worker health and safety. If we, including any contract manufacturers that we may employ, do not comply with these laws, including any new regulations, such non-compliance could reduce our products’ net realizable value, resulting in an immediate charge to our income statements. Our non-compliance with such laws could also negatively impact our operations and financial position as a result of fines and penalties that may be imposed on us and increase the cost of mandated remediation or delays to any contract manufacturers we may utilize; thus, we may suffer a loss of revenues, be unable to sell our products in specific markets and/or countries, be subject to penalties and enforced fees and/or suffer a competitive disadvantage. If applicable, costs to comply with current laws and regulations and/or similar future laws and regulations could include costs associated with modifying our products, recycling and other waste processing costs, legal and regulatory costs, and insurance costs. We cannot assure you that the costs to comply with these new laws or current and future environmental and worker health and safety laws will not adversely affect our business, operating results, and financial condition.

 

25
 

 

Governmental regulations affecting the import or export of products or affecting products containing encryption capabilities could negatively affect our revenues.

 

The United States and various foreign governments have imposed controls, export license requirements, and restrictions on importing or exporting some technologies, especially encryption technology. Also, governmental agencies have occasionally proposed additional regulation of encryption technology, such as requiring certification, notifications, review of source code, or the escrow and governmental recovery of private encryption keys. For example, Russia and China recently have implemented new requirements for encryption products, and India has imposed certain warranties and other obligations associated with critical technology. Governmental regulation of encryption or IP networking technology and regulation of imports or exports, or our failure to obtain required import or export approval for our products, could harm our international and domestic sales prospects and adversely affect our revenue expectations. In addition, the U.S. and other international organizations have imposed numerous sanctions and restrictions, such as the EU, on exporting specific goods and services to Russia due to the armed conflict with Ukraine. Failure to comply with such regulations could result in penalties, costs, and restrictions on import or export privileges or adversely affect sales to government agencies or government-funded projects.

 

If wireless devices pose safety risks, we may be subject to new regulations, and demand for our products, licensees, and customers may decrease.

 

In recent years, the FCC and foreign regulatory agencies have updated the guidelines and methods for evaluating radiofrequency emissions from radio equipment, including wireless phones and other wireless devices. Even if unfounded, concerns over the effects of radiofrequency emissions may discourage the use of wireless devices, decreasing demand for our products and those of our licensees and customers. Interest groups have also requested that the FCC investigate claims that wireless communication technologies pose health concerns and cause interference with airbags, hearing aids, and medical devices. Concerns have also been expressed over the possibility of safety risks due to a lack of attention associated with wireless devices while driving. Any legislation adopted in response to these expressions of concern could reduce demand for our products and those of our licensees and customers in the United States and foreign countries.

 

Risks Related to Our Common Stock

 

Our stock price may be volatile, and you may not be able to resell shares of our Common Stock at or above the price you paid.

 

Our Common Stock trading price could be highly volatile and subject to wide fluctuations in response to various factors, including factors beyond our control. These factors include those discussed in the other “Risk Factors” section of this Report on Form 10-K.

 

Also, the stock markets in general and the markets for telecommunication stocks have experienced volatility. These broad market fluctuations may adversely affect the trading price or liquidity of our Common Stock. In the past, when the market price has been volatile, holders of that stock have sometimes instituted securities class action litigation against the issuer. If any of our stockholders were to bring such a lawsuit against us, we could incur substantial costs defending the case, and our management’s attention would be diverted from the operation of our business, which could seriously harm our financial position. Any adverse determination in litigation could also subject us to significant liabilities.

 

If we cannot regain or maintain compliance with Nasdaq’s applicable continued listing requirements or standards, Nasdaq could delist our Common Stock.

 

We currently list our Common Stock on the Nasdaq Capital Market. To maintain such a listing, we must satisfy minimum financial and other continued listing requirements and standards, including director independence and independent committee requirements, minimum stockholders’ equity, minimum share price, and specific corporate governance requirements. According to Nasdaq Rule 5550(a)(2), we must maintain a minimum bid price for our common stock, par value of $0.00001 per share (“Common Stock”), of at least $1.00 per share (the “Bid Price Rule”). If our Common Stock stayed consistently traded below $1.00 per share, our common stock would be at risk of delisting from the Nasdaq Capital Market. As previously reported, on May 20, 2022, we received notice from the Nasdaq Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company of its noncompliance with Bid Price Rule by failing to maintain a minimum bid price for its common Stock on the Nasdaq Capital Market of at least $1.00 per share for 30 consecutive business days. The Company received a grace period of 180 days, or until November 16, 2022, to regain compliance with the minimum bid price requirement.

 

On November 10, 2022, the Company submitted a request to Nasdaq for an additional 180-day grace period to regain compliance with the minimum bid price requirement. On November 17, 2022, the Company received a letter from Nasdaq advising that the Company had been granted an additional 180-day grace period extension until May 15, 2023, to regain compliance with the minimum bid price requirement and all other applicable requirements for initial listing on the Nasdaq Capital Market except for the minimum bid price requirement. On January 11, 2023, the Company held a special meeting of stockholders (the “Special Meeting”) whereby stockholders approved a proposal to authorize the Board of Directors of the Company (the “Board”), in its discretion but before the one-year anniversary of the date of the Special Meeting, to implement an amendment to the Company’s certificate of incorporation to effect a reverse stock split (the “Reverse Stock Split”) of all of the outstanding shares of Common Stock, of the Company, at a ratio in the range of 1-for-2 to 1-for-50. The Company intends to monitor the closing bid price of its Common Stock and may, if appropriate, consider available options to regain compliance with the Bid Price Rule, including initiating the Reverse Stock Split.

 

26
 

 

There can be no assurance that a Reverse Stock Split will result in a sustained increase in the per share market price for the Common Stock for the minimum period necessary to permit the Company to timely regain compliance with the Bid Price Rule. There can be no assurance that the Company will be able to regain compliance with the Bid Price Rule or otherwise comply with other Nasdaq Listing Rules during or following the 180-day extension period ending May 15, 2023. If the Company does not regain compliance within the allotted compliance period, Nasdaq will provide notice that the Common Stock will be subject to delisting. The Company would then be entitled to appeal that determination to a Nasdaq hearings panel.

 

If the Company timely appeals, the Common Stock will continue to be listed and traded on The Nasdaq Capital Market under the symbol “VISL,” subject to the Company’s compliance with the other continued listing requirements of The Nasdaq Capital Market during the pendency of the appeals process.

 

Any Nasdaq action relating to a delisting could have a negative effect on the price of our Common Stock, impair the ability to sell or purchase our common Stock when persons wish to do so, and any such delisting action may materially adversely affect our ability to raise capital or pursue strategic restructuring, refinancing or other transactions on acceptable terms, or at all. Delisting from the Nasdaq Capital Market could also have other negative results, including the potential loss of institutional investor interest and fewer business development opportunities.

 

If our Common Stock is delisted from Nasdaq, U.S. broker-dealers may be discouraged from effecting transactions in shares of our Common Stock because they may be considered penny stocks and thus be subject to the penny stock rules.

 

The SEC has adopted several rules to regulate “penny stock” that restrict transactions involving stock deemed penny stock. Such rules include Rules 3a51-1, 15g-1, 15g-2, 15g-3, 15g-4, 15g-5, 15g-6, 15g-7, and 15g-9 under the Exchange Act. These rules may have the effect of reducing the liquidity of penny stocks. “Penny stocks” generally are equity securities with a price of less than $5.00 per share (other than securities registered on certain national securities exchanges or quoted on Nasdaq if the exchange or system provides current price and volume information concerning transactions in such securities). Our shares of Common Stock have in the past constituted, and may again in the future constitute, “penny stock” within the meaning of the rules. The additional sales practice and disclosure requirements imposed upon U.S. broker-dealers may discourage them from effecting transactions in shares of our Common Stock, which could severely limit the market liquidity of such shares of Common Stock and impede their sale in the secondary market.

 

A U.S. broker-dealer selling penny stock to anyone other than an established customer or “accredited investor” (generally, an individual with a net worth above $1,000,000 or an annual income exceeding $200,000 or $300,000 together with their spouse) must make a unique suitability determination for the purchaser and must receive the purchaser’s written consent to the transaction before a sale unless the broker-dealer or the transaction is otherwise exempt. Also, the “penny stock” regulations require the U.S. broker-dealer to deliver, before any transaction involving a “penny stock,” a disclosure schedule prepared under SEC standards relating to the “penny stock” market unless the broker-dealer or the transaction is otherwise exempt. A U.S. broker-dealer must also disclose commissions payable to the U.S. broker-dealer, the registered representative, and current quotations for the securities. Finally, a U.S. broker-dealer must submit monthly statements disclosing recent price information concerning the “penny stock” held in a customer’s account and information for the limited market in “penny stocks.”

 

According to the SEC, stockholders should know that the “penny stocks” market has suffered from fraud and abuse patterns in recent years. Such practices include (i) control of the market for the security by one or a few broker-dealers that are often related to the promoter or issuer; (ii) manipulation of prices through prearranged matching of purchases and sales and false and misleading press releases; (iii) “boiler room” practices involving high-pressure sales tactics and unrealistic price projections by inexperienced salespersons; (iv) excessive and undisclosed bid-ask differentials and markups by selling broker-dealers; and (v) the wholesale dumping of the same securities by promoters and broker-dealers after prices have been manipulated to the desired level, resulting in investor losses. Our management is aware of the abuses historically in the penny stock market. Although we do not expect to dictate the market’s behavior or broker-dealers who participate, management will strive within the confines of practical limitations to prevent the described patterns from being established concerning our securities.

 

27
 

 

General Risk Factors

 

We may fail to meet publicly announced financial guidance or other expectations about our business, which would cause our Common Stock to decline in value.

 

We provide preliminary financial results or forward-looking financial guidance to our investors from time to time. Such statements are based on our current views, expectations, and assumptions, and they involve unknown risks and uncertainties that may cause actual results, performance, achievements, or share prices to materially differ from future performance, achievements, or share prices expressed or implied by such statements. Such risks and uncertainties include, among others, changes to the assumptions used to forecast or calculate such guidance or expectations or the occurrence of risks related to our performance and business, including those discussed in these risk factors. Failure to meet financial guidance or expectations regarding our future performance could harm our reputation and cause our stock price to decline.

 

The requirements of being a U.S. public company may strain our resources and divert management’s attention.

 

As a U.S. public company, we are subject to the reporting requirements of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), the Sarbanes-Oxley Act of 2002, the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, the listing requirements of Nasdaq, and other applicable securities rules and regulations. The Exchange Act requires, among other things, that we file annual and current reports concerning our business and operating results. Compliance with these rules and regulations will increase our legal and financial compliance costs, make some activities more difficult, time-consuming, or costly, and increase demand for our systems and resources.

 

As a result of the disclosure of information filing, our business and financial condition is more visible, which we believe may result in threatened or actual litigation, including by competitors and other third parties. If such claims are successful, our business and operating results could be harmed, and even if the claims do not result in litigation or are resolved in our favor, these claims, and the time and resources necessary to fix them, could divert resources from our management and harm our business and operating results.

 

SEC regulations limit the funds we can raise during 12 months under our shelf registration statement on Form S-3.

 

As of March 16, 2023, our public float was approximately $18.8 million, based on 47,619,317 shares of outstanding common stock held by non-affiliates and at $0.39 per share, which was the last reported sale price of our common stock on the Nasdaq Capital Market on March 16, 2023. SEC regulations limit the amount companies with a public float of less than $75 million may raise during 12 months under a shelf registration statement on Form S-3. We are subject to General Instruction I.B.6, Form S-3, or the Baby Shelf Rule. As of the filing of this Annual Report on Form 10-K, we are subject to the Baby Shelf Rule. Under the Baby Shelf Rule, the amount of funds we can raise through primary public securities offerings in any 12 months using a registration statement on Form S-3 is limited to one-third of the aggregate market value of the shares of our common stock held by non-affiliates of the Company. Therefore, we will be limited in the proceeds we can raise by selling shares of our common stock using our Form S-3 until our public float exceeds $75 million. Before our public float exceeds $75 million, if our public float decreases, the number of securities we may sell under our Form S-3 shelf registration statement will also decrease. Even if sufficient funding is available, there can be no assurance that it will be available on terms acceptable to our stockholders or us. Furthermore, if we are required or choose to file a new registration statement on a form other than Form S-3, we may incur additional costs and be subject to delays due to review by the SEC staff.

 

If securities or industry analysts do not publish or cease publishing research or reports about us, our business, or our market, or if they change their recommendations regarding our Common Stock adversely, our share price and trading volume could decline.

 

The trading market for our shares of Common Stock will be influenced by the research and reports that industry or securities analysts may publish about us, our business, our market, or our competitors. If any analysts who may cover us change their recommendation regarding our Common Stock adversely or provide more favorable relative recommendations about our competitors, our share price would likely decline. If any analyst who may cover us were to cease coverage of our Company or fail to publish reports on us regularly, we could lose visibility in the financial markets, which could cause our Common Stock price or trading volume to decline.

 

Future impairment charges could have a material adverse effect on our financial condition and the results of operations.

 

We must test our finite-lived intangible assets for impairment if events occur or circumstances change that would indicate that the remaining net book value of the intangible assets might not be recoverable. These events or circumstances could include a significant change in the business climate, including a significant, sustained decline in an entity’s market value, legal factors, operating performance indicators, competition, sale or disposition of a considerable portion of our business, potential government actions, and other factors. If our finite-lived intangible assets’ fair value is less than their book value in the future, we could be required to record impairment charges. The amount of any future impairment could be significant and could have a material adverse effect on our reported financial results for the period in which the charge is taken.

 

28
 

 

If our estimates relating to our critical accounting policies are based on assumptions or judgments that change or prove incorrect, our operating results could fall below the expectations of securities analysts and investors, resulting in a decline in our stock price.

 

Preparing financial statements conforming with U.S. generally accepted accounting principles requires our management to make estimates, assumptions, and judgments that affect the amounts reported in the financial statements and accompanying notes. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets, liabilities, equity, revenue, and expenses that are not readily apparent from other sources. Our operating results may be adversely affected if our assumptions change or if actual circumstances differ from those in our assumptions, which could cause our operating results to fall below the expectations of financial analysts and investors, resulting in a decline in our stock price. Management makes estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates and assumptions include reserves and write-downs related to receivables and inventories, the recoverability of long-lived assets, the valuation allowance relating to the Company’s deferred tax assets, valuation of equity and derivative instruments, and debt discounts, and the valuation of the assets and liabilities acquired by us.

 

Future sales and issuances of our Common Stock or rights to purchase our Common Stock, stock incentive plans, and upon the exercise of outstanding securities exercisable for shares of our Common Stock could result in substantial additional dilution of our stockholders, cause our stock price to fall and adversely affect our ability to raise capital.

 

We will require additional capital to continue to execute our business plan and advance our research and development efforts. If we raise additional capital by issuing additional equity securities and exercising outstanding warrants, our stockholders may experience substantial dilution. We may sell shares of preferred stock or Common Stock in one or more transactions at prices that may be at a discount to the then-current market value of our Common Stock and on such other terms and conditions as we determine from time to time. Any such transaction could result in substantial dilution of our existing stockholders. If we sell shares of our Common Stock in more than one transaction, stockholders who purchase our Common Stock may be materially diluted by subsequent sales. Such sales could also cause a drop in the market price of our Common Stock. The issuance of shares of our Common Stock in connection with public or private financing, in connection with our compensation programs, and upon exercise of outstanding warrants will have a dilutive impact on our other stockholders, and the issuance, or even potential issuance, of such shares, could hurt the market price of our Common Stock.

 

The exercise of stock options, warrants, and other securities could cause our stockholders to experience substantial dilution. In addition to warrants issued in 2018, 2019, and 2020, in February 2021, we issued warrants to purchase up to 9,090,910 shares of our common stock. Moreover, holders of our stock options and warrants are likely to exercise them, if ever, when we otherwise could obtain a price for the sale of our securities that is higher than the exercise price per security of the options or warrants. Such exercises, or the possibility of such exercises, may impede our efforts to obtain additional financing by selling additional securities or making such financing more costly. It may also reduce the price of our Common Stock.

 

Risks Relating to Acquisitions

 

Our acquisition strategy involves several risks.

 

As we engage in the acquisition discussion with other companies anticipating potential acquisition opportunities, including those that would be material or could involve businesses with operating characteristics that differ from our existing business operations, it may become available shortly. We intend to pursue them actively if appropriate acquisition opportunities are available. Acquisitions involve several unique risks, including:

 

  Failure of the acquired business to achieve expected results, as well as the potential impairment of the acquired assets if operating results decline after acquisition;
  diversion of management’s attention;
  additional financing, if necessary and available, which could increase leverage and costs, dilute equity, or both;
  the potential adverse effect on our financial statements from the increase in goodwill and other intangibles;
  difficulties in integrating the operations, systems, technologies, products, and personnel of acquired companies;
  initial dependence on unfamiliar supply chains or relatively small supply partners;
  the potential loss of key employees, customers, distributors, vendors, and other business partners of the companies we acquire after the acquisition;
  the high cost and expenses of identifying, negotiating, and completing acquisitions;
  the integration of acquisitions requires significant time and resources; and
  risks associated with unanticipated events or liabilities.

 

29
 

 

These risks could adversely affect our business, the results of operations, and our financial condition. Furthermore, the inability to effectively manage the integration of acquisitions could reduce our focus on subsequent acquisitions and current operations, which, in turn, could negatively impact our earnings and growth.

 

We have faced intense competition for acquisition candidates and expect to continue to meet them, limiting our ability to make acquisitions and leading to higher acquisition prices. We cannot assure you that we will be able to identify, acquire or manage other businesses profitably or successfully integrate any acquired businesses into our existing business without substantial costs, delays, or other operational or financial difficulties. In future acquisitions, we could incur additional indebtedness or pay consideration above fair value, which could have a material adverse effect on our business, results of operations, and financial condition.

 

Any impairment of goodwill, other intangible assets, or long-lived assets could negatively impact our results of operations.

 

Our goodwill, other intangible assets, and long-lived assets are subject to an impairment test annually and tested whenever events and circumstances indicate that goodwill, intangible assets, and/or long-lived assets may be impaired. Any excess goodwill resulting from the impairment test is written off in the determination period. Intangible assets (other than goodwill and indefinite-lived intangible assets) and other long-lived assets are generally amortized or depreciated over the useful life of such assets. From time to time, we may acquire or invest in a business that will require us to record goodwill based on the purchase price and the value of the acquired tangible and intangible assets. We may subsequently experience unforeseen issues with the businesses we acquire, which may adversely affect the company’s anticipated returns or value of the intangible assets and trigger an evaluation of the recoverability of the recorded goodwill and intangible assets. Future determinations of significant write-offs of goodwill, intangible assets, or other long-lived assets due to an impairment test or any accelerated amortization or depreciation of other intangible or long-lived assets could have a material adverse impact on our results of operations and financial condition.

 

30
 

 

Item 1B. Unresolved Staff Comments

 

Not applicable.

 

Item 2. Properties

 

Mount Olive, NJ

 

On November 1, 2021, the Company entered into a lease agreement with a non-affiliated third party (the “Landlord”) to rent approximately 7,979 square feet of commercial space for general business offices, light manufacturing, operating of a testing laboratory, assembly, and inventory storage in Mount Olive, NJ. The lease commencement date was November 1, 2021, and the expiration date is January 31, 2027. The initial monthly obligation is $10,869, with annual rent increases of 3.0% until the lease expires. The Company relocated its corporate facilities from Hackettstown, NJ, in connection to Mount Olive, NJ, with the lease commencement date of March 1, 2022.

 

Lutton, UK

 

On April 28, 2022, the Company entered a one-year lease for 600 square feet of administrative office space in Lutton, UK, commencing on May 3, 2022, and terminating on May 31, 2023, for £1,320 monthly or approximately $1,800 per month

 

Dubai, UAE

 

On June 9, 2022, the Company renewed its lease for 976 square feet of administrative office space commencing on July 3, 2022, and terminating on July 2, 2023, in Dubai Studio City, UAE, for approximately $1,632 monthly.

 

Billerica, MA

 

On January 20, 2020, the Company terminated its former lease agreement. On January 24, 2020, the Company negotiated a new lease agreement with the landlord at our Billerica location, decreasing the required square footage to 8,204 from 39,327 square feet or approximately 79%. The new lease agreement’s effective date is March 24, 2020, expiring December 31, 2026. The total annual rent under this lease is approximately $95,000. During the third quarter of the fiscal year 2022, management vacated the Billerica property. Under ASC 360, leased space abandonment is an impairment indicator, and the Company assessed the lease ROU assets for impairment, and we recognized a loss on impairment of right-of-use assets of approximately $88,000 for the year ended December 31, 2022.

 

Singapore

 

On July 3, 2020, the Company negotiated a new lease agreement with the landlord, maintaining 950 square feet of administrative office space. The new lease agreement’s effective date is August 10, 2020, expiring on August 9, 2023. The total annual rent under this lease is approximately $30,500.

 

Hemel, United Kingdom

 

Under the original lease agreement dated April 28, 2017, a “break clause” signifying a “break date” of October 28, 2020, sighted the following: the Company may terminate this lease on the “break date” by giving the landlord such notice within six months of the “break date.” At the lease’s commencement, it was not reasonably sure if the Company would exercise its right by the break clause’s date. These measures upheld the determination of the lease’s noncancellable period for adopting ASC 842 on January 1, 2019. The lease term of 22 months as of January 1, 2019, helped calculate the remaining lease payments’ net present value assigned to the right-of-use asset and operating lease liability upon the adoption date. Neither party exercised their unilateral termination rights by the “break date,” triggering a lease extension. Both parties’ inaction creates new enforceable rights and obligations in the extended period, such that ending the lease agreement terminates on October 27, 2023. The total annual rent under this lease is approximately $175,000, covering 12,870 square feet of manufacturing and administrative office space.

 

Colchester, UK

 

On February 2, 2017, the original lease agreement was for 16,000 square feet, with the initial lease commencing on March 25, 2007, and expiring on March 24, 2025. The total annual rent under this lease is approximately $275,000, covering 16,000 square feet of manufacturing and administrative office space.

 

Item 3. Legal Proceedings

 

The nature of our business and activities are such that we may faces frequent claims and litigation, including securities litigation, claims regarding patent and other intellectual property rights, and other liability claims. As a result, we may be involved in various legal proceedings from time to time. We are not currently a party to any material litigation, nor are we aware of any pending or threatened litigation against us that we believe, if adversely determined against us, would materially affect our business, operating results, financial condition, or cash flows.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

31
 

 

PART II

 

Item 5. Market for Registrant’s Common Equity Related Stockholder Matters and Issuer Purchases of Equity Securities.

 

Our common stock shares are listed on the Nasdaq Capital Market under the symbol “VISL.”

 

Holders

 

As of March 16, 2023, 47,619,317 shares of common stock were outstanding, together with approximately 30 shareholders of record.

 

The Company’s transfer agent and registrar are Continental Stock Transfer & Trust Company, 17 Battery Place, 8th Floor, New York, New York 10004.

 

Dividend Policy

 

We have never declared or paid any cash dividend on our common stock. We intend to retain any future earnings and do not expect to pay any cash dividends in the foreseeable future.

 

Securities Authorized for Issuance under Equity Compensation Plans

 

Reference is made to “Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters—Securities Authorized for Issuance under Equity Compensation Plans” for the information required by this item.

 

Recent Sales of Unregistered Securities

 

None

 

Item 6. Reserved

 

Not applicable.

 

32
 

 

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and related notes appearing elsewhere in this Annual Report on Form 10-K. In addition to historical financial information, the following discussion contains forward-looking statements based on current plans, expectations, and beliefs that involve risks and uncertainties. Our actual results may differ materially from those anticipated in these forward-looking statements due to various factors, including the impact of the COVID-19 pandemic and those other factors discussed in the “Risk Factors” section and other parts of this Annual Report on Form 10-K. Our fiscal year-end is December 31.

 

Overview

 

Vislink, incorporated in Delaware in 2006, is a global technology business specializing in collecting, delivering, and managing high-quality, live video and associated data from the action scene to the viewing screen. Vislink provides solutions for collecting live news, sports, entertainment, and news events for the broadcast markets. Vislink also furnishes the surveillance and defense markets with real-time video intelligence solutions using various tailored transmission products. The Vislink team also provides professional and technical services utilizing a staff of technology experts with decades of applied knowledge and real-world experience in the terrestrial microwave, satellite, fiber optic, surveillance, and wireless communications systems delivering a broad spectrum of customer solutions.

 

Live Broadcast:

 

Vislink delivers an extensive portfolio of solutions for live news, sports, and entertainment industries. These solutions include video collection, transmission, management, and distribution via microwave, satellite, cellular, I.P. (Internet Protocol), MESH, and bonded cellular/5G networks. We also provide solutions utilizing A.I. (Artificial Intelligence) technologies to provide automated news and sporting events coverage. With over 50 years in operation, Vislink has the expertise and technology portfolio to deliver fully integrated, seamless, end-to-end solutions.

 

Industry-wide contributors acknowledge Vislink’s live broadcast solutions. The transmission of most of all outside wireless broadcast video content uses our equipment, with over 200,000 systems installed worldwide. We work closely with the majority of the world’s broadcasters. Vislink wireless cameras and ultra-compact encoders help bring many of the world’s most prestigious sporting and entertainment events to life. Recent examples include globally watched international sporting contests, award shows, racing events, and annual music and cultural events.

 

Military And Government:

 

Vislink has developed high-quality solutions to meet surveillance and defense markets’ operational and industry challenges based on our knowledge of live video delivery. Vislink solutions are specifically designed with interagency cooperation, utilizing the internationally-recognized I.P. platform and a web interface for video delivery. Vislink provides comprehensive video, audio, and data communications solutions to law enforcement and the public safety community, including Airborne, Unmanned Systems, Maritime, and Tactical Mobile Command Posts. These solutions may include:

 

integrated suites of airborne downlink transmitters, receivers, and antenna systems
data and video connectivity for airborne, marine, and ground assets
UAV video distribution
flexible support for COFDM and bonded cellular/5G Networks
terrestrial point-to-point
tactical mobile command
IP-based, high-end encryption, full-duplex, real-time connectivity at extended operating ranges
high-throughput air/marine/ground-to-anywhere uplink and downlink systems
secure live streaming platforms for use in mobile and fixed assets
personal portable products

 

Vislink public safety and surveillance solutions are deployed worldwide, including throughout the U.S., Europe, and the Middle East, at the local, regional, and federal levels of operation, criminal investigation, crisis management, mobile command posts, and field operations. These solutions are designed to meet the demands of field operations, command centers, and central receiving sites. Short-range and long-range solutions are available in areas including established infrastructure and exceptionally remote regions, making valuable video intelligence available regardless of location.

 

Satellite Communications:

 

Over 30 years of technical expertise support Vislink’s satellite solutions. These solutions ensure robust, secure communications while delivering low transmission costs for any organization that needs high-quality, reliable satellite transmission. We offer turnkey solutions that begin with state-of-the-art coding, compression, and engine modulation and end with our robust, lightweight antenna systems. Vislink Satellite solutions focus heavily on being the smallest, lightest, and most efficient in their categories, making transportation and ease of use a key driver in the customer experience. Vislink offers an extensive range of satellite designs that allow customers to optimize bit rate, size, weight, and total cost. Our satellite systems are used extensively globally, with over 2,000 systems deployed by governments, militaries, and broadcasters. While we continue offering satellite solutions, we no longer invest in the engineering and product development necessary to stay relevant in the sector. We will continue to market and sell our current solutions but do not anticipate introducing further upgrades or features to our satellite product line.

 

33
 

 

Connected Edge Solutions:

 

Vislink offers the hardware and software solutions needed to acquire, produce, contribute, and deliver video over all private and public networks with the Mobile Viewpoint acquisition. Connected edge solutions aid the video transport concept of ubiquitous IP networks and cloud-scale computing across 5G, WiFi6, Mesh, and COFDM-enabled networks. These solutions include:

 

  Live video encoding, stream adaptation, decoding, and production solutions
  Remote production workflows
  Wireless cameras
  AI-driven automated production
  Ability to contribute video over:
    Bonded cellular (3G and 4G)
    Satellite
    Fiber
    Emerging networks, including 5G and Starlink

 

COVID-19 Update

 

The Company closely monitors the continued impact of the ongoing COVID-19 pandemic on all aspects of our business and geographies, including how it will impact business partners. The Company continues to experience supply chain shortages and delays in obtaining specific inventory items. The Company’s operations team is mitigating the risk by increasing inventory levels in its purchase management of these components. The execution of this policy has improved our ability to ship products. It is unclear how such restrictions will contribute to a general slowdown in the global economy, and it is difficult to isolate the impact of the pandemic on our business, the results of operations, our financial condition, and our future strategic plans. Further, while many companies have survived the past year, and some have thrived, as the pandemic endures, we cannot predict how the global economy will respond to the return to normalcy or whether it will continue to sustain steadily.

 

In addition, the Company is uncertain of the total effect the pandemic will have on it in the long term since the scope and duration of the pandemic is unknown. The protocol followed in distributing effective vaccines worldwide, and the extent of any resurgences of the virus or emergence of new variants, such as the Delta, Omicron, and others, will impact the stability of economic recovery and growth. The extent to which the operations of the Company, and the operations of its customers and supply chain, may be adversely impacted by the COVID-19 pandemic will depend mainly on these future developments. The Company may experience long-term disruptions to its operations resulting from government policy or guidance; quarantines of employees, customers, and suppliers in areas affected by the pandemic; and closures of businesses or manufacturing facilities critical to its business or supply chains. The Company is actively monitoring and will continue monitoring the pandemic and its potential impact on its operations, financial condition, liquidity, suppliers, industry, and workforce.

 

For further discussion of the challenges and risks related to the COVID-19 pandemic, please refer to Part I, Item 1A “Risk Factors” of this Annual Report on Form 10-K.

 

We face various challenges and risks that we will need to address and manage as we pursue our strategies, including our ability to develop and deliver high-quality live video products and video transmission solutions.

 

Because of the numerous risks and uncertainties associated with our commercialization efforts and research and development activities, we cannot predict the timing or amount of increased expenses or when, if ever, we will be able to achieve or maintain profitability. Even if we can increase sales of our products, we may not become profitable. If we fail to become profitable or sustain profitability, we may be unable to continue our operations at planned levels and be forced to reduce or terminate our operations.

 

34
 

 

Ukraine/Russian Conflict

 

The war increasingly affects economic and global financial markets and exacerbates ongoing economic challenges, including rising inflation and global supply-chain disruption. The degree to which entities are or will be mainly affected depends on the nature and duration of uncertain and unpredictable events, such as further military action, additional sanctions, and reactions to ongoing developments by global financial markets. Because of its broader impact on these macroeconomic conditions, many companies globally may need to consider the war’s effect on specific accounting and financial reporting matters.

 

The Company does not generate revenue from Russia or Ukraine, nor do we have a physical presence, employees, or contractors in these countries. The Russian government’s invasion of Ukraine and the resultant sanctions imposed by the U.S., EU, and other governments and international organizations—designed to inflict severe consequences on the Russian economy—are impacting business continuity, liquidity, and asset values in Ukraine and Russia. It is difficult to estimate the impact of the ongoing invasion on the global economy, including increased inflation and higher energy and transportation costs. As a result, the invasion of Ukraine could adversely impact our financial results. Although we do not presently foresee risks that may affect our Company’s liquidity, operating results, and financial reporting, we continue to monitor developments in Ukraine to assess direct material adverse effects on our business, financial condition, or results of operations.

 

Climate Change-Related Effects

 

Climate change is an important global issue that presents opportunities and challenges for our Company, partners, and communities. Climate change matters for our Company are likely to be driven by changes in physical climate parameters, regulations and/or public policy, and changes in technology and product demand.

 

The lack of empirical data surrounding the credit and other financial risks posed by climate change renders it impossible to predict how specifically climate change may impact our financial condition and results of operations; however, the physical effects of climate change may also directly affect us. The global business community has increased its political and social awareness surrounding the issue, and the United States has entered into international agreements to reduce global temperatures, such as reentering the Paris Agreement. Further, the U.S. Congress, state legislatures, and federal and state regulatory agencies continue to propose numerous initiatives to supplement the global effort to combat climate change.

 

Further, the effects of climate change may negatively impact regional and local economic activity, which could adversely affect our customers and the communities in which we operate. In addition, there is a growing concern from advocacy groups and the general public that the emissions of greenhouse gases and other human activities have caused, or will cause, significant changes in weather patterns and temperatures and the frequency and severity of natural disasters.

 

While we seek to mitigate the risks associated with climate change, we recognize inherent climate-related risks regardless of where we conduct our businesses. Any of our locations may be vulnerable to the adverse effects of climate change. Climate-related events can disrupt our business, including our customers, and cause us to experience higher attrition, losses, and additional costs to resume operations. Access to clean water and reliable energy in the communities where we operate our Company is a priority.

 

35
 

 

Results of Operations

 

The following table sets forth the items in the consolidated statements of operations of the financial statements included herewith for the fiscal years ended December 31, 2022, and 2021 (in thousands).

 

   For the Years Ended 
   December 31, 
   2022   2021 
Revenue, net  $28,402   $33,882 
Cost of revenue and operating expenses          
Cost of components and personnel   15,204    15,164 
Inventory valuation adjustments   2,930    843 
General and administrative expenses   18,195    22,039 
Research and development   4,058    3,051 
Impairment of right-of-use assets   88     
Impairment of goodwill       9,189 
Amortization and depreciation   1,722    1,343 
Total cost of revenue and operating expenses   42,197    51,629 
Loss from operations   (13,795)   (17,747)
Other income (expenses)          
Changes in fair value of derivative liabilities       22 
Gain on settlement of debt   46    1,362 
Other income   32     
Interest expense, net   (38)   (29)
Total other income   40    1,355 
           
Net loss before income taxes  $(13,755)  $(16,392)

 

Revenue

 

The revenues for the year ended December 31, 2022, and 2021 were $28.4 million and $33.9 million, respectively, representing a decrease of $5.5 million or 16%. The revenue drop experienced a decline geographically of $6.0 million in North America, and $2.2 million in Europe, offset by an increase in sales of $3.0 million in the rest of the world.

 

The decrease in revenue is primarily due to: (1) a delay in the completion of several large government contracts and (2) management’s decision to reevaluate and discontinue several product lines due to their decline in performance expectations and lack of appeal to our customer base.

 

Cost of Revenue and Operating Expenses

 

Cost of Components and Personnel

 

The cost of components and personnel is $15.2 million for each year ending December 31, 2022, and 2021, respectively. The Company attributes maintaining this cost to (1) adopting a cost-savings plan in the third quarter of 2022, including a partial workforce reduction, and (2) eliminating specific product lines.

 

Inventory Valuation Adjustments

 

Inventory valuation adjustments are tools used to determine inventory measurement at lower-of-cost-or-market or lower-of-cost and net realizable value. For the years ended December 31, 2022, and 2021 inventory valuation adjustments amounted to $2.9 million and $0.9 million, representing an increase of $2.0 million or 222%. The cause of the increase is twofold: (1) the identifying of items of inventory considered obsolete, and (2) the observation of a decline in the profitability and consumer demand of specific product lines prompting the write down in the value of certain inventory items acknowledging a shift in market trends.

 

36
 

 

General and Administrative Expenses

 

General and administrative expenses are costs incurred in operating the business daily and include salary and benefit expenses, including stock-based compensation and payroll taxes, as well as the costs of trade shows, marketing programs, promotional materials, professional services, facilities, general liability insurance, travel and expenses associated with being a public company.

 

For the years ended December 31, 2022, and 2021, general and administrative expenses were $18.2 million and $22.0 million, respectively, representing a decrease of $3.8 million or 17%.

 

The decrease is principally connected with the reduction of $2.8 million in acquisition costs, $2.3 million in stock-based compensation, and $1.4 million in salaries and benefits. It was offset by an increase of $0.9 million in advertising, $0.5 million in legal fees, and $0.3 million in warranty costs and consulting fees.

 

Research and Development

 

Research and development expenses consist primarily of salary and benefit expenses, including stock-based compensation, payroll taxes, prototypes, facilities, and travel costs. For the years ended December 31, 2022, and 2021, research and development expenses were $4.1 million and $3.1 million, respectively, representing an increase of $1.0 million or 32%. The increase is primarily attributable to $0.8 million in salaries and miscellaneous research and consulting fees of $0.2 million.

 

Impairment of right-of-use assets

 

The Company recorded impairments related to the right-of-use assets operating leases for the years ended December 31, 2022, and 2021 totaling $0.88 million and $-0- million, respectively. The increase is due to the Company abandoning its leased facility in Billerica, Massachusetts.

 

Amortization and Depreciation

 

Amortization and depreciation expenses for the years ended December 31, 2022, and 2021 were $1.7 million and $1.3 million, respectively, representing an increase of $0.4 million or 31%. The increase is attributable to the recognition of a full year of amortization of intangible assets created by the acquisition of MVP.

 

Gain on settlement of debt

 

For the years ended December 31, 2022, and 2021, the Company recognized a gain on the settlement of debt amounting to $0.1 million and $1.4 million, respectively, a decrease of $1.3 million or 93%. The decline is predominantly attributable to the forgiveness in July 2021 of the U.S. government Payroll Protection Program grant procured by the Company in 2020.

 

Net Loss

 

Net losses for the years ended December 31, 2022, and 2021 were $13.8 million and $16.4 million, respectively, representing a decrease of $2.6 million or 16%.

 

The Company experienced significant decreases in costs attributable to acquisition expenditures, stock-based compensation, salaries, and benefits, offset by the recognition of inventory impairment and a decline in revenue.

 

37
 

 

Liquidity and Capital Resources

 

The Company incurred an approximate $13.8 million loss from operations and $9.2 million of cash used in operating activities for the year ended December 31, 2022. The Company had $38.6 million in working capital, $300.1 million in accumulated deficits, and $25.6 million cash on hand as of December 31, 2022.

 

During the year ended December 31, 2021, the Company issued 6,163,198 shares of common stock for net proceeds of $12,600,000 under its at-the-market facility with Alliance Global Partners (the “ATM”). As of March 31, 2022, approximately $4,500,000 of capacity remains under the ATM. On February 8, 2021, the Company completed an underwritten public offering for net proceeds of $46,820,000. The Company issued 18,181,820 shares of common stock, supplemented by 9,090,910 five-year warrants with an exercise price of $3.25 per share exercisable for one share.

 

The enduring effect of the COVID-19 pandemic, including the advent of successive variants, plus the uncertainty of possible future variants, may subject the Company to particular challenges in its business, financial condition, results of operations, and cash flows. The unpredictability of the pandemic’s scope, severity, duration, and actions implemented to alleviate its direct and indirect economic effects and containment measures provide no assurances that the pandemic will not have material adverse repercussions on the Company’s operations, liquidity, financial condition, and any residual unfavorable consequences to global economics.

 

Developments, including those beyond our control, may cause us to consume our available capital more quickly. The Company bases its evaluation on possibilities that may prove wrong and could exhaust our available capital resources sooner than we expect. These may include but are not limited to economic conditions, including inflation, foreign exchange, fluctuations, and the markets in which we compete or wish to enter, strategic acquisitions, our market strategy, our research and development activities, regulatory matters, and technology and product innovations. The Company believes it will have sufficient funds to continue its operations for at least twelve months from the filing date of these financial statements.

 

Our operations primarily have been funded through cash generated by debt and equity financing. Cash consists of cash on hand and demand deposits. Our cash balances were as follows (in thousands):

 

   Year Ended
December 31, 2022
   Year Ended
December 31, 2021
 
Cash  $25,627   $36,231 

 

Cash Flows

 

The following table sets forth the major components of our consolidated statements of cash flows data for the periods presented (in thousands).

 

   Year Ended
December 31, 2022
   Year Ended
December 31, 2021
 
Net cash used in operating activities  $(9,226)  $(9,601)
Net cash used in investment activities   (466)   (17,547)
Net cash provided by financing activities   (958)   58,312 
Effect of exchange rate changes on cash   46    (123)
Net (decrease) increase in cash  $(10,604)  $31,041 

 

Operating Activities

 

Net cash used in operating activities of approximately $9.2 million during the year ended December 31, 2022, was principally attributable to a decrease of $3.2 million in accounts receivable, $2.1 million in prepaid expenses and other current assets, $1.8 million in accrued expenses and interest expense, offset by an increase of $3.7 million in inventory. Additionally, the Company experienced a net loss of $13.5 million, $1.8 million in inventory impairment, $1.7 million of depreciation and amortization, and $1.1 million in inventory valuation adjustments.

 

Net cash used in operating activities of approximately $9.6 million during the year ended December 31, 2021, was principally attributable to a decrease of $1.4 million in accounts payable, a decrease of $0.5 million in operating lease liabilities, offset by an increase of $3.6 million in accounts receivable, $3.2 million of inventory, and $0.9 million of deferred revenue and customer deposits. Additionally, the Company experienced a net loss of $7.2 million, a $1.4 million gain on debt settlement, offset by an impairment in goodwill of $8.2 million, $3.9 million in stock-based compensation, $1.3 million in depreciation and amortization, and $0.8 million of an inventory valuation adjustment.

 

Investing Activities

 

Net cash in investing activities of $0.5 million during the year ended December 31, 2022, was principally related to the cash used to acquire furniture and computer equipment. Net cash used in investing activities of $17.5 million during the year ended December 31, 2021, was principally related to the cash used in the acquisition of 100% of MVP’s outstanding shares, cash acquired from the MVP acquisition, offset by a decrease in capital expenditures for furniture and computer equipment.

 

38
 

 

Financing Activities

 

Net cash used in financing activities of $0.96 million during the year ended December 31, 2022, was principally attributable to the principal payment of $1.0 million for the Company D & O insurance policy.Net cash provided by financing activities of $58.3 million during the year ended December 31, 2021, was principally attributable to net proceeds from equity raises and common stock warrants’ exercise offset by the principal payment of $1.0 million for the Company D & O insurance policy.

 

Nasdaq Compliance

 

As previously reported, on May 20, 2022, the Company received notice from the Nasdaq Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company of its noncompliance with Nasdaq Listing Rule 5550(a)(2) (the “Rule”) by failing to maintain a minimum bid price for its common stock on the Nasdaq Capital Market of at least $1.00 per share for 30 consecutive business days. The Company received a grace period of 180 days, or until November 16, 2022, to regain compliance with the minimum bid price requirement.

 

On November 10, 2022, the Company submitted a request to Nasdaq for an additional 180-day grace period to regain compliance with the Rule. On November 17, 2022, the Company received a letter from Nasdaq advising that the Company had been granted an additional 180-day grace period extension until May 15, 2023, to regain compliance with the Rule and all other applicable requirements for initial listing on the Nasdaq Capital Market except for the minimum bid price requirement of the Rule.

 

On January 11, 2023, the Company held a special meeting of stockholders (the “Special Meeting”) whereby stockholders voted and approved a proposal to authorize the Board of Directors of the Company (the “Board”), in its discretion but before the one-year anniversary of the date of the Special Meeting, to implement an amendment to the Company’s certificate of incorporation to effect a reverse stock split (the “Reverse Stock Split”) of all of the outstanding shares of Common Stock, par value $0.00001 per share (“Common Stock”), of the Company, at a ratio in the range of 1-for-2 to 1-for-50. The Company intends to monitor the closing bid price of its common stock and may, if appropriate, consider available options to regain compliance with the Rule, including initiating a Reverse Stock Split.

 

There can be no assurance that the Reverse Stock Split will result in a sustained increase in the per share market price for the Common Stock for the minimum period necessary to permit the Company to regain compliance with the Rule timely. There can be no assurance that the Company will be able to regain compliance with the Rule or other Nasdaq Listing Rules during the 180-day extension period ending May 15, 2023. If the Company does not regain compliance within the allotted compliance period, Nasdaq will provide notice that the common stock will be subject to delisting. The Company would then be entitled to appeal that determination to a Nasdaq hearings panel; if the Company timely appeals, the Company’s common stock will continue to be listed and traded on The Nasdaq Capital Market under the symbol “VISL,” subject to the Company’s compliance with the other continued listing requirements of The Nasdaq Capital Market pending the outcome of the appeal process.

 

Off-Balance Sheet Arrangements

 

We had no off-balance sheet arrangements for December 31, 2022, and 2021.

 

39
 

 

Critical Accounting Policies, Estimates, and Judgments

 

Our consolidated financial statements are prepared under the United States’ generally accepted accounting principles (“U.S. GAAP”), which require us to make estimates and assumptions. Critical accounting policies affect the more significant accounts, particularly judgments, assessments, and assumptions used to prepare our consolidated financial statements. Our management has determined the development and selection of these critical accounting policies. We have reviewed our critical accounting policies and estimates with the audit committee of our board of directors. Due to the significant judgment involved in selecting certain assumptions used in these policies, other parties may choose different assumptions and reach different conclusions. We consider our policies relating to the following matters to be critical accounting policies.

 

Business Combinations

 

The Company accounts for acquisitions that qualify as business combinations by applying the acquisition method according to Accounting Standards Codification (“ASC”) 805, Business Combinations (“ASC 805”). Transaction costs related to the acquisition of a business are expensed as incurred and excluded from the fair value of consideration transferred. The identifiable assets acquired, liabilities assumed, and noncontrolling interests in an acquired entity are recognized and measured at their estimated fair values. The excess of the fair value of consideration transferred over the fair values of identifiable assets acquired, liabilities assumed, and noncontrolling interests in an acquired entity, net of the fair value of any previously held interest in the acquired entity, is recorded as goodwill. Such valuations require management to make significant estimates and assumptions.

 

Principles of Consolidation

 

The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America or (“U.S. GAAP”) as found in the Accounting Standards Codification (“ASC”), the Accounting Standards Update (“ASU”) of the Financial Accounting Standards Board (“FASB”) and the rules and regulations of the US Securities and Exchange Commission (the “SEC”). The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. We have eliminated all intercompany accounts and transactions upon consolidating our subsidiaries.

 

Use of Estimates

 

The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements. These estimates also affect the reported revenues and expenses during the reporting periods. Significant accounting estimates reflected in the Company’s consolidated financial statements include the useful lives of property, plant, and equipment, the useful lives of right-of-use assets, the useful lives of intangible assets, impairment of long-lived assets, allowance for accounts receivable doubtful accounts, allowance for inventory obsolescence reserve, allowance for deferred tax assets, valuation of warranty reserves, contingent consideration liabilities, and the accrual of potential liabilities. Actual results could differ from estimates, and any such differences may be material to our financial statements.

 

Risks and Uncertainties

 

The future impacts of the Russia-Ukraine war, the novel coronavirus (“COVID-19”) pandemic, and their residual effects include economic uncertainty, an inflationary environment, currency fluctuations, disruption within the global supply chain, and labor markets worldwide industries remain uncertain. These circumstances have created prevalent uncertainty and risk. The impact of these issues on our business will vary by geographic market and discipline. In response to potential reductions in revenue, we may take actions to align our cost structure with changes in customer demand and manage our working capital. However, there can be no assurance as to the effectiveness of our efforts to mitigate any impact of the current and future adverse economic conditions, reductions in client revenue, changes in client creditworthiness, and other developments. We monitor the circumstances mentioned above to assess direct material adverse effects on our business, financial condition, or results of operations. Therefore, these impacts may change accounting estimates and assumptions over time. Interim period results are not necessarily indicative of the expected results for the full fiscal year.

 

Segment Reporting

 

The Company identifies operating segments as components of an enterprise about which separate discrete financial information is available for evaluation by the operating decision-makers, or decision-making group, in deciding how to allocate resources and assess performance. The Company’s decision-making group is the senior executive management team. The Company and the decision-making group view the Company’s operations and manage its business as one operating segment with different product offerings. All long-lived assets of the Company reside in the U.S., the U.K., and the Netherlands.

 

40
 

 

Critical Accounting Policies, Estimates, and Judgments (continued)

 

Accounts Receivable and Allowance for Doubtful Accounts

 

The Company extends credit to its customers in the ordinary course of business. Further, the Company regularly reviews outstanding receivables and provides for estimated losses through an allowance for doubtful accounts. In evaluating the level of established loss reserves, the Company makes judgments regarding its customer’s ability to make required payments, prevailing economic conditions, previous experience, and other factors. As these factors’ financial situation changes, circumstances develop, or additional information becomes available, adjustments to the allowance for doubtful accounts may be required. The Company maintains reserves for credit losses, and losses have been within its expectations.

 

Inventories

 

Inventories consist of raw materials, work-in-process, and finished goods and are recorded at the lower of cost, on a first-in, first-out basis, or net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable completion, disposal, and transportation costs. The Company evaluates inventory balances and either writes down obsolete inventory or records a reserve for slow-moving or excess inventory based on net realizable value analysis.

 

Property and Equipment

 

Property and equipment are presented at cost at the date of acquisition, less depreciation. Depreciation is computed using the straight-line method over estimated useful asset lives, ranging from 1 to 14 years. The costs of the day-to-day servicing of property and equipment and repairs and maintenance are recognized in expenses as incurred.

 

Goodwill

 

Goodwill represents the excess cost of an acquired business over the fair value of the identifiable tangible, and intangible assets acquired and liabilities assumed in a business combination under the acquisition method of accounting under ASC 805 “Business Combinations” (see Note 4). Goodwill is not amortized but, per ASC 350, is tested for impairment annually. Goodwill is also tested for impairment between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. Judgment determines if an indicator of impairment has occurred during a year. When testing goodwill for impairment, we may assess qualitative factors for some or all of our reporting units to determine whether it is more likely than not (that is, a likelihood of more than 50 percent) that the fair value of a reporting unit is less than its carrying amount, including goodwill. Alternatively, we may bypass this qualitative assessment for some or all of our reporting units and perform step 1 of the two-step goodwill impairment test. If we perform step 1 and the reporting unit’s carrying amount exceeds its fair value, we will perform step 2 to measure such impairment. We have completed our annual impairment test and recorded $-0- and $9,189,000 in goodwill impairment charges for the year ended December 31, 2022, and 2021, respectively.

 

Intangible Assets

 

Patents and licenses:

 

Patents and licenses, measured initially at purchase cost, are included in intangible assets on the Company’s balance sheet and are amortized on a straight-line basis over their estimated useful lives of 18.5 to 20 years. Amortization totaled $535,000 and $668,000 for the years ended December 31, 2022, and 2021, respectively.

 

Other intangible assets:

 

The Company’s remaining intangible assets include the trade names, technology, and customer lists acquired in IMT, Vislink, and Mobile Viewpoint Corporate B.V., a third-party appraiser, determined the value of these acquired assets for these business combinations. Absent an indication of fair value from a potential buyer or similar specific transactions, we have determined that using the methods employed provided a reasonable estimate in reporting the values assigned.

 

The Company amortizes intangible asset costs over their useful lives of 3 to 15 years with its net book value reported on the balance sheet. Amortization totaled approximately $986,000 and $480,000 for the years ended December 31, 2022, and 2021, respectively

 

Revenue Recognition

 

The Company recognizes revenue when we satisfy a performance obligation by transferring control of the promised goods or services to a customer in an amount that reflects the consideration we expect to receive in exchange for those services. The Company determines revenue recognition through the five (5) steps identified in Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers.

 

41
 

 

Critical Accounting Policies, Estimates, and Judgments (continued)

 

Stock-Based Compensation

 

The Company accounts for stock compensation with persons classified as employees for accounting purposes under ASC 718 “Compensation-Stock Compensation,” which recognizes awards at fair value on the date of grant and recognition of compensation over the service period for awards expected to vest. The fair value of stock options is determined using the Black-Scholes Option Pricing Model, and the fair value of common stock issued for services is determined based on the Company’s stock price on the issuance date.

 

The expansion of Topic 718 fell under ASU 2018-07 to include share-based payment transactions for acquiring goods and services from nonemployees. The measurement date for equity-classified nonemployee share-based payment awards is no longer at the earlier date at which a commitment for performance by the counterparty is reached or the date at which the counterparty’s performance is complete. Instead, the grant date is now considered the measurement date. Under today’s guidance, the measurement of nonemployee share-based payment awards with performance conditions is at the lowest aggregate fair value, often resulting in a zero value. The new ASU aligns the accounting for nonemployee share-based payment awards with performance conditions with accounting for employee share-based payment awards under Topic 718 by requiring entities to consider the probability of satisfying performance conditions. Current guidance requires entities to use the contractual term to measure the nonemployee share-based payment awards. The new ASU allows entities to make an award-by-award election to use the expected duration (consistent with employee share-based payment awards) or the contractual term for nonemployee awards.

 

Stock-Option Awards — Time-based and performance-based:

 

Under ASC Topic 718, the compensation cost is measured based on an award’s fair value at the grant’s date for the time vested option award using the Black Scholes-Merton formula as a valuation technique. The Company used the U.S. Treasury note’s rate over the expected option term for the risk-free rate. Employees’ expected term represents the period that options granted are expected to be outstanding using the simplified method. The Company’s historical share option exercise experience does not provide a reasonable basis for estimating the expected term. For nonemployee options, the expected term is the entire term of the option. Expected volatility is based on the average weekly share price changes over the shorter expected term or the period from the Nasdaq Capital Markets Exchange placement to the grant’s date. The Company estimates forfeiture and volatility using historical information. The risk-free interest rate is based on the implied yield on U.S. Treasury zero-coupon issues over the options’ equivalent lives.

 

The Company has not paid dividends on its common stock, and no assumption of dividend payment(s) is made in the model. For employee equity-classified awards, compensation cost is recognized over the employee’s requisite service period with a corresponding credit to additional paid-in capital. The employee’s requisite service period begins at the service inception date and ends when the requisite service has been provided.

 

Restricted Stock Unit Awards (“RSUs”) — Time-Based:

 

Under ASC 718, the exercise price for RSUs is determined using the fair market value of the Company’s common stock on the grant date. For an award with graded vesting subject only to a service condition (e.g., time-based vesting), ASC 718-10-35-8 provides an accounting policy choice between either graded vesting attribution or straight-line attribution. The Company elects the graded vesting method, recognizing compensation expense for only the portion of awards expected to vest. Forfeitures of time-based units and awards are recognized as they occur. Stock-based compensation costs are calculated using the closing stock price on the grant date to estimate the fair value of time-based restricted stock units.

 

Restricted Stock Unit Awards (“RSUs”) — Performance-Based:

 

The accruals of compensation cost for an award with a performance condition are related to that performance condition’s probable outcome. Under ASC 718, a “performance condition” is the achievement of a specified target that is defined by referring to the employer’s operations or activities, such as an option that vests if the employer’s growth rate increases by a certain amount or there are the attainments of regulatory approval for a product. There is an accrual of compensation cost upon the likely achievement of the performance condition, and there is no accrual if the accomplishment of the performance condition is not probable. The exercise price for RSUs is determined using the fair market value of the Company’s common stock on the grant date. Stock-based compensation costs are calculated using the closing stock price on the grant date to estimate performance-based restricted stock units’ fair value.

 

42
 

 

Critical Accounting Policies, Estimates, and Judgments (continued)

 

Impairment of long-lived assets

 

Management reviews long-lived assets, including property, plant, equipment, other intangible assets with definite lives, and right-of-use operating lease assets for impairment whenever events or changes in circumstances indicate that the asset’s carrying amount may not be recoverable. We conduct the Company’s long-lived asset impairment analyses under ASC 360-10-15, “Impairment or Disposal of Long-Lived Assets.” ASC 360-10-15 requires the Company to group assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities and evaluate the asset group against the sum of the undiscounted future cash flows. The contemplation of measuring an impairment charge occurs if the undiscounted cash flows do not indicate the asset’s carrying amount is recoverable, by which the asset group’s carrying amount exceeds its fair value based on discounted cash flow analysis appraisals. Under Topic 360, consideration is given to asset impairment, for intangible assets with definite lives continue to be amortized over their estimated useful lives and are subject to impairment testing as part of their asset group if and when events or changes in circumstances indicate. In performing the impairment tests, management utilizes considerable judgment and assumptions.

 

Right-of-use operating lease abandonment

 

Management decided to vacate the Billerica, MA facility as part of the Company’s cost savings strategy implemented in the third quarter of the fiscal year 2022. The economic environment of the location precluded the action of sub-letting, and management determined the (leased facility) to be abandoned. Under ASC 360, leased space abandonment is an impairment indicator, and the Company assessed the lease right-of-use (“ROU”) assets for impairment. The Company considered approximately $131,000 of right-of-use operating assets impaired, and for the years ending December 31, 2022, and 2021, we recognized a loss on impairment of right-of-use assets of approximately $88,000 and $-0-.

 

Common Stock Purchase Warrants and Other Derivative Financial Instruments

 

The Company assesses the classification of its freestanding derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required. The Company classifies common stock purchase warrants and other freestanding financial instruments as equity if the contracts (i) require physical settlement or net-share settlement in common stock or (ii) give the Company a choice of net-cash settlement or settlement in common stock (physical settlement or net-share settlement). The Company classifies the following contracts as either an asset or a liability: contracts that (i) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), (ii) give the counterparty a choice of net-cash settlement or settlement in common stock (physical settlement or net-share settlement) or (iii) contain reset provisions.

 

Commitments and Contingencies

 

Unless otherwise disclosed in this Report, we have no material commitments or contingent liabilities.

 

Recently Issued Accounting Pronouncements

 

Recently Issued Accounting Standards Adopted and Not Yet Adopted

 

Adopted on January 1, 2023

 

In June 2016, the FASB established Topic 326, Financial Instruments—Credit Losses, Measurement of Credit Losses on Financial Instruments (ASU) No. 2016-13, which requires a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates, including accounts receivable.

 

The standard replaces the existing incurred credit loss model with the Current Expected Credit Losses (“CECL”) model. It is required to measure credit losses based on the Company’s estimate of expected losses rather than incurred losses, which generally results in earlier recognition of allowances for credit losses. Under ASC 326, the Company evaluates specific criteria, including aging and historical write-offs, the current economic condition of particular customers, and future economic conditions of countries utilizing a consumption index to determine the appropriate allowance for credit losses. The Company completed its assessment of the new standard, and no adjustment will be made to its opening balance of retained earnings relating to its trade receivables. The Company writes off receivables once it is determined that the receivables are no longer collectible and as allowed by local laws.

 

Recent Accounting Pronouncements

 

Other recent accounting standards issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the SEC did not or are not believed by management to have a material impact on the Company’s present or future consolidated

financial statements.

 

43
 

 

Item 7A. Quantitative and Qualitative Disclosures About Market Risk

 

There is no requirement to include the disclosures required under Item 7A as a smaller reporting company under SEC rules.

 

Item 8. Financial Statements and Supplementary Data

 

The Company’s audited financial statements and notes appear in this report beginning on page F-1.

 

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

 

None.

 

Item 9A. Controls and Procedures

 

(a) Evaluation of Disclosure Controls and Procedures

 

Disclosure controls and procedures are controls and other procedures designed to ensure that the disclosure of required information in our reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information requiring disclosure in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer (our “Certifying Officers”), to allow timely decisions regarding required disclosure.

 

Management’s assessment of the Company’s design and operation of disclosure controls is ongoing. Based on the evaluation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Exchange Act) as of December 31, 2022, our Certifying Officers have concluded that, as of December 31, 2022, our disclosure controls and procedures were not effective at the reasonable assurance level, due to material weaknesses in internal control over financial reporting, as described below.

 

(b) Management’s Report on Internal Control over Financial Reporting

 

Management is responsible for establishing and maintaining adequate internal control over financial reporting (as such term is defined in Rule 13a-15(f) under the Exchange Act). Internal control over financial reporting is a process designed under the supervision and with the participation of our management, including our Certifying Officers, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes under generally accepted accounting principles. Our internal control over financial reporting includes those policies and procedures that: (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets; (2) provide reasonable assurance (a) that transactions are recorded as necessary to permit preparation of financial statements under generally accepted accounting principles, (b) that our receipts and expenditures are being made only following authorizations of our management and directors; and (3) provide reasonable assurance regarding the prevention or timely detection of the unauthorized acquisition, use or disposition of assets that could have a material effect on our financial statements.

 

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any effectiveness evaluation in future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.

 

As required by Rule 13a-15(c) under the Exchange Act, our Certifying Officers evaluated the effectiveness of our internal control over financial reporting as of December 31, 2022, using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control-Integrated Framework (2013). In their assessment of the effectiveness of internal control over financial reporting as of December 31, 2022, management concluded that such control was ineffective and that there were control deficiencies that constituted material weaknesses because (i) we currently do not employ the appropriate number of accounting personnel to ensure (a) we maintain proper segregation of duties, (b) conduct a tolerable risk assessment, and (ii) we have not adequately documented a complete assessment of the effectiveness of the design and operation of our internal control over financial reporting.

 

Management has engaged a third-party consultant to identify and document our internal control deficiencies and provide an assessment of current controls and recommendations regarding remediation efforts to eliminate or mitigate the control deficiencies.

 

Notwithstanding the identified material weakness as of December 31, 2022, management, including the Certifying Officers, believe that the condensed consolidated financial statements contained in this Annual Report filing fairly present, in all material respect, our financial condition, results of operations, and cash flows for the fiscal period presented in conformity with GAAP.

 

c) Changes in Internal Controls over Financial Reporting

 

Our remediation efforts specifically targeted the supervisory review of our accounting procedures. Additionally, these efforts have included integrating the August 16, 2021, acquisition of Mobile Viewpoint Corporate B.V. (“MVP”). Our assessment of the effectiveness of internal controls over financial reporting concerning MVP runs similar to the Company’s conclusion above of the material weaknesses identified in our annual report for December 31, 2022. See Note 3 of “Notes to The Condensed Consolidated Financial Statements.”

 

44
 

 

d) Auditor’s Report on Internal Control over Financial Reporting

 

This annual report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. According to SEC rules, management’s report was not subject to attestation by the Company’s registered public accounting firm, which permits us to provide only management’s report on internal control over financial reporting in this annual report on Form 10-K.

 

Item 9B. Other Information

 

None.

 

Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

 

None.

 

45
 

 

PART III

 

Item 10. Directors, Executive Officers, and Corporate Governance

 

The information required by this Item 10 is incorporated into this Report by reference to the information that will be contained in our proxy statement related to the 2023 Annual Meeting of Stockholders or an amendment to this Annual Report, which we intend to file with the SEC within 120 days of the end of our fiscal year.

 

Item 11. Executive Compensation

 

The information required by this Item 10 is incorporated into this Report by reference to the information that will be contained in our proxy statement related to the 2023 Annual Meeting of Stockholders or an amendment to this Annual Report, which we intend to file with the SEC within 120 days of the end of our fiscal year.

 

Item 12. Security Ownership of Certain Beneficial Owners and Management

 

The information required by Item 12 is incorporated into this Report by reference to the information that will be contained in our proxy statement related to the 2023 Annual Meeting of Stockholders or an amendment to this Annual Report, which we intend to file with the SEC within 120 days of the end of our fiscal year.

 

Item 13. Certain Relationships and Related Transactions, and Director Independence

 

The information required by this Item 13 is incorporated into this Report by reference to the information that will be contained in our proxy statement related to the 2023 Annual Meeting of Stockholders or an amendment to this Annual Report, which we intend to file with the SEC within 120 days of the end of our fiscal year.

 

Item 14. Principal Accountant Fees and Services

 

The information required by this Item 14 is incorporated into this Report by reference to the information that will be contained in our proxy statement related to the 2023 Annual Meeting of Stockholders or an amendment to this Annual Report, which we intend to file with the SEC within 120 days of the end of our fiscal year.

 

46
 

 

PART IV

 

Item 15. Exhibits, Financial Statement Schedules

 

(a) The following documents are filed as part of this Report:

 

  (1) Financial Statements:

 

The audited consolidated balance sheets of the Company as of December 31, 2022, and 2021, the related statements of operations and comprehensive loss, changes in stockholders’ equity and cash flows for each of the two years in the period ended December 31, 2022, the footnotes thereto, and the report of Marcum LLP, independent registered public accountants, are filed herewith.

 

  (2) Financial Schedules:

 

None.

 

Financial statement schedules have been omitted because they are either not applicable or the required information is included in the financial statements or notes thereto.

 

  (3) Exhibits:

 

The exhibits listed in the accompanying index to exhibits are filed or incorporated by reference as part of this Report.

 

(b) The following are exhibits to this Report, and, if incorporated by reference, we have indicated the document previously filed with the SEC in which the exhibit was included.

 

Certain agreements filed as exhibits to this Report contain representations and warranties by the parties to the agreements made solely for the agreement’s benefit. These representations and warranties:

 

  may have been qualified by disclosures that were made to the other parties in connection with the negotiation of the agreements, which disclosures are not necessarily reflected in the agreements;
  may apply standards of materiality that differ from those of a reasonable investor; and
  were made only as specified dates in the agreements and subject to subsequent developments and changed circumstances.

 

Accordingly, these representations and warranties may not describe the actual state of affairs as of the date that these representations and warranties were made or at any other time. Investors should not rely on them as statements of fact.

 

47
 

 

Exhibit
Number
  Description of Exhibit
1.1   Sales Agreement, dated May 5, 2020, by and between Vislink Technologies, Inc. and A.G.P./Alliance Global Partners(1)
3.1(i)   Amended & Restated Certificate of Incorporation (2)
3.1(i)(a)   Amendment to Certificate of Incorporation filed June 11, 2014 (3)
3.1 (i)(b)   Amendment to Certificate of Incorporation filed July 10, 2015 (4)
3.1(i)(c)   Amended and Restated Certificate of Designation of Series B Convertible Preferred Stock (5)
3.1(i)(d)   Certificate of Designation of Series C Convertible Preferred Stock (6)
3.1(i)(e)   Certificate of Designation of Series D Convertible Preferred Stock (7)
3.1(i)(f)   Certificate of Designation of Series E Convertible Preferred Stock (9)
3.1(i)(g)   Certificate of Designation of the Series A Preferred Stock of the Company, dated November 9, 2022(12)
3.1(i)(h)   Certificate of Elimination for Series C Convertible Preferred Stock (5)
3.1(i)(i)   Certificate of Elimination for Series B Convertible Preferred Stock (8)
3.1(i)(j)   Certificate of Elimination for Series D Preferred Stock of the Company, dated November 9, 2022(12)
3.1(i)(k)   Certificate of Elimination for Series E Preferred Stock of the Company, dated November 9, 2022(12)
3.1(i)(l)   Certificate of Elimination for Series A Preferred Stock of the Company, dated March 24, 2023(32)
3.1(i)(m)   Amendment to Certificate of Incorporation filed June 10, 2016 (31)
3.1(i)(n)   Certificate of Amendment to Certificate of Incorporation of the Company, filed with the Secretary of State of the State of Delaware on February 11, 2019(10)
3.1(i)(o)   Certificate of Amendment to the Certificate of Incorporation of the Company, filed with the Secretary of State of the State of Delaware on July 31, 2020(11)
3.1(ii)   Third Amended & Restated Bylaws (13)
4.1   Form of Common Stock Certificate of the Registrant (14)
4.2   Form of Warrant Agreement by and between the Registrant and Continental Stock Transfer & Trust Company and Form of Warrant Certificate for the offering closed July 24, 2013, and August 19, 2013 (15)
4.3   Form of Warrant (16)
4.4   Form of Vislink Promissory Note (17)
4.5   Form of Underwriters’ Warrant for February 2017 Offering (18)
4.6   Form of Warrant for August 2017 Offering (19)
4.7   Form of 6% Senior Secured Convertible Debenture(20)
4.8   Form of Common Stock Purchase Warrant(20)
4.9   Form of Amended and Restated 6% Senior Secured Debenture(21)
4.10   Warrant Agreement, including Form of Common Warrant and Form of Pre-Funded Warrant from July 2019 Offering(22)
4.11*   Description of Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934.
10.1   2013 Long Term Incentive Plan (23)
10.2   Amendment No.1 to 2013 Long Term Incentive Plan (24)
10.3   Forms of Agreement Under 2013 Long Term Incentive Plan (23)

 

48
 

 

Exhibit
Number
  Description of Exhibit
10.4   Employment Agreement by and between the Company and Carleton Miller, dated as of January 22, 2020 (25)
10.5   Notice of Grant of Stock Option for Time-Vested Options and Stock Option Agreement by and between the Company and Carleton Miller, dated as of January 22, 2020 (25)
10.6   Notice of Grant of Stock Option for Performance-Vested Options and Stock Option Agreement by and between the Company and Carleton Miller, dated as of January 22, 2020 (25)
10.7   Employment Agreement by and between the Company and Michael Bond, dated as of February 27, 2020 (26)
10.8   Form of Indemnification Agreement by and between the Company and its officers and directors (26)
10.9   Non-Employee Director Compensation Policy (27)
10.10   Form of Non-Employee Director Restricted Shares Agreement (27)
14.1   Code of Ethics (28)
21.1   Subsidiaries of the Registrant (29)
23.1*   Consent of Marcum LLP
31.1*   Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2*   Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1*   Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2*   Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS   Inline XBRL Instance Document
101.SCH   Inline XBRL Taxonomy Schema
101.CAL   Inline XBRL Taxonomy Calculation Linkbase
101.DEF   Inline XBRL Taxonomy Definition Linkbase
101.LAB   Inline XBRL Taxonomy Label Linkbase
101.PRE   Inline XBRL Taxonomy Presentation Linkbase
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

49
 

 

In accordance with SEC Release 33-8238, Exhibits 32.1 and 32.2 are being furnished and not filed.

 

* Filed herewith
(1) Filed as an Exhibit on Current Report on Form 8-K with the SEC on May 5, 2020.
(2) Filed as an Exhibit on Form S-1 with the SEC on October 23, 2013.
(3) Filed as an Exhibit on Current Report on Form 8-K with the SEC on June 13, 2014.
(4) Filed as an Exhibit on Current Report on Form 8-K with the SEC on July 20, 2015.
(5) Filed as an Exhibit on Current Report on Form 8-K with the SEC on February 10, 2016.
(6) Filed as an Exhibit on Current Report on Form 8-K with the SEC on February 26, 2015.
(7) Filed as an Exhibit on Current Report on Form 8-K with the SEC on April 27, 2016
(8) Filed as an Exhibit on Current Report on Form 8-K with the SEC on December 7, 2016.
(9) Filed as an Exhibit on Current Report on Form 8-K with the SEC on December 27, 2016.
(10) Filed an Exhibit on Current Report on Form 8-K with the SEC on February 26, 2019.
(11) Filed as an Exhibit on Current Report on Form 8-K with the SEC on August 5, 2020.
(12) Filed as an Exhibit on Current Report on Form 8-K with the SEC on November 9, 2022.
(13) Filed as an Exhibit on Current Report on Form 8-K with the SEC on August 20, 2021.
(14) Filed as an Exhibit on Form S-1/A with the SEC on May 21, 2013.
(15) Filed as an Exhibit on Current Report to Form 8-K with the SEC on August 19, 2013.
(16) Filed as an Exhibit on Current Report on Form 8-K with the SEC on May 13, 2016.
(17) Filed as an Exhibit on Current Report on Form 8-K with the SEC on February 6, 2017.
(18) Filed as an Exhibit on Current Report on Form 8-K with the SEC on February 10, 2017.
(19) Filed as an Exhibit on Current Report on Form 8-K with the SEC on August 16, 2017.
(20) Filed as an Exhibit on Current Report on Form 8-K with the SEC on May 29, 2018.
(21) Filed as an Exhibit on Current Report on Form 8-K with the SEC on October 11, 2018.
(22) Filed as an Exhibit on Current Report on Form 8-K with the SEC on July 16, 2019.
(23) Filed as an Exhibit on Form S-1 with the SEC on March 7, 2013.
(24) Filed as an Exhibit on Current Report on Form 8-K with the SEC on January 7, 2021.
(25) Filed as an Exhibit on Current Report on Form 8-K/A with the SEC on January 24, 2020.
(26) Filed as an Exhibit on Annual Report on Form 10-K with the SEC on April 1, 2020.
(27) Filed as an Exhibit on Quarterly Report on Form 10-Q with the SEC on November 12, 2020.
(28) Filed as an Exhibit on Annual Report on Form 10-K with the SEC on March 6, 2014.
(29) Filed as an Exhibit on Form S-1/A with the SEC on October 30, 2019.
(30) Filed as an Exhibit on Current Report on Form 8-K with the SEC on March 26, 2023.
(31) Filed as an Exhibit on Current Report on Form 8-K with the SEC on June 20, 2016.

 

50
 

 

SIGNATURES

 

Pursuant to the requirement of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  VISLINK TECHNOLOGIES, INC.
     
Date: March 31, 2023 By: /s/ Carleton Miller
    Carleton Miller
   

Chief Executive Officer

(Duly Authorized Officer and Principal Executive Officer)

     
Date: March 31, 2023 By: /s/ Michael C. Bond
    Michael C. Bond
   

Chief Financial Officer

(Duly Authorized Officer and Principal Financial Officer)

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Signature   Title   Date
         
/s/ Carleton Miller   Chief Executive Officer   March 31, 2023
Carleton Miller   (Principal Executive Officer)    
         
/s/ Michael C. Bond   Chief Financial Officer   March 31, 2023
Michael C. Bond   (Principal Financial and Accounting Officer)    
         
/s/ Susan Swenson   Chairman of the Board of Directors   March 31, 2023
Susan Swenson        
         
/s/ Jude T. Panetta   Director   March 31, 2023
Jude T. Panetta        
         
/s/ James T. Conway   Director   March 31, 2023
James T. Conway        
         
/s/ Ralph Faison   Director   March 31, 2023
Ralph Faison        
         
/s/ Brian K. Krolicki   Director   March 31, 2023
Brian K. Krolicki        

 

51
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

December 31, 2022, and 2021

 

    Page
Consolidated Financial Statements    
Report of Independent Registered Public Accounting Firm (PCAOB ID Number 688)   F-2
Consolidated Balance Sheets   F-3
Consolidated Statements of Operations and Comprehensive Loss   F-4
Consolidated Statements of Changes in Stockholders’ Equity   F-5
Consolidated Statements of Cash Flows   F-6
Notes to Consolidated Financial Statements   F-8

 

F-1
 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Shareholders and Board of Directors of

Vislink Technologies, Inc.

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of Vislink Technologies, Inc. (the “Company”) as of December 31, 2022 and 2021, the related consolidated statements of operations, comprehensive loss, change in stockholders’ equity and cash flows for each of the two years in the period ended December 31, 2022, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2022 and 2021, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2022 and 2021, in conformity with accounting principles generally accepted in the United States of America.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (“PCAOB”) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

Critical Audit Matters

 

Critical audit matters are matters arising from the current period audit of the financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. We determined that there are no critical audit matters.

 

/s/ Marcum LLP  
   
Marcum LLP  
   
We have served as the Company’s auditor since 2015  
   
New York, NY  
March 31, 2023  

 

F-2
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(IN THOUSANDS, EXCEPT SHARE DATA)

 

   2022   2021 
   December 31, 
   2022   2021 
ASSETS          
Current assets          
Cash  $25,627   $36,231 
Accounts receivable, net   6,007    9,069 
Inventories, net   12,021    11,894 
Prepaid expenses and other current assets   1,232    2,470 
Total current assets   44,887    59,664 
Right of use assets, operating leases   1,075    1,362 
Property and equipment, net   1,434    1,173 
Intangible assets, net   4,400    5,921 
Total assets  $51,796   $68,120 
LIABILITIES AND STOCKHOLDERS’ EQUITY          
Current liabilities          
Accounts payable  $2,626   $3,075 
Accrued expenses   1,568    3,155 
Notes payable   84    99 
Operating lease obligations, current   455    560 
Customer deposits and deferred revenue   1,540    2,113 
Total current liabilities   6,273    9,002 
Operating lease obligations, net of current portion   1,107    1,507 
Deferred tax liabilities   764    978 
Total liabilities   8,144    11,487 
Commitments and contingencies (See Note 1)   -    - 
           
Series A Preferred stock, $0.00001 par value per share: 47,500 and -0- shares authorized on December 31, 2022, and 2021, respectively; 47,419 and -0- shares issued and outstanding on December 31, 2022, and 2021, respectively at a redemption value equal to $0.10 in cash for each ten thousand (10,000) whole shares.        
           
Stockholders’ equity          
Preferred stock, $0.00001 par value per share: 10,000,000 shares authorized on December 31, 2022, and 2021, respectively        
Common stock, $0.00001 par value per share, 100,000,000 shares authorized on December 31, 2022, and 2021, respectively:          
Common stock, 47,419,317 and 45,825,089 were issued, and 47,416,658 and 45,822,430 were outstanding on December 31, 2022, and 2021, respectively.        
Additional paid-in capital   345,365    343,746 
Accumulated other comprehensive loss   (1,337)   (297)
Treasury stock, at cost – 2,659 shares as of December 31, 2022, and 2021, respectively   (277)   (277)
Accumulated deficit   (300,099)   (286,539)
Total stockholders’ equity   43,652    56,633 
Total liabilities and stockholders’ equity  $51,796   $68,120 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-3
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(IN THOUSANDS, EXCEPT NET LOSS PER SHARE DATA)

 

   2022   2021 
   For the Years Ended 
   December 31, 
   2022   2021 
Revenue, net  $28,402   $33,882 
Cost of revenue and operating expenses          
Cost of components and personnel   15,204    15,164 
Inventory valuation adjustments   2,930    843 
General and administrative expenses   18,195    22,039 
Research and development   4,058    3,051 
Impairment of right-of-use assets   88     
Impairment of goodwill       9,189 
Amortization and depreciation   1,722    1,343 
Total cost of revenue and operating expenses   42,197    51,629 
Loss from operations   (13,795)   (17,747)
Other income (expenses)          
Changes in fair value of derivative liabilities       22 
Gain on settlement of debt   46    1,362 
Other income   32     
Interest expense, net   (38)   (29)
Total other income   40    1,355 
           
Net loss before income taxes   (13,755)   (16,392)
           
Income taxes          
Deferred tax benefits   215     
           
Net loss   (13,540)   (16,392)
           
Dividends   (20)    
           
Net loss attributable to common shareholders  $(13,560)  $(16,392)
           
Net loss per share attributable to Common Shareholders:          
Basic and diluted loss per share  $(0.29)  $(0.38)
           
Weighted average number of shares outstanding:          
Basic and Diluted   46,692    43,484 
           
Comprehensive loss:          
Net loss  $(13,540)  $(16,392)
Unrealized gain (loss) on currency translation adjustment   1,040    (445)
Comprehensive loss  $(12,500)  $(16,837)

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-4
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(IN THOUSANDS, EXCEPT SHARE DATA)

 

   Shares   Amount   Shares    Amount   Capital   Income (Loss)    Stock   Deficit   

Total

 
   Series A Preferred Stock   Common Stock  

Additional

Paid In

  

Accumulated

Other

Comprehensive

   Treasury   Accumulated     
   Shares   Amount   Shares    Amount   Capital   Income (Loss)    Stock   Deficit   

Total

 
                                     
Balance, December 31, 2020      $    21,382,290   $   $280,273   $148   $(277)  $(270,147)  $9,997 
                                              
Net loss                                            (16,392)   (16,392)
                                              
Unrealized gain on currency translation adjustment                       (445)           (445)
                                              
Issuance of common stock in connection with:                                             
                                              
Underwriting equity raises, net of offering costs           24,348,018        59,334                17,346 
                                              
Exercise of common stock warrants           3,811        2                11 
                                              
Exercise of cashless common stock warrants           6,250                         
                                              
Stock issuance commitments           87,720        200                330 
                                              
Warrants issued in settlement agreement                   74                 
                                              
Stock-based compensation                   3,863                715 
                                              
Balance, December 31, 2021      $    45,825,089   $   $343,746   $(297)  $(277)  $(286,539)  $56,633 
                                              
Net loss                               (13,540)   (13,540)
                                              
Unrealized gain on currency translation adjustment                       (1,040)           (1,040)
                                              
Issuance of shares of Series A Preferred Stock as dividends for common stock shareholders   47,419                                  (20)   (20)
                                              
Issuance of common stock in connection with:                                             
                                              
Satisfaction of accounts payable vendor balance           77,406        54                54 
                                              
Satisfaction of withholding tax upon conversion of restricted stock units           357,778                         
                                              
Satisfaction with the conversion of restricted stock units           1,159,044                         
                                              
Stock-based compensation                   1,565                1,565 
                                              
Balance, December 31, 2022   47,419   $    47,419,317   $   $345,365   $(1,337)  $(277)  $(300,099)  $43,652 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-5
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(IN THOUSANDS)

 

   2022   2021 
   Years Ended December 31, 
   2022   2021 
Cash flows used in operating activities          
Net loss  $(13,540)  $(16,392)
Adjustments to reconcile net loss to net cash used in operating activities          
Gain on settlement of debt   (46)   (1,362)
Stock-based compensation   1,565    3,863 
Stock issuance commitments   200    200 
Warrants issued in settlement agreement       74 
Provision for bad debt   21    233 
Recovery of bad debt   (517)   (310)
Inventory valuation adjustments   2,930    843 
Amortization of right-of-use assets, operating assets   201    237 
Impairment of right-of-use assets   88     
Impairment of goodwill       9,189 
Depreciation and amortization   1,722    1,343 
Change in fair value of derivative liabilities       (22)
Deferred tax benefits   (215)    
Changes in assets and liabilities          
Accounts receivable   3,197    (3,611)
Inventory   (3,731)   (3,187)
Prepaid expenses and other current assets   2,090    96 
Accounts payable   (347)   (2,388)
Accrued expenses and interest expense   (1,780)   231 
Operating lease liabilities   (506)   (483)
Deferred revenue and customer deposits   (558)   867 
Deferred tax liabilities       978 
Net cash used in operating activities   (9,226)   (9,601)
Cash flows used in investing activities          
Cash acquired from MVP for acquisition       965 
Cash used in MVP stock acquisition       (18,311)
Cash used for property and equipment   (466)   (201)
Net cash used in investing activities   (466)   (17,547)
Cash flows (used in) provided by financing activities          
Proceeds received from equity financings       62,914 
Costs incurred in connection with equity financing       (3,580)
Proceeds from the exercise of common stock warrants       2 
Principal payments made on D & O notes payable   (958)   (1,024)
Net cash (used) provided in financing activities   (958)   58,312 
Effect of exchange rate changes on cash   46    (123)
Net (decrease) increase in cash   (10,604)   31,041 
Cash, beginning of the period   36,231    5,190 
Cash, end of the period  $25,627   $36,231 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-6
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS (continued)

(IN THOUSANDS)

 

   Years Ended December 31 
   2022   2021 
Supplemental disclosure of cash payments:          
Cash paid during the period for interest  $41   $56 
           
Supplemental disclosure of non-cash information:          
Notes payable recognized on D & O Insurance policy (Note 11)  $943   $1,098 
           
Issuance of shares of Series A Preferred Stock as dividends for common stock shareholders  $20   $ 
           
Common stock issued in connection with:          
Board compensation awards previously accrued  $200   $200 
           
Settlement of amounts due accounts payable  $54   $ 
           
Warrants issued in settlement agreement  $   $74 
           
ROU assets and operating lease obligations recognized (Note 12):          
Operating lease assets recognized  $   $522 
Less: non-cash changes to operating lease assets amortization          
amortization   (1,185)   (237)
impairments   (43)    
loss on lease impairments   (88)    
ROU assets and operating lease obligations recognized  $(1,316)  $285 
           
Operating lease liabilities recognized  $   $531 
Less: non-cash changes to operating lease liabilities accretion      (506 )      (483 )
Operating lease liabilities recognized  $(506)  $48 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-7
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1 — NATURE OF OPERATIONS

 

Vislink, incorporated in Delaware in 2006, is a global technology business specializing in collecting, delivering, and managing high-quality, live video and associated data from the action scene to the viewing screen. Vislink provides solutions for collecting live news, sports, entertainment, and news events for the broadcast markets. Vislink also furnishes the surveillance and defense markets with real-time video intelligence solutions using various tailored transmission products. The Vislink team also provides professional and technical services utilizing a staff of technology experts with decades of applied knowledge and real-world experience in the terrestrial microwave, satellite, fiber optic, surveillance, and wireless communications systems delivering a broad spectrum of customer solutions.

 

Live Broadcast:

 

Vislink delivers an extensive portfolio of solutions for live news, sports, and entertainment industries. These solutions include video collection, transmission, management, and distribution via microwave, satellite, cellular, I.P. (Internet Protocol), MESH, and bonded cellular/5G networks. We also provide solutions utilizing A.I. (Artificial Intelligence) technologies to provide automated news and sporting events coverage. With over 50 years in operation, Vislink has the expertise and technology portfolio to deliver fully integrated, seamless, end-to-end solutions.

 

Industry-wide contributors acknowledge Vislink’s live broadcast solutions. The transmission of most of all outside wireless broadcast video content uses our equipment, with over 200,000 systems installed worldwide. We work closely with the majority of the world’s broadcasters. Vislink wireless cameras and ultra-compact encoders help bring many of the world’s most prestigious sporting and entertainment events to life. Recent examples include globally watched international sporting contests, award shows, racing events, and annual music and cultural events.

 

Military And Government:

 

Vislink has developed high-quality solutions to meet surveillance and defense markets’ operational and industry challenges based on our knowledge of live video delivery. Vislink solutions are specifically designed with interagency cooperation, utilizing the internationally-recognized I.P. platform and a web interface for video delivery. Vislink provides comprehensive video, audio, and data communications solutions to law enforcement and the public safety community, including Airborne, Unmanned Systems, Maritime, and Tactical Mobile Command Posts. These solutions may include:

 

integrated suites of airborne downlink transmitters, receivers, and antenna systems
data and video connectivity for airborne, marine, and ground assets
UAV video distribution
flexible support for COFDM and bonded cellular/5G Networks
terrestrial point-to-point
tactical mobile command
IP-based, high-end encryption, full-duplex, real-time connectivity at extended operating ranges
high-throughput air/marine/ground-to-anywhere uplink and downlink systems
secure live streaming platforms for use in mobile and fixed assets
personal portable products

 

Vislink public safety and surveillance solutions are deployed worldwide, including throughout the U.S., Europe, and the Middle East, at the local, regional, and federal levels of operation, criminal investigation, crisis management, mobile command posts, and field operations. These solutions are designed to meet the demands of field operations, command centers, and central receiving sites. Short-range and long-range solutions are available in areas including established infrastructure and exceptionally remote regions, making valuable video intelligence available regardless of location.

 

Satellite Communications:

 

Over 30 years of technical expertise support Vislink’s satellite solutions. These solutions ensure robust, secure communications while delivering low transmission costs for any organization that needs high-quality, reliable satellite transmission. We offer turnkey solutions that begin with state-of-the-art coding, compression, and engine modulation and end with our robust, lightweight antenna systems. Vislink Satellite solutions focus heavily on being the smallest, lightest, and most efficient in their categories, making transportation and ease of use a key driver in the customer experience. Vislink offers an extensive range of satellite designs that allow customers to optimize bit rate, size, weight, and total cost. Our satellite systems are used extensively globally, with over 2,000 systems deployed by governments, militaries, and broadcasters. While we continue offering satellite solutions, we no longer invest in the engineering and product development necessary to stay relevant in the sector. We will continue to market and sell our current solutions but do not anticipate introducing further upgrades or features to our satellite product line.

 

F-8
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1 — NATURE OF OPERATIONS (continued)

 

Connected Edge Solutions:

 

Vislink offers the hardware and software solutions needed to acquire, produce, contribute, and deliver video over all private and public networks with the Mobile Viewpoint acquisition. Connected edge solutions aid the video transport concept of ubiquitous IP networks and cloud-scale computing across 5G, WiFi6, Mesh, and COFDM-enabled networks. These solutions include:

 

  Live video encoding, stream adaptation, decoding, and production solutions
  Remote production workflows
  Wireless cameras
  AI-driven automated production
  Ability to contribute video over:
    Bonded cellular (3G and 4G)
    Satellite
    Fiber
    Emerging networks, including 5G and Starlink

 

NOTE 2 — LIQUIDITY AND FINANCIAL CONDITION

 

The Company incurred an approximate $13.8 million loss from operations and $9.2 million of cash used in operating activities for the year ended December 31, 2022. The Company had $38.6 million in working capital, $300.1 million in accumulated deficits, and $25.6 million cash on hand as of December 31, 2022.

 

During the year ended December 31, 2021, the Company issued 6,163,198 shares of common stock for net proceeds of $12,600,000 under its at-the-market facility with Alliance Global Partners (the “ATM”). As of March 16, 2023, approximately $4,500,000 of capacity remains under the ATM. On February 8, 2021, the Company completed an underwritten public offering for net proceeds of $46,820,000. The Company issued 18,181,820 shares of common stock, supplemented by 9,090,910 five-year warrants with an exercise price of $3.25 per share exercisable for one share.

 

The enduring effect of the COVID-19 pandemic, including the advent of successive variants, plus the uncertainty of possible future variants, may subject the Company to particular challenges in its business, financial condition, results of operations, and cash flows. The unpredictability of the pandemic’s scope, severity, duration, and actions implemented to alleviate its direct and indirect economic effects and containment measures provide no assurances that the pandemic will not have material adverse repercussions on the Company’s operations, liquidity, financial condition, and any residual unfavorable consequences to global economics.

 

Developments, including those beyond our control, may cause us to consume our available capital more quickly. The Company bases its evaluation on possibilities that may prove wrong and could exhaust our available capital resources sooner than we expect. These may include but are not limited to economic conditions, including inflation, foreign exchange, fluctuations, and the markets in which we compete or wish to enter, strategic acquisitions, our market strategy, our research and development activities, regulatory matters, and technology and product innovations. The Company believes it will have sufficient funds to continue its operations for at least twelve months from the filing date of these financial statements.

 

NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Business Combinations

 

The Company accounts for acquisitions that qualify as business combinations by applying the acquisition method according to Accounting Standards Codification (“ASC”) 805, Business Combinations (“ASC 805”). Transaction costs related to the acquisition of a business are expensed as incurred and excluded from the fair value of consideration transferred. The identifiable assets acquired, liabilities assumed, and noncontrolling interests in an acquired entity are recognized and measured at their estimated fair values. The excess of the fair value of consideration transferred over the fair values of identifiable assets acquired, liabilities assumed, and noncontrolling interests in an acquired entity, net of the fair value of any previously held interest in the acquired entity, is recorded as goodwill. Such valuations require management to make significant estimates and assumptions.

 

F-9
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

Principles of Consolidation

 

The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America or (“U.S. GAAP”) as found in the Accounting Standards Codification (“ASC”), the Accounting Standards Update (“ASU”) of the Financial Accounting Standards Board (“FASB”) and the rules and regulations of the US Securities and Exchange Commission (the “SEC”). The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. We have eliminated all intercompany accounts and transactions upon consolidating our subsidiaries.

 

Segment Reporting

 

The Company identifies operating segments as components of an enterprise about which separate discrete financial information is available for evaluation by the operating decision-makers, or decision-making group, in deciding how to allocate resources and assess performance. The Company’s decision-making group is the senior executive management team. The Company and the decision-making group view the Company’s operations and manage its business as one operating segment with different product offerings. All long-lived assets of the Company reside in the U.S., the U.K., and the Netherlands.

 

Use of Estimates

 

The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities in the consolidated financial statements. Significant accounting estimates reflected in the Company’s consolidated financial statements include the useful lives of property, plant, and equipment, the useful lives of right-of-use assets, the useful lives of intangible assets, impairment of long-lived assets, allowance for accounts receivable doubtful accounts, allowance for inventory obsolescence reserve, allowance for deferred tax assets, valuation of warranty reserves, contingent consideration liabilities, and the accrual of potential liabilities. These estimates also affect the reported revenues and expenses during the reporting periods. Actual results could differ from estimates, and any such differences may be material to our financial statements.

 

Risks and Uncertainties

 

The future impacts of the Russia-Ukraine war, the novel coronavirus (“COVID-19”) pandemic, and their residual effects include economic uncertainty, an inflationary environment, currency fluctuations, disruption within the global supply chain, and labor markets worldwide industries remain uncertain. These circumstances have created prevalent uncertainty and risk. The impact of these issues on our business will vary by geographic market and discipline. In response to potential reductions in revenue, we may take actions to align our cost structure with changes in customer demand and manage our working capital. However, there can be no assurance as to the effectiveness of our efforts to mitigate any impact of the current and future adverse economic conditions, reductions in client revenue, changes in client creditworthiness, and other developments. We monitor the circumstances mentioned above to assess direct material adverse effects on our business, financial condition, or results of operations. Therefore, these impacts may change accounting estimates and assumptions over time. Interim period results are not necessarily indicative of the expected results for the full fiscal year.

 

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. The Company did not have cash equivalents as of December 31, 2022, and 2021.

 

F-10
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

 

Concentrations

 

The Company does not have any off-balance-sheet concentrations of credit risk. Credit risk is that the counterparty will default on its contractual obligations, resulting in a company’s financial loss. The Company’s credit risk is primarily attributable to its cash and accounts receivables. The Company’s policy is to maintain its cash with high-credit quality financial institutions to limit its risk of loss exposure. Financial instruments potentially subject the Company to credit risk concentration consisting of cash deposits. The Federal Deposit Insurance Corporation (“FDIC”) insures accounts held within the United States up to $250,000. The Company maintains cash balance accounts at financial institutions in the United Kingdom insured by the Financial Services Compensation Scheme up to £85,000, subject to currency translation rates to the United States dollar. Lastly, the Company maintains cash balance accounts at financial institutions in the Netherlands insured by the “Dutch deposit guarantee scheme” up to €100,000 per person, per bank.

 

On December 31, 2022, and 2021, the Company had approximately $24.5 million and $35.2 million above insured limits, respectively. The Company has not experienced any losses in its bank accounts between December 31, 2022, and 2021.

 

Management assesses their credit quality for customers, considering their financial position and historical experience. During the year ended December 31, 2022, the Company recorded sales to a single customer of $3,436,000 (12%), in excess of 10% of the Company’s total sales. For the year ended December 31, 2021, the Company recorded sales to a single customer of $8,511,000 (25%) in excess of 10% of the Company’s total sales.

 

On December 31, 2022, and 2021, the Company recorded accounts receivable of approximately $1,138,000 (19%) and $4,204,000 (46%), respectively, to a single customer in excess of 10% of the Company’s total consolidated accounts receivable.

 

Accounts Receivable and Allowance for Doubtful Accounts

 

The Company extends credit to its customers in the ordinary course of business. Further, the Company regularly reviews outstanding receivables and provides for estimated losses through an allowance for doubtful accounts. In evaluating the level of established loss reserves, the Company makes judgments regarding its customer’s ability to make required payments, prevailing economic conditions, previous experience, and other factors. As these factors’ financial situation changes, circumstances develop, or additional information becomes available, adjustments to the allowance for doubtful accounts may be required. The Company maintains reserves for credit losses, and losses have been within its expectations.

 

Inventories

 

Inventories consist of raw materials, work-in-process, and finished goods and are recorded at the lower of cost, on a first-in, first-out basis, or net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable completion, disposal, and transportation costs. The Company evaluates inventory balances and either writes down obsolete inventory or records a reserve for slow-moving or excess inventory based on net realizable value analysis.

 

Property and Equipment

 

Property and equipment are presented at cost at the date of acquisition, less depreciation. Depreciation is computed using the straight-line method over estimated useful asset lives, ranging from 1 to 14 years. The costs of the day-to-day servicing of property and equipment and repairs and maintenance are recognized in expenses as incurred.

 

Goodwill

 

Goodwill represents the excess cost of an acquired business over the fair value of the identifiable tangible, and intangible assets acquired and liabilities assumed in a business combination under the acquisition method of accounting under ASC 805 “Business Combinations” (see Note 4). Goodwill is not amortized but, per ASC 350, is tested for impairment annually. Goodwill is also tested for impairment between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. Judgment determines if an indicator of impairment has occurred during a year. When testing goodwill for impairment, we may assess qualitative factors for some or all of our reporting units to determine whether it is more likely than not (that is, a likelihood of more than 50 percent) that the fair value of a reporting unit is less than its carrying amount, including goodwill. Alternatively, we may bypass this qualitative assessment for some or all of our reporting units and perform step 1 of the two-step goodwill impairment test. If we perform step 1 and the reporting unit’s carrying amount exceeds its fair value, we will perform step 2 to measure such impairment. We have completed our annual impairment test and recorded $-0- and $9,189,000 in goodwill impairment charges for the years ended December 31, 2022, and 2021, respectively.

 

F-11
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

 

Intangible Assets

 

Patents and licenses:

 

Patents and licenses, measured initially at purchase cost, are included in intangible assets on the Company’s balance sheet and are amortized on a straight-line basis over their estimated useful lives of 18.5 to 20 years. Amortization totaled approximately $535,000 and $668,000 for the years ended December 31, 2022, and 2021, respectively.

 

Other intangible assets:

 

The Company’s remaining intangible assets include the trade names, technology, and customer lists acquired in its acquisition of IMT, Vislink, and Mobile Viewpoint Corporate B.V. (“MVP”). A third-party appraiser determined the value of these acquired assets for these business combinations. Absent an indication of fair value from a potential buyer or similar specific transactions, we have determined that using the methods employed provided a reasonable estimate in reporting the values assigned.

 

The Company amortizes intangible asset costs over their useful lives of 3 to 15 years with its net book value reported on the balance sheet. Amortization totaled approximately $985,000 and $480,000 for the years ended December 31, 2022, and 2021, respectively.

 

Warranty Reserve

 

Although the Company tests its product under its quality programs and processes, its warranty obligation is affected by product failure rates and service delivery costs incurred in correcting a product failure. Required revisions to the estimated warranty liability will occur should actual product failure rates or service costs differ from the Company’s estimates, where applicable, based on limited historical data.

 

The claims made during the year ended December 31, 2022, and 2021 were ordinary and customary. The warranty reserve is included in accrued expenses on the accompanying consolidated balance sheets and the cost of components in the accompanying consolidated statement of operations.

 

   Warranty Reserve 
December 31, 2020  $283,000 
Warranty reserve expense    
Warranty claims settled, and true-up of accrual   (152,000)
December 31, 2021  $131,000 
Warranty reserve expense   98,000 
Warranty claims settled, and true-up of accrual   (117,000)
December 31, 2022  $112,000 

 

Shipping and Handling Costs

 

The Company invoices its shipping and handling charges to the customer, and we net these charges against the respective costs within general and administrative expenses. For the years ended December 31, 2022, and 2021, the shipping and handling costs incurred were $796,000 and $581,000, respectively.

 

Common Stock Purchase Warrants and Other Derivative Financial Instruments

 

The Company assesses the classification of its freestanding derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required. The Company classifies common stock purchase warrants and other freestanding financial instruments as equity if the contracts (i) require physical settlement or net-share settlement in common stock or (ii) give the Company a choice of net-cash settlement or settlement in common stock (physical settlement or net-share settlement). The Company classifies the following contracts as either an asset or a liability: contracts that (i) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), (ii) give the counterparty a choice of net-cash settlement or settlement in common stock (physical settlement or net-share settlement) or (iii) contain reset provisions.

 

F-12
 

 

VISLINK TECHNOLOGIES, INC AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

 

Treasury Stock

 

Treasury stock is recorded at cost upon the repurchasing of common shares. The cost method is used upon the re-issuance of shares. Under U.S. GAAP, the excess of the acquisition cost over the re-issuance price of the treasury stock, if any, is recorded to additional paid-in capital, limited to the amount previously credited to additional paid-in capital if any. The Company charges the accumulated deficit for any excess.

 

Revenue Recognition

 

We account for the Company’s operating results under ASC Topic 606, adopted on January 1, 2019. It is a comprehensive revenue recognition model that requires recognition when the Company transfers control of the promised goods or services to our customers at an amount that reflects the consideration we expect to receive. The application of ASC Topic 606 requires us to use more judgment and make more estimates than under previously issued guidance.

 

The Company generates all its revenue from contracts with customers. The Company recognizes revenue when we satisfy a performance obligation by transferring control of the promised goods or services to a customer in an amount that reflects the consideration we expect to receive in exchange for those services.

 

Revenue Recognition (continued)

 

The Company determines revenue recognition through the following steps:

 

1. Identification of the contract, or contracts, with a customer.

2. Identification of the performance obligations in the contract.

3. Determination of the transaction price.

4. Allocation of the transaction price to the performance obligations in the contract; and

5. Recognition of revenue when, or as, we satisfy a performance obligation.

 

At contract inception, the Company assesses the goods and services promised in our customer contracts and identifies a performance obligation for each. To determine the performance obligations, the Company considers all the products and services promised in the contract regardless of whether they are explicitly stated or implied by customary business practices. The timing of satisfaction of the performance obligation is not subject to significant judgment. We measure revenue as the consideration we expect to receive in exchange for transferring goods and services. The value-added sales taxes and other charges we collect concurrent with revenue-producing activities are excluded from income.

 

Remaining Performance Obligations:

 

The remaining performance obligations, or backlog, represent the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less.

 

Research and Development Expenses

 

As the Company performs research, design, and development activities, we charge these costs to research and development expenses in the Consolidated Statements of Operations and Comprehensive Loss. These expenses consist primarily of salary and benefit expenses, including stock-based compensation and payroll taxes for employees’ and contractors’ costs engaged in research, design, development activities, prototypes, facilities, and travel costs.

 

F-13
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

 

Leases

 

We determine if an arrangement is a lease at inception. We recognize lease expense for lease payments on a straight-line basis over the lease term. The Company includes operating leases as ROU assets as “Right of use assets, operating leases” in the consolidated balance sheets. For lease liabilities, operating lease liabilities are included in “Operating lease obligations, current” and “Operating lease liabilities, net of current portion” in the consolidated balance sheets. We recognize Operating lease ROU assets and liabilities on the commencement date based on the present value of lease payments for all leases with a term longer than 12 months. No lease and non-lease components are separated for all our real estate contracts.

 

There were no capital leases, now titled “finance leases” under ASC 842, in the Company’s lease portfolio as of December 31, 2022. The ROU assets and related lease liabilities recorded under ASC 842 are calculated based on the present value of the lease payments using (1) the rate implicit in the lease or (2) the lessee’s incremental borrowing rate (“IBR”), defined as the rate of interest that a lessee would have to pay to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a comparable economic environment. As most of our leases do not provide an implicit rate, we determined our incremental borrowing rates based on an analysis of prior collateralized borrowings over similar terms of the lease payments at the commencement date to estimate the IBR under ASC 842.

 

Stock-Based Compensation

 

The Company accounts for stock compensation with persons classified as employees for accounting purposes under ASC 718 “Compensation-Stock Compensation,” which recognizes awards at fair value on the date of grant and recognition of compensation over the service period for awards expected to vest. The fair value of stock options is determined using the Black-Scholes Option Pricing Model, and the fair value of common stock issued for services is determined based on the Company’s stock price on the issuance date.

 

The expansion of Topic 718 fell under ASU 2018-07 to include share-based payment transactions for acquiring goods and services from nonemployees. The measurement date for equity-classified nonemployee share-based payment awards is no longer at the earlier date at which a commitment for performance by the counterparty is reached or the date at which the counterparty’s performance is complete. Instead, the grant date is now considered the measurement date. Under today’s guidance, the measurement of nonemployee share-based payment awards with performance conditions is at the lowest aggregate fair value, often resulting in a zero value. The new ASU aligns the accounting for nonemployee share-based payment awards with performance conditions with accounting for employee share-based payment awards under Topic 718 by requiring entities to consider the probability of satisfying performance conditions. Current guidance requires entities to use the contractual term to measure the nonemployee share-based payment awards. The new ASU allows entities to make an award-by-award election to use the expected duration (consistent with employee share-based payment awards) or the contractual term for nonemployee awards.

 

Stock-Option Awards — Time-based and performance-based:

 

Under ASC Topic 718, the compensation cost is measured based on an award’s fair value at the grant’s date for the time vested option award using the Black Scholes-Merton formula as a valuation technique. The Company used the U.S. Treasury note’s rate over the expected option term for the risk-free rate. Employees’ expected term represents the period that options granted are expected to be outstanding using the simplified method. The Company’s historical share option exercise experience does not provide a reasonable basis for estimating the expected term. For nonemployee options, the expected term is the entire term of the option. Expected volatility is based on the average weekly share price changes over the shorter expected term or the period from the Nasdaq Capital Markets Exchange placement to the grant’s date. The Company estimates forfeiture and volatility using historical information. The risk-free interest rate is based on the implied yield on U.S. Treasury zero-coupon issues over the options’ equivalent lives.

 

The Company has not paid dividends on its common stock, and no assumption of dividend payment(s) is made in the model. For employee equity-classified awards, compensation cost is recognized over the employee’s requisite service period with a corresponding credit to additional paid-in capital. The employee’s requisite service period begins at the service inception date and ends when the requisite service has been provided.

 

Restricted Stock Unit Awards (“RSUs”) — Time-Based:

 

Under ASC 718, the exercise price for RSUs is determined using the fair market value of the Company’s common stock on the grant date. For an award with graded vesting subject only to a service condition (e.g., time-based vesting), ASC 718-10-35-8 provides an accounting policy choice between graded vesting attribution or straight-line attribution. The Company elects the graded vesting method, recognizing compensation expense for only the portion of awards expected to vest. Forfeitures of time-based units and awards are recognized as they occur. Stock-based compensation costs are calculated using the closing stock price on the grant date to estimate the fair value of time-based restricted stock units.

 

F-14
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

 

Stock-Based Compensation (continued

 

Restricted Stock Unit Awards (“RSUs”) — Performance-Based:

 

The accruals of compensation cost for an award with a performance condition are related to that performance condition’s probable outcome. Under ASC 718, a “performance condition” is the achievement of a specified target that is defined by referring to the employer’s operations or activities, such as an option that vests if the employer’s growth rate increases by a certain amount or there are the attainments of regulatory approval for a product. There is an accrual of compensation cost upon the likely achievement of the performance condition, and there is no accrual if the accomplishment of the performance condition is not probable. The exercise price for RSUs is determined using the fair market value of the Company’s common stock on the grant date. Stock-based compensation costs are calculated using the closing stock price on the grant date to estimate performance-based restricted stock units’ fair value.

 

Impairment and Abandonment

 

Right-of-use operating lease abandonment:

 

Management decided to vacate the Billerica, MA facility as part of the Company’s cost savings strategy implemented in the third quarter of the fiscal year 2022. The economic environment of the location precluded the action of sub-letting, and management determined the (leased facility) to be abandoned as of September 30, 2022. Under ASC 360, leased space abandonment is an impairment indicator, and the Company assessed the lease right-of-use (“ROU”) assets for impairment. The Company considered approximately $131,000 of right-of-use operating assets impaired, less $43,000 of accumulated amortization, and for the years ending December 31, 2022, and 2021, the Company recognized a loss on impairment of ROU assets of approximately $88,000 and $-0-, respectively.

 

Income Taxes

 

Under ASC 740, as part of our consolidated financial statements, we must estimate our income tax provision (benefit) in each jurisdiction in which we operate. The Company uses the asset and liability method of accounting for income taxes. The recognition of deferred income tax assets and liabilities for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases fall under this method. Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years these temporary differences are expected to be recovered or settled. The recognition of the effect on deferred tax assets and liabilities of a change in tax rates in income is in the period that includes the enactment date. A valuation allowance is provided for those deferred tax assets for which management cannot conclude that it is more likely than not that such deferred tax assets will be realized. The Company will file income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. The Company recognizes the impact of an uncertain tax position in its financial statements if, in management’s judgment, it is more likely than not sustainable upon audit based upon the position’s technical merits. It involves identifying potential uncertain tax positions, evaluating applicable tax laws, and assessing whether the liability for uncertain tax positions is necessary. The Company’s policy is to classify assessments, if any, for tax-related interest expense and penalties as general and administrative expenses.

 

Advertising Costs

 

Advertising costs are charged to operations as incurred. Advertising costs amounted to approximately $1,038,000 and $139,000 for the years ended December 31, 2022, and 2021, respectively. The Company includes advertising costs in general and administrative expenses in the accompanying consolidated statement of operations.

 

Sales Tax and Value-Added Taxes

 

The Company accounts for sales taxes and value-added taxes imposed on its goods and services on a net basis.

 

F-15
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

 

Loss Per Share

 

The Company reports loss per share under ASC Topic 260, “Earnings Per Share,” which establishes standards for computing and presenting earnings per share. The basic loss per share calculation divides the net loss allocable to common stockholders by the weighted-average shares of common stock outstanding during the period without considering common stock equivalents. The diluted loss per share calculation is calculated by adjusting the weighted-average shares of common stock outstanding for the dilutive effect of common stock equivalents, including stock options and warrants, outstanding for the period as determined using the treasury stock method. Common stock equivalents are excluded from the diluted net loss per share calculation because their effect would be anti-dilutive. Therefore, basic and diluted net loss per share applicable to common stockholders is the same for periods with a net loss.

 

The following table illustrates the anti-dilutive potential common stock equivalents excluded from the calculation of loss per share (in thousands):

 

   2022   2021 
   For the Years Ended 
   December 31, 
   2022   2021 
Anti-dilutive potential common stock equivalents excluded from the calculation of loss per share:          
Stock options   828    1,553 
Warrants   9,175    9,210 
Total   10,003    10,763 

 

Foreign Currency and Other Comprehensive (Gains) Losses

 

We record gains or losses resulting from foreign currency transactions in foreign currency income or loss except for the effect of exchange rates on long-term inter-company transactions that are considered long-term investments that are accumulated and credited or charged to other comprehensive income. We have two foreign subsidiaries, one in the United Kingdom and the other in the Netherlands, and their functional currencies are British Pounds and Euros, respectively. The translation from the respective foreign currency to United States Dollars (“US Dollars”) is performed for balance sheet accounts using current exchange rates at the balance sheet date and for income statement accounts using an average exchange rate for the years ending December 31, 2022, and 2021, respectively. We included gains or losses from such translation as a separate component of accumulated other comprehensive (loss) income.

 

Transaction gains and losses are recognized in our operations’ results based on the difference between the foreign exchange rates on the transaction date and the reporting date. The foreign currency exchange gains and losses are a component of general and administrative expenses in the accompanying Condensed Consolidated Statements of Operations.

 

The Company has recognized foreign exchange gains and losses and changes in accumulated comprehensive income approximately as follows:

 

   2022   2021 
   For the years ended 
   December 31, 
   2022   2021 
Net foreign exchange transactions:          
(Gains) Losses  $24,000   $100,000 
           
Accumulated comprehensive income:          
Unrealized (gains) losses on currency translation adjustment  $1,040,000   $445,000 

 

The exchange rates adopted for the foreign exchange transactions are quoted on OANDA, a Canadian-based foreign exchange company, and an internet website providing currency conversion, online retail foreign exchange trading, foreign currency transfers, and forex information. The Company translated amounts from British Pounds into United States Dollars and Euros to British Pounds at the following exchange rates for the respective periods:

 

  As of December 31, 2022 – £ 1.208970 to $1.00; € 1.069850 to $1.00
     
  The average exchange rate for the year ended December 31, 2022 – £ 1.236579 to $1.00; € 1.052082 to $1.00
     
  As of December 31, 2021 – £1.351043 to $1.00; €0.839362 to £1.00
     
  The average exchange rate for the year ended December 31, 2021 – £1.375369 to $1.00; €0.850858 to £1.00

 

F-16
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

 

Fair Value of Financial Instruments and Fair Value Measurements

 

The authoritative guidance for fair value measurements under topic ASC 820, “Fair Value Measurements and Disclosures,” establishes a three-tier fair value hierarchy, prioritizing the inputs used in measuring fair value. These tiers include:

 

Level 1 is observable inputs such as quoted prices in active markets.
Level 2 is defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and
Level 3 is defined as unobservable inputs in which little or no market data exists, requiring an entity to develop its assumptions.

 

Our financial instruments include cash equivalents, accounts receivable, prepaid expenses and other assets, accounts payable, accrued expenses, and short-term debt. Fair value estimates of these instruments are made at a specific point in time based on relevant market information. These estimates may be subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. The carrying amount of cash equivalents, accounts receivable, prepaid expenses and other assets, accounts payable, and accrued expenses are generally considered representative of their respective fair values because of the short-term nature of those instruments.

 

In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. The new guidance modifies the disclosure requirements on fair value measurements in Topic 820. The amendments in ASU 2018-13 are effective for all entities for fiscal years and interim periods within those fiscal years beginning after December 15, 2019. Effective January 1, 2020, the Company adopted the provisions of ASU 2018-13. The adoption had no material impact on the Company’s consolidated financial statements or related financial statement disclosures.

 

The following table presents the Company’s assets and liabilities measured at fair value on a non-recurring basis on December 31, 2022, consistent with the fair value hierarchy provisions. The asset impairment is a non-recurring level 3 measurement.

 

  

Quoted Prices in

Active Markets

for Identical

Assets/Liabilities

(Level 1)

  

Significant

Observable

Inputs

(Level 2)

  

Significant

Unobservable

Inputs

(Level 3)

   Total 
                 
Assets (non-recurring):                    
Abandonment of right-of-use operating leases           88,000    88,000 
   $   $   $88,000   $88,000 
                     
Liabilities:                    
Other  $   $   $   $ 
   $   $   $   $ 

 

The Company did not have reportable assets and liabilities under ASC Topic 820 disclosure requirements for the year ended December 31, 2021. See Note 13 for additional disclosure regarding the Company’s warrants liabilities accounted for at fair value.

 

Redeemable Preferred Stock

 

In November 2022, the Company’s board of directors approved the designation of a Series A Preferred Stock created for the sole purpose of the January 11, 2023, Special Meeting of stockholders voting on the consideration of a “Reverse Stock Split Proposal.” The Series A Preferred Stock had a par value of $0.00001 per share. The Preferred Stock was redeemable upon the holder participating at any meeting of stockholders held to vote on the Reverse Stock Split immediately before the opening of the polls at such meeting (the “Initial Redemption Time”) shall automatically be redeemed by the Corporation at the Initial Redemption Time without further action on the part of the Corporation or the holder thereof (the “Initial Redemption”). Any outstanding shares of Series A Preferred Stock that were not redeemed under an Initial Redemption were redeemed in whole, but not in part (i) if such redemption was ordered by the Board of Directors in its sole discretion, automatically and effective on such time and date specified by the Board of Directors in its sole discretion or (ii) automatically upon the approval by the Corporation’s stockholders of the Reverse Stock Split at the Special Meeting held for voting on the Reverse Stock Split proposal.

 

Under the guidance of ASC Topic 480, all Series A Preferred Stock shares have been presented outside of permanent equity in the mezzanine equity section on the Consolidated Balance Sheets.

 

F-17
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

 

Subsequent Events

 

Management has evaluated subsequent events or transactions occurring through the date the consolidated financial statements were issued and determined that no events or transactions are required to be disclosed herein except as disclosed.

 

Recently Issued Accounting Pronouncements

 

Recently Issued Accounting Standards Adopted and Not Yet Adopted

 

Adopted on January 1, 2023

 

In June 2016, the FASB established Topic 326, Financial Instruments—Credit Losses, Measurement of Credit Losses on Financial Instruments (ASU) No. 2016-13, which requires a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates, including accounts receivable.

 

The standard replaces the existing incurred credit loss model with the Current Expected Credit Losses (“CECL”) model. It is required to measure credit losses based on the Company’s estimate of expected losses rather than incurred losses, which generally results in earlier recognition of allowances for credit losses. Under ASC 326, the Company evaluates specific criteria, including aging and historical write-offs, the current economic condition of particular customers, and future economic conditions of countries utilizing a consumption index to determine the appropriate allowance for credit losses. The Company completed its assessment of the new standard, and no adjustment will be made to its opening balance of retained earnings relating to its trade receivables. The Company writes off receivables once it is determined that the receivables are no longer collectible and as allowed by local laws.

 

Recent Accounting Pronouncements

 

Other recent accounting standards issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the SEC did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.

 

NOTE 4 – ACQUISITION OF MOBILE VIEWPOINT CORPORATE B.V.

 

On August 16, 2021, the Company, through a wholly-owned subsidiary, entered into a stock purchase agreement with Triple I.T. Corporate B.V., a private company incorporated in the Netherlands, under which the Company acquired 100% of the outstanding capital of MVP for an aggregate purchase price of €14,824,278 (or approximately $17.5 million based on a USD to EUR exchange rate of 0.85 as of August 13, 2021) plus the assumption and payment of €717,785 of intercompany indebtedness, all paid by the Company in cash, subject to certain routine closing adjustments in respect of working capital and net indebtedness (“The Transaction”). The Transaction was closed on August 16, 2021.

 

The Company accounts for the acquisition under the acquisition method under ASC 805 “Business Combinations,” and we elected not to apply pushdown accounting upon the purchase of MVP. Therefore, we recognized the preliminary historical basis of MVP’s acquired assets and liabilities. We identified any excess of the consideration paid in excess of the net assets acquired in the table below. In addition, we recorded approximately $1.6 million of preliminary acquisition-related transaction costs (e.g., legal, due diligence, valuation, and other professional fees) not included as a component of consideration transferred but are required to be expensed as incurred and included in our consolidated statement of operations. Future transaction costs are indeterminable as the Company progresses to the finalization of the Transaction.

 

The Company received a final valuation report from our third-party appraiser regarding allocating the consideration paid in excess of the net assets acquired. Additionally, the Company received an updated list of certain assets and liabilities acquired on August 16, 2021. Under ASC 805, we recorded measurement period adjustments under the previously mentioned revisions.

 

We have completed integrating MVP into our operations and internal control processes. As we finished this integration, we analyzed, evaluated, and, where necessary, made changes in control and procedures related to the MVP business.

 

F-18
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – ACQUISITION OF MOBILE VIEWPOINT CORPORATE B.V. (continued)

 

The following table summarizes the historical value of the assets and liabilities as of the acquisition date, allocation of the consideration paid in excess of net assets acquired, relative useful lives, and the amortization method of the listed intangible assets.

 

   As Initially
Reported
   Measurement
Period
Adjustments
   As Adjusted 
Fair value of consideration transferred:               
Cash  $18,311,000   $   $18,311,000 
                
Recognized amounts of identifiable assets acquired and liabilities assumed:               
Cash  $965,000   $   $965,000 
Accounts receivable, net   911,000        911,000 
Inventories, net   2,534,000    1,231,000    3,765,000 
Prepaid expenses and other assets   625,000    (112,000)   513,000 
Property and equipment, net   149,000        149,000 
Accounts payable   (507,000)       (507,000)
Accrued expenses   (551,000)       (551,000)
Customer deposits and deferred revenue   (293,000)       (293,000)
Deferred tax liabilities       (978,000)   (978,000)
Total identifiable net assets  $3,833,000   $141,000   $3,974,000 
                
Consideration paid  $18,311,000   $   $18,311,000 
Total identifiable assets acquired   3,833,000    141,000    3,974,000 
Excess of consideration paid over net assets acquired  $14,478,000   $(141,000)  $14,337,000 
                
Preliminary allocation of the consideration paid in excess of the net assets acquired:               
Trade name  $730,000   $70,688   $800,688 
Proprietary technology   1,850,000    282,749    2,132,749 
Customer relationship   3,723,000    (1,508,003)   2,214,997 
Goodwill   8,175,000    1,013,566    9,188,856 
Total intangible assets acquired  $14,478,000   $(141,000)  $14,337,000 

 

As a result of the updated purchase price allocations for the MVP acquisition on August 16, 2021, specific fair value amounts previously estimated were adjusted during the measurement period. These measurement period adjustments resulted from our external valuation specialists’ updated valuation reports and appraisals and revisions to internal account classifications. The changes from the final valuation report included an increase of $1.23 million in inventory, $0.07 million in the trade name, $.028 million in proprietary technology, and $0.04 million in goodwill, offset by a reduction of $1.51 million in customer relationships. The revision in internal account classification resulted in a decrease of $0.11 million in prepaid expenses and other current assets with a reciprocal increase of $0.11 million in inventory.

 

In estimating the fair value of the assets and liabilities, the valuation specialist considered three fundamental techniques or approaches to valuing an asset: the Income Approach (present value of future economic benefits for customer lists), the Market Approach (analysis of recent comparable entity asset sales for trade names, and proprietary technology) and the Cost Approach (replacement or reconstruction cost of similar assets of like utility for the step-up in inventory). To ascribe value to the Subject Assets, it was necessary first to determine an appropriate discount rate. The discount rate for the acquired assets was developed using a Weighted Average Cost of Capital (“WACC”) methodology. The discount rate applied under WACC was 20%. To perform the process outlined by ASC 805, the valuation specialists defined the buyer’s expected rate of return, referred to as the internal rate of return (“IRR,” 19.5%), a market participant’s rate of return, which is WACC; and the rates of returns for the identified assets: working capital (20.3%), intangible assets (21.0%), and goodwill (23.0%).

  

F-19
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 4 – ACQUISITION OF MOBILE VIEWPOINT CORPORATE B.V. (continued)

 

Intangible assets acquired:

 

The Purchaser acquired intangible assets from MVP as a result of the Transaction. The Tradename, Proprietary Technology, and Customer Relationships are intangible assets noted to have a finite life, while Goodwill has an indefinite life span. The finite life intangible assets will be amortized using the straight-line method of the respective lives of each asset, while the indefinite life intangible assets will not be amortized.

 

Based thereon, below are the acquired intangibles with their relative useful lives and method of amortization:

 

Intangible Asset   Useful Life   Amortization Method
         
Tradename   15 Years   Straight-line
Proprietary Technology   5 Years   Straight-line
Customer Relationships   10 Years   Straight-line
Goodwill   Indefinite   N/A

 

The following presents the unaudited Pro-forma combined results of operations of Vislink with MVP as if the combination of the entities occurred on January 1, 2021.

 

  

Year

Ending

December 31,

 
   2021 
Revenues, net  $36,843 
      
Net loss allocable to common stockholders  $(16,173)
      
Net loss per share  $(0.37)
      
Weighted average number of shares outstanding   43,484 

 

The revenue and earnings of MVP since the acquisition date included in the consolidated statements of operations and comprehensive loss amount to approximately $2.3 million for the year ending December 31, 2021.

 

NOTE 5 — ACCOUNTS RECEIVABLE

 

Accounts receivable consist of the following:

 

   December 31, 2022   December 31, 2021 
Accounts receivable  $6,680,000   $10,327,000 
Allowance for doubtful accounts   (673,000)   (1,258,000)
Net accounts receivable  $6,007,000   $9,069,000 

 

During the years ended December 31, 2022, and 2021, the Company incurred bad debt expenses of $21,000 and $233,000, respectively. Additionally, for the years ended December 31, 2022, and 2021, the Company experienced bad debt recoveries of $517,000 and $310,000, respectively.

 

F-20
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 6 — INVENTORIES

 

Inventories included in the accompanying consolidated balance sheet are stated at the lower of cost or market as summarized below:

 

   December 31, 2022   December 31, 2021 
Raw materials  $12,038,000   $11,308,000 
Work-in-process   1,474,000    2,105,000 
Finished goods   4,460,000    5,011,000 
Sub-total inventories   17,972,000    18,424,000 
Less reserve for slow-moving and excess inventory   (5,951,000)   (6,530,000)
Total inventories, net  $12,021,000   $11,894,000 

 

Inventory valuation adjustments consist primarily of written-off items due to obsolescence or reserved for slow-moving or excess inventory. The Company recorded inventory valuation adjustments of $1,143,000 and $843,000 as of December 31, 2022, and 2021. Additionally, under the Company’s product rationalization program, management eliminated specific product lines impairing $1,787,000 and $-0- of inventory as of December 31, 2022, and 2021, respectively.

 

NOTE 7 — PROPERTY AND EQUIPMENT

 

Property and equipment consist of the following:

 

   Useful Life  December 31, 
   (Years)  2022   2021 
Cost:           
Furniture and fixtures  110  $308,000   $282,000 
Leasehold improvements (a)  1 - 14   443,000    439,000 
Computers, software, and equipment  1 - 11   3,016,000    2,813,000 
       3,767,000    3,534,000 
Accumulated depreciation      (2,333,000)   (2,361,000)
Property and equipment, net     $1,434,000   $1,173,000 

 

Depreciation of property and equipment amounted to $201,000 and $195,000 for the years ended December 31, 2022, and 2021, respectively. Additionally, the Company removed $228,000 of fully depreciation leasehold improvement from its records.

 

(a) The shorter economic life or remaining lease term.

 

NOTE 8 — GOODWILL

 

Goodwill represents the excess cost of an acquired business over the fair value of the identifiable tangible and intangible assets acquired and liabilities assumed in a business combination (see Note 4). Under ASC 350, the Company chose to assess qualitative factors first to determine whether performing the first step of the two-step goodwill impairment test is necessary. The Company assessed qualitative factors to determine if it is more likely than not (that is, a likelihood of more than 50 percent) that the fair value of a reporting unit is less than its carrying amount, including goodwill. In other words, it was not required to calculate the fair value of a reporting unit. As part of the MVP acquisition on August 16, 2021, we engaged a valuation analyst to estimate the fair value of specific assets acquired by performing appropriate valuations procedures. The valuation analyst expressed the results of the valuation engagement in a report in the late fourth quarter of 2021. As a result of the acquisition, the report concluded that the amount paid in excess of the net asset acquired relates to finite intangible assets, with a remaining amount allocated to goodwill.

 

Under ASC 350, “Goodwill and other,” we completed our annual goodwill impairment test on December 31, 2021; we elected to perform a quantitative assessment to determine if it was more likely than not (that is, a likelihood of more than 50 percent) that the fair value of our reporting unit was less than its carrying value as of the test date. Our assessment recognized a decline in our market capitalization due to unfavorable changes in the market and the rise in inflation as “triggering event” conditions increasing the risk of impairment.

 

Based on the quantitative assessment, we concluded that the carrying amount of our reporting unit exceeded the fair value. As a result, we recorded $9,189,000 in goodwill impairment charges on the consolidated operations statements and comprehensive loss for the year ended December 31, 2021. The Company did not recognize goodwill during the year ended December 31, 2022.

 

F-21
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 8 — GOODWILL (continued)

 

The following table illustrates goodwill for the years ended December 31, 2022, and 2021:

 

   12/31/22   12/31/21 
Beginning balance  $   $ 
Additions       8,211,000 
Deferred tax liabilities associated with MVP acquisition       978,000 
Impairments       (9,189,000)
Ending balance  $-0-   $-0- 

 

NOTE 9 — INTANGIBLE ASSETS

 

The Company continuously monitors operating results, events, and circumstances that may indicate potential impairment of intangible assets. Management concluded that no triggering events occurred during the year ended December 31, 2022.

 

The following table illustrates finite intangible assets as of December 31, 2022, and 2021:

 

   Proprietary Technology   Patents and Licenses   Trade Names & Technology   Customer Relationships     
       Accumulated       Accumulated       Accumulated       Accumulated     
   Cost   Amortization   Cost   Amortization   Cost   Amortization   Cost   Amortization   Net 
                                     
Balance, December 31, 2020  $       $12,378,000   $(11,175,000)  $1,450,000   $(914,000)  $2,880,000   $(2,698,000)  $1,921,000 
                                              
Additions   2,132,000                801,000        2,215,000        5,148,000 
                                              
Amortization   -    (223,000)   -    (668,000)   -    (138,000)   -    (119,000)   (1,148,000)
                                              
Balance, December 31, 2021   2,132,000    (223,000)   12,378,000    (11,843,000)   2,251,000    (1,052,000)   5,095,000    (2,817,000)   5,921,000 
                                              
Amortization       (592,000)       (535,000)       (137,000)       (257,000)   (1,521,000)
                                              
Balance, December 31, 2022  $2,132,000   $(815,000)  $12,378,000   $(12,378,000)  $2,251,000   $(1,189,000)  $5,095,000   $(3,074,000)  $4,400,000 

 

Proprietary Technology:

 

The Company amortizes proprietary technology over their useful lives of 3 to 5 years. The proprietary technology consists of wireless multiplex transmitters, and artificial intelligence developed and used by MVP internally to produce and sell products or services to the end-user or customer.

 

Patents and Licenses:

 

The Company amortizes filed patents and licenses over their useful lives, ranging from 18.5 to 20 years. The amortization of the costs incurred by processing provisional patents and pending applications begins after successful review and filing.

 

Trade Name, Technology, and Customer Relationships:

 

The Company amortizes these other intangible assets over their estimated useful lives of 3 to 15 years. Prior acquisitions of the Company’s subsidiaries, IMT, Vislink, and MVP, created these intangible assets of trade names, technology, and customer lists.

 

The Company has recognized net capitalized intangible costs as follows:

 

   December 31,   December 31, 
   2022   2021 
Proprietary Technology  $1,319,000   $1,910,000 
Patents and Licenses       535,000 
Trade Names and Technology   1,060,000    1,198,000 
Customer Relationships   2,021,000    2,278,000 
   $4,400,000   $5,921,000 

 

F-22
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 9 — INTANGIBLE ASSETS (continued)

 

The Company has recognized the amortization of intangible assets as follows:

 

   For the years ended 
   December 31, 
   2022   2021 
         
Proprietary Technology  $592,000   $223,000 
           
Patents and Licenses   535,000    668,000 
           
Trade Names and Technology   137,000    138,000 
           
Customer Relationships   257,000    119,000 
           
   $1,521,000   $1,148,000 

 

The weighted average remaining life of the amortization of the Company’s intangible assets is approximately 5.3 years. The following table represents the estimated amortization expense for total intangible assets for the succeeding five years:

 

Period ending December 31,     
2023  $645,000 
2024   645,000 
2025   645,000 
2026   556,000 
2027   539,000 
Thereafter   1,370,000 
Finite-Lived Intangible Assets, Net, Total  $4,400,000 

 

NOTE 10 — ACCRUED EXPENSES

 

Accrued expenses consist of the following:

 

   December 31, 2022   December 31, 2021 
Compensation  $246,000   $2,069,000 
Commissions   47,000    29,000 
Warranty   112,000    130,000 
Rent       185,000 
Accrued expenses other   908,000    687,000 
Deferred Equity   255,000    55,000 
Accrued expenses  $1,568,000   $3,155,000 

 

NOTE 11 — NOTES PAYABLE

 

The table below represents the Company’s notes payable as of December 31, 2022, and 2021:

 SCHEDULE OF NOTES PAYABLE

   Principal 
   12/31/22   12/31/21 
         
On April 5, 2021  $   $99,000 
On April 5, 2021, the Company renewed its D & O insurance policy and increased the premium to approximately $1,098,000, less a down payment of $225,000, financing the remaining balance of approximately $872,000. The loan’s terms are nine months at a 5.25% annual interest rate and a monthly principal and interest payment of approximately $99,000. As of March 31, 2022, the loan is paid in full. The Company recorded interest expense of $-0- and $19,000 for the years ended December 31, 2022, and 2021, respectively.  $   $99,000 
           
On April 5, 2022, the Company renewed its D & O insurance policy, decreasing the premium to approximately $1,037,000, less a down payment of $194,000, financing the remaining balance of approximately $943,000. The loan’s terms are nine months at a 2.09% annual interest rate and a monthly principal and interest payment of approximately $84,000. The Company recorded interest expense of $6,000 and $-0- for the years ended December 31, 2022, and 2021, respectively.   84,000     
   $84,000   $99,000 

 

F-23
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 12 — LEASES

 

The Company’s leasing arrangements include office space, deployment sites, and storage warehouses, both domestically and internationally. The operating leases contain various terms and provisions, with lease terms of approximately one to four years remaining as of December 31, 2022. Certain individual leases contain rent escalation clauses and lease concessions that require additional rental payments later in the term. We recognize rent expense for these contracts straight-line over the minimum lease term.

 

On December 31, 2022, the Company recorded approximately $1.1 million of ROU assets net of $1.2 million accumulated amortization on the balance sheet. Additionally, the Company recorded relatively $1.6 million of operating lease liabilities, of which $0.5 million is current and $1.1 million is non-current, as reported on the balance sheet. The weighted-average remaining term for lease contracts was 3.4 years on December 31, 2022, with maturity dates from July 2023 to January 2027 and a weighted-average discount rate of 9.4% on December 31, 2022.

 

Adjustments for straight-line rental expense for the respective periods was not material. Most costs recognized are reflected in cash used in operating activities for the respective periods. This expense consisted primarily of payments for base rent on office and warehouse leases. Amounts related to short-term lease costs, taxes, and variable service charges on leased properties were immaterial. Besides, we have the right to renew individual leases for various renewal terms but no obligation.

 

The following represents lease activity for the year ending December 31, 2022:

 

Lutton, UK

 

On April 28, 2022, the Company entered a one-year lease for 600 square feet of administrative office space in Lutton, UK, commencing on May 3, 2022, and terminating on May 31, 2023, for £1,320 monthly or approximately $1,800 per month.

 

Dubai, UAE

 

The Company renewed its lease for 976 square feet of administrative office space commencing on July 3, 2022, and terminating on July 2, 2023, in Dubai Studio City, UAE, for AED 5,995 or approximately US$ 1,632 monthly.

 

Billerica, MA

 

During the third quarter of the fiscal year 2022, management vacated the Billerica property. The economic environment of this location precluded the action of sub-letting an unoccupied site and determined the leased facility abandoned. Under ASC 360, leased space abandonment is an impairment indicator, and the Company assessed the lease ROU assets for impairment, and we recognized a loss on impairment of right-of-use assets of approximately $88,000.

 

The following represents lease activity for the year ending December 31, 2021:

 

Lutton, UK

 

On February 1, 2021, the Company entered into a one-year lease for 600 square feet of administrative office space in Lutton, UK, commencing on February 1, 2021, and terminating on January 31, 2022, for £1,674 or approximately $2,290 monthly.

 

Dubai, UAE

 

On May 24, 2021, the Company renewed its lease for office space commencing on July 3, 2021, and terminating on July 2, 2022, for 976 square feet of administrative office space in Dubai Studio City, UAE, for AED 5,995 or approximately $1,620 monthly.

 

Mount Olive, NJ

 

On November 1, 2021, the Company entered into a lease agreement with a non-affiliated third party (the “Landlord”) to rent approximately 7,979 square feet of commercial space for general business offices, light manufacturing, operating of a testing laboratory, assembly, and inventory storage in Mount Olive, NJ. The lease commencement date is November 1, 2021, and the expiration date is January 31, 2027. The initial monthly obligation is $10,869, with annual rent increases of 3.0% per year until the lease expiration date. The Company is relocating its corporate facilities from Hackettstown, NJ, to Mount Olive, NJ, with the projected completion date by March 2022, as part of the strategic initiative plan implemented in early 2020. The Company recognized approximately $522,000 of Right of Use Assets and Operating lease obligations for the new lease under ASC Topic 842.

 

F-24
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 12 — LEASES (continued)

 

The following table illustrates operating lease data for the years ended December 31, 2022, and 2021:

 

 SCHEDULE OF OPERATING LEASE DATA

   2022   2021 
   For the years ended 
   December 31, 
   2022   2021 
Lease cost:          
Operating lease cost  $438,000   $472,000 
Short-term lease cost   93,000    417,000 
           
Total lease cost  $531,000   $889,000 
           
Cash paid for lease liabilities:          
Cash flows from operating leases  $543,000   $635,000 
           
Weighted-average remaining lease term—operating leases   3.4 years    3.8 years 
           
Weighted-average discount rate—operating leases   9.4%   9.3%

 

Maturities of our operating lease liabilities were as follows as of December 31, 2022:

 

 SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES

   Amount 
     
2023  $589,000 
2024   455,000 
2025   443,000 
2026   249,000 
2027   59,000 
Thereafter    
Total lease payments   1,795,000 
Less: imputed interest   233,000 
Present value of lease liabilities   1,562,000 
Less: Current lease liabilities   455,000 
Non-current lease liabilities  $1,107,000 

 

The table below lists the location and lease expiration date from 2023 through 2027: 

 SCHEDULE OF LEASE OBLIGATIONS ASSUMED

Location  Square Footage    Lease-End Date  Approximate Future Payments 
Colchester, U.K. – Waterside House   16,000   Dec 2025  $639,000 
Singapore   950   July 2023   19,000 
Billerica, MA   2,000   Dec 2026   416,000 
Hemel, UK   12,870   Oct 2023   123,000 
Mount Olive, NJ   7,979   Jan 2027   598,000 

 

F-25
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 13 — DERIVATIVE LIABILITIES

 

Under the guidance of ASC 815, Accounting for Derivative Instruments and Hedging Activities, the Company identified common stock warrants in various offerings containing a net cash settlement provision whereby, upon certain fundamental events, the holders could put these warrants back to the Company for cash. We identified and classified the following transactions as derivative liabilities: warrants issued with the May 2016 financing, the July 2016 financing, the August 2017 underwritten offering, and the May 2018 Financing.

 

The Company records derivative liabilities on its consolidated balance sheet at their fair value on the issuance date. The Company revalues the derivative liabilities on each subsequent balance sheet until exercised or expired, with any changes in the fair value between reporting periods recorded as other income or expense. The Company uses option pricing models and assumptions based on the instruments’ characteristics on the valuation date. We use assumptions for future financings, expected volatility, expected life, yield, and risk-free interest rate to estimate fair value.

 

The following are the key assumptions used in connection with the valuation of the warrants exercisable into common stock on December 31, 2022, and 2021:

 

 SCHEDULE OF VALUATION AND WARRANTS EXERCISABLE

   For the Years Ended December 31, 
   2022   2021 
Number of shares underlying the warrants   55,333    66,341 
The fair market value of stock  $0.56   $1.18 
Exercise price  $ 0.00 to $ 60.00    $ 60.00 to $ 150.00  
Volatility   0% to 64 %   97% to 101 %
Risk-free interest rate   0% to 4.54 %   0.19% to 0.39 %
Expected dividend yield        
Warrant life (years)   0.0 to 0.4     0.6 to 1.4  

 

Level 3 liabilities are valued using unobservable inputs to the valuation methodology significant in measuring the liabilities’ fair value. For fair value measurements categorized within Level 3 of the fair value hierarchy, the Company’s accounting and finance department, subject to the approval of the Chief Financial Officer, determines the applicable valuation policies and procedures.

 

Level 3 Valuation Techniques:

 

Level 3 financial liabilities consist of the derivative liabilities for which there is no current market for these securities, such that determining fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate. The Company deems financial instruments that do not have fixed settlement provisions as derivative instruments. Under US GAAP, the fair value of these warrants is classified as a liability on the Company’s consolidated balance sheets because, according to the terms of the warrants, a fundamental transaction could give rise to an obligation of the Company to pay cash to its warrant holders. Such instruments do not have fixed settlement provisions and have also been recorded as derivative liabilities. Corresponding changes in the fair value of the derivative liabilities are recognized in earnings on the Company’s consolidated operations statements in each subsequent period. The Company uses a binomial model style simulation to calculate fair value, as the standard Black-Scholes model would not capture the value of certain features of the warrant derivative liabilities.

 

The following table sets forth a summary of the changes in the fair value of Level 3 financial liabilities that are measured at fair value on a recurring basis:

 

 SCHEDULE OF CHANGES IN FAIR VALUE OF LEVEL 3 FINANCIAL LIABILITIES

   2022   2021 
   For the years ended 
   December 31 
   2022   2021 
         
Beginning balance  $   $22,000 
Change in fair value of derivative liabilities       (22,000)
Ending balance  $   $ 

 

F-26
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 14 — PREFERRED SHARES

 

Preferred Stock

 

In March 2013, the issuance of 10.0 million shares of “Blank Check” preferred stock with a par value of $0.00001 per share received approval from the majority of stockholders.

 

The following shares were designated as authorized:

 

  Three million shares of Series A Convertible Preferred Stock (“Series A Preferred Stock”) on December 31, 2014.
  Three million shares of Series B Convertible Preferred Stock (“Series B Preferred Stock”) on February 11, 2015.
  Three million shares of Series C Convertible Preferred Stock (“Series C Preferred Stock”) on February 24, 2015.

 

On February 5, 2016, the Company terminated the Series A Preferred Stock and Series C Preferred Stock and increased the number of designated shares of Series B Preferred Stock to 5,000,000. The following shares were designated as authorized: Five million shares of Series D Convertible Preferred Stock (“Series D Preferred Stock”) on April 25, 2016. On December 6, 2016, the Company terminated the Series B Preferred Stock. The following shares were designated as authorized: Five thousand shares of Series E Convertible Preferred Stock (“Series E Preferred Stock”) on December 21, 2016. On November 9, 2022, the Company’s Board of Directors (i) terminated the Series D Preferred Stock and Series E Preferred Stock and (ii) designated the following shares as authorized: 47,500 shares of new Series A Preferred Stock.

 

Series A Preferred Stock

 

On November 9, 2022, the Company’s board of directors declared a dividend of one one-thousandth of a share of Series A Preferred Stock, par value $0.00001 per share (“Series A Preferred Stock”), for each outstanding share of the Company’s common stock, to stockholders of record on November 21, 2022.

 

Each share of Series A Preferred Stock entitled the holder to 1,000,000 votes per share, and each fraction of a share had a ratable number of votes. Thus, each one-thousandth share of Series A Preferred Stock was entitled to 1,000 votes. The outstanding shares of Series A Preferred Stock voted together with the outstanding shares of the Company’s common stock as a single class exclusively concerning the proposal to adopt an amendment to the Company’s Certificate of Incorporation, as amended, to reclassify the outstanding shares of the Company’s Common Stock into a smaller number of shares of common stock at a ratio specified in or determined under the terms of such amendment (the “Reverse Stock Split”). The Series A Preferred Stock was not entitled to vote on any other matter except to the extent required under the Delaware General Corporation Law.

 

The holders of Series A Preferred Stock were not entitled to receive dividends.

 

On January 11, 2023, the Company held a special meeting of stockholders (the “Special Meeting”) whereby stockholders voted on a proposal to authorize the Board, at its discretion, to effect the Reverse Stock Split. All shares of Series A Preferred Stock that were not present in person or by proxy at the Special Meeting held to vote on the Reverse Stock Split immediately before the opening of the polls at such meeting (the “Initial Redemption Time”) were automatically redeemed in whole, but not in part, by the Company at the Initial Redemption Time without further action on the part of the Company or the holder of shares of Series A Preferred Stock (the “Initial Redemption”). Any outstanding shares of Series A Preferred Stock that were not redeemed according to an Initial Redemption were redeemed in whole but not in part (i) if the Board ordered such redemption in its sole discretion, automatically and effective on such time and date specified by the Board in its sole discretion or (ii) automatically upon the approval by the Company’s stockholders of the Reverse Stock Split at the Special Meeting held for the purpose of voting on a such proposal (“the Subsequent Redemption”).

 

Each share of Series A Preferred Stock redeemed in any redemption described above was redeemed in consideration for the right to receive an amount equal to $0.00001 in cash for each ten (10) whole shares of Series A Preferred Stock that were “beneficially owned” by the “beneficial owner” (as such terms are defined in the certificate of designation concerning the Series A Preferred Stock) thereof as of the applicable redemption time and redeemed under such redemption, payable upon receipt by the Company of a written request submitted by the relevant holder to the corporate secretary of the Company following the applicable redemption time.

 

F-27
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 14 — PREFERRED SHARES (continued)

 

Series A Preferred Stock (continued)

 

The Series A Preferred Stock was not convertible into, or exchangeable for, shares of any other class, series of stock, or other securities of the Company. The Series A Preferred Stock had no stated maturity and is not subject to any sinking fund. The Series A Preferred Stock was not restricted to the Company’s redemption or repurchase of shares while there is any arrearage in the payment of dividends or sinking fund installments. The Certificate of Designation was filed with the Delaware Secretary of State and became effective on November 9, 2022.

 

The Company was not solely in control of the redemption of the shares of Series A Preferred Stock since the holders had the option of deciding whether to vote in respect of the above-described Reverse Stock Split, which determined whether a given holder’s shares of Series A Preferred Stock were redeemed in the Initial Redemption or the Subsequent Redemption. Since the redemption of the Series A Preferred Stock was not solely in the control of the Company, the shares of Series A Preferred Stock were classified within mezzanine equity in the Company’s audited consolidated balance sheet. The shares of Series A Preferred Stock were measured at redemption value. The value of Series A Preferred Stock shares as of December 31, 2022, was de minimis.

 

Certificate of Elimination

 

On April 25, 2016, the Company filed a Certificate of Designation with the Secretary of State of the State of Delaware, designating 5,000,000 shares out of the Company’s authorized but unissued shares of its preferred stock as Series D Convertible Preferred Stock, par value $0.00001 per share.

 

On December 21, 2016, the Company filed a Certificate of Designation with the Secretary of State of the State of Delaware, designating 5,000 shares out of the Company’s authorized but unissued shares of its preferred stock as Series E Convertible Preferred Stock, par value $0.00001 per share.

 

On November 9, 2022, the Company filed Certificates of Elimination for each of the Series D Preferred Stock and Series E Preferred Stock with the Secretary of State of the State of Delaware, which, effective upon filing, eliminated all matters outlined in the Certificates of Designation of Series D Preferred Stock and Series E Preferred Stock previously filed by the Company. According to the Certificates of Elimination, the shares that were previously designated as Series D Preferred Stock and Series E Preferred Stock resume the status of authorized but unissued shares of preferred stock, par value $0.00001 per share, of the Company, issuable from time to time, in one or more series, under the Certificate of Incorporation.

 

On March 24, 2023, the Company filed a certificate of elimination (the “Certificate of Elimination”) with the Secretary of State of the State of Delaware for the Series A Preferred Stock. The Certificate of Elimination (i) eliminated the previous designation of 47,500 shares of Series A Preferred Stock from the Company’s Certificate of Incorporation, as amended, none of which were outstanding at the time of the filing of such Certificate of Elimination, and (ii) caused such shares of Series A Preferred Stock to resume their status as authorized but unissued and non-designated shares of preferred stock of the Company.

 

F-28
 

  

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 15 — STOCKHOLDERS’ EQUITY

 

Common Stock

 

The Company is authorized to issue up to 100,000,000 shares of Common Stock, $0.00001 par value per share. As of December 31, 2022, and 2021, the Company had 47,419,317 and 45,825,089 shares issued, and 47,416,658 and 45,822,430 shares outstanding, respectively.

 

Common Stock Issuances

 

For the year ending December 31, 2022

 

  Issued 357,778 shares of common stock as payment of the minimum withholding tax obligation due upon the vesting of shares restricted stock units.
     
  Issued 1,159,044 shares of common stock, net of 357,778 shares attributable to withholding tax, upon the exercise of restricted stock units under the Company’s various stock compensation plans.
     
  Under the terms of an $80,000 consulting agreement: on May 4, 2022, issued 38,703 shares of common stock were valued at $0.81 per share on the issuance date with a total value of $31,349 in satisfaction of $40,000. The value of the common stock issued was based on the fair value of the stock at the time of the issuance. On July 19, 2022, 38,703 shares of common stock were valued at $0.59 per share on the issuance date, with a total value of $22,835 in satisfaction of the remaining balance of $40,000. The Company recognized a total gain on debt settlement of $25,816.

 

Other stockholders’ equity transactions

 

  Recognized approximately $1,565,000 of stock-based compensation costs associated with outstanding stock options recorded in general and administrative expenses offsetting additional paid-in capital.

 

For the year ending December 31, 2021

 

February 2021 Financing

 

The Company issued 18,181,820 shares of common stock, supplemented by 9,090,910 five-year warrants with an exercise price of $3.25 per share exercisable for one share of common stock. The Company has earmarked the net proceeds from equity financing for working capital and general corporate purposes. Specifically, on February 8, 2021, the Company closed on equity financing and received gross proceeds of approximately $50,000,000, less offering costs of $3,180,000 for net proceeds of $46,820,000.

 

Other Stockholders’ Equity Transactions

 

During the year ended December 31, 2021, the Company:

 

  Issued 6,163,198 shares of common stock and received gross proceeds of approximately $13,000,000, less offering costs of $400,000 for net proceeds of $12,600,000 under the Company’s shelf registration filed on May 5, 2020.
     
  Issued 3,811 shares of common stock upon warrant holders exercising 3,811 common stock warrants, receiving approximately $3,500 in net proceeds.
     
  Issued 6,250 shares of common stock upon warrant holders exercising 6,250 cashless public common stock warrants.
     
  Issued 30,000 three-year common stock warrants with an exercise price of $3.41 per share exercisable for one share each of common stock in satisfaction of a settlement agreement. We computed the value of approximately $74,000 under the Cox-Rubenstein binomial lattice valuation model method. The Company used the following assumptions in connection with the warrants’ valuation: fair market value of the stock of $3.05, the exercise price of $3.41, volatility of 153.96%, risk-free interest rate of 0.08%, expected dividend yield of -0-, and the warrant life of 3 years.
     
  Issued 87,720 shares of common stock to specific board members under a commitment agreement valued at $200,000. The value of the common stock was determined on the original date of the agreement.
     
  Recognized approximately $3,860,000 of stock-based compensation costs associated with outstanding stock options and restricted stock units recorded in general and administrative expenses with the offset to additional paid-in capital.

 

F-29
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 15 — STOCKHOLDERS’ EQUITY (continued)

 

Common Stock Warrants

 

During the year ended December 31, 2022, 34,885 warrants expired. As of December 31, 2022, these outstanding warrants contained no intrinsic value. The weighted average exercise price of warrants outstanding on December 31, 2022, is $3.60, with a weighted average remaining contractual life of 3.1 years.

 

The following tables set forth common stock purchase warrants outstanding as of December 31, 2022:

 SCHEDULE OF WARRANT OUTSTANDING

  

Number of Warrants

(in shares)

  

Weighted

Average

Exercise

Price

 
         
Outstanding, December 31, 2020   222,360   $89.60 
Warrants granted   9,120,910    3.30 
Warrants exercised   (10,063)   (1.20)
Warrants canceled/expired   (123,396)   (98.30)
Outstanding, December 31, 2021   9,209,811    4.10 
Warrants expired   (34,885)   (131.20)
Outstanding and exercisable, December 31, 2022   9,174,926   $3.60 

 

 SCHEDULE OF WARRANT OUTSTANDING EXERCISE PRICE

    Common stock issuable upon exercise of warrants outstanding and exercisable 
    For the year ending   For the year ending 
    December 31, 2022   December 31, 2021 
Range of Exercise Prices   Warrants Outstanding and Exercisable (in shares)   Weighted Average Remaining Contractual Life (years)  

Weighted Average Exercise

Price

  

Warrants Outstanding and Exercisable

(in shares)

   Weighted Average Remaining Exercisable Contractual Life (years) 

Weighted Average Exercise

Price

 
$3.25    9,090,910    3.11 yrs   $3.30    9,090,910   4.11 yrs  $3.30 
$3.41    30,000    1.18 yrs   $3.50    30,000   2.18 yrs  $3.50 
$30.000    683    1.54 yrs   $30.00    683   2.54 yrs  $30.00 
$60.000    53,333    0.41 yrs   $60.00    53,333   1.41 yrs  $60.00 
$120.000           $    21,877   0.12 yrs  $120.00 
$150.000           $    13,008   0.63 yrs  $150.00 
      9,174,926    3.10 yrs   $3.60    9,209,811   4.08 yrs  $4.10 

 

F-30
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 16 — STOCK-BASED COMPENSATION

 

Equity Incentive Plans:

 

The Company’s stock option plans provide options to purchase shares of common stock to officers, directors, other key employees, and consultants. The purchase price may be paid in cash or “net settled” in the Company’s common stock shares. In a net settlement of an option, the Company does not require payment of the exercise price from the holder but reduces the number of shares of common stock issued upon the exercise of the stock option by the smallest amount of whole shares that have an aggregate fair market value equal to or over the aggregate exercise price for the option shares covered by the option exercised. Options generally vest over three years from the grant date and expire ten years from the grant date.

 

The Company has four plans under which they awarded share-based compensation grants of options to individual directors, employees, and advisors of the Company: the 2013 Stock Option Plan, the 2015 Incentive Compensation Plan, the 2016 Incentive Compensation Plan, and the 2017 Incentive Compensation Plan.

 

Effective April 30, 2018, the Board of Directors, by unanimous written consent, approved the immediate vesting of all remaining options for terminated employees as part of the cost curtailment measures on April 30, 2018, and June 25, 2018.

 

On December 31, 2020, the board of directors of the Company approved an amendment (the “Amendment”) to the Company’s 2013 Long-Term Stock Incentive Plan (the “Plan”), effective January 1, 2021. The Amendment removed a provision that no participant may receive more than 25% of the total shares awarded in any year under the Plan and incorporated specific immaterial clarifying changes.

 

The following table illustrates various plan data under the amended Long-Term Stock Incentive Plan (the “Plan”):

 

SCHEDULE OF STOCK OPTION PLANS

   For the years ended 
   December 31, 
   2022   2021 
Stock-based compensation expense  $1,000   $27,000 
           
Remaining expense of stock-based compensation  $   $1,000 
           
Remaining amortization period   0.0 years    0.3 years 
           
Weighted average remaining contractual life – options outstanding and exercisable   4.5 years    5.5 years 
           
Intrinsic value per share  $   $ 
           
Range of exercise prices  $6.96 to $97.20   $6.96 to $1,173.60 
           
Quantity:          
           
Beginning balance-January 1st, outstanding options   49,925    56,399 
           
Stock options forfeited   (4,916)   (6,474)
           
Ending balance-December 31st, outstanding options   45,009    49,925 
           
Ending balance-December 31st, exercisable options   45,009    48,703 
           
Weighted Averages:          
           
Beginning balance-January 1st, outstanding options  $88.04   $89.79 
           
Stock options forfeited  $(96.70)  $(84.13)
           
Ending balance-December 31st, outstanding options  $87.80   $88.04 
           
Ending balance-December 31st, exercisable options  $87.80   $89.80 

 

F-31
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 16 — STOCK-BASED COMPENSATION (continued)

 

Time-vested stock options:

 

In connection with their employment agreement(s), the Company granted the following ten-year, non-statutory time-vested option inducement awards under the NASDAQ Listing Rule 5653(c)(4) outside of the Company’s existing equity compensation plans (all subject to continued employment):

 

Recipient  Date of Grant   Options Granted   Exercise Price   Vesting Commencement Date  Expiration Date  25% Vesting   75% Remaining Vesting
●Carleton M. Miller — CEO   1/22/20    359,247   $1.71   1/22/20  1/22/30   1/22/21   36 equal monthly payments
●Michael Bond — CFO   2/27/20    135,168   $0.96   4/1/20  4/1/30   4/1/21   36 equal monthly payments

 

 In determining the time-vested options award’s grant-date fair value, the following assumptions were used:

 

 

   Expected term (years)   Expected dividend yield   Risk-free interest rate   Volatility   Exercise Price 
                     
● Carleton M. Miller — CEO   6.5        1.57%   153.0%  $1.71 
● Michael Bond — CFO   6.3        0.62%   155.0%  $0.96 

 

Note: no time-vested option awards were granted during the year ended December 31, 2022.

 

The following table illustrates various plan data under time-based stock option awards:

 

   2022   2021 
   For the years ended 
   December 31, 
   2022   2021 
Stock-based compensation expense  $179,000   $113,000 
           
Remaining expense of stock-based compensation  $319,000   $498,000 
           
Remaining amortization period   1.1 years    2.1 years 
           
Weighted average remaining contractual life – options outstanding and exercisable   7.1 years    8.1 years 
           
Intrinsic value per share  $   $.38 
           
Range of exercise prices   $0.96 to $1.71    $0.96 to $1.71 
           
Quantity:          
           
Beginning balance-January 1st, outstanding    494,415    494,415 
           
Granted, canceled, expired        
           
Ending balance-December 31st, outstanding    494,415    494,415 
           
Ending balance-December 31st, exercisable    360,515    236,915 
           
Weighted Averages:          
           
Beginning balance-January 1st, outstanding   $1.01   $1.24 
           
Granted, canceled, expired  $   $ 
           
Ending balance-December 31st, outstanding   $0.60   $1.01 
           
Ending balance-December 31st, exercisable   $0.80   $0.48 

 

F-32
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 16 — STOCK-BASED COMPENSATION (continued)

 

Performance-based stock options:

 

In connection with their employment agreement, the Company granted the following ten-year, non-statutory performance-based stock option inducement award under the NASDAQ Listing Rule 5653(c)(4) outside of the Company’s existing equity compensation plans that will vest in three equal tranches upon attainment of applicable performance conditions for each tranche (all subject to continued employment):

 

   Date of   Options   Exercise   Options Vesting Dates  Options Vesting Schedule 
Recipient  Grant   Granted   Price   Commencement  Expiration   Tranche 1   Tranche 2   Tranche 3 
                                       
Carleton M. Miller — CEO   1/22/20    250,000   $1.71    1/22/20    1/22/30    *83,334    **83,333    ***83,333 

 

Applicable performance conditions:

 

*Shares will vest upon the Company’s attainment, on or before the fifth (5th) anniversary of the Vesting Commencement Date, of Cumulative EBITDA of more than $6,000,000 accumulated over four consecutive fiscal quarters.

 

**Shares will vest upon the Company’s attainment, on or before the fifth (5th) anniversary of the Vesting Commencement Date, of Cumulative EBITDA of more than $15,000,000 accumulated over four consecutive fiscal quarters.

 

***Shares will vest upon the Company’s attainment, on or before the fifth (5th) anniversary of the Vesting Commencement Date, of Cumulative EBITDA of more than $23,000,000 accumulated over four consecutive fiscal quarters.

 

In determining the time-vested options award’s grant-date fair value, the following assumptions were used:

 

   Expected term (years)   Expected dividend yield   Risk-free interest rate   Volatility   Exercise Price 
                     
For the year ended December 31, 2020:                       
                          
● Carleton M. Miller — CEO   6.5        1.57%   153.0%  $1.71 

 

Note: no time-vested option awards were granted during the year ended December 31, 2022

 

F-33
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 16 — STOCK-BASED COMPENSATION (continued)

 

Performance-based stock options (continued):

 

The following table illustrates various plan data under performance-based stock option awards:

 

   2022   2021 
   For the years ended 
   December 31, 
   2022   2021 
Stock-based compensation expense  $   $ 
           
Remaining expense of stock-based compensation  $414,000   $414,000 
           
Remaining amortization period   2.1 years    3.1 years 
           
Weighted average remaining contractual life – options outstanding and exercisable   7.1 years    8.1 years 
           
Intrinsic value per share  $   $. 
           
Range of exercise prices  $1.71   $1.71 
           
Quantity:          
           
Beginning balance-January 1st, outstanding    250,000    250,000 
           
Granted, canceled, expired        
           
Ending balance-December 31st, outstanding    250,000    250,000 
           
Ending balance-December 31st, exercisable         
           
Weighted Averages:          
           
Beginning balance-January 1st, outstanding   $1.65   $1.65 
           
Granted, canceled, expired  $   $ 
           
Ending balance-December 31st, outstanding   $1.65   $1.65 
           
Ending balance-December 31st, exercisable   $   $ 

 

The probability of achieving any required metrics for vesting is inconclusive, and no options are exercisable as of December 31, 2022. When the Company determines that the remaining performance metrics’ achievement becomes probable, the Company will record a cumulative catch-up stock-based compensation amount. We will record any unrecognized costs over the remaining requisite service period of the awards.

 

F-34
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 16 — STOCK-BASED COMPENSATION (continued)

 

Restricted Stock Units

 

Restricted stock awards — time-based:

 

The Company granted the following awards under the amended Plan for restricted stock units (“RSUs”) subject to continued employment:

 

   Grant       Initial RSUs Vesting  Remaining RSUs Vesting
Recipient  Date   Units   Exercise Price   Date  Units   Units   Terms
                           
Carleton M. Miller — CEO   3/3/21    598,665   $3.60   3/3/22   199,555    399,110   24 equal monthly periods
                                
Michel Bais — Managing Director   8/17/21    200,000   $1.89   8/17/22   50,000    150,000   36 equal monthly periods
                                
Ronnie Hamilton — VP Global Operations   1/12/22    200,000   $1.10   1/12/23   66,000    134,000   24 equal monthly periods
                                
Group of 22 Employees   2/17/22    515,000   $0.98   2/17/23   169,950    345,050   24 equal monthly periods
                                
Carleton M. Miller — CEO   2/16/22    1,033,076   $1.05   2/16/23   258,269    774,807   36 equal monthly periods
                                
Mike Bond — CFO   2/16/22    392,985   $1.05   2/16/23   98,256    294,739   36 equal monthly periods

 

The following table illustrates various plan data under time-based restricted stock awards:

 

   2022   2021 
   For the years ended 
   December 31, 
   2022   2021 
Stock-based compensation expense  $1,385,000   $ 
           
Remaining expense of stock-based compensation  $3,248,000   $2,533,000 
           
Remaining amortization period    2.3 years    3.5 years 
           
Weighted average remaining contractual life – options outstanding and exercisable   2.5 years    2.5 years 
           
Intrinsic value per share  $   $ 
           
Range of exercise prices  $0.98 to $3.60   $1.89 to $3.60 
           
Quantity:          
           
Beginning balance-January 1st, outstanding    798,665     
           
Granted   2,141,061    798,665 
           
Forfeited   (125,000)    
           
Ending balance-December 31st, outstanding    2,814,726    798,665 
           
Ending balance-December 31st, exercisable    415,885     
           
Weighted Averages:          
           
Beginning balance-January 1st, outstanding   $3.17   $ 
           
Granted  $1.04    3.17 
           
Forfeited  $(.98)  $ 
           
Ending balance-December 31st, outstanding   $1.20   $3.17 
           
Ending balance-December 31st, exercisable   $3.30   $ 

 

F-35
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 16 — STOCK-BASED COMPENSATION (continued)

 

Restricted Stock Units (continued)

 

Restricted stock awards — performance-based:

 

The Company granted the following awards under the amended Plan for restricted stock units (“RSUs”) subject to performance vesting conditions and continued employment:

 

   Grant       Units Vesting Schedule 
Recipient  Date   Units   Exercise Price   Tranche 1   Tranche 2   Tranche 3 
Carleton M. Miller — CEO   3/3/21    896,665   $3.60    299,555    299,555    299,555 
                               
Michael Bond — CFO   12/31/20    368,715   $1.32    122,905    122,905    122,905 

 

Note: The above performance-based restricted stock units met all three revenue thresholds in the last quarter of 2021, and the Company recognized stock-based compensation expense accordingly for the year ending December 31, 2021.

 

   Grant       Units Vesting Schedule 
Recipient  Date   Units   Exercise Price   Tranche 1   Tranche 2   Tranche 3 
Carleton M. Miller — CEO   2/16/22    1,033,076   $1.05    *344,359    **344,359    ***344,359 
                               
Michael Bond — CFO   2/16/22    392,985   $1.05    *130,995    **130,995    ***130,994 

 

* RSUs will vest upon the Company’s attainment, on or before December 31, 2026, of revenue of more than $35,575,000 accumulated over four consecutive fiscal quarters.
   
** RSUs will vest upon the Company’s attainment, on or before December 31, 2026, of revenue of more than $37,353,000 accumulated over four consecutive fiscal quarters.
   
*** RSUs will vest upon the Company’s attainment, on or before December 31, 2026, of revenue of more than $39,220,000 accumulated over four consecutive fiscal quarters.

 

Note: the determination of revenue for any fiscal period shall be made based on the Company’s revenues on a consolidated basis for each such fiscal period if the employee remains in continuous employment with the Company through the date the Compensation Committee certifies the revenue for such fiscal period and authorizes the issuance of the underlying shares of common stock to the employee according to his award agreement. Except as provided in each employment agreement, if an individual ceases to be an employee of the Company before any vesting date, the remaining portion of the total number of shares unvested is forfeited. The probability of achieving any required metrics for vesting is inconclusive, and no awards are exercisable as of December 31, 2022. When the Company determines that the remaining performance metrics’ achievement becomes probable, the Company will record a cumulative catch-up stock-based compensation amount. We will record any unrecognized costs over the remaining requisite service period of the awards.

 

F-36
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 16 — STOCK-BASED COMPENSATION (continued)

 

Restricted Stock Units (continued)

 

Restricted stock awards — performance-based (continued):

 

The following table illustrates various plan data under performance-based restricted stock awards:

 

   2022   2021 
   For the years ended 
   December 31, 
   2022   2021 
Stock-based compensation expense  $   $3,722,000 
           
Remaining expense of stock-based compensation  $1,498,000   $ 
           
Remaining amortization period   2.8 years    0.0 years 
           
Weighted average remaining contractual life – options outstanding and exercisable   2.8 years    4.0 years 
           
Intrinsic value per share  $   $1.18 
           
Range of exercise prices  $1.05    $1.32 to 3.60 
           
Quantity:          
           
Beginning balance-January 1st, outstanding    1,267,380    368,715 
           
Granted, canceled, expired   1,426,062    898,665 
           
Exercised   (1,267,380)    
           
Ending balance-December 31st, outstanding    1,426,062    1,267,380 
           
Ending balance-December 31st, exercisable        1,267,380 
           
Weighted Averages:          
           
Beginning balance-January 1st, outstanding   $2.90   $1.32 
           
Granted, canceled, expired   1.05    3.60 
           
Exercised  $(2.90)  $ 
           
Ending balance-December 31st, outstanding   $1.10   $2.90 
           
Ending balance-December 31st, exercisable   $   $2.90 

 

F-37
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 17 — COMMITMENTS AND CONTINGENCIES

 

Pension:

 

The Company may make a matching contribution to its employees’ 401(k) plan. Vislink also has a Group Personal Plan in our U.K. Subsidiary, investing funds with Royal London. U.K. employees are entitled to join the Plan to which the Company contributes varying amounts subject to status. Additionally, the Company operates a stakeholder pension scheme in the U.K.

 

The table below represents the Company’s matching contributions as follows:

 

   For the year ended 
   December 31, 
   2022   2021 
Company matching contributions - Group Personal Pension Plan, U.K.  $166,000   $169,000 

 

Nasdaq Compliance:

 

As previously reported, on May 20, 2022, Vislink Technologies, Inc. (the “Company”) received notice from the Nasdaq Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company of its noncompliance with Nasdaq Listing Rule 5550(a)(2) (the “Rule”) by failing to maintain a minimum bid price for its common stock on the Nasdaq Capital Market of at least $1.00 per share for 30 consecutive business days. The Company received a grace period of 180 days, or until November 16, 2022, to regain compliance with the minimum bid price requirement.

 

On November 10, 2022, the Company submitted a request to Nasdaq for an additional 180-day grace period, or until May 15, 2023, to regain compliance with the minimum bid price requirement. On November 17, 2022, the Company received a letter from Nasdaq advising that the Company had been granted an additional 180-day grace period extension until May 15, 2023, to regain compliance with the minimum bid price requirement and all other applicable requirements for initial listing on the Nasdaq Capital Market except for the minimum bid price requirement.

 

On January 11, 2023, the Company held a special meeting of stockholders (the “Special Meeting”) whereby stockholders voted and approved a proposal to authorize the Board of Directors of the Company (the “Board”), in its discretion but before the one-year anniversary of the date of the Special Meeting, to implement an amendment to the Company’s certificate of incorporation to effect a reverse stock split (the “Reverse Stock Split”) of all of the outstanding shares of Common Stock, par value $0.00001 per share (“Common Stock”), of the Company, at a ratio in the range of 1-for-2 to 1-for-50. The Company intends to monitor the closing bid price of its common stock and may, if appropriate, consider available options to regain compliance with the Rule, including initiating the Reverse Stock Split.

 

There can be no assurance that the Reverse Split will result in a sustained increase in the per share market price for the Common Stock for the minimum period necessary to permit the Company to be timely regain compliance with the Rule. There can be no assurance that the Company will be able to regain compliance with the Rule or otherwise be in compliance with other Nasdaq Listing Rules during this additional 180-day extension period. If the Company does not regain compliance within the allotted compliance period, Nasdaq will provide notice that the common stock will be subject to delisting. The Company would then be entitled to appeal that determination to a Nasdaq hearings panel.

 

The Nasdaq notice has no immediate impact on the listing of the Company’s common stock, which will continue to be listed and traded on The Nasdaq Capital Market under the symbol “VISL,” subject to the Company’s compliance with the other continued listing requirements of The Nasdaq Capital Market

 

F-38
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 18 — CONCENTRATIONS

 

Customer concentration risk

 

During the year ended December 31, 2022, the Company recorded sales to a single customer of $3,436,000 (12%), in excess of 10% of the Company’s total sales. For the year ended December 31, 2021, the Company recorded sales to a single customer of $8,511,000 (25%) in excess of 10% of the Company’s total sales.

 

On December 31, 2022, and 2021, the Company recorded accounts receivable of approximately $1,138,000 (19%) and $4,204,000 (46%), respectively, to a single customer in excess of 10% of the Company’s total consolidated accounts receivable.

 

Vendor concentration risk

 

During the years ended December 31, 2022, and 2021, there were no individual vendor inventory purchases in excess of 10% of the Company’s consolidated inventory purchases, respectively.

 

On December 31, 2022, and 2021, the Company recorded one vendor balance of approximately $0.27 million (10%) and $-0-, respectively, in excess of 10% of the Company’s total consolidated accounts payable.

 

NOTE 19 – REVENUE

 

The Company has one operating segment, and the decision-making group is the senior executive management team. The Company disaggregated revenue by primary geographical markets and revenue sources in the following tables:

 

   For the years ended 
   December 31, 
   2022   2021 
Primary geographical markets:          
North America  $12,037,000   $18,050,000 
South America   182,000    361,000 
Europe   9,229,000    11,389,000 
Asia   1,851,000    1,975,000 
Rest of World   5,103,000    2,107,000 
   $28,402,000   $33,882,000 
Primary revenue source:          
Equipment sales  $25,667,000   $31,733,000 
Installation, integration, and repairs   1,450,000    1,082,000 
Warranties   1,014,000    743,000 
Other (See Note 20)   271,000    324,000 
   $28,402,000   $33,882,000 
Long-Lived Assets:          
United States  $1,970,000   $2,410,000 
Netherlands   27,000     
United Kingdom   4,912,000    14,257,000 
   $6,909,000   $16,667,000 

 

NOTE 20 — REBATES

 

The amounts generated in Note 18 as part of the Primary revenue source “other” resulted from rebates issued to the Company’s filing appropriate governmental forms related to the research costs incurred by our U.K. subsidiary in prior fiscal years. The Company expects to continue filing applicable rebate forms for the 2022 fiscal year but can provide no assurances that such rebates will be available in future financial periods at similar levels or at all.

 

F-39
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 21 — GAINS ON SETTLEMENT OF DEBT

 

The following table represents the Company’s gains on settlement of debt for the years ending December 31, 2022 and 2021:

 

    2022    2021 
   For the Years Ended 
   December 31, 
    2022    2021 
           
On March 10, 2021, the Company negotiated a vendor accounts payable balance of $494,000 with a remittance settlement of $300,000  $   $194,000 
           
On July 26, 2021, the Payroll Protection Program (“PPP”) loan of $1,168,000 received on April 10, 2020, was forgiven. Under ASC 405-20, the Company recorded the transaction as a gain on settlement of debt   -    1,168,000 
           
On May 4, 2022, and July 19, 2022, the Company issued 38,703 shares of common stock on each date with an accumulated value of $54,184 in satisfaction of an amount payable of $80,000   25,816     
           
On November 21, 2022, the Company settled the dividends payable in the amount of $19,916 by issuing 47,419 Series A Preferred shares with a zero carrying value   19,916     
           
GAINS ON SETTLEMENT OF DEBT  $45,732   $1,362,000 

 

F-40
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 22— INCOME TAXES

 

The provision (benefit) for income taxes consists of the following:

 

   2022   2021 
   For the Years Ended 
   December 31, 
   2022   2021 
Current tax provision          
Federal  $   $ 
State   25,000    7,000 
Current income tax expense, total   25,000    7,000 
Deferred tax provision (benefit)          
Federal   (532,000)   (503,000)
State   (427,000)   1,025,000 
Foreign   (978,000)   (2,052,000)
Change in the valuation allowance   1,722,000    1,530,000 
Total deferred tax provision (benefit)   (215,000)    
           
Income tax provision  $(190,000)  $7,000 

 

A reconciliation of the statutory tax rate to the effective tax rate is as follows:

 

   2022   2021 
   For the Years Ended 
   December 31, 
   2022   2021 
Statutory federal income tax rate   21.00%   21.00%
State and local taxes, net of federal benefit   0.30    (6.27)
Permanent differences   5.28    (9.12)
Executive compensation   (2.26)    
Equity compensation   (11.06)    
Provision to return   0.00    (0.03)
DTA adjustment for state NOL   0.00    (0.06)
Foreign Rate Differential   (1.27)   (1.96)
Change rate   2.66    (5.06)
Valuation allowance   (13.27)   1.46 
Effective tax rate   1.37%   (0.04)%

 

Under the provisions of ASC 740, the Company may recognize the benefits of uncertain tax positions when it is more likely than not that the merits of the position(s) will be sustained upon audit by the relevant tax authorities. No uncertain tax positions were taken or expected on a tax return that would be determined to be an unrecognized tax benefit recorded on the Company’s financial statements for the years ended December 31, 2022, or 2021. The Company does not expect its unrecognized tax benefit position to change during the next twelve months

 

F-41
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 22 — INCOME TAXES (continued)

 

Deferred income taxes reflect the tax effects of temporary differences between the carrying amounts of assets and liabilities for financial accounting purposes and the amounts used for income tax reporting. Significant components of the Company’s deferred tax assets are as follows:

 

   2022   2021 
   For the Years Ended 
   December 31, 
   2022   2021 
Deferred Tax Assets          
Federal R&D credit  $3,007,000   $3,007,000 
Inventory   576,000    457,000 
Allowance for bad debt   72,000    76,000 
Compensation related   7,000    298,000 
Pension   72,000    39,000 
Other accruals   7,000    16,000 
State net operating losses   4,779,000    4,644,000 
Federal net operating losses   44,821,000    43,045,000 
Interest disallowance   1,151,000    82,000 
Stock options   7,172,000    7,621,000 
Other   296,000    1,097,000 
Valuation Allowance   (61,731,000)   (60,048,000)
Total Deferred Tax Assets   229,000    334,000 
Deferred Tax Liabilities          
Property and Equipment   (90,000)   (47,000)
Intangibles   (870,000)   (1,230,000)
Prepaid Expenses   (33,000)   (35,000)
Total Deferred Tax Liabilities   (993,000)   (1,312,000)
Net Deferred Tax Liability  $(764,000)  $(978,000)

 

As of December 31, 2022, the Company has federal net operating losses (“NOL”) of approximately $183.0 million that will expire beginning in 2027. The Company has federal NOLs of approximately $26.3 million that may be carried forward indefinitely. The Company also has state NOL carryforwards of $158.6 million, which will expire beginning in 2027. Besides, the Company has foreign NOL carryforwards of approximately $26.1 million that generally do not expire except under certain circumstances. The Company also has research and development credits of approximately $3.0 million, which will begin to expire in 2027. The years that remain open for review by taxing authorities are 2019 to 2022 for Federal, Foreign, and State Income Tax returns.

 

Realizing the NOL carryforwards and other temporary deferred tax differences is contingent on future taxable earnings. The Company’s deferred tax assets were reviewed for expected utilization using a “more likely than not” approach by assessing the available positive and negative evidence surrounding its recoverability. Accordingly, a valuation allowance has been recorded against the Company’s deferred tax assets, as it was determined, based on past and present losses, that it was “more likely than not” that the Company’s deferred tax assets would not be realized. The valuation allowance was increased to the full carrying amount of the Company’s deferred tax assets. In future years, if the deferred tax assets are determined by management to be “more likely than not” to be realized, the recognized tax benefits relating to the reversal of the valuation allowance will be recorded. The Company will continue to assess and evaluate strategies that enable the deferred tax asset, or portion thereof, to be utilized. It will reduce the valuation allowance appropriately when it is determined that the “more likely than not” criteria are satisfied.

 

The net operating loss carryovers may be subject to annual limitations under Internal Revenue Code Section 382 and similar state provisions should there be a greater than 50% ownership change as determined under the applicable income tax regulations. The limitation amount would be determined based on the company’s value immediately before the ownership change, and subsequent ownership changes could further impact the annual limitation amount. An ownership change under Section 382 may have occurred in the past or could happen in the future, such that the NOLs available for utilization could be significantly limited. The Company plans to perform a Section 382 analysis in the future.

 

F-42
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 22 — INCOME TAXES (continued)

 

Effective for tax years beginning after December 31, 2017, the Tax Act includes a participation exemption system of taxation, which generally provides for 100% dividends received deduction on certain qualifying dividend distributions received by U.S. C-corporation shareholders from their 10% or more owned foreign subsidiaries. As a result of this new participation exemption system, it is generally anticipated that the Company should not be subject to additional U.S. federal income taxation on its future receipt of actual dividend income (instead of deemed inclusion amounts under specific anti-deferral rules) from its foreign subsidiary.

 

For tax years beginning after December 31, 2017, the Tax Act introduced a new limitation on the deduction of interest expense whereby current-year interest deductions are limited (among other restrictions) to 30% of adjusted taxable income, with various modifications and exceptions. The Company does incur interest expenses and evaluates each year the impact, if any, of the new limitation.

 

The Company has not provided for deferred taxes and foreign withholding taxes on the excess of the financial reporting basis over the tax basis in our investments in foreign subsidiaries that are nearly permanent in duration. In general, it is the Company’s practice and intention to reinvest our foreign subsidiary’s earnings in those operations. Generally, our foreign subsidiary’s earnings have become subject to U.S. taxation based on specific U.S. tax law provisions, such as the recently enacted territorial transition tax under section 965 and under certain other circumstances. Due to the complexities of the provisions introduced with the Tax Act, and the underlying assumptions that would have to be made, it is not practicable to estimate the amount of tax provision required to account for these foreign undistributed earnings. The Company will account for any additional expense or deduction in the year it is claimed. The Company will continue to review each year whether this treatment is appropriate.

 

The Company did not identify any material uncertain tax positions and is not under any income tax examinations.

 

F-43
 

 

VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 23 — SUBSEQUENT EVENTS

 

Under ASC 855-10, the Company has analyzed its operations subsequent to December 31, 2022, and has determined that it does not have any other material subsequent events to disclose in these financial statements except for the following:

  

On March 27, 2023, the Company announced that it is entering into an agreed separation with Michael Bond, the Chief Financial Officer (“CFO”), to be effective on or about March 31, 2023. Effective at the close of business on March 31, 2023, Paul Norridge will become the Company’s new CFO.

 

F-44

EX-4.11 2 ex4-11.htm

 

Exhibit 4.11

 

DESCRIPTION OF SECURITIES

REGISTERED PURSUANT TO SECTION 12 OF THE

SECURITIES EXCHANGE ACT OF 1934

 

As of December 31, 2022, Vislink Technologies, Inc. (the “Company,” “we,” “us,” or “our”) has one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”): our common stock, par value $0.00001 per share (the “Common Stock).

 

General

 

The following description of our capital stock and specific provisions of our Certificate of Incorporation and Bylaws are summaries and are qualified by reference to our Certificate of Incorporation and Bylaws. Copies of these documents can be accessed through hyperlinks to those documents in the list of exhibits in our Annual Report on Form 10-K for the fiscal year ending December 31, 2022.

 

Our authorized capital stock comprises 100,000,000 shares of common stock, a par value of $0.00001 per share, and 10,000,000 shares of  “blank check” preferred stock. As of March 24, 2023, we had 47,619,317 shares of common stock issued and outstanding, and no shares of preferred stock were outstanding.

 

Common Stock

 

Voting Rights

 

Each stockholder has one vote for each share of Common Stock held on all matters submitted to a vote of stockholders. A stockholder may vote in person or by proxy. A plurality of the votes cast determines the elections of directors.

 

Because our stockholders do not have cumulative voting rights, stockholders holding a majority of the voting power of our shares of Common Stock will be able to elect all of our directors. Our Certificate of Incorporation and Bylaws provide that stockholder actions may be effected at a duly called meeting of stockholders or pursuant to the written consent of the majority of stockholders. A special meeting of stockholders may be called by the majority of our Board of Directors or by a committee determined by the Board of Directors with the power to call such meetings.

 

Dividend Rights

 

The holders of outstanding shares of Common Stock are entitled to receive dividends out of funds legally available at times and in the amounts that our Board of Directors may determine, provided that required dividends, if any, on the preferred stock have been paid or provided. However, to date, we have not paid or declared cash distributions or dividends on our common stock and do not currently intend to pay cash dividends on our common stock in the foreseeable future. The Board of Directors will determine the declaration of cash dividends in the future based on our earnings, financial condition, capital requirements, and other relevant factors. To finance our operations, we intend to retain all earnings if and when generated.

 

No Preemptive or Similar Rights

 

Holders of our Common Stock do not have preemptive rights, and our Common Stock is not convertible or redeemable.

 

Right to Receive Liquidation Distributions

 

Upon our dissolution, liquidation, or winding-up, the assets legally available for distribution to our stockholders and remaining after payment to holders of preferred stock of the amounts, if any, to which they are entitled are distributable ratably among the holders of our common stock subject to any senior class of securities.

 

Anti-Takeover Provisions

 

The authorization of undesignated preferred stock makes it possible for our Board of Directors to issue preferred stock with voting or other rights or preferences that could impede the success of any attempt to change our control.

 

Provisions such as these, which are intended to make an acquisition of control by a third party more difficult, are designed to enhance the likelihood of continued stability in the composition of our Board of Directors and its policies and to discourage certain types of transactions that may involve an actual or threatened acquisition of us.

 

 
 

 

 

These provisions are also designed to reduce our vulnerability to an unsolicited acquisition proposal and discourage certain tactics used in proxy fights. However, such provisions could have the effect of discouraging others from making tender offers for our shares and may have the effect of deterring hostile takeovers or delaying changes in our control or management. Consequently, these provisions also may inhibit fluctuations in the market price of our stock that may result from actual or rumored takeover attempts.

 

Our Certificate of Incorporation and Bylaws

 

Our certificate of incorporation and bylaws include a number of provisions that could deter hostile takeovers or delay or prevent changes in control of our company, including the following:

 

 

 

No Cumulative Voting. The Delaware General Corporation Law (“DGCL”) provides that stockholders are denied the right to cumulate votes in the election of directors unless the company’s certificate of incorporation provides otherwise. Our amended and restated certificate of incorporation does not provide for cumulative voting.
     
  Special Meetings of Stockholders and Stockholder Action by Written Consent. Our certificate of incorporation and bylaws provide that all stockholder actions must be effected at a duly called meeting of stockholders and eliminate the right of stockholders to act by written consent without a meeting. Our bylaws also provide that only our chairman of the board, Chief Executive Officer (or if there is no Chief Executive Officer, the President) or the board of directors, pursuant to a resolution adopted by a majority of the total number of authorized directors may call a special meeting of stockholders.
     
  Advance Notice Requirements for Stockholder Proposals. Our bylaws provide that stockholders seeking to present proposals before a meeting of stockholders, including the nomination of director candidates, must provide timely advance notice in writing and specifies requirements as to the form and content of a stockholder’s notice.
     
  Amendment to Certificate of Incorporation and Bylaws. Our certificate of incorporation and bylaws provide that the stockholders cannot amend the provisions described above except by a vote of 66 2/3% or more of our outstanding common stock.

 

These provisions are intended to enhance the likelihood of continued stability in the composition of our Board and its policies and to discourage coercive takeover practices and inadequate takeover bids. These provisions are also designed to reduce our vulnerability to hostile takeovers and discourage tactics used in proxy fights. However, such provisions could have the effect of discouraging others from making tender offers for our shares and may have the effect of delaying changes in our control or management. Consequently, these provisions may also inhibit fluctuations in the market price of our stock that could result from actual or rumored takeover attempts. We believe that the benefits of these provisions, including increased protection of our potential ability to negotiate with the proponent of an unfriendly or unsolicited proposal to acquire or restructure our company, outweigh the disadvantages of discouraging takeover proposals because negotiation of takeover proposals could result in an improvement of their terms.

 

Choice of Forum

 

Our certificate of incorporation provides that the Court of Chancery of the state of Delaware (the “Chancery Court”) is the exclusive forum for (i) any derivative action or proceeding brought on behalf of the Corporation, (ii) any action asserting a claim for breach of a fiduciary duty owed by any director, officer, employee or agent of the Corporation to the Corporation or the Corporation’s stockholders, (iii) any action asserting a claim arising pursuant to any provision of the DGCL, the Corporation’s certificate of incorporation or by-laws or (iv) any action asserting a claim governed by the internal affairs doctrine, in each case subject to said Court of Chancery having personal jurisdiction over the indispensable parties named as defendants therein.

 

This exclusive forum provision does not apply to suits brought to enforce any liability or duty created by the Securities Exchange Act of 1934 (the “Exchange Act”)or any other claim for which the federal courts have exclusive jurisdiction. To the extent that any such claims may be based upon federal law claims, Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder.

 

 
 

 

 

Our bylaws further provide that the federal district courts of the United States will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act. However, stockholders cannot waive compliance with the federal securities laws and the rules and regulations thereunder. The enforceability of similar choice of forum provisions in some other companies’ bylaws has been challenged in legal proceedings, and it is possible that, in connection with any action, a court could find the choice of forum provisions contained in our bylaws to be inapplicable or unenforceable.

 

Section 203 of the DGCL

 

We are subject to Section 203 of the DGCL, which prohibits a Delaware corporation from engaging in any “business combination” with any interested stockholder for a period of three years after the date that such stockholder became an interested stockholder. In general, Section 203 defines an “interested stockholder” as an entity or person who, together with the person’s affiliates and associates, beneficially owns, or within three years prior to the time of determination of interested stockholder status did own, 15% or more of the outstanding voting stock of the corporation.

We are subject to Section 203 with the following exceptions:

 

  before the date that such a stockholder became an interested stockholder, the Board of Directors of the corporation approved either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder;
     
  upon closing of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction began, excluding for purposes of determining the voting stock outstanding (but not the outstanding voting stock owned by the interested stockholder) those shares owned (i) by persons who are directors and also officers and (ii) employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or
     
  on or after such date that such stockholder became an interested stockholder, the business combination is approved by the Board of Directors and authorized at an annual or special meeting of the stockholders, and not by written consent, by the affirmative vote of at least 66 2/3% of the outstanding voting stock that the interested stockholder does not own.

 

In general, Section 203 defines business combination to include the following:

 

  any merger or consolidation involving the corporation and the interested stockholder;
     
  any sale, transfer, pledge, or other disposition of 10% or more of the assets of the corporation involving the interested stockholder;
     
  subject to certain exceptions, any transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested stockholder;
     
  any transaction involving the corporation that has the effect of increasing the proportionate share of the stock of any class or series of the corporation beneficially owned by the interested stockholder; or
     
  guarantees, pledges or other financial benefits provided by or through the corporation.

 

Transfer Agent, Warrant Agent, and Registrars

 

Our transfer agent and registrar for our Common Stock in the United States is Continental Stock Transfer & Trust Company. Our Common Stock is listed on the Nasdaq Capital Market under the symbol “VISL.”

 

 

 

EX-23.1 3 ex23-1.htm

 

Exhibit 23.1

 

INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT

 

We consent to the incorporation by reference in this Registration Statement of Vislink Technologies, Inc. on Forms S-3 [File Nos. 333-228793 and 333-238013] and Forms S-8 [File Nos. 333-270912, 333-264124, 333-255305, 333-233849, 333-233848, 333-224107, 333-224106, 333-224105, 333-215461, 333-214658, 333-212621, 333-210773, 333-208313, 333-206486, 333-205687, and 333-203399] of our report dated March 31, 2023, with respect to our audits of the consolidated financial statements of Vislink Technologies, Inc. as of December 31, 2022 and for the years ended December 31, 2022 and 2021 appearing in the Annual Report on Form 10-K of Vislink Technologies, Inc. for the year ended December 31, 2022.

 

/s/ Marcum LLP  
   
Marcum LLP  
New York, NY  
March 31, 2023  

 

 

 

EX-31.1 4 ex31-1.htm

 

Exhibit 31.1

 

CERTIFICATION

OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

 

I, Carleton M. Miller, certify that:

 

1. I have reviewed this annual report on Form 10-K of Vislink Technologies, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15(d)-15(e)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(c) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether material, involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 31, 2023  
   
  /s/ Carleton M. Miller
  Carleton M. Miller
  Chief Executive Officer

 

 

 

EX-31.2 5 ex31-2.htm

 

Exhibit 31.2

 

CERTIFICATION

OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

 

I, Michael C. Bond, certify that:

 

1. I have reviewed this annual report on Form 10-K of Vislink Technologies, Inc.;

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

 

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(c) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b) Any fraud, whether material, involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 31, 2023  
   
  /s/ Michael C. Bond
  Michael C. Bond
  Chief Financial Officer

 

 

 

EX-32.1 6 ex32-1.htm

 

Exhibit 32.1

 

CERTIFICATION

OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Vislink Technologies, Inc. (the “Company”) on Form 10-K for the period ended December 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Carleton M. Miller, Chief Executive Officer of Vislink Technologies, Inc., certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

 

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: March 31, 2023  
   
  /s/ Carleton M. Miller
  Carleton M. Miller
  Chief Executive Officer

 

 

EX-32.2 7 ex32-2.htm

 

Exhibit 32.2

 

CERTIFICATION

OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report of Vislink Technologies, Inc. (the “Company”) on Form 10-K for the period ended December 31, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Carleton M. Miller, Chief Executive Officer of Vislink Technologies, Inc., certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

 

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Date: March 31, 2023  
   
  /s/ Michael C. Bond
  Michael C. Bond
  Chief Financial Officer

 

 

 

GRAPHIC 8 form10-k_001.jpg begin 644 form10-k_001.jpg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
  •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end GRAPHIC 9 form10-k_002.jpg begin 644 form10-k_002.jpg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form10-k_003.jpg begin 644 form10-k_003.jpg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form10-k_004.jpg begin 644 form10-k_004.jpg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form10-k_005.jpg begin 644 form10-k_005.jpg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form10-k_006.jpg begin 644 form10-k_006.jpg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end GRAPHIC 14 form10-k_007.jpg begin 644 form10-k_007.jpg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end GRAPHIC 15 form10-k_008.jpg begin 644 form10-k_008.jpg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form10-k_009.jpg begin 644 form10-k_009.jpg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end GRAPHIC 17 form10-k_010.jpg begin 644 form10-k_010.jpg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ⅅ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

    >&)M<@AM_L9N;4JPN(,8"R1MW XR#SBJ6D_M;6 MG@3-OX&\0WT&AYS%HGB:P:9;8?W8YT8MM'8'I7W]JW_!*GX Z@S-;Z+JNFL? M^?74Y-H_ YKAM:_X(\?#*ZW'3?%/B#3B>@=DE _,5I[5F?LD?+-G\?/"OQ1N MX+GXG_$.*71[5A.GAK2["6&WF=3D>:[?-(/]GH:[_P"$/[9G@GQ%\1/%%CJ$ MJZ#I-R\?]EW-X B2HB!"K=ESC(![5UVL_P#!&.V8YTOXFW*^BW>GH1^8-<+K MG_!&_P >0Y_LWQOHM^G]VXMGC/Z$U2K,ET4S%/$6LZK)Q':_8S$N[ MT=SP![UX#K'_ 27^.6D[FT^/P[J"CIY.H&)C^:_UKC=1_8!_:2\+Y>+PCJD MRJ?O:9JZOCWQO!_2J]L3[$^B8[9?AWJ$/C'XEZM9P>-/%6J6ULEK'(/*L;=2 M=D">H'5F]377_&+2]3\$^.M(^)VBV,KQT&T336LMUM'H"-V!5[3?BI\>?AS816"7OBK3K M2W4(D.H:=(P1?3+KG%4JJ)=)GZ,^'/&'@3XA:0MYIUYI.HVT@W.K%-RGT93R M"/>O-_C!X^T9XM1\&>!$BU?QMXC7[-)]B/F+:QGAYIF'"A5S]37Y_P"M?%?6 M]5U)[[7-*TF>];F27[";5I/][RRN37=>"_VP=?\ A[I,UCX=\->&M*:08-U! M"1(3ZL2A !!]Z^$/@S^V%XO^%NL:U< M:A&/%%GK%P;RYAFEVLLQX+HPZ C^'IQ74>+/VKO#GB;Q$GBC3=(UOP1XM""* M34M)F66.X0=%FB. _P!3S352.Y+IRV/OKPSX-A\,ZE<7-O>2O%-&(_LS "-2 M"3N '\1SR>]?./[46K1^*O'4D.FLLZ>$="O;O49D.5B>5-B1$^ISG%>16W[8 MVJ:Y&++5_B#?Z+:,,/<6.@IY[#V.XX/OBF_$+]HGX<>'O@[J_@WX=V^H:EJ. MM@C4-6U*-ED=F^_([-RS'L.@IN<6A*$DSY(C4>6OTI<>U2-#L9D!#A!]Y3P1 MZTT=*XCM(+K_ %>._P#]>M!4.T@_#^=:2#Y::$R)E[4PK@&K)7-=S\" M8-%D^-7@A?$0C;0SJUO]K$OW=FX?>]LXI@=Q\+OV$_C/\7M!&L:)X3EMM/D M:";4F%N)@>Z[N<5I:[_P3I^/^@L0_@9[Q0,EK.Y20?H:_=^S,!LX#:[/LNQ? M*\K&S;CC&.V*EK/F95C^:;QQ\/\ Q+\-=:.D^*M"OM U$=(+Z$QEAZJ3P1]* M]8_86T\ZG^UO\-( -V-1\S_OF-C_ $K];/\ @H+\./"GCK]FOQ3=>(HK>&]T MRW-UI]^Z@2Q3*>%5NN#T(]Z_+K_@FUIO]I?MC^!CMR+=;J<_A"P_K3OH+9G[ MM4445!84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !FH9K&V MNE(FMX9@>HDC#?SJ:B@#F]2^&OA'6-POO"VC7F[KYUA$V?S6N,UC]E'X/Z]O M^V_#O0)"W4K9(G\@*]7HH ^;=8_X)U_ #6MWG> X(-W_ #ZW$D7\FKAM7_X) M._ C4-WV:SUO3,]/LVI.\Z/\4_,YRHOM+ _,JYK]/:*=V*R/R&U;_@C[\4['<=/\5> M&M2Q]W>)8B?S6N&UK_@EE\>].RR:1HNH@=/LFHJ"?P.*_;*BGS,+(_ S7?\ M@GW\?-'\SS/A]>SK'\Q:VD20$>V#S7):M^S7\6=!XO?ASXBB 'WA8NP_,5_1 M!FCK1S,7*?S::AX#\4:2Q%[X9UBT(X/G6,@_I6+<++8L//CEM6!R#(A0@_C7 M]+TVGVMRN)K6&8>DD8;^8K%U#X=^%-65EO?#&CW:MU$UA$^?S6GS!RGXD_"; M_@H1\6/A/HL6EZ?KRZC91<)'?*)P . !NY'X&O8--_X*\_$NUAV76A:+?/\ MWVB=#^C5^D.M?LI?![Q%N_M#X;^'9]W7_0E3_P!!Q7"ZO_P3M_9^U@,&^'UI M:[N]I-)%_)J5T/4_*K]HS]MKQ[^T=9IIVL31V6DJV[[': HA/N._XUW/_!*G M2_MG[6UC+C(MM(NY>G3(4?UK[FU;_@E+\"[X'[)9ZQIQ/3RM09L?]]9KIOV< MOV!?"'[-/Q(N?%WA[6]2O9IK-[,VUX%*JK$'((YSQ3;5A6/J"BBBH*"BBB@ MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *** <* "BBB@ HHHH **** "BBB@ HHHH **** /_V0$! end EX-101.SCH 18 visl-20221231.xsd INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - NATURE OF OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - LIQUIDITY AND FINANCIAL CONDITION link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - ACQUISITION OF MOBILE VIEWPOINT CORPORATE B.V. link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - ACCOUNTS RECEIVABLE link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - INVENTORIES link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - PROPERTY AND EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - GOODWILL link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - ACCRUED EXPENSES link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - NOTES PAYABLE link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - LEASES link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - DERIVATIVE LIABILITIES link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - PREFERRED SHARES link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - STOCKHOLDERS’ EQUITY link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - STOCK-BASED COMPENSATION link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - CONCENTRATIONS link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - REVENUE link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - REBATES link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - GAINS ON SETTLEMENT OF DEBT link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - ACQUISITION OF MOBILE VIEWPOINT CORPORATE B.V. (Tables) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - ACCOUNTS RECEIVABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - INVENTORIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - PROPERTY AND EQUIPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - GOODWILL (Tables) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - ACCRUED EXPENSES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - NOTES PAYABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - LEASES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - DERIVATIVE LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - STOCKHOLDERS’ EQUITY (Tables) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - STOCK-BASED COMPENSATION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - REVENUE (Tables) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - GAINS ON SETTLEMENT OF DEBT (Tables) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - LIQUIDITY AND FINANCIAL CONDITION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - SCHEDULE OF PRODUCT WARRANTY LIABILITY (Details) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - SCHEDULE OF ANTI-DILIUTIVE POTENTIAL COMMON STOCK EQUIVALENTS EXCLUDE FROM THE CALCULATION OF LOSS PER SHARE (Details) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - SCHEDULE OF FOREIGN EXCHANGE AND CHANGE IN ACCUMULATED COMPREHENSIVE INCOME (Details) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON NON-RECURRING BASIS (Details) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - SCHEDULE OF IDENTIFIABLE ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - SCHEDULE OF ACQUIRED INTANGIBLE WITH THEIR RELATIVE USEFUL LIVES (Details) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - SCHEDULE OF UNAUDITED PRO-FORMA COMBINED RESULTS OF OPERATIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00000057 - Disclosure - ACQUISITION OF MOBILE VIEWPOINT CORPORATE B.V. (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000058 - Disclosure - SCHEDULE OF ACCOUNTS RECEIVABLE (Details) link:presentationLink link:calculationLink link:definitionLink 00000059 - Disclosure - ACCOUNTS RECEIVABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000060 - Disclosure - SCHEDULE OF INVENTORIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000061 - Disclosure - INVENTORIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000062 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 00000063 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000064 - Disclosure - SCHEDULE OF GOODWILL (Details) link:presentationLink link:calculationLink link:definitionLink 00000065 - Disclosure - GOODWILL (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000066 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000067 - Disclosure - SCHEDULE OF CAPITALIZED INTANGIBLE COSTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000068 - Disclosure - SCHEDULE OF AMORTIZATION OF INTANGIBLE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000069 - Disclosure - SCHEDULE OF ESTIMATED AMORTIZATION EXPENSE FOR INTANGIBLE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000070 - Disclosure - INTANGIBLE ASSETS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000071 - Disclosure - SCHEDULE OF ACCRUED EXPENSES (Details) link:presentationLink link:calculationLink link:definitionLink 00000072 - Disclosure - SCHEDULE OF NOTES PAYABLE (Details) link:presentationLink link:calculationLink link:definitionLink 00000073 - Disclosure - SCHEDULE OF NOTES PAYABLE (Details) (Parenthethical) link:presentationLink link:calculationLink link:definitionLink 00000074 - Disclosure - SCHEDULE OF OPERATING LEASE DATA (Details) link:presentationLink link:calculationLink link:definitionLink 00000075 - Disclosure - SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES (Details) link:presentationLink link:calculationLink link:definitionLink 00000076 - Disclosure - SCHEDULE OF LEASE OBLIGATIONS ASSUMED (Details) link:presentationLink link:calculationLink link:definitionLink 00000077 - Disclosure - LEASES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000078 - Disclosure - SCHEDULE OF VALUATION AND WARRANTS EXERCISABLE (Details) link:presentationLink link:calculationLink link:definitionLink 00000079 - Disclosure - SCHEDULE OF CHANGES IN FAIR VALUE OF LEVEL 3 FINANCIAL LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000080 - Disclosure - PREFERRED SHARES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000081 - Disclosure - SCHEDULE OF WARRANT OUTSTANDING (Details) link:presentationLink link:calculationLink link:definitionLink 00000082 - Disclosure - SCHEDULE OF WARRANT OUTSTANDING EXERCISE PRICE (Details) link:presentationLink link:calculationLink link:definitionLink 00000083 - Disclosure - STOCKHOLDERS’ EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000084 - Disclosure - SCHEDULE OF STOCK OPTION PLANS (Details) link:presentationLink link:calculationLink link:definitionLink 00000085 - Disclosure - SCHEDULE OF STOCK OPTION PLANS FOR VESTED OPTION (Details) link:presentationLink link:calculationLink link:definitionLink 00000086 - Disclosure - SCHEDULE OF SHARE-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00000087 - Disclosure - SCHEDULE OF STOCK OPTION PLANS FOR VESTED OPTION (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000088 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000089 - Disclosure - SCHEDULE OF MATCHING CONTRIBUTIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00000090 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000091 - Disclosure - CONCENTRATIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000092 - Disclosure - SCHEDULE OF DISAGGREGATION OF REVENUE (Details) link:presentationLink link:calculationLink link:definitionLink 00000093 - Disclosure - SCHEDULE OF GAINS ON SETTLEMENT OF DEBT (Details) link:presentationLink link:calculationLink link:definitionLink 00000094 - Disclosure - SCHEDULE OF GAINS ON SETTLEMENT OF DEBT (Details) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000095 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT) (Details) link:presentationLink link:calculationLink link:definitionLink 00000096 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details) link:presentationLink link:calculationLink link:definitionLink 00000097 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000098 - Disclosure - INCOME TAXES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 19 visl-20221231_cal.xml INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 20 visl-20221231_def.xml INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 21 visl-20221231_lab.xml INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Class of Stock [Axis] Series A Preferred Stock [Member] Equity Components [Axis] Preferred Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] AOCI Attributable to Parent [Member] Treasury Stock [Member] Retained Earnings [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Statistical Measurement [Axis] Minimum [Member] Customer [Axis] Single Customer [Member] Concentration Risk Benchmark [Axis] Revenue Benchmark [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Accounts Receivable [Member] Maximum [Member] Finite-Lived Intangible Assets by Major Class [Axis] Patents and Licenses [Member] Other Intangible Assets [Member] Award Type [Axis] GBP [Member] Derivative Instrument [Axis] GBP To USD [Member] Euro [Member] Euro To GBP [Member] Antidilutive Securities [Axis] Equity Option [Member] Warrant [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Financial Instrument [Axis] Abandonment of Right-of-use Operating Leases [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Other [Member] Business Acquisition [Axis] Mobile Viewpoint Corporate BV [Member] Trade Names [Member] Proprietary Technology [Member] Goodwill [Member] Customer Relationships [Member] Asset Class [Axis] Internal Rate Of Return [Member] Working Capital [Member] Intangible Assets [Member] Revision of Prior Period [Axis] Previously Reported [Member] Revision of Prior Period, Adjustment [Member] Trade name [Member] Proprietary Technologies [Member] Customer Relationship [Member] Goodwill Intangibles [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Product Rationalization Program [Member] Long-Lived Tangible Asset [Axis] Furniture and Fixtures [Member] Leasehold Improvements [Member] Computer Equipment [Member] Trade Names And Technology [Member] Debt Instrument [Axis] Notes Payable One [Member] Notes Payable Two [Member] D & O Insurance Policy Renewed [Member] Geographical [Axis] Lutton, UK [Member] Dubai, UAE [Member] Billerica, MA [Member] Mount Olive, NJ [Member] Colchester, U.K. - Waterside House [Member] SINGAPORE Hemel, UK [Member] Measurement Input Type [Axis] Measurement Input, Share Price [Member] Measurement Input, Exercise Price [Member] Measurement Input, Price Volatility [Member] Measurement Input, Risk Free Interest Rate [Member] Measurement Input, Expected Dividend Rate [Member] Series B Preferred Stock [Member] Series D Preferred Stock [Member] Series E Preferred Stock [Member] Series D Convertible Preferred Stock [Member] Series E Convertible Preferred Stock [Member] Series D Preferred Stock and Series E Preferred Stock [Member] Restricted Stock Units (RSUs) [Member] Consulting Agreement [Member] February 2021 Financing [Member] Title of Individual [Axis] Warrant Holders [Member] Warrant Holders One [Member] Common Stock Warrants [Member] Specific Board Members [Member] Warrants [Member] Exercise Price Range [Axis] Exercise Price Range One [Member] Exercise Price Range Two [Member] Exercise Price Range Three [Member] Exercise Price Range Four [Member] Exercise Price Range Five [Member] Exercise Price Range Six [Member] Plan Name [Axis] 2013 Long-Term Stock Incentive Plan [Member] Time Vested Option [Member] Performance Based Option [Member] Restricted Stock [Member] Chief Executive Officer [Member] Chief Financial Officer [Member] Performance Based Stock Option [Member] Vesting [Axis] Share-Based Payment Arrangement, Tranche One [Member] Share-Based Payment Arrangement, Tranche Two [Member] Share-Based Payment Arrangement, Tranche Three [Member] Director [Member] VP Global Operations [Member] Group of 22 Employees [Member] Carleton M. Miller [Member] Mike Bond [Member] Performance Based Restricted Stock Units [Member] Group Personal Pension Plan, UK [Member] Customer One [Member] Accounts Payable [Member] Supplier Concentration Risk [Member] One Vendor [Member] North America [Member] South America [Member] Europe [Member] Asia [Member] Rest of World [Member] Income Statement Location [Axis] Equipment Sales [Member] Installation, Integration and Repairs [Member] Warranties [Member] UNITED STATES NETHERLANDS UNITED KINGDOM Vendor [Member] Payroll Protection Program [Member] Dividends Payable [Member] Income Tax Authority [Axis] Domestic Tax Authority [Member] Hale Capital Partners, LP [Member] State and Local Jurisdiction [Member] Foreign Tax Authority [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Auditor Firm ID Auditor Name Auditor Location Statement of Financial Position [Abstract] ASSETS Current assets Cash Accounts receivable, net Inventories, net Prepaid expenses and other current assets Total current assets Right of use assets, operating leases Property and equipment, net Intangible assets, net Total assets LIABILITIES AND STOCKHOLDERS’ EQUITY Current liabilities Accounts payable Accrued expenses Notes payable Operating lease obligations, current Customer deposits and deferred revenue Total current liabilities Operating lease obligations, net of current portion Deferred tax liabilities Total liabilities Commitments and contingencies (See Note 1) Series A Preferred stock, $0.00001 par value per share: 47,500 and -0- shares authorized on December 31, 2022, and 2021, respectively; 47,419 and -0- shares issued and outstanding on December 31, 2022, and 2021, respectively at a redemption value equal to $0.10 in cash for each ten thousand (10,000) whole shares. Stockholders’ equity Preferred stock, $0.00001 par value per share: 10,000,000 shares authorized on December 31, 2022, and 2021, respectively Common stock value Additional paid-in capital Accumulated other comprehensive loss Treasury stock, at cost – 2,659 shares as of December 31, 2022, and 2021, respectively Accumulated deficit Total stockholders’ equity Total liabilities and stockholders’ equity Statement [Table] Statement [Line Items] Temporary equity, par value Temporary equity, shares authorized Temporary equity, shares issued Temporary equity, shares outstanding Temporary equity, redemption value per share Temporary equity, redemption shares Preferred stock, par value Preferred stock, shares authorized Common stock, par value Common stock, shares authorized Common stock, shares issued Common Stock, shares outstanding Treasury stock, shares Income Statement [Abstract] Revenue, net Cost of revenue and operating expenses Cost of components and personnel Inventory valuation adjustments General and administrative expenses Research and development Impairment of right-of-use assets Impairment of goodwill Amortization and depreciation Total cost of revenue and operating expenses Loss from operations Other income (expenses) Changes in fair value of derivative liabilities Gain on settlement of debt Other income Interest expense, net Total other income Net loss before income taxes Income taxes Deferred tax benefits Net loss Dividends Net loss attributable to common shareholders Net loss per share attributable to Common Shareholders: Basic and diluted loss per share Weighted average number of shares outstanding: Basic and Diluted Comprehensive loss: Unrealized gain (loss) on currency translation adjustment Comprehensive loss Balance Balance, shares Net loss Unrealized gain on currency translation adjustment Issuance of common stock in connection with: Underwriting equity raises, net of offering costs Underwriting equity raise, net of offering costs,shares Exercise of common stock warrants Exercise of common stock warrants,shares Exercise of cashless common stock warrants Exercise of cashless common stock warrants,shares Stock issuance commitments Stock issuance commitments,shares Warrants issued in settlement agreement Stock-based compensation Issuance of shares of Series A Preferred Stock as dividends for common stock shareholders Issuance of shares of Series A Preferred Stock as dividends for common stock shareholders, shares Satisfaction of accounts payable vendor balance Satisfaction of accounts payable vendor balance, shares Satisfaction of withholding tax upon conversion of restricted stock units Satisfaction of withholding tax upon conversion of restricted stock units, shares Satisfaction with the conversion of restricted stock units Satisfaction with the conversion of restricted stock units, shares Balance Balance, shares Statement of Cash Flows [Abstract] Cash flows used in operating activities Adjustments to reconcile net loss to net cash used in operating activities Gain on settlement of debt Stock-based compensation Stock issuance commitments Warrants issued in settlement agreement Provision for bad debt Recovery of bad debt Inventory valuation adjustments Amortization of right-of-use assets, operating assets Depreciation and amortization Change in fair value of derivative liabilities Deferred tax benefits Changes in assets and liabilities Accounts receivable Inventory Prepaid expenses and other current assets Accounts payable Accrued expenses and interest expense Operating lease liabilities Deferred revenue and customer deposits Deferred tax liabilities Net cash used in operating activities Cash flows used in investing activities Cash acquired from MVP for acquisition Cash used in MVP stock acquisition Cash used for property and equipment Net cash used in investing activities Cash flows (used in) provided by financing activities Proceeds received from equity financings Costs incurred in connection with equity financing Proceeds from the exercise of common stock warrants Principal payments made on D & O notes payable Net cash (used) provided in financing activities Effect of exchange rate changes on cash Net (decrease) increase in cash Cash, beginning of the period Cash, end of the period Supplemental disclosure of cash payments: Cash paid during the period for interest Supplemental disclosure of non-cash information: Notes payable recognized on D & O Insurance policy (Note 11) Issuance of shares of Series A Preferred Stock as dividends for common stock shareholders Common stock issued in connection with: Board compensation awards previously accrued Settlement of amounts due accounts payable Warrants issued in settlement agreement ROU assets and operating lease obligations recognized (Note 12): Operating lease assets recognized Less: non-cash changes to operating lease assets amortization amortization impairments loss on lease impairments ROU assets and operating lease obligations recognized Operating lease liabilities recognized Less: non-cash changes to operating lease liabilities accretion Operating lease liabilities recognized Organization, Consolidation and Presentation of Financial Statements [Abstract] NATURE OF OPERATIONS Liquidity And Financial Condition LIQUIDITY AND FINANCIAL CONDITION Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Business Combination and Asset Acquisition [Abstract] ACQUISITION OF MOBILE VIEWPOINT CORPORATE B.V. Receivables [Abstract] ACCOUNTS RECEIVABLE Inventory Disclosure [Abstract] INVENTORIES Property, Plant and Equipment [Abstract] PROPERTY AND EQUIPMENT Goodwill GOODWILL Goodwill and Intangible Assets Disclosure [Abstract] INTANGIBLE ASSETS Payables and Accruals [Abstract] ACCRUED EXPENSES Debt Disclosure [Abstract] NOTES PAYABLE Leases LEASES Derivative Instruments and Hedging Activities Disclosure [Abstract] DERIVATIVE LIABILITIES Equity [Abstract] PREFERRED SHARES STOCKHOLDERS’ EQUITY Share-Based Payment Arrangement [Abstract] STOCK-BASED COMPENSATION Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Risks and Uncertainties [Abstract] CONCENTRATIONS Revenue from Contract with Customer [Abstract] REVENUE Rebates REBATES Gains On Settlement Of Debt GAINS ON SETTLEMENT OF DEBT Income Tax Disclosure [Abstract] INCOME TAXES Subsequent Events [Abstract] SUBSEQUENT EVENTS Business Combinations Principles of Consolidation Segment Reporting Use of Estimates Risks and Uncertainties Cash and Cash Equivalents Concentrations Accounts Receivable and Allowance for Doubtful Accounts Inventories Property and Equipment Goodwill Intangible Assets Warranty Reserve Shipping and Handling Costs Common Stock Purchase Warrants and Other Derivative Financial Instruments Treasury Stock Revenue Recognition Research and Development Expenses Leases Stock-Based Compensation Impairment and Abandonment Income Taxes Advertising Costs Sales Tax and Value-Added Taxes Loss Per Share Foreign Currency and Other Comprehensive (Gains) Losses Fair Value of Financial Instruments and Fair Value Measurements Redeemable Preferred Stock Subsequent Events Recently Issued Accounting Pronouncements Recent Accounting Pronouncements SCHEDULE OF PRODUCT WARRANTY LIABILITY SCHEDULE OF ANTI-DILIUTIVE POTENTIAL COMMON STOCK EQUIVALENTS EXCLUDE FROM THE CALCULATION OF LOSS PER SHARE SCHEDULE OF FOREIGN EXCHANGE AND CHANGE IN ACCUMULATED COMPREHENSIVE INCOME SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON NON-RECURRING BASIS SCHEDULE OF IDENTIFIABLE ASSETS ACQUIRED AND LIABILITIES ASSUMED SCHEDULE OF ACQUIRED INTANGIBLE WITH THEIR RELATIVE USEFUL LIVES SCHEDULE OF UNAUDITED PRO-FORMA COMBINED RESULTS OF OPERATIONS SCHEDULE OF ACCOUNTS RECEIVABLE SCHEDULE OF INVENTORIES SCHEDULE OF PROPERTY AND EQUIPMENT SCHEDULE OF GOODWILL SCHEDULE OF INTANGIBLE ASSETS SCHEDULE OF CAPITALIZED INTANGIBLE COSTS SCHEDULE OF AMORTIZATION OF INTANGIBLE ASSETS SCHEDULE OF ESTIMATED AMORTIZATION EXPENSE FOR INTANGIBLE ASSETS SCHEDULE OF ACCRUED EXPENSES SCHEDULE OF NOTES PAYABLE SCHEDULE OF OPERATING LEASE DATA SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES SCHEDULE OF LEASE OBLIGATIONS ASSUMED SCHEDULE OF VALUATION AND WARRANTS EXERCISABLE SCHEDULE OF CHANGES IN FAIR VALUE OF LEVEL 3 FINANCIAL LIABILITIES SCHEDULE OF WARRANT OUTSTANDING SCHEDULE OF WARRANT OUTSTANDING EXERCISE PRICE Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] SCHEDULE OF STOCK OPTION PLANS SCHEDULE OF STOCK OPTION PLANS FOR VESTED OPTION SCHEDULE OF SHARE-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS SCHEDULE OF MATCHING CONTRIBUTIONS SCHEDULE OF DISAGGREGATION OF REVENUE SCHEDULE OF GAINS ON SETTLEMENT OF DEBT SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT) SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES Subsequent Event [Table] Subsequent Event [Line Items] Operating income loss Net cash provided by used in operating activities Working capital Accumulated deficit Cash Issuance of common stock shares Proceeds from issuance of common stock Common stock value Proceeds from public offering Warrants to purchase shares of common stock Warrant term Warrant exercise price Warranty reserve, beginning Warranty reserve expense Warranty claims settled and true-up of accrual Warranty reserve, ending Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Anti-dilutive potential common stock equivalents excluded from the calculation of loss per share: Total Net foreign exchange transactions: Losses Accumulated comprehensive income: Unrealized losses on currency translation adjustment Schedule of Defined Benefit Plans Disclosures [Table] Defined Benefit Plan Disclosure [Line Items] Total Assets (non-recurring) Total Liabilities Schedule of Product Information [Table] Product Information [Line Items] Cash FDIC insured amount Dutch deposit guarantee scheme Cash uninsured amount Revenue Concentration risk percentage Accounts Receivable, after Allowance for Credit Loss Estimated useful life Amortization Finite-lived intangible asset, useful life Shipping and handling costs Right-of-use operating assets impaired Right-of-use Loss on impairment of right-of-use assets Advertising costs Foreign currency exchange rate, translation Foreign currency exchange rate, remeasurement Preferred stock voting discription Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table] Acquired Finite-Lived Intangible Assets [Line Items] Fair value of consideration transferred: Cash Recognized amounts of identifiable assets acquired and liabilities assumed: Cash Accounts receivable, net Inventories, net Prepaid expenses and other assets Property and equipment, net Accounts payable Accrued expenses Customer deposits and deferred revenue Deferred tax liabilities Total identifiable net assets Consideration paid Total identifiable assets acquired Excess of consideration paid over net assets acquired Preliminary allocation of the consideration paid in excess of the net assets acquired: Total intangible assets acquired Impairment Effects on Earnings Per Share [Table] Impairment Effects on Earnings Per Share [Line Items] Useful life Useful life, description Revenues, net Net loss allocable to common stockholders Net loss per share Weighted average number of shares outstanding Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Line Items] Percentage of outstanding capital acquired Purchase price Foreign currency exchange rate Acquisition payment amount Acquisition related costs Increase of inventory Customer Relationships Decrease in prepaid expenses and other current assets Reciprocal of inventory, increased Weighted average cost capital percentage Accounts receivable Allowance for doubtful accounts Net accounts receivable Bad debt expense Recovered bad debts Raw materials Work-in-process Finished goods Sub-total inventories Less reserve for slow-moving and excess inventory Total inventories, net Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Inventory valuation adjustments Product lines impairing of inventories Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Property and equipment, gross Accumulated depreciation Property and equipment, depreciation Depreciation leasehold improvement Schedule Of Goodwill Beginning balance, Goodwill Goodwill additions Deferred tax liabilties associated with MVP acquistion Goodwill impairment Ending balance, Goodwill Goodwill impairment charges Beginning balance cost Beginning balance, accumulated Amortization Beginning balance net Intangible assets, Additions Intangible assets accumulated amortization, Additions Intangible assets, net Addition Intangible assets, Amortization Intangible assets, net Amortization Beginning balance net Ending balance cost Ending balance, accumulated Amortization Ending balance net Intangible assets Amortization of intangible assets 2023 2024 2025 2026 2027 Thereafter Finite-Lived Intangible Assets, Net, Total Schedule of Finite-Lived Intangible Assets [Table] Finite-Lived Intangible Assets [Line Items] Finite-lived intangible assets, remaining amortization period Compensation Commissions Warranty Rent Accrued expenses other Deferred Equity Accrued expenses Schedule of Short-Term Debt [Table] Short-Term Debt [Line Items] Debt instrument, face amount Debt instrument down payment Notes Payable Debt instrument, interest rate, stated percentage Debt instrument, periodic payment, interest Interest expense Schedule Of Operating Lease Data Operating lease cost Short-term lease cost Total lease cost Cash flows from operating leases Weighted-average remaining lease term-operating leases Weighted-average discount rate-operating leases Schedule Of Future Minimum Rental Payments For Operating Leases 2023 2024 2025 2026 2027 Thereafter Total lease payments Less: imputed interest Present value of lease liabilities Less: Current lease liabilities Non-current lease liabilities Area of land Lease-End Date Approximate Future Payments Lease term, description Right of Use Assets Right of use assets, accumulated depreciation Operating lease liability Current operating lease liabilities Non-current operating lease liabilities Weighted-average remaining term Lease maturity description Weighted-average discount rate Area of land description Area of Land Lease expiration Payment for rent Loss on impairment of Right Of Use Asset Payment for rent percentage Derivative [Table] Derivative [Line Items] Number of shares underlying the warrants Warrants measurement input Warrant life (years) Beginning balance Change in fair value of derivative liabilities Ending balance Schedule of Stock by Class [Table] Class of Stock [Line Items] Preferred stock shares authorized Share issued price per share Preferred stock voting rights Preferred stock redemption terms, description Preferred stock unissued Preferred stock par value Number of warrants ending outstanding Weighted average exercise price ending outstanding Number of warrants granted Weighted average exercise price granted Number of warrants exercised Weighted Average Exercise Price, exercised Number of warrants cancelled/expired Weighted average exercise price cancelled/expired Number of warrants ending outstanding Weighted average exercise price ending outstanding Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Line Items] Warrants outstanding and exercisable, Range of exercise prices Warrants Outstanding and Exercisable (in shares) Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years) Warrants outstanding and exercisable, Weighted Average Exercise Price Common stock shares authorized Common stock shares outstanding Shares attributable to withholding tax Restricted stock options, granted Issuance of common stock share value Stock issued during period for services, shares Shares issued price per share Stock issued during period for services, value+ Services liabilities Gain on extinguishment debt Stock compensation costs Issuance of common stock share Number of shares issued for exercise of warrants Warrant exercise price per share Proceeds from issuance of offering Offering cost Net proceeds from offering cost Number of shares issued for exercise of warrants Proceeds from exercise of warrants Warrants term Warrants outstanding Expected dividend yield Number of warrants cancelled/expired Weighted average exercise price ending exercisable Weighted average remaining contractual life Stock-based compensation expense Remaining expense of stock-based compensation Remaining amortization period Outstanding and exercisable term Intrinsic value per share Range of exercise prices Number of options beginning balance Number of options, Stock options forfeited Number of options, ending outstanding Number of options exercisable Weighted average exercise price, outstanding beginning balance Weighted average exercise price, Stock options forfeited Weighted average exercise price, outstanding ending balance Weighted average exercise price, exercisable balance Weighted average remaining contractual life - options exercisable Range of exercise prices Weighted average remaining contractual life options outstanding and exercisable RSUs range of exercise prices, upper limit Range of exercise prices, upper Number of options, Stock options granted Weighted average exercise price, Stock options granted Number of options RSUs, outstanding, beginning balance Restricted stock units granted Restricted stock units exercised outstanding Number of options RSUs outstanding ending balance Number of weighted-averages exercise price exercisable beginning balance Weighted average exercise price Restricted stock units , granted Weighted average exercise price Restricted stock units exercised outstanding Weighted average exercise price RSUs, exercisable, ending balance Grant date Grant units Exercise Price Vesting commencement date Expiration date 25% Vesting 75% Remaining Vesting Units vesting schedule, tranche three Grant date Grant, Units Initial RSUs Vesting, Vested Date Initial RSUs Vesting, Vested Units Remaining RSUs Vesting, Units Remaining RSUs Vesting, Term Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table] Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] Expected term (years) Expected dividend yield Risk-free interest rate Volatility Exercise price Vesting rights description Award vesting description Company matching contributions Common stock per share value Reverse split Concentration Risk [Table] Concentration Risk [Line Items] Revenue from Contract with Customer, Excluding Assessed Tax Concentration risk threshold percentage Accounts receivable Accounts payable Disaggregation of Revenue [Table] Disaggregation of Revenue [Line Items] Long-Lived Assets GAINS ON SETTLEMENT OF DEBT Amount payable Remittance settlement Payroll protection program loan Shares of common stock issued Common stock accumulated value Dividends payable amount Current tax provision Federal State Current income tax expense, total Deferred tax provision (benefit) Federal State Foreign Change in the valuation allowance Total deferred tax provision (benefit) Income tax provision Statutory federal income tax rate State and local taxes, net of federal benefit Permanent differences Executive compensation Equity compensation Provision to return DTA adjustment for state NOL Foreign Rate Differential Change rate Valuation allowance Effective tax rate Federal R&D credit Inventory Allowance for bad debt Compensation related Pension Other accruals State net operating losses Federal net operating losses Interest disallowance Stock options Other Valuation Allowance Total Deferred Tax Assets Property and Equipment Intangibles Prepaid Expenses Total Deferred Tax Liabilities Net Deferred Tax Liability Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Line Items] Operating loss carryforwards Deferred tax assets, tax credit carryforwards, research Operating loss carryforwards, expiration description Effective for tax years, description Liquidity and financial condition [Text block] Working capital. Risks And Uncertainties [Policy Text Block] Dutch deposit guarantee scheme. Customer One [Member] Patents and Licenses [Member] Shipping and handling costs [Policy text block] Cost incurred during the period in shipping and handling goods and services to customers. Common stock purchase warrants and other derivative financial instruments [Policy text block] Treasury stock [Policy text block] Inventory valuation adjustments. Impairment of right of use assets. Impairment and Abandonment [Policy text block] Sales tax and value added taxes [Policy text block] Accumulated comprehensive income unrealized loss on currency translation adjustment. GBP [Member] GBP To USD [Member] Euro [Member] Euro To GBP [Member] Issuance of common stock in connection with abstract. Stock issued during period value exchange for payment of offering costs. Common stock issued from exercise of warrants. Exercise of cashless common stock warrants. Issuance of common stock in connection with warrants issued in settlement agreement. Satisfaction of accounts payable vendor balance. Satisfaction of withholding tax upon conversion of restricted stock units. Satisfaction with conversion of restricted stock units. Abandonment of Right-of-use Operating Leases [Member] Stock issued during period shares exchange for payment of offering costs. Common stock issued from exercise of warrants shares. Redeemable preferred stock [Policy Text Block] Exercise of cashless common stock warrants shares. Stock issued during period shares commitments. Satisfaction of accounts payable vendor balance shares. Satisfaction of withholding tax upon conversion of restricted stock units shares. Satisfaction of withholding tax upon conversion. Business acquisition percentage of outstanding capital acquired. Mobile Viewpoint Corporate BV [Member] Payment of intercompany indebtness. Business combination consideration transferred cash. Business combination recognized identifiable assets acquired and liabilities assumed current liabilities deferred tax liabilities. Business combination consideration paid. Excess of consideration paid over net assets acquired. Increase in inventory. Proprietary Technology [Member] Increased reciprocal of inventory. Trade name [Member] Proprietary Technologies [Member] Customer Relationship [Member] Acquire finite lived intangible assets weighted average useful life description. Goodwill Intangibles [Member] Warrants issued in settlement agreements. Recovery of bad debt. Mobile Viewpoint Corporate [Member] Product Rationalization Program [Member] Goodwill additions. Deferred tax liabilties. Goodwill impairments. Proceeds from other connection with equity financing. Common stock issued in connection with abstract. Common stock issued in connection with warrants issued in settlement agreements. Non cash disclosures of rou assets and operating lease obligation abstract. Trade Names And Technology [Member] Operating lease assets recognized. Beginning balance cost accumulated amortization. Operating lease asset abstract. Operating lease asset amortization. Intangible assets accumulated amortization additions. Operating impairments. Operating lease liabilities recognized. Additionscost accumulated amortizations. Cash used in acquisition. Ending Balance Cost Accumulated Amortization. Issuance of shares of Series A Preferred Stock as dividends for common stock shareholders. Board compensation awards previously accrued. Settlement of amounts due accounts payable. loss on lease impairments. Operating lease liabilities recognized. ROU assets and operating lease obligations recognized. Stock issuance commitments value. Notes Payable One [Member] Notes Payable Two [Member] D & O Insurance Policy Renewed [Member] Debt instrument down payment. Remaining lease term. Operating lease accumulated amortization. Area of land description. Payment for rent percentage. Colchester, U.K. - Waterside House [Member] Billerica, MA [Member] Hemel, UK [Member] Mount Olive, NJ [Member] Lease expiration date description. Schedule of valuation and warrants exercisable [Table text block] Number of shares underlying the warrants. Consulting Agreement [Member] February 2021 Financing [Member] Gross proceeds from issuance of common stock. Warrant Holders [Member] Number of shares issued for exercise of warrants. Warrant Holders One [Member] Common Stock Warrants [Member] Warrants And Rights Outstanding Terms. Specific Board Members [Member] Weighted Average Exercise Price. Schedule of warrant outstanding exercise price [Table text block] Weighted Average Exercise Price. Weighted Average Exercise Price, granted. Weighted Average Exercise Price, exercised. Weighted Average Exercise Price, cancelled/expired. Range of Exercise Prices. Warrants [Member]. Type of estimate of range of exercise prices, one including, but not limited to, upper and lower bound amounts, maximum and minimum amounts, and point estimates. Share based compensation shares authorized under non option outstanding and exercise price range. Type of estimate of range of exercise prices, one including, but not limited to, upper and lower bound amounts, maximum and minimum amounts, and point estimates. Type of estimate of range of exercise prices, one including, but not limited to, upper and lower bound amounts, maximum and minimum amounts, and point estimates. Type of estimate of range of exercise prices, one including, but not limited to, upper and lower bound amounts, maximum and minimum amounts, and point estimates. Exercise Price Range Five [Member] Exercise Price Range Six [Member] Share based compensation arrangement by share based payment award non option equity instruments outstanding and exercisable numbers. Share based compensation shares authorized under stock option plans exercise price range outstanding and exercisable options weighted average remaining contractual term two. Share based compensation shares authorized under stock option plans exercise price range outstanding and exercisable options weighted average exercise price one. Schedule of share based compensation employee stock purchase plan activities [Table text block] Common Stock Options [Member] Remaining stock compensation expense. Amortization period. Remaining erercisable price. Intrinsic value per share. Time Vested Option [Member] Share based compensation arrangement by share based payment award grant date. Options vesting commencement date. Share based compensation arrangement by share based payment award vesting date. Group Personal Pension Plan, UK [Member] Schedule Of Share Based Compensation Employees Stock Purchase Plan Activity [Table Text Block] Performance Based Option [Member] Performance Based Stock Option [Member] Schedule Of Stock Based Compensation Awarded Under Amended Plan [Table Text Block] Options grant date. VP Global Operations [Member] Group of 22 Employees [Member] Carleton M. Miller [Member] Mike Bond [Member] Vested date. Vested Remaning contractual term Veated Remaning contractual terms. Share based compensation arrangement by share based payment award equity instruments other than options outstanding and exercisable weighted average remaining contractual terms. Restricted stock units, exercise price lower limit. Restricted stock units, exercise price upper limit. Performance Based Restricted Stock Units [Member] Share based compensation arrangement by share based payment award equity instruments other than exercised Share based compensation arrangement by share based payment award equity instruments other than options grants in period weighted average outstanding Restricted stock units, exercisable weighted average exercise price. Single Customer [Member] Concentration Risk Threshold Percentage. Vendor [Member] Rest of World [Member] Equipment Sales [Member] Installation, Integration and Repairs [Member] Warranties [Member] Other [Member] Rebates [Text Block] Stock issuance commitments. Gain On Settlement Of Debt [Text Block] Gain On Settlement Of Debt [Table Text Block] Payroll Protection Program [Member] Dividends Payable [Member] Remittance settlement. Effective income tax rate reconciliation in respect of provision to return. Effective income tax rate reconciliation tax contingencies DTA adjustment for state NOL. Effective income tax rate reconciliation executive compensation tax benefit percent Carried Forward Indefinitely [Member] Effective for tax years, description. HSBC USA INC CP [Member] Federal Home Loan Banks [Member] Federal National Mortgage Association [Member] Multiple Board [Member] Temporary equity, redemption shares. Recently Issued Accounting Pronouncement [Policy Text Block] Schedule of Lease Obligations Assumed [Table Text Block] Lutton, UK [Member] Dubai, UAE [Member] Series D Convertible Preferred Stock [Member] Series E Convertible Preferred Stock [Member] Series D Preferred Stock and Series E Preferred Stock [Member] One Vendor [Member] Operating loss carryforwards, expiration description. 2013 Long-Term Stock Incentive Plan [Member] Weighted average cost capital percentage. Internal Rate Of Return [Member] Working Capital [Member] Intangible Assets [Member] Assets, Current Assets Liabilities, Current Liabilities Treasury Stock, Value Stockholders' Equity Attributable to Parent Liabilities and Equity Costs and Expenses Operating Income (Loss) Nonoperating Income (Expense) Redeemable Preferred Stock Dividends Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax Comprehensive Income (Loss), Net of Tax, Attributable to Parent Shares, Outstanding StockIssuanceCommitments WarrantsIssuedInSettlementAgreements Inventory, LIFO Reserve, Effect on Income, Net Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Accounts Payable Increase (Decrease) in Deferred Liabilities Net Cash Provided by (Used in) Operating Activities CashUsedInAcquisition Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Repayments of Medium-term Notes Net Cash Provided by (Used in) Financing Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Issuance of shares of Series A Preferred Stock as dividends for common stock shareholders [Default Label] CommonStockIssuedInConnectionWithWarrantsIssuedInSettlementAgreements OperatingLeaseAssetAmortization Operating lease liabilities recognized [Default Label] Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] Lessee, Leases [Policy Text Block] Cash [Default Label] Standard and Extended Product Warranty Accrual Standard and Extended Product Warranty Accrual, Decrease for Payments BusinessCombinationConsiderationTransferredCash Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredTaxLiabilities Accounts Receivable, Allowance for Credit Loss, Current Inventory, Gross Inventory Valuation Reserves Effect of LIFO Inventory Liquidation on Income Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Goodwill [Default Label] Intangible Assets, Gross (Excluding Goodwill) Finite-Lived Intangible Assets, Accumulated Amortization BeginningBalanceCostAccumulatedAmortization Amortization [Default Label] EndingBalanceCostAccumulatedAmortization Lease, Cost Lessee, Operating Lease, Liability, to be Paid, Year One Lessee, Operating Lease, Liability, to be Paid, Year Two Lessee, Operating Lease, Liability, to be Paid, Year Three Lessee, Operating Lease, Liability, to be Paid, Year Four Lessee, Operating Lease, Liability, to be Paid, Year Five Lessee, Operating Lease, Liability, to be Paid, after Year Five Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised Number of shares issued for exercise of warrants [Default Label] Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisableWeightedAverageGrantDateFairValue ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInDate Accounts Payable Current Income Tax Expense (Benefit) Deferred Federal Income Tax Expense (Benefit) Deferred State and Local Income Tax Expense (Benefit) Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Income Tax Expense (Benefit) Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent Deferred Tax Assets, Valuation Allowance Deferred Tax Assets, Gross Deferred Tax Liabilities, Property, Plant and Equipment Deferred Tax Liabilities, Intangible Assets Deferred Tax Liabilities, Prepaid Expenses Deferred Tax Liabilities, Gross Deferred Tax Liabilities, Net EX-101.PRE 22 visl-20221231_pre.xml INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 23 R1.htm IDEA: XBRL DOCUMENT v3.23.1
    Cover - USD ($)
    $ in Millions
    12 Months Ended
    Dec. 31, 2022
    Mar. 16, 2023
    Jun. 30, 2022
    Cover [Abstract]      
    Document Type 10-K    
    Amendment Flag false    
    Document Annual Report true    
    Document Transition Report false    
    Document Period End Date Dec. 31, 2022    
    Document Fiscal Period Focus FY    
    Document Fiscal Year Focus 2022    
    Current Fiscal Year End Date --12-31    
    Entity File Number 001-35988    
    Entity Registrant Name Vislink Technologies, Inc.    
    Entity Central Index Key 0001565228    
    Entity Tax Identification Number 20-5856795    
    Entity Incorporation, State or Country Code DE    
    Entity Address, Address Line One 350 Clark Drive    
    Entity Address, Address Line Two Suite 125    
    Entity Address, City or Town Mt. Olive    
    Entity Address, State or Province NJ    
    Entity Address, Postal Zip Code 07828    
    City Area Code 908    
    Local Phone Number 852-3700    
    Title of 12(b) Security Common Stock, par value $0.00001    
    Trading Symbol VISL    
    Security Exchange Name NASDAQ    
    Entity Well-known Seasoned Issuer No    
    Entity Voluntary Filers No    
    Entity Current Reporting Status Yes    
    Entity Interactive Data Current Yes    
    Entity Filer Category Non-accelerated Filer    
    Entity Small Business true    
    Entity Emerging Growth Company false    
    Entity Shell Company false    
    Entity Public Float     $ 28.4
    Entity Common Stock, Shares Outstanding   47,619,317  
    Auditor Firm ID 688    
    Auditor Name Marcum LLP    
    Auditor Location New York, NY    

    XML 24 R2.htm IDEA: XBRL DOCUMENT v3.23.1
    Consolidated Balance Sheets - USD ($)
    Dec. 31, 2022
    Dec. 31, 2021
    Current assets    
    Cash $ 25,627,000 $ 36,231,000
    Accounts receivable, net 6,007,000 9,069,000
    Inventories, net 12,021,000 11,894,000
    Prepaid expenses and other current assets 1,232,000 2,470,000
    Total current assets 44,887,000 59,664,000
    Right of use assets, operating leases 1,075,000 1,362,000
    Property and equipment, net 1,434,000 1,173,000
    Intangible assets, net 4,400,000 5,921,000
    Total assets 51,796,000 68,120,000
    Current liabilities    
    Accounts payable 2,626,000 3,075,000
    Accrued expenses 1,568,000 3,155,000
    Notes payable 84,000 99,000
    Operating lease obligations, current 455,000 560,000
    Customer deposits and deferred revenue 1,540,000 2,113,000
    Total current liabilities 6,273,000 9,002,000
    Operating lease obligations, net of current portion 1,107,000 1,507,000
    Deferred tax liabilities 764,000 978,000
    Total liabilities 8,144,000 11,487,000
    Commitments and contingencies (See Note 1)
    Series A Preferred stock, $0.00001 par value per share: 47,500 and -0- shares authorized on December 31, 2022, and 2021, respectively; 47,419 and -0- shares issued and outstanding on December 31, 2022, and 2021, respectively at a redemption value equal to $0.10 in cash for each ten thousand (10,000) whole shares.
    Stockholders’ equity    
    Preferred stock, $0.00001 par value per share: 10,000,000 shares authorized on December 31, 2022, and 2021, respectively
    Common stock value
    Additional paid-in capital 345,365,000 343,746,000
    Accumulated other comprehensive loss (1,337,000) (297,000)
    Treasury stock, at cost – 2,659 shares as of December 31, 2022, and 2021, respectively (277,000) (277,000)
    Accumulated deficit (300,099,000) (286,539,000)
    Total stockholders’ equity 43,652,000 56,633,000
    Total liabilities and stockholders’ equity $ 51,796,000 $ 68,120,000
    XML 25 R3.htm IDEA: XBRL DOCUMENT v3.23.1
    Consolidated Balance Sheets (Parenthetical) - $ / shares
    Dec. 31, 2022
    Dec. 31, 2021
    Preferred stock, par value $ 0.00001 $ 0.00001
    Preferred stock, shares authorized 10,000,000 10,000,000
    Common stock, par value $ 0.00001 $ 0.00001
    Common stock, shares authorized 100,000,000 100,000,000
    Common stock, shares issued 47,419,317 45,825,089
    Common Stock, shares outstanding 47,416,658 45,822,430
    Treasury stock, shares 2,659 2,659
    Series A Preferred Stock [Member]    
    Temporary equity, par value $ 0.00001 $ 0.00001
    Temporary equity, shares authorized 47,500 0
    Temporary equity, shares issued 47,419 0
    Temporary equity, shares outstanding 47,419 0
    Temporary equity, redemption value per share $ 0.10 $ 0.10
    Temporary equity, redemption shares 10,000 10,000
    XML 26 R4.htm IDEA: XBRL DOCUMENT v3.23.1
    Consolidated Statements of Operations and Comprehensive Loss - USD ($)
    shares in Thousands
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Income Statement [Abstract]    
    Revenue, net $ 28,402,000 $ 33,882,000
    Cost of revenue and operating expenses    
    Cost of components and personnel 15,204,000 15,164,000
    Inventory valuation adjustments 2,930,000 843,000
    General and administrative expenses 18,195,000 22,039,000
    Research and development 4,058,000 3,051,000
    Impairment of right-of-use assets 88,000
    Impairment of goodwill 9,189,000
    Amortization and depreciation 1,722,000 1,343,000
    Total cost of revenue and operating expenses 42,197,000 51,629,000
    Loss from operations (13,795,000) (17,747,000)
    Other income (expenses)    
    Changes in fair value of derivative liabilities 22,000
    Gain on settlement of debt 45,732 1,362,000
    Other income 32,000
    Interest expense, net (38,000) (29,000)
    Total other income 40,000 1,355,000
    Net loss before income taxes (13,755,000) (16,392,000)
    Income taxes    
    Deferred tax benefits 215,000
    Net loss (13,540,000) (16,392,000)
    Dividends (20,000)
    Net loss attributable to common shareholders $ (13,560,000) $ (16,392,000)
    Net loss per share attributable to Common Shareholders:    
    Basic and diluted loss per share $ (0.29) $ (0.38)
    Weighted average number of shares outstanding:    
    Basic and Diluted 46,692 43,484
    Comprehensive loss:    
    Unrealized gain (loss) on currency translation adjustment $ 1,040,000 $ (445,000)
    Comprehensive loss $ (12,500,000) $ (16,837,000)
    XML 27 R5.htm IDEA: XBRL DOCUMENT v3.23.1
    Consolidated Statements of Changes in Stockholders' Equity - USD ($)
    $ in Thousands
    Preferred Stock [Member]
    Series A Preferred Stock [Member]
    Common Stock [Member]
    Additional Paid-in Capital [Member]
    AOCI Attributable to Parent [Member]
    Treasury Stock [Member]
    Retained Earnings [Member]
    Total
    Balance at Dec. 31, 2020 $ 280,273 $ 148 $ (277) $ (270,147) $ 9,997
    Balance, shares at Dec. 31, 2020 21,382,290          
    Net loss (16,392) (16,392)
    Unrealized gain on currency translation adjustment (445) (445)
    Issuance of common stock in connection with:              
    Underwriting equity raises, net of offering costs 59,334 17,346
    Underwriting equity raise, net of offering costs,shares   24,348,018          
    Exercise of common stock warrants 2 11
    Exercise of common stock warrants,shares   3,811          
    Exercise of cashless common stock warrants
    Exercise of cashless common stock warrants,shares   6,250          
    Stock issuance commitments 200 330
    Stock issuance commitments,shares   87,720          
    Warrants issued in settlement agreement 74
    Stock-based compensation 3,863 $ 715
    Issuance of shares of Series A Preferred Stock as dividends for common stock shareholders, shares             6,163,198
    Balance at Dec. 31, 2021 343,746 (297) (277) (286,539) $ 56,633
    Balance, shares at Dec. 31, 2021 45,825,089          
    Net loss (13,540) (13,540)
    Unrealized gain on currency translation adjustment (1,040) (1,040)
    Issuance of common stock in connection with:              
    Stock-based compensation 1,565 1,565
    Issuance of shares of Series A Preferred Stock as dividends for common stock shareholders           (20) (20)
    Issuance of shares of Series A Preferred Stock as dividends for common stock shareholders, shares 47,419            
    Satisfaction of accounts payable vendor balance 54 54
    Satisfaction of accounts payable vendor balance, shares   77,406          
    Satisfaction of withholding tax upon conversion of restricted stock units
    Satisfaction of withholding tax upon conversion of restricted stock units, shares   357,778          
    Satisfaction with the conversion of restricted stock units
    Satisfaction with the conversion of restricted stock units, shares   1,159,044          
    Balance at Dec. 31, 2022 $ 345,365 $ (1,337) $ (277) $ (300,099) $ 43,652
    Balance, shares at Dec. 31, 2022 47,419 47,419,317          
    XML 28 R6.htm IDEA: XBRL DOCUMENT v3.23.1
    Consolidated Statements of Cash Flows - USD ($)
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Cash flows used in operating activities    
    Net loss $ (13,540,000) $ (16,392,000)
    Adjustments to reconcile net loss to net cash used in operating activities    
    Gain on settlement of debt (45,732) (1,362,000)
    Stock-based compensation 1,565,000 3,863,000
    Stock issuance commitments 200,000 200,000
    Warrants issued in settlement agreement 74,000
    Provision for bad debt 21,000 233,000
    Recovery of bad debt (517,000) (310,000)
    Inventory valuation adjustments 2,930,000 843,000
    Amortization of right-of-use assets, operating assets 201,000 237,000
    Impairment of right-of-use assets 88,000
    Impairment of goodwill 9,189,000
    Depreciation and amortization 1,722,000 1,343,000
    Change in fair value of derivative liabilities (22,000)
    Deferred tax benefits (215,000)
    Changes in assets and liabilities    
    Accounts receivable 3,197,000 (3,611,000)
    Inventory (3,731,000) (3,187,000)
    Prepaid expenses and other current assets 2,090,000 96,000
    Accounts payable (347,000) (2,388,000)
    Accrued expenses and interest expense (1,780,000) 231,000
    Operating lease liabilities (506,000) (483,000)
    Deferred revenue and customer deposits (558,000) 867,000
    Deferred tax liabilities 978,000
    Net cash used in operating activities (9,226,000) (9,601,000)
    Cash flows used in investing activities    
    Cash acquired from MVP for acquisition 965,000
    Cash used in MVP stock acquisition (18,311,000)
    Cash used for property and equipment (466,000) (201,000)
    Net cash used in investing activities (466,000) (17,547,000)
    Cash flows (used in) provided by financing activities    
    Proceeds received from equity financings 62,914,000
    Costs incurred in connection with equity financing (3,580,000)
    Proceeds from the exercise of common stock warrants 2,000
    Principal payments made on D & O notes payable (958,000) (1,024,000)
    Net cash (used) provided in financing activities (958,000) 58,312,000
    Effect of exchange rate changes on cash 46,000 (123,000)
    Net (decrease) increase in cash (10,604,000) 31,041,000
    Cash, beginning of the period 36,231,000 5,190,000
    Cash, end of the period 25,627,000 36,231,000
    Supplemental disclosure of cash payments:    
    Cash paid during the period for interest 41,000 56,000
    Supplemental disclosure of non-cash information:    
    Notes payable recognized on D & O Insurance policy (Note 11) 943,000 1,098,000
    Issuance of shares of Series A Preferred Stock as dividends for common stock shareholders 20,000
    Common stock issued in connection with:    
    Board compensation awards previously accrued 200,000 200,000
    Settlement of amounts due accounts payable 54,000
    Warrants issued in settlement agreement 74,000
    ROU assets and operating lease obligations recognized (Note 12):    
    Operating lease assets recognized 522,000
    Less: non-cash changes to operating lease assets amortization    
    amortization (1,185,000) (237,000)
    impairments (43,000)
    loss on lease impairments (88,000)
    ROU assets and operating lease obligations recognized (1,316,000) 285,000
    Operating lease liabilities recognized 531,000
    Less: non-cash changes to operating lease liabilities accretion (506,000) (483,000)
    Operating lease liabilities recognized $ (506,000) $ 48,000
    XML 29 R7.htm IDEA: XBRL DOCUMENT v3.23.1
    NATURE OF OPERATIONS
    12 Months Ended
    Dec. 31, 2022
    Organization, Consolidation and Presentation of Financial Statements [Abstract]  
    NATURE OF OPERATIONS

    NOTE 1 — NATURE OF OPERATIONS

     

    Vislink, incorporated in Delaware in 2006, is a global technology business specializing in collecting, delivering, and managing high-quality, live video and associated data from the action scene to the viewing screen. Vislink provides solutions for collecting live news, sports, entertainment, and news events for the broadcast markets. Vislink also furnishes the surveillance and defense markets with real-time video intelligence solutions using various tailored transmission products. The Vislink team also provides professional and technical services utilizing a staff of technology experts with decades of applied knowledge and real-world experience in the terrestrial microwave, satellite, fiber optic, surveillance, and wireless communications systems delivering a broad spectrum of customer solutions.

     

    Live Broadcast:

     

    Vislink delivers an extensive portfolio of solutions for live news, sports, and entertainment industries. These solutions include video collection, transmission, management, and distribution via microwave, satellite, cellular, I.P. (Internet Protocol), MESH, and bonded cellular/5G networks. We also provide solutions utilizing A.I. (Artificial Intelligence) technologies to provide automated news and sporting events coverage. With over 50 years in operation, Vislink has the expertise and technology portfolio to deliver fully integrated, seamless, end-to-end solutions.

     

    Industry-wide contributors acknowledge Vislink’s live broadcast solutions. The transmission of most of all outside wireless broadcast video content uses our equipment, with over 200,000 systems installed worldwide. We work closely with the majority of the world’s broadcasters. Vislink wireless cameras and ultra-compact encoders help bring many of the world’s most prestigious sporting and entertainment events to life. Recent examples include globally watched international sporting contests, award shows, racing events, and annual music and cultural events.

     

    Military And Government:

     

    Vislink has developed high-quality solutions to meet surveillance and defense markets’ operational and industry challenges based on our knowledge of live video delivery. Vislink solutions are specifically designed with interagency cooperation, utilizing the internationally-recognized I.P. platform and a web interface for video delivery. Vislink provides comprehensive video, audio, and data communications solutions to law enforcement and the public safety community, including Airborne, Unmanned Systems, Maritime, and Tactical Mobile Command Posts. These solutions may include:

     

    integrated suites of airborne downlink transmitters, receivers, and antenna systems
    data and video connectivity for airborne, marine, and ground assets
    UAV video distribution
    flexible support for COFDM and bonded cellular/5G Networks
    terrestrial point-to-point
    tactical mobile command
    IP-based, high-end encryption, full-duplex, real-time connectivity at extended operating ranges
    high-throughput air/marine/ground-to-anywhere uplink and downlink systems
    secure live streaming platforms for use in mobile and fixed assets
    personal portable products

     

    Vislink public safety and surveillance solutions are deployed worldwide, including throughout the U.S., Europe, and the Middle East, at the local, regional, and federal levels of operation, criminal investigation, crisis management, mobile command posts, and field operations. These solutions are designed to meet the demands of field operations, command centers, and central receiving sites. Short-range and long-range solutions are available in areas including established infrastructure and exceptionally remote regions, making valuable video intelligence available regardless of location.

     

    Satellite Communications:

     

    Over 30 years of technical expertise support Vislink’s satellite solutions. These solutions ensure robust, secure communications while delivering low transmission costs for any organization that needs high-quality, reliable satellite transmission. We offer turnkey solutions that begin with state-of-the-art coding, compression, and engine modulation and end with our robust, lightweight antenna systems. Vislink Satellite solutions focus heavily on being the smallest, lightest, and most efficient in their categories, making transportation and ease of use a key driver in the customer experience. Vislink offers an extensive range of satellite designs that allow customers to optimize bit rate, size, weight, and total cost. Our satellite systems are used extensively globally, with over 2,000 systems deployed by governments, militaries, and broadcasters. While we continue offering satellite solutions, we no longer invest in the engineering and product development necessary to stay relevant in the sector. We will continue to market and sell our current solutions but do not anticipate introducing further upgrades or features to our satellite product line.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 1 — NATURE OF OPERATIONS (continued)

     

    Connected Edge Solutions:

     

    Vislink offers the hardware and software solutions needed to acquire, produce, contribute, and deliver video over all private and public networks with the Mobile Viewpoint acquisition. Connected edge solutions aid the video transport concept of ubiquitous IP networks and cloud-scale computing across 5G, WiFi6, Mesh, and COFDM-enabled networks. These solutions include:

     

      Live video encoding, stream adaptation, decoding, and production solutions
      Remote production workflows
      Wireless cameras
      AI-driven automated production
      Ability to contribute video over:
        Bonded cellular (3G and 4G)
        Satellite
        Fiber
        Emerging networks, including 5G and Starlink

     

    XML 30 R8.htm IDEA: XBRL DOCUMENT v3.23.1
    LIQUIDITY AND FINANCIAL CONDITION
    12 Months Ended
    Dec. 31, 2022
    Liquidity And Financial Condition  
    LIQUIDITY AND FINANCIAL CONDITION

    NOTE 2 — LIQUIDITY AND FINANCIAL CONDITION

     

    The Company incurred an approximate $13.8 million loss from operations and $9.2 million of cash used in operating activities for the year ended December 31, 2022. The Company had $38.6 million in working capital, $300.1 million in accumulated deficits, and $25.6 million cash on hand as of December 31, 2022.

     

    During the year ended December 31, 2021, the Company issued 6,163,198 shares of common stock for net proceeds of $12,600,000 under its at-the-market facility with Alliance Global Partners (the “ATM”). As of March 16, 2023, approximately $4,500,000 of capacity remains under the ATM. On February 8, 2021, the Company completed an underwritten public offering for net proceeds of $46,820,000. The Company issued 18,181,820 shares of common stock, supplemented by 9,090,910 five-year warrants with an exercise price of $3.25 per share exercisable for one share.

     

    The enduring effect of the COVID-19 pandemic, including the advent of successive variants, plus the uncertainty of possible future variants, may subject the Company to particular challenges in its business, financial condition, results of operations, and cash flows. The unpredictability of the pandemic’s scope, severity, duration, and actions implemented to alleviate its direct and indirect economic effects and containment measures provide no assurances that the pandemic will not have material adverse repercussions on the Company’s operations, liquidity, financial condition, and any residual unfavorable consequences to global economics.

     

    Developments, including those beyond our control, may cause us to consume our available capital more quickly. The Company bases its evaluation on possibilities that may prove wrong and could exhaust our available capital resources sooner than we expect. These may include but are not limited to economic conditions, including inflation, foreign exchange, fluctuations, and the markets in which we compete or wish to enter, strategic acquisitions, our market strategy, our research and development activities, regulatory matters, and technology and product innovations. The Company believes it will have sufficient funds to continue its operations for at least twelve months from the filing date of these financial statements.

     

    XML 31 R9.htm IDEA: XBRL DOCUMENT v3.23.1
    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
    12 Months Ended
    Dec. 31, 2022
    Accounting Policies [Abstract]  
    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

    NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

     

    Business Combinations

     

    The Company accounts for acquisitions that qualify as business combinations by applying the acquisition method according to Accounting Standards Codification (“ASC”) 805, Business Combinations (“ASC 805”). Transaction costs related to the acquisition of a business are expensed as incurred and excluded from the fair value of consideration transferred. The identifiable assets acquired, liabilities assumed, and noncontrolling interests in an acquired entity are recognized and measured at their estimated fair values. The excess of the fair value of consideration transferred over the fair values of identifiable assets acquired, liabilities assumed, and noncontrolling interests in an acquired entity, net of the fair value of any previously held interest in the acquired entity, is recorded as goodwill. Such valuations require management to make significant estimates and assumptions.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

     

    Principles of Consolidation

     

    The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America or (“U.S. GAAP”) as found in the Accounting Standards Codification (“ASC”), the Accounting Standards Update (“ASU”) of the Financial Accounting Standards Board (“FASB”) and the rules and regulations of the US Securities and Exchange Commission (the “SEC”). The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. We have eliminated all intercompany accounts and transactions upon consolidating our subsidiaries.

     

    Segment Reporting

     

    The Company identifies operating segments as components of an enterprise about which separate discrete financial information is available for evaluation by the operating decision-makers, or decision-making group, in deciding how to allocate resources and assess performance. The Company’s decision-making group is the senior executive management team. The Company and the decision-making group view the Company’s operations and manage its business as one operating segment with different product offerings. All long-lived assets of the Company reside in the U.S., the U.K., and the Netherlands.

     

    Use of Estimates

     

    The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities in the consolidated financial statements. Significant accounting estimates reflected in the Company’s consolidated financial statements include the useful lives of property, plant, and equipment, the useful lives of right-of-use assets, the useful lives of intangible assets, impairment of long-lived assets, allowance for accounts receivable doubtful accounts, allowance for inventory obsolescence reserve, allowance for deferred tax assets, valuation of warranty reserves, contingent consideration liabilities, and the accrual of potential liabilities. These estimates also affect the reported revenues and expenses during the reporting periods. Actual results could differ from estimates, and any such differences may be material to our financial statements.

     

    Risks and Uncertainties

     

    The future impacts of the Russia-Ukraine war, the novel coronavirus (“COVID-19”) pandemic, and their residual effects include economic uncertainty, an inflationary environment, currency fluctuations, disruption within the global supply chain, and labor markets worldwide industries remain uncertain. These circumstances have created prevalent uncertainty and risk. The impact of these issues on our business will vary by geographic market and discipline. In response to potential reductions in revenue, we may take actions to align our cost structure with changes in customer demand and manage our working capital. However, there can be no assurance as to the effectiveness of our efforts to mitigate any impact of the current and future adverse economic conditions, reductions in client revenue, changes in client creditworthiness, and other developments. We monitor the circumstances mentioned above to assess direct material adverse effects on our business, financial condition, or results of operations. Therefore, these impacts may change accounting estimates and assumptions over time. Interim period results are not necessarily indicative of the expected results for the full fiscal year.

     

    Cash and Cash Equivalents

     

    The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. The Company did not have cash equivalents as of December 31, 2022, and 2021.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

     

    Concentrations

     

    The Company does not have any off-balance-sheet concentrations of credit risk. Credit risk is that the counterparty will default on its contractual obligations, resulting in a company’s financial loss. The Company’s credit risk is primarily attributable to its cash and accounts receivables. The Company’s policy is to maintain its cash with high-credit quality financial institutions to limit its risk of loss exposure. Financial instruments potentially subject the Company to credit risk concentration consisting of cash deposits. The Federal Deposit Insurance Corporation (“FDIC”) insures accounts held within the United States up to $250,000. The Company maintains cash balance accounts at financial institutions in the United Kingdom insured by the Financial Services Compensation Scheme up to £85,000, subject to currency translation rates to the United States dollar. Lastly, the Company maintains cash balance accounts at financial institutions in the Netherlands insured by the “Dutch deposit guarantee scheme” up to €100,000 per person, per bank.

     

    On December 31, 2022, and 2021, the Company had approximately $24.5 million and $35.2 million above insured limits, respectively. The Company has not experienced any losses in its bank accounts between December 31, 2022, and 2021.

     

    Management assesses their credit quality for customers, considering their financial position and historical experience. During the year ended December 31, 2022, the Company recorded sales to a single customer of $3,436,000 (12%), in excess of 10% of the Company’s total sales. For the year ended December 31, 2021, the Company recorded sales to a single customer of $8,511,000 (25%) in excess of 10% of the Company’s total sales.

     

    On December 31, 2022, and 2021, the Company recorded accounts receivable of approximately $1,138,000 (19%) and $4,204,000 (46%), respectively, to a single customer in excess of 10% of the Company’s total consolidated accounts receivable.

     

    Accounts Receivable and Allowance for Doubtful Accounts

     

    The Company extends credit to its customers in the ordinary course of business. Further, the Company regularly reviews outstanding receivables and provides for estimated losses through an allowance for doubtful accounts. In evaluating the level of established loss reserves, the Company makes judgments regarding its customer’s ability to make required payments, prevailing economic conditions, previous experience, and other factors. As these factors’ financial situation changes, circumstances develop, or additional information becomes available, adjustments to the allowance for doubtful accounts may be required. The Company maintains reserves for credit losses, and losses have been within its expectations.

     

    Inventories

     

    Inventories consist of raw materials, work-in-process, and finished goods and are recorded at the lower of cost, on a first-in, first-out basis, or net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable completion, disposal, and transportation costs. The Company evaluates inventory balances and either writes down obsolete inventory or records a reserve for slow-moving or excess inventory based on net realizable value analysis.

     

    Property and Equipment

     

    Property and equipment are presented at cost at the date of acquisition, less depreciation. Depreciation is computed using the straight-line method over estimated useful asset lives, ranging from 1 to 14 years. The costs of the day-to-day servicing of property and equipment and repairs and maintenance are recognized in expenses as incurred.

     

    Goodwill

     

    Goodwill represents the excess cost of an acquired business over the fair value of the identifiable tangible, and intangible assets acquired and liabilities assumed in a business combination under the acquisition method of accounting under ASC 805 “Business Combinations” (see Note 4). Goodwill is not amortized but, per ASC 350, is tested for impairment annually. Goodwill is also tested for impairment between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. Judgment determines if an indicator of impairment has occurred during a year. When testing goodwill for impairment, we may assess qualitative factors for some or all of our reporting units to determine whether it is more likely than not (that is, a likelihood of more than 50 percent) that the fair value of a reporting unit is less than its carrying amount, including goodwill. Alternatively, we may bypass this qualitative assessment for some or all of our reporting units and perform step 1 of the two-step goodwill impairment test. If we perform step 1 and the reporting unit’s carrying amount exceeds its fair value, we will perform step 2 to measure such impairment. We have completed our annual impairment test and recorded $-0- and $9,189,000 in goodwill impairment charges for the years ended December 31, 2022, and 2021, respectively.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

     

    Intangible Assets

     

    Patents and licenses:

     

    Patents and licenses, measured initially at purchase cost, are included in intangible assets on the Company’s balance sheet and are amortized on a straight-line basis over their estimated useful lives of 18.5 to 20 years. Amortization totaled approximately $535,000 and $668,000 for the years ended December 31, 2022, and 2021, respectively.

     

    Other intangible assets:

     

    The Company’s remaining intangible assets include the trade names, technology, and customer lists acquired in its acquisition of IMT, Vislink, and Mobile Viewpoint Corporate B.V. (“MVP”). A third-party appraiser determined the value of these acquired assets for these business combinations. Absent an indication of fair value from a potential buyer or similar specific transactions, we have determined that using the methods employed provided a reasonable estimate in reporting the values assigned.

     

    The Company amortizes intangible asset costs over their useful lives of 3 to 15 years with its net book value reported on the balance sheet. Amortization totaled approximately $985,000 and $480,000 for the years ended December 31, 2022, and 2021, respectively.

     

    Warranty Reserve

     

    Although the Company tests its product under its quality programs and processes, its warranty obligation is affected by product failure rates and service delivery costs incurred in correcting a product failure. Required revisions to the estimated warranty liability will occur should actual product failure rates or service costs differ from the Company’s estimates, where applicable, based on limited historical data.

     

    The claims made during the year ended December 31, 2022, and 2021 were ordinary and customary. The warranty reserve is included in accrued expenses on the accompanying consolidated balance sheets and the cost of components in the accompanying consolidated statement of operations.

     

       Warranty Reserve 
    December 31, 2020  $283,000 
    Warranty reserve expense    
    Warranty claims settled, and true-up of accrual   (152,000)
    December 31, 2021  $131,000 
    Warranty reserve expense   98,000 
    Warranty claims settled, and true-up of accrual   (117,000)
    December 31, 2022  $112,000 

     

    Shipping and Handling Costs

     

    The Company invoices its shipping and handling charges to the customer, and we net these charges against the respective costs within general and administrative expenses. For the years ended December 31, 2022, and 2021, the shipping and handling costs incurred were $796,000 and $581,000, respectively.

     

    Common Stock Purchase Warrants and Other Derivative Financial Instruments

     

    The Company assesses the classification of its freestanding derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required. The Company classifies common stock purchase warrants and other freestanding financial instruments as equity if the contracts (i) require physical settlement or net-share settlement in common stock or (ii) give the Company a choice of net-cash settlement or settlement in common stock (physical settlement or net-share settlement). The Company classifies the following contracts as either an asset or a liability: contracts that (i) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), (ii) give the counterparty a choice of net-cash settlement or settlement in common stock (physical settlement or net-share settlement) or (iii) contain reset provisions.

     

     

    VISLINK TECHNOLOGIES, INC AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

     

    Treasury Stock

     

    Treasury stock is recorded at cost upon the repurchasing of common shares. The cost method is used upon the re-issuance of shares. Under U.S. GAAP, the excess of the acquisition cost over the re-issuance price of the treasury stock, if any, is recorded to additional paid-in capital, limited to the amount previously credited to additional paid-in capital if any. The Company charges the accumulated deficit for any excess.

     

    Revenue Recognition

     

    We account for the Company’s operating results under ASC Topic 606, adopted on January 1, 2019. It is a comprehensive revenue recognition model that requires recognition when the Company transfers control of the promised goods or services to our customers at an amount that reflects the consideration we expect to receive. The application of ASC Topic 606 requires us to use more judgment and make more estimates than under previously issued guidance.

     

    The Company generates all its revenue from contracts with customers. The Company recognizes revenue when we satisfy a performance obligation by transferring control of the promised goods or services to a customer in an amount that reflects the consideration we expect to receive in exchange for those services.

     

    Revenue Recognition (continued)

     

    The Company determines revenue recognition through the following steps:

     

    1. Identification of the contract, or contracts, with a customer.

    2. Identification of the performance obligations in the contract.

    3. Determination of the transaction price.

    4. Allocation of the transaction price to the performance obligations in the contract; and

    5. Recognition of revenue when, or as, we satisfy a performance obligation.

     

    At contract inception, the Company assesses the goods and services promised in our customer contracts and identifies a performance obligation for each. To determine the performance obligations, the Company considers all the products and services promised in the contract regardless of whether they are explicitly stated or implied by customary business practices. The timing of satisfaction of the performance obligation is not subject to significant judgment. We measure revenue as the consideration we expect to receive in exchange for transferring goods and services. The value-added sales taxes and other charges we collect concurrent with revenue-producing activities are excluded from income.

     

    Remaining Performance Obligations:

     

    The remaining performance obligations, or backlog, represent the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less.

     

    Research and Development Expenses

     

    As the Company performs research, design, and development activities, we charge these costs to research and development expenses in the Consolidated Statements of Operations and Comprehensive Loss. These expenses consist primarily of salary and benefit expenses, including stock-based compensation and payroll taxes for employees’ and contractors’ costs engaged in research, design, development activities, prototypes, facilities, and travel costs.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

     

    Leases

     

    We determine if an arrangement is a lease at inception. We recognize lease expense for lease payments on a straight-line basis over the lease term. The Company includes operating leases as ROU assets as “Right of use assets, operating leases” in the consolidated balance sheets. For lease liabilities, operating lease liabilities are included in “Operating lease obligations, current” and “Operating lease liabilities, net of current portion” in the consolidated balance sheets. We recognize Operating lease ROU assets and liabilities on the commencement date based on the present value of lease payments for all leases with a term longer than 12 months. No lease and non-lease components are separated for all our real estate contracts.

     

    There were no capital leases, now titled “finance leases” under ASC 842, in the Company’s lease portfolio as of December 31, 2022. The ROU assets and related lease liabilities recorded under ASC 842 are calculated based on the present value of the lease payments using (1) the rate implicit in the lease or (2) the lessee’s incremental borrowing rate (“IBR”), defined as the rate of interest that a lessee would have to pay to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a comparable economic environment. As most of our leases do not provide an implicit rate, we determined our incremental borrowing rates based on an analysis of prior collateralized borrowings over similar terms of the lease payments at the commencement date to estimate the IBR under ASC 842.

     

    Stock-Based Compensation

     

    The Company accounts for stock compensation with persons classified as employees for accounting purposes under ASC 718 “Compensation-Stock Compensation,” which recognizes awards at fair value on the date of grant and recognition of compensation over the service period for awards expected to vest. The fair value of stock options is determined using the Black-Scholes Option Pricing Model, and the fair value of common stock issued for services is determined based on the Company’s stock price on the issuance date.

     

    The expansion of Topic 718 fell under ASU 2018-07 to include share-based payment transactions for acquiring goods and services from nonemployees. The measurement date for equity-classified nonemployee share-based payment awards is no longer at the earlier date at which a commitment for performance by the counterparty is reached or the date at which the counterparty’s performance is complete. Instead, the grant date is now considered the measurement date. Under today’s guidance, the measurement of nonemployee share-based payment awards with performance conditions is at the lowest aggregate fair value, often resulting in a zero value. The new ASU aligns the accounting for nonemployee share-based payment awards with performance conditions with accounting for employee share-based payment awards under Topic 718 by requiring entities to consider the probability of satisfying performance conditions. Current guidance requires entities to use the contractual term to measure the nonemployee share-based payment awards. The new ASU allows entities to make an award-by-award election to use the expected duration (consistent with employee share-based payment awards) or the contractual term for nonemployee awards.

     

    Stock-Option Awards — Time-based and performance-based:

     

    Under ASC Topic 718, the compensation cost is measured based on an award’s fair value at the grant’s date for the time vested option award using the Black Scholes-Merton formula as a valuation technique. The Company used the U.S. Treasury note’s rate over the expected option term for the risk-free rate. Employees’ expected term represents the period that options granted are expected to be outstanding using the simplified method. The Company’s historical share option exercise experience does not provide a reasonable basis for estimating the expected term. For nonemployee options, the expected term is the entire term of the option. Expected volatility is based on the average weekly share price changes over the shorter expected term or the period from the Nasdaq Capital Markets Exchange placement to the grant’s date. The Company estimates forfeiture and volatility using historical information. The risk-free interest rate is based on the implied yield on U.S. Treasury zero-coupon issues over the options’ equivalent lives.

     

    The Company has not paid dividends on its common stock, and no assumption of dividend payment(s) is made in the model. For employee equity-classified awards, compensation cost is recognized over the employee’s requisite service period with a corresponding credit to additional paid-in capital. The employee’s requisite service period begins at the service inception date and ends when the requisite service has been provided.

     

    Restricted Stock Unit Awards (“RSUs”) — Time-Based:

     

    Under ASC 718, the exercise price for RSUs is determined using the fair market value of the Company’s common stock on the grant date. For an award with graded vesting subject only to a service condition (e.g., time-based vesting), ASC 718-10-35-8 provides an accounting policy choice between graded vesting attribution or straight-line attribution. The Company elects the graded vesting method, recognizing compensation expense for only the portion of awards expected to vest. Forfeitures of time-based units and awards are recognized as they occur. Stock-based compensation costs are calculated using the closing stock price on the grant date to estimate the fair value of time-based restricted stock units.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

     

    Stock-Based Compensation (continued

     

    Restricted Stock Unit Awards (“RSUs”) — Performance-Based:

     

    The accruals of compensation cost for an award with a performance condition are related to that performance condition’s probable outcome. Under ASC 718, a “performance condition” is the achievement of a specified target that is defined by referring to the employer’s operations or activities, such as an option that vests if the employer’s growth rate increases by a certain amount or there are the attainments of regulatory approval for a product. There is an accrual of compensation cost upon the likely achievement of the performance condition, and there is no accrual if the accomplishment of the performance condition is not probable. The exercise price for RSUs is determined using the fair market value of the Company’s common stock on the grant date. Stock-based compensation costs are calculated using the closing stock price on the grant date to estimate performance-based restricted stock units’ fair value.

     

    Impairment and Abandonment

     

    Right-of-use operating lease abandonment:

     

    Management decided to vacate the Billerica, MA facility as part of the Company’s cost savings strategy implemented in the third quarter of the fiscal year 2022. The economic environment of the location precluded the action of sub-letting, and management determined the (leased facility) to be abandoned as of September 30, 2022. Under ASC 360, leased space abandonment is an impairment indicator, and the Company assessed the lease right-of-use (“ROU”) assets for impairment. The Company considered approximately $131,000 of right-of-use operating assets impaired, less $43,000 of accumulated amortization, and for the years ending December 31, 2022, and 2021, the Company recognized a loss on impairment of ROU assets of approximately $88,000 and $-0-, respectively.

     

    Income Taxes

     

    Under ASC 740, as part of our consolidated financial statements, we must estimate our income tax provision (benefit) in each jurisdiction in which we operate. The Company uses the asset and liability method of accounting for income taxes. The recognition of deferred income tax assets and liabilities for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases fall under this method. Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years these temporary differences are expected to be recovered or settled. The recognition of the effect on deferred tax assets and liabilities of a change in tax rates in income is in the period that includes the enactment date. A valuation allowance is provided for those deferred tax assets for which management cannot conclude that it is more likely than not that such deferred tax assets will be realized. The Company will file income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. The Company recognizes the impact of an uncertain tax position in its financial statements if, in management’s judgment, it is more likely than not sustainable upon audit based upon the position’s technical merits. It involves identifying potential uncertain tax positions, evaluating applicable tax laws, and assessing whether the liability for uncertain tax positions is necessary. The Company’s policy is to classify assessments, if any, for tax-related interest expense and penalties as general and administrative expenses.

     

    Advertising Costs

     

    Advertising costs are charged to operations as incurred. Advertising costs amounted to approximately $1,038,000 and $139,000 for the years ended December 31, 2022, and 2021, respectively. The Company includes advertising costs in general and administrative expenses in the accompanying consolidated statement of operations.

     

    Sales Tax and Value-Added Taxes

     

    The Company accounts for sales taxes and value-added taxes imposed on its goods and services on a net basis.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

     

    Loss Per Share

     

    The Company reports loss per share under ASC Topic 260, “Earnings Per Share,” which establishes standards for computing and presenting earnings per share. The basic loss per share calculation divides the net loss allocable to common stockholders by the weighted-average shares of common stock outstanding during the period without considering common stock equivalents. The diluted loss per share calculation is calculated by adjusting the weighted-average shares of common stock outstanding for the dilutive effect of common stock equivalents, including stock options and warrants, outstanding for the period as determined using the treasury stock method. Common stock equivalents are excluded from the diluted net loss per share calculation because their effect would be anti-dilutive. Therefore, basic and diluted net loss per share applicable to common stockholders is the same for periods with a net loss.

     

    The following table illustrates the anti-dilutive potential common stock equivalents excluded from the calculation of loss per share (in thousands):

     

       2022   2021 
       For the Years Ended 
       December 31, 
       2022   2021 
    Anti-dilutive potential common stock equivalents excluded from the calculation of loss per share:          
    Stock options   828    1,553 
    Warrants   9,175    9,210 
    Total   10,003    10,763 

     

    Foreign Currency and Other Comprehensive (Gains) Losses

     

    We record gains or losses resulting from foreign currency transactions in foreign currency income or loss except for the effect of exchange rates on long-term inter-company transactions that are considered long-term investments that are accumulated and credited or charged to other comprehensive income. We have two foreign subsidiaries, one in the United Kingdom and the other in the Netherlands, and their functional currencies are British Pounds and Euros, respectively. The translation from the respective foreign currency to United States Dollars (“US Dollars”) is performed for balance sheet accounts using current exchange rates at the balance sheet date and for income statement accounts using an average exchange rate for the years ending December 31, 2022, and 2021, respectively. We included gains or losses from such translation as a separate component of accumulated other comprehensive (loss) income.

     

    Transaction gains and losses are recognized in our operations’ results based on the difference between the foreign exchange rates on the transaction date and the reporting date. The foreign currency exchange gains and losses are a component of general and administrative expenses in the accompanying Condensed Consolidated Statements of Operations.

     

    The Company has recognized foreign exchange gains and losses and changes in accumulated comprehensive income approximately as follows:

     

       2022   2021 
       For the years ended 
       December 31, 
       2022   2021 
    Net foreign exchange transactions:          
    (Gains) Losses  $24,000   $100,000 
               
    Accumulated comprehensive income:          
    Unrealized (gains) losses on currency translation adjustment  $1,040,000   $445,000 

     

    The exchange rates adopted for the foreign exchange transactions are quoted on OANDA, a Canadian-based foreign exchange company, and an internet website providing currency conversion, online retail foreign exchange trading, foreign currency transfers, and forex information. The Company translated amounts from British Pounds into United States Dollars and Euros to British Pounds at the following exchange rates for the respective periods:

     

      As of December 31, 2022 – £ 1.208970 to $1.00; € 1.069850 to $1.00
         
      The average exchange rate for the year ended December 31, 2022 – £ 1.236579 to $1.00; € 1.052082 to $1.00
         
      As of December 31, 2021 – £1.351043 to $1.00; €0.839362 to £1.00
         
      The average exchange rate for the year ended December 31, 2021 – £1.375369 to $1.00; €0.850858 to £1.00

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

     

    Fair Value of Financial Instruments and Fair Value Measurements

     

    The authoritative guidance for fair value measurements under topic ASC 820, “Fair Value Measurements and Disclosures,” establishes a three-tier fair value hierarchy, prioritizing the inputs used in measuring fair value. These tiers include:

     

    Level 1 is observable inputs such as quoted prices in active markets.
    Level 2 is defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and
    Level 3 is defined as unobservable inputs in which little or no market data exists, requiring an entity to develop its assumptions.

     

    Our financial instruments include cash equivalents, accounts receivable, prepaid expenses and other assets, accounts payable, accrued expenses, and short-term debt. Fair value estimates of these instruments are made at a specific point in time based on relevant market information. These estimates may be subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. The carrying amount of cash equivalents, accounts receivable, prepaid expenses and other assets, accounts payable, and accrued expenses are generally considered representative of their respective fair values because of the short-term nature of those instruments.

     

    In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. The new guidance modifies the disclosure requirements on fair value measurements in Topic 820. The amendments in ASU 2018-13 are effective for all entities for fiscal years and interim periods within those fiscal years beginning after December 15, 2019. Effective January 1, 2020, the Company adopted the provisions of ASU 2018-13. The adoption had no material impact on the Company’s consolidated financial statements or related financial statement disclosures.

     

    The following table presents the Company’s assets and liabilities measured at fair value on a non-recurring basis on December 31, 2022, consistent with the fair value hierarchy provisions. The asset impairment is a non-recurring level 3 measurement.

     

      

    Quoted Prices in

    Active Markets

    for Identical

    Assets/Liabilities

    (Level 1)

      

    Significant

    Observable

    Inputs

    (Level 2)

      

    Significant

    Unobservable

    Inputs

    (Level 3)

       Total 
                     
    Assets (non-recurring):                    
    Abandonment of right-of-use operating leases           88,000    88,000 
       $   $   $88,000   $88,000 
                         
    Liabilities:                    
    Other  $   $   $   $ 
       $   $   $   $ 

     

    The Company did not have reportable assets and liabilities under ASC Topic 820 disclosure requirements for the year ended December 31, 2021. See Note 13 for additional disclosure regarding the Company’s warrants liabilities accounted for at fair value.

     

    Redeemable Preferred Stock

     

    In November 2022, the Company’s board of directors approved the designation of a Series A Preferred Stock created for the sole purpose of the January 11, 2023, Special Meeting of stockholders voting on the consideration of a “Reverse Stock Split Proposal.” The Series A Preferred Stock had a par value of $0.00001 per share. The Preferred Stock was redeemable upon the holder participating at any meeting of stockholders held to vote on the Reverse Stock Split immediately before the opening of the polls at such meeting (the “Initial Redemption Time”) shall automatically be redeemed by the Corporation at the Initial Redemption Time without further action on the part of the Corporation or the holder thereof (the “Initial Redemption”). Any outstanding shares of Series A Preferred Stock that were not redeemed under an Initial Redemption were redeemed in whole, but not in part (i) if such redemption was ordered by the Board of Directors in its sole discretion, automatically and effective on such time and date specified by the Board of Directors in its sole discretion or (ii) automatically upon the approval by the Corporation’s stockholders of the Reverse Stock Split at the Special Meeting held for voting on the Reverse Stock Split proposal.

     

    Under the guidance of ASC Topic 480, all Series A Preferred Stock shares have been presented outside of permanent equity in the mezzanine equity section on the Consolidated Balance Sheets.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

     

    Subsequent Events

     

    Management has evaluated subsequent events or transactions occurring through the date the consolidated financial statements were issued and determined that no events or transactions are required to be disclosed herein except as disclosed.

     

    Recently Issued Accounting Pronouncements

     

    Recently Issued Accounting Standards Adopted and Not Yet Adopted

     

    Adopted on January 1, 2023

     

    In June 2016, the FASB established Topic 326, Financial Instruments—Credit Losses, Measurement of Credit Losses on Financial Instruments (ASU) No. 2016-13, which requires a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates, including accounts receivable.

     

    The standard replaces the existing incurred credit loss model with the Current Expected Credit Losses (“CECL”) model. It is required to measure credit losses based on the Company’s estimate of expected losses rather than incurred losses, which generally results in earlier recognition of allowances for credit losses. Under ASC 326, the Company evaluates specific criteria, including aging and historical write-offs, the current economic condition of particular customers, and future economic conditions of countries utilizing a consumption index to determine the appropriate allowance for credit losses. The Company completed its assessment of the new standard, and no adjustment will be made to its opening balance of retained earnings relating to its trade receivables. The Company writes off receivables once it is determined that the receivables are no longer collectible and as allowed by local laws.

     

    Recent Accounting Pronouncements

     

    Other recent accounting standards issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the SEC did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.

     

    XML 32 R10.htm IDEA: XBRL DOCUMENT v3.23.1
    ACQUISITION OF MOBILE VIEWPOINT CORPORATE B.V.
    12 Months Ended
    Dec. 31, 2022
    Business Combination and Asset Acquisition [Abstract]  
    ACQUISITION OF MOBILE VIEWPOINT CORPORATE B.V.

    NOTE 4 – ACQUISITION OF MOBILE VIEWPOINT CORPORATE B.V.

     

    On August 16, 2021, the Company, through a wholly-owned subsidiary, entered into a stock purchase agreement with Triple I.T. Corporate B.V., a private company incorporated in the Netherlands, under which the Company acquired 100% of the outstanding capital of MVP for an aggregate purchase price of €14,824,278 (or approximately $17.5 million based on a USD to EUR exchange rate of 0.85 as of August 13, 2021) plus the assumption and payment of €717,785 of intercompany indebtedness, all paid by the Company in cash, subject to certain routine closing adjustments in respect of working capital and net indebtedness (“The Transaction”). The Transaction was closed on August 16, 2021.

     

    The Company accounts for the acquisition under the acquisition method under ASC 805 “Business Combinations,” and we elected not to apply pushdown accounting upon the purchase of MVP. Therefore, we recognized the preliminary historical basis of MVP’s acquired assets and liabilities. We identified any excess of the consideration paid in excess of the net assets acquired in the table below. In addition, we recorded approximately $1.6 million of preliminary acquisition-related transaction costs (e.g., legal, due diligence, valuation, and other professional fees) not included as a component of consideration transferred but are required to be expensed as incurred and included in our consolidated statement of operations. Future transaction costs are indeterminable as the Company progresses to the finalization of the Transaction.

     

    The Company received a final valuation report from our third-party appraiser regarding allocating the consideration paid in excess of the net assets acquired. Additionally, the Company received an updated list of certain assets and liabilities acquired on August 16, 2021. Under ASC 805, we recorded measurement period adjustments under the previously mentioned revisions.

     

    We have completed integrating MVP into our operations and internal control processes. As we finished this integration, we analyzed, evaluated, and, where necessary, made changes in control and procedures related to the MVP business.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 4 – ACQUISITION OF MOBILE VIEWPOINT CORPORATE B.V. (continued)

     

    The following table summarizes the historical value of the assets and liabilities as of the acquisition date, allocation of the consideration paid in excess of net assets acquired, relative useful lives, and the amortization method of the listed intangible assets.

     

       As Initially
    Reported
       Measurement
    Period
    Adjustments
       As Adjusted 
    Fair value of consideration transferred:               
    Cash  $18,311,000   $   $18,311,000 
                    
    Recognized amounts of identifiable assets acquired and liabilities assumed:               
    Cash  $965,000   $   $965,000 
    Accounts receivable, net   911,000        911,000 
    Inventories, net   2,534,000    1,231,000    3,765,000 
    Prepaid expenses and other assets   625,000    (112,000)   513,000 
    Property and equipment, net   149,000        149,000 
    Accounts payable   (507,000)       (507,000)
    Accrued expenses   (551,000)       (551,000)
    Customer deposits and deferred revenue   (293,000)       (293,000)
    Deferred tax liabilities       (978,000)   (978,000)
    Total identifiable net assets  $3,833,000   $141,000   $3,974,000 
                    
    Consideration paid  $18,311,000   $   $18,311,000 
    Total identifiable assets acquired   3,833,000    141,000    3,974,000 
    Excess of consideration paid over net assets acquired  $14,478,000   $(141,000)  $14,337,000 
                    
    Preliminary allocation of the consideration paid in excess of the net assets acquired:               
    Trade name  $730,000   $70,688   $800,688 
    Proprietary technology   1,850,000    282,749    2,132,749 
    Customer relationship   3,723,000    (1,508,003)   2,214,997 
    Goodwill   8,175,000    1,013,566    9,188,856 
    Total intangible assets acquired  $14,478,000   $(141,000)  $14,337,000 

     

    As a result of the updated purchase price allocations for the MVP acquisition on August 16, 2021, specific fair value amounts previously estimated were adjusted during the measurement period. These measurement period adjustments resulted from our external valuation specialists’ updated valuation reports and appraisals and revisions to internal account classifications. The changes from the final valuation report included an increase of $1.23 million in inventory, $0.07 million in the trade name, $.028 million in proprietary technology, and $0.04 million in goodwill, offset by a reduction of $1.51 million in customer relationships. The revision in internal account classification resulted in a decrease of $0.11 million in prepaid expenses and other current assets with a reciprocal increase of $0.11 million in inventory.

     

    In estimating the fair value of the assets and liabilities, the valuation specialist considered three fundamental techniques or approaches to valuing an asset: the Income Approach (present value of future economic benefits for customer lists), the Market Approach (analysis of recent comparable entity asset sales for trade names, and proprietary technology) and the Cost Approach (replacement or reconstruction cost of similar assets of like utility for the step-up in inventory). To ascribe value to the Subject Assets, it was necessary first to determine an appropriate discount rate. The discount rate for the acquired assets was developed using a Weighted Average Cost of Capital (“WACC”) methodology. The discount rate applied under WACC was 20%. To perform the process outlined by ASC 805, the valuation specialists defined the buyer’s expected rate of return, referred to as the internal rate of return (“IRR,” 19.5%), a market participant’s rate of return, which is WACC; and the rates of returns for the identified assets: working capital (20.3%), intangible assets (21.0%), and goodwill (23.0%).

      

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 4 – ACQUISITION OF MOBILE VIEWPOINT CORPORATE B.V. (continued)

     

    Intangible assets acquired:

     

    The Purchaser acquired intangible assets from MVP as a result of the Transaction. The Tradename, Proprietary Technology, and Customer Relationships are intangible assets noted to have a finite life, while Goodwill has an indefinite life span. The finite life intangible assets will be amortized using the straight-line method of the respective lives of each asset, while the indefinite life intangible assets will not be amortized.

     

    Based thereon, below are the acquired intangibles with their relative useful lives and method of amortization:

     

    Intangible Asset   Useful Life   Amortization Method
             
    Tradename   15 Years   Straight-line
    Proprietary Technology   5 Years   Straight-line
    Customer Relationships   10 Years   Straight-line
    Goodwill   Indefinite   N/A

     

    The following presents the unaudited Pro-forma combined results of operations of Vislink with MVP as if the combination of the entities occurred on January 1, 2021.

     

      

    Year

    Ending

    December 31,

     
       2021 
    Revenues, net  $36,843 
          
    Net loss allocable to common stockholders  $(16,173)
          
    Net loss per share  $(0.37)
          
    Weighted average number of shares outstanding   43,484 

     

    The revenue and earnings of MVP since the acquisition date included in the consolidated statements of operations and comprehensive loss amount to approximately $2.3 million for the year ending December 31, 2021.

     

    XML 33 R11.htm IDEA: XBRL DOCUMENT v3.23.1
    ACCOUNTS RECEIVABLE
    12 Months Ended
    Dec. 31, 2022
    Receivables [Abstract]  
    ACCOUNTS RECEIVABLE

    NOTE 5 — ACCOUNTS RECEIVABLE

     

    Accounts receivable consist of the following:

     

       December 31, 2022   December 31, 2021 
    Accounts receivable  $6,680,000   $10,327,000 
    Allowance for doubtful accounts   (673,000)   (1,258,000)
    Net accounts receivable  $6,007,000   $9,069,000 

     

    During the years ended December 31, 2022, and 2021, the Company incurred bad debt expenses of $21,000 and $233,000, respectively. Additionally, for the years ended December 31, 2022, and 2021, the Company experienced bad debt recoveries of $517,000 and $310,000, respectively.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    XML 34 R12.htm IDEA: XBRL DOCUMENT v3.23.1
    INVENTORIES
    12 Months Ended
    Dec. 31, 2022
    Inventory Disclosure [Abstract]  
    INVENTORIES

    NOTE 6 — INVENTORIES

     

    Inventories included in the accompanying consolidated balance sheet are stated at the lower of cost or market as summarized below:

     

       December 31, 2022   December 31, 2021 
    Raw materials  $12,038,000   $11,308,000 
    Work-in-process   1,474,000    2,105,000 
    Finished goods   4,460,000    5,011,000 
    Sub-total inventories   17,972,000    18,424,000 
    Less reserve for slow-moving and excess inventory   (5,951,000)   (6,530,000)
    Total inventories, net  $12,021,000   $11,894,000 

     

    Inventory valuation adjustments consist primarily of written-off items due to obsolescence or reserved for slow-moving or excess inventory. The Company recorded inventory valuation adjustments of $1,143,000 and $843,000 as of December 31, 2022, and 2021. Additionally, under the Company’s product rationalization program, management eliminated specific product lines impairing $1,787,000 and $-0- of inventory as of December 31, 2022, and 2021, respectively.

     

    XML 35 R13.htm IDEA: XBRL DOCUMENT v3.23.1
    PROPERTY AND EQUIPMENT
    12 Months Ended
    Dec. 31, 2022
    Property, Plant and Equipment [Abstract]  
    PROPERTY AND EQUIPMENT

    NOTE 7 — PROPERTY AND EQUIPMENT

     

    Property and equipment consist of the following:

     

       Useful Life  December 31, 
       (Years)  2022   2021 
    Cost:           
    Furniture and fixtures  110  $308,000   $282,000 
    Leasehold improvements (a)  1 - 14   443,000    439,000 
    Computers, software, and equipment  1 - 11   3,016,000    2,813,000 
           3,767,000    3,534,000 
    Accumulated depreciation      (2,333,000)   (2,361,000)
    Property and equipment, net     $1,434,000   $1,173,000 

     

    Depreciation of property and equipment amounted to $201,000 and $195,000 for the years ended December 31, 2022, and 2021, respectively. Additionally, the Company removed $228,000 of fully depreciation leasehold improvement from its records.

     

    (a) The shorter economic life or remaining lease term.

     

    XML 36 R14.htm IDEA: XBRL DOCUMENT v3.23.1
    GOODWILL
    12 Months Ended
    Dec. 31, 2022
    Goodwill  
    GOODWILL

    NOTE 8 — GOODWILL

     

    Goodwill represents the excess cost of an acquired business over the fair value of the identifiable tangible and intangible assets acquired and liabilities assumed in a business combination (see Note 4). Under ASC 350, the Company chose to assess qualitative factors first to determine whether performing the first step of the two-step goodwill impairment test is necessary. The Company assessed qualitative factors to determine if it is more likely than not (that is, a likelihood of more than 50 percent) that the fair value of a reporting unit is less than its carrying amount, including goodwill. In other words, it was not required to calculate the fair value of a reporting unit. As part of the MVP acquisition on August 16, 2021, we engaged a valuation analyst to estimate the fair value of specific assets acquired by performing appropriate valuations procedures. The valuation analyst expressed the results of the valuation engagement in a report in the late fourth quarter of 2021. As a result of the acquisition, the report concluded that the amount paid in excess of the net asset acquired relates to finite intangible assets, with a remaining amount allocated to goodwill.

     

    Under ASC 350, “Goodwill and other,” we completed our annual goodwill impairment test on December 31, 2021; we elected to perform a quantitative assessment to determine if it was more likely than not (that is, a likelihood of more than 50 percent) that the fair value of our reporting unit was less than its carrying value as of the test date. Our assessment recognized a decline in our market capitalization due to unfavorable changes in the market and the rise in inflation as “triggering event” conditions increasing the risk of impairment.

     

    Based on the quantitative assessment, we concluded that the carrying amount of our reporting unit exceeded the fair value. As a result, we recorded $9,189,000 in goodwill impairment charges on the consolidated operations statements and comprehensive loss for the year ended December 31, 2021. The Company did not recognize goodwill during the year ended December 31, 2022.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 8 — GOODWILL (continued)

     

    The following table illustrates goodwill for the years ended December 31, 2022, and 2021:

     

       12/31/22   12/31/21 
    Beginning balance  $   $ 
    Additions       8,211,000 
    Deferred tax liabilities associated with MVP acquisition       978,000 
    Impairments       (9,189,000)
    Ending balance  $-0-   $-0- 

     

    XML 37 R15.htm IDEA: XBRL DOCUMENT v3.23.1
    INTANGIBLE ASSETS
    12 Months Ended
    Dec. 31, 2022
    Goodwill and Intangible Assets Disclosure [Abstract]  
    INTANGIBLE ASSETS

    NOTE 9 — INTANGIBLE ASSETS

     

    The Company continuously monitors operating results, events, and circumstances that may indicate potential impairment of intangible assets. Management concluded that no triggering events occurred during the year ended December 31, 2022.

     

    The following table illustrates finite intangible assets as of December 31, 2022, and 2021:

     

       Proprietary Technology   Patents and Licenses   Trade Names & Technology   Customer Relationships     
           Accumulated       Accumulated       Accumulated       Accumulated     
       Cost   Amortization   Cost   Amortization   Cost   Amortization   Cost   Amortization   Net 
                                         
    Balance, December 31, 2020  $       $12,378,000   $(11,175,000)  $1,450,000   $(914,000)  $2,880,000   $(2,698,000)  $1,921,000 
                                                  
    Additions   2,132,000                801,000        2,215,000        5,148,000 
                                                  
    Amortization   -    (223,000)   -    (668,000)   -    (138,000)   -    (119,000)   (1,148,000)
                                                  
    Balance, December 31, 2021   2,132,000    (223,000)   12,378,000    (11,843,000)   2,251,000    (1,052,000)   5,095,000    (2,817,000)   5,921,000 
                                                  
    Amortization       (592,000)       (535,000)       (137,000)       (257,000)   (1,521,000)
                                                  
    Balance, December 31, 2022  $2,132,000   $(815,000)  $12,378,000   $(12,378,000)  $2,251,000   $(1,189,000)  $5,095,000   $(3,074,000)  $4,400,000 

     

    Proprietary Technology:

     

    The Company amortizes proprietary technology over their useful lives of 3 to 5 years. The proprietary technology consists of wireless multiplex transmitters, and artificial intelligence developed and used by MVP internally to produce and sell products or services to the end-user or customer.

     

    Patents and Licenses:

     

    The Company amortizes filed patents and licenses over their useful lives, ranging from 18.5 to 20 years. The amortization of the costs incurred by processing provisional patents and pending applications begins after successful review and filing.

     

    Trade Name, Technology, and Customer Relationships:

     

    The Company amortizes these other intangible assets over their estimated useful lives of 3 to 15 years. Prior acquisitions of the Company’s subsidiaries, IMT, Vislink, and MVP, created these intangible assets of trade names, technology, and customer lists.

     

    The Company has recognized net capitalized intangible costs as follows:

     

       December 31,   December 31, 
       2022   2021 
    Proprietary Technology  $1,319,000   $1,910,000 
    Patents and Licenses       535,000 
    Trade Names and Technology   1,060,000    1,198,000 
    Customer Relationships   2,021,000    2,278,000 
       $4,400,000   $5,921,000 

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 9 — INTANGIBLE ASSETS (continued)

     

    The Company has recognized the amortization of intangible assets as follows:

     

       For the years ended 
       December 31, 
       2022   2021 
             
    Proprietary Technology  $592,000   $223,000 
               
    Patents and Licenses   535,000    668,000 
               
    Trade Names and Technology   137,000    138,000 
               
    Customer Relationships   257,000    119,000 
               
       $1,521,000   $1,148,000 

     

    The weighted average remaining life of the amortization of the Company’s intangible assets is approximately 5.3 years. The following table represents the estimated amortization expense for total intangible assets for the succeeding five years:

     

    Period ending December 31,     
    2023  $645,000 
    2024   645,000 
    2025   645,000 
    2026   556,000 
    2027   539,000 
    Thereafter   1,370,000 
    Finite-Lived Intangible Assets, Net, Total  $4,400,000 

     

    XML 38 R16.htm IDEA: XBRL DOCUMENT v3.23.1
    ACCRUED EXPENSES
    12 Months Ended
    Dec. 31, 2022
    Payables and Accruals [Abstract]  
    ACCRUED EXPENSES

    NOTE 10 — ACCRUED EXPENSES

     

    Accrued expenses consist of the following:

     

       December 31, 2022   December 31, 2021 
    Compensation  $246,000   $2,069,000 
    Commissions   47,000    29,000 
    Warranty   112,000    130,000 
    Rent       185,000 
    Accrued expenses other   908,000    687,000 
    Deferred Equity   255,000    55,000 
    Accrued expenses  $1,568,000   $3,155,000 

     

    XML 39 R17.htm IDEA: XBRL DOCUMENT v3.23.1
    NOTES PAYABLE
    12 Months Ended
    Dec. 31, 2022
    Debt Disclosure [Abstract]  
    NOTES PAYABLE

    NOTE 11 — NOTES PAYABLE

     

    The table below represents the Company’s notes payable as of December 31, 2022, and 2021:

     SCHEDULE OF NOTES PAYABLE

       Principal 
       12/31/22   12/31/21 
             
    On April 5, 2021  $   $99,000 
    On April 5, 2021, the Company renewed its D & O insurance policy and increased the premium to approximately $1,098,000, less a down payment of $225,000, financing the remaining balance of approximately $872,000. The loan’s terms are nine months at a 5.25% annual interest rate and a monthly principal and interest payment of approximately $99,000. As of March 31, 2022, the loan is paid in full. The Company recorded interest expense of $-0- and $19,000 for the years ended December 31, 2022, and 2021, respectively.  $   $99,000 
               
    On April 5, 2022, the Company renewed its D & O insurance policy, decreasing the premium to approximately $1,037,000, less a down payment of $194,000, financing the remaining balance of approximately $943,000. The loan’s terms are nine months at a 2.09% annual interest rate and a monthly principal and interest payment of approximately $84,000. The Company recorded interest expense of $6,000 and $-0- for the years ended December 31, 2022, and 2021, respectively.   84,000     
       $84,000   $99,000 

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    XML 40 R18.htm IDEA: XBRL DOCUMENT v3.23.1
    LEASES
    12 Months Ended
    Dec. 31, 2022
    Leases  
    LEASES

    NOTE 12 — LEASES

     

    The Company’s leasing arrangements include office space, deployment sites, and storage warehouses, both domestically and internationally. The operating leases contain various terms and provisions, with lease terms of approximately one to four years remaining as of December 31, 2022. Certain individual leases contain rent escalation clauses and lease concessions that require additional rental payments later in the term. We recognize rent expense for these contracts straight-line over the minimum lease term.

     

    On December 31, 2022, the Company recorded approximately $1.1 million of ROU assets net of $1.2 million accumulated amortization on the balance sheet. Additionally, the Company recorded relatively $1.6 million of operating lease liabilities, of which $0.5 million is current and $1.1 million is non-current, as reported on the balance sheet. The weighted-average remaining term for lease contracts was 3.4 years on December 31, 2022, with maturity dates from July 2023 to January 2027 and a weighted-average discount rate of 9.4% on December 31, 2022.

     

    Adjustments for straight-line rental expense for the respective periods was not material. Most costs recognized are reflected in cash used in operating activities for the respective periods. This expense consisted primarily of payments for base rent on office and warehouse leases. Amounts related to short-term lease costs, taxes, and variable service charges on leased properties were immaterial. Besides, we have the right to renew individual leases for various renewal terms but no obligation.

     

    The following represents lease activity for the year ending December 31, 2022:

     

    Lutton, UK

     

    On April 28, 2022, the Company entered a one-year lease for 600 square feet of administrative office space in Lutton, UK, commencing on May 3, 2022, and terminating on May 31, 2023, for £1,320 monthly or approximately $1,800 per month.

     

    Dubai, UAE

     

    The Company renewed its lease for 976 square feet of administrative office space commencing on July 3, 2022, and terminating on July 2, 2023, in Dubai Studio City, UAE, for AED 5,995 or approximately US$ 1,632 monthly.

     

    Billerica, MA

     

    During the third quarter of the fiscal year 2022, management vacated the Billerica property. The economic environment of this location precluded the action of sub-letting an unoccupied site and determined the leased facility abandoned. Under ASC 360, leased space abandonment is an impairment indicator, and the Company assessed the lease ROU assets for impairment, and we recognized a loss on impairment of right-of-use assets of approximately $88,000.

     

    The following represents lease activity for the year ending December 31, 2021:

     

    Lutton, UK

     

    On February 1, 2021, the Company entered into a one-year lease for 600 square feet of administrative office space in Lutton, UK, commencing on February 1, 2021, and terminating on January 31, 2022, for £1,674 or approximately $2,290 monthly.

     

    Dubai, UAE

     

    On May 24, 2021, the Company renewed its lease for office space commencing on July 3, 2021, and terminating on July 2, 2022, for 976 square feet of administrative office space in Dubai Studio City, UAE, for AED 5,995 or approximately $1,620 monthly.

     

    Mount Olive, NJ

     

    On November 1, 2021, the Company entered into a lease agreement with a non-affiliated third party (the “Landlord”) to rent approximately 7,979 square feet of commercial space for general business offices, light manufacturing, operating of a testing laboratory, assembly, and inventory storage in Mount Olive, NJ. The lease commencement date is November 1, 2021, and the expiration date is January 31, 2027. The initial monthly obligation is $10,869, with annual rent increases of 3.0% per year until the lease expiration date. The Company is relocating its corporate facilities from Hackettstown, NJ, to Mount Olive, NJ, with the projected completion date by March 2022, as part of the strategic initiative plan implemented in early 2020. The Company recognized approximately $522,000 of Right of Use Assets and Operating lease obligations for the new lease under ASC Topic 842.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 12 — LEASES (continued)

     

    The following table illustrates operating lease data for the years ended December 31, 2022, and 2021:

     

     SCHEDULE OF OPERATING LEASE DATA

       2022   2021 
       For the years ended 
       December 31, 
       2022   2021 
    Lease cost:          
    Operating lease cost  $438,000   $472,000 
    Short-term lease cost   93,000    417,000 
               
    Total lease cost  $531,000   $889,000 
               
    Cash paid for lease liabilities:          
    Cash flows from operating leases  $543,000   $635,000 
               
    Weighted-average remaining lease term—operating leases   3.4 years    3.8 years 
               
    Weighted-average discount rate—operating leases   9.4%   9.3%

     

    Maturities of our operating lease liabilities were as follows as of December 31, 2022:

     

     SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES

       Amount 
         
    2023  $589,000 
    2024   455,000 
    2025   443,000 
    2026   249,000 
    2027   59,000 
    Thereafter    
    Total lease payments   1,795,000 
    Less: imputed interest   233,000 
    Present value of lease liabilities   1,562,000 
    Less: Current lease liabilities   455,000 
    Non-current lease liabilities  $1,107,000 

     

    The table below lists the location and lease expiration date from 2023 through 2027: 

     SCHEDULE OF LEASE OBLIGATIONS ASSUMED

    Location  Square Footage    Lease-End Date  Approximate Future Payments 
    Colchester, U.K. – Waterside House   16,000   Dec 2025  $639,000 
    Singapore   950   July 2023   19,000 
    Billerica, MA   2,000   Dec 2026   416,000 
    Hemel, UK   12,870   Oct 2023   123,000 
    Mount Olive, NJ   7,979   Jan 2027   598,000 

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    XML 41 R19.htm IDEA: XBRL DOCUMENT v3.23.1
    DERIVATIVE LIABILITIES
    12 Months Ended
    Dec. 31, 2022
    Derivative Instruments and Hedging Activities Disclosure [Abstract]  
    DERIVATIVE LIABILITIES

    NOTE 13 — DERIVATIVE LIABILITIES

     

    Under the guidance of ASC 815, Accounting for Derivative Instruments and Hedging Activities, the Company identified common stock warrants in various offerings containing a net cash settlement provision whereby, upon certain fundamental events, the holders could put these warrants back to the Company for cash. We identified and classified the following transactions as derivative liabilities: warrants issued with the May 2016 financing, the July 2016 financing, the August 2017 underwritten offering, and the May 2018 Financing.

     

    The Company records derivative liabilities on its consolidated balance sheet at their fair value on the issuance date. The Company revalues the derivative liabilities on each subsequent balance sheet until exercised or expired, with any changes in the fair value between reporting periods recorded as other income or expense. The Company uses option pricing models and assumptions based on the instruments’ characteristics on the valuation date. We use assumptions for future financings, expected volatility, expected life, yield, and risk-free interest rate to estimate fair value.

     

    The following are the key assumptions used in connection with the valuation of the warrants exercisable into common stock on December 31, 2022, and 2021:

     

     SCHEDULE OF VALUATION AND WARRANTS EXERCISABLE

       For the Years Ended December 31, 
       2022   2021 
    Number of shares underlying the warrants   55,333    66,341 
    The fair market value of stock  $0.56   $1.18 
    Exercise price  $ 0.00 to $ 60.00    $ 60.00 to $ 150.00  
    Volatility   0% to 64 %   97% to 101 %
    Risk-free interest rate   0% to 4.54 %   0.19% to 0.39 %
    Expected dividend yield        
    Warrant life (years)   0.0 to 0.4     0.6 to 1.4  

     

    Level 3 liabilities are valued using unobservable inputs to the valuation methodology significant in measuring the liabilities’ fair value. For fair value measurements categorized within Level 3 of the fair value hierarchy, the Company’s accounting and finance department, subject to the approval of the Chief Financial Officer, determines the applicable valuation policies and procedures.

     

    Level 3 Valuation Techniques:

     

    Level 3 financial liabilities consist of the derivative liabilities for which there is no current market for these securities, such that determining fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate. The Company deems financial instruments that do not have fixed settlement provisions as derivative instruments. Under US GAAP, the fair value of these warrants is classified as a liability on the Company’s consolidated balance sheets because, according to the terms of the warrants, a fundamental transaction could give rise to an obligation of the Company to pay cash to its warrant holders. Such instruments do not have fixed settlement provisions and have also been recorded as derivative liabilities. Corresponding changes in the fair value of the derivative liabilities are recognized in earnings on the Company’s consolidated operations statements in each subsequent period. The Company uses a binomial model style simulation to calculate fair value, as the standard Black-Scholes model would not capture the value of certain features of the warrant derivative liabilities.

     

    The following table sets forth a summary of the changes in the fair value of Level 3 financial liabilities that are measured at fair value on a recurring basis:

     

     SCHEDULE OF CHANGES IN FAIR VALUE OF LEVEL 3 FINANCIAL LIABILITIES

       2022   2021 
       For the years ended 
       December 31 
       2022   2021 
             
    Beginning balance  $   $22,000 
    Change in fair value of derivative liabilities       (22,000)
    Ending balance  $   $ 

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    XML 42 R20.htm IDEA: XBRL DOCUMENT v3.23.1
    PREFERRED SHARES
    12 Months Ended
    Dec. 31, 2022
    Equity [Abstract]  
    PREFERRED SHARES

    NOTE 14 — PREFERRED SHARES

     

    Preferred Stock

     

    In March 2013, the issuance of 10.0 million shares of “Blank Check” preferred stock with a par value of $0.00001 per share received approval from the majority of stockholders.

     

    The following shares were designated as authorized:

     

      Three million shares of Series A Convertible Preferred Stock (“Series A Preferred Stock”) on December 31, 2014.
      Three million shares of Series B Convertible Preferred Stock (“Series B Preferred Stock”) on February 11, 2015.
      Three million shares of Series C Convertible Preferred Stock (“Series C Preferred Stock”) on February 24, 2015.

     

    On February 5, 2016, the Company terminated the Series A Preferred Stock and Series C Preferred Stock and increased the number of designated shares of Series B Preferred Stock to 5,000,000. The following shares were designated as authorized: Five million shares of Series D Convertible Preferred Stock (“Series D Preferred Stock”) on April 25, 2016. On December 6, 2016, the Company terminated the Series B Preferred Stock. The following shares were designated as authorized: Five thousand shares of Series E Convertible Preferred Stock (“Series E Preferred Stock”) on December 21, 2016. On November 9, 2022, the Company’s Board of Directors (i) terminated the Series D Preferred Stock and Series E Preferred Stock and (ii) designated the following shares as authorized: 47,500 shares of new Series A Preferred Stock.

     

    Series A Preferred Stock

     

    On November 9, 2022, the Company’s board of directors declared a dividend of one one-thousandth of a share of Series A Preferred Stock, par value $0.00001 per share (“Series A Preferred Stock”), for each outstanding share of the Company’s common stock, to stockholders of record on November 21, 2022.

     

    Each share of Series A Preferred Stock entitled the holder to 1,000,000 votes per share, and each fraction of a share had a ratable number of votes. Thus, each one-thousandth share of Series A Preferred Stock was entitled to 1,000 votes. The outstanding shares of Series A Preferred Stock voted together with the outstanding shares of the Company’s common stock as a single class exclusively concerning the proposal to adopt an amendment to the Company’s Certificate of Incorporation, as amended, to reclassify the outstanding shares of the Company’s Common Stock into a smaller number of shares of common stock at a ratio specified in or determined under the terms of such amendment (the “Reverse Stock Split”). The Series A Preferred Stock was not entitled to vote on any other matter except to the extent required under the Delaware General Corporation Law.

     

    The holders of Series A Preferred Stock were not entitled to receive dividends.

     

    On January 11, 2023, the Company held a special meeting of stockholders (the “Special Meeting”) whereby stockholders voted on a proposal to authorize the Board, at its discretion, to effect the Reverse Stock Split. All shares of Series A Preferred Stock that were not present in person or by proxy at the Special Meeting held to vote on the Reverse Stock Split immediately before the opening of the polls at such meeting (the “Initial Redemption Time”) were automatically redeemed in whole, but not in part, by the Company at the Initial Redemption Time without further action on the part of the Company or the holder of shares of Series A Preferred Stock (the “Initial Redemption”). Any outstanding shares of Series A Preferred Stock that were not redeemed according to an Initial Redemption were redeemed in whole but not in part (i) if the Board ordered such redemption in its sole discretion, automatically and effective on such time and date specified by the Board in its sole discretion or (ii) automatically upon the approval by the Company’s stockholders of the Reverse Stock Split at the Special Meeting held for the purpose of voting on a such proposal (“the Subsequent Redemption”).

     

    Each share of Series A Preferred Stock redeemed in any redemption described above was redeemed in consideration for the right to receive an amount equal to $0.00001 in cash for each ten (10) whole shares of Series A Preferred Stock that were “beneficially owned” by the “beneficial owner” (as such terms are defined in the certificate of designation concerning the Series A Preferred Stock) thereof as of the applicable redemption time and redeemed under such redemption, payable upon receipt by the Company of a written request submitted by the relevant holder to the corporate secretary of the Company following the applicable redemption time.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 14 — PREFERRED SHARES (continued)

     

    Series A Preferred Stock (continued)

     

    The Series A Preferred Stock was not convertible into, or exchangeable for, shares of any other class, series of stock, or other securities of the Company. The Series A Preferred Stock had no stated maturity and is not subject to any sinking fund. The Series A Preferred Stock was not restricted to the Company’s redemption or repurchase of shares while there is any arrearage in the payment of dividends or sinking fund installments. The Certificate of Designation was filed with the Delaware Secretary of State and became effective on November 9, 2022.

     

    The Company was not solely in control of the redemption of the shares of Series A Preferred Stock since the holders had the option of deciding whether to vote in respect of the above-described Reverse Stock Split, which determined whether a given holder’s shares of Series A Preferred Stock were redeemed in the Initial Redemption or the Subsequent Redemption. Since the redemption of the Series A Preferred Stock was not solely in the control of the Company, the shares of Series A Preferred Stock were classified within mezzanine equity in the Company’s audited consolidated balance sheet. The shares of Series A Preferred Stock were measured at redemption value. The value of Series A Preferred Stock shares as of December 31, 2022, was de minimis.

     

    Certificate of Elimination

     

    On April 25, 2016, the Company filed a Certificate of Designation with the Secretary of State of the State of Delaware, designating 5,000,000 shares out of the Company’s authorized but unissued shares of its preferred stock as Series D Convertible Preferred Stock, par value $0.00001 per share.

     

    On December 21, 2016, the Company filed a Certificate of Designation with the Secretary of State of the State of Delaware, designating 5,000 shares out of the Company’s authorized but unissued shares of its preferred stock as Series E Convertible Preferred Stock, par value $0.00001 per share.

     

    On November 9, 2022, the Company filed Certificates of Elimination for each of the Series D Preferred Stock and Series E Preferred Stock with the Secretary of State of the State of Delaware, which, effective upon filing, eliminated all matters outlined in the Certificates of Designation of Series D Preferred Stock and Series E Preferred Stock previously filed by the Company. According to the Certificates of Elimination, the shares that were previously designated as Series D Preferred Stock and Series E Preferred Stock resume the status of authorized but unissued shares of preferred stock, par value $0.00001 per share, of the Company, issuable from time to time, in one or more series, under the Certificate of Incorporation.

     

    On March 24, 2023, the Company filed a certificate of elimination (the “Certificate of Elimination”) with the Secretary of State of the State of Delaware for the Series A Preferred Stock. The Certificate of Elimination (i) eliminated the previous designation of 47,500 shares of Series A Preferred Stock from the Company’s Certificate of Incorporation, as amended, none of which were outstanding at the time of the filing of such Certificate of Elimination, and (ii) caused such shares of Series A Preferred Stock to resume their status as authorized but unissued and non-designated shares of preferred stock of the Company.

     

      

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    XML 43 R21.htm IDEA: XBRL DOCUMENT v3.23.1
    STOCKHOLDERS’ EQUITY
    12 Months Ended
    Dec. 31, 2022
    Equity [Abstract]  
    STOCKHOLDERS’ EQUITY

    NOTE 15 — STOCKHOLDERS’ EQUITY

     

    Common Stock

     

    The Company is authorized to issue up to 100,000,000 shares of Common Stock, $0.00001 par value per share. As of December 31, 2022, and 2021, the Company had 47,419,317 and 45,825,089 shares issued, and 47,416,658 and 45,822,430 shares outstanding, respectively.

     

    Common Stock Issuances

     

    For the year ending December 31, 2022

     

      Issued 357,778 shares of common stock as payment of the minimum withholding tax obligation due upon the vesting of shares restricted stock units.
         
      Issued 1,159,044 shares of common stock, net of 357,778 shares attributable to withholding tax, upon the exercise of restricted stock units under the Company’s various stock compensation plans.
         
      Under the terms of an $80,000 consulting agreement: on May 4, 2022, issued 38,703 shares of common stock were valued at $0.81 per share on the issuance date with a total value of $31,349 in satisfaction of $40,000. The value of the common stock issued was based on the fair value of the stock at the time of the issuance. On July 19, 2022, 38,703 shares of common stock were valued at $0.59 per share on the issuance date, with a total value of $22,835 in satisfaction of the remaining balance of $40,000. The Company recognized a total gain on debt settlement of $25,816.

     

    Other stockholders’ equity transactions

     

      Recognized approximately $1,565,000 of stock-based compensation costs associated with outstanding stock options recorded in general and administrative expenses offsetting additional paid-in capital.

     

    For the year ending December 31, 2021

     

    February 2021 Financing

     

    The Company issued 18,181,820 shares of common stock, supplemented by 9,090,910 five-year warrants with an exercise price of $3.25 per share exercisable for one share of common stock. The Company has earmarked the net proceeds from equity financing for working capital and general corporate purposes. Specifically, on February 8, 2021, the Company closed on equity financing and received gross proceeds of approximately $50,000,000, less offering costs of $3,180,000 for net proceeds of $46,820,000.

     

    Other Stockholders’ Equity Transactions

     

    During the year ended December 31, 2021, the Company:

     

      Issued 6,163,198 shares of common stock and received gross proceeds of approximately $13,000,000, less offering costs of $400,000 for net proceeds of $12,600,000 under the Company’s shelf registration filed on May 5, 2020.
         
      Issued 3,811 shares of common stock upon warrant holders exercising 3,811 common stock warrants, receiving approximately $3,500 in net proceeds.
         
      Issued 6,250 shares of common stock upon warrant holders exercising 6,250 cashless public common stock warrants.
         
      Issued 30,000 three-year common stock warrants with an exercise price of $3.41 per share exercisable for one share each of common stock in satisfaction of a settlement agreement. We computed the value of approximately $74,000 under the Cox-Rubenstein binomial lattice valuation model method. The Company used the following assumptions in connection with the warrants’ valuation: fair market value of the stock of $3.05, the exercise price of $3.41, volatility of 153.96%, risk-free interest rate of 0.08%, expected dividend yield of -0-, and the warrant life of 3 years.
         
      Issued 87,720 shares of common stock to specific board members under a commitment agreement valued at $200,000. The value of the common stock was determined on the original date of the agreement.
         
      Recognized approximately $3,860,000 of stock-based compensation costs associated with outstanding stock options and restricted stock units recorded in general and administrative expenses with the offset to additional paid-in capital.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 15 — STOCKHOLDERS’ EQUITY (continued)

     

    Common Stock Warrants

     

    During the year ended December 31, 2022, 34,885 warrants expired. As of December 31, 2022, these outstanding warrants contained no intrinsic value. The weighted average exercise price of warrants outstanding on December 31, 2022, is $3.60, with a weighted average remaining contractual life of 3.1 years.

     

    The following tables set forth common stock purchase warrants outstanding as of December 31, 2022:

     SCHEDULE OF WARRANT OUTSTANDING

      

    Number of Warrants

    (in shares)

      

    Weighted

    Average

    Exercise

    Price

     
             
    Outstanding, December 31, 2020   222,360   $89.60 
    Warrants granted   9,120,910    3.30 
    Warrants exercised   (10,063)   (1.20)
    Warrants canceled/expired   (123,396)   (98.30)
    Outstanding, December 31, 2021   9,209,811    4.10 
    Warrants expired   (34,885)   (131.20)
    Outstanding and exercisable, December 31, 2022   9,174,926   $3.60 

     

     SCHEDULE OF WARRANT OUTSTANDING EXERCISE PRICE

        Common stock issuable upon exercise of warrants outstanding and exercisable 
        For the year ending   For the year ending 
        December 31, 2022   December 31, 2021 
    Range of Exercise Prices   Warrants Outstanding and Exercisable (in shares)   Weighted Average Remaining Contractual Life (years)  

    Weighted Average Exercise

    Price

      

    Warrants Outstanding and Exercisable

    (in shares)

       Weighted Average Remaining Exercisable Contractual Life (years) 

    Weighted Average Exercise

    Price

     
    $3.25    9,090,910    3.11 yrs   $3.30    9,090,910   4.11 yrs  $3.30 
    $3.41    30,000    1.18 yrs   $3.50    30,000   2.18 yrs  $3.50 
    $30.000    683    1.54 yrs   $30.00    683   2.54 yrs  $30.00 
    $60.000    53,333    0.41 yrs   $60.00    53,333   1.41 yrs  $60.00 
    $120.000           $    21,877   0.12 yrs  $120.00 
    $150.000           $    13,008   0.63 yrs  $150.00 
          9,174,926    3.10 yrs   $3.60    9,209,811   4.08 yrs  $4.10 

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    XML 44 R22.htm IDEA: XBRL DOCUMENT v3.23.1
    STOCK-BASED COMPENSATION
    12 Months Ended
    Dec. 31, 2022
    Share-Based Payment Arrangement [Abstract]  
    STOCK-BASED COMPENSATION

    NOTE 16 — STOCK-BASED COMPENSATION

     

    Equity Incentive Plans:

     

    The Company’s stock option plans provide options to purchase shares of common stock to officers, directors, other key employees, and consultants. The purchase price may be paid in cash or “net settled” in the Company’s common stock shares. In a net settlement of an option, the Company does not require payment of the exercise price from the holder but reduces the number of shares of common stock issued upon the exercise of the stock option by the smallest amount of whole shares that have an aggregate fair market value equal to or over the aggregate exercise price for the option shares covered by the option exercised. Options generally vest over three years from the grant date and expire ten years from the grant date.

     

    The Company has four plans under which they awarded share-based compensation grants of options to individual directors, employees, and advisors of the Company: the 2013 Stock Option Plan, the 2015 Incentive Compensation Plan, the 2016 Incentive Compensation Plan, and the 2017 Incentive Compensation Plan.

     

    Effective April 30, 2018, the Board of Directors, by unanimous written consent, approved the immediate vesting of all remaining options for terminated employees as part of the cost curtailment measures on April 30, 2018, and June 25, 2018.

     

    On December 31, 2020, the board of directors of the Company approved an amendment (the “Amendment”) to the Company’s 2013 Long-Term Stock Incentive Plan (the “Plan”), effective January 1, 2021. The Amendment removed a provision that no participant may receive more than 25% of the total shares awarded in any year under the Plan and incorporated specific immaterial clarifying changes.

     

    The following table illustrates various plan data under the amended Long-Term Stock Incentive Plan (the “Plan”):

     

    SCHEDULE OF STOCK OPTION PLANS

       For the years ended 
       December 31, 
       2022   2021 
    Stock-based compensation expense  $1,000   $27,000 
               
    Remaining expense of stock-based compensation  $   $1,000 
               
    Remaining amortization period   0.0 years    0.3 years 
               
    Weighted average remaining contractual life – options outstanding and exercisable   4.5 years    5.5 years 
               
    Intrinsic value per share  $   $ 
               
    Range of exercise prices  $6.96 to $97.20   $6.96 to $1,173.60 
               
    Quantity:          
               
    Beginning balance-January 1st, outstanding options   49,925    56,399 
               
    Stock options forfeited   (4,916)   (6,474)
               
    Ending balance-December 31st, outstanding options   45,009    49,925 
               
    Ending balance-December 31st, exercisable options   45,009    48,703 
               
    Weighted Averages:          
               
    Beginning balance-January 1st, outstanding options  $88.04   $89.79 
               
    Stock options forfeited  $(96.70)  $(84.13)
               
    Ending balance-December 31st, outstanding options  $87.80   $88.04 
               
    Ending balance-December 31st, exercisable options  $87.80   $89.80 

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 16 — STOCK-BASED COMPENSATION (continued)

     

    Time-vested stock options:

     

    In connection with their employment agreement(s), the Company granted the following ten-year, non-statutory time-vested option inducement awards under the NASDAQ Listing Rule 5653(c)(4) outside of the Company’s existing equity compensation plans (all subject to continued employment):

     

    Recipient  Date of Grant   Options Granted   Exercise Price   Vesting Commencement Date  Expiration Date  25% Vesting   75% Remaining Vesting
    ●Carleton M. Miller — CEO   1/22/20    359,247   $1.71   1/22/20  1/22/30   1/22/21   36 equal monthly payments
    ●Michael Bond — CFO   2/27/20    135,168   $0.96   4/1/20  4/1/30   4/1/21   36 equal monthly payments

     

     In determining the time-vested options award’s grant-date fair value, the following assumptions were used:

     

     

       Expected term (years)   Expected dividend yield   Risk-free interest rate   Volatility   Exercise Price 
                         
    ● Carleton M. Miller — CEO   6.5        1.57%   153.0%  $1.71 
    ● Michael Bond — CFO   6.3        0.62%   155.0%  $0.96 

     

    Note: no time-vested option awards were granted during the year ended December 31, 2022.

     

    The following table illustrates various plan data under time-based stock option awards:

     

       2022   2021 
       For the years ended 
       December 31, 
       2022   2021 
    Stock-based compensation expense  $179,000   $113,000 
               
    Remaining expense of stock-based compensation  $319,000   $498,000 
               
    Remaining amortization period   1.1 years    2.1 years 
               
    Weighted average remaining contractual life – options outstanding and exercisable   7.1 years    8.1 years 
               
    Intrinsic value per share  $   $.38 
               
    Range of exercise prices   $0.96 to $1.71    $0.96 to $1.71 
               
    Quantity:          
               
    Beginning balance-January 1st, outstanding    494,415    494,415 
               
    Granted, canceled, expired        
               
    Ending balance-December 31st, outstanding    494,415    494,415 
               
    Ending balance-December 31st, exercisable    360,515    236,915 
               
    Weighted Averages:          
               
    Beginning balance-January 1st, outstanding   $1.01   $1.24 
               
    Granted, canceled, expired  $   $ 
               
    Ending balance-December 31st, outstanding   $0.60   $1.01 
               
    Ending balance-December 31st, exercisable   $0.80   $0.48 

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 16 — STOCK-BASED COMPENSATION (continued)

     

    Performance-based stock options:

     

    In connection with their employment agreement, the Company granted the following ten-year, non-statutory performance-based stock option inducement award under the NASDAQ Listing Rule 5653(c)(4) outside of the Company’s existing equity compensation plans that will vest in three equal tranches upon attainment of applicable performance conditions for each tranche (all subject to continued employment):

     

       Date of   Options   Exercise   Options Vesting Dates  Options Vesting Schedule 
    Recipient  Grant   Granted   Price   Commencement  Expiration   Tranche 1   Tranche 2   Tranche 3 
                                           
    Carleton M. Miller — CEO   1/22/20    250,000   $1.71    1/22/20    1/22/30    *83,334    **83,333    ***83,333 

     

    Applicable performance conditions:

     

    *Shares will vest upon the Company’s attainment, on or before the fifth (5th) anniversary of the Vesting Commencement Date, of Cumulative EBITDA of more than $6,000,000 accumulated over four consecutive fiscal quarters.

     

    **Shares will vest upon the Company’s attainment, on or before the fifth (5th) anniversary of the Vesting Commencement Date, of Cumulative EBITDA of more than $15,000,000 accumulated over four consecutive fiscal quarters.

     

    ***Shares will vest upon the Company’s attainment, on or before the fifth (5th) anniversary of the Vesting Commencement Date, of Cumulative EBITDA of more than $23,000,000 accumulated over four consecutive fiscal quarters.

     

    In determining the time-vested options award’s grant-date fair value, the following assumptions were used:

     

       Expected term (years)   Expected dividend yield   Risk-free interest rate   Volatility   Exercise Price 
                         
    For the year ended December 31, 2020:                       
                              
    ● Carleton M. Miller — CEO   6.5        1.57%   153.0%  $1.71 

     

    Note: no time-vested option awards were granted during the year ended December 31, 2022

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 16 — STOCK-BASED COMPENSATION (continued)

     

    Performance-based stock options (continued):

     

    The following table illustrates various plan data under performance-based stock option awards:

     

       2022   2021 
       For the years ended 
       December 31, 
       2022   2021 
    Stock-based compensation expense  $   $ 
               
    Remaining expense of stock-based compensation  $414,000   $414,000 
               
    Remaining amortization period   2.1 years    3.1 years 
               
    Weighted average remaining contractual life – options outstanding and exercisable   7.1 years    8.1 years 
               
    Intrinsic value per share  $   $. 
               
    Range of exercise prices  $1.71   $1.71 
               
    Quantity:          
               
    Beginning balance-January 1st, outstanding    250,000    250,000 
               
    Granted, canceled, expired        
               
    Ending balance-December 31st, outstanding    250,000    250,000 
               
    Ending balance-December 31st, exercisable         
               
    Weighted Averages:          
               
    Beginning balance-January 1st, outstanding   $1.65   $1.65 
               
    Granted, canceled, expired  $   $ 
               
    Ending balance-December 31st, outstanding   $1.65   $1.65 
               
    Ending balance-December 31st, exercisable   $   $ 

     

    The probability of achieving any required metrics for vesting is inconclusive, and no options are exercisable as of December 31, 2022. When the Company determines that the remaining performance metrics’ achievement becomes probable, the Company will record a cumulative catch-up stock-based compensation amount. We will record any unrecognized costs over the remaining requisite service period of the awards.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 16 — STOCK-BASED COMPENSATION (continued)

     

    Restricted Stock Units

     

    Restricted stock awards — time-based:

     

    The Company granted the following awards under the amended Plan for restricted stock units (“RSUs”) subject to continued employment:

     

       Grant       Initial RSUs Vesting  Remaining RSUs Vesting
    Recipient  Date   Units   Exercise Price   Date  Units   Units   Terms
                               
    Carleton M. Miller — CEO   3/3/21    598,665   $3.60   3/3/22   199,555    399,110   24 equal monthly periods
                                    
    Michel Bais — Managing Director   8/17/21    200,000   $1.89   8/17/22   50,000    150,000   36 equal monthly periods
                                    
    Ronnie Hamilton — VP Global Operations   1/12/22    200,000   $1.10   1/12/23   66,000    134,000   24 equal monthly periods
                                    
    Group of 22 Employees   2/17/22    515,000   $0.98   2/17/23   169,950    345,050   24 equal monthly periods
                                    
    Carleton M. Miller — CEO   2/16/22    1,033,076   $1.05   2/16/23   258,269    774,807   36 equal monthly periods
                                    
    Mike Bond — CFO   2/16/22    392,985   $1.05   2/16/23   98,256    294,739   36 equal monthly periods

     

    The following table illustrates various plan data under time-based restricted stock awards:

     

       2022   2021 
       For the years ended 
       December 31, 
       2022   2021 
    Stock-based compensation expense  $1,385,000   $ 
               
    Remaining expense of stock-based compensation  $3,248,000   $2,533,000 
               
    Remaining amortization period    2.3 years    3.5 years 
               
    Weighted average remaining contractual life – options outstanding and exercisable   2.5 years    2.5 years 
               
    Intrinsic value per share  $   $ 
               
    Range of exercise prices  $0.98 to $3.60   $1.89 to $3.60 
               
    Quantity:          
               
    Beginning balance-January 1st, outstanding    798,665     
               
    Granted   2,141,061    798,665 
               
    Forfeited   (125,000)    
               
    Ending balance-December 31st, outstanding    2,814,726    798,665 
               
    Ending balance-December 31st, exercisable    415,885     
               
    Weighted Averages:          
               
    Beginning balance-January 1st, outstanding   $3.17   $ 
               
    Granted  $1.04    3.17 
               
    Forfeited  $(.98)  $ 
               
    Ending balance-December 31st, outstanding   $1.20   $3.17 
               
    Ending balance-December 31st, exercisable   $3.30   $ 

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 16 — STOCK-BASED COMPENSATION (continued)

     

    Restricted Stock Units (continued)

     

    Restricted stock awards — performance-based:

     

    The Company granted the following awards under the amended Plan for restricted stock units (“RSUs”) subject to performance vesting conditions and continued employment:

     

       Grant       Units Vesting Schedule 
    Recipient  Date   Units   Exercise Price   Tranche 1   Tranche 2   Tranche 3 
    Carleton M. Miller — CEO   3/3/21    896,665   $3.60    299,555    299,555    299,555 
                                   
    Michael Bond — CFO   12/31/20    368,715   $1.32    122,905    122,905    122,905 

     

    Note: The above performance-based restricted stock units met all three revenue thresholds in the last quarter of 2021, and the Company recognized stock-based compensation expense accordingly for the year ending December 31, 2021.

     

       Grant       Units Vesting Schedule 
    Recipient  Date   Units   Exercise Price   Tranche 1   Tranche 2   Tranche 3 
    Carleton M. Miller — CEO   2/16/22    1,033,076   $1.05    *344,359    **344,359    ***344,359 
                                   
    Michael Bond — CFO   2/16/22    392,985   $1.05    *130,995    **130,995    ***130,994 

     

    * RSUs will vest upon the Company’s attainment, on or before December 31, 2026, of revenue of more than $35,575,000 accumulated over four consecutive fiscal quarters.
       
    ** RSUs will vest upon the Company’s attainment, on or before December 31, 2026, of revenue of more than $37,353,000 accumulated over four consecutive fiscal quarters.
       
    *** RSUs will vest upon the Company’s attainment, on or before December 31, 2026, of revenue of more than $39,220,000 accumulated over four consecutive fiscal quarters.

     

    Note: the determination of revenue for any fiscal period shall be made based on the Company’s revenues on a consolidated basis for each such fiscal period if the employee remains in continuous employment with the Company through the date the Compensation Committee certifies the revenue for such fiscal period and authorizes the issuance of the underlying shares of common stock to the employee according to his award agreement. Except as provided in each employment agreement, if an individual ceases to be an employee of the Company before any vesting date, the remaining portion of the total number of shares unvested is forfeited. The probability of achieving any required metrics for vesting is inconclusive, and no awards are exercisable as of December 31, 2022. When the Company determines that the remaining performance metrics’ achievement becomes probable, the Company will record a cumulative catch-up stock-based compensation amount. We will record any unrecognized costs over the remaining requisite service period of the awards.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 16 — STOCK-BASED COMPENSATION (continued)

     

    Restricted Stock Units (continued)

     

    Restricted stock awards — performance-based (continued):

     

    The following table illustrates various plan data under performance-based restricted stock awards:

     

       2022   2021 
       For the years ended 
       December 31, 
       2022   2021 
    Stock-based compensation expense  $   $3,722,000 
               
    Remaining expense of stock-based compensation  $1,498,000   $ 
               
    Remaining amortization period   2.8 years    0.0 years 
               
    Weighted average remaining contractual life – options outstanding and exercisable   2.8 years    4.0 years 
               
    Intrinsic value per share  $   $1.18 
               
    Range of exercise prices  $1.05    $1.32 to 3.60 
               
    Quantity:          
               
    Beginning balance-January 1st, outstanding    1,267,380    368,715 
               
    Granted, canceled, expired   1,426,062    898,665 
               
    Exercised   (1,267,380)    
               
    Ending balance-December 31st, outstanding    1,426,062    1,267,380 
               
    Ending balance-December 31st, exercisable        1,267,380 
               
    Weighted Averages:          
               
    Beginning balance-January 1st, outstanding   $2.90   $1.32 
               
    Granted, canceled, expired   1.05    3.60 
               
    Exercised  $(2.90)  $ 
               
    Ending balance-December 31st, outstanding   $1.10   $2.90 
               
    Ending balance-December 31st, exercisable   $   $2.90 

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    XML 45 R23.htm IDEA: XBRL DOCUMENT v3.23.1
    COMMITMENTS AND CONTINGENCIES
    12 Months Ended
    Dec. 31, 2022
    Commitments and Contingencies Disclosure [Abstract]  
    COMMITMENTS AND CONTINGENCIES

    NOTE 17 — COMMITMENTS AND CONTINGENCIES

     

    Pension:

     

    The Company may make a matching contribution to its employees’ 401(k) plan. Vislink also has a Group Personal Plan in our U.K. Subsidiary, investing funds with Royal London. U.K. employees are entitled to join the Plan to which the Company contributes varying amounts subject to status. Additionally, the Company operates a stakeholder pension scheme in the U.K.

     

    The table below represents the Company’s matching contributions as follows:

     

       For the year ended 
       December 31, 
       2022   2021 
    Company matching contributions - Group Personal Pension Plan, U.K.  $166,000   $169,000 

     

    Nasdaq Compliance:

     

    As previously reported, on May 20, 2022, Vislink Technologies, Inc. (the “Company”) received notice from the Nasdaq Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company of its noncompliance with Nasdaq Listing Rule 5550(a)(2) (the “Rule”) by failing to maintain a minimum bid price for its common stock on the Nasdaq Capital Market of at least $1.00 per share for 30 consecutive business days. The Company received a grace period of 180 days, or until November 16, 2022, to regain compliance with the minimum bid price requirement.

     

    On November 10, 2022, the Company submitted a request to Nasdaq for an additional 180-day grace period, or until May 15, 2023, to regain compliance with the minimum bid price requirement. On November 17, 2022, the Company received a letter from Nasdaq advising that the Company had been granted an additional 180-day grace period extension until May 15, 2023, to regain compliance with the minimum bid price requirement and all other applicable requirements for initial listing on the Nasdaq Capital Market except for the minimum bid price requirement.

     

    On January 11, 2023, the Company held a special meeting of stockholders (the “Special Meeting”) whereby stockholders voted and approved a proposal to authorize the Board of Directors of the Company (the “Board”), in its discretion but before the one-year anniversary of the date of the Special Meeting, to implement an amendment to the Company’s certificate of incorporation to effect a reverse stock split (the “Reverse Stock Split”) of all of the outstanding shares of Common Stock, par value $0.00001 per share (“Common Stock”), of the Company, at a ratio in the range of 1-for-2 to 1-for-50. The Company intends to monitor the closing bid price of its common stock and may, if appropriate, consider available options to regain compliance with the Rule, including initiating the Reverse Stock Split.

     

    There can be no assurance that the Reverse Split will result in a sustained increase in the per share market price for the Common Stock for the minimum period necessary to permit the Company to be timely regain compliance with the Rule. There can be no assurance that the Company will be able to regain compliance with the Rule or otherwise be in compliance with other Nasdaq Listing Rules during this additional 180-day extension period. If the Company does not regain compliance within the allotted compliance period, Nasdaq will provide notice that the common stock will be subject to delisting. The Company would then be entitled to appeal that determination to a Nasdaq hearings panel.

     

    The Nasdaq notice has no immediate impact on the listing of the Company’s common stock, which will continue to be listed and traded on The Nasdaq Capital Market under the symbol “VISL,” subject to the Company’s compliance with the other continued listing requirements of The Nasdaq Capital Market

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    XML 46 R24.htm IDEA: XBRL DOCUMENT v3.23.1
    CONCENTRATIONS
    12 Months Ended
    Dec. 31, 2022
    Risks and Uncertainties [Abstract]  
    CONCENTRATIONS

    NOTE 18 — CONCENTRATIONS

     

    Customer concentration risk

     

    During the year ended December 31, 2022, the Company recorded sales to a single customer of $3,436,000 (12%), in excess of 10% of the Company’s total sales. For the year ended December 31, 2021, the Company recorded sales to a single customer of $8,511,000 (25%) in excess of 10% of the Company’s total sales.

     

    On December 31, 2022, and 2021, the Company recorded accounts receivable of approximately $1,138,000 (19%) and $4,204,000 (46%), respectively, to a single customer in excess of 10% of the Company’s total consolidated accounts receivable.

     

    Vendor concentration risk

     

    During the years ended December 31, 2022, and 2021, there were no individual vendor inventory purchases in excess of 10% of the Company’s consolidated inventory purchases, respectively.

     

    On December 31, 2022, and 2021, the Company recorded one vendor balance of approximately $0.27 million (10%) and $-0-, respectively, in excess of 10% of the Company’s total consolidated accounts payable.

     

    XML 47 R25.htm IDEA: XBRL DOCUMENT v3.23.1
    REVENUE
    12 Months Ended
    Dec. 31, 2022
    Revenue from Contract with Customer [Abstract]  
    REVENUE

    NOTE 19 – REVENUE

     

    The Company has one operating segment, and the decision-making group is the senior executive management team. The Company disaggregated revenue by primary geographical markets and revenue sources in the following tables:

     

       For the years ended 
       December 31, 
       2022   2021 
    Primary geographical markets:          
    North America  $12,037,000   $18,050,000 
    South America   182,000    361,000 
    Europe   9,229,000    11,389,000 
    Asia   1,851,000    1,975,000 
    Rest of World   5,103,000    2,107,000 
       $28,402,000   $33,882,000 
    Primary revenue source:          
    Equipment sales  $25,667,000   $31,733,000 
    Installation, integration, and repairs   1,450,000    1,082,000 
    Warranties   1,014,000    743,000 
    Other (See Note 20)   271,000    324,000 
       $28,402,000   $33,882,000 
    Long-Lived Assets:          
    United States  $1,970,000   $2,410,000 
    Netherlands   27,000     
    United Kingdom   4,912,000    14,257,000 
       $6,909,000   $16,667,000 

     

    XML 48 R26.htm IDEA: XBRL DOCUMENT v3.23.1
    REBATES
    12 Months Ended
    Dec. 31, 2022
    Rebates  
    REBATES

    NOTE 20 — REBATES

     

    The amounts generated in Note 18 as part of the Primary revenue source “other” resulted from rebates issued to the Company’s filing appropriate governmental forms related to the research costs incurred by our U.K. subsidiary in prior fiscal years. The Company expects to continue filing applicable rebate forms for the 2022 fiscal year but can provide no assurances that such rebates will be available in future financial periods at similar levels or at all.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    XML 49 R27.htm IDEA: XBRL DOCUMENT v3.23.1
    GAINS ON SETTLEMENT OF DEBT
    12 Months Ended
    Dec. 31, 2022
    Gains On Settlement Of Debt  
    GAINS ON SETTLEMENT OF DEBT

    NOTE 21 — GAINS ON SETTLEMENT OF DEBT

     

    The following table represents the Company’s gains on settlement of debt for the years ending December 31, 2022 and 2021:

     

        2022    2021 
       For the Years Ended 
       December 31, 
        2022    2021 
               
    On March 10, 2021, the Company negotiated a vendor accounts payable balance of $494,000 with a remittance settlement of $300,000  $   $194,000 
               
    On July 26, 2021, the Payroll Protection Program (“PPP”) loan of $1,168,000 received on April 10, 2020, was forgiven. Under ASC 405-20, the Company recorded the transaction as a gain on settlement of debt   -    1,168,000 
               
    On May 4, 2022, and July 19, 2022, the Company issued 38,703 shares of common stock on each date with an accumulated value of $54,184 in satisfaction of an amount payable of $80,000   25,816     
               
    On November 21, 2022, the Company settled the dividends payable in the amount of $19,916 by issuing 47,419 Series A Preferred shares with a zero carrying value   19,916     
               
    GAINS ON SETTLEMENT OF DEBT  $45,732   $1,362,000 

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    XML 50 R28.htm IDEA: XBRL DOCUMENT v3.23.1
    INCOME TAXES
    12 Months Ended
    Dec. 31, 2022
    Income taxes  
    INCOME TAXES

    NOTE 22— INCOME TAXES

     

    The provision (benefit) for income taxes consists of the following:

     

       2022   2021 
       For the Years Ended 
       December 31, 
       2022   2021 
    Current tax provision          
    Federal  $   $ 
    State   25,000    7,000 
    Current income tax expense, total   25,000    7,000 
    Deferred tax provision (benefit)          
    Federal   (532,000)   (503,000)
    State   (427,000)   1,025,000 
    Foreign   (978,000)   (2,052,000)
    Change in the valuation allowance   1,722,000    1,530,000 
    Total deferred tax provision (benefit)   (215,000)    
               
    Income tax provision  $(190,000)  $7,000 

     

    A reconciliation of the statutory tax rate to the effective tax rate is as follows:

     

       2022   2021 
       For the Years Ended 
       December 31, 
       2022   2021 
    Statutory federal income tax rate   21.00%   21.00%
    State and local taxes, net of federal benefit   0.30    (6.27)
    Permanent differences   5.28    (9.12)
    Executive compensation   (2.26)    
    Equity compensation   (11.06)    
    Provision to return   0.00    (0.03)
    DTA adjustment for state NOL   0.00    (0.06)
    Foreign Rate Differential   (1.27)   (1.96)
    Change rate   2.66    (5.06)
    Valuation allowance   (13.27)   1.46 
    Effective tax rate   1.37%   (0.04)%

     

    Under the provisions of ASC 740, the Company may recognize the benefits of uncertain tax positions when it is more likely than not that the merits of the position(s) will be sustained upon audit by the relevant tax authorities. No uncertain tax positions were taken or expected on a tax return that would be determined to be an unrecognized tax benefit recorded on the Company’s financial statements for the years ended December 31, 2022, or 2021. The Company does not expect its unrecognized tax benefit position to change during the next twelve months

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 22 — INCOME TAXES (continued)

     

    Deferred income taxes reflect the tax effects of temporary differences between the carrying amounts of assets and liabilities for financial accounting purposes and the amounts used for income tax reporting. Significant components of the Company’s deferred tax assets are as follows:

     

       2022   2021 
       For the Years Ended 
       December 31, 
       2022   2021 
    Deferred Tax Assets          
    Federal R&D credit  $3,007,000   $3,007,000 
    Inventory   576,000    457,000 
    Allowance for bad debt   72,000    76,000 
    Compensation related   7,000    298,000 
    Pension   72,000    39,000 
    Other accruals   7,000    16,000 
    State net operating losses   4,779,000    4,644,000 
    Federal net operating losses   44,821,000    43,045,000 
    Interest disallowance   1,151,000    82,000 
    Stock options   7,172,000    7,621,000 
    Other   296,000    1,097,000 
    Valuation Allowance   (61,731,000)   (60,048,000)
    Total Deferred Tax Assets   229,000    334,000 
    Deferred Tax Liabilities          
    Property and Equipment   (90,000)   (47,000)
    Intangibles   (870,000)   (1,230,000)
    Prepaid Expenses   (33,000)   (35,000)
    Total Deferred Tax Liabilities   (993,000)   (1,312,000)
    Net Deferred Tax Liability  $(764,000)  $(978,000)

     

    As of December 31, 2022, the Company has federal net operating losses (“NOL”) of approximately $183.0 million that will expire beginning in 2027. The Company has federal NOLs of approximately $26.3 million that may be carried forward indefinitely. The Company also has state NOL carryforwards of $158.6 million, which will expire beginning in 2027. Besides, the Company has foreign NOL carryforwards of approximately $26.1 million that generally do not expire except under certain circumstances. The Company also has research and development credits of approximately $3.0 million, which will begin to expire in 2027. The years that remain open for review by taxing authorities are 2019 to 2022 for Federal, Foreign, and State Income Tax returns.

     

    Realizing the NOL carryforwards and other temporary deferred tax differences is contingent on future taxable earnings. The Company’s deferred tax assets were reviewed for expected utilization using a “more likely than not” approach by assessing the available positive and negative evidence surrounding its recoverability. Accordingly, a valuation allowance has been recorded against the Company’s deferred tax assets, as it was determined, based on past and present losses, that it was “more likely than not” that the Company’s deferred tax assets would not be realized. The valuation allowance was increased to the full carrying amount of the Company’s deferred tax assets. In future years, if the deferred tax assets are determined by management to be “more likely than not” to be realized, the recognized tax benefits relating to the reversal of the valuation allowance will be recorded. The Company will continue to assess and evaluate strategies that enable the deferred tax asset, or portion thereof, to be utilized. It will reduce the valuation allowance appropriately when it is determined that the “more likely than not” criteria are satisfied.

     

    The net operating loss carryovers may be subject to annual limitations under Internal Revenue Code Section 382 and similar state provisions should there be a greater than 50% ownership change as determined under the applicable income tax regulations. The limitation amount would be determined based on the company’s value immediately before the ownership change, and subsequent ownership changes could further impact the annual limitation amount. An ownership change under Section 382 may have occurred in the past or could happen in the future, such that the NOLs available for utilization could be significantly limited. The Company plans to perform a Section 382 analysis in the future.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 22 — INCOME TAXES (continued)

     

    Effective for tax years beginning after December 31, 2017, the Tax Act includes a participation exemption system of taxation, which generally provides for 100% dividends received deduction on certain qualifying dividend distributions received by U.S. C-corporation shareholders from their 10% or more owned foreign subsidiaries. As a result of this new participation exemption system, it is generally anticipated that the Company should not be subject to additional U.S. federal income taxation on its future receipt of actual dividend income (instead of deemed inclusion amounts under specific anti-deferral rules) from its foreign subsidiary.

     

    For tax years beginning after December 31, 2017, the Tax Act introduced a new limitation on the deduction of interest expense whereby current-year interest deductions are limited (among other restrictions) to 30% of adjusted taxable income, with various modifications and exceptions. The Company does incur interest expenses and evaluates each year the impact, if any, of the new limitation.

     

    The Company has not provided for deferred taxes and foreign withholding taxes on the excess of the financial reporting basis over the tax basis in our investments in foreign subsidiaries that are nearly permanent in duration. In general, it is the Company’s practice and intention to reinvest our foreign subsidiary’s earnings in those operations. Generally, our foreign subsidiary’s earnings have become subject to U.S. taxation based on specific U.S. tax law provisions, such as the recently enacted territorial transition tax under section 965 and under certain other circumstances. Due to the complexities of the provisions introduced with the Tax Act, and the underlying assumptions that would have to be made, it is not practicable to estimate the amount of tax provision required to account for these foreign undistributed earnings. The Company will account for any additional expense or deduction in the year it is claimed. The Company will continue to review each year whether this treatment is appropriate.

     

    The Company did not identify any material uncertain tax positions and is not under any income tax examinations.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    XML 51 R29.htm IDEA: XBRL DOCUMENT v3.23.1
    SUBSEQUENT EVENTS
    12 Months Ended
    Dec. 31, 2022
    Subsequent Events [Abstract]  
    SUBSEQUENT EVENTS

    NOTE 23 — SUBSEQUENT EVENTS

     

    Under ASC 855-10, the Company has analyzed its operations subsequent to December 31, 2022, and has determined that it does not have any other material subsequent events to disclose in these financial statements except for the following:

      

    On March 27, 2023, the Company announced that it is entering into an agreed separation with Michael Bond, the Chief Financial Officer (“CFO”), to be effective on or about March 31, 2023. Effective at the close of business on March 31, 2023, Paul Norridge will become the Company’s new CFO.

    XML 52 R30.htm IDEA: XBRL DOCUMENT v3.23.1
    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
    12 Months Ended
    Dec. 31, 2022
    Accounting Policies [Abstract]  
    Business Combinations

    Business Combinations

     

    The Company accounts for acquisitions that qualify as business combinations by applying the acquisition method according to Accounting Standards Codification (“ASC”) 805, Business Combinations (“ASC 805”). Transaction costs related to the acquisition of a business are expensed as incurred and excluded from the fair value of consideration transferred. The identifiable assets acquired, liabilities assumed, and noncontrolling interests in an acquired entity are recognized and measured at their estimated fair values. The excess of the fair value of consideration transferred over the fair values of identifiable assets acquired, liabilities assumed, and noncontrolling interests in an acquired entity, net of the fair value of any previously held interest in the acquired entity, is recorded as goodwill. Such valuations require management to make significant estimates and assumptions.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

     

    Principles of Consolidation

    Principles of Consolidation

     

    The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America or (“U.S. GAAP”) as found in the Accounting Standards Codification (“ASC”), the Accounting Standards Update (“ASU”) of the Financial Accounting Standards Board (“FASB”) and the rules and regulations of the US Securities and Exchange Commission (the “SEC”). The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. We have eliminated all intercompany accounts and transactions upon consolidating our subsidiaries.

     

    Segment Reporting

    Segment Reporting

     

    The Company identifies operating segments as components of an enterprise about which separate discrete financial information is available for evaluation by the operating decision-makers, or decision-making group, in deciding how to allocate resources and assess performance. The Company’s decision-making group is the senior executive management team. The Company and the decision-making group view the Company’s operations and manage its business as one operating segment with different product offerings. All long-lived assets of the Company reside in the U.S., the U.K., and the Netherlands.

     

    Use of Estimates

    Use of Estimates

     

    The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities in the consolidated financial statements. Significant accounting estimates reflected in the Company’s consolidated financial statements include the useful lives of property, plant, and equipment, the useful lives of right-of-use assets, the useful lives of intangible assets, impairment of long-lived assets, allowance for accounts receivable doubtful accounts, allowance for inventory obsolescence reserve, allowance for deferred tax assets, valuation of warranty reserves, contingent consideration liabilities, and the accrual of potential liabilities. These estimates also affect the reported revenues and expenses during the reporting periods. Actual results could differ from estimates, and any such differences may be material to our financial statements.

     

    Risks and Uncertainties

    Risks and Uncertainties

     

    The future impacts of the Russia-Ukraine war, the novel coronavirus (“COVID-19”) pandemic, and their residual effects include economic uncertainty, an inflationary environment, currency fluctuations, disruption within the global supply chain, and labor markets worldwide industries remain uncertain. These circumstances have created prevalent uncertainty and risk. The impact of these issues on our business will vary by geographic market and discipline. In response to potential reductions in revenue, we may take actions to align our cost structure with changes in customer demand and manage our working capital. However, there can be no assurance as to the effectiveness of our efforts to mitigate any impact of the current and future adverse economic conditions, reductions in client revenue, changes in client creditworthiness, and other developments. We monitor the circumstances mentioned above to assess direct material adverse effects on our business, financial condition, or results of operations. Therefore, these impacts may change accounting estimates and assumptions over time. Interim period results are not necessarily indicative of the expected results for the full fiscal year.

     

    Cash and Cash Equivalents

    Cash and Cash Equivalents

     

    The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. The Company did not have cash equivalents as of December 31, 2022, and 2021.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)

     

    Concentrations

    Concentrations

     

    The Company does not have any off-balance-sheet concentrations of credit risk. Credit risk is that the counterparty will default on its contractual obligations, resulting in a company’s financial loss. The Company’s credit risk is primarily attributable to its cash and accounts receivables. The Company’s policy is to maintain its cash with high-credit quality financial institutions to limit its risk of loss exposure. Financial instruments potentially subject the Company to credit risk concentration consisting of cash deposits. The Federal Deposit Insurance Corporation (“FDIC”) insures accounts held within the United States up to $250,000. The Company maintains cash balance accounts at financial institutions in the United Kingdom insured by the Financial Services Compensation Scheme up to £85,000, subject to currency translation rates to the United States dollar. Lastly, the Company maintains cash balance accounts at financial institutions in the Netherlands insured by the “Dutch deposit guarantee scheme” up to €100,000 per person, per bank.

     

    On December 31, 2022, and 2021, the Company had approximately $24.5 million and $35.2 million above insured limits, respectively. The Company has not experienced any losses in its bank accounts between December 31, 2022, and 2021.

     

    Management assesses their credit quality for customers, considering their financial position and historical experience. During the year ended December 31, 2022, the Company recorded sales to a single customer of $3,436,000 (12%), in excess of 10% of the Company’s total sales. For the year ended December 31, 2021, the Company recorded sales to a single customer of $8,511,000 (25%) in excess of 10% of the Company’s total sales.

     

    On December 31, 2022, and 2021, the Company recorded accounts receivable of approximately $1,138,000 (19%) and $4,204,000 (46%), respectively, to a single customer in excess of 10% of the Company’s total consolidated accounts receivable.

     

    Accounts Receivable and Allowance for Doubtful Accounts

    Accounts Receivable and Allowance for Doubtful Accounts

     

    The Company extends credit to its customers in the ordinary course of business. Further, the Company regularly reviews outstanding receivables and provides for estimated losses through an allowance for doubtful accounts. In evaluating the level of established loss reserves, the Company makes judgments regarding its customer’s ability to make required payments, prevailing economic conditions, previous experience, and other factors. As these factors’ financial situation changes, circumstances develop, or additional information becomes available, adjustments to the allowance for doubtful accounts may be required. The Company maintains reserves for credit losses, and losses have been within its expectations.

     

    Inventories

    Inventories

     

    Inventories consist of raw materials, work-in-process, and finished goods and are recorded at the lower of cost, on a first-in, first-out basis, or net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable completion, disposal, and transportation costs. The Company evaluates inventory balances and either writes down obsolete inventory or records a reserve for slow-moving or excess inventory based on net realizable value analysis.

     

    Property and Equipment

    Property and Equipment

     

    Property and equipment are presented at cost at the date of acquisition, less depreciation. Depreciation is computed using the straight-line method over estimated useful asset lives, ranging from 1 to 14 years. The costs of the day-to-day servicing of property and equipment and repairs and maintenance are recognized in expenses as incurred.

     

    Goodwill

    Goodwill

     

    Goodwill represents the excess cost of an acquired business over the fair value of the identifiable tangible, and intangible assets acquired and liabilities assumed in a business combination under the acquisition method of accounting under ASC 805 “Business Combinations” (see Note 4). Goodwill is not amortized but, per ASC 350, is tested for impairment annually. Goodwill is also tested for impairment between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. Judgment determines if an indicator of impairment has occurred during a year. When testing goodwill for impairment, we may assess qualitative factors for some or all of our reporting units to determine whether it is more likely than not (that is, a likelihood of more than 50 percent) that the fair value of a reporting unit is less than its carrying amount, including goodwill. Alternatively, we may bypass this qualitative assessment for some or all of our reporting units and perform step 1 of the two-step goodwill impairment test. If we perform step 1 and the reporting unit’s carrying amount exceeds its fair value, we will perform step 2 to measure such impairment. We have completed our annual impairment test and recorded $-0- and $9,189,000 in goodwill impairment charges for the years ended December 31, 2022, and 2021, respectively.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

     

    Intangible Assets

    Intangible Assets

     

    Patents and licenses:

     

    Patents and licenses, measured initially at purchase cost, are included in intangible assets on the Company’s balance sheet and are amortized on a straight-line basis over their estimated useful lives of 18.5 to 20 years. Amortization totaled approximately $535,000 and $668,000 for the years ended December 31, 2022, and 2021, respectively.

     

    Other intangible assets:

     

    The Company’s remaining intangible assets include the trade names, technology, and customer lists acquired in its acquisition of IMT, Vislink, and Mobile Viewpoint Corporate B.V. (“MVP”). A third-party appraiser determined the value of these acquired assets for these business combinations. Absent an indication of fair value from a potential buyer or similar specific transactions, we have determined that using the methods employed provided a reasonable estimate in reporting the values assigned.

     

    The Company amortizes intangible asset costs over their useful lives of 3 to 15 years with its net book value reported on the balance sheet. Amortization totaled approximately $985,000 and $480,000 for the years ended December 31, 2022, and 2021, respectively.

     

    Warranty Reserve

    Warranty Reserve

     

    Although the Company tests its product under its quality programs and processes, its warranty obligation is affected by product failure rates and service delivery costs incurred in correcting a product failure. Required revisions to the estimated warranty liability will occur should actual product failure rates or service costs differ from the Company’s estimates, where applicable, based on limited historical data.

     

    The claims made during the year ended December 31, 2022, and 2021 were ordinary and customary. The warranty reserve is included in accrued expenses on the accompanying consolidated balance sheets and the cost of components in the accompanying consolidated statement of operations.

     

       Warranty Reserve 
    December 31, 2020  $283,000 
    Warranty reserve expense    
    Warranty claims settled, and true-up of accrual   (152,000)
    December 31, 2021  $131,000 
    Warranty reserve expense   98,000 
    Warranty claims settled, and true-up of accrual   (117,000)
    December 31, 2022  $112,000 

     

    Shipping and Handling Costs

    Shipping and Handling Costs

     

    The Company invoices its shipping and handling charges to the customer, and we net these charges against the respective costs within general and administrative expenses. For the years ended December 31, 2022, and 2021, the shipping and handling costs incurred were $796,000 and $581,000, respectively.

     

    Common Stock Purchase Warrants and Other Derivative Financial Instruments

    Common Stock Purchase Warrants and Other Derivative Financial Instruments

     

    The Company assesses the classification of its freestanding derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required. The Company classifies common stock purchase warrants and other freestanding financial instruments as equity if the contracts (i) require physical settlement or net-share settlement in common stock or (ii) give the Company a choice of net-cash settlement or settlement in common stock (physical settlement or net-share settlement). The Company classifies the following contracts as either an asset or a liability: contracts that (i) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), (ii) give the counterparty a choice of net-cash settlement or settlement in common stock (physical settlement or net-share settlement) or (iii) contain reset provisions.

     

     

    VISLINK TECHNOLOGIES, INC AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

     

    Treasury Stock

    Treasury Stock

     

    Treasury stock is recorded at cost upon the repurchasing of common shares. The cost method is used upon the re-issuance of shares. Under U.S. GAAP, the excess of the acquisition cost over the re-issuance price of the treasury stock, if any, is recorded to additional paid-in capital, limited to the amount previously credited to additional paid-in capital if any. The Company charges the accumulated deficit for any excess.

     

    Revenue Recognition

    Revenue Recognition

     

    We account for the Company’s operating results under ASC Topic 606, adopted on January 1, 2019. It is a comprehensive revenue recognition model that requires recognition when the Company transfers control of the promised goods or services to our customers at an amount that reflects the consideration we expect to receive. The application of ASC Topic 606 requires us to use more judgment and make more estimates than under previously issued guidance.

     

    The Company generates all its revenue from contracts with customers. The Company recognizes revenue when we satisfy a performance obligation by transferring control of the promised goods or services to a customer in an amount that reflects the consideration we expect to receive in exchange for those services.

     

    Revenue Recognition (continued)

     

    The Company determines revenue recognition through the following steps:

     

    1. Identification of the contract, or contracts, with a customer.

    2. Identification of the performance obligations in the contract.

    3. Determination of the transaction price.

    4. Allocation of the transaction price to the performance obligations in the contract; and

    5. Recognition of revenue when, or as, we satisfy a performance obligation.

     

    At contract inception, the Company assesses the goods and services promised in our customer contracts and identifies a performance obligation for each. To determine the performance obligations, the Company considers all the products and services promised in the contract regardless of whether they are explicitly stated or implied by customary business practices. The timing of satisfaction of the performance obligation is not subject to significant judgment. We measure revenue as the consideration we expect to receive in exchange for transferring goods and services. The value-added sales taxes and other charges we collect concurrent with revenue-producing activities are excluded from income.

     

    Remaining Performance Obligations:

     

    The remaining performance obligations, or backlog, represent the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less.

     

    Research and Development Expenses

    Research and Development Expenses

     

    As the Company performs research, design, and development activities, we charge these costs to research and development expenses in the Consolidated Statements of Operations and Comprehensive Loss. These expenses consist primarily of salary and benefit expenses, including stock-based compensation and payroll taxes for employees’ and contractors’ costs engaged in research, design, development activities, prototypes, facilities, and travel costs.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

     

    Leases

    Leases

     

    We determine if an arrangement is a lease at inception. We recognize lease expense for lease payments on a straight-line basis over the lease term. The Company includes operating leases as ROU assets as “Right of use assets, operating leases” in the consolidated balance sheets. For lease liabilities, operating lease liabilities are included in “Operating lease obligations, current” and “Operating lease liabilities, net of current portion” in the consolidated balance sheets. We recognize Operating lease ROU assets and liabilities on the commencement date based on the present value of lease payments for all leases with a term longer than 12 months. No lease and non-lease components are separated for all our real estate contracts.

     

    There were no capital leases, now titled “finance leases” under ASC 842, in the Company’s lease portfolio as of December 31, 2022. The ROU assets and related lease liabilities recorded under ASC 842 are calculated based on the present value of the lease payments using (1) the rate implicit in the lease or (2) the lessee’s incremental borrowing rate (“IBR”), defined as the rate of interest that a lessee would have to pay to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a comparable economic environment. As most of our leases do not provide an implicit rate, we determined our incremental borrowing rates based on an analysis of prior collateralized borrowings over similar terms of the lease payments at the commencement date to estimate the IBR under ASC 842.

     

    Stock-Based Compensation

    Stock-Based Compensation

     

    The Company accounts for stock compensation with persons classified as employees for accounting purposes under ASC 718 “Compensation-Stock Compensation,” which recognizes awards at fair value on the date of grant and recognition of compensation over the service period for awards expected to vest. The fair value of stock options is determined using the Black-Scholes Option Pricing Model, and the fair value of common stock issued for services is determined based on the Company’s stock price on the issuance date.

     

    The expansion of Topic 718 fell under ASU 2018-07 to include share-based payment transactions for acquiring goods and services from nonemployees. The measurement date for equity-classified nonemployee share-based payment awards is no longer at the earlier date at which a commitment for performance by the counterparty is reached or the date at which the counterparty’s performance is complete. Instead, the grant date is now considered the measurement date. Under today’s guidance, the measurement of nonemployee share-based payment awards with performance conditions is at the lowest aggregate fair value, often resulting in a zero value. The new ASU aligns the accounting for nonemployee share-based payment awards with performance conditions with accounting for employee share-based payment awards under Topic 718 by requiring entities to consider the probability of satisfying performance conditions. Current guidance requires entities to use the contractual term to measure the nonemployee share-based payment awards. The new ASU allows entities to make an award-by-award election to use the expected duration (consistent with employee share-based payment awards) or the contractual term for nonemployee awards.

     

    Stock-Option Awards — Time-based and performance-based:

     

    Under ASC Topic 718, the compensation cost is measured based on an award’s fair value at the grant’s date for the time vested option award using the Black Scholes-Merton formula as a valuation technique. The Company used the U.S. Treasury note’s rate over the expected option term for the risk-free rate. Employees’ expected term represents the period that options granted are expected to be outstanding using the simplified method. The Company’s historical share option exercise experience does not provide a reasonable basis for estimating the expected term. For nonemployee options, the expected term is the entire term of the option. Expected volatility is based on the average weekly share price changes over the shorter expected term or the period from the Nasdaq Capital Markets Exchange placement to the grant’s date. The Company estimates forfeiture and volatility using historical information. The risk-free interest rate is based on the implied yield on U.S. Treasury zero-coupon issues over the options’ equivalent lives.

     

    The Company has not paid dividends on its common stock, and no assumption of dividend payment(s) is made in the model. For employee equity-classified awards, compensation cost is recognized over the employee’s requisite service period with a corresponding credit to additional paid-in capital. The employee’s requisite service period begins at the service inception date and ends when the requisite service has been provided.

     

    Restricted Stock Unit Awards (“RSUs”) — Time-Based:

     

    Under ASC 718, the exercise price for RSUs is determined using the fair market value of the Company’s common stock on the grant date. For an award with graded vesting subject only to a service condition (e.g., time-based vesting), ASC 718-10-35-8 provides an accounting policy choice between graded vesting attribution or straight-line attribution. The Company elects the graded vesting method, recognizing compensation expense for only the portion of awards expected to vest. Forfeitures of time-based units and awards are recognized as they occur. Stock-based compensation costs are calculated using the closing stock price on the grant date to estimate the fair value of time-based restricted stock units.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

     

    Stock-Based Compensation (continued

     

    Restricted Stock Unit Awards (“RSUs”) — Performance-Based:

     

    The accruals of compensation cost for an award with a performance condition are related to that performance condition’s probable outcome. Under ASC 718, a “performance condition” is the achievement of a specified target that is defined by referring to the employer’s operations or activities, such as an option that vests if the employer’s growth rate increases by a certain amount or there are the attainments of regulatory approval for a product. There is an accrual of compensation cost upon the likely achievement of the performance condition, and there is no accrual if the accomplishment of the performance condition is not probable. The exercise price for RSUs is determined using the fair market value of the Company’s common stock on the grant date. Stock-based compensation costs are calculated using the closing stock price on the grant date to estimate performance-based restricted stock units’ fair value.

     

    Impairment and Abandonment

    Impairment and Abandonment

     

    Right-of-use operating lease abandonment:

     

    Management decided to vacate the Billerica, MA facility as part of the Company’s cost savings strategy implemented in the third quarter of the fiscal year 2022. The economic environment of the location precluded the action of sub-letting, and management determined the (leased facility) to be abandoned as of September 30, 2022. Under ASC 360, leased space abandonment is an impairment indicator, and the Company assessed the lease right-of-use (“ROU”) assets for impairment. The Company considered approximately $131,000 of right-of-use operating assets impaired, less $43,000 of accumulated amortization, and for the years ending December 31, 2022, and 2021, the Company recognized a loss on impairment of ROU assets of approximately $88,000 and $-0-, respectively.

     

    Income Taxes

    Income Taxes

     

    Under ASC 740, as part of our consolidated financial statements, we must estimate our income tax provision (benefit) in each jurisdiction in which we operate. The Company uses the asset and liability method of accounting for income taxes. The recognition of deferred income tax assets and liabilities for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases fall under this method. Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years these temporary differences are expected to be recovered or settled. The recognition of the effect on deferred tax assets and liabilities of a change in tax rates in income is in the period that includes the enactment date. A valuation allowance is provided for those deferred tax assets for which management cannot conclude that it is more likely than not that such deferred tax assets will be realized. The Company will file income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. The Company recognizes the impact of an uncertain tax position in its financial statements if, in management’s judgment, it is more likely than not sustainable upon audit based upon the position’s technical merits. It involves identifying potential uncertain tax positions, evaluating applicable tax laws, and assessing whether the liability for uncertain tax positions is necessary. The Company’s policy is to classify assessments, if any, for tax-related interest expense and penalties as general and administrative expenses.

     

    Advertising Costs

    Advertising Costs

     

    Advertising costs are charged to operations as incurred. Advertising costs amounted to approximately $1,038,000 and $139,000 for the years ended December 31, 2022, and 2021, respectively. The Company includes advertising costs in general and administrative expenses in the accompanying consolidated statement of operations.

     

    Sales Tax and Value-Added Taxes

    Sales Tax and Value-Added Taxes

     

    The Company accounts for sales taxes and value-added taxes imposed on its goods and services on a net basis.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

     

    Loss Per Share

    Loss Per Share

     

    The Company reports loss per share under ASC Topic 260, “Earnings Per Share,” which establishes standards for computing and presenting earnings per share. The basic loss per share calculation divides the net loss allocable to common stockholders by the weighted-average shares of common stock outstanding during the period without considering common stock equivalents. The diluted loss per share calculation is calculated by adjusting the weighted-average shares of common stock outstanding for the dilutive effect of common stock equivalents, including stock options and warrants, outstanding for the period as determined using the treasury stock method. Common stock equivalents are excluded from the diluted net loss per share calculation because their effect would be anti-dilutive. Therefore, basic and diluted net loss per share applicable to common stockholders is the same for periods with a net loss.

     

    The following table illustrates the anti-dilutive potential common stock equivalents excluded from the calculation of loss per share (in thousands):

     

       2022   2021 
       For the Years Ended 
       December 31, 
       2022   2021 
    Anti-dilutive potential common stock equivalents excluded from the calculation of loss per share:          
    Stock options   828    1,553 
    Warrants   9,175    9,210 
    Total   10,003    10,763 

     

    Foreign Currency and Other Comprehensive (Gains) Losses

    Foreign Currency and Other Comprehensive (Gains) Losses

     

    We record gains or losses resulting from foreign currency transactions in foreign currency income or loss except for the effect of exchange rates on long-term inter-company transactions that are considered long-term investments that are accumulated and credited or charged to other comprehensive income. We have two foreign subsidiaries, one in the United Kingdom and the other in the Netherlands, and their functional currencies are British Pounds and Euros, respectively. The translation from the respective foreign currency to United States Dollars (“US Dollars”) is performed for balance sheet accounts using current exchange rates at the balance sheet date and for income statement accounts using an average exchange rate for the years ending December 31, 2022, and 2021, respectively. We included gains or losses from such translation as a separate component of accumulated other comprehensive (loss) income.

     

    Transaction gains and losses are recognized in our operations’ results based on the difference between the foreign exchange rates on the transaction date and the reporting date. The foreign currency exchange gains and losses are a component of general and administrative expenses in the accompanying Condensed Consolidated Statements of Operations.

     

    The Company has recognized foreign exchange gains and losses and changes in accumulated comprehensive income approximately as follows:

     

       2022   2021 
       For the years ended 
       December 31, 
       2022   2021 
    Net foreign exchange transactions:          
    (Gains) Losses  $24,000   $100,000 
               
    Accumulated comprehensive income:          
    Unrealized (gains) losses on currency translation adjustment  $1,040,000   $445,000 

     

    The exchange rates adopted for the foreign exchange transactions are quoted on OANDA, a Canadian-based foreign exchange company, and an internet website providing currency conversion, online retail foreign exchange trading, foreign currency transfers, and forex information. The Company translated amounts from British Pounds into United States Dollars and Euros to British Pounds at the following exchange rates for the respective periods:

     

      As of December 31, 2022 – £ 1.208970 to $1.00; € 1.069850 to $1.00
         
      The average exchange rate for the year ended December 31, 2022 – £ 1.236579 to $1.00; € 1.052082 to $1.00
         
      As of December 31, 2021 – £1.351043 to $1.00; €0.839362 to £1.00
         
      The average exchange rate for the year ended December 31, 2021 – £1.375369 to $1.00; €0.850858 to £1.00

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

     

    Fair Value of Financial Instruments and Fair Value Measurements

    Fair Value of Financial Instruments and Fair Value Measurements

     

    The authoritative guidance for fair value measurements under topic ASC 820, “Fair Value Measurements and Disclosures,” establishes a three-tier fair value hierarchy, prioritizing the inputs used in measuring fair value. These tiers include:

     

    Level 1 is observable inputs such as quoted prices in active markets.
    Level 2 is defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and
    Level 3 is defined as unobservable inputs in which little or no market data exists, requiring an entity to develop its assumptions.

     

    Our financial instruments include cash equivalents, accounts receivable, prepaid expenses and other assets, accounts payable, accrued expenses, and short-term debt. Fair value estimates of these instruments are made at a specific point in time based on relevant market information. These estimates may be subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. The carrying amount of cash equivalents, accounts receivable, prepaid expenses and other assets, accounts payable, and accrued expenses are generally considered representative of their respective fair values because of the short-term nature of those instruments.

     

    In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. The new guidance modifies the disclosure requirements on fair value measurements in Topic 820. The amendments in ASU 2018-13 are effective for all entities for fiscal years and interim periods within those fiscal years beginning after December 15, 2019. Effective January 1, 2020, the Company adopted the provisions of ASU 2018-13. The adoption had no material impact on the Company’s consolidated financial statements or related financial statement disclosures.

     

    The following table presents the Company’s assets and liabilities measured at fair value on a non-recurring basis on December 31, 2022, consistent with the fair value hierarchy provisions. The asset impairment is a non-recurring level 3 measurement.

     

      

    Quoted Prices in

    Active Markets

    for Identical

    Assets/Liabilities

    (Level 1)

      

    Significant

    Observable

    Inputs

    (Level 2)

      

    Significant

    Unobservable

    Inputs

    (Level 3)

       Total 
                     
    Assets (non-recurring):                    
    Abandonment of right-of-use operating leases           88,000    88,000 
       $   $   $88,000   $88,000 
                         
    Liabilities:                    
    Other  $   $   $   $ 
       $   $   $   $ 

     

    The Company did not have reportable assets and liabilities under ASC Topic 820 disclosure requirements for the year ended December 31, 2021. See Note 13 for additional disclosure regarding the Company’s warrants liabilities accounted for at fair value.

     

    Redeemable Preferred Stock

    Redeemable Preferred Stock

     

    In November 2022, the Company’s board of directors approved the designation of a Series A Preferred Stock created for the sole purpose of the January 11, 2023, Special Meeting of stockholders voting on the consideration of a “Reverse Stock Split Proposal.” The Series A Preferred Stock had a par value of $0.00001 per share. The Preferred Stock was redeemable upon the holder participating at any meeting of stockholders held to vote on the Reverse Stock Split immediately before the opening of the polls at such meeting (the “Initial Redemption Time”) shall automatically be redeemed by the Corporation at the Initial Redemption Time without further action on the part of the Corporation or the holder thereof (the “Initial Redemption”). Any outstanding shares of Series A Preferred Stock that were not redeemed under an Initial Redemption were redeemed in whole, but not in part (i) if such redemption was ordered by the Board of Directors in its sole discretion, automatically and effective on such time and date specified by the Board of Directors in its sole discretion or (ii) automatically upon the approval by the Corporation’s stockholders of the Reverse Stock Split at the Special Meeting held for voting on the Reverse Stock Split proposal.

     

    Under the guidance of ASC Topic 480, all Series A Preferred Stock shares have been presented outside of permanent equity in the mezzanine equity section on the Consolidated Balance Sheets.

     

     

    VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES

    NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

     

    NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)

     

    Subsequent Events

    Subsequent Events

     

    Management has evaluated subsequent events or transactions occurring through the date the consolidated financial statements were issued and determined that no events or transactions are required to be disclosed herein except as disclosed.

     

    Recently Issued Accounting Pronouncements

    Recently Issued Accounting Pronouncements

     

    Recently Issued Accounting Standards Adopted and Not Yet Adopted

     

    Adopted on January 1, 2023

     

    In June 2016, the FASB established Topic 326, Financial Instruments—Credit Losses, Measurement of Credit Losses on Financial Instruments (ASU) No. 2016-13, which requires a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates, including accounts receivable.

     

    The standard replaces the existing incurred credit loss model with the Current Expected Credit Losses (“CECL”) model. It is required to measure credit losses based on the Company’s estimate of expected losses rather than incurred losses, which generally results in earlier recognition of allowances for credit losses. Under ASC 326, the Company evaluates specific criteria, including aging and historical write-offs, the current economic condition of particular customers, and future economic conditions of countries utilizing a consumption index to determine the appropriate allowance for credit losses. The Company completed its assessment of the new standard, and no adjustment will be made to its opening balance of retained earnings relating to its trade receivables. The Company writes off receivables once it is determined that the receivables are no longer collectible and as allowed by local laws.

     

    Recent Accounting Pronouncements

    Recent Accounting Pronouncements

     

    Other recent accounting standards issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the SEC did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.

    XML 53 R31.htm IDEA: XBRL DOCUMENT v3.23.1
    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
    12 Months Ended
    Dec. 31, 2022
    Accounting Policies [Abstract]  
    SCHEDULE OF PRODUCT WARRANTY LIABILITY

    The claims made during the year ended December 31, 2022, and 2021 were ordinary and customary. The warranty reserve is included in accrued expenses on the accompanying consolidated balance sheets and the cost of components in the accompanying consolidated statement of operations.

     

       Warranty Reserve 
    December 31, 2020  $283,000 
    Warranty reserve expense    
    Warranty claims settled, and true-up of accrual   (152,000)
    December 31, 2021  $131,000 
    Warranty reserve expense   98,000 
    Warranty claims settled, and true-up of accrual   (117,000)
    December 31, 2022  $112,000 
    SCHEDULE OF ANTI-DILIUTIVE POTENTIAL COMMON STOCK EQUIVALENTS EXCLUDE FROM THE CALCULATION OF LOSS PER SHARE

    The following table illustrates the anti-dilutive potential common stock equivalents excluded from the calculation of loss per share (in thousands):

     

       2022   2021 
       For the Years Ended 
       December 31, 
       2022   2021 
    Anti-dilutive potential common stock equivalents excluded from the calculation of loss per share:          
    Stock options   828    1,553 
    Warrants   9,175    9,210 
    Total   10,003    10,763 
    SCHEDULE OF FOREIGN EXCHANGE AND CHANGE IN ACCUMULATED COMPREHENSIVE INCOME

    The Company has recognized foreign exchange gains and losses and changes in accumulated comprehensive income approximately as follows:

     

       2022   2021 
       For the years ended 
       December 31, 
       2022   2021 
    Net foreign exchange transactions:          
    (Gains) Losses  $24,000   $100,000 
               
    Accumulated comprehensive income:          
    Unrealized (gains) losses on currency translation adjustment  $1,040,000   $445,000 
    SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON NON-RECURRING BASIS

    The following table presents the Company’s assets and liabilities measured at fair value on a non-recurring basis on December 31, 2022, consistent with the fair value hierarchy provisions. The asset impairment is a non-recurring level 3 measurement.

     

      

    Quoted Prices in

    Active Markets

    for Identical

    Assets/Liabilities

    (Level 1)

      

    Significant

    Observable

    Inputs

    (Level 2)

      

    Significant

    Unobservable

    Inputs

    (Level 3)

       Total 
                     
    Assets (non-recurring):                    
    Abandonment of right-of-use operating leases           88,000    88,000 
       $   $   $88,000   $88,000 
                         
    Liabilities:                    
    Other  $   $   $   $ 
       $   $   $   $ 
    XML 54 R32.htm IDEA: XBRL DOCUMENT v3.23.1
    ACQUISITION OF MOBILE VIEWPOINT CORPORATE B.V. (Tables)
    12 Months Ended
    Dec. 31, 2022
    Business Combination and Asset Acquisition [Abstract]  
    SCHEDULE OF IDENTIFIABLE ASSETS ACQUIRED AND LIABILITIES ASSUMED

     

       As Initially
    Reported
       Measurement
    Period
    Adjustments
       As Adjusted 
    Fair value of consideration transferred:               
    Cash  $18,311,000   $   $18,311,000 
                    
    Recognized amounts of identifiable assets acquired and liabilities assumed:               
    Cash  $965,000   $   $965,000 
    Accounts receivable, net   911,000        911,000 
    Inventories, net   2,534,000    1,231,000    3,765,000 
    Prepaid expenses and other assets   625,000    (112,000)   513,000 
    Property and equipment, net   149,000        149,000 
    Accounts payable   (507,000)       (507,000)
    Accrued expenses   (551,000)       (551,000)
    Customer deposits and deferred revenue   (293,000)       (293,000)
    Deferred tax liabilities       (978,000)   (978,000)
    Total identifiable net assets  $3,833,000   $141,000   $3,974,000 
                    
    Consideration paid  $18,311,000   $   $18,311,000 
    Total identifiable assets acquired   3,833,000    141,000    3,974,000 
    Excess of consideration paid over net assets acquired  $14,478,000   $(141,000)  $14,337,000 
                    
    Preliminary allocation of the consideration paid in excess of the net assets acquired:               
    Trade name  $730,000   $70,688   $800,688 
    Proprietary technology   1,850,000    282,749    2,132,749 
    Customer relationship   3,723,000    (1,508,003)   2,214,997 
    Goodwill   8,175,000    1,013,566    9,188,856 
    Total intangible assets acquired  $14,478,000   $(141,000)  $14,337,000 
    SCHEDULE OF ACQUIRED INTANGIBLE WITH THEIR RELATIVE USEFUL LIVES

    Based thereon, below are the acquired intangibles with their relative useful lives and method of amortization:

     

    Intangible Asset   Useful Life   Amortization Method
             
    Tradename   15 Years   Straight-line
    Proprietary Technology   5 Years   Straight-line
    Customer Relationships   10 Years   Straight-line
    Goodwill   Indefinite   N/A
    SCHEDULE OF UNAUDITED PRO-FORMA COMBINED RESULTS OF OPERATIONS

    The following presents the unaudited Pro-forma combined results of operations of Vislink with MVP as if the combination of the entities occurred on January 1, 2021.

     

      

    Year

    Ending

    December 31,

     
       2021 
    Revenues, net  $36,843 
          
    Net loss allocable to common stockholders  $(16,173)
          
    Net loss per share  $(0.37)
          
    Weighted average number of shares outstanding   43,484 
    XML 55 R33.htm IDEA: XBRL DOCUMENT v3.23.1
    ACCOUNTS RECEIVABLE (Tables)
    12 Months Ended
    Dec. 31, 2022
    Receivables [Abstract]  
    SCHEDULE OF ACCOUNTS RECEIVABLE

    Accounts receivable consist of the following:

     

       December 31, 2022   December 31, 2021 
    Accounts receivable  $6,680,000   $10,327,000 
    Allowance for doubtful accounts   (673,000)   (1,258,000)
    Net accounts receivable  $6,007,000   $9,069,000 
    XML 56 R34.htm IDEA: XBRL DOCUMENT v3.23.1
    INVENTORIES (Tables)
    12 Months Ended
    Dec. 31, 2022
    Inventory Disclosure [Abstract]  
    SCHEDULE OF INVENTORIES

    Inventories included in the accompanying consolidated balance sheet are stated at the lower of cost or market as summarized below:

     

       December 31, 2022   December 31, 2021 
    Raw materials  $12,038,000   $11,308,000 
    Work-in-process   1,474,000    2,105,000 
    Finished goods   4,460,000    5,011,000 
    Sub-total inventories   17,972,000    18,424,000 
    Less reserve for slow-moving and excess inventory   (5,951,000)   (6,530,000)
    Total inventories, net  $12,021,000   $11,894,000 
    XML 57 R35.htm IDEA: XBRL DOCUMENT v3.23.1
    PROPERTY AND EQUIPMENT (Tables)
    12 Months Ended
    Dec. 31, 2022
    Property, Plant and Equipment [Abstract]  
    SCHEDULE OF PROPERTY AND EQUIPMENT

    Property and equipment consist of the following:

     

       Useful Life  December 31, 
       (Years)  2022   2021 
    Cost:           
    Furniture and fixtures  110  $308,000   $282,000 
    Leasehold improvements (a)  1 - 14   443,000    439,000 
    Computers, software, and equipment  1 - 11   3,016,000    2,813,000 
           3,767,000    3,534,000 
    Accumulated depreciation      (2,333,000)   (2,361,000)
    Property and equipment, net     $1,434,000   $1,173,000 
    XML 58 R36.htm IDEA: XBRL DOCUMENT v3.23.1
    GOODWILL (Tables)
    12 Months Ended
    Dec. 31, 2022
    Goodwill  
    SCHEDULE OF GOODWILL

    The following table illustrates goodwill for the years ended December 31, 2022, and 2021:

     

       12/31/22   12/31/21 
    Beginning balance  $   $ 
    Additions       8,211,000 
    Deferred tax liabilities associated with MVP acquisition       978,000 
    Impairments       (9,189,000)
    Ending balance  $-0-   $-0- 
    XML 59 R37.htm IDEA: XBRL DOCUMENT v3.23.1
    INTANGIBLE ASSETS (Tables)
    12 Months Ended
    Dec. 31, 2022
    Goodwill and Intangible Assets Disclosure [Abstract]  
    SCHEDULE OF INTANGIBLE ASSETS

    The following table illustrates finite intangible assets as of December 31, 2022, and 2021:

     

       Proprietary Technology   Patents and Licenses   Trade Names & Technology   Customer Relationships     
           Accumulated       Accumulated       Accumulated       Accumulated     
       Cost   Amortization   Cost   Amortization   Cost   Amortization   Cost   Amortization   Net 
                                         
    Balance, December 31, 2020  $       $12,378,000   $(11,175,000)  $1,450,000   $(914,000)  $2,880,000   $(2,698,000)  $1,921,000 
                                                  
    Additions   2,132,000                801,000        2,215,000        5,148,000 
                                                  
    Amortization   -    (223,000)   -    (668,000)   -    (138,000)   -    (119,000)   (1,148,000)
                                                  
    Balance, December 31, 2021   2,132,000    (223,000)   12,378,000    (11,843,000)   2,251,000    (1,052,000)   5,095,000    (2,817,000)   5,921,000 
                                                  
    Amortization       (592,000)       (535,000)       (137,000)       (257,000)   (1,521,000)
                                                  
    Balance, December 31, 2022  $2,132,000   $(815,000)  $12,378,000   $(12,378,000)  $2,251,000   $(1,189,000)  $5,095,000   $(3,074,000)  $4,400,000 
    SCHEDULE OF CAPITALIZED INTANGIBLE COSTS

    The Company has recognized net capitalized intangible costs as follows:

     

       December 31,   December 31, 
       2022   2021 
    Proprietary Technology  $1,319,000   $1,910,000 
    Patents and Licenses       535,000 
    Trade Names and Technology   1,060,000    1,198,000 
    Customer Relationships   2,021,000    2,278,000 
       $4,400,000   $5,921,000 
    SCHEDULE OF AMORTIZATION OF INTANGIBLE ASSETS

    The Company has recognized the amortization of intangible assets as follows:

     

       For the years ended 
       December 31, 
       2022   2021 
             
    Proprietary Technology  $592,000   $223,000 
               
    Patents and Licenses   535,000    668,000 
               
    Trade Names and Technology   137,000    138,000 
               
    Customer Relationships   257,000    119,000 
               
       $1,521,000   $1,148,000 
    SCHEDULE OF ESTIMATED AMORTIZATION EXPENSE FOR INTANGIBLE ASSETS

    The weighted average remaining life of the amortization of the Company’s intangible assets is approximately 5.3 years. The following table represents the estimated amortization expense for total intangible assets for the succeeding five years:

     

    Period ending December 31,     
    2023  $645,000 
    2024   645,000 
    2025   645,000 
    2026   556,000 
    2027   539,000 
    Thereafter   1,370,000 
    Finite-Lived Intangible Assets, Net, Total  $4,400,000 
    XML 60 R38.htm IDEA: XBRL DOCUMENT v3.23.1
    ACCRUED EXPENSES (Tables)
    12 Months Ended
    Dec. 31, 2022
    Payables and Accruals [Abstract]  
    SCHEDULE OF ACCRUED EXPENSES

    Accrued expenses consist of the following:

     

       December 31, 2022   December 31, 2021 
    Compensation  $246,000   $2,069,000 
    Commissions   47,000    29,000 
    Warranty   112,000    130,000 
    Rent       185,000 
    Accrued expenses other   908,000    687,000 
    Deferred Equity   255,000    55,000 
    Accrued expenses  $1,568,000   $3,155,000 

     

    XML 61 R39.htm IDEA: XBRL DOCUMENT v3.23.1
    NOTES PAYABLE (Tables)
    12 Months Ended
    Dec. 31, 2022
    Debt Disclosure [Abstract]  
    SCHEDULE OF NOTES PAYABLE

    The table below represents the Company’s notes payable as of December 31, 2022, and 2021:

     SCHEDULE OF NOTES PAYABLE

       Principal 
       12/31/22   12/31/21 
             
    On April 5, 2021  $   $99,000 
    On April 5, 2021, the Company renewed its D & O insurance policy and increased the premium to approximately $1,098,000, less a down payment of $225,000, financing the remaining balance of approximately $872,000. The loan’s terms are nine months at a 5.25% annual interest rate and a monthly principal and interest payment of approximately $99,000. As of March 31, 2022, the loan is paid in full. The Company recorded interest expense of $-0- and $19,000 for the years ended December 31, 2022, and 2021, respectively.  $   $99,000 
               
    On April 5, 2022, the Company renewed its D & O insurance policy, decreasing the premium to approximately $1,037,000, less a down payment of $194,000, financing the remaining balance of approximately $943,000. The loan’s terms are nine months at a 2.09% annual interest rate and a monthly principal and interest payment of approximately $84,000. The Company recorded interest expense of $6,000 and $-0- for the years ended December 31, 2022, and 2021, respectively.   84,000     
       $84,000   $99,000 
    XML 62 R40.htm IDEA: XBRL DOCUMENT v3.23.1
    LEASES (Tables)
    12 Months Ended
    Dec. 31, 2022
    Leases  
    SCHEDULE OF OPERATING LEASE DATA

    The following table illustrates operating lease data for the years ended December 31, 2022, and 2021:

     

     SCHEDULE OF OPERATING LEASE DATA

       2022   2021 
       For the years ended 
       December 31, 
       2022   2021 
    Lease cost:          
    Operating lease cost  $438,000   $472,000 
    Short-term lease cost   93,000    417,000 
               
    Total lease cost  $531,000   $889,000 
               
    Cash paid for lease liabilities:          
    Cash flows from operating leases  $543,000   $635,000 
               
    Weighted-average remaining lease term—operating leases   3.4 years    3.8 years 
               
    Weighted-average discount rate—operating leases   9.4%   9.3%
    SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES

    Maturities of our operating lease liabilities were as follows as of December 31, 2022:

     

     SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES

       Amount 
         
    2023  $589,000 
    2024   455,000 
    2025   443,000 
    2026   249,000 
    2027   59,000 
    Thereafter    
    Total lease payments   1,795,000 
    Less: imputed interest   233,000 
    Present value of lease liabilities   1,562,000 
    Less: Current lease liabilities   455,000 
    Non-current lease liabilities  $1,107,000 
    SCHEDULE OF LEASE OBLIGATIONS ASSUMED

    The table below lists the location and lease expiration date from 2023 through 2027: 

     SCHEDULE OF LEASE OBLIGATIONS ASSUMED

    Location  Square Footage    Lease-End Date  Approximate Future Payments 
    Colchester, U.K. – Waterside House   16,000   Dec 2025  $639,000 
    Singapore   950   July 2023   19,000 
    Billerica, MA   2,000   Dec 2026   416,000 
    Hemel, UK   12,870   Oct 2023   123,000 
    Mount Olive, NJ   7,979   Jan 2027   598,000 

    XML 63 R41.htm IDEA: XBRL DOCUMENT v3.23.1
    DERIVATIVE LIABILITIES (Tables)
    12 Months Ended
    Dec. 31, 2022
    Derivative Instruments and Hedging Activities Disclosure [Abstract]  
    SCHEDULE OF VALUATION AND WARRANTS EXERCISABLE

    The following are the key assumptions used in connection with the valuation of the warrants exercisable into common stock on December 31, 2022, and 2021:

     

     SCHEDULE OF VALUATION AND WARRANTS EXERCISABLE

       For the Years Ended December 31, 
       2022   2021 
    Number of shares underlying the warrants   55,333    66,341 
    The fair market value of stock  $0.56   $1.18 
    Exercise price  $ 0.00 to $ 60.00    $ 60.00 to $ 150.00  
    Volatility   0% to 64 %   97% to 101 %
    Risk-free interest rate   0% to 4.54 %   0.19% to 0.39 %
    Expected dividend yield        
    Warrant life (years)   0.0 to 0.4     0.6 to 1.4  
    SCHEDULE OF CHANGES IN FAIR VALUE OF LEVEL 3 FINANCIAL LIABILITIES

    The following table sets forth a summary of the changes in the fair value of Level 3 financial liabilities that are measured at fair value on a recurring basis:

     

     SCHEDULE OF CHANGES IN FAIR VALUE OF LEVEL 3 FINANCIAL LIABILITIES

       2022   2021 
       For the years ended 
       December 31 
       2022   2021 
             
    Beginning balance  $   $22,000 
    Change in fair value of derivative liabilities       (22,000)
    Ending balance  $   $ 
    XML 64 R42.htm IDEA: XBRL DOCUMENT v3.23.1
    STOCKHOLDERS’ EQUITY (Tables)
    12 Months Ended
    Dec. 31, 2022
    Equity [Abstract]  
    SCHEDULE OF WARRANT OUTSTANDING

    The following tables set forth common stock purchase warrants outstanding as of December 31, 2022:

     SCHEDULE OF WARRANT OUTSTANDING

      

    Number of Warrants

    (in shares)

      

    Weighted

    Average

    Exercise

    Price

     
             
    Outstanding, December 31, 2020   222,360   $89.60 
    Warrants granted   9,120,910    3.30 
    Warrants exercised   (10,063)   (1.20)
    Warrants canceled/expired   (123,396)   (98.30)
    Outstanding, December 31, 2021   9,209,811    4.10 
    Warrants expired   (34,885)   (131.20)
    Outstanding and exercisable, December 31, 2022   9,174,926   $3.60 
    SCHEDULE OF WARRANT OUTSTANDING EXERCISE PRICE

     SCHEDULE OF WARRANT OUTSTANDING EXERCISE PRICE

        Common stock issuable upon exercise of warrants outstanding and exercisable 
        For the year ending   For the year ending 
        December 31, 2022   December 31, 2021 
    Range of Exercise Prices   Warrants Outstanding and Exercisable (in shares)   Weighted Average Remaining Contractual Life (years)  

    Weighted Average Exercise

    Price

      

    Warrants Outstanding and Exercisable

    (in shares)

       Weighted Average Remaining Exercisable Contractual Life (years) 

    Weighted Average Exercise

    Price

     
    $3.25    9,090,910    3.11 yrs   $3.30    9,090,910   4.11 yrs  $3.30 
    $3.41    30,000    1.18 yrs   $3.50    30,000   2.18 yrs  $3.50 
    $30.000    683    1.54 yrs   $30.00    683   2.54 yrs  $30.00 
    $60.000    53,333    0.41 yrs   $60.00    53,333   1.41 yrs  $60.00 
    $120.000           $    21,877   0.12 yrs  $120.00 
    $150.000           $    13,008   0.63 yrs  $150.00 
          9,174,926    3.10 yrs   $3.60    9,209,811   4.08 yrs  $4.10 
    XML 65 R43.htm IDEA: XBRL DOCUMENT v3.23.1
    STOCK-BASED COMPENSATION (Tables)
    12 Months Ended
    Dec. 31, 2022
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
    SCHEDULE OF STOCK OPTION PLANS

    The following table illustrates various plan data under performance-based restricted stock awards:

     

       2022   2021 
       For the years ended 
       December 31, 
       2022   2021 
    Stock-based compensation expense  $   $3,722,000 
               
    Remaining expense of stock-based compensation  $1,498,000   $ 
               
    Remaining amortization period   2.8 years    0.0 years 
               
    Weighted average remaining contractual life – options outstanding and exercisable   2.8 years    4.0 years 
               
    Intrinsic value per share  $   $1.18 
               
    Range of exercise prices  $1.05    $1.32 to 3.60 
               
    Quantity:          
               
    Beginning balance-January 1st, outstanding    1,267,380    368,715 
               
    Granted, canceled, expired   1,426,062    898,665 
               
    Exercised   (1,267,380)    
               
    Ending balance-December 31st, outstanding    1,426,062    1,267,380 
               
    Ending balance-December 31st, exercisable        1,267,380 
               
    Weighted Averages:          
               
    Beginning balance-January 1st, outstanding   $2.90   $1.32 
               
    Granted, canceled, expired   1.05    3.60 
               
    Exercised  $(2.90)  $ 
               
    Ending balance-December 31st, outstanding   $1.10   $2.90 
               
    Ending balance-December 31st, exercisable   $   $2.90 
    SCHEDULE OF STOCK OPTION PLANS FOR VESTED OPTION

       Grant       Units Vesting Schedule 
    Recipient  Date   Units   Exercise Price   Tranche 1   Tranche 2   Tranche 3 
    Carleton M. Miller — CEO   3/3/21    896,665   $3.60    299,555    299,555    299,555 
                                   
    Michael Bond — CFO   12/31/20    368,715   $1.32    122,905    122,905    122,905 

     

    Note: The above performance-based restricted stock units met all three revenue thresholds in the last quarter of 2021, and the Company recognized stock-based compensation expense accordingly for the year ending December 31, 2021.

     

       Grant       Units Vesting Schedule 
    Recipient  Date   Units   Exercise Price   Tranche 1   Tranche 2   Tranche 3 
    Carleton M. Miller — CEO   2/16/22    1,033,076   $1.05    *344,359    **344,359    ***344,359 
                                   
    Michael Bond — CFO   2/16/22    392,985   $1.05    *130,995    **130,995    ***130,994 

     

    * RSUs will vest upon the Company’s attainment, on or before December 31, 2026, of revenue of more than $35,575,000 accumulated over four consecutive fiscal quarters.
       
    ** RSUs will vest upon the Company’s attainment, on or before December 31, 2026, of revenue of more than $37,353,000 accumulated over four consecutive fiscal quarters.
       
    *** RSUs will vest upon the Company’s attainment, on or before December 31, 2026, of revenue of more than $39,220,000 accumulated over four consecutive fiscal quarters.
    Restricted Stock [Member]  
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
    SCHEDULE OF STOCK OPTION PLANS

    The following table illustrates various plan data under time-based restricted stock awards:

     

       2022   2021 
       For the years ended 
       December 31, 
       2022   2021 
    Stock-based compensation expense  $1,385,000   $ 
               
    Remaining expense of stock-based compensation  $3,248,000   $2,533,000 
               
    Remaining amortization period    2.3 years    3.5 years 
               
    Weighted average remaining contractual life – options outstanding and exercisable   2.5 years    2.5 years 
               
    Intrinsic value per share  $   $ 
               
    Range of exercise prices  $0.98 to $3.60   $1.89 to $3.60 
               
    Quantity:          
               
    Beginning balance-January 1st, outstanding    798,665     
               
    Granted   2,141,061    798,665 
               
    Forfeited   (125,000)    
               
    Ending balance-December 31st, outstanding    2,814,726    798,665 
               
    Ending balance-December 31st, exercisable    415,885     
               
    Weighted Averages:          
               
    Beginning balance-January 1st, outstanding   $3.17   $ 
               
    Granted  $1.04    3.17 
               
    Forfeited  $(.98)  $ 
               
    Ending balance-December 31st, outstanding   $1.20   $3.17 
               
    Ending balance-December 31st, exercisable   $3.30   $ 
    SCHEDULE OF STOCK OPTION PLANS FOR VESTED OPTION

    The Company granted the following awards under the amended Plan for restricted stock units (“RSUs”) subject to continued employment:

     

       Grant       Initial RSUs Vesting  Remaining RSUs Vesting
    Recipient  Date   Units   Exercise Price   Date  Units   Units   Terms
                               
    Carleton M. Miller — CEO   3/3/21    598,665   $3.60   3/3/22   199,555    399,110   24 equal monthly periods
                                    
    Michel Bais — Managing Director   8/17/21    200,000   $1.89   8/17/22   50,000    150,000   36 equal monthly periods
                                    
    Ronnie Hamilton — VP Global Operations   1/12/22    200,000   $1.10   1/12/23   66,000    134,000   24 equal monthly periods
                                    
    Group of 22 Employees   2/17/22    515,000   $0.98   2/17/23   169,950    345,050   24 equal monthly periods
                                    
    Carleton M. Miller — CEO   2/16/22    1,033,076   $1.05   2/16/23   258,269    774,807   36 equal monthly periods
                                    
    Mike Bond — CFO   2/16/22    392,985   $1.05   2/16/23   98,256    294,739   36 equal monthly periods
    Time Vested Option [Member]  
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
    SCHEDULE OF STOCK OPTION PLANS

    The following table illustrates various plan data under time-based stock option awards:

     

       2022   2021 
       For the years ended 
       December 31, 
       2022   2021 
    Stock-based compensation expense  $179,000   $113,000 
               
    Remaining expense of stock-based compensation  $319,000   $498,000 
               
    Remaining amortization period   1.1 years    2.1 years 
               
    Weighted average remaining contractual life – options outstanding and exercisable   7.1 years    8.1 years 
               
    Intrinsic value per share  $   $.38 
               
    Range of exercise prices   $0.96 to $1.71    $0.96 to $1.71 
               
    Quantity:          
               
    Beginning balance-January 1st, outstanding    494,415    494,415 
               
    Granted, canceled, expired        
               
    Ending balance-December 31st, outstanding    494,415    494,415 
               
    Ending balance-December 31st, exercisable    360,515    236,915 
               
    Weighted Averages:          
               
    Beginning balance-January 1st, outstanding   $1.01   $1.24 
               
    Granted, canceled, expired  $   $ 
               
    Ending balance-December 31st, outstanding   $0.60   $1.01 
               
    Ending balance-December 31st, exercisable   $0.80   $0.48 
    SCHEDULE OF STOCK OPTION PLANS FOR VESTED OPTION

    In connection with their employment agreement(s), the Company granted the following ten-year, non-statutory time-vested option inducement awards under the NASDAQ Listing Rule 5653(c)(4) outside of the Company’s existing equity compensation plans (all subject to continued employment):

     

    Recipient  Date of Grant   Options Granted   Exercise Price   Vesting Commencement Date  Expiration Date  25% Vesting   75% Remaining Vesting
    ●Carleton M. Miller — CEO   1/22/20    359,247   $1.71   1/22/20  1/22/30   1/22/21   36 equal monthly payments
    ●Michael Bond — CFO   2/27/20    135,168   $0.96   4/1/20  4/1/30   4/1/21   36 equal monthly payments
    SCHEDULE OF SHARE-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS

     In determining the time-vested options award’s grant-date fair value, the following assumptions were used:

     

     

       Expected term (years)   Expected dividend yield   Risk-free interest rate   Volatility   Exercise Price 
                         
    ● Carleton M. Miller — CEO   6.5        1.57%   153.0%  $1.71 
    ● Michael Bond — CFO   6.3        0.62%   155.0%  $0.96 
    Performance Based Option [Member]  
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
    SCHEDULE OF STOCK OPTION PLANS

    The following table illustrates various plan data under performance-based stock option awards:

     

       2022   2021 
       For the years ended 
       December 31, 
       2022   2021 
    Stock-based compensation expense  $   $ 
               
    Remaining expense of stock-based compensation  $414,000   $414,000 
               
    Remaining amortization period   2.1 years    3.1 years 
               
    Weighted average remaining contractual life – options outstanding and exercisable   7.1 years    8.1 years 
               
    Intrinsic value per share  $   $. 
               
    Range of exercise prices  $1.71   $1.71 
               
    Quantity:          
               
    Beginning balance-January 1st, outstanding    250,000    250,000 
               
    Granted, canceled, expired        
               
    Ending balance-December 31st, outstanding    250,000    250,000 
               
    Ending balance-December 31st, exercisable         
               
    Weighted Averages:          
               
    Beginning balance-January 1st, outstanding   $1.65   $1.65 
               
    Granted, canceled, expired  $   $ 
               
    Ending balance-December 31st, outstanding   $1.65   $1.65 
               
    Ending balance-December 31st, exercisable   $   $ 
    SCHEDULE OF STOCK OPTION PLANS FOR VESTED OPTION

    In connection with their employment agreement, the Company granted the following ten-year, non-statutory performance-based stock option inducement award under the NASDAQ Listing Rule 5653(c)(4) outside of the Company’s existing equity compensation plans that will vest in three equal tranches upon attainment of applicable performance conditions for each tranche (all subject to continued employment):

     

       Date of   Options   Exercise   Options Vesting Dates  Options Vesting Schedule 
    Recipient  Grant   Granted   Price   Commencement  Expiration   Tranche 1   Tranche 2   Tranche 3 
                                           
    Carleton M. Miller — CEO   1/22/20    250,000   $1.71    1/22/20    1/22/30    *83,334    **83,333    ***83,333 

     

    Applicable performance conditions:

     

    *Shares will vest upon the Company’s attainment, on or before the fifth (5th) anniversary of the Vesting Commencement Date, of Cumulative EBITDA of more than $6,000,000 accumulated over four consecutive fiscal quarters.

     

    **Shares will vest upon the Company’s attainment, on or before the fifth (5th) anniversary of the Vesting Commencement Date, of Cumulative EBITDA of more than $15,000,000 accumulated over four consecutive fiscal quarters.

     

    ***Shares will vest upon the Company’s attainment, on or before the fifth (5th) anniversary of the Vesting Commencement Date, of Cumulative EBITDA of more than $23,000,000 accumulated over four consecutive fiscal quarters.
    SCHEDULE OF SHARE-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS

    In determining the time-vested options award’s grant-date fair value, the following assumptions were used:

     

       Expected term (years)   Expected dividend yield   Risk-free interest rate   Volatility   Exercise Price 
                         
    For the year ended December 31, 2020:                       
                              
    ● Carleton M. Miller — CEO   6.5        1.57%   153.0%  $1.71 
    2013 Long-Term Stock Incentive Plan [Member]  
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
    SCHEDULE OF STOCK OPTION PLANS

    The following table illustrates various plan data under the amended Long-Term Stock Incentive Plan (the “Plan”):

     

    SCHEDULE OF STOCK OPTION PLANS

       For the years ended 
       December 31, 
       2022   2021 
    Stock-based compensation expense  $1,000   $27,000 
               
    Remaining expense of stock-based compensation  $   $1,000 
               
    Remaining amortization period   0.0 years    0.3 years 
               
    Weighted average remaining contractual life – options outstanding and exercisable   4.5 years    5.5 years 
               
    Intrinsic value per share  $   $ 
               
    Range of exercise prices  $6.96 to $97.20   $6.96 to $1,173.60 
               
    Quantity:          
               
    Beginning balance-January 1st, outstanding options   49,925    56,399 
               
    Stock options forfeited   (4,916)   (6,474)
               
    Ending balance-December 31st, outstanding options   45,009    49,925 
               
    Ending balance-December 31st, exercisable options   45,009    48,703 
               
    Weighted Averages:          
               
    Beginning balance-January 1st, outstanding options  $88.04   $89.79 
               
    Stock options forfeited  $(96.70)  $(84.13)
               
    Ending balance-December 31st, outstanding options  $87.80   $88.04 
               
    Ending balance-December 31st, exercisable options  $87.80   $89.80 
    XML 66 R44.htm IDEA: XBRL DOCUMENT v3.23.1
    COMMITMENTS AND CONTINGENCIES (Tables)
    12 Months Ended
    Dec. 31, 2022
    Commitments and Contingencies Disclosure [Abstract]  
    SCHEDULE OF MATCHING CONTRIBUTIONS

    The table below represents the Company’s matching contributions as follows:

     

       For the year ended 
       December 31, 
       2022   2021 
    Company matching contributions - Group Personal Pension Plan, U.K.  $166,000   $169,000 
    XML 67 R45.htm IDEA: XBRL DOCUMENT v3.23.1
    REVENUE (Tables)
    12 Months Ended
    Dec. 31, 2022
    Revenue from Contract with Customer [Abstract]  
    SCHEDULE OF DISAGGREGATION OF REVENUE

    The Company has one operating segment, and the decision-making group is the senior executive management team. The Company disaggregated revenue by primary geographical markets and revenue sources in the following tables:

     

       For the years ended 
       December 31, 
       2022   2021 
    Primary geographical markets:          
    North America  $12,037,000   $18,050,000 
    South America   182,000    361,000 
    Europe   9,229,000    11,389,000 
    Asia   1,851,000    1,975,000 
    Rest of World   5,103,000    2,107,000 
       $28,402,000   $33,882,000 
    Primary revenue source:          
    Equipment sales  $25,667,000   $31,733,000 
    Installation, integration, and repairs   1,450,000    1,082,000 
    Warranties   1,014,000    743,000 
    Other (See Note 20)   271,000    324,000 
       $28,402,000   $33,882,000 
    Long-Lived Assets:          
    United States  $1,970,000   $2,410,000 
    Netherlands   27,000     
    United Kingdom   4,912,000    14,257,000 
       $6,909,000   $16,667,000 
    XML 68 R46.htm IDEA: XBRL DOCUMENT v3.23.1
    GAINS ON SETTLEMENT OF DEBT (Tables)
    12 Months Ended
    Dec. 31, 2022
    Gains On Settlement Of Debt  
    SCHEDULE OF GAINS ON SETTLEMENT OF DEBT

    The following table represents the Company’s gains on settlement of debt for the years ending December 31, 2022 and 2021:

     

        2022    2021 
       For the Years Ended 
       December 31, 
        2022    2021 
               
    On March 10, 2021, the Company negotiated a vendor accounts payable balance of $494,000 with a remittance settlement of $300,000  $   $194,000 
               
    On July 26, 2021, the Payroll Protection Program (“PPP”) loan of $1,168,000 received on April 10, 2020, was forgiven. Under ASC 405-20, the Company recorded the transaction as a gain on settlement of debt   -    1,168,000 
               
    On May 4, 2022, and July 19, 2022, the Company issued 38,703 shares of common stock on each date with an accumulated value of $54,184 in satisfaction of an amount payable of $80,000   25,816     
               
    On November 21, 2022, the Company settled the dividends payable in the amount of $19,916 by issuing 47,419 Series A Preferred shares with a zero carrying value   19,916     
               
    GAINS ON SETTLEMENT OF DEBT  $45,732   $1,362,000 
    XML 69 R47.htm IDEA: XBRL DOCUMENT v3.23.1
    INCOME TAXES (Tables)
    12 Months Ended
    Dec. 31, 2022
    Income taxes  
    SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT)

    The provision (benefit) for income taxes consists of the following:

     

       2022   2021 
       For the Years Ended 
       December 31, 
       2022   2021 
    Current tax provision          
    Federal  $   $ 
    State   25,000    7,000 
    Current income tax expense, total   25,000    7,000 
    Deferred tax provision (benefit)          
    Federal   (532,000)   (503,000)
    State   (427,000)   1,025,000 
    Foreign   (978,000)   (2,052,000)
    Change in the valuation allowance   1,722,000    1,530,000 
    Total deferred tax provision (benefit)   (215,000)    
               
    Income tax provision  $(190,000)  $7,000 
    SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION

    A reconciliation of the statutory tax rate to the effective tax rate is as follows:

     

       2022   2021 
       For the Years Ended 
       December 31, 
       2022   2021 
    Statutory federal income tax rate   21.00%   21.00%
    State and local taxes, net of federal benefit   0.30    (6.27)
    Permanent differences   5.28    (9.12)
    Executive compensation   (2.26)    
    Equity compensation   (11.06)    
    Provision to return   0.00    (0.03)
    DTA adjustment for state NOL   0.00    (0.06)
    Foreign Rate Differential   (1.27)   (1.96)
    Change rate   2.66    (5.06)
    Valuation allowance   (13.27)   1.46 
    Effective tax rate   1.37%   (0.04)%
    SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES

     

       2022   2021 
       For the Years Ended 
       December 31, 
       2022   2021 
    Deferred Tax Assets          
    Federal R&D credit  $3,007,000   $3,007,000 
    Inventory   576,000    457,000 
    Allowance for bad debt   72,000    76,000 
    Compensation related   7,000    298,000 
    Pension   72,000    39,000 
    Other accruals   7,000    16,000 
    State net operating losses   4,779,000    4,644,000 
    Federal net operating losses   44,821,000    43,045,000 
    Interest disallowance   1,151,000    82,000 
    Stock options   7,172,000    7,621,000 
    Other   296,000    1,097,000 
    Valuation Allowance   (61,731,000)   (60,048,000)
    Total Deferred Tax Assets   229,000    334,000 
    Deferred Tax Liabilities          
    Property and Equipment   (90,000)   (47,000)
    Intangibles   (870,000)   (1,230,000)
    Prepaid Expenses   (33,000)   (35,000)
    Total Deferred Tax Liabilities   (993,000)   (1,312,000)
    Net Deferred Tax Liability  $(764,000)  $(978,000)
    XML 70 R48.htm IDEA: XBRL DOCUMENT v3.23.1
    LIQUIDITY AND FINANCIAL CONDITION (Details Narrative) - USD ($)
    12 Months Ended
    Mar. 16, 2023
    Feb. 08, 2021
    Dec. 31, 2022
    Dec. 31, 2021
    Subsequent Event [Line Items]        
    Operating income loss     $ 13,795,000 $ 17,747,000
    Net cash provided by used in operating activities     9,226,000 9,601,000
    Working capital     38,600,000  
    Accumulated deficit     300,099,000 $ 286,539,000
    Cash     25,600,000  
    Issuance of common stock shares       6,163,198
    Proceeds from issuance of common stock       $ 12,600,000
    Common stock value     $ (20,000)  
    Proceeds from public offering       $ 12,600,000
    Common Stock [Member]        
    Subsequent Event [Line Items]        
    Issuance of common stock shares   18,181,820    
    Proceeds from public offering   $ 46,820,000    
    Warrants to purchase shares of common stock   9,090,910    
    Warrant term   5 years    
    Warrant exercise price   $ 3.25    
    Subsequent Event [Member]        
    Subsequent Event [Line Items]        
    Common stock value $ 4,500,000      
    XML 71 R49.htm IDEA: XBRL DOCUMENT v3.23.1
    SCHEDULE OF PRODUCT WARRANTY LIABILITY (Details) - USD ($)
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Accounting Policies [Abstract]    
    Warranty reserve, beginning $ 131,000 $ 283,000
    Warranty reserve expense 98,000
    Warranty claims settled and true-up of accrual (117,000) (152,000)
    Warranty reserve, ending $ 112,000 $ 131,000
    XML 72 R50.htm IDEA: XBRL DOCUMENT v3.23.1
    SCHEDULE OF ANTI-DILIUTIVE POTENTIAL COMMON STOCK EQUIVALENTS EXCLUDE FROM THE CALCULATION OF LOSS PER SHARE (Details) - shares
    shares in Thousands
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Anti-dilutive potential common stock equivalents excluded from the calculation of loss per share:    
    Total 10,003 10,763
    Equity Option [Member]    
    Anti-dilutive potential common stock equivalents excluded from the calculation of loss per share:    
    Total 828 1,553
    Warrant [Member]    
    Anti-dilutive potential common stock equivalents excluded from the calculation of loss per share:    
    Total 9,175 9,210
    XML 73 R51.htm IDEA: XBRL DOCUMENT v3.23.1
    SCHEDULE OF FOREIGN EXCHANGE AND CHANGE IN ACCUMULATED COMPREHENSIVE INCOME (Details) - USD ($)
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Accounting Policies [Abstract]    
    Net foreign exchange transactions: Losses $ 24,000 $ 100,000
    Accumulated comprehensive income: Unrealized losses on currency translation adjustment $ 1,040,000 $ 445,000
    XML 74 R52.htm IDEA: XBRL DOCUMENT v3.23.1
    SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON NON-RECURRING BASIS (Details)
    Dec. 31, 2022
    USD ($)
    Defined Benefit Plan Disclosure [Line Items]  
    Total Assets (non-recurring) $ 88,000
    Total Liabilities
    Abandonment of Right-of-use Operating Leases [Member]  
    Defined Benefit Plan Disclosure [Line Items]  
    Total Assets (non-recurring) 88,000
    Other [Member]  
    Defined Benefit Plan Disclosure [Line Items]  
    Total Liabilities
    Fair Value, Inputs, Level 1 [Member]  
    Defined Benefit Plan Disclosure [Line Items]  
    Total Assets (non-recurring)
    Total Liabilities
    Fair Value, Inputs, Level 1 [Member] | Abandonment of Right-of-use Operating Leases [Member]  
    Defined Benefit Plan Disclosure [Line Items]  
    Total Assets (non-recurring)
    Fair Value, Inputs, Level 1 [Member] | Other [Member]  
    Defined Benefit Plan Disclosure [Line Items]  
    Total Liabilities
    Fair Value, Inputs, Level 2 [Member]  
    Defined Benefit Plan Disclosure [Line Items]  
    Total Assets (non-recurring)
    Total Liabilities
    Fair Value, Inputs, Level 2 [Member] | Abandonment of Right-of-use Operating Leases [Member]  
    Defined Benefit Plan Disclosure [Line Items]  
    Total Assets (non-recurring)
    Fair Value, Inputs, Level 2 [Member] | Other [Member]  
    Defined Benefit Plan Disclosure [Line Items]  
    Total Liabilities
    Fair Value, Inputs, Level 3 [Member]  
    Defined Benefit Plan Disclosure [Line Items]  
    Total Assets (non-recurring) 88,000
    Total Liabilities
    Fair Value, Inputs, Level 3 [Member] | Abandonment of Right-of-use Operating Leases [Member]  
    Defined Benefit Plan Disclosure [Line Items]  
    Total Assets (non-recurring) 88,000
    Fair Value, Inputs, Level 3 [Member] | Other [Member]  
    Defined Benefit Plan Disclosure [Line Items]  
    Total Liabilities
    XML 75 R53.htm IDEA: XBRL DOCUMENT v3.23.1
    SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)
    1 Months Ended 12 Months Ended
    Nov. 09, 2022
    Nov. 30, 2022
    $ / shares
    Dec. 31, 2022
    USD ($)
    $ / shares
    Dec. 31, 2021
    USD ($)
    $ / shares
    Dec. 31, 2022
    GBP (£)
    Dec. 31, 2022
    EUR (€)
    Mar. 31, 2013
    $ / shares
    Product Information [Line Items]              
    Cash FDIC insured amount     $ 250,000   £ 85,000    
    Dutch deposit guarantee scheme | €           € 100,000  
    Revenue     28,402,000 $ 33,882,000      
    Impairment of goodwill     9,189,000      
    Amortization     1,521,000 1,148,000      
    Shipping and handling costs     796,000 581,000      
    Right-of-use operating assets impaired     131,000 131,000      
    Right-of-use       43,000      
    Loss on impairment of right-of-use assets     88,000 0      
    Advertising costs     $ 1,038,000 $ 139,000      
    Preferred stock voting discription   the Company’s board of directors approved the designation of a Series A Preferred Stock created for the sole purpose of the January 11, 2023, Special Meeting of stockholders voting on the consideration of a “Reverse Stock Split Proposal.” The Series A Preferred Stock had a par value of $0.00001 per share. The Preferred Stock was redeemable upon the holder participating at any meeting of stockholders held to vote on the Reverse Stock Split immediately before the opening of the polls at such meeting (the “Initial Redemption Time”) shall automatically be redeemed by the Corporation at the Initial Redemption Time without further action on the part of the Corporation or the holder thereof (the “Initial Redemption”). Any outstanding shares of Series A Preferred Stock that were not redeemed under an Initial Redemption were redeemed in whole, but not in part (i) if such redemption was ordered by the Board of Directors in its sole discretion, automatically and effective on such time and date specified by the Board of Directors in its sole discretion or (ii) automatically upon the approval by the Corporation’s stockholders of the Reverse Stock Split at the Special Meeting held for voting on the Reverse Stock Split proposal.          
    Preferred stock, par value | $ / shares     $ 0.00001 $ 0.00001     $ 0.00001
    Series A Preferred Stock [Member]              
    Product Information [Line Items]              
    Preferred stock voting discription Each share of Series A Preferred Stock entitled the holder to 1,000,000 votes per share, and each fraction of a share had a ratable number of votes. Thus, each one-thousandth share of Series A Preferred Stock was entitled to 1,000 votes            
    Preferred stock, par value | $ / shares   $ 0.00001          
    GBP To USD [Member]              
    Product Information [Line Items]              
    Foreign currency exchange rate, translation     1.00 1.00 1.00 1.00  
    Foreign currency exchange rate, remeasurement     1.00 1.00 1.00 1.00  
    GBP [Member] | GBP To USD [Member]              
    Product Information [Line Items]              
    Foreign currency exchange rate, translation     1.208970 1.351043 1.208970 1.208970  
    Foreign currency exchange rate, remeasurement     1.236579 1.375369 1.236579 1.236579  
    GBP [Member] | Euro To GBP [Member]              
    Product Information [Line Items]              
    Foreign currency exchange rate, translation     1.00 1.00 1.00 1.00  
    Foreign currency exchange rate, remeasurement     1.00 1.00 1.00 1.00  
    Euro [Member] | Euro To GBP [Member]              
    Product Information [Line Items]              
    Foreign currency exchange rate, translation     1.069850 0.839362 1.069850 1.069850  
    Foreign currency exchange rate, remeasurement     1.052082 0.850858 1.052082 1.052082  
    Patents and Licenses [Member]              
    Product Information [Line Items]              
    Amortization     $ 535,000 $ 668,000      
    Other Intangible Assets [Member]              
    Product Information [Line Items]              
    Amortization     985,000 480,000      
    Single Customer [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]              
    Product Information [Line Items]              
    Revenue     $ 3,436,000 $ 8,511,000      
    Concentration risk percentage     12.00% 25.00%      
    Single Customer [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]              
    Product Information [Line Items]              
    Concentration risk percentage     19.00% 46.00%      
    Accounts Receivable, after Allowance for Credit Loss     $ 1,138,000 $ 4,204,000      
    Minimum [Member]              
    Product Information [Line Items]              
    Cash uninsured amount     $ 24,500,000 $ 35,200,000      
    Estimated useful life     1 year        
    Minimum [Member] | Patents and Licenses [Member]              
    Product Information [Line Items]              
    Estimated useful life     18 years 6 months        
    Minimum [Member] | Other Intangible Assets [Member]              
    Product Information [Line Items]              
    Finite-lived intangible asset, useful life     3 years        
    Maximum [Member]              
    Product Information [Line Items]              
    Estimated useful life     14 years        
    Maximum [Member] | Patents and Licenses [Member]              
    Product Information [Line Items]              
    Estimated useful life     20 years        
    Maximum [Member] | Other Intangible Assets [Member]              
    Product Information [Line Items]              
    Finite-lived intangible asset, useful life     15 years        
    XML 76 R54.htm IDEA: XBRL DOCUMENT v3.23.1
    SCHEDULE OF IDENTIFIABLE ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)
    Aug. 16, 2021
    USD ($)
    Fair value of consideration transferred:  
    Cash $ 18,311,000
    Recognized amounts of identifiable assets acquired and liabilities assumed:  
    Cash 965,000
    Accounts receivable, net 911,000
    Inventories, net 3,765,000
    Prepaid expenses and other assets 513,000
    Property and equipment, net 149,000
    Accounts payable (507,000)
    Accrued expenses (551,000)
    Customer deposits and deferred revenue (293,000)
    Deferred tax liabilities (978,000)
    Total identifiable net assets 3,974,000
    Consideration paid 18,311,000
    Total identifiable assets acquired 3,974,000
    Excess of consideration paid over net assets acquired 14,337,000
    Preliminary allocation of the consideration paid in excess of the net assets acquired:  
    Total intangible assets acquired 14,337,000
    Goodwill [Member]  
    Preliminary allocation of the consideration paid in excess of the net assets acquired:  
    Total intangible assets acquired 9,188,856
    Trade Names [Member]  
    Preliminary allocation of the consideration paid in excess of the net assets acquired:  
    Total intangible assets acquired 800,688
    Proprietary Technology [Member]  
    Preliminary allocation of the consideration paid in excess of the net assets acquired:  
    Total intangible assets acquired 2,132,749
    Customer Relationships [Member]  
    Preliminary allocation of the consideration paid in excess of the net assets acquired:  
    Total intangible assets acquired 2,214,997
    Previously Reported [Member]  
    Fair value of consideration transferred:  
    Cash 18,311,000
    Recognized amounts of identifiable assets acquired and liabilities assumed:  
    Cash 965,000
    Accounts receivable, net 911,000
    Inventories, net 2,534,000
    Prepaid expenses and other assets 625,000
    Property and equipment, net 149,000
    Accounts payable (507,000)
    Accrued expenses (551,000)
    Customer deposits and deferred revenue (293,000)
    Deferred tax liabilities
    Total identifiable net assets 3,833,000
    Consideration paid 18,311,000
    Total identifiable assets acquired 3,833,000
    Excess of consideration paid over net assets acquired 14,478,000
    Preliminary allocation of the consideration paid in excess of the net assets acquired:  
    Total intangible assets acquired 14,478,000
    Previously Reported [Member] | Goodwill [Member]  
    Preliminary allocation of the consideration paid in excess of the net assets acquired:  
    Total intangible assets acquired 8,175,000
    Previously Reported [Member] | Trade Names [Member]  
    Preliminary allocation of the consideration paid in excess of the net assets acquired:  
    Total intangible assets acquired 730,000
    Previously Reported [Member] | Proprietary Technology [Member]  
    Preliminary allocation of the consideration paid in excess of the net assets acquired:  
    Total intangible assets acquired 1,850,000
    Previously Reported [Member] | Customer Relationships [Member]  
    Preliminary allocation of the consideration paid in excess of the net assets acquired:  
    Total intangible assets acquired 3,723,000
    Revision of Prior Period, Adjustment [Member]  
    Fair value of consideration transferred:  
    Cash
    Recognized amounts of identifiable assets acquired and liabilities assumed:  
    Cash
    Accounts receivable, net
    Inventories, net 1,231,000
    Prepaid expenses and other assets (112,000)
    Property and equipment, net
    Accounts payable
    Accrued expenses
    Customer deposits and deferred revenue
    Deferred tax liabilities (978,000)
    Total identifiable net assets 141,000
    Consideration paid
    Total identifiable assets acquired 141,000
    Excess of consideration paid over net assets acquired (141,000)
    Preliminary allocation of the consideration paid in excess of the net assets acquired:  
    Total intangible assets acquired (141,000)
    Revision of Prior Period, Adjustment [Member] | Goodwill [Member]  
    Preliminary allocation of the consideration paid in excess of the net assets acquired:  
    Total intangible assets acquired 1,013,566
    Revision of Prior Period, Adjustment [Member] | Trade Names [Member]  
    Preliminary allocation of the consideration paid in excess of the net assets acquired:  
    Total intangible assets acquired 70,688
    Revision of Prior Period, Adjustment [Member] | Proprietary Technology [Member]  
    Preliminary allocation of the consideration paid in excess of the net assets acquired:  
    Total intangible assets acquired 282,749
    Revision of Prior Period, Adjustment [Member] | Customer Relationships [Member]  
    Preliminary allocation of the consideration paid in excess of the net assets acquired:  
    Total intangible assets acquired $ (1,508,003)
    XML 77 R55.htm IDEA: XBRL DOCUMENT v3.23.1
    SCHEDULE OF ACQUIRED INTANGIBLE WITH THEIR RELATIVE USEFUL LIVES (Details)
    12 Months Ended
    Dec. 31, 2022
    Trade name [Member]  
    Impairment Effects on Earnings Per Share [Line Items]  
    Useful life 15 years
    Proprietary Technologies [Member]  
    Impairment Effects on Earnings Per Share [Line Items]  
    Useful life 5 years
    Customer Relationship [Member]  
    Impairment Effects on Earnings Per Share [Line Items]  
    Useful life 10 years
    Goodwill Intangibles [Member]  
    Impairment Effects on Earnings Per Share [Line Items]  
    Useful life, description Indefinite
    XML 78 R56.htm IDEA: XBRL DOCUMENT v3.23.1
    SCHEDULE OF UNAUDITED PRO-FORMA COMBINED RESULTS OF OPERATIONS (Details)
    12 Months Ended
    Dec. 31, 2021
    USD ($)
    $ / shares
    shares
    Business Combination and Asset Acquisition [Abstract]  
    Revenues, net $ 36,843
    Net loss allocable to common stockholders $ (16,173)
    Net loss per share | $ / shares $ (0.37)
    Weighted average number of shares outstanding | shares 43,484
    XML 79 R57.htm IDEA: XBRL DOCUMENT v3.23.1
    ACQUISITION OF MOBILE VIEWPOINT CORPORATE B.V. (Details Narrative)
    $ in Thousands
    12 Months Ended
    Aug. 16, 2021
    USD ($)
    Aug. 16, 2021
    EUR (€)
    Dec. 31, 2022
    USD ($)
    Dec. 31, 2021
    USD ($)
    Aug. 13, 2021
    Business Acquisition [Line Items]          
    Increase of inventory $ 1,230        
    Decrease in prepaid expenses and other current assets 110   $ 1,232 $ 2,470  
    Reciprocal of inventory, increased $ 110        
    Weighted average cost capital percentage 20.00%        
    Internal Rate Of Return [Member]          
    Business Acquisition [Line Items]          
    Weighted average cost capital percentage 19.50%        
    Working Capital [Member]          
    Business Acquisition [Line Items]          
    Weighted average cost capital percentage 20.30%        
    Intangible Assets [Member]          
    Business Acquisition [Line Items]          
    Weighted average cost capital percentage 21.00%        
    Goodwill [Member]          
    Business Acquisition [Line Items]          
    Weighted average cost capital percentage 23.00%        
    Trade Names [Member]          
    Business Acquisition [Line Items]          
    Customer Relationships $ 70        
    Proprietary Technology [Member]          
    Business Acquisition [Line Items]          
    Customer Relationships 28        
    Goodwill [Member]          
    Business Acquisition [Line Items]          
    Customer Relationships 40        
    Customer Relationships [Member]          
    Business Acquisition [Line Items]          
    Customer Relationships 1,510        
    Mobile Viewpoint Corporate BV [Member]          
    Business Acquisition [Line Items]          
    Purchase price $ 17,500 € 14,824,278      
    Foreign currency exchange rate         0.85
    Acquisition payment amount | €   € 717,785      
    Acquisition related costs     $ 1,600    
    Mobile Viewpoint Corporate BV [Member] | Maximum [Member]          
    Business Acquisition [Line Items]          
    Percentage of outstanding capital acquired 100.00%        
    XML 80 R58.htm IDEA: XBRL DOCUMENT v3.23.1
    SCHEDULE OF ACCOUNTS RECEIVABLE (Details) - USD ($)
    Dec. 31, 2022
    Dec. 31, 2021
    Receivables [Abstract]    
    Accounts receivable $ 6,680,000 $ 10,327,000
    Allowance for doubtful accounts (673,000) (1,258,000)
    Net accounts receivable $ 6,007,000 $ 9,069,000
    XML 81 R59.htm IDEA: XBRL DOCUMENT v3.23.1
    ACCOUNTS RECEIVABLE (Details Narrative) - USD ($)
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Receivables [Abstract]    
    Bad debt expense $ 21,000 $ 233,000
    Recovered bad debts $ 517,000 $ 310,000
    XML 82 R60.htm IDEA: XBRL DOCUMENT v3.23.1
    SCHEDULE OF INVENTORIES (Details) - USD ($)
    Dec. 31, 2022
    Dec. 31, 2021
    Inventory Disclosure [Abstract]    
    Raw materials $ 12,038,000 $ 11,308,000
    Work-in-process 1,474,000 2,105,000
    Finished goods 4,460,000 5,011,000
    Sub-total inventories 17,972,000 18,424,000
    Less reserve for slow-moving and excess inventory (5,951,000) (6,530,000)
    Total inventories, net $ 12,021,000 $ 11,894,000
    XML 83 R61.htm IDEA: XBRL DOCUMENT v3.23.1
    INVENTORIES (Details Narrative) - USD ($)
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
    Inventory valuation adjustments $ 1,143,000 $ 843,000
    Product Rationalization Program [Member]    
    Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
    Product lines impairing of inventories $ 1,787,000 $ 0
    XML 84 R62.htm IDEA: XBRL DOCUMENT v3.23.1
    SCHEDULE OF PROPERTY AND EQUIPMENT (Details) - USD ($)
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Property, Plant and Equipment [Line Items]    
    Property and equipment, gross $ 3,767,000 $ 3,534,000
    Accumulated depreciation (2,333,000) (2,361,000)
    Property and equipment, net $ 1,434,000 1,173,000
    Minimum [Member]    
    Property, Plant and Equipment [Line Items]    
    Estimated useful life 1 year  
    Maximum [Member]    
    Property, Plant and Equipment [Line Items]    
    Estimated useful life 14 years  
    Furniture and Fixtures [Member]    
    Property, Plant and Equipment [Line Items]    
    Property and equipment, gross $ 308,000 282,000
    Furniture and Fixtures [Member] | Minimum [Member]    
    Property, Plant and Equipment [Line Items]    
    Estimated useful life 1 year  
    Furniture and Fixtures [Member] | Maximum [Member]    
    Property, Plant and Equipment [Line Items]    
    Estimated useful life 10 years  
    Leasehold Improvements [Member]    
    Property, Plant and Equipment [Line Items]    
    Property and equipment, gross $ 443,000 439,000
    Leasehold Improvements [Member] | Minimum [Member]    
    Property, Plant and Equipment [Line Items]    
    Estimated useful life 1 year  
    Leasehold Improvements [Member] | Maximum [Member]    
    Property, Plant and Equipment [Line Items]    
    Estimated useful life 14 years  
    Computer Equipment [Member]    
    Property, Plant and Equipment [Line Items]    
    Property and equipment, gross $ 3,016,000 $ 2,813,000
    Computer Equipment [Member] | Minimum [Member]    
    Property, Plant and Equipment [Line Items]    
    Estimated useful life 1 year  
    Computer Equipment [Member] | Maximum [Member]    
    Property, Plant and Equipment [Line Items]    
    Estimated useful life 11 years  
    XML 85 R63.htm IDEA: XBRL DOCUMENT v3.23.1
    PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Property, Plant and Equipment [Abstract]    
    Property and equipment, depreciation $ 201,000 $ 195,000
    Depreciation leasehold improvement $ 228,000  
    XML 86 R64.htm IDEA: XBRL DOCUMENT v3.23.1
    SCHEDULE OF GOODWILL (Details) - USD ($)
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Goodwill    
    Beginning balance, Goodwill $ 0
    Goodwill additions 8,211,000
    Deferred tax liabilties associated with MVP acquistion 978,000
    Goodwill impairment (9,189,000)
    Ending balance, Goodwill $ 0 $ 0
    XML 87 R65.htm IDEA: XBRL DOCUMENT v3.23.1
    GOODWILL (Details Narrative) - USD ($)
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Goodwill    
    Goodwill impairment charges $ 9,189,000
    XML 88 R66.htm IDEA: XBRL DOCUMENT v3.23.1
    SCHEDULE OF INTANGIBLE ASSETS (Details) - USD ($)
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Property, Plant and Equipment [Line Items]    
    Beginning balance net   $ 1,921,000
    Intangible assets, net Addition   5,148,000
    Intangible assets, net Amortization $ (1,521,000) (1,148,000)
    Beginning balance net 5,921,000  
    Ending balance net 4,400,000 5,921,000
    Proprietary Technology [Member]    
    Property, Plant and Equipment [Line Items]    
    Beginning balance cost 2,132,000
    Beginning balance, accumulated Amortization (223,000)
    Intangible assets, Additions   2,132,000
    Intangible assets accumulated amortization, Additions  
    Intangible assets, Amortization
    Intangible assets, net Amortization (592,000) (223,000)
    Ending balance cost 2,132,000 2,132,000
    Ending balance, accumulated Amortization (815,000) (223,000)
    Patents and Licenses [Member]    
    Property, Plant and Equipment [Line Items]    
    Beginning balance cost 12,378,000 12,378,000
    Beginning balance, accumulated Amortization (11,843,000) (11,175,000)
    Intangible assets, Additions  
    Intangible assets accumulated amortization, Additions  
    Intangible assets, Amortization
    Intangible assets, net Amortization (535,000) (668,000)
    Ending balance cost 12,378,000 12,378,000
    Ending balance, accumulated Amortization (12,378,000) (11,843,000)
    Trade Names And Technology [Member]    
    Property, Plant and Equipment [Line Items]    
    Beginning balance cost 2,251,000 1,450,000
    Beginning balance, accumulated Amortization (1,052,000) (914,000)
    Intangible assets, Additions   801,000
    Intangible assets accumulated amortization, Additions  
    Intangible assets, Amortization
    Intangible assets, net Amortization (137,000) (138,000)
    Ending balance cost 2,251,000 2,251,000
    Ending balance, accumulated Amortization (1,189,000) (1,052,000)
    Customer Relationships [Member]    
    Property, Plant and Equipment [Line Items]    
    Beginning balance cost 5,095,000 2,880,000
    Beginning balance, accumulated Amortization (2,817,000) (2,698,000)
    Intangible assets, Additions   2,215,000
    Intangible assets accumulated amortization, Additions  
    Intangible assets, Amortization
    Intangible assets, net Amortization (257,000) (119,000)
    Ending balance cost 5,095,000 5,095,000
    Ending balance, accumulated Amortization $ (3,074,000) $ (2,817,000)
    XML 89 R67.htm IDEA: XBRL DOCUMENT v3.23.1
    SCHEDULE OF CAPITALIZED INTANGIBLE COSTS (Details) - USD ($)
    Dec. 31, 2022
    Dec. 31, 2021
    Property, Plant and Equipment [Line Items]    
    Intangible assets $ 4,400,000 $ 5,921,000
    Proprietary Technology [Member]    
    Property, Plant and Equipment [Line Items]    
    Intangible assets 1,319,000 1,910,000
    Patents and Licenses [Member]    
    Property, Plant and Equipment [Line Items]    
    Intangible assets 535,000
    Trade Names And Technology [Member]    
    Property, Plant and Equipment [Line Items]    
    Intangible assets 1,060,000 1,198,000
    Customer Relationships [Member]    
    Property, Plant and Equipment [Line Items]    
    Intangible assets $ 2,021,000 $ 2,278,000
    XML 90 R68.htm IDEA: XBRL DOCUMENT v3.23.1
    SCHEDULE OF AMORTIZATION OF INTANGIBLE ASSETS (Details) - USD ($)
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Property, Plant and Equipment [Line Items]    
    Amortization of intangible assets $ 1,521,000 $ 1,148,000
    Proprietary Technology [Member]    
    Property, Plant and Equipment [Line Items]    
    Amortization of intangible assets 592,000 223,000
    Patents and Licenses [Member]    
    Property, Plant and Equipment [Line Items]    
    Amortization of intangible assets 535,000 668,000
    Trade Names And Technology [Member]    
    Property, Plant and Equipment [Line Items]    
    Amortization of intangible assets 137,000 138,000
    Customer Relationships [Member]    
    Property, Plant and Equipment [Line Items]    
    Amortization of intangible assets $ 257,000 $ 119,000
    XML 91 R69.htm IDEA: XBRL DOCUMENT v3.23.1
    SCHEDULE OF ESTIMATED AMORTIZATION EXPENSE FOR INTANGIBLE ASSETS (Details) - USD ($)
    Dec. 31, 2022
    Dec. 31, 2021
    Goodwill and Intangible Assets Disclosure [Abstract]    
    2023 $ 645,000  
    2024 645,000  
    2025 645,000  
    2026 556,000  
    2027 539,000  
    Thereafter 1,370,000  
    Finite-Lived Intangible Assets, Net, Total $ 4,400,000 $ 5,921,000
    XML 92 R70.htm IDEA: XBRL DOCUMENT v3.23.1
    INTANGIBLE ASSETS (Details Narrative)
    12 Months Ended
    Dec. 31, 2022
    Finite-Lived Intangible Assets [Line Items]  
    Finite-lived intangible assets, remaining amortization period 5 years 3 months 18 days
    Proprietary Technology [Member] | Minimum [Member]  
    Finite-Lived Intangible Assets [Line Items]  
    Finite-lived intangible asset, useful life 3 years
    Proprietary Technology [Member] | Maximum [Member]  
    Finite-Lived Intangible Assets [Line Items]  
    Finite-lived intangible asset, useful life 5 years
    Patents and Licenses [Member] | Minimum [Member]  
    Finite-Lived Intangible Assets [Line Items]  
    Finite-lived intangible asset, useful life 18 years 6 months
    Patents and Licenses [Member] | Maximum [Member]  
    Finite-Lived Intangible Assets [Line Items]  
    Finite-lived intangible asset, useful life 20 years
    Trade Names And Technology [Member] | Minimum [Member]  
    Finite-Lived Intangible Assets [Line Items]  
    Finite-lived intangible asset, useful life 3 years
    Trade Names And Technology [Member] | Maximum [Member]  
    Finite-Lived Intangible Assets [Line Items]  
    Finite-lived intangible asset, useful life 15 years
    XML 93 R71.htm IDEA: XBRL DOCUMENT v3.23.1
    SCHEDULE OF ACCRUED EXPENSES (Details) - USD ($)
    Dec. 31, 2022
    Dec. 31, 2021
    Payables and Accruals [Abstract]    
    Compensation $ 246,000 $ 2,069,000
    Commissions 47,000 29,000
    Warranty 112,000 130,000
    Rent 185,000
    Accrued expenses other 908,000 687,000
    Deferred Equity 255,000 55,000
    Accrued expenses $ 1,568,000 $ 3,155,000
    XML 94 R72.htm IDEA: XBRL DOCUMENT v3.23.1
    SCHEDULE OF NOTES PAYABLE (Details) - USD ($)
    Dec. 31, 2022
    Dec. 31, 2021
    Short-Term Debt [Line Items]    
    Notes payable $ 84,000 $ 99,000
    Notes Payable One [Member]    
    Short-Term Debt [Line Items]    
    Notes payable 99,000
    Notes Payable Two [Member]    
    Short-Term Debt [Line Items]    
    Notes payable $ 84,000
    XML 95 R73.htm IDEA: XBRL DOCUMENT v3.23.1
    SCHEDULE OF NOTES PAYABLE (Details) (Parenthethical) - USD ($)
    12 Months Ended
    Apr. 05, 2022
    Apr. 05, 2021
    Dec. 31, 2022
    Dec. 31, 2021
    Short-Term Debt [Line Items]        
    Interest expense     $ 38,000 $ 29,000
    D & O Insurance Policy Renewed [Member] | Notes Payable One [Member]        
    Short-Term Debt [Line Items]        
    Debt instrument, face amount   $ 1,098,000    
    Debt instrument down payment   225,000    
    Notes Payable   $ 872,000    
    Debt instrument, interest rate, stated percentage   5.25%    
    Debt instrument, periodic payment, interest   $ 99,000    
    Interest expense     0 19,000
    D & O Insurance Policy Renewed [Member] | Notes Payable Two [Member]        
    Short-Term Debt [Line Items]        
    Debt instrument, face amount $ 1,037,000      
    Debt instrument down payment 194,000      
    Notes Payable $ 943,000      
    Debt instrument, interest rate, stated percentage 2.09%      
    Debt instrument, periodic payment, interest $ 84,000      
    Interest expense     $ 6,000 $ 0
    XML 96 R74.htm IDEA: XBRL DOCUMENT v3.23.1
    SCHEDULE OF OPERATING LEASE DATA (Details) - USD ($)
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Leases    
    Operating lease cost $ 438,000 $ 472,000
    Short-term lease cost 93,000 417,000
    Total lease cost 531,000 889,000
    Cash flows from operating leases $ 543,000 $ 635,000
    Weighted-average remaining lease term-operating leases 3 years 4 months 24 days 3 years 9 months 18 days
    Weighted-average discount rate-operating leases 9.40% 9.30%
    XML 97 R75.htm IDEA: XBRL DOCUMENT v3.23.1
    SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES (Details) - USD ($)
    Dec. 31, 2022
    Dec. 31, 2021
    Leases    
    2023 $ 589,000  
    2024 455,000  
    2025 443,000  
    2026 249,000  
    2027 59,000  
    Thereafter  
    Total lease payments 1,795,000  
    Less: imputed interest 233,000  
    Present value of lease liabilities 1,562,000  
    Less: Current lease liabilities 455,000 $ 560,000
    Non-current lease liabilities $ 1,107,000 $ 1,507,000
    XML 98 R76.htm IDEA: XBRL DOCUMENT v3.23.1
    SCHEDULE OF LEASE OBLIGATIONS ASSUMED (Details)
    12 Months Ended
    Dec. 31, 2022
    USD ($)
    ft²
    Nov. 01, 2021
    ft²
    Approximate Future Payments $ 1,795,000  
    Colchester, U.K. - Waterside House [Member]    
    Area of land | ft² 16,000  
    Lease-End Date Dec 2025  
    Approximate Future Payments $ 639,000  
    SINGAPORE    
    Area of land | ft² 950  
    Lease-End Date July 2023  
    Approximate Future Payments $ 19,000  
    Billerica, MA [Member]    
    Area of land | ft² 2,000  
    Lease-End Date Dec 2026  
    Approximate Future Payments $ 416,000  
    Hemel, UK [Member]    
    Area of land | ft² 12,870  
    Lease-End Date Oct 2023  
    Approximate Future Payments $ 123,000  
    Mount Olive, NJ [Member]    
    Area of land | ft² 7,979 7,979
    Lease-End Date Jan 2027  
    Approximate Future Payments $ 598,000  
    XML 99 R77.htm IDEA: XBRL DOCUMENT v3.23.1
    LEASES (Details Narrative)
    3 Months Ended 12 Months Ended
    Jul. 03, 2022
    USD ($)
    ft²
    Jul. 03, 2022
    AED (د.إ)
    ft²
    Apr. 28, 2022
    USD ($)
    ft²
    Apr. 28, 2022
    GBP (£)
    ft²
    Nov. 01, 2021
    USD ($)
    ft²
    May 24, 2021
    USD ($)
    ft²
    May 24, 2021
    AED (د.إ)
    ft²
    Feb. 01, 2021
    USD ($)
    ft²
    Feb. 01, 2021
    GBP (£)
    ft²
    Dec. 31, 2022
    USD ($)
    ft²
    Dec. 31, 2022
    USD ($)
    ft²
    Dec. 31, 2021
    USD ($)
    Lease term, description                     one to four years  
    Right of Use Assets                   $ 1,075,000 $ 1,075,000 $ 1,362,000
    Right of use assets, accumulated depreciation                     1,200,000  
    Operating lease liability                   1,562,000 1,562,000  
    Current operating lease liabilities                   455,000 455,000 560,000
    Non-current operating lease liabilities                   $ 1,107,000 $ 1,107,000 $ 1,507,000
    Weighted-average remaining term                   3 years 4 months 24 days 3 years 4 months 24 days 3 years 9 months 18 days
    Lease maturity description                     July 2023 to January 2027  
    Weighted-average discount rate                   9.40% 9.40% 9.30%
    Loss on impairment of Right Of Use Asset                     $ 88,000 $ 0
    Lutton, UK [Member]                        
    Area of land description                     the Company entered a one-year lease for 600 square feet of administrative office space in Lutton, UK, commencing on May 3, 2022, and terminating on May 31, 2023, for £1,320 monthly or approximately $1,800 per month. the Company entered into a one-year lease for 600 square feet of administrative office space in Lutton, UK, commencing on February 1, 2021, and terminating on January 31, 2022, for £1,674 or approximately $2,290 monthl
    Area of Land | ft²     600 600       600 600      
    Lease expiration     May 31, 2023 May 31, 2023       Jan. 31, 2022 Jan. 31, 2022      
    Payment for rent     $ 1,800 £ 1,320       $ 2,290 £ 1,674      
    Dubai, UAE [Member]                        
    Area of land description                     lease for 976 square feet of administrative office space commencing on July 3, 2022, and terminating on July 2, 2023, in Dubai Studio City, UAE, for AED 5,995 or approximately US$ 1,632 monthly. commencing on July 3, 2021, and terminating on July 2, 2022, for 976 square feet of administrative office space in Dubai Studio City, UAE, for AED 5,995 or approximately $1,620 monthly.
    Area of Land | ft² 976 976       976 976          
    Lease expiration Jul. 02, 2023 Jul. 02, 2023       Jul. 02, 2022 Jul. 02, 2022          
    Payment for rent $ 1,632 د.إ 5,995       $ 1,620 د.إ 5,995          
    Billerica, MA [Member]                        
    Area of Land | ft²                   2,000 2,000  
    Loss on impairment of Right Of Use Asset                   $ 88,000    
    Mount Olive, NJ [Member]                        
    Right of Use Assets         $ 522,000              
    Operating lease liability         $ 522,000              
    Area of Land | ft²         7,979         7,979 7,979  
    Lease expiration         Jan. 31, 2027              
    Payment for rent         $ 10,869              
    Payment for rent percentage         3.00%              
    XML 100 R78.htm IDEA: XBRL DOCUMENT v3.23.1
    SCHEDULE OF VALUATION AND WARRANTS EXERCISABLE (Details)
    12 Months Ended
    Dec. 31, 2022
    $ / shares
    shares
    Dec. 31, 2021
    $ / shares
    shares
    Derivative [Line Items]    
    Number of shares underlying the warrants | shares 55,333 66,341
    Minimum [Member]    
    Derivative [Line Items]    
    Warrant life (years) 0 years 7 months 6 days
    Maximum [Member]    
    Derivative [Line Items]    
    Warrant life (years) 4 months 24 days 1 year 4 months 24 days
    Measurement Input, Share Price [Member]    
    Derivative [Line Items]    
    Warrant exercise price $ 0.56 $ 1.18
    Measurement Input, Exercise Price [Member] | Minimum [Member]    
    Derivative [Line Items]    
    Warrant exercise price 0.00 60.00
    Measurement Input, Exercise Price [Member] | Maximum [Member]    
    Derivative [Line Items]    
    Warrant exercise price $ 60.00 $ 150.00
    Measurement Input, Price Volatility [Member] | Minimum [Member]    
    Derivative [Line Items]    
    Warrants measurement input 0 97
    Measurement Input, Price Volatility [Member] | Maximum [Member]    
    Derivative [Line Items]    
    Warrants measurement input 64 101
    Measurement Input, Risk Free Interest Rate [Member] | Minimum [Member]    
    Derivative [Line Items]    
    Warrants measurement input 0 0.19
    Measurement Input, Risk Free Interest Rate [Member] | Maximum [Member]    
    Derivative [Line Items]    
    Warrants measurement input 4.54 0.39
    Measurement Input, Expected Dividend Rate [Member]    
    Derivative [Line Items]    
    Warrants measurement input
    XML 101 R79.htm IDEA: XBRL DOCUMENT v3.23.1
    SCHEDULE OF CHANGES IN FAIR VALUE OF LEVEL 3 FINANCIAL LIABILITIES (Details) - USD ($)
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Derivative Instruments and Hedging Activities Disclosure [Abstract]    
    Beginning balance $ 22,000
    Change in fair value of derivative liabilities (22,000)
    Ending balance
    XML 102 R80.htm IDEA: XBRL DOCUMENT v3.23.1
    PREFERRED SHARES (Details Narrative) - $ / shares
    1 Months Ended
    Jan. 23, 2023
    Nov. 09, 2022
    Nov. 30, 2022
    Mar. 24, 2023
    Dec. 31, 2022
    Dec. 31, 2021
    Dec. 21, 2016
    Apr. 25, 2016
    Feb. 05, 2016
    Mar. 31, 2013
    Class of Stock [Line Items]                    
    Preferred stock shares authorized         10,000,000 10,000,000       10,000,000.0
    Preferred stock, par value         $ 0.00001 $ 0.00001       $ 0.00001
    Preferred stock voting rights     the Company’s board of directors approved the designation of a Series A Preferred Stock created for the sole purpose of the January 11, 2023, Special Meeting of stockholders voting on the consideration of a “Reverse Stock Split Proposal.” The Series A Preferred Stock had a par value of $0.00001 per share. The Preferred Stock was redeemable upon the holder participating at any meeting of stockholders held to vote on the Reverse Stock Split immediately before the opening of the polls at such meeting (the “Initial Redemption Time”) shall automatically be redeemed by the Corporation at the Initial Redemption Time without further action on the part of the Corporation or the holder thereof (the “Initial Redemption”). Any outstanding shares of Series A Preferred Stock that were not redeemed under an Initial Redemption were redeemed in whole, but not in part (i) if such redemption was ordered by the Board of Directors in its sole discretion, automatically and effective on such time and date specified by the Board of Directors in its sole discretion or (ii) automatically upon the approval by the Corporation’s stockholders of the Reverse Stock Split at the Special Meeting held for voting on the Reverse Stock Split proposal.              
    Series B Preferred Stock [Member]                    
    Class of Stock [Line Items]                    
    Preferred stock shares authorized                 5,000,000  
    Series D Preferred Stock [Member]                    
    Class of Stock [Line Items]                    
    Preferred stock shares authorized               5,000,000    
    Series E Preferred Stock [Member]                    
    Class of Stock [Line Items]                    
    Preferred stock shares authorized             5,000      
    Series A Preferred Stock [Member]                    
    Class of Stock [Line Items]                    
    Preferred stock shares authorized   47,500                
    Preferred stock, par value     $ 0.00001              
    Share issued price per share   $ 0.00001                
    Preferred stock voting rights   Each share of Series A Preferred Stock entitled the holder to 1,000,000 votes per share, and each fraction of a share had a ratable number of votes. Thus, each one-thousandth share of Series A Preferred Stock was entitled to 1,000 votes                
    Series A Preferred Stock [Member] | Subsequent Event [Member]                    
    Class of Stock [Line Items]                    
    Preferred stock redemption terms, description Each share of Series A Preferred Stock redeemed in any redemption described above was redeemed in consideration for the right to receive an amount equal to $0.00001 in cash for each ten (10) whole shares of Series A Preferred Stock that were “beneficially owned” by the “beneficial owner” (as such terms are defined in the certificate of designation concerning the Series A Preferred Stock) thereof as of the applicable redemption time and redeemed under such redemption, payable upon receipt by the Company of a written request submitted by the relevant holder to the corporate secretary of the Company following the applicable redemption time                  
    Preferred stock unissued       47,500            
    Series D Convertible Preferred Stock [Member]                    
    Class of Stock [Line Items]                    
    Preferred stock unissued               5,000,000    
    Preferred stock par value               $ 0.00001    
    Series E Convertible Preferred Stock [Member]                    
    Class of Stock [Line Items]                    
    Preferred stock unissued             5,000      
    Preferred stock par value             $ 0.00001      
    Series D Preferred Stock and Series E Preferred Stock [Member]                    
    Class of Stock [Line Items]                    
    Preferred stock par value             $ 0.00001      
    XML 103 R81.htm IDEA: XBRL DOCUMENT v3.23.1
    SCHEDULE OF WARRANT OUTSTANDING (Details) - $ / shares
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Equity [Abstract]    
    Number of warrants ending outstanding 9,209,811 222,360
    Weighted average exercise price ending outstanding $ 4.10 $ 89.60
    Number of warrants granted   9,120,910
    Weighted average exercise price granted   $ 3.30
    Number of warrants exercised   (10,063)
    Weighted Average Exercise Price, exercised   $ (1.20)
    Number of warrants cancelled/expired (34,885) (123,396)
    Weighted average exercise price cancelled/expired $ (131.20) $ (98.30)
    Number of warrants ending outstanding 9,174,926 9,209,811
    Weighted average exercise price ending outstanding $ 3.60 $ 4.10
    XML 104 R82.htm IDEA: XBRL DOCUMENT v3.23.1
    SCHEDULE OF WARRANT OUTSTANDING EXERCISE PRICE (Details) - Warrants [Member] - $ / shares
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Accumulated Other Comprehensive Income (Loss) [Line Items]    
    Warrants Outstanding and Exercisable (in shares) 9,174,926 9,209,811
    Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years) 3 years 1 month 6 days 4 years 29 days
    Warrants outstanding and exercisable, Weighted Average Exercise Price $ 3.60 $ 4.10
    Exercise Price Range One [Member]    
    Accumulated Other Comprehensive Income (Loss) [Line Items]    
    Warrants outstanding and exercisable, Range of exercise prices $ 3.25  
    Warrants Outstanding and Exercisable (in shares) 9,090,910 9,090,910
    Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years) 3 years 1 month 9 days 4 years 1 month 9 days
    Warrants outstanding and exercisable, Weighted Average Exercise Price $ 3.30 $ 3.30
    Exercise Price Range Two [Member]    
    Accumulated Other Comprehensive Income (Loss) [Line Items]    
    Warrants outstanding and exercisable, Range of exercise prices $ 3.41  
    Warrants Outstanding and Exercisable (in shares) 30,000 30,000
    Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years) 1 year 2 months 4 days 2 years 2 months 4 days
    Warrants outstanding and exercisable, Weighted Average Exercise Price $ 3.50 $ 3.50
    Exercise Price Range Three [Member]    
    Accumulated Other Comprehensive Income (Loss) [Line Items]    
    Warrants outstanding and exercisable, Range of exercise prices $ 30.000  
    Warrants Outstanding and Exercisable (in shares) 683 683
    Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years) 1 year 6 months 14 days 2 years 6 months 14 days
    Warrants outstanding and exercisable, Weighted Average Exercise Price $ 30.00 $ 30.00
    Exercise Price Range Four [Member]    
    Accumulated Other Comprehensive Income (Loss) [Line Items]    
    Warrants outstanding and exercisable, Range of exercise prices $ 60.000  
    Warrants Outstanding and Exercisable (in shares) 53,333 53,333
    Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years) 4 months 28 days 1 year 4 months 28 days
    Warrants outstanding and exercisable, Weighted Average Exercise Price $ 60.00 $ 60.00
    Exercise Price Range Five [Member]    
    Accumulated Other Comprehensive Income (Loss) [Line Items]    
    Warrants outstanding and exercisable, Range of exercise prices $ 120.000  
    Warrants Outstanding and Exercisable (in shares) 21,877
    Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years) 1 month 13 days
    Warrants outstanding and exercisable, Weighted Average Exercise Price $ 120.00
    Exercise Price Range Six [Member]    
    Accumulated Other Comprehensive Income (Loss) [Line Items]    
    Warrants outstanding and exercisable, Range of exercise prices $ 150.000  
    Warrants Outstanding and Exercisable (in shares) 13,008
    Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years) 7 months 17 days
    Warrants outstanding and exercisable, Weighted Average Exercise Price $ 150.00
    XML 105 R83.htm IDEA: XBRL DOCUMENT v3.23.1
    STOCKHOLDERS’ EQUITY (Details Narrative)
    12 Months Ended
    Jul. 19, 2022
    USD ($)
    $ / shares
    shares
    May 04, 2022
    USD ($)
    $ / shares
    shares
    Feb. 08, 2021
    USD ($)
    $ / shares
    shares
    Dec. 31, 2022
    USD ($)
    $ / shares
    shares
    Dec. 31, 2021
    USD ($)
    $ / shares
    shares
    May 20, 2022
    $ / shares
    Accumulated Other Comprehensive Income (Loss) [Line Items]            
    Common stock shares authorized       100,000,000 100,000,000  
    Common stock, par value | $ / shares       $ 0.00001 $ 0.00001 $ 1.00
    Common stock, shares issued       47,419,317 45,825,089  
    Common stock shares outstanding       47,416,658 45,822,430  
    Issuance of common stock share value | $       $ (20,000)    
    Stock compensation costs | $       1,565,000 $ 3,860,000  
    Issuance of common stock share         6,163,198  
    Proceeds from issuance of offering | $         $ 13,000,000  
    Offering cost | $         400,000  
    Net proceeds from offering cost | $         12,600,000  
    Proceeds from exercise of warrants | $       $ 2,000  
    Number of warrants cancelled/expired       34,885 123,396  
    Measurement Input, Share Price [Member]            
    Accumulated Other Comprehensive Income (Loss) [Line Items]            
    Warrant exercise price per share | $ / shares       $ 0.56 $ 1.18  
    Measurement Input, Expected Dividend Rate [Member]            
    Accumulated Other Comprehensive Income (Loss) [Line Items]            
    Expected dividend yield        
    Warrant Holders [Member]            
    Accumulated Other Comprehensive Income (Loss) [Line Items]            
    Issuance of common stock share         3,811  
    Number of shares issued for exercise of warrants         3,811  
    Proceeds from exercise of warrants | $         $ 3,500  
    Warrant Holders One [Member]            
    Accumulated Other Comprehensive Income (Loss) [Line Items]            
    Issuance of common stock share         6,250  
    Number of shares issued for exercise of warrants         6,250  
    Specific Board Members [Member]            
    Accumulated Other Comprehensive Income (Loss) [Line Items]            
    Issuance of common stock share value | $         $ 200,000  
    Issuance of common stock share         87,720  
    Consulting Agreement [Member]            
    Accumulated Other Comprehensive Income (Loss) [Line Items]            
    Issuance of common stock share value | $       $ 80,000    
    Stock issued during period for services, shares 38,703 38,703        
    Shares issued price per share | $ / shares $ 0.59 $ 0.81        
    Stock issued during period for services, value+ | $ $ 22,835 $ 31,349        
    Services liabilities | $ 40,000 $ 40,000        
    Gain on extinguishment debt | $ $ 25,816          
    Common Stock [Member]            
    Accumulated Other Comprehensive Income (Loss) [Line Items]            
    Issuance of common stock share     18,181,820      
    Warrant life (years)     5 years      
    Warrant exercise price per share | $ / shares     $ 3.25      
    Net proceeds from offering cost | $     $ 46,820,000      
    Common Stock Warrants [Member]            
    Accumulated Other Comprehensive Income (Loss) [Line Items]            
    Number of shares issued for exercise of warrants         30,000  
    Warrant life (years)         3 years  
    Warrant exercise price per share | $ / shares         $ 3.41  
    Warrants term         3 years  
    Warrants outstanding | $         $ 74,000  
    Number of warrants cancelled/expired       34,885    
    Weighted average exercise price ending exercisable | $ / shares       $ 3.60    
    Weighted average remaining contractual life       3 years 1 month 6 days    
    Common Stock Warrants [Member] | Measurement Input, Share Price [Member]            
    Accumulated Other Comprehensive Income (Loss) [Line Items]            
    Warrant exercise price per share | $ / shares         $ 3.05  
    Common Stock Warrants [Member] | Measurement Input, Exercise Price [Member]            
    Accumulated Other Comprehensive Income (Loss) [Line Items]            
    Warrant exercise price per share | $ / shares         $ 3.41  
    Common Stock Warrants [Member] | Measurement Input, Price Volatility [Member]            
    Accumulated Other Comprehensive Income (Loss) [Line Items]            
    Expected dividend yield         153.96  
    Common Stock Warrants [Member] | Measurement Input, Risk Free Interest Rate [Member]            
    Accumulated Other Comprehensive Income (Loss) [Line Items]            
    Expected dividend yield         0.08  
    Common Stock Warrants [Member] | Measurement Input, Expected Dividend Rate [Member]            
    Accumulated Other Comprehensive Income (Loss) [Line Items]            
    Expected dividend yield         0  
    Restricted Stock Units (RSUs) [Member]            
    Accumulated Other Comprehensive Income (Loss) [Line Items]            
    Shares attributable to withholding tax       357,778    
    Restricted Stock Units (RSUs) [Member] | Common Stock [Member]            
    Accumulated Other Comprehensive Income (Loss) [Line Items]            
    Restricted stock options, granted       1,159,044    
    February 2021 Financing [Member]            
    Accumulated Other Comprehensive Income (Loss) [Line Items]            
    Issuance of common stock share         18,181,820  
    Number of shares issued for exercise of warrants         9,090,910  
    Warrant life (years)         5 years  
    Warrant exercise price per share | $ / shares         $ 3.25  
    Proceeds from issuance of offering | $     50,000,000      
    Offering cost | $     3,180,000      
    Net proceeds from offering cost | $     $ 46,820,000      
    XML 106 R84.htm IDEA: XBRL DOCUMENT v3.23.1
    SCHEDULE OF STOCK OPTION PLANS (Details) - USD ($)
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Stock-based compensation expense $ 1,565,000 $ 3,863,000
    Restricted Stock Units (RSUs) [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Stock-based compensation expense 1,385,000
    Remaining expense of stock-based compensation $ 3,248,000 $ 2,533,000
    Remaining amortization period 2 years 3 months 18 days 3 years 6 months
    Intrinsic value per share
    Number of options beginning balance 798,665
    Number of options, Stock options forfeited (125,000)
    Number of options, ending outstanding 2,814,726 798,665
    Number of options exercisable 415,885
    Weighted average exercise price, outstanding beginning balance $ 3.17
    Weighted average exercise price, Stock options forfeited (0.98)
    Weighted average exercise price, outstanding ending balance 1.20 3.17
    Weighted average exercise price, exercisable balance $ 3.30
    Weighted average remaining contractual life options outstanding and exercisable 2 years 6 months 2 years 6 months
    Number of options, Stock options granted 2,141,061 798,665
    Weighted average exercise price, Stock options granted $ 1.04 $ 3.17
    Time Vested Option [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Stock-based compensation expense $ 179,000 $ 113,000
    Remaining expense of stock-based compensation $ 319,000 $ 498,000
    Remaining amortization period 1 year 1 month 6 days 2 years 1 month 6 days
    Intrinsic value per share $ 0.38
    Number of options beginning balance 494,415 494,415
    Number of options, Stock options forfeited
    Number of options, ending outstanding 494,415 494,415
    Number of options exercisable 360,515 236,915
    Weighted average exercise price, outstanding beginning balance $ 1.01 $ 1.24
    Weighted average exercise price, Stock options forfeited
    Weighted average exercise price, outstanding ending balance 0.60 1.01
    Weighted average exercise price, exercisable balance $ 0.80 $ 0.48
    Weighted average remaining contractual life - options exercisable 7 years 1 month 6 days 8 years 1 month 6 days
    Performance Based Option [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Stock-based compensation expense
    Remaining expense of stock-based compensation $ 414,000,000 $ 414,000,000
    Remaining amortization period 2 years 1 month 6 days 3 years 1 month 6 days
    Intrinsic value per share
    Number of options beginning balance 250,000 250,000
    Number of options, Stock options forfeited
    Number of options, ending outstanding 250,000 250,000
    Number of options exercisable
    Weighted average exercise price, outstanding beginning balance $ 1.65 $ 1.65
    Weighted average exercise price, Stock options forfeited
    Weighted average exercise price, outstanding ending balance 1.65 1.65
    Weighted average exercise price, exercisable balance
    Weighted average remaining contractual life - options exercisable 7 years 1 month 6 days 8 years 1 month 6 days
    Range of exercise prices $ 1.71 $ 1.71
    Performance Based Option [Member] | Restricted Stock [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Stock-based compensation expense $ 3,722,000
    Remaining expense of stock-based compensation $ 1,498,000
    Remaining amortization period 2 years 9 months 18 days 0 years
    Intrinsic value per share $ 1.18
    Number of options exercisable 1,267,380
    Weighted average exercise price, exercisable balance $ 2.90
    Weighted average remaining contractual life options outstanding and exercisable 2 years 9 months 18 days 4 years
    RSUs range of exercise prices, upper limit $ 1.05  
    Number of options RSUs, outstanding, beginning balance 1,267,380 368,715
    Restricted stock units granted 1,426,062 898,665
    Restricted stock units exercised outstanding (1,267,380)
    Number of options RSUs outstanding ending balance 1,426,062 1,267,380
    Number of weighted-averages exercise price exercisable beginning balance $ 2.90 $ 1.32
    Weighted average exercise price Restricted stock units , granted 1.05 3.60
    Weighted average exercise price Restricted stock units exercised outstanding (2.90)
    Weighted average exercise price RSUs, exercisable, ending balance 1.10 2.90
    Minimum [Member] | Restricted Stock Units (RSUs) [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    RSUs range of exercise prices, upper limit 0.98 1.89
    Minimum [Member] | Time Vested Option [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Range of exercise prices 0.96 0.96
    Minimum [Member] | Performance Based Option [Member] | Restricted Stock [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    RSUs range of exercise prices, upper limit   1.32
    Maximum [Member] | Restricted Stock Units (RSUs) [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Range of exercise prices, upper 3.60 3.60
    Maximum [Member] | Time Vested Option [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Range of exercise prices $ 1.71 1.71
    Maximum [Member] | Performance Based Option [Member] | Restricted Stock [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    RSUs range of exercise prices, upper limit   $ 3.60
    2013 Long-Term Stock Incentive Plan [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Stock-based compensation expense $ 1,000 $ 27,000
    Remaining expense of stock-based compensation $ 1,000
    Remaining amortization period 0 years 3 months 18 days
    Outstanding and exercisable term 4 years 6 months 5 years 6 months
    Intrinsic value per share
    Number of options beginning balance 49,925 56,399
    Number of options, Stock options forfeited (4,916) (6,474)
    Number of options, ending outstanding 45,009 49,925
    Number of options exercisable 45,009 48,703
    Weighted average exercise price, outstanding beginning balance $ 88.04 $ 89.79
    Weighted average exercise price, Stock options forfeited (96.70) (84.13)
    Weighted average exercise price, outstanding ending balance 87.80 88.04
    Weighted average exercise price, exercisable balance 87.80 89.80
    2013 Long-Term Stock Incentive Plan [Member] | Minimum [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Range of exercise prices 6.96 6.96
    2013 Long-Term Stock Incentive Plan [Member] | Maximum [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Range of exercise prices $ 97.20 $ 1,173.60
    XML 107 R85.htm IDEA: XBRL DOCUMENT v3.23.1
    SCHEDULE OF STOCK OPTION PLANS FOR VESTED OPTION (Details) - $ / shares
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Performance Based Stock Option [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Expiration date Jan. 22, 2030  
    Performance Based Stock Option [Member] | Share-Based Payment Arrangement, Tranche One [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Units vesting schedule, tranche three [1] 83,334  
    Performance Based Stock Option [Member] | Share-Based Payment Arrangement, Tranche Two [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Units vesting schedule, tranche three [2] 83,333  
    Performance Based Stock Option [Member] | Share-Based Payment Arrangement, Tranche Three [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Units vesting schedule, tranche three [3] 83,333  
    Chief Executive Officer [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Grant date Jan. 22, 2020  
    Chief Executive Officer [Member] | Restricted Stock Units (RSUs) [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Exercise Price $ 3.60  
    Grant date Mar. 03, 2021  
    Grant, Units 598,665  
    Initial RSUs Vesting, Vested Date Mar. 03, 2022  
    Initial RSUs Vesting, Vested Units 199,555  
    Remaining RSUs Vesting, Units 399,110  
    Remaining RSUs Vesting, Term 24 equal monthly periods  
    Chief Executive Officer [Member] | Share-Based Payment Arrangement, Tranche One [Member] | Restricted Stock Units (RSUs) [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    75% Remaining Vesting   RSUs will vest upon the Company’s attainment, on or before December 31, 2026, of revenue of more than $35,575,000 accumulated over four consecutive fiscal quarters.
    Chief Executive Officer [Member] | Share-Based Payment Arrangement, Tranche Two [Member] | Restricted Stock Units (RSUs) [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    75% Remaining Vesting   RSUs will vest upon the Company’s attainment, on or before December 31, 2026, of revenue of more than $37,353,000 accumulated over four consecutive fiscal quarters
    Chief Executive Officer [Member] | Share-Based Payment Arrangement, Tranche Three [Member] | Restricted Stock Units (RSUs) [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    75% Remaining Vesting   RSUs will vest upon the Company’s attainment, on or before December 31, 2026, of revenue of more than $39,220,000 accumulated over four consecutive fiscal quarters
    Chief Executive Officer [Member] | Time Vested Option [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Grant date Jan. 22, 2020  
    Grant units 359,247  
    Exercise Price $ 1.71  
    Vesting commencement date Jan. 22, 2020  
    Expiration date Jan. 22, 2030  
    25% Vesting Jan. 22, 2021  
    75% Remaining Vesting 36 equal monthly payments  
    Chief Executive Officer [Member] | Performance Based Stock Option [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Grant units 250,000  
    Exercise Price $ 1.71  
    Vesting commencement date Jan. 22, 2020  
    Chief Executive Officer [Member] | Performance Based Option [Member] | Restricted Stock Units (RSUs) [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Grant date   Feb. 16, 2022
    Grant units 896,665 1,033,076
    Exercise Price $ 3.60 $ 1.05
    Grant date Mar. 03, 2021  
    Chief Executive Officer [Member] | Performance Based Option [Member] | Share-Based Payment Arrangement, Tranche One [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    75% Remaining Vesting Shares will vest upon the Company’s attainment, on or before the fifth (5th) anniversary of the Vesting Commencement Date, of Cumulative EBITDA of more than $6,000,000 accumulated over four consecutive fiscal quarters  
    Chief Executive Officer [Member] | Performance Based Option [Member] | Share-Based Payment Arrangement, Tranche One [Member] | Restricted Stock Units (RSUs) [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Units vesting schedule, tranche three 299,555 344,359 [4]
    Chief Executive Officer [Member] | Performance Based Option [Member] | Share-Based Payment Arrangement, Tranche Two [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    75% Remaining Vesting Shares will vest upon the Company’s attainment, on or before the fifth (5th) anniversary of the Vesting Commencement Date, of Cumulative EBITDA of more than $15,000,000 accumulated over four consecutive fiscal quarters  
    Chief Executive Officer [Member] | Performance Based Option [Member] | Share-Based Payment Arrangement, Tranche Two [Member] | Restricted Stock Units (RSUs) [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Units vesting schedule, tranche three 299,555 344,359 [5]
    Chief Executive Officer [Member] | Performance Based Option [Member] | Share-Based Payment Arrangement, Tranche Three [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    75% Remaining Vesting Shares will vest upon the Company’s attainment, on or before the fifth (5th) anniversary of the Vesting Commencement Date, of Cumulative EBITDA of more than $23,000,000 accumulated over four consecutive fiscal quarters  
    Chief Executive Officer [Member] | Performance Based Option [Member] | Share-Based Payment Arrangement, Tranche Three [Member] | Restricted Stock Units (RSUs) [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Units vesting schedule, tranche three 299,555 344,359 [6]
    Chief Financial Officer [Member] | Share-Based Payment Arrangement, Tranche Two [Member] | Performance Based Restricted Stock Units [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Units vesting schedule, tranche three [5]   130,995
    Chief Financial Officer [Member] | Time Vested Option [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Grant date Feb. 27, 2020  
    Grant units 135,168  
    Exercise Price $ 0.96  
    Vesting commencement date Apr. 01, 2020  
    Expiration date Apr. 01, 2030  
    25% Vesting Apr. 01, 2021  
    75% Remaining Vesting 36 equal monthly payments  
    Chief Financial Officer [Member] | Performance Based Option [Member] | Restricted Stock Units (RSUs) [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Grant date   Feb. 16, 2022
    Grant units 368,715 392,985
    Exercise Price $ 1.32 $ 1.05
    Grant date Dec. 31, 2020  
    Chief Financial Officer [Member] | Performance Based Option [Member] | Share-Based Payment Arrangement, Tranche One [Member] | Restricted Stock Units (RSUs) [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Units vesting schedule, tranche three 122,905 130,995 [4]
    Chief Financial Officer [Member] | Performance Based Option [Member] | Share-Based Payment Arrangement, Tranche Two [Member] | Restricted Stock Units (RSUs) [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Units vesting schedule, tranche three 122,905  
    Chief Financial Officer [Member] | Performance Based Option [Member] | Share-Based Payment Arrangement, Tranche Three [Member] | Restricted Stock Units (RSUs) [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Units vesting schedule, tranche three 122,905 130,994 [6]
    Director [Member] | Restricted Stock Units (RSUs) [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Exercise Price $ 1.89  
    Grant date Aug. 17, 2021  
    Grant, Units 200,000  
    Initial RSUs Vesting, Vested Date Aug. 17, 2022  
    Initial RSUs Vesting, Vested Units 50,000  
    Remaining RSUs Vesting, Units 150,000  
    Remaining RSUs Vesting, Term 36 equal monthly periods  
    VP Global Operations [Member] | Restricted Stock Units (RSUs) [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Exercise Price $ 1.10  
    Grant date Jan. 12, 2022  
    Grant, Units 200,000  
    Initial RSUs Vesting, Vested Date Jan. 12, 2023  
    Initial RSUs Vesting, Vested Units 66,000  
    Remaining RSUs Vesting, Units 134,000  
    Remaining RSUs Vesting, Term 24 equal monthly periods  
    Group of 22 Employees [Member] | Restricted Stock Units (RSUs) [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Exercise Price $ 0.98  
    Grant date Feb. 17, 2022  
    Grant, Units 515,000  
    Initial RSUs Vesting, Vested Date Feb. 17, 2023  
    Initial RSUs Vesting, Vested Units 169,950  
    Remaining RSUs Vesting, Units 345,050  
    Remaining RSUs Vesting, Term 24 equal monthly periods  
    Carleton M. Miller [Member] | Restricted Stock Units (RSUs) [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Exercise Price $ 1.05  
    Grant date Feb. 16, 2022  
    Grant, Units 1,033,076  
    Initial RSUs Vesting, Vested Date Feb. 16, 2023  
    Initial RSUs Vesting, Vested Units 258,269  
    Remaining RSUs Vesting, Units 774,807  
    Remaining RSUs Vesting, Term 36 equal monthly periods  
    Mike Bond [Member] | Restricted Stock Units (RSUs) [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Exercise Price $ 1.05  
    Grant date Feb. 16, 2022  
    Grant, Units 392,985  
    Initial RSUs Vesting, Vested Date Feb. 16, 2023  
    Initial RSUs Vesting, Vested Units 98,256  
    Remaining RSUs Vesting, Units 294,739  
    Remaining RSUs Vesting, Term 36 equal monthly periods  
    [1] Shares will vest upon the Company’s attainment, on or before the fifth (5th) anniversary of the Vesting Commencement Date, of Cumulative EBITDA of more than $6,000,000 accumulated over four consecutive fiscal quarters.
    [2] Shares will vest upon the Company’s attainment, on or before the fifth (5th) anniversary of the Vesting Commencement Date, of Cumulative EBITDA of more than $15,000,000 accumulated over four consecutive fiscal quarters.
    [3] Shares will vest upon the Company’s attainment, on or before the fifth (5th) anniversary of the Vesting Commencement Date, of Cumulative EBITDA of more than $23,000,000 accumulated over four consecutive fiscal quarters.
    [4] RSUs will vest upon the Company’s attainment, on or before December 31, 2026, of revenue of more than $35,575,000 accumulated over four consecutive fiscal quarters.
    [5] RSUs will vest upon the Company’s attainment, on or before December 31, 2026, of revenue of more than $37,353,000 accumulated over four consecutive fiscal quarters.
    [6] RSUs will vest upon the Company’s attainment, on or before December 31, 2026, of revenue of more than $39,220,000 accumulated over four consecutive fiscal quarters.
    XML 108 R86.htm IDEA: XBRL DOCUMENT v3.23.1
    SCHEDULE OF SHARE-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS (Details)
    12 Months Ended
    Dec. 31, 2022
    $ / shares
    Performance Based Option [Member]  
    Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]  
    Expected term (years) 6 years 6 months
    Expected dividend yield
    Risk-free interest rate 1.57%
    Volatility 153.00%
    Exercise price $ 1.71
    Chief Executive Officer [Member] | Time Vested Option [Member]  
    Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]  
    Expected term (years) 6 years 6 months
    Expected dividend yield
    Risk-free interest rate 1.57%
    Volatility 153.00%
    Exercise price $ 1.71
    Chief Financial Officer [Member] | Time Vested Option [Member]  
    Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]  
    Expected term (years) 6 years 3 months 18 days
    Expected dividend yield
    Risk-free interest rate 0.62%
    Volatility 155.00%
    Exercise price $ 0.96
    XML 109 R87.htm IDEA: XBRL DOCUMENT v3.23.1
    SCHEDULE OF STOCK OPTION PLANS FOR VESTED OPTION (Details) (Parenthetical) - Chief Executive Officer [Member]
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Share-Based Payment Arrangement, Tranche One [Member] | Restricted Stock Units (RSUs) [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Vesting rights description   RSUs will vest upon the Company’s attainment, on or before December 31, 2026, of revenue of more than $35,575,000 accumulated over four consecutive fiscal quarters.
    Share-Based Payment Arrangement, Tranche One [Member] | Performance Based Option [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Vesting rights description Shares will vest upon the Company’s attainment, on or before the fifth (5th) anniversary of the Vesting Commencement Date, of Cumulative EBITDA of more than $6,000,000 accumulated over four consecutive fiscal quarters  
    Share-Based Payment Arrangement, Tranche Two [Member] | Restricted Stock Units (RSUs) [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Vesting rights description   RSUs will vest upon the Company’s attainment, on or before December 31, 2026, of revenue of more than $37,353,000 accumulated over four consecutive fiscal quarters
    Share-Based Payment Arrangement, Tranche Two [Member] | Performance Based Option [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Vesting rights description Shares will vest upon the Company’s attainment, on or before the fifth (5th) anniversary of the Vesting Commencement Date, of Cumulative EBITDA of more than $15,000,000 accumulated over four consecutive fiscal quarters  
    Share-Based Payment Arrangement, Tranche Three [Member] | Restricted Stock Units (RSUs) [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Vesting rights description   RSUs will vest upon the Company’s attainment, on or before December 31, 2026, of revenue of more than $39,220,000 accumulated over four consecutive fiscal quarters
    Share-Based Payment Arrangement, Tranche Three [Member] | Performance Based Option [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Vesting rights description Shares will vest upon the Company’s attainment, on or before the fifth (5th) anniversary of the Vesting Commencement Date, of Cumulative EBITDA of more than $23,000,000 accumulated over four consecutive fiscal quarters  
    XML 110 R88.htm IDEA: XBRL DOCUMENT v3.23.1
    STOCK-BASED COMPENSATION (Details Narrative)
    12 Months Ended
    Dec. 31, 2022
    Performance Based Option [Member]  
    Award vesting description three equal tranches
    XML 111 R89.htm IDEA: XBRL DOCUMENT v3.23.1
    SCHEDULE OF MATCHING CONTRIBUTIONS (Details) - USD ($)
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Group Personal Pension Plan, UK [Member]    
    Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
    Company matching contributions $ 166,000 $ 169,000
    XML 112 R90.htm IDEA: XBRL DOCUMENT v3.23.1
    COMMITMENTS AND CONTINGENCIES (Details Narrative) - $ / shares
    Jan. 11, 2023
    Jan. 10, 2023
    Dec. 31, 2022
    May 20, 2022
    Dec. 31, 2021
    Subsequent Event [Line Items]          
    Common stock per share value     $ 0.00001 $ 1.00 $ 0.00001
    Subsequent Event [Member]          
    Subsequent Event [Line Items]          
    Common stock per share value $ 0.00001        
    Reverse split 1-for-50 1-for-2      
    XML 113 R91.htm IDEA: XBRL DOCUMENT v3.23.1
    CONCENTRATIONS (Details Narrative) - USD ($)
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Concentration Risk [Line Items]    
    Revenue from Contract with Customer, Excluding Assessed Tax $ 28,402,000 $ 33,882,000
    Single Customer [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]    
    Concentration Risk [Line Items]    
    Revenue from Contract with Customer, Excluding Assessed Tax $ 3,436,000 $ 8,511,000
    Concentration risk threshold percentage 12.00% 25.00%
    Single Customer [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]    
    Concentration Risk [Line Items]    
    Concentration risk threshold percentage 19.00%  
    Accounts receivable $ 1,138,000 $ 4,204,000
    Customer One [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]    
    Concentration Risk [Line Items]    
    Concentration risk threshold percentage   46.00%
    One Vendor [Member] | Accounts Payable [Member] | Supplier Concentration Risk [Member]    
    Concentration Risk [Line Items]    
    Concentration risk threshold percentage 10.00%  
    Accounts payable $ 270,000 $ 0
    XML 114 R92.htm IDEA: XBRL DOCUMENT v3.23.1
    SCHEDULE OF DISAGGREGATION OF REVENUE (Details) - USD ($)
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Disaggregation of Revenue [Line Items]    
    Revenue, net $ 28,402,000 $ 33,882,000
    Long-Lived Assets 6,909,000 16,667,000
    Equipment Sales [Member]    
    Disaggregation of Revenue [Line Items]    
    Revenue, net 25,667,000 31,733,000
    Installation, Integration and Repairs [Member]    
    Disaggregation of Revenue [Line Items]    
    Revenue, net 1,450,000 1,082,000
    Warranties [Member]    
    Disaggregation of Revenue [Line Items]    
    Revenue, net 1,014,000 743,000
    Other [Member]    
    Disaggregation of Revenue [Line Items]    
    Revenue, net 271,000 324,000
    North America [Member]    
    Disaggregation of Revenue [Line Items]    
    Revenue, net 12,037,000 18,050,000
    South America [Member]    
    Disaggregation of Revenue [Line Items]    
    Revenue, net 182,000 361,000
    Europe [Member]    
    Disaggregation of Revenue [Line Items]    
    Revenue, net 9,229,000 11,389,000
    Asia [Member]    
    Disaggregation of Revenue [Line Items]    
    Revenue, net 1,851,000 1,975,000
    Rest of World [Member]    
    Disaggregation of Revenue [Line Items]    
    Revenue, net 5,103,000 2,107,000
    UNITED STATES    
    Disaggregation of Revenue [Line Items]    
    Long-Lived Assets 1,970,000 2,410,000
    NETHERLANDS    
    Disaggregation of Revenue [Line Items]    
    Long-Lived Assets 27,000
    UNITED KINGDOM    
    Disaggregation of Revenue [Line Items]    
    Long-Lived Assets $ 4,912,000 $ 14,257,000
    XML 115 R93.htm IDEA: XBRL DOCUMENT v3.23.1
    SCHEDULE OF GAINS ON SETTLEMENT OF DEBT (Details) - USD ($)
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]    
    GAINS ON SETTLEMENT OF DEBT $ 45,732 $ 1,362,000
    Payroll Protection Program [Member]    
    Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]    
    GAINS ON SETTLEMENT OF DEBT 1,168,000
    Consulting Agreement [Member]    
    Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]    
    GAINS ON SETTLEMENT OF DEBT 25,816
    Dividends Payable [Member]    
    Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]    
    GAINS ON SETTLEMENT OF DEBT 19,916
    Vendor [Member]    
    Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]    
    GAINS ON SETTLEMENT OF DEBT $ 194,000
    XML 116 R94.htm IDEA: XBRL DOCUMENT v3.23.1
    SCHEDULE OF GAINS ON SETTLEMENT OF DEBT (Details) (Parenthetical) - USD ($)
    12 Months Ended
    Nov. 21, 2022
    Jul. 19, 2022
    May 04, 2022
    Jul. 26, 2021
    Mar. 10, 2021
    Feb. 08, 2021
    Dec. 31, 2021
    Dec. 31, 2022
    Amount payable             $ 3,075,000 $ 2,626,000
    Dividends payable amount $ 19,916              
    Issuance of shares of Series A Preferred Stock as dividends for common stock shareholders, shares             6,163,198  
    Series A Preferred Stock [Member]                
    Issuance of shares of Series A Preferred Stock as dividends for common stock shareholders, shares 47,419              
    Common Stock [Member]                
    Amount payable   $ 80,000 $ 80,000          
    Shares of common stock issued   38,703 38,703          
    Common stock accumulated value   $ 54,184 $ 54,184          
    Issuance of shares of Series A Preferred Stock as dividends for common stock shareholders, shares           18,181,820    
    Payroll Protection Program [Member]                
    Payroll protection program loan       $ 1,168,000        
    Vendor [Member]                
    Amount payable         $ 494,000      
    Remittance settlement         $ 300,000      
    XML 117 R95.htm IDEA: XBRL DOCUMENT v3.23.1
    SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT) (Details) - USD ($)
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Current tax provision    
    Federal
    State 25,000 7,000
    Current income tax expense, total 25,000 7,000
    Deferred tax provision (benefit)    
    Federal (532,000) (503,000)
    State (427,000) 1,025,000
    Foreign (978,000) (2,052,000)
    Change in the valuation allowance 1,722,000 1,530,000
    Total deferred tax provision (benefit) (215,000)
    Income tax provision $ (190,000) $ 7,000
    XML 118 R96.htm IDEA: XBRL DOCUMENT v3.23.1
    SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details)
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Income taxes    
    Statutory federal income tax rate 21.00% 21.00%
    State and local taxes, net of federal benefit 0.30% (6.27%)
    Permanent differences 5.28% (9.12%)
    Executive compensation (2.26%)
    Equity compensation (11.06%)
    Provision to return 0.00% (0.03%)
    DTA adjustment for state NOL 0.00% (0.06%)
    Foreign Rate Differential (1.27%) (1.96%)
    Change rate 2.66% (5.06%)
    Valuation allowance (13.27%) 1.46%
    Effective tax rate 1.37% (0.04%)
    XML 119 R97.htm IDEA: XBRL DOCUMENT v3.23.1
    SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) - USD ($)
    Dec. 31, 2022
    Dec. 31, 2021
    Income taxes    
    Federal R&D credit $ 3,007,000 $ 3,007,000
    Inventory 576,000 457,000
    Allowance for bad debt 72,000 76,000
    Compensation related 7,000 298,000
    Pension 72,000 39,000
    Other accruals 7,000 16,000
    State net operating losses 4,779,000 4,644,000
    Federal net operating losses 44,821,000 43,045,000
    Interest disallowance 1,151,000 82,000
    Stock options 7,172,000 7,621,000
    Other 296,000 1,097,000
    Valuation Allowance (61,731,000) (60,048,000)
    Total Deferred Tax Assets 229,000 334,000
    Property and Equipment (90,000) (47,000)
    Intangibles (870,000) (1,230,000)
    Prepaid Expenses (33,000) (35,000)
    Total Deferred Tax Liabilities (993,000) (1,312,000)
    Net Deferred Tax Liability $ (764,000) $ (978,000)
    XML 120 R98.htm IDEA: XBRL DOCUMENT v3.23.1
    INCOME TAXES (Details Narrative) - USD ($)
    $ in Millions
    12 Months Ended
    Dec. 31, 2022
    Dec. 31, 2021
    Dec. 31, 2020
    Operating Loss Carryforwards [Line Items]      
    Deferred tax assets, tax credit carryforwards, research     $ 3.0
    Operating loss carryforwards, expiration description expire in 2027    
    Effective for tax years, description the Tax Act includes a participation exemption system of taxation, which generally provides for 100% dividends received deduction on certain qualifying dividend distributions received by U.S. C-corporation shareholders from their 10% or more owned foreign subsidiaries. As a result of this new participation exemption system, it is generally anticipated that the Company should not be subject to additional U.S. federal income taxation on its future receipt of actual dividend income (instead of deemed inclusion amounts under specific anti-deferral rules) from its foreign subsidiary.    
    Domestic Tax Authority [Member]      
    Operating Loss Carryforwards [Line Items]      
    Operating loss carryforwards   $ 183.0  
    Domestic Tax Authority [Member] | Hale Capital Partners, LP [Member]      
    Operating Loss Carryforwards [Line Items]      
    Operating loss carryforwards     26.3
    State and Local Jurisdiction [Member]      
    Operating Loss Carryforwards [Line Items]      
    Operating loss carryforwards     158.6
    Foreign Tax Authority [Member]      
    Operating Loss Carryforwards [Line Items]      
    Operating loss carryforwards     $ 26.1
    XML 121 form10-k_htm.xml IDEA: XBRL DOCUMENT 0001565228 2022-01-01 2022-12-31 0001565228 2022-06-30 0001565228 2023-03-16 0001565228 2022-12-31 0001565228 2021-12-31 0001565228 us-gaap:SeriesAPreferredStockMember 2022-12-31 0001565228 us-gaap:SeriesAPreferredStockMember 2021-12-31 0001565228 2021-01-01 2021-12-31 0001565228 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2020-12-31 0001565228 us-gaap:CommonStockMember 2020-12-31 0001565228 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001565228 us-gaap:TreasuryStockMember 2020-12-31 0001565228 us-gaap:RetainedEarningsMember 2020-12-31 0001565228 2020-12-31 0001565228 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-12-31 0001565228 us-gaap:CommonStockMember 2021-12-31 0001565228 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001565228 us-gaap:TreasuryStockMember 2021-12-31 0001565228 us-gaap:RetainedEarningsMember 2021-12-31 0001565228 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2021-01-01 2021-12-31 0001565228 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001565228 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-12-31 0001565228 us-gaap:TreasuryStockMember 2021-01-01 2021-12-31 0001565228 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001565228 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-01-01 2022-12-31 0001565228 us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001565228 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-12-31 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-12-31 0001565228 us-gaap:TreasuryStockMember 2022-01-01 2022-12-31 0001565228 us-gaap:RetainedEarningsMember 2022-01-01 2022-12-31 0001565228 us-gaap:SeriesAPreferredStockMember us-gaap:PreferredStockMember 2022-12-31 0001565228 us-gaap:CommonStockMember 2022-12-31 0001565228 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001565228 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001565228 us-gaap:TreasuryStockMember 2022-12-31 0001565228 us-gaap:RetainedEarningsMember 2022-12-31 0001565228 us-gaap:SubsequentEventMember 2023-03-15 2023-03-16 0001565228 us-gaap:CommonStockMember 2021-02-07 2021-02-08 0001565228 us-gaap:CommonStockMember 2021-02-08 0001565228 srt:MinimumMember 2022-12-31 0001565228 srt:MinimumMember 2021-12-31 0001565228 VISL:SingleCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001565228 VISL:SingleCustomerMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001565228 VISL:SingleCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-12-31 0001565228 VISL:SingleCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001565228 VISL:SingleCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-12-31 0001565228 VISL:SingleCustomerMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001565228 srt:MinimumMember 2022-01-01 2022-12-31 0001565228 srt:MaximumMember 2022-01-01 2022-12-31 0001565228 srt:MinimumMember VISL:PatentsAndLicensesMember 2022-01-01 2022-12-31 0001565228 srt:MaximumMember VISL:PatentsAndLicensesMember 2022-01-01 2022-12-31 0001565228 VISL:PatentsAndLicensesMember 2022-01-01 2022-12-31 0001565228 VISL:PatentsAndLicensesMember 2021-01-01 2021-12-31 0001565228 srt:MinimumMember us-gaap:OtherIntangibleAssetsMember 2022-01-01 2022-12-31 0001565228 srt:MaximumMember us-gaap:OtherIntangibleAssetsMember 2022-01-01 2022-12-31 0001565228 us-gaap:OtherIntangibleAssetsMember 2022-01-01 2022-12-31 0001565228 us-gaap:OtherIntangibleAssetsMember 2021-01-01 2021-12-31 0001565228 VISL:GBPMember VISL:GBPToUSDMember 2022-12-31 0001565228 VISL:GBPToUSDMember 2022-12-31 0001565228 VISL:EuroMember VISL:EuroToGBPMember 2022-12-31 0001565228 VISL:GBPMember VISL:EuroToGBPMember 2022-12-31 0001565228 VISL:GBPMember VISL:GBPToUSDMember 2021-12-31 0001565228 VISL:GBPToUSDMember 2021-12-31 0001565228 VISL:EuroMember VISL:EuroToGBPMember 2021-12-31 0001565228 VISL:GBPMember VISL:EuroToGBPMember 2021-12-31 0001565228 2022-11-01 2022-11-30 0001565228 us-gaap:SeriesAPreferredStockMember 2022-11-30 0001565228 us-gaap:StockOptionMember 2022-01-01 2022-12-31 0001565228 us-gaap:StockOptionMember 2021-01-01 2021-12-31 0001565228 us-gaap:WarrantMember 2022-01-01 2022-12-31 0001565228 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001565228 us-gaap:FairValueInputsLevel1Member VISL:AbandonmentOfRightofuseOperatingLeasesMember 2022-12-31 0001565228 us-gaap:FairValueInputsLevel2Member VISL:AbandonmentOfRightofuseOperatingLeasesMember 2022-12-31 0001565228 us-gaap:FairValueInputsLevel3Member VISL:AbandonmentOfRightofuseOperatingLeasesMember 2022-12-31 0001565228 VISL:AbandonmentOfRightofuseOperatingLeasesMember 2022-12-31 0001565228 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001565228 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001565228 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001565228 us-gaap:FairValueInputsLevel1Member VISL:OtherMember 2022-12-31 0001565228 us-gaap:FairValueInputsLevel2Member VISL:OtherMember 2022-12-31 0001565228 us-gaap:FairValueInputsLevel3Member VISL:OtherMember 2022-12-31 0001565228 VISL:OtherMember 2022-12-31 0001565228 srt:MaximumMember VISL:MobileViewpointCorporateBVMember 2021-08-16 0001565228 VISL:MobileViewpointCorporateBVMember 2021-08-15 2021-08-16 0001565228 VISL:MobileViewpointCorporateBVMember 2021-08-13 0001565228 VISL:MobileViewpointCorporateBVMember 2022-01-01 2022-12-31 0001565228 2021-08-16 0001565228 us-gaap:TradeNamesMember 2021-08-15 2021-08-16 0001565228 VISL:ProprietaryTechnologyMember 2021-08-15 2021-08-16 0001565228 us-gaap:GoodwillMember 2021-08-15 2021-08-16 0001565228 us-gaap:CustomerRelationshipsMember 2021-08-15 2021-08-16 0001565228 2021-08-15 2021-08-16 0001565228 VISL:InternalRateOfReturnMember 2021-08-16 0001565228 VISL:WorkingCapitalMember 2021-08-16 0001565228 VISL:IntangibleAssetsMember 2021-08-16 0001565228 us-gaap:GoodwillMember 2021-08-16 0001565228 srt:ScenarioPreviouslyReportedMember 2021-08-16 0001565228 srt:RestatementAdjustmentMember 2021-08-16 0001565228 srt:ScenarioPreviouslyReportedMember us-gaap:TradeNamesMember 2021-08-16 0001565228 srt:RestatementAdjustmentMember us-gaap:TradeNamesMember 2021-08-16 0001565228 us-gaap:TradeNamesMember 2021-08-16 0001565228 srt:ScenarioPreviouslyReportedMember VISL:ProprietaryTechnologyMember 2021-08-16 0001565228 srt:RestatementAdjustmentMember VISL:ProprietaryTechnologyMember 2021-08-16 0001565228 VISL:ProprietaryTechnologyMember 2021-08-16 0001565228 srt:ScenarioPreviouslyReportedMember us-gaap:CustomerRelationshipsMember 2021-08-16 0001565228 srt:RestatementAdjustmentMember us-gaap:CustomerRelationshipsMember 2021-08-16 0001565228 us-gaap:CustomerRelationshipsMember 2021-08-16 0001565228 srt:ScenarioPreviouslyReportedMember us-gaap:GoodwillMember 2021-08-16 0001565228 srt:RestatementAdjustmentMember us-gaap:GoodwillMember 2021-08-16 0001565228 VISL:TradeNameMember 2022-01-01 2022-12-31 0001565228 VISL:ProprietaryTechnologiesMember 2022-01-01 2022-12-31 0001565228 VISL:CustomerRelationshipMember 2022-01-01 2022-12-31 0001565228 VISL:GoodwillIntangiblesMember 2022-01-01 2022-12-31 0001565228 VISL:ProductRationalizationProgramMember 2022-01-01 2022-12-31 0001565228 VISL:ProductRationalizationProgramMember 2021-01-01 2021-12-31 0001565228 srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2022-01-01 2022-12-31 0001565228 srt:MaximumMember us-gaap:FurnitureAndFixturesMember 2022-01-01 2022-12-31 0001565228 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001565228 us-gaap:FurnitureAndFixturesMember 2021-12-31 0001565228 srt:MinimumMember us-gaap:LeaseholdImprovementsMember 2022-01-01 2022-12-31 0001565228 srt:MaximumMember us-gaap:LeaseholdImprovementsMember 2022-01-01 2022-12-31 0001565228 us-gaap:LeaseholdImprovementsMember 2022-12-31 0001565228 us-gaap:LeaseholdImprovementsMember 2021-12-31 0001565228 srt:MinimumMember us-gaap:ComputerEquipmentMember 2022-01-01 2022-12-31 0001565228 srt:MaximumMember us-gaap:ComputerEquipmentMember 2022-01-01 2022-12-31 0001565228 us-gaap:ComputerEquipmentMember 2022-12-31 0001565228 us-gaap:ComputerEquipmentMember 2021-12-31 0001565228 VISL:ProprietaryTechnologyMember 2020-12-31 0001565228 VISL:PatentsAndLicensesMember 2020-12-31 0001565228 VISL:TradeNamesAndTechnologyMember 2020-12-31 0001565228 us-gaap:CustomerRelationshipsMember 2020-12-31 0001565228 VISL:ProprietaryTechnologyMember 2021-01-01 2021-12-31 0001565228 VISL:PatentsAndLicensesMember 2021-01-01 2021-12-31 0001565228 VISL:TradeNamesAndTechnologyMember 2021-01-01 2021-12-31 0001565228 us-gaap:CustomerRelationshipsMember 2021-01-01 2021-12-31 0001565228 VISL:ProprietaryTechnologyMember 2021-12-31 0001565228 VISL:PatentsAndLicensesMember 2021-12-31 0001565228 VISL:TradeNamesAndTechnologyMember 2021-12-31 0001565228 us-gaap:CustomerRelationshipsMember 2021-12-31 0001565228 VISL:ProprietaryTechnologyMember 2022-01-01 2022-12-31 0001565228 VISL:PatentsAndLicensesMember 2022-01-01 2022-12-31 0001565228 VISL:TradeNamesAndTechnologyMember 2022-01-01 2022-12-31 0001565228 us-gaap:CustomerRelationshipsMember 2022-01-01 2022-12-31 0001565228 VISL:ProprietaryTechnologyMember 2022-12-31 0001565228 VISL:PatentsAndLicensesMember 2022-12-31 0001565228 VISL:TradeNamesAndTechnologyMember 2022-12-31 0001565228 us-gaap:CustomerRelationshipsMember 2022-12-31 0001565228 srt:MinimumMember VISL:ProprietaryTechnologyMember 2022-01-01 2022-12-31 0001565228 srt:MaximumMember VISL:ProprietaryTechnologyMember 2022-01-01 2022-12-31 0001565228 srt:MinimumMember VISL:PatentsAndLicensesMember 2022-01-01 2022-12-31 0001565228 srt:MaximumMember VISL:PatentsAndLicensesMember 2022-01-01 2022-12-31 0001565228 srt:MinimumMember VISL:TradeNamesAndTechnologyMember 2022-01-01 2022-12-31 0001565228 srt:MaximumMember VISL:TradeNamesAndTechnologyMember 2022-01-01 2022-12-31 0001565228 VISL:NotesPayableOneMember 2022-12-31 0001565228 VISL:NotesPayableOneMember 2021-12-31 0001565228 VISL:NotesPayableTwoMember 2022-12-31 0001565228 VISL:NotesPayableTwoMember 2021-12-31 0001565228 VISL:NotesPayableOneMember VISL:DAndOInsurancePolicyRenewedMember 2021-04-05 0001565228 VISL:NotesPayableOneMember VISL:DAndOInsurancePolicyRenewedMember 2021-04-04 2021-04-05 0001565228 VISL:NotesPayableOneMember VISL:DAndOInsurancePolicyRenewedMember 2022-01-01 2022-12-31 0001565228 VISL:NotesPayableOneMember VISL:DAndOInsurancePolicyRenewedMember 2021-01-01 2021-12-31 0001565228 VISL:NotesPayableTwoMember VISL:DAndOInsurancePolicyRenewedMember 2022-04-05 0001565228 VISL:NotesPayableTwoMember VISL:DAndOInsurancePolicyRenewedMember 2022-04-04 2022-04-05 0001565228 VISL:NotesPayableTwoMember VISL:DAndOInsurancePolicyRenewedMember 2022-01-01 2022-12-31 0001565228 VISL:NotesPayableTwoMember VISL:DAndOInsurancePolicyRenewedMember 2021-01-01 2021-12-31 0001565228 VISL:LuttonUKMember 2022-01-01 2022-12-31 0001565228 VISL:LuttonUKMember 2022-04-28 0001565228 VISL:LuttonUKMember 2022-04-27 2022-04-28 0001565228 VISL:DubaiUAEMember 2022-01-01 2022-12-31 0001565228 VISL:DubaiUAEMember 2022-07-03 0001565228 VISL:DubaiUAEMember 2022-07-01 2022-07-03 0001565228 VISL:BillericaMaMember 2022-10-01 2022-12-31 0001565228 VISL:LuttonUKMember 2021-01-01 2021-12-31 0001565228 VISL:LuttonUKMember 2021-02-01 0001565228 VISL:LuttonUKMember 2021-01-31 2021-02-01 0001565228 VISL:DubaiUAEMember 2021-01-01 2021-12-31 0001565228 VISL:DubaiUAEMember 2021-05-23 2021-05-24 0001565228 VISL:DubaiUAEMember 2021-05-24 0001565228 VISL:MountOliveNJMember 2021-11-01 0001565228 VISL:MountOliveNJMember 2021-11-01 2021-11-01 0001565228 VISL:ColchesterUKWatersideHouseMember 2022-12-31 0001565228 VISL:ColchesterUKWatersideHouseMember 2022-01-01 2022-12-31 0001565228 country:SG 2022-12-31 0001565228 country:SG 2022-01-01 2022-12-31 0001565228 VISL:BillericaMaMember 2022-12-31 0001565228 VISL:BillericaMaMember 2022-01-01 2022-12-31 0001565228 VISL:HemelUKMember 2022-12-31 0001565228 VISL:HemelUKMember 2022-01-01 2022-12-31 0001565228 VISL:MountOliveNJMember 2022-12-31 0001565228 VISL:MountOliveNJMember 2022-01-01 2022-12-31 0001565228 us-gaap:MeasurementInputSharePriceMember 2022-12-31 0001565228 us-gaap:MeasurementInputSharePriceMember 2021-12-31 0001565228 srt:MinimumMember us-gaap:MeasurementInputExercisePriceMember 2022-12-31 0001565228 srt:MaximumMember us-gaap:MeasurementInputExercisePriceMember 2022-12-31 0001565228 srt:MinimumMember us-gaap:MeasurementInputExercisePriceMember 2021-12-31 0001565228 srt:MaximumMember us-gaap:MeasurementInputExercisePriceMember 2021-12-31 0001565228 srt:MinimumMember us-gaap:MeasurementInputPriceVolatilityMember 2022-12-31 0001565228 srt:MaximumMember us-gaap:MeasurementInputPriceVolatilityMember 2022-12-31 0001565228 srt:MinimumMember us-gaap:MeasurementInputPriceVolatilityMember 2021-12-31 0001565228 srt:MaximumMember us-gaap:MeasurementInputPriceVolatilityMember 2021-12-31 0001565228 srt:MinimumMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-12-31 0001565228 srt:MaximumMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-12-31 0001565228 srt:MinimumMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-12-31 0001565228 srt:MaximumMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-12-31 0001565228 us-gaap:MeasurementInputExpectedDividendRateMember 2022-12-31 0001565228 us-gaap:MeasurementInputExpectedDividendRateMember 2021-12-31 0001565228 srt:MaximumMember 2022-12-31 0001565228 srt:MaximumMember 2021-12-31 0001565228 2013-03-31 0001565228 us-gaap:SeriesBPreferredStockMember 2016-02-05 0001565228 us-gaap:SeriesDPreferredStockMember 2016-04-25 0001565228 us-gaap:SeriesEPreferredStockMember 2016-12-21 0001565228 us-gaap:SeriesAPreferredStockMember 2022-11-09 0001565228 us-gaap:SeriesAPreferredStockMember 2022-11-08 2022-11-09 0001565228 us-gaap:SeriesAPreferredStockMember us-gaap:SubsequentEventMember 2023-01-10 2023-01-23 0001565228 VISL:SeriesDConvertiblePreferredStockMember 2016-04-25 0001565228 VISL:SeriesEConvertiblePreferredStockMember 2016-12-21 0001565228 VISL:SeriesDPreferredStockAndSeriesEPreferredStockMember 2016-12-21 0001565228 us-gaap:SeriesAPreferredStockMember us-gaap:SubsequentEventMember 2023-03-24 0001565228 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001565228 us-gaap:RestrictedStockUnitsRSUMember us-gaap:CommonStockMember 2022-01-01 2022-12-31 0001565228 VISL:ConsultingAgreementMember 2022-01-01 2022-12-31 0001565228 VISL:ConsultingAgreementMember 2022-05-04 2022-05-04 0001565228 VISL:ConsultingAgreementMember 2022-05-04 0001565228 VISL:ConsultingAgreementMember 2022-07-19 2022-07-19 0001565228 VISL:ConsultingAgreementMember 2022-07-19 0001565228 VISL:FebruaryTwoThousandAndTwentyOneFinancingMember 2021-01-01 2021-12-31 0001565228 VISL:FebruaryTwoThousandAndTwentyOneFinancingMember 2021-12-31 0001565228 VISL:FebruaryTwoThousandAndTwentyOneFinancingMember 2021-02-07 2021-02-08 0001565228 VISL:FebruaryTwoThousandAndTwentyOneFinancingMember 2021-02-08 0001565228 VISL:WarrantHoldersMember 2021-01-01 2021-12-31 0001565228 VISL:WarrantHoldersOneMember 2021-01-01 2021-12-31 0001565228 VISL:CommonStockWarrantsMember 2021-12-31 0001565228 VISL:CommonStockWarrantsMember 2021-01-01 2021-12-31 0001565228 us-gaap:MeasurementInputSharePriceMember VISL:CommonStockWarrantsMember 2021-12-31 0001565228 us-gaap:MeasurementInputExercisePriceMember VISL:CommonStockWarrantsMember 2021-12-31 0001565228 us-gaap:MeasurementInputPriceVolatilityMember VISL:CommonStockWarrantsMember 2021-12-31 0001565228 us-gaap:MeasurementInputRiskFreeInterestRateMember VISL:CommonStockWarrantsMember 2021-12-31 0001565228 us-gaap:MeasurementInputExpectedDividendRateMember VISL:CommonStockWarrantsMember 2021-12-31 0001565228 VISL:SpecificBoardMembersMember 2021-01-01 2021-12-31 0001565228 VISL:CommonStockWarrantsMember 2022-01-01 2022-12-31 0001565228 VISL:CommonStockWarrantsMember 2022-12-31 0001565228 VISL:ExercisePriceRangeOneMember VISL:WarrantsMember 2022-01-01 2022-12-31 0001565228 VISL:ExercisePriceRangeOneMember VISL:WarrantsMember 2022-12-31 0001565228 VISL:ExercisePriceRangeOneMember VISL:WarrantsMember 2021-01-01 2021-12-31 0001565228 VISL:ExercisePriceRangeOneMember VISL:WarrantsMember 2021-12-31 0001565228 VISL:ExercisePriceRangeTwoMember VISL:WarrantsMember 2022-01-01 2022-12-31 0001565228 VISL:ExercisePriceRangeTwoMember VISL:WarrantsMember 2022-12-31 0001565228 VISL:ExercisePriceRangeTwoMember VISL:WarrantsMember 2021-01-01 2021-12-31 0001565228 VISL:ExercisePriceRangeTwoMember VISL:WarrantsMember 2021-12-31 0001565228 VISL:ExercisePriceRangeThreeMember VISL:WarrantsMember 2022-01-01 2022-12-31 0001565228 VISL:ExercisePriceRangeThreeMember VISL:WarrantsMember 2022-12-31 0001565228 VISL:ExercisePriceRangeThreeMember VISL:WarrantsMember 2021-01-01 2021-12-31 0001565228 VISL:ExercisePriceRangeThreeMember VISL:WarrantsMember 2021-12-31 0001565228 VISL:ExercisePriceRangeFourMember VISL:WarrantsMember 2022-01-01 2022-12-31 0001565228 VISL:ExercisePriceRangeFourMember VISL:WarrantsMember 2022-12-31 0001565228 VISL:ExercisePriceRangeFourMember VISL:WarrantsMember 2021-01-01 2021-12-31 0001565228 VISL:ExercisePriceRangeFourMember VISL:WarrantsMember 2021-12-31 0001565228 VISL:ExercisePriceRangeFiveMember VISL:WarrantsMember 2022-01-01 2022-12-31 0001565228 VISL:ExercisePriceRangeFiveMember VISL:WarrantsMember 2022-12-31 0001565228 VISL:ExercisePriceRangeFiveMember VISL:WarrantsMember 2021-01-01 2021-12-31 0001565228 VISL:ExercisePriceRangeFiveMember VISL:WarrantsMember 2021-12-31 0001565228 VISL:ExercisePriceRangeSixMember VISL:WarrantsMember 2022-01-01 2022-12-31 0001565228 VISL:ExercisePriceRangeSixMember VISL:WarrantsMember 2022-12-31 0001565228 VISL:ExercisePriceRangeSixMember VISL:WarrantsMember 2021-01-01 2021-12-31 0001565228 VISL:ExercisePriceRangeSixMember VISL:WarrantsMember 2021-12-31 0001565228 VISL:WarrantsMember 2022-01-01 2022-12-31 0001565228 VISL:WarrantsMember 2022-12-31 0001565228 VISL:WarrantsMember 2021-01-01 2021-12-31 0001565228 VISL:WarrantsMember 2021-12-31 0001565228 VISL:TwoThousandThirteenLongTermStockIncentivePlanMember 2022-01-01 2022-12-31 0001565228 VISL:TimeVestedOptionMember 2022-01-01 2022-12-31 0001565228 VISL:PerformanceBasedOptionMember 2022-01-01 2022-12-31 0001565228 us-gaap:RestrictedStockMember 2022-01-01 2022-12-31 0001565228 VISL:TwoThousandThirteenLongTermStockIncentivePlanMember 2021-01-01 2021-12-31 0001565228 srt:MinimumMember VISL:TwoThousandThirteenLongTermStockIncentivePlanMember 2022-01-01 2022-12-31 0001565228 srt:MaximumMember VISL:TwoThousandThirteenLongTermStockIncentivePlanMember 2022-01-01 2022-12-31 0001565228 srt:MinimumMember VISL:TwoThousandThirteenLongTermStockIncentivePlanMember 2021-01-01 2021-12-31 0001565228 srt:MaximumMember VISL:TwoThousandThirteenLongTermStockIncentivePlanMember 2021-01-01 2021-12-31 0001565228 VISL:TwoThousandThirteenLongTermStockIncentivePlanMember 2021-12-31 0001565228 VISL:TwoThousandThirteenLongTermStockIncentivePlanMember 2020-12-31 0001565228 VISL:TwoThousandThirteenLongTermStockIncentivePlanMember 2022-12-31 0001565228 VISL:TimeVestedOptionMember 2021-01-01 2021-12-31 0001565228 srt:MinimumMember VISL:TimeVestedOptionMember 2022-01-01 2022-12-31 0001565228 srt:MaximumMember VISL:TimeVestedOptionMember 2022-01-01 2022-12-31 0001565228 srt:MinimumMember VISL:TimeVestedOptionMember 2021-01-01 2021-12-31 0001565228 srt:MaximumMember VISL:TimeVestedOptionMember 2021-01-01 2021-12-31 0001565228 VISL:TimeVestedOptionMember 2021-12-31 0001565228 VISL:TimeVestedOptionMember 2020-12-31 0001565228 VISL:TimeVestedOptionMember 2022-12-31 0001565228 VISL:PerformanceBasedOptionMember 2021-01-01 2021-12-31 0001565228 VISL:PerformanceBasedOptionMember 2021-12-31 0001565228 VISL:PerformanceBasedOptionMember 2020-12-31 0001565228 VISL:PerformanceBasedOptionMember 2022-12-31 0001565228 us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0001565228 srt:MinimumMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001565228 srt:MaximumMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001565228 srt:MinimumMember us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0001565228 srt:MaximumMember us-gaap:RestrictedStockUnitsRSUMember 2021-01-01 2021-12-31 0001565228 us-gaap:RestrictedStockUnitsRSUMember 2021-12-31 0001565228 us-gaap:RestrictedStockUnitsRSUMember 2020-12-31 0001565228 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001565228 us-gaap:RestrictedStockMember VISL:PerformanceBasedOptionMember 2022-01-01 2022-12-31 0001565228 us-gaap:RestrictedStockMember VISL:PerformanceBasedOptionMember 2021-01-01 2021-12-31 0001565228 srt:MinimumMember us-gaap:RestrictedStockMember VISL:PerformanceBasedOptionMember 2021-01-01 2021-12-31 0001565228 srt:MaximumMember us-gaap:RestrictedStockMember VISL:PerformanceBasedOptionMember 2021-01-01 2021-12-31 0001565228 us-gaap:RestrictedStockMember VISL:PerformanceBasedOptionMember 2021-12-31 0001565228 us-gaap:RestrictedStockMember VISL:PerformanceBasedOptionMember 2020-12-31 0001565228 us-gaap:RestrictedStockMember VISL:PerformanceBasedOptionMember 2022-12-31 0001565228 srt:ChiefExecutiveOfficerMember VISL:TimeVestedOptionMember 2022-01-01 2022-12-31 0001565228 srt:ChiefExecutiveOfficerMember VISL:TimeVestedOptionMember 2022-12-31 0001565228 srt:ChiefFinancialOfficerMember VISL:TimeVestedOptionMember 2022-01-01 2022-12-31 0001565228 srt:ChiefFinancialOfficerMember VISL:TimeVestedOptionMember 2022-12-31 0001565228 srt:ChiefExecutiveOfficerMember 2022-01-01 2022-12-31 0001565228 srt:ChiefExecutiveOfficerMember VISL:PerformanceBasedStockOptionMember 2022-01-01 2022-12-31 0001565228 srt:ChiefExecutiveOfficerMember VISL:PerformanceBasedStockOptionMember 2022-12-31 0001565228 VISL:PerformanceBasedStockOptionMember 2022-01-01 2022-12-31 0001565228 VISL:PerformanceBasedStockOptionMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2022-01-01 2022-12-31 0001565228 VISL:PerformanceBasedStockOptionMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2022-01-01 2022-12-31 0001565228 VISL:PerformanceBasedStockOptionMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2022-01-01 2022-12-31 0001565228 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001565228 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001565228 srt:DirectorMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001565228 srt:DirectorMember us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001565228 VISL:VpGlobalOperationsMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001565228 VISL:VpGlobalOperationsMember us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001565228 VISL:GroupOfTwentyTwoEmployeesMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001565228 VISL:GroupOfTwentyTwoEmployeesMember us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001565228 VISL:CarletonMMillerMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001565228 VISL:CarletonMMillerMember us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001565228 VISL:MikeBondMember us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001565228 VISL:MikeBondMember us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001565228 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember VISL:PerformanceBasedOptionMember 2022-01-01 2022-12-31 0001565228 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember VISL:PerformanceBasedOptionMember 2022-12-31 0001565228 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember VISL:PerformanceBasedOptionMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2022-01-01 2022-12-31 0001565228 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember VISL:PerformanceBasedOptionMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2022-01-01 2022-12-31 0001565228 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember VISL:PerformanceBasedOptionMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2022-01-01 2022-12-31 0001565228 srt:ChiefFinancialOfficerMember us-gaap:RestrictedStockUnitsRSUMember VISL:PerformanceBasedOptionMember 2022-01-01 2022-12-31 0001565228 srt:ChiefFinancialOfficerMember us-gaap:RestrictedStockUnitsRSUMember VISL:PerformanceBasedOptionMember 2022-12-31 0001565228 srt:ChiefFinancialOfficerMember us-gaap:RestrictedStockUnitsRSUMember VISL:PerformanceBasedOptionMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2022-01-01 2022-12-31 0001565228 srt:ChiefFinancialOfficerMember us-gaap:RestrictedStockUnitsRSUMember VISL:PerformanceBasedOptionMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2022-01-01 2022-12-31 0001565228 srt:ChiefFinancialOfficerMember us-gaap:RestrictedStockUnitsRSUMember VISL:PerformanceBasedOptionMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2022-01-01 2022-12-31 0001565228 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember VISL:PerformanceBasedOptionMember 2021-01-01 2021-12-31 0001565228 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember VISL:PerformanceBasedOptionMember 2021-12-31 0001565228 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember VISL:PerformanceBasedOptionMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2021-01-01 2021-12-31 0001565228 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember VISL:PerformanceBasedOptionMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2021-01-01 2021-12-31 0001565228 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember VISL:PerformanceBasedOptionMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2021-01-01 2021-12-31 0001565228 srt:ChiefFinancialOfficerMember us-gaap:RestrictedStockUnitsRSUMember VISL:PerformanceBasedOptionMember 2021-01-01 2021-12-31 0001565228 srt:ChiefFinancialOfficerMember us-gaap:RestrictedStockUnitsRSUMember VISL:PerformanceBasedOptionMember 2021-12-31 0001565228 srt:ChiefFinancialOfficerMember us-gaap:RestrictedStockUnitsRSUMember VISL:PerformanceBasedOptionMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2021-01-01 2021-12-31 0001565228 srt:ChiefFinancialOfficerMember VISL:PerformanceBasedRestrictedStockUnitsMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2021-01-01 2021-12-31 0001565228 srt:ChiefFinancialOfficerMember us-gaap:RestrictedStockUnitsRSUMember VISL:PerformanceBasedOptionMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2021-01-01 2021-12-31 0001565228 srt:ChiefExecutiveOfficerMember VISL:PerformanceBasedOptionMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2022-01-01 2022-12-31 0001565228 srt:ChiefExecutiveOfficerMember VISL:PerformanceBasedOptionMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2022-01-01 2022-12-31 0001565228 srt:ChiefExecutiveOfficerMember VISL:PerformanceBasedOptionMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2022-01-01 2022-12-31 0001565228 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2021-01-01 2021-12-31 0001565228 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2021-01-01 2021-12-31 0001565228 srt:ChiefExecutiveOfficerMember us-gaap:RestrictedStockUnitsRSUMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2021-01-01 2021-12-31 0001565228 VISL:GroupPersonalPensionPlanUKMember 2022-01-01 2022-12-31 0001565228 VISL:GroupPersonalPensionPlanUKMember 2021-01-01 2021-12-31 0001565228 2022-05-20 0001565228 us-gaap:SubsequentEventMember 2023-01-11 0001565228 us-gaap:SubsequentEventMember 2023-01-10 2023-01-10 0001565228 us-gaap:SubsequentEventMember 2023-01-11 2023-01-11 0001565228 VISL:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001565228 VISL:OneVendorMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2022-12-31 0001565228 VISL:OneVendorMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2022-01-01 2022-12-31 0001565228 VISL:OneVendorMember us-gaap:AccountsPayableMember us-gaap:SupplierConcentrationRiskMember 2021-12-31 0001565228 srt:NorthAmericaMember 2022-01-01 2022-12-31 0001565228 srt:NorthAmericaMember 2021-01-01 2021-12-31 0001565228 srt:SouthAmericaMember 2022-01-01 2022-12-31 0001565228 srt:SouthAmericaMember 2021-01-01 2021-12-31 0001565228 srt:EuropeMember 2022-01-01 2022-12-31 0001565228 srt:EuropeMember 2021-01-01 2021-12-31 0001565228 srt:AsiaMember 2022-01-01 2022-12-31 0001565228 srt:AsiaMember 2021-01-01 2021-12-31 0001565228 VISL:RestOfWorldMember 2022-01-01 2022-12-31 0001565228 VISL:RestOfWorldMember 2021-01-01 2021-12-31 0001565228 VISL:EquipmentSalesMember 2022-01-01 2022-12-31 0001565228 VISL:EquipmentSalesMember 2021-01-01 2021-12-31 0001565228 VISL:InstallationIntegrationAndRepairsMember 2022-01-01 2022-12-31 0001565228 VISL:InstallationIntegrationAndRepairsMember 2021-01-01 2021-12-31 0001565228 VISL:WarrantiesMember 2022-01-01 2022-12-31 0001565228 VISL:WarrantiesMember 2021-01-01 2021-12-31 0001565228 VISL:OtherMember 2022-01-01 2022-12-31 0001565228 VISL:OtherMember 2021-01-01 2021-12-31 0001565228 country:US 2022-12-31 0001565228 country:US 2021-12-31 0001565228 country:NL 2022-12-31 0001565228 country:NL 2021-12-31 0001565228 country:GB 2022-12-31 0001565228 country:GB 2021-12-31 0001565228 VISL:VendorMember 2022-01-01 2022-12-31 0001565228 VISL:VendorMember 2021-01-01 2021-12-31 0001565228 VISL:PayrollProtectionProgramMember 2022-01-01 2022-12-31 0001565228 VISL:PayrollProtectionProgramMember 2021-01-01 2021-12-31 0001565228 VISL:ConsultingAgreementMember 2021-01-01 2021-12-31 0001565228 VISL:DividendsPayableMember 2022-01-01 2022-12-31 0001565228 VISL:DividendsPayableMember 2021-01-01 2021-12-31 0001565228 VISL:VendorMember 2021-03-10 0001565228 VISL:VendorMember 2021-03-10 2021-03-10 0001565228 VISL:PayrollProtectionProgramMember 2021-07-26 2021-07-26 0001565228 us-gaap:CommonStockMember 2022-05-04 2022-05-04 0001565228 us-gaap:CommonStockMember 2022-07-19 2022-07-19 0001565228 us-gaap:CommonStockMember 2022-07-19 0001565228 us-gaap:CommonStockMember 2022-05-04 0001565228 2022-11-21 0001565228 us-gaap:SeriesAPreferredStockMember 2022-11-21 2022-11-21 0001565228 us-gaap:DomesticCountryMember 2021-12-31 0001565228 us-gaap:DomesticCountryMember VISL:CarriedForwardIndefinitelyMember 2020-12-31 0001565228 us-gaap:StateAndLocalJurisdictionMember 2020-12-31 0001565228 us-gaap:ForeignCountryMember 2020-12-31 iso4217:USD shares iso4217:USD shares pure iso4217:GBP utr:sqft iso4217:AED iso4217:EUR 0001565228 false FY P5Y P5Y P3Y P3Y 10-K true 2022-12-31 --12-31 2022 false 001-35988 Vislink Technologies, Inc. DE 20-5856795 350 Clark Drive Suite 125 Mt. Olive NJ 07828 908 852-3700 Common Stock, par value $0.00001 NASDAQ No No Yes Yes Non-accelerated Filer true false false 28400000 47619317 VISL 688 Marcum LLP New York, NY 25627000 36231000 6007000 9069000 12021000 11894000 1232000 2470000 44887000 59664000 1075000 1362000 1434000 1173000 4400000 5921000 51796000 68120000 2626000 3075000 1568000 3155000 84000 99000 455000 560000 1540000 2113000 6273000 9002000 1107000 1507000 764000 978000 8144000 11487000 0.00001 0.00001 47500 0 47419 47419 0 0 0.10 0.10 10000 10000 0.00001 0.00001 10000000 10000000 0.00001 0.00001 100000000 100000000 47419317 45825089 47416658 45822430 345365000 343746000 -1337000 -297000 2659 2659 277000 277000 -300099000 -286539000 43652000 56633000 51796000 68120000 28402000 33882000 15204000 15164000 2930000 843000 18195000 22039000 4058000 3051000 88000 9189000 1722000 1343000 42197000 51629000 -13795000 -17747000 22000 46000 1362000 32000 38000 29000 40000 1355000 -13755000 -16392000 -215000 -13540000 -16392000 20000 -13560000 -16392000 -0.29 -0.38 46692000 43484000 -13540000 -16392000 -1040000 445000 -12500000 -16837000 21382290 280273000 148000 -277000 -270147000 9997000 -16392000 -16392000 -445000 -445000 24348018 59334000 17346000 3811 2000 11000 6250 87720 200000 330000 74000 3863000 715000 45825089 343746000 -297000 -277000 -286539000 56633000 45825089 343746000 -297000 -277000 -286539000 56633000 -13540000 -13540000 -1040000 -1040000 47419 -20000 -20000 77406 54000 54000 357778 1159044 1565000 1565000 47419 47419317 345365000 -1337000 -277000 -300099000 43652000 47419 47419317 345365000 -1337000 -277000 -300099000 43652000 -13540000 -16392000 46000 1362000 1565000 3863000 200000 200000 74000 21000 233000 517000 310000 2930000 843000 201000 237000 88000 9189000 1722000 1343000 -22000 -215000 -3197000 3611000 3731000 3187000 -2090000 -96000 -347000 -2388000 -1780000 231000 -506000 -483000 -558000 867000 978000 -9226000 -9601000 965000 18311000 466000 201000 -466000 -17547000 62914000 -3580000 2000 958000 1024000 -958000 58312000 46000 -123000 -10604000 31041000 36231000 5190000 25627000 36231000 41000 56000 943000 1098000 20000 200000 200000 54000 74000 522000 1185000 237000 -43000 -88000 -1316000 285000 531000 -506000 -483000 -506000 48000 <p id="xdx_806_eus-gaap--NatureOfOperations_zLdi78JUHmRa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 — <span id="xdx_823_zDiQYhKSeYA4">NATURE OF OPERATIONS</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vislink, incorporated in Delaware in 2006, is a global technology business specializing in collecting, delivering, and managing high-quality, live video and associated data from the action scene to the viewing screen. Vislink provides solutions for collecting live news, sports, entertainment, and news events for the broadcast markets. Vislink also furnishes the surveillance and defense markets with real-time video intelligence solutions using various tailored transmission products. The Vislink team also provides professional and technical services utilizing a staff of technology experts with decades of applied knowledge and real-world experience in the terrestrial microwave, satellite, fiber optic, surveillance, and wireless communications systems delivering a broad spectrum of customer solutions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Live Broadcast:</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vislink delivers an extensive portfolio of solutions for live news, sports, and entertainment industries. These solutions include video collection, transmission, management, and distribution via microwave, satellite, cellular, I.P. (Internet Protocol), MESH, and bonded cellular/5G networks. We also provide solutions utilizing A.I. (Artificial Intelligence) technologies to provide automated news and sporting events coverage. With over 50 years in operation, Vislink has the expertise and technology portfolio to deliver fully integrated, seamless, end-to-end solutions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Industry-wide contributors acknowledge Vislink’s live broadcast solutions. The transmission of most of all outside wireless broadcast video content uses our equipment, with over 200,000 systems installed worldwide. We work closely with the majority of the world’s broadcasters. Vislink wireless cameras and ultra-compact encoders help bring many of the world’s most prestigious sporting and entertainment events to life. Recent examples include globally watched international sporting contests, award shows, racing events, and annual music and cultural events.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Military And Government:</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vislink has developed high-quality solutions to meet surveillance and defense markets’ operational and industry challenges based on our knowledge of live video delivery. Vislink solutions are specifically designed with interagency cooperation, utilizing the internationally-recognized I.P. platform and a web interface for video delivery. Vislink provides comprehensive video, audio, and data communications solutions to law enforcement and the public safety community, including Airborne, Unmanned Systems, Maritime, and Tactical Mobile Command Posts. These solutions may include:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">integrated suites of airborne downlink transmitters, receivers, and antenna systems</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">data and video connectivity for airborne, marine, and ground assets</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">UAV video distribution</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">flexible support for COFDM and bonded cellular/5G Networks</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">terrestrial point-to-point</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">tactical mobile command</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IP-based, high-end encryption, full-duplex, real-time connectivity at extended operating ranges</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">high-throughput air/marine/ground-to-anywhere uplink and downlink systems</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">secure live streaming platforms for use in mobile and fixed assets</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">personal portable products</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vislink public safety and surveillance solutions are deployed worldwide, including throughout the U.S., Europe, and the Middle East, at the local, regional, and federal levels of operation, criminal investigation, crisis management, mobile command posts, and field operations. These solutions are designed to meet the demands of field operations, command centers, and central receiving sites. Short-range and long-range solutions are available in areas including established infrastructure and exceptionally remote regions, making valuable video intelligence available regardless of location.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Satellite Communications</span>:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Over 30 years of technical expertise support Vislink’s satellite solutions. These solutions ensure robust, secure communications while delivering low transmission costs for any organization that needs high-quality, reliable satellite transmission. We offer turnkey solutions that begin with state-of-the-art coding, compression, and engine modulation and end with our robust, lightweight antenna systems. Vislink Satellite solutions focus heavily on being the smallest, lightest, and most efficient in their categories, making transportation and ease of use a key driver in the customer experience. Vislink offers an extensive range of satellite designs that allow customers to optimize bit rate, size, weight, and total cost. Our satellite systems are used extensively globally, with over 2,000 systems deployed by governments, militaries, and broadcasters. While we continue offering satellite solutions, we no longer invest in the engineering and product development necessary to stay relevant in the sector. We will continue to market and sell our current solutions but do not anticipate introducing further upgrades or features to our satellite product line.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 408.45pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 — NATURE OF OPERATIONS (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Connected Edge Solutions:</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vislink offers the hardware and software solutions needed to acquire, produce, contribute, and deliver video over all private and public networks with the Mobile Viewpoint acquisition. Connected edge solutions aid the video transport concept of ubiquitous IP networks and cloud-scale computing across 5G, WiFi6, Mesh, and COFDM-enabled networks. These solutions include:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Live video encoding, stream adaptation, decoding, and production solutions</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Remote production workflows</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wireless cameras</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">AI-driven automated production</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ability to contribute video over:</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif">○<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Bonded cellular (3G and 4G)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif">○<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Satellite</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif">○<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Fiber</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif">○<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Emerging networks, including 5G and Starlink</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_804_ecustom--LiquidityAndFinancialConditionTextBlock_zCRWh89k2pgl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 — <span id="xdx_82C_zhziQm57dvTl">LIQUIDITY AND FINANCIAL CONDITION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company incurred an approximate $<span id="xdx_904_eus-gaap--OperatingIncomeLoss_iN_pn5n6_di_c20220101__20221231_zqlOxZeitE9b" title="Operating income loss">13.8</span> million loss from operations and $<span id="xdx_90B_eus-gaap--NetCashProvidedByUsedInOperatingActivities_iN_pn5n6_di_c20220101__20221231_zC3I6kgRmE2b" title="Net cash provided by used in operating activities">9.2</span> million of cash used in operating activities for the year ended December 31, 2022. The Company had $<span id="xdx_90F_ecustom--WorkingCapital_iI_pn5n6_c20221231_zrLZ8H0jEdD2" title="Working capital">38.6</span> million in working capital, $<span id="xdx_90D_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn5n6_di_c20221231_zfLoDKne8Ipe" title="Accumulated deficit">300.1</span> million in accumulated deficits, and $<span id="xdx_908_eus-gaap--Cash_iI_pn5n6_c20221231_zHqatLwZR9j7" title="Cash">25.6</span> million cash on hand as of December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2021, the Company issued <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210101__20211231_zAOkqRFuApi2" title="Common stock shares issued">6,163,198</span> shares of common stock for net proceeds of $<span id="xdx_90A_eus-gaap--ProceedsFromIssuanceOfCommonStock_pp0p0_c20210101__20211231_zzN2JhR26tHd" title="Proceeds from issuance of common stock">12,600,000</span> under its at-the-market facility with Alliance Global Partners (the “ATM”). As of March 16, 2023, approximately $<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20230315__20230316__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zYqMJgzw5gB1" title="Common stock value">4,500,000</span> of capacity remains under the ATM. On February 8, 2021, the Company completed an underwritten public offering for net proceeds of $<span id="xdx_905_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pp0p0_c20210207__20210208__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zTUJbNcC5NEi" title="Proceeds from public offering">46,820,000</span>. The Company issued <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210207__20210208__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zvTprl6UM0Nl" title="Issuance of common stock shares">18,181,820</span> shares of common stock, supplemented by <span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20210208__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zj4k0Y3D9bh1" title="Warrants to purchase shares of common stock">9,090,910</span> <span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dxL_c20210208__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zDDtWGo4uIba" title="Warrant term::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl0715">five</span></span>-year warrants with an exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210208__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z6pa5vZiP4Nj" title="Warrant exercise price">3.25</span> per share exercisable for one share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The enduring effect of the COVID-19 pandemic, including the advent of successive variants, plus the uncertainty of possible future variants, may subject the Company to particular challenges in its business, financial condition, results of operations, and cash flows. The unpredictability of the pandemic’s scope, severity, duration, and actions implemented to alleviate its direct and indirect economic effects and containment measures provide no assurances that the pandemic will not have material adverse repercussions on the Company’s operations, liquidity, financial condition, and any residual unfavorable consequences to global economics.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Developments, including those beyond our control, may cause us to consume our available capital more quickly. The Company bases its evaluation on possibilities that may prove wrong and could exhaust our available capital resources sooner than we expect. These may include but are not limited to economic conditions, including inflation, foreign exchange, fluctuations, and the markets in which we compete or wish to enter, strategic acquisitions, our market strategy, our research and development activities, regulatory matters, and technology and product innovations. The Company believes it will have sufficient funds to continue its operations for at least twelve months from the filing date of these financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> -13800000 -9200000 38600000 -300100000 25600000 6163198 12600000 4500000 46820000 18181820 9090910 3.25 <p id="xdx_80F_eus-gaap--SignificantAccountingPoliciesTextBlock_zvRJQm9popH1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 — <span id="xdx_826_znrdxH5iLZsi">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--BusinessCombinationsPolicy_zsF8DMpkdaVk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_860_zVu8UgkIkSNj">Business Combinations</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for acquisitions that qualify as business combinations by applying the acquisition method according to Accounting Standards Codification (“ASC”) 805, Business Combinations (“ASC 805”). Transaction costs related to the acquisition of a business are expensed as incurred and excluded from the fair value of consideration transferred. The identifiable assets acquired, liabilities assumed, and noncontrolling interests in an acquired entity are recognized and measured at their estimated fair values. The excess of the fair value of consideration transferred over the fair values of identifiable assets acquired, liabilities assumed, and noncontrolling interests in an acquired entity, net of the fair value of any previously held interest in the acquired entity, is recorded as goodwill. Such valuations require management to make significant estimates and assumptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_84F_eus-gaap--ConsolidationPolicyTextBlock_zQpVY0EXUbv6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86F_zs29LkNhLQ41">Principles of Consolidation</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America or (“U.S. GAAP”) as found in the Accounting Standards Codification (“ASC”), the Accounting Standards Update (“ASU”) of the Financial Accounting Standards Board (“FASB”) and the rules and regulations of the US Securities and Exchange Commission (the “SEC”). The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. We have eliminated all intercompany accounts and transactions upon consolidating our subsidiaries.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zjxfHSArPWj8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_866_zdYZcFss6fh2">Segment Reporting</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company identifies operating segments as components of an enterprise about which separate discrete financial information is available for evaluation by the operating decision-makers, or decision-making group, in deciding how to allocate resources and assess performance. The Company’s decision-making group is the senior executive management team. The Company and the decision-making group view the Company’s operations and manage its business as one operating segment with different product offerings. All long-lived assets of the Company reside in the U.S., the U.K., and the Netherlands.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--UseOfEstimates_zwF35IJPUT6e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86D_zUo0LdCc554g">Use of Estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities in the consolidated financial statements. Significant accounting estimates reflected in the Company’s consolidated financial statements include the useful lives of property, plant, and equipment, the useful lives of right-of-use assets, the useful lives of intangible assets, impairment of long-lived assets, allowance for accounts receivable doubtful accounts, allowance for inventory obsolescence reserve, allowance for deferred tax assets, valuation of warranty reserves, contingent consideration liabilities, and the accrual of potential liabilities. These estimates also affect the reported revenues and expenses during the reporting periods. Actual results could differ from estimates, and any such differences may be material to our financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_ecustom--RisksAndUncertaintiesPolicyTextBlock_zyRzqrluXMd7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_868_zu4t6IcNA5nf">Risks and Uncertainties</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The future impacts of the Russia-Ukraine war, the novel coronavirus (“COVID-19”) pandemic, and their residual effects include economic uncertainty, an inflationary environment, currency fluctuations, disruption within the global supply chain, and labor markets worldwide industries remain uncertain. These circumstances have created prevalent uncertainty and risk. The impact of these issues on our business will vary by geographic market and discipline. In response to potential reductions in revenue, we may take actions to align our cost structure with changes in customer demand and manage our working capital. However, there can be no assurance as to the effectiveness of our efforts to mitigate any impact of the current and future adverse economic conditions, reductions in client revenue, changes in client creditworthiness, and other developments. We monitor the circumstances mentioned above to assess direct material adverse effects on our business, financial condition, or results of operations. Therefore, these impacts may change accounting estimates and assumptions over time. Interim period results are not necessarily indicative of the expected results for the full fiscal year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zPlx9G3CUW0j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_867_zzFkcOYyUwr4">Cash and Cash Equivalents</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. The Company did not have cash equivalents as of December 31, 2022, and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zcRHsjgW4rh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_865_zsUGO4VaBdS3">Concentrations</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company does not have any off-balance-sheet concentrations of credit risk. Credit risk is that the counterparty will default on its contractual obligations, resulting in a company’s financial loss. The Company’s credit risk is primarily attributable to its cash and accounts receivables. The Company’s policy is to maintain its cash with high-credit quality financial institutions to limit its risk of loss exposure. Financial instruments potentially subject the Company to credit risk concentration consisting of cash deposits. The Federal Deposit Insurance Corporation (“FDIC”) insures accounts held within the United States up to $<span id="xdx_90D_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20221231_zK7cMH6k5bi9" title="Cash FDIC insured amount">250,000</span>. The Company maintains cash balance accounts at financial institutions in the United Kingdom insured by the Financial Services Compensation Scheme up to £<span id="xdx_908_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_uGBP_c20221231_zZyO2pWVn14l" title="Cash FDIC insured amount">85,000</span>, subject to currency translation rates to the United States dollar. Lastly, the Company maintains cash balance accounts at financial institutions in the Netherlands insured by the “Dutch deposit guarantee scheme” up to €<span id="xdx_903_ecustom--DutchDepositGuaranteeScheme_iI_pp0p0_uEUR_c20221231_zyNMtKrnrvke" title="Dutch deposit guarantee scheme">100,000</span> per person, per bank.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 31, 2022, and 2021, the Company had approximately $<span id="xdx_904_eus-gaap--CashUninsuredAmount_iI_pn5n6_c20221231__srt--RangeAxis__srt--MinimumMember_z9Jf4seZ0BOg" title="Cash uninsured amount">24.5</span> million and $<span id="xdx_902_eus-gaap--CashUninsuredAmount_iI_pn5n6_c20211231__srt--RangeAxis__srt--MinimumMember_zFsVcd6n85tc" title="Cash uninsured amount">35.2</span> million above insured limits, respectively. The Company has not experienced any losses in its bank accounts between December 31, 2022, and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management assesses their credit quality for customers, considering their financial position and historical experience. During the year ended December 31, 2022, the Company recorded sales to a single customer of $<span id="xdx_906_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__srt--MajorCustomersAxis__custom--SingleCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zr25JFC31ei2" title="Revenue">3,436,000</span> (<span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--SingleCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z2au0OJSM1U5" title="Concentration risk percentage">12%</span>), in excess of 10% of the Company’s total sales. For the year ended December 31, 2021, the Company recorded sales to a single customer of $<span id="xdx_90D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__srt--MajorCustomersAxis__custom--SingleCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zMyGZFOu4su4" title="Revenue">8,511,000</span> (<span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--MajorCustomersAxis__custom--SingleCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zHEsHEQkZ5g" title="Concentration risk percentage">25%</span>) in excess of 10% of the Company’s total sales.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 31, 2022, and 2021, the Company recorded accounts receivable of approximately $<span id="xdx_905_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20221231__srt--MajorCustomersAxis__custom--SingleCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zUPjcX48xro9">1,138,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--SingleCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zh2aXe6B3f5d">19%</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) and $<span id="xdx_904_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20211231__srt--MajorCustomersAxis__custom--SingleCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zCbRrj6aLTIf">4,204,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--MajorCustomersAxis__custom--SingleCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zMDsVDiznFK1">46%</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">), respectively, to a single customer in excess of 10% of the Company’s total consolidated accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_znuVBelHnuf9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86C_zfzFQOW3T2Q8">Accounts Receivable and Allowance for Doubtful Accounts</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company extends credit to its customers in the ordinary course of business. Further, the Company regularly reviews outstanding receivables and provides for estimated losses through an allowance for doubtful accounts. In evaluating the level of established loss reserves, the Company makes judgments regarding its customer’s ability to make required payments, prevailing economic conditions, previous experience, and other factors. As these factors’ financial situation changes, circumstances develop, or additional information becomes available, adjustments to the allowance for doubtful accounts may be required. The Company maintains reserves for credit losses, and losses have been within its expectations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--InventoryPolicyTextBlock_zcgAGnwIjbV4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_869_zHSH8GiAgzcd">Inventories</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories consist of raw materials, work-in-process, and finished goods and are recorded at the lower of cost, on a first-in, first-out basis, or net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable completion, disposal, and transportation costs. The Company evaluates inventory balances and either writes down obsolete inventory or records a reserve for slow-moving or excess inventory based on net realizable value analysis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_z73Bf458xAS2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_865_zxdKUFRkpJac">Property and Equipment</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are presented at cost at the date of acquisition, less depreciation. Depreciation is computed using the straight-line method over estimated useful asset lives, ranging from <span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zEZqljL1a7Rb" title="Estimated useful life">1</span> to <span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zGs2QiQu8n62" title="Estimated useful life">14</span> years. The costs of the day-to-day servicing of property and equipment and repairs and maintenance are recognized in expenses as incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zdmUpe6iXLt9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_865_z655khiOdXIk">Goodwill</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill represents the excess cost of an acquired business over the fair value of the identifiable tangible, and intangible assets acquired and liabilities assumed in a business combination under the acquisition method of accounting under ASC 805 “Business Combinations” (see Note 4). Goodwill is not amortized but, per ASC 350, is tested for impairment annually. Goodwill is also tested for impairment between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. Judgment determines if an indicator of impairment has occurred during a year. When testing goodwill for impairment, we may assess qualitative factors for some or all of our reporting units to determine whether it is more likely than not (that is, a likelihood of more than 50 percent) that the fair value of a reporting unit is less than its carrying amount, including goodwill. Alternatively, we may bypass this qualitative assessment for some or all of our reporting units and perform step 1 of the two-step goodwill impairment test. If we perform step 1 and the reporting unit’s carrying amount exceeds its fair value, we will perform step 2 to measure such impairment. We have completed our annual impairment test and recorded $-<span id="xdx_905_eus-gaap--GoodwillImpairmentLoss_dxL_c20220101__20221231_za1EXhFVh241" title="Impairment of goodwill::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0769">0</span></span>- and $<span id="xdx_90A_eus-gaap--GoodwillImpairmentLoss_c20210101__20211231_z63k0cmJxCG7" title="Impairment of goodwill">9,189,000</span> in goodwill impairment charges for the years ended December 31, 2022, and 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_84A_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zdo6T7rIp0V8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86B_z1F4qX46an0a">Intangible Assets</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Patents and licenses:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patents and licenses, measured initially at purchase cost, are included in intangible assets on the Company’s balance sheet and are amortized on a straight-line basis over their estimated useful lives of <span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember_z6LVp3Optu79" title="Estimated useful life">18.5</span> to <span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember_zvULSYRNdQZb" title="Estimated useful life">20</span> years. Amortization totaled approximately $<span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember_zHSvOs3mXvu6" title="Amortization">535,000</span> and $<span id="xdx_90E_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember_zLhLJKcEb6Ze" title="Amortization">668,000</span> for the years ended December 31, 2022, and 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other intangible assets:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s remaining intangible assets include the trade names, technology, and customer lists acquired in its acquisition of IMT, Vislink, and Mobile Viewpoint Corporate B.V. (“MVP”). A third-party appraiser determined the value of these acquired assets for these business combinations. Absent an indication of fair value from a potential buyer or similar specific transactions, we have determined that using the methods employed provided a reasonable estimate in reporting the values assigned.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company amortizes intangible asset costs over their useful lives of <span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember__srt--RangeAxis__srt--MinimumMember_zRkoWz0srO" title="Finite-lived intangible asset, useful life">3</span> to <span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember__srt--RangeAxis__srt--MaximumMember_zJHOaPKe8GLe" title="Finite-lived intangible asset, useful life">15</span> years with its net book value reported on the balance sheet. Amortization totaled approximately $<span id="xdx_900_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zqbh49CI8AKf" title="Amortization">985,000</span> and $<span id="xdx_907_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zLLoTEsVwXs1" title="Amortization">480,000</span> for the years ended December 31, 2022, and 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--GuaranteesIndemnificationsAndWarrantiesPolicies_zA6SggpeHQQi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_862_zZUJdZ9Te8X9">Warranty Reserve</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although the Company tests its product under its quality programs and processes, its warranty obligation is affected by product failure rates and service delivery costs incurred in correcting a product failure. Required revisions to the estimated warranty liability will occur should actual product failure rates or service costs differ from the Company’s estimates, where applicable, based on limited historical data.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfProductWarrantyLiabilityTableTextBlock_zsv2i5Bpkx8l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The claims made during the year ended December 31, 2022, and 2021 were ordinary and customary. The warranty reserve is included in accrued expenses on the accompanying consolidated balance sheets and the cost of components in the accompanying consolidated statement of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B0_z3vPvSj3w0Pi" style="display: none">SCHEDULE OF PRODUCT WARRANTY LIABILITY</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Warranty Reserve</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 78%; text-align: justify">December 31, 2020</td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--ProductWarrantyAccrual_iS_pp0p0_c20210101__20211231_zexra0jxaefl" style="font-family: Times New Roman, Times, Serif; width: 18%; text-align: right" title="Warranty reserve, beginning">283,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Warranty reserve expense</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--ProductWarrantyAccrualWarrantiesIssued_pp0p0_c20210101__20211231_z1cm3MPxbho1" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Warranty reserve expense"><span style="-sec-ix-hidden: xdx2ixbrl0797">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Warranty claims settled, and true-up of accrual</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_eus-gaap--ProductWarrantyAccrualPayments_iN_pp0p0_di_c20210101__20211231_zdarR3xq30Kc" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Warranty claims settled and true-up of accrual">(152,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify">December 31, 2021</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--ProductWarrantyAccrual_iS_pp0p0_c20220101__20221231_zvFsGX3JWX4h" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Warranty reserve, beginning">131,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Warranty reserve expense</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ProductWarrantyAccrualWarrantiesIssued_pp0p0_c20220101__20221231_zJOi00VVo5Ih" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Warranty reserve expense">98,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Warranty claims settled, and true-up of accrual</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ProductWarrantyAccrualPayments_iN_pp0p0_di_c20220101__20221231_zscf6MKc62v1" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Warranty claims settled and true-up of accrual">(117,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt">December 31, 2022</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_eus-gaap--ProductWarrantyAccrual_iE_pp0p0_c20220101__20221231_zY00EshyZicc" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Warranty reserve, ending">112,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zbDgv3SgRHK6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_ecustom--ShippingAndHandlingCostsPolicyTextBlock_zuOIzVCu8vF6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86F_zo3YZUCOYbti">Shipping and Handling Costs</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company invoices its shipping and handling charges to the customer, and we net these charges against the respective costs within general and administrative expenses. For the years ended December 31, 2022, and 2021, the shipping and handling costs incurred were $<span id="xdx_902_ecustom--ShippingAndHandlingCosts_pp0p0_c20220101__20221231_zMdFAzgpff6k" title="Shipping and handling costs">796,000</span> and $<span id="xdx_90B_ecustom--ShippingAndHandlingCosts_pp0p0_c20210101__20211231_zvI1PJ6Xky3" title="Shipping and handling costs">581,000</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_ecustom--CommonStockPurchaseWarrantsAndOtherDerivativeFinancialInstrumentsPolicyTextBlock_z6FhlHBX2Rkg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_866_zI7qJKuMYLEf">Common Stock Purchase Warrants and Other Derivative Financial Instruments</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company assesses the classification of its freestanding derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required. The Company classifies common stock purchase warrants and other freestanding financial instruments as equity if the contracts (i) require physical settlement or net-share settlement in common stock or (ii) give the Company a choice of net-cash settlement or settlement in common stock (physical settlement or net-share settlement). The Company classifies the following contracts as either an asset or a liability: contracts that (i) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), (ii) give the counterparty a choice of net-cash settlement or settlement in common stock (physical settlement or net-share settlement) or (iii) contain reset provisions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_849_ecustom--TreasuryStockPolicyTextBlock_zTIb2qESxw6i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86B_z1b4ToodU13d">Treasury Stock</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treasury stock is recorded at cost upon the repurchasing of common shares. The cost method is used upon the re-issuance of shares. Under U.S. GAAP, the excess of the acquisition cost over the re-issuance price of the treasury stock, if any, is recorded to additional paid-in capital, limited to the amount previously credited to additional paid-in capital if any. The Company charges the accumulated deficit for any excess.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_84B_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zbp4rHCy2Djl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86A_zw3bmPiHGjMh">Revenue Recognition</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We account for the Company’s operating results under ASC Topic 606, adopted on January 1, 2019. It is a comprehensive revenue recognition model that requires recognition when the Company transfers control of the promised goods or services to our customers at an amount that reflects the consideration we expect to receive. The application of ASC Topic 606 requires us to use more judgment and make more estimates than under previously issued guidance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company generates all its revenue from contracts with customers. The Company recognizes revenue when we satisfy a performance obligation by transferring control of the promised goods or services to a customer in an amount that reflects the consideration we expect to receive in exchange for those services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Revenue Recognition (continued)</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company determines revenue recognition through the following steps:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. Identification of the contract, or contracts, with a customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. Identification of the performance obligations in the contract.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. Determination of the transaction price.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4. Allocation of the transaction price to the performance obligations in the contract; and</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5. Recognition of revenue when, or as, we satisfy a performance obligation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At contract inception, the Company assesses the goods and services promised in our customer contracts and identifies a performance obligation for each. To determine the performance obligations, the Company considers all the products and services promised in the contract regardless of whether they are explicitly stated or implied by customary business practices. The timing of satisfaction of the performance obligation is not subject to significant judgment. We measure revenue as the consideration we expect to receive in exchange for transferring goods and services. The value-added sales taxes and other charges we collect concurrent with revenue-producing activities are excluded from income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span>Remaining Performance Obligations</span>:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The remaining performance obligations, or backlog, represent the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--ResearchAndDevelopmentExpensePolicy_z3KagkLYCfxi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_861_zoJQ3ujv3NIa">Research and Development Expenses</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As the Company performs research, design, and development activities, we charge these costs to research and development expenses in the Consolidated Statements of Operations and Comprehensive Loss. These expenses consist primarily of salary and benefit expenses, including stock-based compensation and payroll taxes for employees’ and contractors’ costs engaged in research, design, development activities, prototypes, facilities, and travel costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_842_eus-gaap--LesseeLeasesPolicyTextBlock_zwBqsdZoawYd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86A_zPPU4nGdqUA2">Leases</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We determine if an arrangement is a lease at inception. We recognize lease expense for lease payments on a straight-line basis over the lease term. The Company includes operating leases as ROU assets as “Right of use assets, operating leases” in the consolidated balance sheets. For lease liabilities, operating lease liabilities are included in “Operating lease obligations, current” and “Operating lease liabilities, net of current portion” in the consolidated balance sheets. We recognize Operating lease ROU assets and liabilities on the commencement date based on the present value of lease payments for all leases with a term longer than 12 months. No lease and non-lease components are separated for all our real estate contracts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There were no capital leases, now titled “finance leases” under ASC 842, in the Company’s lease portfolio as of December 31, 2022. The ROU assets and related lease liabilities recorded under ASC 842 are calculated based on the present value of the lease payments using (1) the rate implicit in the lease or (2) the lessee’s incremental borrowing rate (“IBR”), defined as the rate of interest that a lessee would have to pay to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a comparable economic environment. As most of our leases do not provide an implicit rate, we determined our incremental borrowing rates based on an analysis of prior collateralized borrowings over similar terms of the lease payments at the commencement date to estimate the IBR under ASC 842.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zVoCnohXERda" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_863_zx4qx0UY4oQ6">Stock-Based Compensation</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for stock compensation with persons classified as employees for accounting purposes under ASC 718 “Compensation-Stock Compensation,” which recognizes awards at fair value on the date of grant and recognition of compensation over the service period for awards expected to vest. The fair value of stock options is determined using the Black-Scholes Option Pricing Model, and the fair value of common stock issued for services is determined based on the Company’s stock price on the issuance date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The expansion of Topic 718 fell under ASU 2018-07 to include share-based payment transactions for acquiring goods and services from nonemployees. The measurement date for equity-classified nonemployee share-based payment awards is no longer at the earlier date at which a commitment for performance by the counterparty is reached or the date at which the counterparty’s performance is complete. Instead, the grant date is now considered the measurement date. Under today’s guidance, the measurement of nonemployee share-based payment awards with performance conditions is at the lowest aggregate fair value, often resulting in a zero value. The new ASU aligns the accounting for nonemployee share-based payment awards with performance conditions with accounting for employee share-based payment awards under Topic 718 by requiring entities to consider the probability of satisfying performance conditions. Current guidance requires entities to use the contractual term to measure the nonemployee share-based payment awards. The new ASU allows entities to make an award-by-award election to use the expected duration (consistent with employee share-based payment awards) or the contractual term for nonemployee awards.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span>Stock-Option Awards — Time-based and performance-based</span>:</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under ASC Topic 718, the compensation cost is measured based on an award’s fair value at the grant’s date for the time vested option award using the Black Scholes-Merton formula as a valuation technique. The Company used the U.S. Treasury note’s rate over the expected option term for the risk-free rate. Employees’ expected term represents the period that options granted are expected to be outstanding using the simplified method. The Company’s historical share option exercise experience does not provide a reasonable basis for estimating the expected term. For nonemployee options, the expected term is the entire term of the option. Expected volatility is based on the average weekly share price changes over the shorter expected term or the period from the Nasdaq Capital Markets Exchange placement to the grant’s date. The Company estimates forfeiture and volatility using historical information. The risk-free interest rate is based on the implied yield on U.S. Treasury zero-coupon issues over the options’ equivalent lives.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has not paid dividends on its common stock, and no assumption of dividend payment(s) is made in the model. For employee equity-classified awards, compensation cost is recognized over the employee’s requisite service period with a corresponding credit to additional paid-in capital. The employee’s requisite service period begins at the service inception date and ends when the requisite service has been provided.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span>Restricted Stock Unit Awards (“RSUs”) — Time-Based</span>:</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under ASC 718, the exercise price for RSUs is determined using the fair market value of the Company’s common stock on the grant date. For an award with graded vesting subject only to a service condition (e.g., time-based vesting), ASC 718-10-35-8 provides an accounting policy choice between graded vesting attribution or straight-line attribution. The Company elects the graded vesting method, recognizing compensation expense for only the portion of awards expected to vest. Forfeitures of time-based units and awards are recognized as they occur. Stock-based compensation costs are calculated using the closing stock price on the grant date to estimate the fair value of time-based restricted stock units.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Stock-Based Compensation (continued</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span>Restricted Stock Unit Awards (“RSUs”) — Performance-Based</span>:</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accruals of compensation cost for an award with a performance condition are related to that performance condition’s probable outcome. Under ASC 718, a “performance condition” is the achievement of a specified target that is defined by referring to the employer’s operations or activities, such as an option that vests if the employer’s growth rate increases by a certain amount or there are the attainments of regulatory approval for a product. There is an accrual of compensation cost upon the likely achievement of the performance condition, and there is no accrual if the accomplishment of the performance condition is not probable. The exercise price for RSUs is determined using the fair market value of the Company’s common stock on the grant date. Stock-based compensation costs are calculated using the closing stock price on the grant date to estimate performance-based restricted stock units’ fair value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_84B_ecustom--ImpairmentAndAbandonmentPolicyTextBlock_zzlDf68k3g5e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_862_ztVmbaTz5gUk">Impairment and Abandonment</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Right-of-use operating lease abandonment:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management decided to vacate the Billerica, MA facility as part of the Company’s cost savings strategy implemented in the third quarter of the fiscal year 2022. The economic environment of the location precluded the action of sub-letting, and management determined the (leased facility) to be abandoned as of September 30, 2022. Under ASC 360, leased space abandonment is an impairment indicator, and the Company assessed the lease right-of-use (“ROU”) assets for impairment. The Company considered approximately $<span id="xdx_905_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_c20220101__20221231_zcHFGJQ5jeMh" title="Right-of-use operating assets impaired"><span id="xdx_909_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_c20210101__20211231_zU7qqRwdrYng" title="Right-of-use operating assets impaired">131,000</span></span> of right-of-use operating assets impaired, less $<span id="xdx_909_ecustom--OperatingLeasesRightOfUseAssetAccumulatedAmortization_c20210101__20211231_zRlBU1kd1D13" title="Right-of-use"><span id="xdx_900_ecustom--OperatingLeasesRightOfUseAssetAccumulatedAmortization_c20210101__20211231_z9cpY1oynZxh" title="Right-of-use">43,000</span></span> of accumulated amortization, and for the years ending December 31, 2022, and 2021, the Company recognized a loss on impairment of ROU assets of approximately $<span id="xdx_903_eus-gaap--OperatingLeaseImpairmentLoss_c20220101__20221231_zwurGpjAVPA2" title="Loss on impairment of right-of-use assets">88,000</span> and $-<span id="xdx_908_eus-gaap--OperatingLeaseImpairmentLoss_c20210101__20211231_zWOBZBEDpBhf" title="Loss on impairment of right-of-use assets">0</span>-, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_844_eus-gaap--IncomeTaxPolicyTextBlock_z14gnPJCjQB8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_864_zqsgm3TkB6sg">Income Taxes</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under ASC 740, as part of our consolidated financial statements, we must estimate our income tax provision (benefit) in each jurisdiction in which we operate. The Company uses the asset and liability method of accounting for income taxes. The recognition of deferred income tax assets and liabilities for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases fall under this method. Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years these temporary differences are expected to be recovered or settled. The recognition of the effect on deferred tax assets and liabilities of a change in tax rates in income is in the period that includes the enactment date. A valuation allowance is provided for those deferred tax assets for which management cannot conclude that it is more likely than not that such deferred tax assets will be realized. The Company will file income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. The Company recognizes the impact of an uncertain tax position in its financial statements if, in management’s judgment, it is more likely than not sustainable upon audit based upon the position’s technical merits. It involves identifying potential uncertain tax positions, evaluating applicable tax laws, and assessing whether the liability for uncertain tax positions is necessary. The Company’s policy is to classify assessments, if any, for tax-related interest expense and penalties as general and administrative expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--AdvertisingCostsPolicyTextBlock_zH9nxQWsLphd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86F_zaTYsduPYppi">Advertising Costs</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising costs are charged to operations as incurred. Advertising costs amounted to approximately $<span id="xdx_905_eus-gaap--AdvertisingExpense_pp0p0_c20220101__20221231_z4CWNPhXsgH7" title="Advertising costs">1,038,000</span> and $<span id="xdx_90C_eus-gaap--AdvertisingExpense_pp0p0_c20210101__20211231_z32nMYRIGew1" title="Advertising costs">139,000</span> for the years ended December 31, 2022, and 2021, respectively. The Company includes advertising costs in general and administrative expenses in the accompanying consolidated statement of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_846_ecustom--SalesTaxAndValueAddedTaxesPolicyTextBlock_z0P1zjSZ2Cjf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_865_zmQIB0erE23l">Sales Tax and Value-Added Taxes</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for sales taxes and value-added taxes imposed on its goods and services on a net basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_84B_eus-gaap--EarningsPerSharePolicyTextBlock_zQ4rdw8vfxDc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_867_z93wzI5RSwp2">Loss Per Share</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reports loss per share under ASC Topic 260, “Earnings Per Share,” which establishes standards for computing and presenting earnings per share. The basic loss per share calculation divides the net loss allocable to common stockholders by the weighted-average shares of common stock outstanding during the period without considering common stock equivalents. The diluted loss per share calculation is calculated by adjusting the weighted-average shares of common stock outstanding for the dilutive effect of common stock equivalents, including stock options and warrants, outstanding for the period as determined using the treasury stock method. Common stock equivalents are excluded from the diluted net loss per share calculation because their effect would be anti-dilutive. Therefore, basic and diluted net loss per share applicable to common stockholders is the same for periods with a net loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zA0oP3tyn1k5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates the anti-dilutive potential common stock equivalents excluded from the calculation of loss per share (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BA_zhURrw32blYc" style="display: none">SCHEDULE OF ANTI-DILIUTIVE POTENTIAL COMMON STOCK EQUIVALENTS EXCLUDE FROM THE CALCULATION OF LOSS PER SHARE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20220101__20221231_zZJHqCneHaW2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2022</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20210101__20211231_z5VMhHz6ZDAe" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2021</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td> <td colspan="6" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">For the Years Ended</td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">December 31,</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2022</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2021</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--EarningsPerShareDilutedOtherDisclosuresAbstract_iB_zSdV87xeQuwl" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify">Anti-dilutive potential common stock equivalents excluded from the calculation of loss per share:</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_zgtciJ4PLfYg" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 68%; text-align: justify">Stock options</td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right">828</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right">1,553</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zQhgdGNAOl2f" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Warrants</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">9,175</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">9,210</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_z1j1Kx5pfSdi" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">10,003</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">10,763</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A1_z2z16v9jEGYd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zkgeCmZigj2g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_868_z6Fy2DghcUS4">Foreign Currency and Other Comprehensive (Gains) Losses</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We record gains or losses resulting from foreign currency transactions in foreign currency income or loss except for the effect of exchange rates on long-term inter-company transactions that are considered long-term investments that are accumulated and credited or charged to other comprehensive income. We have two foreign subsidiaries, one in the United Kingdom and the other in the Netherlands, and their functional currencies are British Pounds and Euros, respectively. The translation from the respective foreign currency to United States Dollars (“US Dollars”) is performed for balance sheet accounts using current exchange rates at the balance sheet date and for income statement accounts using an average exchange rate for the years ending December 31, 2022, and 2021, respectively. We included gains or losses from such translation as a separate component of accumulated other comprehensive (loss) income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction gains and losses are recognized in our operations’ results based on the difference between the foreign exchange rates on the transaction date and the reporting date. The foreign currency exchange gains and losses are a component of general and administrative expenses in the accompanying Condensed Consolidated Statements of Operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_z6mUPkPNNvLf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has recognized foreign exchange gains and losses and changes in accumulated comprehensive income approximately as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B8_zPHygvvC4Rr7" style="display: none">SCHEDULE OF FOREIGN EXCHANGE AND CHANGE IN ACCUMULATED COMPREHENSIVE INCOME</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20220101__20221231_zMe83jyD5EXl" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2022</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20210101__20211231_zE5vQ4llcxY6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2021</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td> <td colspan="6" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">For the years ended</td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">December 31,</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2022</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2021</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify">Net foreign exchange transactions:</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_pp0p0_zcdrjgQelsYk" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; font-family: Times New Roman, Times, Serif; width: 68%; text-align: justify; padding-bottom: 2.5pt">(Gains) Losses</td><td style="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; width: 12%; text-align: right">24,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; width: 12%; text-align: right">100,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_pp0p0_zXYw4bI2bQPd" style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt">Net foreign exchange transactions: Losses </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">24,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">100,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify">Accumulated comprehensive income:</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--AccumulatedComprehensiveIncomeUnrealizedLossOnCurrencyTranslationAdjustment_pp0p0_z4Sr4ao19s3c" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt">Unrealized (gains) losses on currency translation adjustment</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">1,040,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">445,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_402_ecustom--AccumulatedComprehensiveIncomeUnrealizedLossOnCurrencyTranslationAdjustment_pp0p0_zryRprdp2wM2" style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt">Accumulated comprehensive income: Unrealized losses on currency translation adjustment</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">1,040,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">445,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A2_zK2LkJzvwCbe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The exchange rates adopted for the foreign exchange transactions are quoted on OANDA, a Canadian-based foreign exchange company, and an internet website providing currency conversion, online retail foreign exchange trading, foreign currency transfers, and forex information. The Company translated amounts from British Pounds into United States Dollars and Euros to British Pounds at the following exchange rates for the respective periods:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022 – £ <span id="xdx_90F_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20221231__us-gaap--AwardTypeAxis__custom--GBPMember__us-gaap--DerivativeInstrumentRiskAxis__custom--GBPToUSDMember_zdwzWrq4c5mg" title="Foreign currency exchange rate, translation">1.208970</span> to $<span id="xdx_90E_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20221231__us-gaap--DerivativeInstrumentRiskAxis__custom--GBPToUSDMember_zhQ8fYu8nDk2" title="Foreign currency exchange rate, translation">1.00</span>; € <span id="xdx_905_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20221231__us-gaap--AwardTypeAxis__custom--EuroMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EuroToGBPMember_zhj8kw1JCS79" title="Foreign exchange rates">1.069850</span> to $<span id="xdx_90D_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20221231__us-gaap--AwardTypeAxis__custom--GBPMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EuroToGBPMember_zhWEC6k4wNe8" title="Foreign currency exchange rate, translation">1.00</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The average exchange rate for the year ended December 31, 2022 – £ <span id="xdx_902_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20221231__us-gaap--AwardTypeAxis__custom--GBPMember__us-gaap--DerivativeInstrumentRiskAxis__custom--GBPToUSDMember_z70etmVeviu9" title="Foreign currency exchange rate, remeasurement">1.236579</span> to $<span id="xdx_901_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20221231__us-gaap--DerivativeInstrumentRiskAxis__custom--GBPToUSDMember_zyO8szcTAqm1" title="Foreign currency exchange rate, remeasurement">1.00</span>; € <span id="xdx_90F_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20221231__us-gaap--AwardTypeAxis__custom--EuroMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EuroToGBPMember_zOtgagqew9w4" title="Foreign currency exchange rate, remeasurement">1.052082</span> to $<span id="xdx_904_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20221231__us-gaap--AwardTypeAxis__custom--GBPMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EuroToGBPMember_z2xWQ6S0Ehv" title="Foreign currency exchange rate, remeasurement">1.00</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021 – £<span id="xdx_90F_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20211231__us-gaap--AwardTypeAxis__custom--GBPMember__us-gaap--DerivativeInstrumentRiskAxis__custom--GBPToUSDMember_zFk665UKxKD8" title="Foreign currency exchange rate, translation">1.351043</span> to $<span id="xdx_907_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--GBPToUSDMember_zJByCcoysoI3" title="Foreign currency exchange rate, translation">1.00</span>; €<span id="xdx_904_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20211231__us-gaap--AwardTypeAxis__custom--EuroMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EuroToGBPMember_zcrggvJeHSui" title="Foreign currency exchange rate, translation">0.839362</span> to £<span id="xdx_903_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20211231__us-gaap--AwardTypeAxis__custom--GBPMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EuroToGBPMember_zoM8LCqX7J53" title="Foreign currency exchange rate, translation">1.00</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The average exchange rate for the year ended December 31, 2021 – £<span id="xdx_90A_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20211231__us-gaap--AwardTypeAxis__custom--GBPMember__us-gaap--DerivativeInstrumentRiskAxis__custom--GBPToUSDMember_z9IdVf0ucO8g" title="Foreign currency exchange rate, remeasurement">1.375369</span> to $<span id="xdx_907_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--GBPToUSDMember_zDF7OG9V4CLk" title="Foreign currency exchange rate, remeasurement">1.00</span>; €<span id="xdx_90B_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20211231__us-gaap--AwardTypeAxis__custom--EuroMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EuroToGBPMember_zysBaeEU6iV5" title="Foreign currency exchange rate, remeasurement">0.850858</span> to £<span id="xdx_90B_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20211231__us-gaap--AwardTypeAxis__custom--GBPMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EuroToGBPMember_zhEDJE6MnNl6" title="Foreign currency exchange rate, remeasurement">1.00</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_84B_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zLynsV5RQbo1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_868_zLKFugwjo9eh">Fair Value of Financial Instruments and Fair Value Measurements</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The authoritative guidance for fair value measurements under topic ASC 820, “Fair Value Measurements and Disclosures,” establishes a three-tier fair value hierarchy, prioritizing the inputs used in measuring fair value. These tiers include:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 is observable inputs such as quoted prices in active markets.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 is defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 is defined as unobservable inputs in which little or no market data exists, requiring an entity to develop its assumptions.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our financial instruments include cash equivalents, accounts receivable, prepaid expenses and other assets, accounts payable, accrued expenses, and short-term debt. Fair value estimates of these instruments are made at a specific point in time based on relevant market information. These estimates may be subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. The carrying amount of cash equivalents, accounts receivable, prepaid expenses and other assets, accounts payable, and accrued expenses are generally considered representative of their respective fair values because of the short-term nature of those instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. The new guidance modifies the disclosure requirements on fair value measurements in Topic 820. The amendments in ASU 2018-13 are effective for all entities for fiscal years and interim periods within those fiscal years beginning after December 15, 2019. Effective January 1, 2020, the Company adopted the provisions of ASU 2018-13. The adoption had no material impact on the Company’s consolidated financial statements or related financial statement disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"/> <p id="xdx_89C_eus-gaap--FairValueAssetsMeasuredOnNonrecurringBasisTextBlock_zO8HGkC0ohN9" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table presents the Company’s assets and liabilities measured at fair value on a non-recurring basis on December 31, 2022, consistent with the fair value hierarchy provisions. The asset impairment is a non-recurring level 3 measurement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="margin: 0; font-family: Times New Roman, Times, Serif"><span id="xdx_8B4_znrC1h3iFe23" style="display: none">SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON NON-RECURRING BASIS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><p style="margin-top: 0; margin-bottom: 0">Quoted Prices in</p> <p style="margin-top: 0; margin-bottom: 0">Active Markets</p> <p style="margin-top: 0; margin-bottom: 0">for Identical</p> <p style="margin-top: 0; margin-bottom: 0">Assets/Liabilities</p> <p style="margin-top: 0; margin-bottom: 0">(Level 1)</p></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><p style="margin-top: 0; margin-bottom: 0">Significant</p> <p style="margin-top: 0; margin-bottom: 0">Observable</p> <p style="margin-top: 0; margin-bottom: 0">Inputs</p> <p style="margin-top: 0; margin-bottom: 0">(Level 2)</p></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><p style="margin-top: 0; margin-bottom: 0">Significant</p> <p style="margin-top: 0; margin-bottom: 0">Unobservable</p> <p style="margin-top: 0; margin-bottom: 0">Inputs</p> <p style="margin-top: 0; margin-bottom: 0">(Level 3)</p></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left">Assets (non-recurring):</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 40%; text-align: left; padding-bottom: 1.5pt">Abandonment of right-of-use operating leases</td><td style="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FinancialInstrumentAxis__custom--AbandonmentOfRightofuseOperatingLeasesMember_zVPZAoIkpob6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Total Assets (non-recurring)"><span style="-sec-ix-hidden: xdx2ixbrl0919">—</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FinancialInstrumentAxis__custom--AbandonmentOfRightofuseOperatingLeasesMember_zbOA2hORHg9j" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Total Assets (non-recurring)"><span style="-sec-ix-hidden: xdx2ixbrl0921">—</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FinancialInstrumentAxis__custom--AbandonmentOfRightofuseOperatingLeasesMember_zxM14rqjIYzl" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Total Assets (non-recurring)">88,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20221231__us-gaap--FinancialInstrumentAxis__custom--AbandonmentOfRightofuseOperatingLeasesMember_zKFBoFqcN8ak" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Total Assets (non-recurring)">88,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zgR1Z9PyLbCg" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total Assets (non-recurring)"><span style="-sec-ix-hidden: xdx2ixbrl0927">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z11cXKGOEx04" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total Assets (non-recurring)"><span style="-sec-ix-hidden: xdx2ixbrl0929">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z1TONQGLCmh" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total Assets (non-recurring)">88,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20221231_zs2WCFiL0bZc" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total Assets (non-recurring)">88,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif">Liabilities:</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt">Other</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FinancialInstrumentAxis__custom--OtherMember_z1VcTRlS5rwe" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Other liabilities"><span style="-sec-ix-hidden: xdx2ixbrl0935">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FinancialInstrumentAxis__custom--OtherMember_zrxV2CxBUF59" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Other liabilities"><span style="-sec-ix-hidden: xdx2ixbrl0937">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FinancialInstrumentAxis__custom--OtherMember_zFBTpcm444a9" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Other liabilities"><span style="-sec-ix-hidden: xdx2ixbrl0939">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20221231__us-gaap--FinancialInstrumentAxis__custom--OtherMember_zOJt5htXJtAh" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Other liabilities"><span style="-sec-ix-hidden: xdx2ixbrl0941">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zgTQgWSa07u7" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total Liabilities"><span style="-sec-ix-hidden: xdx2ixbrl0943">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z9JEPSCxFT3h" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total Liabilities"><span style="-sec-ix-hidden: xdx2ixbrl0945">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zKdMRt7B3t11" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total Liabilities"><span style="-sec-ix-hidden: xdx2ixbrl0947">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20221231_zOSMBOxT0eRb" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total Liabilities"><span style="-sec-ix-hidden: xdx2ixbrl0949">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zQRe5wM09zyi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company did not have reportable assets and liabilities under ASC Topic 820 disclosure requirements for the year ended December 31, 2021. See Note 13 for additional disclosure regarding the Company’s warrants liabilities accounted for at fair value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_84D_ecustom--RedeemablePreferredStockPolicyTextBlock_zgdsgqzNDC6j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86E_zwhsdAh57sK9">Redeemable Preferred Stock</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In November 2022, <span id="xdx_909_eus-gaap--PreferredStockVotingRights_c20221101__20221130_zTbewRf06EDk" title="Preferred stock voting discription">the Company’s board of directors approved the designation of a Series A Preferred Stock created for the sole purpose of the January 11, 2023, Special Meeting of stockholders voting on the consideration of a “Reverse Stock Split Proposal.” The Series A Preferred Stock had a par value of $<span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20221130__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zK5D9ZvUZGV3" title="Preferred stock, par value">0.00001</span> per share. The Preferred Stock was redeemable upon the holder participating at any meeting of stockholders held to vote on the Reverse Stock Split immediately before the opening of the polls at such meeting (the “Initial Redemption Time”) shall automatically be redeemed by the Corporation at the Initial Redemption Time without further action on the part of the Corporation or the holder thereof (the “Initial Redemption”). Any outstanding shares of Series A Preferred Stock that were not redeemed under an Initial Redemption were redeemed in whole, but not in part (i) if such redemption was ordered by the Board of Directors in its sole discretion, automatically and effective on such time and date specified by the Board of Directors in its sole discretion or (ii) automatically upon the approval by the Corporation’s stockholders of the Reverse Stock Split at the Special Meeting held for voting on the Reverse Stock Split proposal.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the guidance of ASC Topic 480, all Series A Preferred Stock shares have been presented outside of permanent equity in the mezzanine equity section on the Consolidated Balance Sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_846_eus-gaap--SubsequentEventsPolicyPolicyTextBlock_z2Y7kvhEDB78" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_866_zT1coA3bEWje">Subsequent Events</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management has evaluated subsequent events or transactions occurring through the date the consolidated financial statements were issued and determined that no events or transactions are required to be disclosed herein except as disclosed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_ecustom--NewlyIssuedAccountingPronouncementsPolicyPolicyTextBlock_zgivJ1msRRXj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span><span id="xdx_862_zvyWBEvTN8ei">Recently Issued Accounting Pronouncements</span></span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span>Recently Issued Accounting Standards Adopted and Not Yet Adopted</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span>Adopted on January 1, 2023</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2016, the FASB established Topic 326, Financial Instruments—Credit Losses, Measurement of Credit Losses on Financial Instruments (ASU) No. 2016-13, which requires a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates, including accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The standard replaces the existing incurred credit loss model with the Current Expected Credit Losses (“CECL”) model. It is required to measure credit losses based on the Company’s estimate of expected losses rather than incurred losses, which generally results in earlier recognition of allowances for credit losses. Under ASC 326, the Company evaluates specific criteria, including aging and historical write-offs, the current economic condition of particular customers, and future economic conditions of countries utilizing a consumption index to determine the appropriate allowance for credit losses. The Company completed its assessment of the new standard, and no adjustment will be made to its opening balance of retained earnings relating to its trade receivables. The Company writes off receivables once it is determined that the receivables are no longer collectible and as allowed by local laws.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zOQC8OKtKFl8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86A_zcxjnX1rma0a">Recent Accounting Pronouncements</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other recent accounting standards issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the SEC did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.</span></p> <p id="xdx_854_zT0IothWpFDg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--BusinessCombinationsPolicy_zsF8DMpkdaVk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_860_zVu8UgkIkSNj">Business Combinations</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for acquisitions that qualify as business combinations by applying the acquisition method according to Accounting Standards Codification (“ASC”) 805, Business Combinations (“ASC 805”). Transaction costs related to the acquisition of a business are expensed as incurred and excluded from the fair value of consideration transferred. The identifiable assets acquired, liabilities assumed, and noncontrolling interests in an acquired entity are recognized and measured at their estimated fair values. The excess of the fair value of consideration transferred over the fair values of identifiable assets acquired, liabilities assumed, and noncontrolling interests in an acquired entity, net of the fair value of any previously held interest in the acquired entity, is recorded as goodwill. Such valuations require management to make significant estimates and assumptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_84F_eus-gaap--ConsolidationPolicyTextBlock_zQpVY0EXUbv6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86F_zs29LkNhLQ41">Principles of Consolidation</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America or (“U.S. GAAP”) as found in the Accounting Standards Codification (“ASC”), the Accounting Standards Update (“ASU”) of the Financial Accounting Standards Board (“FASB”) and the rules and regulations of the US Securities and Exchange Commission (the “SEC”). The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. We have eliminated all intercompany accounts and transactions upon consolidating our subsidiaries.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zjxfHSArPWj8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_866_zdYZcFss6fh2">Segment Reporting</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company identifies operating segments as components of an enterprise about which separate discrete financial information is available for evaluation by the operating decision-makers, or decision-making group, in deciding how to allocate resources and assess performance. The Company’s decision-making group is the senior executive management team. The Company and the decision-making group view the Company’s operations and manage its business as one operating segment with different product offerings. All long-lived assets of the Company reside in the U.S., the U.K., and the Netherlands.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--UseOfEstimates_zwF35IJPUT6e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86D_zUo0LdCc554g">Use of Estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make estimates, judgments, and assumptions that affect the reported amounts of assets and liabilities in the consolidated financial statements. Significant accounting estimates reflected in the Company’s consolidated financial statements include the useful lives of property, plant, and equipment, the useful lives of right-of-use assets, the useful lives of intangible assets, impairment of long-lived assets, allowance for accounts receivable doubtful accounts, allowance for inventory obsolescence reserve, allowance for deferred tax assets, valuation of warranty reserves, contingent consideration liabilities, and the accrual of potential liabilities. These estimates also affect the reported revenues and expenses during the reporting periods. Actual results could differ from estimates, and any such differences may be material to our financial statements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_ecustom--RisksAndUncertaintiesPolicyTextBlock_zyRzqrluXMd7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_868_zu4t6IcNA5nf">Risks and Uncertainties</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The future impacts of the Russia-Ukraine war, the novel coronavirus (“COVID-19”) pandemic, and their residual effects include economic uncertainty, an inflationary environment, currency fluctuations, disruption within the global supply chain, and labor markets worldwide industries remain uncertain. These circumstances have created prevalent uncertainty and risk. The impact of these issues on our business will vary by geographic market and discipline. In response to potential reductions in revenue, we may take actions to align our cost structure with changes in customer demand and manage our working capital. However, there can be no assurance as to the effectiveness of our efforts to mitigate any impact of the current and future adverse economic conditions, reductions in client revenue, changes in client creditworthiness, and other developments. We monitor the circumstances mentioned above to assess direct material adverse effects on our business, financial condition, or results of operations. Therefore, these impacts may change accounting estimates and assumptions over time. Interim period results are not necessarily indicative of the expected results for the full fiscal year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zPlx9G3CUW0j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_867_zzFkcOYyUwr4">Cash and Cash Equivalents</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers all highly liquid investments with an original maturity of three months or less at the time of purchase to be cash equivalents. The Company did not have cash equivalents as of December 31, 2022, and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_840_eus-gaap--ConcentrationRiskCreditRisk_zcRHsjgW4rh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_865_zsUGO4VaBdS3">Concentrations</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company does not have any off-balance-sheet concentrations of credit risk. Credit risk is that the counterparty will default on its contractual obligations, resulting in a company’s financial loss. The Company’s credit risk is primarily attributable to its cash and accounts receivables. The Company’s policy is to maintain its cash with high-credit quality financial institutions to limit its risk of loss exposure. Financial instruments potentially subject the Company to credit risk concentration consisting of cash deposits. The Federal Deposit Insurance Corporation (“FDIC”) insures accounts held within the United States up to $<span id="xdx_90D_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_c20221231_zK7cMH6k5bi9" title="Cash FDIC insured amount">250,000</span>. The Company maintains cash balance accounts at financial institutions in the United Kingdom insured by the Financial Services Compensation Scheme up to £<span id="xdx_908_eus-gaap--CashFDICInsuredAmount_iI_pp0p0_uGBP_c20221231_zZyO2pWVn14l" title="Cash FDIC insured amount">85,000</span>, subject to currency translation rates to the United States dollar. Lastly, the Company maintains cash balance accounts at financial institutions in the Netherlands insured by the “Dutch deposit guarantee scheme” up to €<span id="xdx_903_ecustom--DutchDepositGuaranteeScheme_iI_pp0p0_uEUR_c20221231_zyNMtKrnrvke" title="Dutch deposit guarantee scheme">100,000</span> per person, per bank.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 31, 2022, and 2021, the Company had approximately $<span id="xdx_904_eus-gaap--CashUninsuredAmount_iI_pn5n6_c20221231__srt--RangeAxis__srt--MinimumMember_z9Jf4seZ0BOg" title="Cash uninsured amount">24.5</span> million and $<span id="xdx_902_eus-gaap--CashUninsuredAmount_iI_pn5n6_c20211231__srt--RangeAxis__srt--MinimumMember_zFsVcd6n85tc" title="Cash uninsured amount">35.2</span> million above insured limits, respectively. The Company has not experienced any losses in its bank accounts between December 31, 2022, and 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management assesses their credit quality for customers, considering their financial position and historical experience. During the year ended December 31, 2022, the Company recorded sales to a single customer of $<span id="xdx_906_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__srt--MajorCustomersAxis__custom--SingleCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zr25JFC31ei2" title="Revenue">3,436,000</span> (<span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--SingleCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z2au0OJSM1U5" title="Concentration risk percentage">12%</span>), in excess of 10% of the Company’s total sales. For the year ended December 31, 2021, the Company recorded sales to a single customer of $<span id="xdx_90D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__srt--MajorCustomersAxis__custom--SingleCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zMyGZFOu4su4" title="Revenue">8,511,000</span> (<span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--MajorCustomersAxis__custom--SingleCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zHEsHEQkZ5g" title="Concentration risk percentage">25%</span>) in excess of 10% of the Company’s total sales.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 31, 2022, and 2021, the Company recorded accounts receivable of approximately $<span id="xdx_905_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20221231__srt--MajorCustomersAxis__custom--SingleCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zUPjcX48xro9">1,138,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--SingleCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zh2aXe6B3f5d">19%</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) and $<span id="xdx_904_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20211231__srt--MajorCustomersAxis__custom--SingleCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zCbRrj6aLTIf">4,204,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20211231__srt--MajorCustomersAxis__custom--SingleCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zMDsVDiznFK1">46%</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">), respectively, to a single customer in excess of 10% of the Company’s total consolidated accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 250000 85000 100000 24500000 35200000 3436000 0.12 8511000 0.25 1138000 0.19 4204000 0.46 <p id="xdx_84D_eus-gaap--ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_znuVBelHnuf9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86C_zfzFQOW3T2Q8">Accounts Receivable and Allowance for Doubtful Accounts</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company extends credit to its customers in the ordinary course of business. Further, the Company regularly reviews outstanding receivables and provides for estimated losses through an allowance for doubtful accounts. In evaluating the level of established loss reserves, the Company makes judgments regarding its customer’s ability to make required payments, prevailing economic conditions, previous experience, and other factors. As these factors’ financial situation changes, circumstances develop, or additional information becomes available, adjustments to the allowance for doubtful accounts may be required. The Company maintains reserves for credit losses, and losses have been within its expectations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--InventoryPolicyTextBlock_zcgAGnwIjbV4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_869_zHSH8GiAgzcd">Inventories</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories consist of raw materials, work-in-process, and finished goods and are recorded at the lower of cost, on a first-in, first-out basis, or net realizable value. Net realizable value is the estimated selling prices in the ordinary course of business, less reasonably predictable completion, disposal, and transportation costs. The Company evaluates inventory balances and either writes down obsolete inventory or records a reserve for slow-moving or excess inventory based on net realizable value analysis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_z73Bf458xAS2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_865_zxdKUFRkpJac">Property and Equipment</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment are presented at cost at the date of acquisition, less depreciation. Depreciation is computed using the straight-line method over estimated useful asset lives, ranging from <span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember_zEZqljL1a7Rb" title="Estimated useful life">1</span> to <span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember_zGs2QiQu8n62" title="Estimated useful life">14</span> years. The costs of the day-to-day servicing of property and equipment and repairs and maintenance are recognized in expenses as incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> P1Y P14Y <p id="xdx_842_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zdmUpe6iXLt9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_865_z655khiOdXIk">Goodwill</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill represents the excess cost of an acquired business over the fair value of the identifiable tangible, and intangible assets acquired and liabilities assumed in a business combination under the acquisition method of accounting under ASC 805 “Business Combinations” (see Note 4). Goodwill is not amortized but, per ASC 350, is tested for impairment annually. Goodwill is also tested for impairment between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. Judgment determines if an indicator of impairment has occurred during a year. When testing goodwill for impairment, we may assess qualitative factors for some or all of our reporting units to determine whether it is more likely than not (that is, a likelihood of more than 50 percent) that the fair value of a reporting unit is less than its carrying amount, including goodwill. Alternatively, we may bypass this qualitative assessment for some or all of our reporting units and perform step 1 of the two-step goodwill impairment test. If we perform step 1 and the reporting unit’s carrying amount exceeds its fair value, we will perform step 2 to measure such impairment. We have completed our annual impairment test and recorded $-<span id="xdx_905_eus-gaap--GoodwillImpairmentLoss_dxL_c20220101__20221231_za1EXhFVh241" title="Impairment of goodwill::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0769">0</span></span>- and $<span id="xdx_90A_eus-gaap--GoodwillImpairmentLoss_c20210101__20211231_z63k0cmJxCG7" title="Impairment of goodwill">9,189,000</span> in goodwill impairment charges for the years ended December 31, 2022, and 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> 9189000 <p id="xdx_84A_eus-gaap--GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_zdo6T7rIp0V8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86B_z1F4qX46an0a">Intangible Assets</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Patents and licenses:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patents and licenses, measured initially at purchase cost, are included in intangible assets on the Company’s balance sheet and are amortized on a straight-line basis over their estimated useful lives of <span id="xdx_90D_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember_z6LVp3Optu79" title="Estimated useful life">18.5</span> to <span id="xdx_905_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember_zvULSYRNdQZb" title="Estimated useful life">20</span> years. Amortization totaled approximately $<span id="xdx_903_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember_zHSvOs3mXvu6" title="Amortization">535,000</span> and $<span id="xdx_90E_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--PatentsAndLicensesMember_zLhLJKcEb6Ze" title="Amortization">668,000</span> for the years ended December 31, 2022, and 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other intangible assets:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s remaining intangible assets include the trade names, technology, and customer lists acquired in its acquisition of IMT, Vislink, and Mobile Viewpoint Corporate B.V. (“MVP”). A third-party appraiser determined the value of these acquired assets for these business combinations. Absent an indication of fair value from a potential buyer or similar specific transactions, we have determined that using the methods employed provided a reasonable estimate in reporting the values assigned.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company amortizes intangible asset costs over their useful lives of <span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember__srt--RangeAxis__srt--MinimumMember_zRkoWz0srO" title="Finite-lived intangible asset, useful life">3</span> to <span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember__srt--RangeAxis__srt--MaximumMember_zJHOaPKe8GLe" title="Finite-lived intangible asset, useful life">15</span> years with its net book value reported on the balance sheet. Amortization totaled approximately $<span id="xdx_900_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zqbh49CI8AKf" title="Amortization">985,000</span> and $<span id="xdx_907_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20210101__20211231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--OtherIntangibleAssetsMember_zLLoTEsVwXs1" title="Amortization">480,000</span> for the years ended December 31, 2022, and 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> P18Y6M P20Y 535000 668000 P3Y P15Y 985000 480000 <p id="xdx_84F_eus-gaap--GuaranteesIndemnificationsAndWarrantiesPolicies_zA6SggpeHQQi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_862_zZUJdZ9Te8X9">Warranty Reserve</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although the Company tests its product under its quality programs and processes, its warranty obligation is affected by product failure rates and service delivery costs incurred in correcting a product failure. Required revisions to the estimated warranty liability will occur should actual product failure rates or service costs differ from the Company’s estimates, where applicable, based on limited historical data.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfProductWarrantyLiabilityTableTextBlock_zsv2i5Bpkx8l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The claims made during the year ended December 31, 2022, and 2021 were ordinary and customary. The warranty reserve is included in accrued expenses on the accompanying consolidated balance sheets and the cost of components in the accompanying consolidated statement of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B0_z3vPvSj3w0Pi" style="display: none">SCHEDULE OF PRODUCT WARRANTY LIABILITY</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Warranty Reserve</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 78%; text-align: justify">December 31, 2020</td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--ProductWarrantyAccrual_iS_pp0p0_c20210101__20211231_zexra0jxaefl" style="font-family: Times New Roman, Times, Serif; width: 18%; text-align: right" title="Warranty reserve, beginning">283,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Warranty reserve expense</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--ProductWarrantyAccrualWarrantiesIssued_pp0p0_c20210101__20211231_z1cm3MPxbho1" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Warranty reserve expense"><span style="-sec-ix-hidden: xdx2ixbrl0797">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Warranty claims settled, and true-up of accrual</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_eus-gaap--ProductWarrantyAccrualPayments_iN_pp0p0_di_c20210101__20211231_zdarR3xq30Kc" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Warranty claims settled and true-up of accrual">(152,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify">December 31, 2021</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--ProductWarrantyAccrual_iS_pp0p0_c20220101__20221231_zvFsGX3JWX4h" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Warranty reserve, beginning">131,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Warranty reserve expense</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ProductWarrantyAccrualWarrantiesIssued_pp0p0_c20220101__20221231_zJOi00VVo5Ih" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Warranty reserve expense">98,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Warranty claims settled, and true-up of accrual</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ProductWarrantyAccrualPayments_iN_pp0p0_di_c20220101__20221231_zscf6MKc62v1" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Warranty claims settled and true-up of accrual">(117,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt">December 31, 2022</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_eus-gaap--ProductWarrantyAccrual_iE_pp0p0_c20220101__20221231_zY00EshyZicc" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Warranty reserve, ending">112,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zbDgv3SgRHK6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfProductWarrantyLiabilityTableTextBlock_zsv2i5Bpkx8l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The claims made during the year ended December 31, 2022, and 2021 were ordinary and customary. The warranty reserve is included in accrued expenses on the accompanying consolidated balance sheets and the cost of components in the accompanying consolidated statement of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B0_z3vPvSj3w0Pi" style="display: none">SCHEDULE OF PRODUCT WARRANTY LIABILITY</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Warranty Reserve</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 78%; text-align: justify">December 31, 2020</td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--ProductWarrantyAccrual_iS_pp0p0_c20210101__20211231_zexra0jxaefl" style="font-family: Times New Roman, Times, Serif; width: 18%; text-align: right" title="Warranty reserve, beginning">283,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Warranty reserve expense</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--ProductWarrantyAccrualWarrantiesIssued_pp0p0_c20210101__20211231_z1cm3MPxbho1" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Warranty reserve expense"><span style="-sec-ix-hidden: xdx2ixbrl0797">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Warranty claims settled, and true-up of accrual</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_eus-gaap--ProductWarrantyAccrualPayments_iN_pp0p0_di_c20210101__20211231_zdarR3xq30Kc" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Warranty claims settled and true-up of accrual">(152,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify">December 31, 2021</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--ProductWarrantyAccrual_iS_pp0p0_c20220101__20221231_zvFsGX3JWX4h" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Warranty reserve, beginning">131,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Warranty reserve expense</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ProductWarrantyAccrualWarrantiesIssued_pp0p0_c20220101__20221231_zJOi00VVo5Ih" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Warranty reserve expense">98,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Warranty claims settled, and true-up of accrual</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ProductWarrantyAccrualPayments_iN_pp0p0_di_c20220101__20221231_zscf6MKc62v1" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Warranty claims settled and true-up of accrual">(117,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt">December 31, 2022</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_eus-gaap--ProductWarrantyAccrual_iE_pp0p0_c20220101__20221231_zY00EshyZicc" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Warranty reserve, ending">112,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 283000 152000 131000 98000 117000 112000 <p id="xdx_844_ecustom--ShippingAndHandlingCostsPolicyTextBlock_zuOIzVCu8vF6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86F_zo3YZUCOYbti">Shipping and Handling Costs</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company invoices its shipping and handling charges to the customer, and we net these charges against the respective costs within general and administrative expenses. For the years ended December 31, 2022, and 2021, the shipping and handling costs incurred were $<span id="xdx_902_ecustom--ShippingAndHandlingCosts_pp0p0_c20220101__20221231_zMdFAzgpff6k" title="Shipping and handling costs">796,000</span> and $<span id="xdx_90B_ecustom--ShippingAndHandlingCosts_pp0p0_c20210101__20211231_zvI1PJ6Xky3" title="Shipping and handling costs">581,000</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 796000 581000 <p id="xdx_846_ecustom--CommonStockPurchaseWarrantsAndOtherDerivativeFinancialInstrumentsPolicyTextBlock_z6FhlHBX2Rkg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_866_zI7qJKuMYLEf">Common Stock Purchase Warrants and Other Derivative Financial Instruments</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company assesses the classification of its freestanding derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required. The Company classifies common stock purchase warrants and other freestanding financial instruments as equity if the contracts (i) require physical settlement or net-share settlement in common stock or (ii) give the Company a choice of net-cash settlement or settlement in common stock (physical settlement or net-share settlement). The Company classifies the following contracts as either an asset or a liability: contracts that (i) require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), (ii) give the counterparty a choice of net-cash settlement or settlement in common stock (physical settlement or net-share settlement) or (iii) contain reset provisions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_849_ecustom--TreasuryStockPolicyTextBlock_zTIb2qESxw6i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86B_z1b4ToodU13d">Treasury Stock</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treasury stock is recorded at cost upon the repurchasing of common shares. The cost method is used upon the re-issuance of shares. Under U.S. GAAP, the excess of the acquisition cost over the re-issuance price of the treasury stock, if any, is recorded to additional paid-in capital, limited to the amount previously credited to additional paid-in capital if any. The Company charges the accumulated deficit for any excess.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_84B_eus-gaap--RevenueFromContractWithCustomerPolicyTextBlock_zbp4rHCy2Djl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86A_zw3bmPiHGjMh">Revenue Recognition</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We account for the Company’s operating results under ASC Topic 606, adopted on January 1, 2019. It is a comprehensive revenue recognition model that requires recognition when the Company transfers control of the promised goods or services to our customers at an amount that reflects the consideration we expect to receive. The application of ASC Topic 606 requires us to use more judgment and make more estimates than under previously issued guidance.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company generates all its revenue from contracts with customers. The Company recognizes revenue when we satisfy a performance obligation by transferring control of the promised goods or services to a customer in an amount that reflects the consideration we expect to receive in exchange for those services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Revenue Recognition (continued)</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company determines revenue recognition through the following steps:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1. Identification of the contract, or contracts, with a customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2. Identification of the performance obligations in the contract.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3. Determination of the transaction price.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4. Allocation of the transaction price to the performance obligations in the contract; and</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5. Recognition of revenue when, or as, we satisfy a performance obligation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At contract inception, the Company assesses the goods and services promised in our customer contracts and identifies a performance obligation for each. To determine the performance obligations, the Company considers all the products and services promised in the contract regardless of whether they are explicitly stated or implied by customary business practices. The timing of satisfaction of the performance obligation is not subject to significant judgment. We measure revenue as the consideration we expect to receive in exchange for transferring goods and services. The value-added sales taxes and other charges we collect concurrent with revenue-producing activities are excluded from income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span>Remaining Performance Obligations</span>:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The remaining performance obligations, or backlog, represent the aggregate amount of the transaction price allocated to the remaining obligations that the Company has not performed under its customer contracts. The Company has elected to use the optional exemption in ASC 606-10-50-14, which exempts an entity from such disclosures if a performance obligation is part of a contract with an original expected duration of one year or less.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--ResearchAndDevelopmentExpensePolicy_z3KagkLYCfxi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_861_zoJQ3ujv3NIa">Research and Development Expenses</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As the Company performs research, design, and development activities, we charge these costs to research and development expenses in the Consolidated Statements of Operations and Comprehensive Loss. These expenses consist primarily of salary and benefit expenses, including stock-based compensation and payroll taxes for employees’ and contractors’ costs engaged in research, design, development activities, prototypes, facilities, and travel costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_842_eus-gaap--LesseeLeasesPolicyTextBlock_zwBqsdZoawYd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86A_zPPU4nGdqUA2">Leases</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We determine if an arrangement is a lease at inception. We recognize lease expense for lease payments on a straight-line basis over the lease term. The Company includes operating leases as ROU assets as “Right of use assets, operating leases” in the consolidated balance sheets. For lease liabilities, operating lease liabilities are included in “Operating lease obligations, current” and “Operating lease liabilities, net of current portion” in the consolidated balance sheets. We recognize Operating lease ROU assets and liabilities on the commencement date based on the present value of lease payments for all leases with a term longer than 12 months. No lease and non-lease components are separated for all our real estate contracts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There were no capital leases, now titled “finance leases” under ASC 842, in the Company’s lease portfolio as of December 31, 2022. The ROU assets and related lease liabilities recorded under ASC 842 are calculated based on the present value of the lease payments using (1) the rate implicit in the lease or (2) the lessee’s incremental borrowing rate (“IBR”), defined as the rate of interest that a lessee would have to pay to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a comparable economic environment. As most of our leases do not provide an implicit rate, we determined our incremental borrowing rates based on an analysis of prior collateralized borrowings over similar terms of the lease payments at the commencement date to estimate the IBR under ASC 842.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_zVoCnohXERda" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_863_zx4qx0UY4oQ6">Stock-Based Compensation</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for stock compensation with persons classified as employees for accounting purposes under ASC 718 “Compensation-Stock Compensation,” which recognizes awards at fair value on the date of grant and recognition of compensation over the service period for awards expected to vest. The fair value of stock options is determined using the Black-Scholes Option Pricing Model, and the fair value of common stock issued for services is determined based on the Company’s stock price on the issuance date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The expansion of Topic 718 fell under ASU 2018-07 to include share-based payment transactions for acquiring goods and services from nonemployees. The measurement date for equity-classified nonemployee share-based payment awards is no longer at the earlier date at which a commitment for performance by the counterparty is reached or the date at which the counterparty’s performance is complete. Instead, the grant date is now considered the measurement date. Under today’s guidance, the measurement of nonemployee share-based payment awards with performance conditions is at the lowest aggregate fair value, often resulting in a zero value. The new ASU aligns the accounting for nonemployee share-based payment awards with performance conditions with accounting for employee share-based payment awards under Topic 718 by requiring entities to consider the probability of satisfying performance conditions. Current guidance requires entities to use the contractual term to measure the nonemployee share-based payment awards. The new ASU allows entities to make an award-by-award election to use the expected duration (consistent with employee share-based payment awards) or the contractual term for nonemployee awards.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span>Stock-Option Awards — Time-based and performance-based</span>:</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under ASC Topic 718, the compensation cost is measured based on an award’s fair value at the grant’s date for the time vested option award using the Black Scholes-Merton formula as a valuation technique. The Company used the U.S. Treasury note’s rate over the expected option term for the risk-free rate. Employees’ expected term represents the period that options granted are expected to be outstanding using the simplified method. The Company’s historical share option exercise experience does not provide a reasonable basis for estimating the expected term. For nonemployee options, the expected term is the entire term of the option. Expected volatility is based on the average weekly share price changes over the shorter expected term or the period from the Nasdaq Capital Markets Exchange placement to the grant’s date. The Company estimates forfeiture and volatility using historical information. The risk-free interest rate is based on the implied yield on U.S. Treasury zero-coupon issues over the options’ equivalent lives.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has not paid dividends on its common stock, and no assumption of dividend payment(s) is made in the model. For employee equity-classified awards, compensation cost is recognized over the employee’s requisite service period with a corresponding credit to additional paid-in capital. The employee’s requisite service period begins at the service inception date and ends when the requisite service has been provided.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span>Restricted Stock Unit Awards (“RSUs”) — Time-Based</span>:</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under ASC 718, the exercise price for RSUs is determined using the fair market value of the Company’s common stock on the grant date. For an award with graded vesting subject only to a service condition (e.g., time-based vesting), ASC 718-10-35-8 provides an accounting policy choice between graded vesting attribution or straight-line attribution. The Company elects the graded vesting method, recognizing compensation expense for only the portion of awards expected to vest. Forfeitures of time-based units and awards are recognized as they occur. Stock-based compensation costs are calculated using the closing stock price on the grant date to estimate the fair value of time-based restricted stock units.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Stock-Based Compensation (continued</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span>Restricted Stock Unit Awards (“RSUs”) — Performance-Based</span>:</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accruals of compensation cost for an award with a performance condition are related to that performance condition’s probable outcome. Under ASC 718, a “performance condition” is the achievement of a specified target that is defined by referring to the employer’s operations or activities, such as an option that vests if the employer’s growth rate increases by a certain amount or there are the attainments of regulatory approval for a product. There is an accrual of compensation cost upon the likely achievement of the performance condition, and there is no accrual if the accomplishment of the performance condition is not probable. The exercise price for RSUs is determined using the fair market value of the Company’s common stock on the grant date. Stock-based compensation costs are calculated using the closing stock price on the grant date to estimate performance-based restricted stock units’ fair value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_84B_ecustom--ImpairmentAndAbandonmentPolicyTextBlock_zzlDf68k3g5e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_862_ztVmbaTz5gUk">Impairment and Abandonment</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Right-of-use operating lease abandonment:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management decided to vacate the Billerica, MA facility as part of the Company’s cost savings strategy implemented in the third quarter of the fiscal year 2022. The economic environment of the location precluded the action of sub-letting, and management determined the (leased facility) to be abandoned as of September 30, 2022. Under ASC 360, leased space abandonment is an impairment indicator, and the Company assessed the lease right-of-use (“ROU”) assets for impairment. The Company considered approximately $<span id="xdx_905_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_c20220101__20221231_zcHFGJQ5jeMh" title="Right-of-use operating assets impaired"><span id="xdx_909_eus-gaap--ImpairmentOfLongLivedAssetsToBeDisposedOf_c20210101__20211231_zU7qqRwdrYng" title="Right-of-use operating assets impaired">131,000</span></span> of right-of-use operating assets impaired, less $<span id="xdx_909_ecustom--OperatingLeasesRightOfUseAssetAccumulatedAmortization_c20210101__20211231_zRlBU1kd1D13" title="Right-of-use"><span id="xdx_900_ecustom--OperatingLeasesRightOfUseAssetAccumulatedAmortization_c20210101__20211231_z9cpY1oynZxh" title="Right-of-use">43,000</span></span> of accumulated amortization, and for the years ending December 31, 2022, and 2021, the Company recognized a loss on impairment of ROU assets of approximately $<span id="xdx_903_eus-gaap--OperatingLeaseImpairmentLoss_c20220101__20221231_zwurGpjAVPA2" title="Loss on impairment of right-of-use assets">88,000</span> and $-<span id="xdx_908_eus-gaap--OperatingLeaseImpairmentLoss_c20210101__20211231_zWOBZBEDpBhf" title="Loss on impairment of right-of-use assets">0</span>-, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 131000 131000 43000 43000 88000 0 <p id="xdx_844_eus-gaap--IncomeTaxPolicyTextBlock_z14gnPJCjQB8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_864_zqsgm3TkB6sg">Income Taxes</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under ASC 740, as part of our consolidated financial statements, we must estimate our income tax provision (benefit) in each jurisdiction in which we operate. The Company uses the asset and liability method of accounting for income taxes. The recognition of deferred income tax assets and liabilities for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases fall under this method. Deferred income tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years these temporary differences are expected to be recovered or settled. The recognition of the effect on deferred tax assets and liabilities of a change in tax rates in income is in the period that includes the enactment date. A valuation allowance is provided for those deferred tax assets for which management cannot conclude that it is more likely than not that such deferred tax assets will be realized. The Company will file income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. The Company recognizes the impact of an uncertain tax position in its financial statements if, in management’s judgment, it is more likely than not sustainable upon audit based upon the position’s technical merits. It involves identifying potential uncertain tax positions, evaluating applicable tax laws, and assessing whether the liability for uncertain tax positions is necessary. The Company’s policy is to classify assessments, if any, for tax-related interest expense and penalties as general and administrative expenses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--AdvertisingCostsPolicyTextBlock_zH9nxQWsLphd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86F_zaTYsduPYppi">Advertising Costs</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising costs are charged to operations as incurred. Advertising costs amounted to approximately $<span id="xdx_905_eus-gaap--AdvertisingExpense_pp0p0_c20220101__20221231_z4CWNPhXsgH7" title="Advertising costs">1,038,000</span> and $<span id="xdx_90C_eus-gaap--AdvertisingExpense_pp0p0_c20210101__20211231_z32nMYRIGew1" title="Advertising costs">139,000</span> for the years ended December 31, 2022, and 2021, respectively. The Company includes advertising costs in general and administrative expenses in the accompanying consolidated statement of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> 1038000 139000 <p id="xdx_846_ecustom--SalesTaxAndValueAddedTaxesPolicyTextBlock_z0P1zjSZ2Cjf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_865_zmQIB0erE23l">Sales Tax and Value-Added Taxes</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for sales taxes and value-added taxes imposed on its goods and services on a net basis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_84B_eus-gaap--EarningsPerSharePolicyTextBlock_zQ4rdw8vfxDc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_867_z93wzI5RSwp2">Loss Per Share</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reports loss per share under ASC Topic 260, “Earnings Per Share,” which establishes standards for computing and presenting earnings per share. The basic loss per share calculation divides the net loss allocable to common stockholders by the weighted-average shares of common stock outstanding during the period without considering common stock equivalents. The diluted loss per share calculation is calculated by adjusting the weighted-average shares of common stock outstanding for the dilutive effect of common stock equivalents, including stock options and warrants, outstanding for the period as determined using the treasury stock method. Common stock equivalents are excluded from the diluted net loss per share calculation because their effect would be anti-dilutive. Therefore, basic and diluted net loss per share applicable to common stockholders is the same for periods with a net loss.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zA0oP3tyn1k5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates the anti-dilutive potential common stock equivalents excluded from the calculation of loss per share (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BA_zhURrw32blYc" style="display: none">SCHEDULE OF ANTI-DILIUTIVE POTENTIAL COMMON STOCK EQUIVALENTS EXCLUDE FROM THE CALCULATION OF LOSS PER SHARE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20220101__20221231_zZJHqCneHaW2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2022</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20210101__20211231_z5VMhHz6ZDAe" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2021</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td> <td colspan="6" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">For the Years Ended</td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">December 31,</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2022</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2021</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--EarningsPerShareDilutedOtherDisclosuresAbstract_iB_zSdV87xeQuwl" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify">Anti-dilutive potential common stock equivalents excluded from the calculation of loss per share:</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_zgtciJ4PLfYg" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 68%; text-align: justify">Stock options</td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right">828</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right">1,553</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zQhgdGNAOl2f" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Warrants</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">9,175</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">9,210</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_z1j1Kx5pfSdi" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">10,003</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">10,763</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A1_z2z16v9jEGYd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_zA0oP3tyn1k5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates the anti-dilutive potential common stock equivalents excluded from the calculation of loss per share (in thousands):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BA_zhURrw32blYc" style="display: none">SCHEDULE OF ANTI-DILIUTIVE POTENTIAL COMMON STOCK EQUIVALENTS EXCLUDE FROM THE CALCULATION OF LOSS PER SHARE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_491_20220101__20221231_zZJHqCneHaW2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2022</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20210101__20211231_z5VMhHz6ZDAe" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2021</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td> <td colspan="6" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">For the Years Ended</td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">December 31,</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2022</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2021</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--EarningsPerShareDilutedOtherDisclosuresAbstract_iB_zSdV87xeQuwl" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify">Anti-dilutive potential common stock equivalents excluded from the calculation of loss per share:</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--StockOptionMember_zgtciJ4PLfYg" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 68%; text-align: justify">Stock options</td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right">828</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right">1,553</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_hus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis__us-gaap--WarrantMember_zQhgdGNAOl2f" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Warrants</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">9,175</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">9,210</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_z1j1Kx5pfSdi" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">10,003</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">10,763</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 828000 1553000 9175000 9210000 10003000 10763000 <p id="xdx_841_eus-gaap--ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_zkgeCmZigj2g" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_868_z6Fy2DghcUS4">Foreign Currency and Other Comprehensive (Gains) Losses</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We record gains or losses resulting from foreign currency transactions in foreign currency income or loss except for the effect of exchange rates on long-term inter-company transactions that are considered long-term investments that are accumulated and credited or charged to other comprehensive income. We have two foreign subsidiaries, one in the United Kingdom and the other in the Netherlands, and their functional currencies are British Pounds and Euros, respectively. The translation from the respective foreign currency to United States Dollars (“US Dollars”) is performed for balance sheet accounts using current exchange rates at the balance sheet date and for income statement accounts using an average exchange rate for the years ending December 31, 2022, and 2021, respectively. We included gains or losses from such translation as a separate component of accumulated other comprehensive (loss) income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction gains and losses are recognized in our operations’ results based on the difference between the foreign exchange rates on the transaction date and the reporting date. The foreign currency exchange gains and losses are a component of general and administrative expenses in the accompanying Condensed Consolidated Statements of Operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_z6mUPkPNNvLf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has recognized foreign exchange gains and losses and changes in accumulated comprehensive income approximately as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B8_zPHygvvC4Rr7" style="display: none">SCHEDULE OF FOREIGN EXCHANGE AND CHANGE IN ACCUMULATED COMPREHENSIVE INCOME</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20220101__20221231_zMe83jyD5EXl" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2022</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20210101__20211231_zE5vQ4llcxY6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2021</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td> <td colspan="6" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">For the years ended</td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">December 31,</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2022</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2021</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify">Net foreign exchange transactions:</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_pp0p0_zcdrjgQelsYk" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; font-family: Times New Roman, Times, Serif; width: 68%; text-align: justify; padding-bottom: 2.5pt">(Gains) Losses</td><td style="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; width: 12%; text-align: right">24,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; width: 12%; text-align: right">100,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_pp0p0_zXYw4bI2bQPd" style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt">Net foreign exchange transactions: Losses </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">24,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">100,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify">Accumulated comprehensive income:</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--AccumulatedComprehensiveIncomeUnrealizedLossOnCurrencyTranslationAdjustment_pp0p0_z4Sr4ao19s3c" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt">Unrealized (gains) losses on currency translation adjustment</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">1,040,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">445,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_402_ecustom--AccumulatedComprehensiveIncomeUnrealizedLossOnCurrencyTranslationAdjustment_pp0p0_zryRprdp2wM2" style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt">Accumulated comprehensive income: Unrealized losses on currency translation adjustment</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">1,040,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">445,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A2_zK2LkJzvwCbe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The exchange rates adopted for the foreign exchange transactions are quoted on OANDA, a Canadian-based foreign exchange company, and an internet website providing currency conversion, online retail foreign exchange trading, foreign currency transfers, and forex information. The Company translated amounts from British Pounds into United States Dollars and Euros to British Pounds at the following exchange rates for the respective periods:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022 – £ <span id="xdx_90F_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20221231__us-gaap--AwardTypeAxis__custom--GBPMember__us-gaap--DerivativeInstrumentRiskAxis__custom--GBPToUSDMember_zdwzWrq4c5mg" title="Foreign currency exchange rate, translation">1.208970</span> to $<span id="xdx_90E_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20221231__us-gaap--DerivativeInstrumentRiskAxis__custom--GBPToUSDMember_zhQ8fYu8nDk2" title="Foreign currency exchange rate, translation">1.00</span>; € <span id="xdx_905_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20221231__us-gaap--AwardTypeAxis__custom--EuroMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EuroToGBPMember_zhj8kw1JCS79" title="Foreign exchange rates">1.069850</span> to $<span id="xdx_90D_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20221231__us-gaap--AwardTypeAxis__custom--GBPMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EuroToGBPMember_zhWEC6k4wNe8" title="Foreign currency exchange rate, translation">1.00</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The average exchange rate for the year ended December 31, 2022 – £ <span id="xdx_902_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20221231__us-gaap--AwardTypeAxis__custom--GBPMember__us-gaap--DerivativeInstrumentRiskAxis__custom--GBPToUSDMember_z70etmVeviu9" title="Foreign currency exchange rate, remeasurement">1.236579</span> to $<span id="xdx_901_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20221231__us-gaap--DerivativeInstrumentRiskAxis__custom--GBPToUSDMember_zyO8szcTAqm1" title="Foreign currency exchange rate, remeasurement">1.00</span>; € <span id="xdx_90F_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20221231__us-gaap--AwardTypeAxis__custom--EuroMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EuroToGBPMember_zOtgagqew9w4" title="Foreign currency exchange rate, remeasurement">1.052082</span> to $<span id="xdx_904_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20221231__us-gaap--AwardTypeAxis__custom--GBPMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EuroToGBPMember_z2xWQ6S0Ehv" title="Foreign currency exchange rate, remeasurement">1.00</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021 – £<span id="xdx_90F_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20211231__us-gaap--AwardTypeAxis__custom--GBPMember__us-gaap--DerivativeInstrumentRiskAxis__custom--GBPToUSDMember_zFk665UKxKD8" title="Foreign currency exchange rate, translation">1.351043</span> to $<span id="xdx_907_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--GBPToUSDMember_zJByCcoysoI3" title="Foreign currency exchange rate, translation">1.00</span>; €<span id="xdx_904_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20211231__us-gaap--AwardTypeAxis__custom--EuroMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EuroToGBPMember_zcrggvJeHSui" title="Foreign currency exchange rate, translation">0.839362</span> to £<span id="xdx_903_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_pid_uPure_c20211231__us-gaap--AwardTypeAxis__custom--GBPMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EuroToGBPMember_zoM8LCqX7J53" title="Foreign currency exchange rate, translation">1.00</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The average exchange rate for the year ended December 31, 2021 – £<span id="xdx_90A_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20211231__us-gaap--AwardTypeAxis__custom--GBPMember__us-gaap--DerivativeInstrumentRiskAxis__custom--GBPToUSDMember_z9IdVf0ucO8g" title="Foreign currency exchange rate, remeasurement">1.375369</span> to $<span id="xdx_907_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20211231__us-gaap--DerivativeInstrumentRiskAxis__custom--GBPToUSDMember_zDF7OG9V4CLk" title="Foreign currency exchange rate, remeasurement">1.00</span>; €<span id="xdx_90B_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20211231__us-gaap--AwardTypeAxis__custom--EuroMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EuroToGBPMember_zysBaeEU6iV5" title="Foreign currency exchange rate, remeasurement">0.850858</span> to £<span id="xdx_90B_eus-gaap--ForeignCurrencyExchangeRateRemeasurement1_iI_pid_uPure_c20211231__us-gaap--AwardTypeAxis__custom--GBPMember__us-gaap--DerivativeInstrumentRiskAxis__custom--EuroToGBPMember_zhEDJE6MnNl6" title="Foreign currency exchange rate, remeasurement">1.00</span></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_899_eus-gaap--ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_z6mUPkPNNvLf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has recognized foreign exchange gains and losses and changes in accumulated comprehensive income approximately as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B8_zPHygvvC4Rr7" style="display: none">SCHEDULE OF FOREIGN EXCHANGE AND CHANGE IN ACCUMULATED COMPREHENSIVE INCOME</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20220101__20221231_zMe83jyD5EXl" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2022</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_493_20210101__20211231_zE5vQ4llcxY6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2021</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td> <td colspan="6" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">For the years ended</td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">December 31,</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2022</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2021</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify">Net foreign exchange transactions:</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_pp0p0_zcdrjgQelsYk" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; font-family: Times New Roman, Times, Serif; width: 68%; text-align: justify; padding-bottom: 2.5pt">(Gains) Losses</td><td style="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; width: 12%; text-align: right">24,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; width: 12%; text-align: right">100,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--ForeignCurrencyTransactionGainLossBeforeTax_pp0p0_zXYw4bI2bQPd" style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt">Net foreign exchange transactions: Losses </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">24,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">100,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify">Accumulated comprehensive income:</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--AccumulatedComprehensiveIncomeUnrealizedLossOnCurrencyTranslationAdjustment_pp0p0_z4Sr4ao19s3c" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt">Unrealized (gains) losses on currency translation adjustment</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">1,040,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">445,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_402_ecustom--AccumulatedComprehensiveIncomeUnrealizedLossOnCurrencyTranslationAdjustment_pp0p0_zryRprdp2wM2" style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt">Accumulated comprehensive income: Unrealized losses on currency translation adjustment</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">1,040,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">445,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 24000 100000 24000 100000 1040000 445000 1040000 445000 1.208970 1.00 1.069850 1.00 1.236579 1.00 1.052082 1.00 1.351043 1.00 0.839362 1.00 1.375369 1.00 0.850858 1.00 <p id="xdx_84B_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zLynsV5RQbo1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_868_zLKFugwjo9eh">Fair Value of Financial Instruments and Fair Value Measurements</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The authoritative guidance for fair value measurements under topic ASC 820, “Fair Value Measurements and Disclosures,” establishes a three-tier fair value hierarchy, prioritizing the inputs used in measuring fair value. These tiers include:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 is observable inputs such as quoted prices in active markets.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 is defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 is defined as unobservable inputs in which little or no market data exists, requiring an entity to develop its assumptions.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our financial instruments include cash equivalents, accounts receivable, prepaid expenses and other assets, accounts payable, accrued expenses, and short-term debt. Fair value estimates of these instruments are made at a specific point in time based on relevant market information. These estimates may be subjective in nature and involve uncertainties and matters of significant judgment and, therefore, cannot be determined with precision. The carrying amount of cash equivalents, accounts receivable, prepaid expenses and other assets, accounts payable, and accrued expenses are generally considered representative of their respective fair values because of the short-term nature of those instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement. The new guidance modifies the disclosure requirements on fair value measurements in Topic 820. The amendments in ASU 2018-13 are effective for all entities for fiscal years and interim periods within those fiscal years beginning after December 15, 2019. Effective January 1, 2020, the Company adopted the provisions of ASU 2018-13. The adoption had no material impact on the Company’s consolidated financial statements or related financial statement disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: right; margin-top: 0pt; margin-bottom: 0pt"/> <p id="xdx_89C_eus-gaap--FairValueAssetsMeasuredOnNonrecurringBasisTextBlock_zO8HGkC0ohN9" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table presents the Company’s assets and liabilities measured at fair value on a non-recurring basis on December 31, 2022, consistent with the fair value hierarchy provisions. The asset impairment is a non-recurring level 3 measurement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="margin: 0; font-family: Times New Roman, Times, Serif"><span id="xdx_8B4_znrC1h3iFe23" style="display: none">SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON NON-RECURRING BASIS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><p style="margin-top: 0; margin-bottom: 0">Quoted Prices in</p> <p style="margin-top: 0; margin-bottom: 0">Active Markets</p> <p style="margin-top: 0; margin-bottom: 0">for Identical</p> <p style="margin-top: 0; margin-bottom: 0">Assets/Liabilities</p> <p style="margin-top: 0; margin-bottom: 0">(Level 1)</p></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><p style="margin-top: 0; margin-bottom: 0">Significant</p> <p style="margin-top: 0; margin-bottom: 0">Observable</p> <p style="margin-top: 0; margin-bottom: 0">Inputs</p> <p style="margin-top: 0; margin-bottom: 0">(Level 2)</p></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><p style="margin-top: 0; margin-bottom: 0">Significant</p> <p style="margin-top: 0; margin-bottom: 0">Unobservable</p> <p style="margin-top: 0; margin-bottom: 0">Inputs</p> <p style="margin-top: 0; margin-bottom: 0">(Level 3)</p></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left">Assets (non-recurring):</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 40%; text-align: left; padding-bottom: 1.5pt">Abandonment of right-of-use operating leases</td><td style="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FinancialInstrumentAxis__custom--AbandonmentOfRightofuseOperatingLeasesMember_zVPZAoIkpob6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Total Assets (non-recurring)"><span style="-sec-ix-hidden: xdx2ixbrl0919">—</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FinancialInstrumentAxis__custom--AbandonmentOfRightofuseOperatingLeasesMember_zbOA2hORHg9j" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Total Assets (non-recurring)"><span style="-sec-ix-hidden: xdx2ixbrl0921">—</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FinancialInstrumentAxis__custom--AbandonmentOfRightofuseOperatingLeasesMember_zxM14rqjIYzl" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Total Assets (non-recurring)">88,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20221231__us-gaap--FinancialInstrumentAxis__custom--AbandonmentOfRightofuseOperatingLeasesMember_zKFBoFqcN8ak" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Total Assets (non-recurring)">88,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zgR1Z9PyLbCg" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total Assets (non-recurring)"><span style="-sec-ix-hidden: xdx2ixbrl0927">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z11cXKGOEx04" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total Assets (non-recurring)"><span style="-sec-ix-hidden: xdx2ixbrl0929">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z1TONQGLCmh" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total Assets (non-recurring)">88,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20221231_zs2WCFiL0bZc" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total Assets (non-recurring)">88,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif">Liabilities:</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt">Other</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FinancialInstrumentAxis__custom--OtherMember_z1VcTRlS5rwe" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Other liabilities"><span style="-sec-ix-hidden: xdx2ixbrl0935">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FinancialInstrumentAxis__custom--OtherMember_zrxV2CxBUF59" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Other liabilities"><span style="-sec-ix-hidden: xdx2ixbrl0937">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FinancialInstrumentAxis__custom--OtherMember_zFBTpcm444a9" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Other liabilities"><span style="-sec-ix-hidden: xdx2ixbrl0939">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20221231__us-gaap--FinancialInstrumentAxis__custom--OtherMember_zOJt5htXJtAh" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Other liabilities"><span style="-sec-ix-hidden: xdx2ixbrl0941">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zgTQgWSa07u7" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total Liabilities"><span style="-sec-ix-hidden: xdx2ixbrl0943">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z9JEPSCxFT3h" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total Liabilities"><span style="-sec-ix-hidden: xdx2ixbrl0945">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zKdMRt7B3t11" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total Liabilities"><span style="-sec-ix-hidden: xdx2ixbrl0947">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20221231_zOSMBOxT0eRb" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total Liabilities"><span style="-sec-ix-hidden: xdx2ixbrl0949">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zQRe5wM09zyi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company did not have reportable assets and liabilities under ASC Topic 820 disclosure requirements for the year ended December 31, 2021. See Note 13 for additional disclosure regarding the Company’s warrants liabilities accounted for at fair value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p id="xdx_89C_eus-gaap--FairValueAssetsMeasuredOnNonrecurringBasisTextBlock_zO8HGkC0ohN9" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table presents the Company’s assets and liabilities measured at fair value on a non-recurring basis on December 31, 2022, consistent with the fair value hierarchy provisions. The asset impairment is a non-recurring level 3 measurement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="margin: 0; font-family: Times New Roman, Times, Serif"><span id="xdx_8B4_znrC1h3iFe23" style="display: none">SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON NON-RECURRING BASIS</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><p style="margin-top: 0; margin-bottom: 0">Quoted Prices in</p> <p style="margin-top: 0; margin-bottom: 0">Active Markets</p> <p style="margin-top: 0; margin-bottom: 0">for Identical</p> <p style="margin-top: 0; margin-bottom: 0">Assets/Liabilities</p> <p style="margin-top: 0; margin-bottom: 0">(Level 1)</p></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><p style="margin-top: 0; margin-bottom: 0">Significant</p> <p style="margin-top: 0; margin-bottom: 0">Observable</p> <p style="margin-top: 0; margin-bottom: 0">Inputs</p> <p style="margin-top: 0; margin-bottom: 0">(Level 2)</p></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center; font-weight: bold"><p style="margin-top: 0; margin-bottom: 0">Significant</p> <p style="margin-top: 0; margin-bottom: 0">Unobservable</p> <p style="margin-top: 0; margin-bottom: 0">Inputs</p> <p style="margin-top: 0; margin-bottom: 0">(Level 3)</p></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></td><td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left">Assets (non-recurring):</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 40%; text-align: left; padding-bottom: 1.5pt">Abandonment of right-of-use operating leases</td><td style="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FinancialInstrumentAxis__custom--AbandonmentOfRightofuseOperatingLeasesMember_zVPZAoIkpob6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Total Assets (non-recurring)"><span style="-sec-ix-hidden: xdx2ixbrl0919">—</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FinancialInstrumentAxis__custom--AbandonmentOfRightofuseOperatingLeasesMember_zbOA2hORHg9j" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Total Assets (non-recurring)"><span style="-sec-ix-hidden: xdx2ixbrl0921">—</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FinancialInstrumentAxis__custom--AbandonmentOfRightofuseOperatingLeasesMember_zxM14rqjIYzl" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Total Assets (non-recurring)">88,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20221231__us-gaap--FinancialInstrumentAxis__custom--AbandonmentOfRightofuseOperatingLeasesMember_zKFBoFqcN8ak" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 11%; text-align: right" title="Total Assets (non-recurring)">88,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--AssetsFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zgR1Z9PyLbCg" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total Assets (non-recurring)"><span style="-sec-ix-hidden: xdx2ixbrl0927">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z11cXKGOEx04" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total Assets (non-recurring)"><span style="-sec-ix-hidden: xdx2ixbrl0929">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_z1TONQGLCmh" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total Assets (non-recurring)">88,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20221231_zs2WCFiL0bZc" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total Assets (non-recurring)">88,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif">Liabilities:</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt">Other</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FinancialInstrumentAxis__custom--OtherMember_z1VcTRlS5rwe" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Other liabilities"><span style="-sec-ix-hidden: xdx2ixbrl0935">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FinancialInstrumentAxis__custom--OtherMember_zrxV2CxBUF59" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Other liabilities"><span style="-sec-ix-hidden: xdx2ixbrl0937">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FinancialInstrumentAxis__custom--OtherMember_zFBTpcm444a9" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Other liabilities"><span style="-sec-ix-hidden: xdx2ixbrl0939">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20221231__us-gaap--FinancialInstrumentAxis__custom--OtherMember_zOJt5htXJtAh" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Other liabilities"><span style="-sec-ix-hidden: xdx2ixbrl0941">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--LiabilitiesFairValueDisclosure_iI_pn3n3_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zgTQgWSa07u7" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total Liabilities"><span style="-sec-ix-hidden: xdx2ixbrl0943">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z9JEPSCxFT3h" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total Liabilities"><span style="-sec-ix-hidden: xdx2ixbrl0945">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zKdMRt7B3t11" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total Liabilities"><span style="-sec-ix-hidden: xdx2ixbrl0947">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--LiabilitiesFairValueDisclosure_iI_c20221231_zOSMBOxT0eRb" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Total Liabilities"><span style="-sec-ix-hidden: xdx2ixbrl0949">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 88000 88000 88000 88000 <p id="xdx_84D_ecustom--RedeemablePreferredStockPolicyTextBlock_zgdsgqzNDC6j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86E_zwhsdAh57sK9">Redeemable Preferred Stock</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In November 2022, <span id="xdx_909_eus-gaap--PreferredStockVotingRights_c20221101__20221130_zTbewRf06EDk" title="Preferred stock voting discription">the Company’s board of directors approved the designation of a Series A Preferred Stock created for the sole purpose of the January 11, 2023, Special Meeting of stockholders voting on the consideration of a “Reverse Stock Split Proposal.” The Series A Preferred Stock had a par value of $<span id="xdx_906_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20221130__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zK5D9ZvUZGV3" title="Preferred stock, par value">0.00001</span> per share. The Preferred Stock was redeemable upon the holder participating at any meeting of stockholders held to vote on the Reverse Stock Split immediately before the opening of the polls at such meeting (the “Initial Redemption Time”) shall automatically be redeemed by the Corporation at the Initial Redemption Time without further action on the part of the Corporation or the holder thereof (the “Initial Redemption”). Any outstanding shares of Series A Preferred Stock that were not redeemed under an Initial Redemption were redeemed in whole, but not in part (i) if such redemption was ordered by the Board of Directors in its sole discretion, automatically and effective on such time and date specified by the Board of Directors in its sole discretion or (ii) automatically upon the approval by the Corporation’s stockholders of the Reverse Stock Split at the Special Meeting held for voting on the Reverse Stock Split proposal.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the guidance of ASC Topic 480, all Series A Preferred Stock shares have been presented outside of permanent equity in the mezzanine equity section on the Consolidated Balance Sheets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES – (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> the Company’s board of directors approved the designation of a Series A Preferred Stock created for the sole purpose of the January 11, 2023, Special Meeting of stockholders voting on the consideration of a “Reverse Stock Split Proposal.” The Series A Preferred Stock had a par value of $0.00001 per share. The Preferred Stock was redeemable upon the holder participating at any meeting of stockholders held to vote on the Reverse Stock Split immediately before the opening of the polls at such meeting (the “Initial Redemption Time”) shall automatically be redeemed by the Corporation at the Initial Redemption Time without further action on the part of the Corporation or the holder thereof (the “Initial Redemption”). Any outstanding shares of Series A Preferred Stock that were not redeemed under an Initial Redemption were redeemed in whole, but not in part (i) if such redemption was ordered by the Board of Directors in its sole discretion, automatically and effective on such time and date specified by the Board of Directors in its sole discretion or (ii) automatically upon the approval by the Corporation’s stockholders of the Reverse Stock Split at the Special Meeting held for voting on the Reverse Stock Split proposal. 0.00001 <p id="xdx_846_eus-gaap--SubsequentEventsPolicyPolicyTextBlock_z2Y7kvhEDB78" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_866_zT1coA3bEWje">Subsequent Events</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management has evaluated subsequent events or transactions occurring through the date the consolidated financial statements were issued and determined that no events or transactions are required to be disclosed herein except as disclosed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_ecustom--NewlyIssuedAccountingPronouncementsPolicyPolicyTextBlock_zgivJ1msRRXj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span><span id="xdx_862_zvyWBEvTN8ei">Recently Issued Accounting Pronouncements</span></span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span>Recently Issued Accounting Standards Adopted and Not Yet Adopted</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span>Adopted on January 1, 2023</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In June 2016, the FASB established Topic 326, Financial Instruments—Credit Losses, Measurement of Credit Losses on Financial Instruments (ASU) No. 2016-13, which requires a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates, including accounts receivable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The standard replaces the existing incurred credit loss model with the Current Expected Credit Losses (“CECL”) model. It is required to measure credit losses based on the Company’s estimate of expected losses rather than incurred losses, which generally results in earlier recognition of allowances for credit losses. Under ASC 326, the Company evaluates specific criteria, including aging and historical write-offs, the current economic condition of particular customers, and future economic conditions of countries utilizing a consumption index to determine the appropriate allowance for credit losses. The Company completed its assessment of the new standard, and no adjustment will be made to its opening balance of retained earnings relating to its trade receivables. The Company writes off receivables once it is determined that the receivables are no longer collectible and as allowed by local laws.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zOQC8OKtKFl8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_86A_zcxjnX1rma0a">Recent Accounting Pronouncements</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other recent accounting standards issued by the FASB, including its Emerging Issues Task Force, the American Institute of Certified Public Accountants, and the SEC did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.</span></p> <p id="xdx_805_eus-gaap--BusinessCombinationDisclosureTextBlock_zSjByNVNbC12" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 4 – <span id="xdx_824_zJn0On90ZpIh">ACQUISITION OF MOBILE VIEWPOINT CORPORATE B.V.</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 16, 2021, the Company, through a wholly-owned subsidiary, entered into a stock purchase agreement with Triple I.T. Corporate B.V., a private company incorporated in the Netherlands, under which the Company acquired <span id="xdx_90A_ecustom--BusinessAcquisitionPercentageOfOutstandingCapitalAcquired_iI_pid_dp_uPure_c20210816__us-gaap--BusinessAcquisitionAxis__custom--MobileViewpointCorporateBVMember__srt--RangeAxis__srt--MaximumMember_zRsN801NYBD4" title="Percentage of outstanding capital acquired">100%</span> of the outstanding capital of MVP for an aggregate purchase price of €<span id="xdx_907_eus-gaap--PaymentsToAcquireBusinessesGross_uEUR_c20210815__20210816__us-gaap--BusinessAcquisitionAxis__custom--MobileViewpointCorporateBVMember_zOZFeIYjDBY6" title="Purchase price">14,824,278</span> (or approximately $<span id="xdx_901_eus-gaap--PaymentsToAcquireBusinessesGross_pn5n6_uUSD_c20210815__20210816__us-gaap--BusinessAcquisitionAxis__custom--MobileViewpointCorporateBVMember_zQW7RBJc6VK4" title="Purchase price">17.5</span> million based on a USD to EUR exchange rate of <span id="xdx_900_eus-gaap--ForeignCurrencyExchangeRateTranslation1_iI_uPure_c20210813__us-gaap--BusinessAcquisitionAxis__custom--MobileViewpointCorporateBVMember_zYTwrEqLu2bg" title="Foreign currency exchange rate">0.85</span> as of August 13, 2021) plus the assumption and payment of €<span id="xdx_903_ecustom--PaymentOfIntercompanyIndebtedness_pp0p0_uEUR_c20210815__20210816__us-gaap--BusinessAcquisitionAxis__custom--MobileViewpointCorporateBVMember_zhOxym56piD7" title="Acquisition payment amount">717,785</span> of intercompany indebtedness, all paid by the Company in cash, subject to certain routine closing adjustments in respect of working capital and net indebtedness (“The Transaction”). The Transaction was closed on August 16, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for the acquisition under the acquisition method under ASC 805 “Business Combinations,” and we elected not to apply pushdown accounting upon the purchase of MVP. Therefore, we recognized the preliminary historical basis of MVP’s acquired assets and liabilities. We identified any excess of the consideration paid in excess of the net assets acquired in the table below. In addition, we recorded approximately $<span id="xdx_90F_eus-gaap--BusinessCombinationAcquisitionRelatedCosts_pn5n6_c20220101__20221231__us-gaap--BusinessAcquisitionAxis__custom--MobileViewpointCorporateBVMember_zA3fdvZ56Tx7" title="Acquisition related costs">1.6</span> million of preliminary acquisition-related transaction costs (e.g., legal, due diligence, valuation, and other professional fees) not included as a component of consideration transferred but are required to be expensed as incurred and included in our consolidated statement of operations. Future transaction costs are indeterminable as the Company progresses to the finalization of the Transaction.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company received a final valuation report from our third-party appraiser regarding allocating the consideration paid in excess of the net assets acquired. Additionally, the Company received an updated list of certain assets and liabilities acquired on August 16, 2021. Under ASC 805, we recorded measurement period adjustments under the previously mentioned revisions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have completed integrating MVP into our operations and internal control processes. As we finished this integration, we analyzed, evaluated, and, where necessary, made changes in control and procedures related to the MVP business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 4 – ACQUISITION OF MOBILE VIEWPOINT CORPORATE B.V. (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the historical value of the assets and liabilities as of the acquisition date, allocation of the consideration paid in excess of net assets acquired, relative useful lives, and the amortization method of the listed intangible assets.</span></p> <p id="xdx_897_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zzhan56ZoQz7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B3_zPIJIVMPwHf2" style="display: none">SCHEDULE OF IDENTIFIABLE ASSETS ACQUIRED AND LIABILITIES ASSUMED</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20210816__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zzBio3FbkLo9" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">As Initially<br/> Reported</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20210816__srt--RestatementAxis__srt--RestatementAdjustmentMember_zxhq8lhJDPr5" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Measurement<br/> Period<br/> Adjustments</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20210816_zgv7jsiznXFa" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">As Adjusted</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_404_eus-gaap--BusinessCombinationConsiderationTransferredAbstract_iB_zM6HBOmVI6Ic" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold">Fair value of consideration transferred:</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--BusinessCombinationConsiderationTransferredCash_iI_pp0p0_zj22vfBgDGwk" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; width: 46%; padding-bottom: 1.5pt">Cash</td><td style="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 14%; text-align: right">18,311,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0984">—</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 14%; text-align: right">18,311,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_iB_zi43JzMTsSW4" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: left">Recognized amounts of identifiable assets acquired and liabilities assumed:</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pp0p0_maBCRIAzGAW_zQXueDYLZyog" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt">Cash</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="font-family: Times New Roman, Times, Serif; text-align: right">965,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0992">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="font-family: Times New Roman, Times, Serif; text-align: right">965,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_pp0p0_maBCRIAzGAW_zHRelfQbxmTh" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Accounts receivable, net</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">911,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0996">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">911,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_pp0p0_maBCRIAzGAW_zvBWPVJpWxa4" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Inventories, net</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">2,534,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">1,231,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">3,765,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_pp0p0_maBCRIAzGAW_za65ft3G1UW4" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Prepaid expenses and other assets</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">625,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">(112,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">513,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_pp0p0_maBCRIAzGAW_z3O53S1ITZG9" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Property and equipment, net</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">149,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1008">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">149,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iNI_pp0p0_di_msBCRIAzGAW_zXhg655hXvbb" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Accounts payable</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">(507,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1012">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">(507,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_iNI_pp0p0_di_msBCRIAzGAW_zQSqqI904202" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Accrued expenses</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">(551,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1016">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">(551,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_iNI_pp0p0_di_msBCRIAzGAW_zFd9vmACFXog" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Customer deposits and deferred revenue</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">(293,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1020">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">(293,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_402_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredTaxLiabilities_iNI_pp0p0_di_msBCRIAzGAW_z2Sztsi1Havd" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Deferred tax liabilities</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1023">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">(978,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">(978,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iTI_pp0p0_mtBCRIAzGAW_zyS9RTtJbIo8" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Total identifiable net assets</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">3,833,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">141,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">3,974,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--BusinessCombinationConsiderationPaid_iI_pp0p0_zbqHNf8YsiP8" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: left">Consideration paid</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="font-family: Times New Roman, Times, Serif; text-align: right">18,311,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1032">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="font-family: Times New Roman, Times, Serif; text-align: right">18,311,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_pp0p0_zYaCBcyfYU76" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Total identifiable assets acquired</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">3,833,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">141,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">3,974,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--ExcessOfConsiderationPaidOverNetAssetsAcquired_iI_pp0p0_z6aHHe1um7e1" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Excess of consideration paid over net assets acquired</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">14,478,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">(141,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">14,337,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_iB_zFMmGpG5jVwh" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: left">Preliminary allocation of the consideration paid in excess of the net assets acquired:</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iI_pp0p0_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_ztoDikgL4E3c" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Trade name</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="font-family: Times New Roman, Times, Serif; text-align: right">730,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="font-family: Times New Roman, Times, Serif; text-align: right">70,688</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="font-family: Times New Roman, Times, Serif; text-align: right">800,688</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iI_pp0p0_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProprietaryTechnologyMember_zesXMSRlvFsl" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Proprietary technology</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">1,850,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">282,749</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">2,132,749</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iI_pp0p0_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zS6RwrM5K1Wg" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Customer relationship</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">3,723,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">(1,508,003</td><td style="font-family: Times New Roman, Times, Serif; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">2,214,997</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iI_pp0p0_hus-gaap--FairValueByAssetClassAxis__us-gaap--GoodwillMember_zIj1VY69OZPd" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt">Goodwill</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">8,175,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">1,013,566</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">9,188,856</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iI_pp0p0_z2N8dMBd9mc6" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Total intangible assets acquired</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">14,478,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">(141,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">14,337,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A4_zglCrEfI4Bzg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of the updated purchase price allocations for the MVP acquisition on August 16, 2021, specific fair value amounts previously estimated were adjusted during the measurement period. These measurement period adjustments resulted from our external valuation specialists’ updated valuation reports and appraisals and revisions to internal account classifications. The changes from the final valuation report included an increase of $<span id="xdx_90C_ecustom--IncreaseInInventory_iI_pn4n6_c20210816_z4967lLInr5h" title="Increase of inventory">1.23</span> million in inventory, $<span id="xdx_909_eus-gaap--IncreaseDecreaseInIntangibleAssetsCurrent_pn4n6_c20210815__20210816__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_zEbdKXker6rc" title="Trade name">0.07</span> million in the trade name, $<span id="xdx_907_eus-gaap--IncreaseDecreaseInIntangibleAssetsCurrent_pn3n6_c20210815__20210816__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProprietaryTechnologyMember_zgNlwFgVf5La" title="Propritory technology">.028</span> million in proprietary technology, and $<span id="xdx_90F_eus-gaap--IncreaseDecreaseInIntangibleAssetsCurrent_pn4n6_c20210815__20210816__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--GoodwillMember_z5TjPTA6usRl" title="Good will">0.04</span> million in goodwill, offset by a reduction of $<span id="xdx_90E_eus-gaap--IncreaseDecreaseInIntangibleAssetsCurrent_pn4n6_c20210815__20210816__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_z6Kx6Vx0rvI2" title="Customer Relationships">1.51</span> million in customer relationships. The revision in internal account classification resulted in a decrease of $<span id="xdx_900_eus-gaap--PrepaidExpenseAndOtherAssetsCurrent_iI_pn4n6_c20210816_zdxeCupMIgwd" title="Decrease in prepaid expenses and other current assets">0.11</span> million in prepaid expenses and other current assets with a reciprocal increase of $<span id="xdx_902_ecustom--IncreasedReciprocalOfInventory_pn4n6_c20210815__20210816_zJbk1GiMJRYj" title="Reciprocal of inventory, increased">0.11</span> million in inventory.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In estimating the fair value of the assets and liabilities, the valuation specialist considered three fundamental techniques or approaches to valuing an asset: the Income Approach (present value of future economic benefits for customer lists), the Market Approach (analysis of recent comparable entity asset sales for trade names, and proprietary technology) and the Cost Approach (replacement or reconstruction cost of similar assets of like utility for the step-up in inventory). To ascribe value to the Subject Assets, it was necessary first to determine an appropriate discount rate. The discount rate for the acquired assets was developed using a Weighted Average Cost of Capital (“WACC”) methodology. The discount rate applied under WACC was <span id="xdx_903_ecustom--WeightedAverageCostCapitalPercentage_iI_pid_dp_c20210816_zFDk7D870Lf1" title="Weighted average cost capital percentage">20</span>%. To perform the process outlined by ASC 805, the valuation specialists defined the buyer’s expected rate of return, referred to as the internal rate of return (“IRR,” <span id="xdx_909_ecustom--WeightedAverageCostCapitalPercentage_iI_pid_dp_c20210816__us-gaap--FairValueByAssetClassAxis__custom--InternalRateOfReturnMember_ziiojTNazFL2" title="Weighted average cost capital percentage">19.5</span>%), a market participant’s rate of return, which is WACC; and the rates of returns for the identified assets: working capital (<span id="xdx_90B_ecustom--WeightedAverageCostCapitalPercentage_iI_pid_dp_c20210816__us-gaap--FairValueByAssetClassAxis__custom--WorkingCapitalMember_z29bNAlZgFYf" title="Weighted average cost capital percentage">20.3</span>%), intangible assets (<span id="xdx_908_ecustom--WeightedAverageCostCapitalPercentage_iI_pid_dp_c20210816__us-gaap--FairValueByAssetClassAxis__custom--IntangibleAssetsMember_zYXGxhFKGzta" title="Weighted average cost capital percentage">21.0</span>%), and goodwill (<span id="xdx_905_ecustom--WeightedAverageCostCapitalPercentage_iI_pid_dp_c20210816__us-gaap--FairValueByAssetClassAxis__us-gaap--GoodwillMember_zuwFkVfGdVL" title="Weighted average cost capital percentage">23.0</span>%).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 4 – ACQUISITION OF MOBILE VIEWPOINT CORPORATE B.V. (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intangible assets acquired:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Purchaser acquired intangible assets from MVP as a result of the Transaction. The Tradename, Proprietary Technology, and Customer Relationships are intangible assets noted to have a finite life, while Goodwill has an indefinite life span. The finite life intangible assets will be amortized using the straight-line method of the respective lives of each asset, while the indefinite life intangible assets will not be amortized.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_ztZ4hTo4Ecd8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based thereon, below are the acquired intangibles with their relative useful lives and method of amortization:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_8B9_zAVNgIAM9LA8" style="display: none">SCHEDULE OF ACQUIRED INTANGIBLE WITH THEIR RELATIVE USEFUL LIVES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intangible Asset</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful Life</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amortization Method</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tradename</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20220101__20221231__us-gaap--FairValueByAssetClassAxis__custom--TradeNameMember_zLrmXtJlmk4k" title="Useful life">15</span> Years</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight-line</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proprietary Technology</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20220101__20221231__us-gaap--FairValueByAssetClassAxis__custom--ProprietaryTechnologiesMember_zfFYqctKrz7d" title="Useful life">5</span> Years</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight-line</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer Relationships</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20220101__20221231__us-gaap--FairValueByAssetClassAxis__custom--CustomerRelationshipMember_zD5FteB72gKh" title="Useful life">10</span> Years</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight-line</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLifeDescription_c20220101__20221231__us-gaap--FairValueByAssetClassAxis__custom--GoodwillIntangiblesMember_zSBo4t8gCj9h" title="Useful life, description">Indefinite</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td></tr> </table> <p id="xdx_8A6_zbX6Ze2viOG7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zIni9XV4V0V5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following presents the unaudited Pro-forma combined results of operations of Vislink with MVP as if the combination of the entities occurred on January 1, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B0_zx6jO03dgub5" style="display: none">SCHEDULE OF UNAUDITED PRO-FORMA COMBINED RESULTS OF OPERATIONS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" id="xdx_494_20210101__20211231_zJNx0hbDx9o7" style="font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ending</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p></td><td style="font-family: Times New Roman, Times, Serif"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2021</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--BusinessAcquisitionsProFormaRevenue_pp0p0_zkI4XLZ3fQz5" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 78%; text-align: justify">Revenues, net</td><td style="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; width: 18%; text-align: right">36,843</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_pp0p0_zbtsb7hHMidj" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify">Net loss allocable to common stockholders</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">(16,173</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--BasicEarningsPerShareProForma_pid_zxPZUjStOU5" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify">Net loss per share</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">(0.37</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--WeightedAverageNumberBasicSharesOutstandingAdjustmentProForma_pid_z9c07ECRziOg" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify">Weighted average number of shares outstanding</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">43,484</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_z2gBTPL6TQOh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The revenue and earnings of MVP since the acquisition date included in the consolidated statements of operations and comprehensive loss amount to approximately $2.3 million for the year ending December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1 14824278 17500000 0.85 717785 1600000 <p id="xdx_897_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zzhan56ZoQz7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B3_zPIJIVMPwHf2" style="display: none">SCHEDULE OF IDENTIFIABLE ASSETS ACQUIRED AND LIABILITIES ASSUMED</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20210816__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zzBio3FbkLo9" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">As Initially<br/> Reported</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20210816__srt--RestatementAxis__srt--RestatementAdjustmentMember_zxhq8lhJDPr5" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Measurement<br/> Period<br/> Adjustments</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20210816_zgv7jsiznXFa" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">As Adjusted</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_404_eus-gaap--BusinessCombinationConsiderationTransferredAbstract_iB_zM6HBOmVI6Ic" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; font-weight: bold">Fair value of consideration transferred:</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--BusinessCombinationConsiderationTransferredCash_iI_pp0p0_zj22vfBgDGwk" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; width: 46%; padding-bottom: 1.5pt">Cash</td><td style="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 14%; text-align: right">18,311,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 14%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0984">—</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; width: 14%; text-align: right">18,311,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract_iB_zi43JzMTsSW4" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: left">Recognized amounts of identifiable assets acquired and liabilities assumed:</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_iI_pp0p0_maBCRIAzGAW_zQXueDYLZyog" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt">Cash</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="font-family: Times New Roman, Times, Serif; text-align: right">965,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0992">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="font-family: Times New Roman, Times, Serif; text-align: right">965,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_pp0p0_maBCRIAzGAW_zHRelfQbxmTh" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Accounts receivable, net</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">911,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0996">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">911,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_pp0p0_maBCRIAzGAW_zvBWPVJpWxa4" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Inventories, net</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">2,534,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">1,231,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">3,765,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets_iI_pp0p0_maBCRIAzGAW_za65ft3G1UW4" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Prepaid expenses and other assets</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">625,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">(112,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">513,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_pp0p0_maBCRIAzGAW_z3O53S1ITZG9" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Property and equipment, net</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">149,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1008">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">149,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iNI_pp0p0_di_msBCRIAzGAW_zXhg655hXvbb" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Accounts payable</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">(507,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1012">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">(507,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_iNI_pp0p0_di_msBCRIAzGAW_zQSqqI904202" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Accrued expenses</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">(551,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1016">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">(551,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue_iNI_pp0p0_di_msBCRIAzGAW_zFd9vmACFXog" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Customer deposits and deferred revenue</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">(293,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1020">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">(293,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_402_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredTaxLiabilities_iNI_pp0p0_di_msBCRIAzGAW_z2Sztsi1Havd" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Deferred tax liabilities</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1023">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">(978,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">(978,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iTI_pp0p0_mtBCRIAzGAW_zyS9RTtJbIo8" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Total identifiable net assets</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">3,833,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">141,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">3,974,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--BusinessCombinationConsiderationPaid_iI_pp0p0_zbqHNf8YsiP8" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: left">Consideration paid</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="font-family: Times New Roman, Times, Serif; text-align: right">18,311,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1032">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="font-family: Times New Roman, Times, Serif; text-align: right">18,311,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet_iI_pp0p0_zYaCBcyfYU76" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Total identifiable assets acquired</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">3,833,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">141,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">3,974,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_408_ecustom--ExcessOfConsiderationPaidOverNetAssetsAcquired_iI_pp0p0_z6aHHe1um7e1" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Excess of consideration paid over net assets acquired</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">14,478,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">(141,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">14,337,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract_iB_zFMmGpG5jVwh" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: left">Preliminary allocation of the consideration paid in excess of the net assets acquired:</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iI_pp0p0_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TradeNamesMember_ztoDikgL4E3c" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Trade name</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="font-family: Times New Roman, Times, Serif; text-align: right">730,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="font-family: Times New Roman, Times, Serif; text-align: right">70,688</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="font-family: Times New Roman, Times, Serif; text-align: right">800,688</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iI_pp0p0_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--ProprietaryTechnologyMember_zesXMSRlvFsl" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Proprietary technology</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">1,850,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">282,749</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">2,132,749</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iI_pp0p0_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerRelationshipsMember_zS6RwrM5K1Wg" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Customer relationship</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">3,723,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">(1,508,003</td><td style="font-family: Times New Roman, Times, Serif; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">2,214,997</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iI_pp0p0_hus-gaap--FairValueByAssetClassAxis__us-gaap--GoodwillMember_zIj1VY69OZPd" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt">Goodwill</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">8,175,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">1,013,566</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">9,188,856</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iI_pp0p0_z2N8dMBd9mc6" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Total intangible assets acquired</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">14,478,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">(141,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">14,337,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 18311000 18311000 965000 965000 911000 911000 2534000 1231000 3765000 625000 -112000 513000 149000 149000 507000 507000 551000 551000 293000 293000 978000 978000 3833000 141000 3974000 18311000 18311000 3833000 141000 3974000 14478000 -141000 14337000 730000 70688 800688 1850000 282749 2132749 3723000 -1508003 2214997 8175000 1013566 9188856 14478000 -141000 14337000 1230000 70000.00 28000.000 40000.00 1510000 110000 110000 0.20 0.195 0.203 0.210 0.230 <p id="xdx_894_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_ztZ4hTo4Ecd8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based thereon, below are the acquired intangibles with their relative useful lives and method of amortization:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_8B9_zAVNgIAM9LA8" style="display: none">SCHEDULE OF ACQUIRED INTANGIBLE WITH THEIR RELATIVE USEFUL LIVES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Intangible Asset</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Useful Life</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Amortization Method</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tradename</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20220101__20221231__us-gaap--FairValueByAssetClassAxis__custom--TradeNameMember_zLrmXtJlmk4k" title="Useful life">15</span> Years</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight-line</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proprietary Technology</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20220101__20221231__us-gaap--FairValueByAssetClassAxis__custom--ProprietaryTechnologiesMember_zfFYqctKrz7d" title="Useful life">5</span> Years</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight-line</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer Relationships</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_eus-gaap--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_dtY_c20220101__20221231__us-gaap--FairValueByAssetClassAxis__custom--CustomerRelationshipMember_zD5FteB72gKh" title="Useful life">10</span> Years</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Straight-line</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLifeDescription_c20220101__20221231__us-gaap--FairValueByAssetClassAxis__custom--GoodwillIntangiblesMember_zSBo4t8gCj9h" title="Useful life, description">Indefinite</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">N/A</span></td></tr> </table> P15Y P5Y P10Y Indefinite <p id="xdx_892_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zIni9XV4V0V5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following presents the unaudited Pro-forma combined results of operations of Vislink with MVP as if the combination of the entities occurred on January 1, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B0_zx6jO03dgub5" style="display: none">SCHEDULE OF UNAUDITED PRO-FORMA COMBINED RESULTS OF OPERATIONS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" id="xdx_494_20210101__20211231_zJNx0hbDx9o7" style="font-family: Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Year </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Ending</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December 31,</b></span></p></td><td style="font-family: Times New Roman, Times, Serif"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2021</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40E_eus-gaap--BusinessAcquisitionsProFormaRevenue_pp0p0_zkI4XLZ3fQz5" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 78%; text-align: justify">Revenues, net</td><td style="font-family: Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; width: 18%; text-align: right">36,843</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_pp0p0_zbtsb7hHMidj" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify">Net loss allocable to common stockholders</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">(16,173</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--BasicEarningsPerShareProForma_pid_zxPZUjStOU5" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify">Net loss per share</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">(0.37</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--WeightedAverageNumberBasicSharesOutstandingAdjustmentProForma_pid_z9c07ECRziOg" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify">Weighted average number of shares outstanding</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">43,484</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 36843 -16173 -0.37 43484 <p id="xdx_80D_eus-gaap--FinancingReceivablesTextBlock_zVfvchzs0RJa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 5 — <span id="xdx_82E_zFU0X9VJOCI5">ACCOUNTS RECEIVABLE</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zuOaUI1df0Bf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B4_zRF81I2se8dk" style="display: none">SCHEDULE OF ACCOUNTS RECEIVABLE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20221231_zrDnH3HDlCJk" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">December 31, 2022</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20211231_zCkELISbhUga" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">December 31, 2021</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_407_eus-gaap--AccountsReceivableGrossCurrent_iI_pp0p0_maARNCz81W_zy2J4k5hfElj" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 56%; text-align: left">Accounts receivable</td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font-family: Times New Roman, Times, Serif; width: 18%; text-align: right">6,680,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font-family: Times New Roman, Times, Serif; width: 18%; text-align: right">10,327,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iNI_pp0p0_di_msARNCz81W_zhf3y3yU56Qj" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Allowance for doubtful accounts</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">(673,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">(1,258,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--AccountsReceivableNetCurrent_iTI_pp0p0_mtARNCz81W_zDvR1MoQp356" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net accounts receivable</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">6,007,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">9,069,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A3_zUiQPy9UPX36" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the years ended December 31, 2022, and 2021, the Company incurred bad debt expenses of $<span id="xdx_903_eus-gaap--ProvisionForDoubtfulAccounts_pp0p0_c20220101__20221231_z3lfBXIOI8y9" title="Bad debt expense">21,000</span> and $<span id="xdx_90C_eus-gaap--ProvisionForDoubtfulAccounts_pp0p0_c20210101__20211231_zZjuGFwRCHz8" title="Bad debt expense">233,000</span>, respectively. Additionally, for the years ended December 31, 2022, and 2021, the Company experienced bad debt recoveries of $<span id="xdx_900_ecustom--RecoveryOfBadDebt_pp0p0_c20220101__20221231_zKBERoyHDj95" title="Recovered bad debts">517,000</span> and $<span id="xdx_90C_ecustom--RecoveryOfBadDebt_pp0p0_c20210101__20211231_zQpQLybJQOli" title="Recovered bad debts">310,000</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_894_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_zuOaUI1df0Bf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B4_zRF81I2se8dk" style="display: none">SCHEDULE OF ACCOUNTS RECEIVABLE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20221231_zrDnH3HDlCJk" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">December 31, 2022</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20211231_zCkELISbhUga" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">December 31, 2021</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_407_eus-gaap--AccountsReceivableGrossCurrent_iI_pp0p0_maARNCz81W_zy2J4k5hfElj" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 56%; text-align: left">Accounts receivable</td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font-family: Times New Roman, Times, Serif; width: 18%; text-align: right">6,680,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font-family: Times New Roman, Times, Serif; width: 18%; text-align: right">10,327,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iNI_pp0p0_di_msARNCz81W_zhf3y3yU56Qj" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Allowance for doubtful accounts</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">(673,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">(1,258,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--AccountsReceivableNetCurrent_iTI_pp0p0_mtARNCz81W_zDvR1MoQp356" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net accounts receivable</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">6,007,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">9,069,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 6680000 10327000 673000 1258000 6007000 9069000 21000 233000 517000 310000 <p id="xdx_800_eus-gaap--InventoryDisclosureTextBlock_zweNoG3PKH4l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 6 — <span id="xdx_822_zJseL0A8ci98">INVENTORIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zu2uVDpBOwIi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories included in the accompanying consolidated balance sheet are stated at the lower of cost or market as summarized below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B7_zs5DHNh5UqRg" style="display: none">SCHEDULE OF INVENTORIES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20221231_z2JSIuMtPg8k" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">December 31, 2022</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20211231_zzBtPeivpay3" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">December 31, 2021</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40D_eus-gaap--InventoryRawMaterialsAndSupplies_iI_pp0p0_maIGzWA3_zTaFmDbXsXyk" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 56%; text-align: left">Raw materials</td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font-family: Times New Roman, Times, Serif; width: 18%; text-align: right">12,038,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font-family: Times New Roman, Times, Serif; width: 18%; text-align: right">11,308,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maIGzWA3_zwtazLuZ52zl" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif">Work-in-process</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">1,474,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">2,105,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maIGzWA3_zHqn6PLHxNj5" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Finished goods</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">4,460,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">5,011,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--InventoryGross_iTI_pp0p0_mtIGzWA3_maINzLxN_zB4VMd8gaNm5" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: left">Sub-total inventories</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">17,972,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">18,424,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--InventoryValuationReserves_iNI_pp0p0_di_msINzLxN_zvmx4wmDL3Oa" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Less reserve for slow-moving and excess inventory</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">(5,951,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">(6,530,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--InventoryNet_iTI_pp0p0_mtINzLxN_zxr7iJR6qloi" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total inventories, net</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">12,021,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">11,894,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AB_z7CB2APe4dJ" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory valuation adjustments consist primarily of written-off items due to obsolescence or reserved for slow-moving or excess inventory. The Company recorded inventory valuation adjustments of $<span id="xdx_908_eus-gaap--EffectOfLIFOInventoryLiquidationOnIncome_pp0p0_c20220101__20221231_zYyqrRIRbb3k" title="Inventory valuation adjustments">1,143,000</span> and $<span id="xdx_901_eus-gaap--EffectOfLIFOInventoryLiquidationOnIncome_pp0p0_c20210101__20211231_zCPf3ipCan21" title="Inventory valuation adjustments">843,000</span> as of December 31, 2022, and 2021. Additionally, under the Company’s product rationalization program, management eliminated specific product lines impairing $<span id="xdx_90C_eus-gaap--AssetImpairmentCharges_pp0p0_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--ProductRationalizationProgramMember_zHgKzGptXK8j" title="Product lines impairing of inventories">1,787,000</span> and $-<span id="xdx_909_eus-gaap--AssetImpairmentCharges_pp0p0_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--ProductRationalizationProgramMember_zy27szRkYqX2" title="Product lines impairing of inventories">0</span>- of inventory as of December 31, 2022, and 2021, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_zu2uVDpBOwIi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventories included in the accompanying consolidated balance sheet are stated at the lower of cost or market as summarized below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B7_zs5DHNh5UqRg" style="display: none">SCHEDULE OF INVENTORIES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20221231_z2JSIuMtPg8k" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">December 31, 2022</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20211231_zzBtPeivpay3" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">December 31, 2021</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40D_eus-gaap--InventoryRawMaterialsAndSupplies_iI_pp0p0_maIGzWA3_zTaFmDbXsXyk" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 56%; text-align: left">Raw materials</td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font-family: Times New Roman, Times, Serif; width: 18%; text-align: right">12,038,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font-family: Times New Roman, Times, Serif; width: 18%; text-align: right">11,308,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--InventoryWorkInProcess_iI_pp0p0_maIGzWA3_zwtazLuZ52zl" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif">Work-in-process</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">1,474,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">2,105,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--InventoryFinishedGoods_iI_pp0p0_maIGzWA3_zHqn6PLHxNj5" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Finished goods</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">4,460,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">5,011,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--InventoryGross_iTI_pp0p0_mtIGzWA3_maINzLxN_zB4VMd8gaNm5" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: left">Sub-total inventories</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">17,972,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">18,424,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--InventoryValuationReserves_iNI_pp0p0_di_msINzLxN_zvmx4wmDL3Oa" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Less reserve for slow-moving and excess inventory</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">(5,951,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">(6,530,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--InventoryNet_iTI_pp0p0_mtINzLxN_zxr7iJR6qloi" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total inventories, net</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">12,021,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">11,894,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 12038000 11308000 1474000 2105000 4460000 5011000 17972000 18424000 5951000 6530000 12021000 11894000 1143000 843000 1787000 0 <p id="xdx_809_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zX0XyfQO4Km1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 7 — <span id="xdx_822_z8b3lUGJhn0l">PROPERTY AND EQUIPMENT</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--PropertyPlantAndEquipmentTextBlock_zgCzSpiCYFNe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_8BF_zXt4uepD5Xfi" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: center">Useful Life</td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">December 31,</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">(Years)</td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2022</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2021</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify">Cost:</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 51%; text-align: justify">Furniture and fixtures</td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 15%; text-align: center"><span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zPgjNM5x7NF6" title="Estimated useful life">1</span> – <span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_zb3idBDpyrIl" title="Estimated useful life">10</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zCfOTyCq9Nah" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Furniture and fixtures">308,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zqmgZrnYrhO1" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Furniture and fixtures">282,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Leasehold improvements (a)</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember__srt--RangeAxis__srt--MinimumMember_zuUa0xyMJL2f" title="Estimated useful life">1</span> - <span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember__srt--RangeAxis__srt--MaximumMember_zifr7Pvwndpk" title="Estimated useful life">14</span></td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z3Gv52J4iaWh" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Leasehold improvements">443,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_znGqC4ZfTvm8" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Leasehold improvements">439,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Computers, software, and equipment</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MinimumMember_zhRUZu2haobf" title="Estimated useful life">1</span> - <span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MaximumMember_zNLun3yqfQ82" title="Estimated useful life">11</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zBpgzQG7d4pg" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Computers, software, and equipment">3,016,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zeX7frHiDBe5" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Computers, software, and equipment">2,813,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231_zqJ2apoiuaKe" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">3,767,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231_zN5w5Do94xql" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">3,534,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Accumulated depreciation</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20221231_z16oloopsqa4" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Accumulated depreciation">(2,333,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20211231_z4IHq0Q3teo3" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Accumulated depreciation">(2,361,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Property and equipment, net</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20221231_z8Z74OI2tLO" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net">1,434,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20211231_zG6roSah6L7f" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net">1,173,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A0_zO0rXRbKGfXd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation of property and equipment amounted to $<span id="xdx_904_eus-gaap--Depreciation_pp0p0_c20220101__20221231_zhSt24zoCvsk" title="Property and equipment, depreciation">201,000</span> and $<span id="xdx_90D_eus-gaap--Depreciation_pp0p0_c20210101__20211231_zh6Lf9mDwgwl" title="Property and equipment, depreciation">195,000</span> for the years ended December 31, 2022, and 2021, respectively. Additionally, the Company removed $<span id="xdx_90B_eus-gaap--ImpairmentOfLeasehold_c20220101__20221231_zaaktMsrrsX5" title="Depreciation leasehold improvement">228,000</span> of fully depreciation leasehold improvement from its records.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a) The shorter economic life or remaining lease term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--PropertyPlantAndEquipmentTextBlock_zgCzSpiCYFNe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_8BF_zXt4uepD5Xfi" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold; text-align: center">Useful Life</td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">December 31,</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">(Years)</td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2022</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2021</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify">Cost:</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 51%; text-align: justify">Furniture and fixtures</td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 15%; text-align: center"><span id="xdx_90C_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MinimumMember_zPgjNM5x7NF6" title="Estimated useful life">1</span> – <span id="xdx_902_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember__srt--RangeAxis__srt--MaximumMember_zb3idBDpyrIl" title="Estimated useful life">10</span></td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zCfOTyCq9Nah" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Furniture and fixtures">308,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zqmgZrnYrhO1" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Furniture and fixtures">282,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Leasehold improvements (a)</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: center"><span id="xdx_904_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember__srt--RangeAxis__srt--MinimumMember_zuUa0xyMJL2f" title="Estimated useful life">1</span> - <span id="xdx_90A_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember__srt--RangeAxis__srt--MaximumMember_zifr7Pvwndpk" title="Estimated useful life">14</span></td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_z3Gv52J4iaWh" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Leasehold improvements">443,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--LeaseholdImprovementsMember_znGqC4ZfTvm8" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Leasehold improvements">439,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Computers, software, and equipment</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span id="xdx_900_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MinimumMember_zhRUZu2haobf" title="Estimated useful life">1</span> - <span id="xdx_909_eus-gaap--PropertyPlantAndEquipmentUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember__srt--RangeAxis__srt--MaximumMember_zNLun3yqfQ82" title="Estimated useful life">11</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zBpgzQG7d4pg" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Computers, software, and equipment">3,016,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--ComputerEquipmentMember_zeX7frHiDBe5" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Computers, software, and equipment">2,813,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20221231_zqJ2apoiuaKe" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">3,767,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_pp0p0_c20211231_zN5w5Do94xql" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, gross">3,534,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Accumulated depreciation</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20221231_z16oloopsqa4" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Accumulated depreciation">(2,333,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_pp0p0_di_c20211231_z4IHq0Q3teo3" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Accumulated depreciation">(2,361,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Property and equipment, net</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20221231_z8Z74OI2tLO" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net">1,434,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentNet_iI_pp0p0_c20211231_zG6roSah6L7f" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Property and equipment, net">1,173,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> P1Y P10Y 308000 282000 P1Y P14Y 443000 439000 P1Y P11Y 3016000 2813000 3767000 3534000 2333000 2361000 1434000 1173000 201000 195000 228000 <p id="xdx_80B_eus-gaap--GoodwillDisclosureTextBlock_zvpHIS8Inz59" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 8 — <span id="xdx_827_ztYBTT8RO0Qj">GOODWILL</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill represents the excess cost of an acquired business over the fair value of the identifiable tangible and intangible assets acquired and liabilities assumed in a business combination (see Note 4). Under ASC 350, the Company chose to assess qualitative factors first to determine whether performing the first step of the two-step goodwill impairment test is necessary. The Company assessed qualitative factors to determine if it is more likely than not (that is, a likelihood of more than 50 percent) that the fair value of a reporting unit is less than its carrying amount, including goodwill. In other words, it was not required to calculate the fair value of a reporting unit. As part of the MVP acquisition on August 16, 2021, we engaged a valuation analyst to estimate the fair value of specific assets acquired by performing appropriate valuations procedures. The valuation analyst expressed the results of the valuation engagement in a report in the late fourth quarter of 2021. As a result of the acquisition, the report concluded that the amount paid in excess of the net asset acquired relates to finite intangible assets, with a remaining amount allocated to goodwill.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under ASC 350, “Goodwill and other,” we completed our annual goodwill impairment test on December 31, 2021; we elected to perform a quantitative assessment to determine if it was more likely than not (that is, a likelihood of more than 50 percent) that the fair value of our reporting unit was less than its carrying value as of the test date. Our assessment recognized a decline in our market capitalization due to unfavorable changes in the market and the rise in inflation as “triggering event” conditions increasing the risk of impairment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Based on the quantitative assessment, we concluded that the carrying amount of our reporting unit exceeded the fair value. As a result, we recorded $<span id="xdx_906_eus-gaap--GoodwillImpairmentLoss_c20210101__20211231_zQ4I8e8Zajni" title="Goodwill impairment charges">9,189,000</span> in goodwill impairment charges on the consolidated operations statements and comprehensive loss for the year ended December 31, 2021. The Company did not recognize goodwill during the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 8 — GOODWILL (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfGoodwillTextBlock_zSlzLK66e3Cc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates goodwill for the years ended December 31, 2022, and 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BA_z2qKaRTwgBYf" style="display: none">SCHEDULE OF GOODWILL</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">12/31/22</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">12/31/21</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left">Beginning balance</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--Goodwill_iS_pp0p0_d0_c20220101__20221231_zyWKyYIFVKxg" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Beginning balance, Goodwill">—</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--Goodwill_iS_pp0p0_c20210101__20211231_zCPC3xsT0yMl" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Beginning balance, Goodwill"><span style="-sec-ix-hidden: xdx2ixbrl1216">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; width: 68%">Additions</td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_988_ecustom--GoodwillAdditions_pp0p0_c20220101__20221231_z9Ob2I6WzwW1" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Goodwill additions"><span style="-sec-ix-hidden: xdx2ixbrl1218">—</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98B_ecustom--GoodwillAdditions_pp0p0_c20210101__20211231_z4EEAkcX0K56" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Goodwill additions">8,211,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left">Deferred tax liabilities associated with MVP acquisition</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_ecustom--DeferredTaxLiabilties_pp0p0_c20220101__20221231_zQnXIftU8Ksb" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Deferred tax liabilties associated with MVP acquistion"><span style="-sec-ix-hidden: xdx2ixbrl1222">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_ecustom--DeferredTaxLiabilties_pp0p0_c20210101__20211231_zthBFbOzzQj7" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Deferred tax liabilties associated with MVP acquistion">978,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt">Impairments</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_ecustom--GoodwillImpairments_pp0p0_c20220101__20221231_zlE1QAWmjaj9" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Goodwill impairment"><span style="-sec-ix-hidden: xdx2ixbrl1226">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_ecustom--GoodwillImpairments_pp0p0_c20210101__20211231_zMc8HYe9ODDd" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Goodwill impairment">(9,189,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt">Ending balance</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">-<span id="xdx_901_eus-gaap--Goodwill_iE_pp0p0_c20220101__20221231_z9ooUbqT6bDf" title="Ending balance, Goodwill">0</span>-</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">-<span id="xdx_90D_eus-gaap--Goodwill_iE_pp0p0_c20210101__20211231_zRsngsJuZvof" title="Ending balance, Goodwill">0</span>-</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zEXtYb1HgCu5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 9189000 <p id="xdx_89C_eus-gaap--ScheduleOfGoodwillTextBlock_zSlzLK66e3Cc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates goodwill for the years ended December 31, 2022, and 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BA_z2qKaRTwgBYf" style="display: none">SCHEDULE OF GOODWILL</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">12/31/22</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">12/31/21</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left">Beginning balance</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--Goodwill_iS_pp0p0_d0_c20220101__20221231_zyWKyYIFVKxg" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Beginning balance, Goodwill">—</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--Goodwill_iS_pp0p0_c20210101__20211231_zCPC3xsT0yMl" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Beginning balance, Goodwill"><span style="-sec-ix-hidden: xdx2ixbrl1216">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; width: 68%">Additions</td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_988_ecustom--GoodwillAdditions_pp0p0_c20220101__20221231_z9Ob2I6WzwW1" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Goodwill additions"><span style="-sec-ix-hidden: xdx2ixbrl1218">—</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98B_ecustom--GoodwillAdditions_pp0p0_c20210101__20211231_z4EEAkcX0K56" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Goodwill additions">8,211,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left">Deferred tax liabilities associated with MVP acquisition</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_ecustom--DeferredTaxLiabilties_pp0p0_c20220101__20221231_zQnXIftU8Ksb" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Deferred tax liabilties associated with MVP acquistion"><span style="-sec-ix-hidden: xdx2ixbrl1222">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_ecustom--DeferredTaxLiabilties_pp0p0_c20210101__20211231_zthBFbOzzQj7" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Deferred tax liabilties associated with MVP acquistion">978,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt">Impairments</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_ecustom--GoodwillImpairments_pp0p0_c20220101__20221231_zlE1QAWmjaj9" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Goodwill impairment"><span style="-sec-ix-hidden: xdx2ixbrl1226">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_ecustom--GoodwillImpairments_pp0p0_c20210101__20211231_zMc8HYe9ODDd" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Goodwill impairment">(9,189,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt">Ending balance</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">-<span id="xdx_901_eus-gaap--Goodwill_iE_pp0p0_c20220101__20221231_z9ooUbqT6bDf" title="Ending balance, Goodwill">0</span>-</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">-<span id="xdx_90D_eus-gaap--Goodwill_iE_pp0p0_c20210101__20211231_zRsngsJuZvof" title="Ending balance, Goodwill">0</span>-</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 0 8211000 978000 -9189000 0 0 <p id="xdx_808_eus-gaap--IntangibleAssetsDisclosureTextBlock_zbl5LMtEe7f7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 9 — <span id="xdx_82D_zLcSRAxwwxC5">INTANGIBLE ASSETS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company continuously monitors operating results, events, and circumstances that may indicate potential impairment of intangible assets. Management concluded that no triggering events occurred during the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/> <p id="xdx_898_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_z0XwHTfKavj4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates finite intangible assets as of December 31, 2022, and 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; font-family: Times New Roman, Times, Serif"><span id="xdx_8B2_z5TUVIlfLIa2" style="display: none">SCHEDULE OF INTANGIBLE ASSETS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Proprietary Technology</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Patents and Licenses</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Trade Names &amp; Technology</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Customer Relationships</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Accumulated</td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Accumulated</td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Accumulated</td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Accumulated</td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Cost</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Amortization</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Cost</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Amortization</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Cost</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Amortization</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Cost</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Amortization</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Net</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 28%">Balance, December 31, 2020</td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iS_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zbF4Ye8GSIGl" style="font-family: Times New Roman, Times, Serif; width: 4%; text-align: right" title="Beginning balance cost"><span style="-sec-ix-hidden: xdx2ixbrl1238">—</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zFNZlnK7TPc3" style="font-family: Times New Roman, Times, Serif; width: 4%; text-align: right" title="Beginning balance, accumulated amortization"><span style="-sec-ix-hidden: xdx2ixbrl1240">—</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iS_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zOA6WapMCHJ2" style="font-family: Times New Roman, Times, Serif; width: 4%; text-align: right" title="Beginning balance cost">12,378,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zy3a3e7FvU8h" style="font-family: Times New Roman, Times, Serif; width: 4%; text-align: right" title="Beginning balance, accumulated amortization">(11,175,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iS_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zTdgfY2YVYh3" style="font-family: Times New Roman, Times, Serif; width: 4%; text-align: right" title="Beginning balance cost">1,450,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zNT4ry5KYkC5" style="font-family: Times New Roman, Times, Serif; width: 4%; text-align: right" title="Beginning balance, accumulated amortization">(914,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iS_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zX4d9A50GO1a" style="font-family: Times New Roman, Times, Serif; width: 4%; text-align: right" title="Beginning balance cost">2,880,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zxsTbXAXaiac" style="font-family: Times New Roman, Times, Serif; width: 4%; text-align: right" title="Beginning balance, accumulated amortization">(2,698,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_988_ecustom--BeginningBalanceCostAccumulatedAmortization_iS_pp0p0_c20210101__20211231_zoE6DI3AW2wl" style="font-family: Times New Roman, Times, Serif; width: 4%; text-align: right" title="Beginning balance net">1,921,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif">Additions</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_eus-gaap--IndefinitelivedIntangibleAssetsAcquired_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zNMXMrdMpX9b" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Additions">2,132,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_ecustom--IntangibleAssetsAccumulatedAmortizationAdditions_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_z8ej0yyQIR56" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated amortization, Additions"><span style="-sec-ix-hidden: xdx2ixbrl1258">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--IndefinitelivedIntangibleAssetsAcquired_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zCLSFpz9aFq6" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Additions"><span style="-sec-ix-hidden: xdx2ixbrl1260">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_ecustom--IntangibleAssetsAccumulatedAmortizationAdditions_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zFBe66NwX0E2" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated amortization, Additions"><span style="-sec-ix-hidden: xdx2ixbrl1262">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--IndefinitelivedIntangibleAssetsAcquired_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_z4Y9I62GHshe" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Additions">801,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_ecustom--IntangibleAssetsAccumulatedAmortizationAdditions_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zJUOWeMNctm9" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated amortization, Additions"><span style="-sec-ix-hidden: xdx2ixbrl1266">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--IndefinitelivedIntangibleAssetsAcquired_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zug27BDoyc8" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Additions">2,215,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_ecustom--IntangibleAssetsAccumulatedAmortizationAdditions_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zM0riv3o4ZTl" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated amortization, Additions"><span style="-sec-ix-hidden: xdx2ixbrl1270">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_ecustom--AdditionscostAccumulatedAmortizations_pp0p0_c20210101__20211231_zcYlM1xUjzka" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, net Addition">5,148,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt">Amortization</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--AdjustmentForAmortization_iN_pp0p0_di_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zY1JlKRqpel7" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Amortization"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1274">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_z4CRpexT4eC3" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated Amortization">(223,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--AdjustmentForAmortization_iN_pp0p0_di_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zcFCnRlyABp4" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Amortization"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1278">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_ztFQj2D33Ba5" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated Amortization">(668,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--AdjustmentForAmortization_iN_pp0p0_di_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_z2PvcaXwT8Zj" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Amortization"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1282">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zcoujJE6BvR2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated Amortization">(138,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--AdjustmentForAmortization_iN_pp0p0_di_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zTaFku0MpXQl" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Amortization"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1286">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zzymJshHH7Qk" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated Amortization">(119,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20210101__20211231_zkixEiISMLla" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, net Amortization">(1,148,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif">Balance, December 31, 2021</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iS_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zt2KRjuTSHM7" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Beginning balance cost">2,132,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_z3EcbmxMUdqb" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Beginning balance, accumulated Amortization">(223,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iS_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zkcRz1nNvKU" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Beginning balance cost">12,378,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zjMBJB1fSVI8" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Beginning balance, accumulated Amortization">(11,843,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iS_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zB4CVz195vxg" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Beginning balance cost">2,251,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zaRw86JuNHI6" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Beginning balance, accumulated Amortization">(1,052,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iS_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zEtWTaO8bsbb" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Beginning balance cost">5,095,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zJxIeIMsbiyl" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Beginning balance, accumulated Amortization">(2,817,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_ecustom--EndingBalanceCostAccumulatedAmortization_iS_pp0p0_c20220101__20221231_ziBlcQdTuEwd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Beginning balance net">5,921,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt">Amortization</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--AdjustmentForAmortization_iN_pp0p0_di_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zq18038DhNLd" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Amortization"><span style="-sec-ix-hidden: xdx2ixbrl1310">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zWH1bp75lyXi" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated Amortization">(592,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--AdjustmentForAmortization_iN_pp0p0_di_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zFfLHgVtqhz2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Amortization"><span style="-sec-ix-hidden: xdx2ixbrl1314">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zm84St0tS2y3" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated Amortization">(535,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--AdjustmentForAmortization_iN_pp0p0_di_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zDlMBPIAsjc7" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Amortization"><span style="-sec-ix-hidden: xdx2ixbrl1318">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zzZW1FJ9jEtf" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated Amortization">(137,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--AdjustmentForAmortization_iN_pp0p0_di_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zAFCTJBiQ1o" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Amortization"><span style="-sec-ix-hidden: xdx2ixbrl1322">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zCzA6rg6jIi1" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated Amortization">(257,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20220101__20221231_zJEybLdKvKE3" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, net Amortization">(1,521,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt">Balance, December 31, 2022</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iE_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zmnMjM4suUv5" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Ending balance cost">2,132,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_z4hSdlhDNOLi" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Ending balance, accumulated Amortization">(815,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iE_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zpDdoZcyjUU8" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Ending balance cost">12,378,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_z9gglTkfYRG7" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Ending balance, accumulated Amortization">(12,378,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iE_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_z9EuAgLf02r9" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Ending balance cost">2,251,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zMkd2Et4t2Sh" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Ending balance, accumulated Amortization">(1,189,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iE_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zqv7PsrtRcWa" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Ending balance cost">5,095,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zFZVwBNFooRl" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Ending balance, accumulated Amortization">(3,074,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_ecustom--EndingBalanceCostAccumulatedAmortization_iE_pp0p0_c20220101__20221231_z1aqoSr1tYg9" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Ending balance net">4,400,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A6_zgpD2DxdCT0l" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Proprietary Technology:</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company amortizes proprietary technology over their useful lives of <span id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember__srt--RangeAxis__srt--MinimumMember_zmuZy5yKOy95" title="Finite-lived intangible asset, useful life">3</span> to <span id="xdx_90D_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember__srt--RangeAxis__srt--MaximumMember_zYXtB1c2IDec" title="Finite-lived intangible asset, useful life">5</span> years. The proprietary technology consists of wireless multiplex transmitters, and artificial intelligence developed and used by MVP internally to produce and sell products or services to the end-user or customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Patents and Licenses:</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company amortizes filed patents and licenses over their useful lives, ranging from <span id="xdx_902_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember__srt--RangeAxis__srt--MinimumMember_zpxw5RtUpRsb" title="Finite-lived intangible asset, useful life">18.5</span> to <span id="xdx_906_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember__srt--RangeAxis__srt--MaximumMember_zmfv2IwPwUw1" title="Finite-lived intangible asset, useful life">20</span> years. The amortization of the costs incurred by processing provisional patents and pending applications begins after successful review and filing.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Trade Name, Technology, and Customer Relationships:</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company amortizes these other intangible assets over their estimated useful lives of <span id="xdx_909_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember__srt--RangeAxis__srt--MinimumMember_z8U20zyd58mg" title="Finite-lived intangible asset, useful life">3</span> to <span id="xdx_905_eus-gaap--FiniteLivedIntangibleAssetUsefulLife_dtY_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember__srt--RangeAxis__srt--MaximumMember_z5ywtyBAgkfd" title="Finite-lived intangible asset, useful life">15</span> years. Prior acquisitions of the Company’s subsidiaries, IMT, Vislink, and MVP, created these intangible assets of trade names, technology, and customer lists.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.7pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--ScheduleOfImpairedIntangibleAssetsTextBlock_zVMcCZ05vMF6" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has recognized net capitalized intangible costs as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; font-family: Times New Roman, Times, Serif"><span id="xdx_8BB_zsrZEpQ7uoXj" style="display: none">SCHEDULE OF CAPITALIZED INTANGIBLE COSTS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">December 31,</td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">December 31,</td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2022</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2021</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left">Proprietary Technology</td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zpTreeITZQU6" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Intangible assets">1,319,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_ztDqHMkeq4zl" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Intangible assets">1,910,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: left">Patents and Licenses</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zj62SaKG9EX9" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets"><span style="-sec-ix-hidden: xdx2ixbrl1364">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zkLXb5HbHqP8" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets">535,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left">Trade Names and Technology</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zX5oofODguK2" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets">1,060,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zl90SujGYJua" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets">1,198,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Customer Relationships</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_z3Yx9xvF45R5" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets">2,021,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zWO7J1SKC2o8" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets">2,278,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20221231_zAihE4djQche" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets">4,400,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231_zwNgRDItiju5" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets">5,921,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A1_zxRwPzyCuvZj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 9 — INTANGIBLE ASSETS (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"/> <p id="xdx_89A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_zo4r8Gv5U5b4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has recognized the amortization of intangible assets as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; font-family: Times New Roman, Times, Serif"><span id="xdx_8B3_zJIiqFdIrbVe" style="display: none">SCHEDULE OF AMORTIZATION OF INTANGIBLE ASSETS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td> <td colspan="6" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">For the years ended</td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">December 31,</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2022</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2021</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left">Proprietary Technology</td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zj0WPllCsO24" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Amortization of intangible assets">592,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_z7zKZ21kMrMl" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Amortization of intangible assets">223,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left">Patents and Licenses</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_z6kg98UyfNL6" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Amortization of intangible assets">535,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zbVIHWWyV5Ph" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Amortization of intangible assets">668,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left">Trade Names and Technology</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zptdzhx8ZuOb" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Amortization of intangible assets">137,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zh1cDQx7spC4" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Amortization of intangible assets">138,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left">Customer Relationships</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zegYFBKOZLq1" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Amortization of intangible assets">257,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zNDu3xTrNkxc" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Amortization of intangible assets">119,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220101__20221231_zBbj8CFtLVab" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Amortization of intangible assets">1,521,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20210101__20211231_z4ugwdGB9FSk" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Amortization of intangible assets">1,148,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zcbDgnQ9jv6j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_89B_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zvJPQfNf2WQg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The weighted average remaining life of the amortization of the Company’s intangible assets is approximately <span class="xdx_phnt_RGlzY2xvc3VyZSAtIElOVEFOR0lCTEUgQVNTRVRTIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_dtY_c20220101__20221231_zhpQfQXrrf86" title="Finite-lived intangible assets, remaining amortization period">5.3</span> years. The following table represents the estimated amortization expense for total intangible assets for the succeeding five years:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B5_zNoYiXKCM6Y7" style="display: none">SCHEDULE OF ESTIMATED AMORTIZATION EXPENSE FOR INTANGIBLE ASSETS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Period ending December 31,</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_49A_20221231_zYIajDtQDEi8" style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_maFLIANzMzA_zxHFDdyRcpy6" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 78%; text-align: justify">2023</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">645,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_maFLIANzMzA_z3TjA6NTQdAh" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">2024</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">645,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_maFLIANzMzA_zFsbFzqYcFMd" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">2025</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">645,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_maFLIANzMzA_zTHvQzvSFnH2" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">2026</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">556,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_maFLIANzMzA_zThYHT4GX81g" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">2027</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">539,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pp0p0_maFLIANzMzA_zc1LKUAcz9V5" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: justify">Thereafter</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,370,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pp0p0_mtFLIANzMzA_zMlSXMJhfNVh" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Finite-Lived Intangible Assets, Net, Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,400,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_zdgbWo2UCLMc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b/></span></p> <p id="xdx_898_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_z0XwHTfKavj4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates finite intangible assets as of December 31, 2022, and 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; font-family: Times New Roman, Times, Serif"><span id="xdx_8B2_z5TUVIlfLIa2" style="display: none">SCHEDULE OF INTANGIBLE ASSETS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Proprietary Technology</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Patents and Licenses</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Trade Names &amp; Technology</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Customer Relationships</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Accumulated</td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Accumulated</td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Accumulated</td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Accumulated</td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Cost</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Amortization</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Cost</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Amortization</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Cost</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Amortization</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Cost</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Amortization</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Net</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 28%">Balance, December 31, 2020</td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iS_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zbF4Ye8GSIGl" style="font-family: Times New Roman, Times, Serif; width: 4%; text-align: right" title="Beginning balance cost"><span style="-sec-ix-hidden: xdx2ixbrl1238">—</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zFNZlnK7TPc3" style="font-family: Times New Roman, Times, Serif; width: 4%; text-align: right" title="Beginning balance, accumulated amortization"><span style="-sec-ix-hidden: xdx2ixbrl1240">—</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iS_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zOA6WapMCHJ2" style="font-family: Times New Roman, Times, Serif; width: 4%; text-align: right" title="Beginning balance cost">12,378,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zy3a3e7FvU8h" style="font-family: Times New Roman, Times, Serif; width: 4%; text-align: right" title="Beginning balance, accumulated amortization">(11,175,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iS_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zTdgfY2YVYh3" style="font-family: Times New Roman, Times, Serif; width: 4%; text-align: right" title="Beginning balance cost">1,450,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zNT4ry5KYkC5" style="font-family: Times New Roman, Times, Serif; width: 4%; text-align: right" title="Beginning balance, accumulated amortization">(914,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iS_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zX4d9A50GO1a" style="font-family: Times New Roman, Times, Serif; width: 4%; text-align: right" title="Beginning balance cost">2,880,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zxsTbXAXaiac" style="font-family: Times New Roman, Times, Serif; width: 4%; text-align: right" title="Beginning balance, accumulated amortization">(2,698,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_988_ecustom--BeginningBalanceCostAccumulatedAmortization_iS_pp0p0_c20210101__20211231_zoE6DI3AW2wl" style="font-family: Times New Roman, Times, Serif; width: 4%; text-align: right" title="Beginning balance net">1,921,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif">Additions</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_eus-gaap--IndefinitelivedIntangibleAssetsAcquired_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zNMXMrdMpX9b" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Additions">2,132,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_ecustom--IntangibleAssetsAccumulatedAmortizationAdditions_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_z8ej0yyQIR56" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated amortization, Additions"><span style="-sec-ix-hidden: xdx2ixbrl1258">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--IndefinitelivedIntangibleAssetsAcquired_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zCLSFpz9aFq6" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Additions"><span style="-sec-ix-hidden: xdx2ixbrl1260">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_ecustom--IntangibleAssetsAccumulatedAmortizationAdditions_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zFBe66NwX0E2" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated amortization, Additions"><span style="-sec-ix-hidden: xdx2ixbrl1262">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--IndefinitelivedIntangibleAssetsAcquired_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_z4Y9I62GHshe" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Additions">801,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_ecustom--IntangibleAssetsAccumulatedAmortizationAdditions_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zJUOWeMNctm9" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated amortization, Additions"><span style="-sec-ix-hidden: xdx2ixbrl1266">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--IndefinitelivedIntangibleAssetsAcquired_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zug27BDoyc8" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Additions">2,215,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_ecustom--IntangibleAssetsAccumulatedAmortizationAdditions_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zM0riv3o4ZTl" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated amortization, Additions"><span style="-sec-ix-hidden: xdx2ixbrl1270">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_ecustom--AdditionscostAccumulatedAmortizations_pp0p0_c20210101__20211231_zcYlM1xUjzka" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, net Addition">5,148,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt">Amortization</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--AdjustmentForAmortization_iN_pp0p0_di_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zY1JlKRqpel7" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Amortization"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1274">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_z4CRpexT4eC3" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated Amortization">(223,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--AdjustmentForAmortization_iN_pp0p0_di_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zcFCnRlyABp4" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Amortization"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1278">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_ztFQj2D33Ba5" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated Amortization">(668,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--AdjustmentForAmortization_iN_pp0p0_di_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_z2PvcaXwT8Zj" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Amortization"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1282">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zcoujJE6BvR2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated Amortization">(138,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--AdjustmentForAmortization_iN_pp0p0_di_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zTaFku0MpXQl" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Amortization"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1286">-</span></span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zzymJshHH7Qk" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated Amortization">(119,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20210101__20211231_zkixEiISMLla" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, net Amortization">(1,148,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif">Balance, December 31, 2021</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iS_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zt2KRjuTSHM7" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Beginning balance cost">2,132,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_z3EcbmxMUdqb" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Beginning balance, accumulated Amortization">(223,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iS_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zkcRz1nNvKU" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Beginning balance cost">12,378,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zjMBJB1fSVI8" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Beginning balance, accumulated Amortization">(11,843,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iS_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zB4CVz195vxg" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Beginning balance cost">2,251,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zaRw86JuNHI6" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Beginning balance, accumulated Amortization">(1,052,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iS_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zEtWTaO8bsbb" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Beginning balance cost">5,095,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iS_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zJxIeIMsbiyl" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Beginning balance, accumulated Amortization">(2,817,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_ecustom--EndingBalanceCostAccumulatedAmortization_iS_pp0p0_c20220101__20221231_ziBlcQdTuEwd" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Beginning balance net">5,921,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt">Amortization</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--AdjustmentForAmortization_iN_pp0p0_di_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zq18038DhNLd" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Amortization"><span style="-sec-ix-hidden: xdx2ixbrl1310">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zWH1bp75lyXi" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated Amortization">(592,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--AdjustmentForAmortization_iN_pp0p0_di_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zFfLHgVtqhz2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Amortization"><span style="-sec-ix-hidden: xdx2ixbrl1314">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zm84St0tS2y3" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated Amortization">(535,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--AdjustmentForAmortization_iN_pp0p0_di_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zDlMBPIAsjc7" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Amortization"><span style="-sec-ix-hidden: xdx2ixbrl1318">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zzZW1FJ9jEtf" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated Amortization">(137,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--AdjustmentForAmortization_iN_pp0p0_di_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zAFCTJBiQ1o" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, Amortization"><span style="-sec-ix-hidden: xdx2ixbrl1322">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zCzA6rg6jIi1" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets accumulated Amortization">(257,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--AmortizationOfIntangibleAssets_iN_pp0p0_di_c20220101__20221231_zJEybLdKvKE3" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets, net Amortization">(1,521,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt">Balance, December 31, 2022</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iE_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zmnMjM4suUv5" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Ending balance cost">2,132,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_z4hSdlhDNOLi" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Ending balance, accumulated Amortization">(815,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iE_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zpDdoZcyjUU8" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Ending balance cost">12,378,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_z9gglTkfYRG7" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Ending balance, accumulated Amortization">(12,378,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iE_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_z9EuAgLf02r9" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Ending balance cost">2,251,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zMkd2Et4t2Sh" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Ending balance, accumulated Amortization">(1,189,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--IntangibleAssetsGrossExcludingGoodwill_iE_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zqv7PsrtRcWa" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Ending balance cost">5,095,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iE_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zFZVwBNFooRl" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Ending balance, accumulated Amortization">(3,074,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_ecustom--EndingBalanceCostAccumulatedAmortization_iE_pp0p0_c20220101__20221231_z1aqoSr1tYg9" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Ending balance net">4,400,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 12378000 -11175000 1450000 -914000 2880000 -2698000 1921000 2132000 801000 2215000 5148000 223000 668000 138000 119000 1148000 2132000 -223000 12378000 -11843000 2251000 -1052000 5095000 -2817000 5921000 592000 535000 137000 257000 1521000 2132000 -815000 12378000 -12378000 2251000 -1189000 5095000 -3074000 4400000 P3Y P5Y P18Y6M P20Y P3Y P15Y <p id="xdx_899_eus-gaap--ScheduleOfImpairedIntangibleAssetsTextBlock_zVMcCZ05vMF6" style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has recognized net capitalized intangible costs as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; font-family: Times New Roman, Times, Serif"><span id="xdx_8BB_zsrZEpQ7uoXj" style="display: none">SCHEDULE OF CAPITALIZED INTANGIBLE COSTS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">December 31,</td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">December 31,</td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2022</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2021</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left">Proprietary Technology</td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zpTreeITZQU6" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Intangible assets">1,319,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_ztDqHMkeq4zl" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Intangible assets">1,910,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: left">Patents and Licenses</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zj62SaKG9EX9" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets"><span style="-sec-ix-hidden: xdx2ixbrl1364">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zkLXb5HbHqP8" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets">535,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left">Trade Names and Technology</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zX5oofODguK2" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets">1,060,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zl90SujGYJua" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets">1,198,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Customer Relationships</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_z3Yx9xvF45R5" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets">2,021,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zWO7J1SKC2o8" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets">2,278,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20221231_zAihE4djQche" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets">4,400,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20211231_zwNgRDItiju5" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Intangible assets">5,921,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1319000 1910000 535000 1060000 1198000 2021000 2278000 4400000 5921000 <p id="xdx_89A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_zo4r8Gv5U5b4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has recognized the amortization of intangible assets as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; font-family: Times New Roman, Times, Serif"><span id="xdx_8B3_zJIiqFdIrbVe" style="display: none">SCHEDULE OF AMORTIZATION OF INTANGIBLE ASSETS</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td> <td colspan="6" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">For the years ended</td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">December 31,</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2022</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2021</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 60%; text-align: left">Proprietary Technology</td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_zj0WPllCsO24" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Amortization of intangible assets">592,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--ProprietaryTechnologyMember_z7zKZ21kMrMl" style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right" title="Amortization of intangible assets">223,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left">Patents and Licenses</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_z6kg98UyfNL6" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Amortization of intangible assets">535,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--PatentsAndLicensesMember_zbVIHWWyV5Ph" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Amortization of intangible assets">668,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left">Trade Names and Technology</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zptdzhx8ZuOb" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Amortization of intangible assets">137,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__custom--TradeNamesAndTechnologyMember_zh1cDQx7spC4" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Amortization of intangible assets">138,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left">Customer Relationships</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220101__20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zegYFBKOZLq1" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Amortization of intangible assets">257,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20210101__20211231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--CustomerRelationshipsMember_zNDu3xTrNkxc" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Amortization of intangible assets">119,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20220101__20221231_zBbj8CFtLVab" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Amortization of intangible assets">1,521,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--AmortizationOfIntangibleAssets_pp0p0_c20210101__20211231_z4ugwdGB9FSk" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Amortization of intangible assets">1,148,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 592000 223000 535000 668000 137000 138000 257000 119000 1521000 1148000 <p id="xdx_89B_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zvJPQfNf2WQg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The weighted average remaining life of the amortization of the Company’s intangible assets is approximately <span class="xdx_phnt_RGlzY2xvc3VyZSAtIElOVEFOR0lCTEUgQVNTRVRTIChEZXRhaWxzIE5hcnJhdGl2ZSkA" id="xdx_907_eus-gaap--FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_dtY_c20220101__20221231_zhpQfQXrrf86" title="Finite-lived intangible assets, remaining amortization period">5.3</span> years. The following table represents the estimated amortization expense for total intangible assets for the succeeding five years:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B5_zNoYiXKCM6Y7" style="display: none">SCHEDULE OF ESTIMATED AMORTIZATION EXPENSE FOR INTANGIBLE ASSETS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 11pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Period ending December 31,</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_49A_20221231_zYIajDtQDEi8" style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_pp0p0_maFLIANzMzA_zxHFDdyRcpy6" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 78%; text-align: justify">2023</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">645,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_pp0p0_maFLIANzMzA_z3TjA6NTQdAh" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">2024</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">645,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_pp0p0_maFLIANzMzA_zFsbFzqYcFMd" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">2025</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">645,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_iI_pp0p0_maFLIANzMzA_zTHvQzvSFnH2" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">2026</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">556,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_iI_pp0p0_maFLIANzMzA_zThYHT4GX81g" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">2027</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">539,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_iI_pp0p0_maFLIANzMzA_zc1LKUAcz9V5" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: justify">Thereafter</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,370,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsNet_iTI_pp0p0_mtFLIANzMzA_zMlSXMJhfNVh" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Finite-Lived Intangible Assets, Net, Total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,400,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> P5Y3M18D 645000 645000 645000 556000 539000 1370000 4400000 <p id="xdx_80E_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zyqsOUhYZvbb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 10 — <span id="xdx_820_zaxnPp3KDOea">ACCRUED EXPENSES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zIX5B9DBIIJb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued expenses consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BB_zsPvc66T292f" style="display: none">SCHEDULE OF ACCRUED EXPENSES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20221231_zzAfL9PsWWy" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">December 31, 2022</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20211231_zyKO1iPOCPXc" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">December 31, 2021</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_406_eus-gaap--WorkersCompensationLiabilityCurrent_iI_pp0p0_maALCzM13_zXCQ5vAYzYBa" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 56%">Compensation</td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font-family: Times New Roman, Times, Serif; width: 18%; text-align: right">246,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font-family: Times New Roman, Times, Serif; width: 18%; text-align: right">2,069,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--AccruedSalesCommissionCurrent_iI_pp0p0_maALCzM13_zPg4G4nCAoN5" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif">Commissions</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">47,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">29,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_pp0p0_maALCzM13_zZXP1GtdkUqe" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif">Warranty</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">112,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">130,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--AccruedRentCurrent_iI_pp0p0_maALCzM13_zBAAwVQv14s4" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif">Rent</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1433">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">185,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maALCzM13_zMts3vuG3578" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left">Accrued expenses other</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">908,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">687,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredCompensationLiabilityCurrent_iI_pp0p0_maALCzM13_znAHrK9z1217" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Deferred Equity</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">255,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">55,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AccruedLiabilitiesCurrent_iTI_pp0p0_mtALCzM13_zYf7YwdhdtAl" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued expenses</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">1,568,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">3,155,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_899_eus-gaap--ScheduleOfAccruedLiabilitiesTableTextBlock_zIX5B9DBIIJb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued expenses consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BB_zsPvc66T292f" style="display: none">SCHEDULE OF ACCRUED EXPENSES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20221231_zzAfL9PsWWy" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">December 31, 2022</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20211231_zyKO1iPOCPXc" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">December 31, 2021</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_406_eus-gaap--WorkersCompensationLiabilityCurrent_iI_pp0p0_maALCzM13_zXCQ5vAYzYBa" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 56%">Compensation</td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font-family: Times New Roman, Times, Serif; width: 18%; text-align: right">246,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font-family: Times New Roman, Times, Serif; width: 18%; text-align: right">2,069,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--AccruedSalesCommissionCurrent_iI_pp0p0_maALCzM13_zPg4G4nCAoN5" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif">Commissions</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">47,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">29,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--ProductWarrantyAccrualClassifiedCurrent_iI_pp0p0_maALCzM13_zZXP1GtdkUqe" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif">Warranty</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">112,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">130,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--AccruedRentCurrent_iI_pp0p0_maALCzM13_zBAAwVQv14s4" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif">Rent</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1433">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">185,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--OtherAccruedLiabilitiesCurrent_iI_pp0p0_maALCzM13_zMts3vuG3578" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left">Accrued expenses other</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">908,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">687,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredCompensationLiabilityCurrent_iI_pp0p0_maALCzM13_znAHrK9z1217" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Deferred Equity</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">255,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">55,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--AccruedLiabilitiesCurrent_iTI_pp0p0_mtALCzM13_zYf7YwdhdtAl" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued expenses</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">1,568,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">3,155,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 246000 2069000 47000 29000 112000 130000 185000 908000 687000 255000 55000 1568000 3155000 <p id="xdx_80E_eus-gaap--DebtDisclosureTextBlock_zEju0GLUbTP6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 11 — <span id="xdx_823_zn3IijaNjnRi">NOTES PAYABLE</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_eus-gaap--ScheduleOfDebtTableTextBlock_zGjj78vqtUJc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below represents the Company’s notes payable as of December 31, 2022, and 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_zjA4HfB11b49">SCHEDULE OF NOTES PAYABLE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Principal</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">12/31/22</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">12/31/21</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif"> </td></tr> <tr style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify">On April 5, 2021</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--NotesPayableCurrent_iI_pp0p0_c20221231__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zasJci5srSM3" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Notes payable"><span style="-sec-ix-hidden: xdx2ixbrl1449">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98B_eus-gaap--NotesPayableCurrent_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zH38c3CsJ1x7" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Notes payable">99,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 68%; text-align: justify">On April 5, 2021, the Company renewed its D &amp; O insurance policy and increased the premium to approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zuxbBUkGA5ie" title="Debt instrument, face amount">1,098,000</span>, less a down payment of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_904_ecustom--DebtInstrumentDownPayment_iI_pp0p0_c20210405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zi8FSBpuzWXe" title="Debt instrument down payment">225,000</span>, financing the remaining balance of approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_909_eus-gaap--NotesPayable_iI_pp0p0_c20210405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zAz41zApc5dc" title="Notes Payable">872,000</span>. The loan’s terms are nine months at a <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zHasA69vbal1" title="Debt instrument, interest rate, stated percentage">5.25</span>% annual interest rate and a monthly principal and interest payment of approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_906_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp0p0_c20210404__20210405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_z5cdwHtINOid" title="Debt instrument, periodic payment, interest">99,000</span>. As of March 31, 2022, the loan is paid in full. The Company recorded interest expense of $-<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_90D_eus-gaap--InterestExpenseDebt_pp0p0_do_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zxWUmFSiQk0h" title="Interest expense">0</span>- and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_90C_eus-gaap--InterestExpenseDebt_pp0p0_do_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zBhDJ9lNRGy6" title="Interest expense">19,000</span> for the years ended December 31, 2022, and 2021, respectively.</td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--NotesPayableCurrent_iI_pp0p0_c20221231__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_z3U1ivfqNxO3" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Notes payable"><span style="-sec-ix-hidden: xdx2ixbrl1467">—</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--NotesPayableCurrent_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zaC6WVT5WDI3" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Notes payable">99,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt">On April 5, 2022, the Company renewed its D &amp; O insurance policy, decreasing the premium to approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20220405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zPNzME61ED2j" title="Debt instrument, face amount">1,037,000</span>, less a down payment of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_909_ecustom--DebtInstrumentDownPayment_iI_pp0p0_c20220405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zP90nqJRLIm4" title="Debt instrument down payment">194,000</span>, financing the remaining balance of approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_90F_eus-gaap--NotesPayable_iI_pp0p0_c20220405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zu1TTvAe082e" title="Notes Payable">943,000</span>. The loan’s terms are nine months at a <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zXc0RSa7sNx1" title="Debt instrument, interest rate, stated percentage">2.09</span>% annual interest rate and a monthly principal and interest payment of approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_900_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp0p0_c20220404__20220405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zGOu48bl4xC9">84,000</span>. The Company recorded interest expense of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_907_eus-gaap--InterestExpenseDebt_pp0p0_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_z3opSmFp0zah" title="Interest expense">6,000</span> and $-<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_902_eus-gaap--InterestExpenseDebt_pp0p0_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_z7W7z4QcRTgc" title="Interest expense">0</span>- for the years ended December 31, 2022, and 2021, respectively.</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--NotesPayableCurrent_iI_pp0p0_c20221231__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zvlIwyZ5C802" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Notes payable">84,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--NotesPayableCurrent_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_z9lKQvuZHSg7" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Notes payable"><span style="-sec-ix-hidden: xdx2ixbrl1486">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98B_eus-gaap--NotesPayableCurrent_iI_pp0p0_c20221231_zn9wG3BLfGL7" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Notes payable">84,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--NotesPayableCurrent_iI_pp0p0_c20211231_zACsX6DwI9Qa" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Notes payable">99,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_zC0SRYtOcU1b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_890_eus-gaap--ScheduleOfDebtTableTextBlock_zGjj78vqtUJc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below represents the Company’s notes payable as of December 31, 2022, and 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_zjA4HfB11b49">SCHEDULE OF NOTES PAYABLE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Principal</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">12/31/22</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">12/31/21</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif"> </td></tr> <tr style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify">On April 5, 2021</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--NotesPayableCurrent_iI_pp0p0_c20221231__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zasJci5srSM3" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Notes payable"><span style="-sec-ix-hidden: xdx2ixbrl1449">—</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98B_eus-gaap--NotesPayableCurrent_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zH38c3CsJ1x7" style="font-family: Times New Roman, Times, Serif; text-align: right" title="Notes payable">99,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 68%; text-align: justify">On April 5, 2021, the Company renewed its D &amp; O insurance policy and increased the premium to approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20210405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zuxbBUkGA5ie" title="Debt instrument, face amount">1,098,000</span>, less a down payment of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_904_ecustom--DebtInstrumentDownPayment_iI_pp0p0_c20210405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zi8FSBpuzWXe" title="Debt instrument down payment">225,000</span>, financing the remaining balance of approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_909_eus-gaap--NotesPayable_iI_pp0p0_c20210405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zAz41zApc5dc" title="Notes Payable">872,000</span>. The loan’s terms are nine months at a <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_908_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20210405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zHasA69vbal1" title="Debt instrument, interest rate, stated percentage">5.25</span>% annual interest rate and a monthly principal and interest payment of approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_906_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp0p0_c20210404__20210405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_z5cdwHtINOid" title="Debt instrument, periodic payment, interest">99,000</span>. As of March 31, 2022, the loan is paid in full. The Company recorded interest expense of $-<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_90D_eus-gaap--InterestExpenseDebt_pp0p0_do_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zxWUmFSiQk0h" title="Interest expense">0</span>- and $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_90C_eus-gaap--InterestExpenseDebt_pp0p0_do_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zBhDJ9lNRGy6" title="Interest expense">19,000</span> for the years ended December 31, 2022, and 2021, respectively.</td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_982_eus-gaap--NotesPayableCurrent_iI_pp0p0_c20221231__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_z3U1ivfqNxO3" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Notes payable"><span style="-sec-ix-hidden: xdx2ixbrl1467">—</span></td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--NotesPayableCurrent_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayableOneMember_zaC6WVT5WDI3" style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right" title="Notes payable">99,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt">On April 5, 2022, the Company renewed its D &amp; O insurance policy, decreasing the premium to approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20220405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zPNzME61ED2j" title="Debt instrument, face amount">1,037,000</span>, less a down payment of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_909_ecustom--DebtInstrumentDownPayment_iI_pp0p0_c20220405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zP90nqJRLIm4" title="Debt instrument down payment">194,000</span>, financing the remaining balance of approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_90F_eus-gaap--NotesPayable_iI_pp0p0_c20220405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zu1TTvAe082e" title="Notes Payable">943,000</span>. The loan’s terms are nine months at a <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_902_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20220405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zXc0RSa7sNx1" title="Debt instrument, interest rate, stated percentage">2.09</span>% annual interest rate and a monthly principal and interest payment of approximately $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_900_eus-gaap--DebtInstrumentPeriodicPaymentInterest_pp0p0_c20220404__20220405__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zGOu48bl4xC9">84,000</span>. The Company recorded interest expense of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_907_eus-gaap--InterestExpenseDebt_pp0p0_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_z3opSmFp0zah" title="Interest expense">6,000</span> and $-<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIE5PVEVTIFBBWUFCTEUgKERldGFpbHMpIChQYXJlbnRoZXRoaWNhbCkA" id="xdx_902_eus-gaap--InterestExpenseDebt_pp0p0_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--DAndOInsurancePolicyRenewedMember__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_z7W7z4QcRTgc" title="Interest expense">0</span>- for the years ended December 31, 2022, and 2021, respectively.</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--NotesPayableCurrent_iI_pp0p0_c20221231__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_zvlIwyZ5C802" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Notes payable">84,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--NotesPayableCurrent_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--NotesPayableTwoMember_z9lKQvuZHSg7" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right" title="Notes payable"><span style="-sec-ix-hidden: xdx2ixbrl1486">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98B_eus-gaap--NotesPayableCurrent_iI_pp0p0_c20221231_zn9wG3BLfGL7" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Notes payable">84,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--NotesPayableCurrent_iI_pp0p0_c20211231_zACsX6DwI9Qa" style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right" title="Notes payable">99,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 99000 1098000 225000 872000 0.0525 99000 0 19000 99000 1037000 194000 943000 0.0209 84000 6000 0 84000 84000 99000 <p id="xdx_809_eus-gaap--LesseeOperatingLeasesTextBlock_zz9QAWF96pTk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 12 — <span id="xdx_827_zTexuH00OcBl">LEASES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s leasing arrangements include office space, deployment sites, and storage warehouses, both domestically and internationally. The operating leases contain various terms and provisions, with lease terms of approximately <span id="xdx_901_ecustom--LesseeOperatingLeaseRemainingLeaseTerms_c20220101__20221231_zueMjhL4zqBa" title="Lease term, description">one to four years</span> remaining as of December 31, 2022. Certain individual leases contain rent escalation clauses and lease concessions that require additional rental payments later in the term. We recognize rent expense for these contracts straight-line over the minimum lease term.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #242424"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 31, 2022, the Company recorded approximately $<span id="xdx_907_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pn5n6_c20221231_zZm6t7esWj52" title="Right of use of assets">1.1</span> million of ROU assets net of $<span id="xdx_905_ecustom--OperatingLeaseRightOfUseAssetAccumulatedAmortization_pn5n6_c20220101__20221231_zqT5KdCeIwK6" title="Right of use assets, accumulated depreciation">1.2</span> million accumulated amortization on the balance sheet. Additionally, the Company recorded relatively $<span id="xdx_90D_eus-gaap--OperatingLeaseLiability_iI_pn5n6_c20221231_zPVJkwWjiDgh" title="Operating lease liabilities">1.6</span> million of operating lease liabilities, of which $<span id="xdx_909_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pn5n6_c20221231_zlOhsgGy8Gp4" title="Current operating lease liabilities">0.5</span> million is current and $<span id="xdx_905_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn5n6_c20221231_zcWYZXh8LTQ4" title="Non-current operating lease liabilities">1.1</span> million is non-current, as reported on the balance sheet. The weighted-average remaining term for lease contracts was <span id="xdx_90F_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20221231_zROitKaJGMif" title="Weighted-average remaining term">3.4</span> years on December 31, 2022, with maturity dates from <span id="xdx_902_eus-gaap--LesseeOperatingLeaseOptionToTerminate_c20220101__20221231_z1b7b5KY5C49" title="Lease maturity description">July 2023 to January 2027</span> and a weighted-average discount rate of <span id="xdx_903_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20221231_zfHWPWRBwRy7" title="Weighted-average discount rate">9.4</span>% on December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #242424"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adjustments for straight-line rental expense for the respective periods was not material. Most costs recognized are reflected in cash used in operating activities for the respective periods. This expense consisted primarily of payments for base rent on office and warehouse leases. Amounts related to short-term lease costs, taxes, and variable service charges on leased properties were immaterial. Besides, we have the right to renew individual leases for various renewal terms but no obligation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">The following represents lease activity for the year ending December 31, 2022:</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Lutton, UK</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 28, 2022, <span id="xdx_90E_ecustom--AreaOfLandDescription_pp0p0_c20220101__20221231__srt--StatementGeographicalAxis__custom--LuttonUKMember_zjLcyA56O3y5" title="Area of land">the Company entered a one-year lease for <span id="xdx_905_eus-gaap--AreaOfLand_iI_uSquareFeet_c20220428__srt--StatementGeographicalAxis__custom--LuttonUKMember_zgEBCtFbu0X7" title="Area of Land">600</span> square feet of administrative office space in Lutton, UK, commencing on May 3, 2022, and terminating on <span id="xdx_906_eus-gaap--LeaseExpirationDate1_c20220427__20220428__srt--StatementGeographicalAxis__custom--LuttonUKMember" title="Lease expiration">May 31, 2023</span>, for £<span id="xdx_900_eus-gaap--PaymentsForRent_uGBP_c20220427__20220428__srt--StatementGeographicalAxis__custom--LuttonUKMember_zTdhfm0r16k4" title="Payments for rent">1,320</span> monthly or approximately $<span id="xdx_900_eus-gaap--PaymentsForRent_c20220427__20220428__srt--StatementGeographicalAxis__custom--LuttonUKMember_ztajtYmEtJ47" title="Payments for rent">1,800</span> per month.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Dubai, UAE</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company renewed its <span id="xdx_905_ecustom--AreaOfLandDescription_pp0p0_c20220101__20221231__srt--StatementGeographicalAxis__custom--DubaiUAEMember_zLUb3gpji0r9" title="Area of land description">lease for <span id="xdx_903_eus-gaap--AreaOfLand_iI_uSquareFeet_c20220703__srt--StatementGeographicalAxis__custom--DubaiUAEMember_zjmlhhn6aqI5" title="Area of Land">976</span> square feet of administrative office space commencing on July 3, 2022, and terminating on <span id="xdx_906_eus-gaap--LeaseExpirationDate1_c20220701__20220703__srt--StatementGeographicalAxis__custom--DubaiUAEMember" title="Lease expiration">July 2, 2023</span>, in Dubai Studio City, UAE, for AED <span id="xdx_90B_eus-gaap--PaymentsForRent_uAED_c20220701__20220703__srt--StatementGeographicalAxis__custom--DubaiUAEMember_zwD0AenSRmcc" title="Payments for rent">5,995</span> or approximately US$ <span id="xdx_90E_eus-gaap--PaymentsForRent_c20220701__20220703__srt--StatementGeographicalAxis__custom--DubaiUAEMember_zFcim7Op6Cc2" title="Payments for rent">1,632</span> monthly.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Billerica, MA</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the third quarter of the fiscal year 2022, management vacated the Billerica property. The economic environment of this location precluded the action of sub-letting an unoccupied site and determined the leased facility abandoned. Under ASC 360, leased space abandonment is an impairment indicator, and the Company assessed the lease ROU assets for impairment, and we recognized a loss on impairment of right-of-use assets of approximately $<span id="xdx_908_eus-gaap--OperatingLeaseImpairmentLoss_c20221001__20221231__srt--StatementGeographicalAxis__custom--BillericaMaMember_zI4VddG2lAyd" title="Loss on impairment of Right Of Use Asset">88,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">The following represents lease activity for the year ending December 31, 2021</span>:</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Lutton, UK</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 1, 2021, <span id="xdx_902_ecustom--AreaOfLandDescription_pp0p0_c20210101__20211231__srt--StatementGeographicalAxis__custom--LuttonUKMember_zrWGMf01qVXf" title="Area of land">the Company entered into a one-year lease for <span id="xdx_903_eus-gaap--AreaOfLand_iI_uSquareFeet_c20210201__srt--StatementGeographicalAxis__custom--LuttonUKMember_zo5MK3NoO4al" title="Area of Land">600 </span>square feet of administrative office space in Lutton, UK, commencing on February 1, 2021, and terminating on <span id="xdx_90A_eus-gaap--LeaseExpirationDate1_c20210131__20210201__srt--StatementGeographicalAxis__custom--LuttonUKMember" title="Lease expiration">January 31, 2022</span>, for £<span id="xdx_903_eus-gaap--PaymentsForRent_uGBP_c20210131__20210201__srt--StatementGeographicalAxis__custom--LuttonUKMember_zvBsvKAE1mff" title="Payments for rent">1,674</span> or approximately $<span id="xdx_90F_eus-gaap--PaymentsForRent_c20210131__20210201__srt--StatementGeographicalAxis__custom--LuttonUKMember_zGlgQN7IBuy8" title="Payments for rent">2,290</span> monthl</span>y.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Dubai, UAE</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.75pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 24, 2021, the Company renewed its lease for office space <span id="xdx_905_ecustom--AreaOfLandDescription_pp0p0_c20210101__20211231__srt--StatementGeographicalAxis__custom--DubaiUAEMember_zK9Y3ObV1msa" title="Area of land description">commencing on July 3, 2021, and terminating on <span id="xdx_907_eus-gaap--LeaseExpirationDate1_c20210523__20210524__srt--StatementGeographicalAxis__custom--DubaiUAEMember" title="Lease expiration">July 2, 2022</span>, for <span id="xdx_90C_eus-gaap--AreaOfLand_iI_uSquareFeet_c20210524__srt--StatementGeographicalAxis__custom--DubaiUAEMember_zMIMF8gbFU6j" title="Area of Land">976</span> square feet of administrative office space in Dubai Studio City, UAE, for AED <span id="xdx_900_eus-gaap--PaymentsForRent_uAED_c20210523__20210524__srt--StatementGeographicalAxis__custom--DubaiUAEMember_zonGa6ZinxRb" title="Payments for rent">5,995</span> or approximately $<span id="xdx_900_eus-gaap--PaymentsForRent_c20210523__20210524__srt--StatementGeographicalAxis__custom--DubaiUAEMember_zUpnY9ABYPch" title="Payments for rent">1,620</span> monthly.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Mount Olive, NJ</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 1, 2021, the Company entered into a lease agreement with a non-affiliated third party (the “Landlord”) to rent approximately <span id="xdx_903_eus-gaap--AreaOfLand_iI_uSquareFeet_c20211101__srt--StatementGeographicalAxis__custom--MountOliveNJMember_zYgxDUZEjdnh" title="Area of Land">7,979</span> square feet of commercial space for general business offices, light manufacturing, operating of a testing laboratory, assembly, and inventory storage in Mount Olive, NJ. The lease commencement date is November 1, 2021, and the expiration date is <span id="xdx_909_eus-gaap--LeaseExpirationDate1_c20211101__20211101__srt--StatementGeographicalAxis__custom--MountOliveNJMember_zVmVKcd7LGW4" title="Lease expiration">January 31, 2027</span>. The initial monthly obligation is $<span id="xdx_906_eus-gaap--PaymentsForRent_pp0p0_c20211101__20211101__srt--StatementGeographicalAxis__custom--MountOliveNJMember_zBlCenyLFxk4" title="Payment for rent">10,869</span>, with annual rent increases of <span id="xdx_90D_ecustom--PaymentForRentPercentage_pid_dp_uPure_c20211101__20211101__srt--StatementGeographicalAxis__custom--MountOliveNJMember_zzGRfIXAfYyg" title="Payment for rent percentage">3.0</span>% per year until the lease expiration date. The Company is relocating its corporate facilities from Hackettstown, NJ, to Mount Olive, NJ, with the projected completion date by March 2022, as part of the strategic initiative plan implemented in early 2020. The Company recognized approximately $<span id="xdx_902_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_c20211101__srt--StatementGeographicalAxis__custom--MountOliveNJMember_z19M0ElkKqu2" title="Right of Use Assets"><span id="xdx_900_eus-gaap--OperatingLeaseLiability_iI_pp0p0_c20211101__srt--StatementGeographicalAxis__custom--MountOliveNJMember_zQLWCzhvDvW3" title="Operating lease liability">522,000</span></span> of Right of Use Assets and Operating lease obligations for the new lease under ASC Topic 842.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 12 — LEASES (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--LeaseCostTableTextBlock_z7JhoRyTjmk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates operating lease data for the years ended December 31, 2022, and 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zAjKb1TmkTVh">SCHEDULE OF OPERATING LEASE DATA</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20220101__20221231_zxZMmGlmpNUl" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2022</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20210101__20211231_zJKXDDQRFeR5" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2021</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td> <td colspan="6" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">For the years ended</td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">December 31,</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2022</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2021</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left">Lease cost:</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--OperatingLeaseCost_pp0p0_maLCzF3E_zkvqfm90Dbgc" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 68%; text-align: left">Operating lease cost</td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right">438,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right">472,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--ShortTermLeaseCost_pp0p0_maLCzF3E_zvDH8U4diQa1" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Short-term lease cost</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">93,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">417,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--LeaseCost_iT_pp0p0_mtLCzF3E_zeHl5cfEO4W8" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total lease cost</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">531,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">889,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left">Cash paid for lease liabilities:</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--OperatingLeasePayments_pp0p0_zEncnm55XBmc" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Cash flows from operating leases</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">543,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">635,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: left">Weighted-average remaining lease term—operating leases</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20221231_zc7DVrRbGLSl" title="Weighted-average remaining lease term-operating leases">3.4</span> years</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20211231_zqsd4B6vGzak" title="Weighted-average remaining lease term-operating leases">3.8</span> years</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: left">Weighted-average discount rate—operating leases</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20221231_zf9QM4rjYDZg" title="Weighted-average discount rate-operating leases">9.4</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left">%</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20211231_zULewgX9jbN3" title="Weighted-average discount rate-operating leases">9.3</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left">%</td></tr> </table> <p id="xdx_8AA_zqMTchngrA01" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #252525"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zghySGIHW034" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #252525"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maturities of our operating lease liabilities were as follows as of December 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #252525"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B3_zPbFLcKXiZEa">SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20221231_z4RBXxKK96ka" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Amount</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzCqh_z7KNUMfPbLPj" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 80%; text-align: justify">2023</td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right">589,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pn3d_maLOLLPzCqh_zKmrFTlDfDw2" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify">2024</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">455,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pn3d_maLOLLPzCqh_zjzXeisUu1M3" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify">2025</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">443,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pn3d_maLOLLPzCqh_zrCFc76Hthf5" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify">2026</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">249,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pn3d_maLOLLPzCqh_z0Xulwlua2T" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify">2027</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">59,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_maLOLLPzCqh_zoeM8Uzx7V05" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt">Thereafter</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1600">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pn3d_mtLOLLPzCqh_zMgNAPisWcjj" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify">Total lease payments</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">1,795,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_pn3d_zKkzqZp6zn51" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Less: imputed interest</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">233,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--OperatingLeaseLiability_iI_pn3d_zXfVD0a3ImR4" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify">Present value of lease liabilities</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">1,562,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pn3d_zHls8Ho0ZEQ5" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Less: Current lease liabilities</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">455,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3d_z4sifZyUFTl2" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt">Non-current lease liabilities</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">1,107,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A7_zur4mdf2XGk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_ecustom--ScheduleOfLeasesObligationsAssumedTableTextBlock_zWvG6caao4I8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #252525"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below lists the location and lease expiration date from 2023 through 2027: </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BC_z4D6qQ1v8dEh">SCHEDULE OF LEASE OBLIGATIONS ASSUMED</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span/></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Location</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Square Footage </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; color: #252525"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center; color: #252525"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease-End Date</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approximate Future Payments</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Colchester, U.K. – Waterside House</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--AreaOfLand_iI_pp0p0_uSquareFeet_c20221231__srt--StatementGeographicalAxis__custom--ColchesterUKWatersideHouseMember_zudkEfoTbJSk" style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right" title="Area of land"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--LeaseExpirationDateDescription_c20220101__20221231__srt--StatementGeographicalAxis__custom--ColchesterUKWatersideHouseMember_zO1v2QBE3va6" title="Lease-End Date">Dec 2025</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20221231__srt--StatementGeographicalAxis__custom--ColchesterUKWatersideHouseMember_zA6efNq8cP68" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Approximate Future Payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">639,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Singapore</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--AreaOfLand_iI_pp0p0_uSquareFeet_c20221231__srt--StatementGeographicalAxis__country--SG_zW1VYwAyQiag" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Area of land"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">950</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--LeaseExpirationDateDescription_c20220101__20221231__srt--StatementGeographicalAxis__country--SG_z8Nqo3U5ION9" title="Lease-End Date">July 2023</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20221231__srt--StatementGeographicalAxis__country--SG_zoMvamCNi3L3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Approximate Future Payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Billerica, MA</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--AreaOfLand_iI_pp0p0_uSquareFeet_c20221231__srt--StatementGeographicalAxis__custom--BillericaMaMember_zPbM7FkqYp7d" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Area of land"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--LeaseExpirationDateDescription_c20220101__20221231__srt--StatementGeographicalAxis__custom--BillericaMaMember_zLEqZQwRTwLk" title="Lease-End Date">Dec 2026</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20221231__srt--StatementGeographicalAxis__custom--BillericaMaMember_z19l3kZxHSFd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Approximate Future Payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">416,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hemel, UK</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--AreaOfLand_iI_pp0p0_uSquareFeet_c20221231__srt--StatementGeographicalAxis__custom--HemelUKMember_z0HtafJ4WIda" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Area of land"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,870</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--LeaseExpirationDateDescription_c20220101__20221231__srt--StatementGeographicalAxis__custom--HemelUKMember_zIi3T7byMrKh" title="Lease-End Date">Oct 2023</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20221231__srt--StatementGeographicalAxis__custom--HemelUKMember_zWSrIBFHYj6f" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Approximate Future Payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">123,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mount Olive, NJ</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--AreaOfLand_iI_pp0p0_uSquareFeet_c20221231__srt--StatementGeographicalAxis__custom--MountOliveNJMember_zimTesAWlnY6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Area of land"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,979</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--LeaseExpirationDateDescription_c20220101__20221231__srt--StatementGeographicalAxis__custom--MountOliveNJMember_zEtZy1oxvvG4" title="Lease-End Date">Jan 2027</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20221231__srt--StatementGeographicalAxis__custom--MountOliveNJMember_z4tnqC0OPwY6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Approximate Future Payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">598,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p id="xdx_8AE_z8RaMvtXQ6R3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> one to four years 1100000 1200000 1600000 500000 1100000 P3Y4M24D July 2023 to January 2027 0.094 the Company entered a one-year lease for 600 square feet of administrative office space in Lutton, UK, commencing on May 3, 2022, and terminating on May 31, 2023, for £1,320 monthly or approximately $1,800 per month. 600 2023-05-31 1320 1800 lease for 976 square feet of administrative office space commencing on July 3, 2022, and terminating on July 2, 2023, in Dubai Studio City, UAE, for AED 5,995 or approximately US$ 1,632 monthly. 976 2023-07-02 5995 1632 88000 the Company entered into a one-year lease for 600 square feet of administrative office space in Lutton, UK, commencing on February 1, 2021, and terminating on January 31, 2022, for £1,674 or approximately $2,290 monthl 600 2022-01-31 1674 2290 commencing on July 3, 2021, and terminating on July 2, 2022, for 976 square feet of administrative office space in Dubai Studio City, UAE, for AED 5,995 or approximately $1,620 monthly. 2022-07-02 976 5995 1620 7979 2027-01-31 10869 0.030 522000 522000 <p id="xdx_896_eus-gaap--LeaseCostTableTextBlock_z7JhoRyTjmk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates operating lease data for the years ended December 31, 2022, and 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_zAjKb1TmkTVh">SCHEDULE OF OPERATING LEASE DATA</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20220101__20221231_zxZMmGlmpNUl" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2022</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20210101__20211231_zJKXDDQRFeR5" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2021</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td> <td colspan="6" style="font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">For the years ended</td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">December 31,</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: center"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2022</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">2021</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left">Lease cost:</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--OperatingLeaseCost_pp0p0_maLCzF3E_zkvqfm90Dbgc" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; width: 68%; text-align: left">Operating lease cost</td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right">438,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font-family: Times New Roman, Times, Serif; width: 12%; text-align: right">472,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--ShortTermLeaseCost_pp0p0_maLCzF3E_zvDH8U4diQa1" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Short-term lease cost</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">93,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">417,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--LeaseCost_iT_pp0p0_mtLCzF3E_zeHl5cfEO4W8" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total lease cost</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">531,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">889,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: left">Cash paid for lease liabilities:</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--OperatingLeasePayments_pp0p0_zEncnm55XBmc" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Cash flows from operating leases</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">543,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">635,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: left">Weighted-average remaining lease term—operating leases</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20221231_zc7DVrRbGLSl" title="Weighted-average remaining lease term-operating leases">3.4</span> years</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20211231_zqsd4B6vGzak" title="Weighted-average remaining lease term-operating leases">3.8</span> years</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: left">Weighted-average discount rate—operating leases</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20221231_zf9QM4rjYDZg" title="Weighted-average discount rate-operating leases">9.4</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left">%</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_uPure_c20211231_zULewgX9jbN3" title="Weighted-average discount rate-operating leases">9.3</span></td><td style="font-family: Times New Roman, Times, Serif; text-align: left">%</td></tr> </table> 438000 472000 93000 417000 531000 889000 543000 635000 P3Y4M24D P3Y9M18D 0.094 0.093 <p id="xdx_899_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zghySGIHW034" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #252525"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maturities of our operating lease liabilities were as follows as of December 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #252525"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B3_zPbFLcKXiZEa">SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20221231_z4RBXxKK96ka" style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; font-weight: bold; text-align: center">Amount</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="font-family: Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify"> </td><td style="font-family: Times New Roman, Times, Serif"> </td> <td colspan="2" style="font-family: Times New Roman, Times, Serif"> </td><td style="font-family: Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzCqh_z7KNUMfPbLPj" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; width: 80%; text-align: justify">2023</td><td style="font-family: Times New Roman, Times, Serif; width: 2%"> </td> <td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font-family: Times New Roman, Times, Serif; width: 16%; text-align: right">589,000</td><td style="font-family: Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pn3d_maLOLLPzCqh_zKmrFTlDfDw2" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify">2024</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">455,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pn3d_maLOLLPzCqh_zjzXeisUu1M3" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify">2025</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">443,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFour_iI_pn3d_maLOLLPzCqh_zrCFc76Hthf5" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify">2026</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">249,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearFive_iI_pn3d_maLOLLPzCqh_z0Xulwlua2T" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify">2027</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">59,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_iI_maLOLLPzCqh_zoeM8Uzx7V05" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt">Thereafter</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1600">—</span></td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pn3d_mtLOLLPzCqh_zMgNAPisWcjj" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify">Total lease payments</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">1,795,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iI_pn3d_zKkzqZp6zn51" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Less: imputed interest</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">233,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--OperatingLeaseLiability_iI_pn3d_zXfVD0a3ImR4" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify">Present value of lease liabilities</td><td style="font-family: Times New Roman, Times, Serif"> </td> <td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="font-family: Times New Roman, Times, Serif; text-align: right">1,562,000</td><td style="font-family: Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pn3d_zHls8Ho0ZEQ5" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font-family: Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Less: Current lease liabilities</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font-family: Times New Roman, Times, Serif; text-align: right">455,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pn3d_z4sifZyUFTl2" style="font-family: Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-family: Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt">Non-current lease liabilities</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font-family: Times New Roman, Times, Serif; text-align: right">1,107,000</td><td style="font-family: Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 589000 455000 443000 249000 59000 1795000 233000 1562000 455000 1107000 <p id="xdx_89B_ecustom--ScheduleOfLeasesObligationsAssumedTableTextBlock_zWvG6caao4I8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; color: #252525"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below lists the location and lease expiration date from 2023 through 2027: </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BC_z4D6qQ1v8dEh">SCHEDULE OF LEASE OBLIGATIONS ASSUMED</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span/></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Location</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Square Footage </b></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; color: #252525"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center; color: #252525"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lease-End Date</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approximate Future Payments</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 43%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Colchester, U.K. – Waterside House</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--AreaOfLand_iI_pp0p0_uSquareFeet_c20221231__srt--StatementGeographicalAxis__custom--ColchesterUKWatersideHouseMember_zudkEfoTbJSk" style="font: 10pt Times New Roman, Times, Serif; width: 15%; text-align: right" title="Area of land"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--LeaseExpirationDateDescription_c20220101__20221231__srt--StatementGeographicalAxis__custom--ColchesterUKWatersideHouseMember_zO1v2QBE3va6" title="Lease-End Date">Dec 2025</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20221231__srt--StatementGeographicalAxis__custom--ColchesterUKWatersideHouseMember_zA6efNq8cP68" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Approximate Future Payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">639,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Singapore</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--AreaOfLand_iI_pp0p0_uSquareFeet_c20221231__srt--StatementGeographicalAxis__country--SG_zW1VYwAyQiag" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Area of land"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">950</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--LeaseExpirationDateDescription_c20220101__20221231__srt--StatementGeographicalAxis__country--SG_z8Nqo3U5ION9" title="Lease-End Date">July 2023</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20221231__srt--StatementGeographicalAxis__country--SG_zoMvamCNi3L3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Approximate Future Payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Billerica, MA</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--AreaOfLand_iI_pp0p0_uSquareFeet_c20221231__srt--StatementGeographicalAxis__custom--BillericaMaMember_zPbM7FkqYp7d" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Area of land"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--LeaseExpirationDateDescription_c20220101__20221231__srt--StatementGeographicalAxis__custom--BillericaMaMember_zLEqZQwRTwLk" title="Lease-End Date">Dec 2026</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20221231__srt--StatementGeographicalAxis__custom--BillericaMaMember_z19l3kZxHSFd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Approximate Future Payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">416,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hemel, UK</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--AreaOfLand_iI_pp0p0_uSquareFeet_c20221231__srt--StatementGeographicalAxis__custom--HemelUKMember_z0HtafJ4WIda" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Area of land"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,870</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--LeaseExpirationDateDescription_c20220101__20221231__srt--StatementGeographicalAxis__custom--HemelUKMember_zIi3T7byMrKh" title="Lease-End Date">Oct 2023</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20221231__srt--StatementGeographicalAxis__custom--HemelUKMember_zWSrIBFHYj6f" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Approximate Future Payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">123,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mount Olive, NJ</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--AreaOfLand_iI_pp0p0_uSquareFeet_c20221231__srt--StatementGeographicalAxis__custom--MountOliveNJMember_zimTesAWlnY6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Area of land"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,979</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--LeaseExpirationDateDescription_c20220101__20221231__srt--StatementGeographicalAxis__custom--MountOliveNJMember_zEtZy1oxvvG4" title="Lease-End Date">Jan 2027</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0_c20221231__srt--StatementGeographicalAxis__custom--MountOliveNJMember_z4tnqC0OPwY6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Approximate Future Payments"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">598,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> 16000 Dec 2025 639000 950 July 2023 19000 2000 Dec 2026 416000 12870 Oct 2023 123000 7979 Jan 2027 598000 <p id="xdx_80A_eus-gaap--DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_zYNoW0fALyZd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 13 —<span id="xdx_825_zjc1WyLXQGM7"> DERIVATIVE LIABILITIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the guidance of ASC 815, Accounting for Derivative Instruments and Hedging Activities, the Company identified common stock warrants in various offerings containing a net cash settlement provision whereby, upon certain fundamental events, the holders could put these warrants back to the Company for cash. We identified and classified the following transactions as derivative liabilities: warrants issued with the May 2016 financing, the July 2016 financing, the August 2017 underwritten offering, and the May 2018 Financing.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company records derivative liabilities on its consolidated balance sheet at their fair value on the issuance date. The Company revalues the derivative liabilities on each subsequent balance sheet until exercised or expired, with any changes in the fair value between reporting periods recorded as other income or expense. The Company uses option pricing models and assumptions based on the instruments’ characteristics on the valuation date. We use assumptions for future financings, expected volatility, expected life, yield, and risk-free interest rate to estimate fair value.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_ecustom--ScheduleOfValuationAndWarrantsExercisableTableTextBlock_zrad5hddrmV3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following are the key assumptions used in connection with the valuation of the warrants exercisable into common stock on December 31, 2022, and 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B0_zx1DPzFHcX0b">SCHEDULE OF VALUATION AND WARRANTS EXERCISABLE</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the Years Ended December 31,</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Number of shares underlying the warrants</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_982_ecustom--NumberOfSharesUnderlyingWarrants_pid_c20220101__20221231_zPVDH4R4gmbb" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Number of shares underlying the warrants">55,333</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98B_ecustom--NumberOfSharesUnderlyingWarrants_pid_c20210101__20211231_zpnZw5A7bsni" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Number of shares underlying the warrants">66,341</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">The fair market value of stock</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zbQLosT2iFG6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrant exercise price">0.56</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_ziEFPmIllfYh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrant exercise price">1.18</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Exercise price</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__srt--RangeAxis__srt--MinimumMember_zD76aOrZRB4k" title="Warrant exercise price">0.00</span> to $ <span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__srt--RangeAxis__srt--MaximumMember_zMg1SAdY1eQg" title="Warrant exercise price">60.00</span> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__srt--RangeAxis__srt--MinimumMember_zkP4cfKuJ68d" title="Warrant exercise price">60.00</span> to $ <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__srt--RangeAxis__srt--MaximumMember_ziNU0Aey7Xfe" title="Warrant exercise price">150.00</span> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Volatility</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MinimumMember_z5VVUf5hGqUh" title="Expected dividend yield">0</span>% to <span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MaximumMember_zpIVyMQaPMN5" title="Expected dividend yield">64</span> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MinimumMember_zEZ6eLaRKqO3" title="Expected dividend yield">97</span>% to <span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MaximumMember_zIXFNi7FNj54" title="Expected dividend yield">101</span> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Risk-free interest rate</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zXHzzlzyB9J4" title="Expected dividend yield">0</span>% to <span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zjZFKfTYTJog" title="Expected dividend yield">4.54</span> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zDFxA1xgpVnf" title="Expected dividend yield">0.19</span>% to <span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zSquz5828vCl" title="Expected dividend yield">0.39</span> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected dividend yield</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zvzjCNmP54u7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants measurement input"><span style="-sec-ix-hidden: xdx2ixbrl1680">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_z172zLqKX0P9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants measurement input"><span style="-sec-ix-hidden: xdx2ixbrl1682">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Warrant life (years)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20221231__srt--RangeAxis__srt--MinimumMember_z6zfyYZ9d6ed" title="Warrant life (years)">0.0</span> to <span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20221231__srt--RangeAxis__srt--MaximumMember_zRbrjbzLkDRd" title="Warrant life (years)">0.4</span> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20211231__srt--RangeAxis__srt--MinimumMember_z8NQy8Hb1ga7" title="Warrant life (years)">0.6</span> to <span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20211231__srt--RangeAxis__srt--MaximumMember_ztVnzI1HlQQe" title="Warrant life (years)">1.4</span> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> <p id="xdx_8AF_zOX2To8MQJs" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 liabilities are valued using unobservable inputs to the valuation methodology significant in measuring the liabilities’ fair value. For fair value measurements categorized within Level 3 of the fair value hierarchy, the Company’s accounting and finance department, subject to the approval of the Chief Financial Officer, determines the applicable valuation policies and procedures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Level 3 Valuation Techniques:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 financial liabilities consist of the derivative liabilities for which there is no current market for these securities, such that determining fair value requires significant judgment or estimation. Changes in fair value measurements categorized within Level 3 of the fair value hierarchy are analyzed each period based on changes in estimates or assumptions and recorded as appropriate. The Company deems financial instruments that do not have fixed settlement provisions as derivative instruments. Under US GAAP, the fair value of these warrants is classified as a liability on the Company’s consolidated balance sheets because, according to the terms of the warrants, a fundamental transaction could give rise to an obligation of the Company to pay cash to its warrant holders. Such instruments do not have fixed settlement provisions and have also been recorded as derivative liabilities. Corresponding changes in the fair value of the derivative liabilities are recognized in earnings on the Company’s consolidated operations statements in each subsequent period. The Company uses a binomial model style simulation to calculate fair value, as the standard Black-Scholes model would not capture the value of certain features of the warrant derivative liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_zjiBqnFll3T4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth a summary of the changes in the fair value of Level 3 financial liabilities that are measured at fair value on a recurring basis:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BC_zIei942Y0Hff">SCHEDULE OF CHANGES IN FAIR VALUE OF LEVEL 3 FINANCIAL LIABILITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20220101__20221231_znxMY9M6ktW5" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20210101__20211231_zDsNM7wHEOD1" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the years ended</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_401_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pp0p0_zL3Vh5oiayN" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: justify">Beginning balance</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1694">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">22,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_pp0p0_zP3yscqSZpK2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt">Change in fair value of derivative liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1697">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(22,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pp0p0_zxc8xyaiKJ9i" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt">Ending balance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1700">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1701">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zns1iYkPnee" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_893_ecustom--ScheduleOfValuationAndWarrantsExercisableTableTextBlock_zrad5hddrmV3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following are the key assumptions used in connection with the valuation of the warrants exercisable into common stock on December 31, 2022, and 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8B0_zx1DPzFHcX0b">SCHEDULE OF VALUATION AND WARRANTS EXERCISABLE</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the Years Ended December 31,</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Number of shares underlying the warrants</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_982_ecustom--NumberOfSharesUnderlyingWarrants_pid_c20220101__20221231_zPVDH4R4gmbb" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Number of shares underlying the warrants">55,333</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98B_ecustom--NumberOfSharesUnderlyingWarrants_pid_c20210101__20211231_zpnZw5A7bsni" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Number of shares underlying the warrants">66,341</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">The fair market value of stock</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_zbQLosT2iFG6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrant exercise price">0.56</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember_ziEFPmIllfYh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrant exercise price">1.18</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Exercise price</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__srt--RangeAxis__srt--MinimumMember_zD76aOrZRB4k" title="Warrant exercise price">0.00</span> to $ <span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__srt--RangeAxis__srt--MaximumMember_zMg1SAdY1eQg" title="Warrant exercise price">60.00</span> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> <span id="xdx_909_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__srt--RangeAxis__srt--MinimumMember_zkP4cfKuJ68d" title="Warrant exercise price">60.00</span> to $ <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__srt--RangeAxis__srt--MaximumMember_ziNU0Aey7Xfe" title="Warrant exercise price">150.00</span> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Volatility</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MinimumMember_z5VVUf5hGqUh" title="Expected dividend yield">0</span>% to <span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MaximumMember_zpIVyMQaPMN5" title="Expected dividend yield">64</span> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MinimumMember_zEZ6eLaRKqO3" title="Expected dividend yield">97</span>% to <span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__srt--RangeAxis__srt--MaximumMember_zIXFNi7FNj54" title="Expected dividend yield">101</span> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Risk-free interest rate</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zXHzzlzyB9J4" title="Expected dividend yield">0</span>% to <span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zjZFKfTYTJog" title="Expected dividend yield">4.54</span> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_zDFxA1xgpVnf" title="Expected dividend yield">0.19</span>% to <span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zSquz5828vCl" title="Expected dividend yield">0.39</span> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Expected dividend yield</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20221231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zvzjCNmP54u7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants measurement input"><span style="-sec-ix-hidden: xdx2ixbrl1680">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_z172zLqKX0P9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants measurement input"><span style="-sec-ix-hidden: xdx2ixbrl1682">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Warrant life (years)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20221231__srt--RangeAxis__srt--MinimumMember_z6zfyYZ9d6ed" title="Warrant life (years)">0.0</span> to <span id="xdx_902_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20221231__srt--RangeAxis__srt--MaximumMember_zRbrjbzLkDRd" title="Warrant life (years)">0.4</span> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20211231__srt--RangeAxis__srt--MinimumMember_z8NQy8Hb1ga7" title="Warrant life (years)">0.6</span> to <span id="xdx_90F_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20211231__srt--RangeAxis__srt--MaximumMember_ztVnzI1HlQQe" title="Warrant life (years)">1.4</span> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> 55333 66341 0.56 1.18 0.00 60.00 60.00 150.00 0 64 97 101 0 4.54 0.19 0.39 P0Y P0Y4M24D P0Y7M6D P1Y4M24D <p id="xdx_89D_eus-gaap--FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock_zjiBqnFll3T4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table sets forth a summary of the changes in the fair value of Level 3 financial liabilities that are measured at fair value on a recurring basis:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BC_zIei942Y0Hff">SCHEDULE OF CHANGES IN FAIR VALUE OF LEVEL 3 FINANCIAL LIABILITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20220101__20221231_znxMY9M6ktW5" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20210101__20211231_zDsNM7wHEOD1" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the years ended</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_401_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iS_pp0p0_zL3Vh5oiayN" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: justify">Beginning balance</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1694">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">22,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease_pp0p0_zP3yscqSZpK2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt">Change in fair value of derivative liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1697">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(22,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_iE_pp0p0_zxc8xyaiKJ9i" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt">Ending balance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1700">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1701">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 22000 -22000 <p id="xdx_803_eus-gaap--PreferredStockTextBlock_zNLFixgXQUsg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 14 — <span id="xdx_825_zqReXKObu193">PREFERRED SHARES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Preferred Stock</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2013, the issuance of <span id="xdx_906_eus-gaap--PreferredStockSharesAuthorized_iI_pn5n6_c20130331_zUdG3obAlyfi" title="Preferred stock shares authorized">10.0</span> million shares of “Blank Check” preferred stock with a par value of $<span id="xdx_90F_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20130331_z3qgr1z2G34h" title="Preferred stock, par value">0.00001</span> per share received approval from the majority of stockholders.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following shares were designated as authorized:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three million shares of Series A Convertible Preferred Stock (“Series A Preferred Stock”) on December 31, 2014.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three million shares of Series B Convertible Preferred Stock (“Series B Preferred Stock”) on February 11, 2015.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three million shares of Series C Convertible Preferred Stock (“Series C Preferred Stock”) on February 24, 2015.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 5, 2016, the Company terminated the Series A Preferred Stock and Series C Preferred Stock and increased the number of designated shares of Series B Preferred Stock to <span id="xdx_901_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20160205__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesBPreferredStockMember_zfUzj4W9N6J6" title="Preferred stock shares authorized">5,000,000</span>. The following shares were designated as authorized: <span id="xdx_90C_eus-gaap--PreferredStockSharesAuthorized_iI_pn6n6_dc_c20160425__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesDPreferredStockMember_zFt8ROE5NBXa" title="Preferred stock shares authorized">Five</span> million shares of Series D Convertible Preferred Stock (“Series D Preferred Stock”) on April 25, 2016. On December 6, 2016, the Company terminated the Series B Preferred Stock. The following shares were designated as authorized: <span id="xdx_90B_eus-gaap--PreferredStockSharesAuthorized_iI_pn3n3_dc_c20161221__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesEPreferredStockMember_zpzY2vYiOvT7" title="Preferred stock shares authorized">Five</span> thousand shares of Series E Convertible Preferred Stock (“Series E Preferred Stock”) on December 21, 2016. On November 9, 2022, the Company’s Board of Directors (i) terminated the Series D Preferred Stock and Series E Preferred Stock and (ii) designated the following shares as authorized: <span id="xdx_90A_eus-gaap--PreferredStockSharesAuthorized_iI_pid_c20221109__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z7XE2cJNwHBl" title="Preferred stock shares authorized">47,500</span> shares of new Series A Preferred Stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Series A Preferred Stock</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 9, 2022, the Company’s board of directors declared a dividend of one one-thousandth of a share of Series A Preferred Stock, par value $<span id="xdx_902_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20221109__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zEHiPhiUEZz7" title="Share issued price per share">0.00001</span> per share (“Series A Preferred Stock”), for each outstanding share of the Company’s common stock, to stockholders of record on November 21, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--PreferredStockVotingRights_c20221108__20221109__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zEWOVUUbNzC5" title="Preferred stock voting rights">Each share of Series A Preferred Stock entitled the holder to 1,000,000 votes per share, and each fraction of a share had a ratable number of votes. Thus, each one-thousandth share of Series A Preferred Stock was entitled to 1,000 votes</span>. The outstanding shares of Series A Preferred Stock voted together with the outstanding shares of the Company’s common stock as a single class exclusively concerning the proposal to adopt an amendment to the Company’s Certificate of Incorporation, as amended, to reclassify the outstanding shares of the Company’s Common Stock into a smaller number of shares of common stock at a ratio specified in or determined under the terms of such amendment (the “Reverse Stock Split”). The Series A Preferred Stock was not entitled to vote on any other matter except to the extent required under the Delaware General Corporation Law.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The holders of Series A Preferred Stock were not entitled to receive dividends.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 11, 2023, the Company held a special meeting of stockholders (the “Special Meeting”) whereby stockholders voted on a proposal to authorize the Board, at its discretion, to effect the Reverse Stock Split. All shares of Series A Preferred Stock that were not present in person or by proxy at the Special Meeting held to vote on the Reverse Stock Split immediately before the opening of the polls at such meeting (the “Initial Redemption Time”) were automatically redeemed in whole, but not in part, by the Company at the Initial Redemption Time without further action on the part of the Company or the holder of shares of Series A Preferred Stock (the “Initial Redemption”). Any outstanding shares of Series A Preferred Stock that were not redeemed according to an Initial Redemption were redeemed in whole but not in part (i) if the Board ordered such redemption in its sole discretion, automatically and effective on such time and date specified by the Board in its sole discretion or (ii) automatically upon the approval by the Company’s stockholders of the Reverse Stock Split at the Special Meeting held for the purpose of voting on a such proposal (“the Subsequent Redemption”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_eus-gaap--PreferredStockRedemptionTerms_c20230110__20230123__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zAaKKKcPqosc" title="Preferred stock redemption terms, description">Each share of Series A Preferred Stock redeemed in any redemption described above was redeemed in consideration for the right to receive an amount equal to $0.00001 in cash for each ten (10) whole shares of Series A Preferred Stock that were “beneficially owned” by the “beneficial owner” (as such terms are defined in the certificate of designation concerning the Series A Preferred Stock) thereof as of the applicable redemption time and redeemed under such redemption, payable upon receipt by the Company of a written request submitted by the relevant holder to the corporate secretary of the Company following the applicable redemption time</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 14 — PREFERRED SHARES (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Series A Preferred Stock (continued)</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Series A Preferred Stock was not convertible into, or exchangeable for, shares of any other class, series of stock, or other securities of the Company. The Series A Preferred Stock had no stated maturity and is not subject to any sinking fund. The Series A Preferred Stock was not restricted to the Company’s redemption or repurchase of shares while there is any arrearage in the payment of dividends or sinking fund installments. The Certificate of Designation was filed with the Delaware Secretary of State and became effective on November 9, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company was not solely in control of the redemption of the shares of Series A Preferred Stock since the holders had the option of deciding whether to vote in respect of the above-described Reverse Stock Split, which determined whether a given holder’s shares of Series A Preferred Stock were redeemed in the Initial Redemption or the Subsequent Redemption. Since the redemption of the Series A Preferred Stock was not solely in the control of the Company, the shares of Series A Preferred Stock were classified within mezzanine equity in the Company’s audited consolidated balance sheet. The shares of Series A Preferred Stock were measured at redemption value. The value of Series A Preferred Stock shares as of December 31, 2022, was de minimis.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Certificate of Elimination</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 25, 2016, the Company filed a Certificate of Designation with the Secretary of State of the State of Delaware, designating <span id="xdx_90C_eus-gaap--PreferredStockShareSubscriptions_iI_pid_c20160425__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_zNfEvAZcyCTh" title="Preferred stock unissued">5,000,000</span> shares out of the Company’s authorized but unissued shares of its preferred stock as Series D Convertible Preferred Stock, par value $<span id="xdx_905_eus-gaap--PreferredStockNoParValue_iI_pid_c20160425__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_zYIRHtUu8IOg" title="Preferred stock par value">0.00001</span> </span>per share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 21, 2016, the Company filed a Certificate of Designation with the Secretary of State of the State of Delaware, designating <span id="xdx_901_eus-gaap--PreferredStockShareSubscriptions_iI_pid_c20161221__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_zlXhzSvAr9yd" title="Preferred stock unissued">5,000</span> shares out of the Company’s authorized but unissued shares of its preferred stock as Series E Convertible Preferred Stock, par value $<span id="xdx_909_eus-gaap--PreferredStockNoParValue_iI_pid_c20161221__us-gaap--StatementClassOfStockAxis__custom--SeriesEConvertiblePreferredStockMember_z3K2r5PyjbTe" title="Preferred stock par value">0.00001</span> per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 9, 2022, the Company filed Certificates of Elimination for each of the Series D Preferred Stock and Series E Preferred Stock with the Secretary of State of the State of Delaware, which, effective upon filing, eliminated all matters outlined in the Certificates of Designation of Series D Preferred Stock and Series E Preferred Stock previously filed by the Company. According to the Certificates of Elimination, the shares that were previously designated as Series D Preferred Stock and Series E Preferred Stock resume the status of authorized but unissued shares of preferred stock, par value $<span id="xdx_90C_eus-gaap--PreferredStockNoParValue_iI_pid_c20161221__us-gaap--StatementClassOfStockAxis__custom--SeriesDPreferredStockAndSeriesEPreferredStockMember_zcU7ehF0UkT5" title="Preferred stock par value">0.00001</span> per share, of the Company, issuable from time to time, in one or more series, under the Certificate of Incorporation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 24, 2023, the Company filed a certificate of elimination (the “Certificate of Elimination”) with the Secretary of State of the State of Delaware for the Series A Preferred Stock. The Certificate of Elimination (i) eliminated the previous designation of <span id="xdx_90D_eus-gaap--PreferredStockShareSubscriptions_iI_pid_c20230324__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zWT1F8cG2z14" title="Preferred stock unissued">47,500</span> shares of Series A Preferred Stock from the Company’s Certificate of Incorporation, as amended, none of which were outstanding at the time of the filing of such Certificate of Elimination, and (ii) caused such shares of Series A Preferred Stock to resume their status as authorized but unissued and non-designated shares of preferred stock of the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 10000000.0 0.00001 5000000 5000000 5000 47500 0.00001 Each share of Series A Preferred Stock entitled the holder to 1,000,000 votes per share, and each fraction of a share had a ratable number of votes. Thus, each one-thousandth share of Series A Preferred Stock was entitled to 1,000 votes Each share of Series A Preferred Stock redeemed in any redemption described above was redeemed in consideration for the right to receive an amount equal to $0.00001 in cash for each ten (10) whole shares of Series A Preferred Stock that were “beneficially owned” by the “beneficial owner” (as such terms are defined in the certificate of designation concerning the Series A Preferred Stock) thereof as of the applicable redemption time and redeemed under such redemption, payable upon receipt by the Company of a written request submitted by the relevant holder to the corporate secretary of the Company following the applicable redemption time 5000000 0.00001 5000 0.00001 0.00001 47500 <p id="xdx_802_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zwrcM5sefz27" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 15 — <span id="xdx_822_zFa8WtaFjg7i">STOCKHOLDERS’ EQUITY</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Common Stock</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is authorized to issue up to <span id="xdx_90E_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20221231_zcUDQrFNEHX7" title="Common stock shares authorized"><span id="xdx_907_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20211231_zvqVnQW199Hg" title="Common stock shares authorized">100,000,000</span></span> shares of Common Stock, $<span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20221231_zAsn8vmxWrEf" title="Common stock, par value"><span id="xdx_907_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20211231_z927EEaSrLtj" title="Common stock, par value">0.00001</span></span> par value per share. As of December 31, 2022, and 2021, the Company had <span id="xdx_908_eus-gaap--CommonStockSharesIssued_iI_pid_c20221231_zFxlXGDtA9e6" title="Common stock, shares issued">47,419,317</span> and <span id="xdx_907_eus-gaap--CommonStockSharesIssued_iI_pid_c20211231_zO1ttVVciJqc" title="Common stock, shares issued">45,825,089</span> shares issued, and <span id="xdx_907_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20221231_zZsCQ1jbPVah" title="Common stock shares outstanding">47,416,658</span> and <span id="xdx_90D_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20211231_zgEx1SuNZ0O5" title="Common stock shares outstanding">45,822,430</span> shares outstanding, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Common Stock Issuances</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">For the year ending December 31, 2022</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued <span id="xdx_90D_eus-gaap--SharesPaidForTaxWithholdingForShareBasedCompensation_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zfqiXVrp2TA4" title="Shares attributable to withholding tax">357,778</span> shares of common stock as payment of the minimum withholding tax obligation due upon the vesting of shares restricted stock units.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zxsMFCgCbDAb" title="Restricted stock options, granted">1,159,044</span> shares of common stock, net of <span id="xdx_904_eus-gaap--SharesPaidForTaxWithholdingForShareBasedCompensation_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z2QpLZgiS644" title="Shares attributable to withholding tax">357,778</span> shares attributable to withholding tax, upon the exercise of restricted stock units under the Company’s various stock compensation plans.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the terms of an $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20220101__20221231__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zwv5SnmieSu6" title="Stock issued during period">80,000</span> consulting agreement: on May 4, 2022, issued <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220504__20220504__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zvM7IvbRAkz6" title="Stock issued during period for services, shares">38,703</span> shares of common stock were valued at $<span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20220504__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zWaKKBMLrv4f" title="Shares issued price per share">0.81</span> per share on the issuance date with a total value of $<span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pp0p0_c20220504__20220504__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zKBIh8CfaiWb" title="Stock issued during period for services, value+">31,349</span> in satisfaction of $<span id="xdx_905_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_c20220504__20220504__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zAnm90aCotc3" title="Repayment of consulting obligation">40,000</span>. The value of the common stock issued was based on the fair value of the stock at the time of the issuance. On July 19, 2022, <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesIssuedForServices_pid_c20220719__20220719__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zgqozcQk6MM3" title="Stock issued during period for services, shares">38,703</span> shares of common stock were valued at $<span id="xdx_90D_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20220719__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zDyhh4W70kX4" title="Shares issued price per share">0.59</span> per share on the issuance date, with a total value of $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueIssuedForServices_pp0p0_c20220719__20220719__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_z6terg9nD3m1" title="Stock issued during period for services, value+">22,835</span> in satisfaction of the remaining balance of $<span id="xdx_908_eus-gaap--RepaymentsOfRelatedPartyDebt_pp0p0_c20220719__20220719__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zIT5fqggFOck" title="Services liabilities">40,000</span>. The Company recognized a total gain on debt settlement of $<span id="xdx_907_eus-gaap--ExtinguishmentOfDebtGainLossNetOfTax_pp0p0_c20220719__20220719__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_z5eWypY9Dw1g" title="Gain on extinguishment debt">25,816</span>.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other stockholders’ equity transactions</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recognized approximately $<span id="xdx_906_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20220101__20221231_zIoTq4WzeZY9" title="Stock compensation costs">1,565,000</span> of stock-based compensation costs associated with outstanding stock options recorded in general and administrative expenses offsetting additional paid-in capital.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">For the year ending December 31, 2021</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>February 2021 Financing</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company issued <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210101__20211231__us-gaap--AwardTypeAxis__custom--FebruaryTwoThousandAndTwentyOneFinancingMember_z3XjJfn700Xf" title="Issuance of common stock share">18,181,820</span> shares of common stock, supplemented by <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20211231__us-gaap--AwardTypeAxis__custom--FebruaryTwoThousandAndTwentyOneFinancingMember_zfyn0zH1Px6e" title="Number of warrants exercised">9,090,910</span> <span id="xdx_90B_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_pid_dxL_c20211231__us-gaap--AwardTypeAxis__custom--FebruaryTwoThousandAndTwentyOneFinancingMember_z99t11r4EUE8" title="Warrant term::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl1785">five</span></span>-year warrants with an exercise price of $<span id="xdx_907_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20211231__us-gaap--AwardTypeAxis__custom--FebruaryTwoThousandAndTwentyOneFinancingMember_zBFMhoYcNoel" title="Warrant exercise price per share">3.25</span> per share exercisable for one share of common stock. The Company has earmarked the net proceeds from equity financing for working capital and general corporate purposes. Specifically, on February 8, 2021, the Company closed on equity financing and received gross proceeds of approximately $<span id="xdx_903_ecustom--GrossProceedsFromIssuanceOfCommonStock_pp0p0_c20210207__20210208__us-gaap--AwardTypeAxis__custom--FebruaryTwoThousandAndTwentyOneFinancingMember_zyZruyvkGzX6" title="Proceeds from issuance of offering">50,000,000</span>, less offering costs of $<span id="xdx_907_eus-gaap--DeferredOfferingCosts_iI_pp0p0_c20210208__us-gaap--AwardTypeAxis__custom--FebruaryTwoThousandAndTwentyOneFinancingMember_zWV15qtE0b3l" title="Offering cost">3,180,000</span> for net proceeds of $<span id="xdx_903_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pp0p0_c20210207__20210208__us-gaap--AwardTypeAxis__custom--FebruaryTwoThousandAndTwentyOneFinancingMember_zfCL8Nhi8p0c" title="Net proceeds from offering cost">46,820,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other Stockholders’ Equity Transactions</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2021, the Company:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210101__20211231_zktQvq0WlNih" title="Issuance of common stock share">6,163,198</span> shares of common stock and received gross proceeds of approximately $<span id="xdx_902_ecustom--GrossProceedsFromIssuanceOfCommonStock_pp0p0_c20210101__20211231_zW0aF3Xyc4Mb" title="Proceeds from issuance of offering">13,000,000</span>, less offering costs of $<span id="xdx_907_eus-gaap--DeferredOfferingCosts_iI_pp0p0_c20211231_zCA2C1Sn3Ppi" title="Offering cost">400,000</span> for net proceeds of $<span id="xdx_90E_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pp0p0_c20210101__20211231_z4EE2lmxS9K" title="Net proceeds from offering cost">12,600,000</span> under the Company’s shelf registration filed on May 5, 2020.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210101__20211231__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_zuU22qX8Zsad" title="Issuance of common stock share">3,811</span> shares of common stock upon warrant holders exercising <span id="xdx_905_ecustom--NumberOfSharesIssuedForExerciseOfWarrants_pid_c20210101__20211231__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_zIs3EwY40wBi" title="Number of shares issued for exercise of warrants">3,811</span> common stock warrants, receiving approximately $<span id="xdx_90F_eus-gaap--ProceedsFromWarrantExercises_pp0p0_c20210101__20211231__srt--TitleOfIndividualAxis__custom--WarrantHoldersMember_z39nfXun0An1" title="Proceeds from exercise of warrants">3,500</span> in net proceeds.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210101__20211231__srt--TitleOfIndividualAxis__custom--WarrantHoldersOneMember_z0eA6o5kucQg" title="Issuance of common stock share">6,250</span> shares of common stock upon warrant holders exercising <span id="xdx_900_ecustom--NumberOfSharesIssuedForExerciseOfWarrants_pid_c20210101__20211231__srt--TitleOfIndividualAxis__custom--WarrantHoldersOneMember_zJWpg3AAp0F8" title="Number of shares issued for exercise of warrants">6,250</span> cashless public common stock warrants.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_pid_c20211231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockWarrantsMember_zWYKlSQmZQeb" title="Number of shares issued for exercise of warrants">30,000</span> <span id="xdx_904_ecustom--WarrantsAndRightsOutstandingTerms_dxL_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockWarrantsMember_zfBw5lF7k4Vg" title="Warrants term::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl1815">three</span></span>-year common stock warrants with an exercise price of $<span id="xdx_906_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20211231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockWarrantsMember_zDa77SylqCo3" title="Warrant exercise price per share">3.41</span> per share exercisable for one share each of common stock in satisfaction of a settlement agreement. We computed the value of approximately $<span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstanding_iI_pp0p0_c20211231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockWarrantsMember_zoACRWAcXfC2" title="Warrants outstanding">74,000</span> under the Cox-Rubenstein binomial lattice valuation model method. The Company used the following assumptions in connection with the warrants’ valuation: fair market value of the stock of $<span id="xdx_908_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputSharePriceMember__us-gaap--StatementEquityComponentsAxis__custom--CommonStockWarrantsMember_zrMl7Mo2P6Qh" title="Warrant exercise price per share">3.05</span>, the exercise price of $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExercisePriceMember__us-gaap--StatementEquityComponentsAxis__custom--CommonStockWarrantsMember_zt4pMtwJqJj7" title="Warrant exercise price per share">3.41</span>, volatility of <span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember__us-gaap--StatementEquityComponentsAxis__custom--CommonStockWarrantsMember_zSwPwVAbteNc" title="volatility rate">153.96</span>%, risk-free interest rate of <span id="xdx_907_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__us-gaap--StatementEquityComponentsAxis__custom--CommonStockWarrantsMember_zMtRvku8UiNb" title="Risk free interest rate">0.08</span>%, expected dividend yield of -<span id="xdx_901_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20211231__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember__us-gaap--StatementEquityComponentsAxis__custom--CommonStockWarrantsMember_zJTKxwJXjkY5" title="Expected dividend yield">0</span>-, and the warrant life of <span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtYxL_c20211231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockWarrantsMember_zP2hI53K2u74" title="Warrant life (years)::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl1831">3 years</span></span>.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SpecificBoardMembersMember_zZJ0VF4CVx02" title="Issuance of common stock share">87,720</span> shares of common stock to specific board members under a commitment agreement valued at $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20210101__20211231__srt--TitleOfIndividualAxis__custom--SpecificBoardMembersMember_zguAMYhwfq0a" title="Issuance of common stock share value">200,000</span>. The value of the common stock was determined on the original date of the agreement.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recognized approximately $<span id="xdx_906_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210101__20211231_zkfHa7r7nsH5" title="Stock compensation costs">3,860,000</span> of stock-based compensation costs associated with outstanding stock options and restricted stock units recorded in general and administrative expenses with the offset to additional paid-in capital.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 15 — STOCKHOLDERS’ EQUITY (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Common Stock Warrants</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2022, <span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockWarrantsMember_zj7NQqOFHm4h" title="Number of warrants cancelled/expired">34,885</span> warrants expired. As of December 31, 2022, these outstanding warrants contained no intrinsic value. The weighted average exercise price of warrants outstanding on December 31, 2022, is $<span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableOutstandingWeightedAverageExercisePrice_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockWarrantsMember_zyI5YOZpPIaf" title="Weighted average exercise price ending exercisable">3.60</span>, with a weighted average remaining contractual life of <span id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--CommonStockWarrantsMember_zHdSR9W7OwAl" title="Weighted average remaining contractual life">3.1</span> years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zHXQppk62et2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following tables set forth common stock purchase warrants outstanding as of December 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_zU9CXEIBcIke">SCHEDULE OF WARRANT OUTSTANDING</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of Warrants</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in shares)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify">Outstanding, December 31, 2020</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20210101__20211231_z9JiBALNYYC5" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Number of warrants beginning balance">222,360</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20211231_zQ8k74aTcMU7" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Weighted average exercise price beginning balance">89.60</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Warrants granted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20210101__20211231_zdwr4a5u2QXj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of warrants granted">9,120,910</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_zrzoPoSP4j5g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price granted">3.30</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Warrants exercised</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20210101__20211231_zD2b5Bzq72A9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of warrants exercised">(10,063</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_zpWHGsad4xNe" style="font: 10pt Times New Roman, Times, Serif; text-align: right">(1.20</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Warrants canceled/expired</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_pid_di_c20210101__20211231_zOUGHlVSjRNk" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of warrants cancelled/expired">(123,396</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_z3nL5OwVhMAc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price cancelled/expired">(98.30</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Outstanding, December 31, 2021</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20220101__20221231_zJg5uFluVPs3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of warrants ending outstanding">9,209,811</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231_zffXk2Mzueml" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price ending outstanding">4.10</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Warrants expired</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_pid_di_c20220101__20221231_zDXBmXZxedRc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of warrants cancelled/expired">(34,885</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zW3uvi9wPTpd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price cancelled/expired">(131.20</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt">Outstanding and exercisable, December 31, 2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20220101__20221231_zR3woEv8hJWe" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of warrants ending outstanding">9,174,926</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20221231_z0VwFhJUgWab" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price ending outstanding">3.60</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AB_zYkrfAuXsr27" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_896_ecustom--ScheduleOfWarrantOutstandingExercisePriceTableTextBlock_z0hfTX4xMhI2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8BA_zUdRLfQXxUyd">SCHEDULE OF WARRANT OUTSTANDING EXERCISE PRICE</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="20" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Common stock issuable upon exercise of warrants outstanding and exercisable</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="10" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the year ending</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="8" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the year ending</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="8" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Range of Exercise Prices</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Warrants Outstanding and Exercisable (in shares)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average Remaining Contractual Life (years)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted Average Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants Outstanding and Exercisable</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in shares)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average Remaining Exercisable Contractual Life (years)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted Average Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98D_ecustom--ShareBasedCompensationSharesAuthorizedUnderNonOptionOutstandingAndExercisePriceRange_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zeQfY47F5cY6" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Warrants outstanding and exercisable, Range of exercise prices">3.25</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zEfT5I3qpZJ8" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Warrants Outstanding and Exercisable (in shares)">9,090,910</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z0jIMREikuv3" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">3.11</span> yrs</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_984_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zG8V9tfW3Rv8" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price">3.30</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zfgZ7IBFTrUj" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Warrants Outstanding and Exercisable (in shares)">9,090,910</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span id="xdx_901_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zzvZTXDW0N9c" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">4.11</span> yrs</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zk4NU69JvOAk" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price">3.30</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_ecustom--ShareBasedCompensationSharesAuthorizedUnderNonOptionOutstandingAndExercisePriceRange_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zhYMaNf1otq4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Range of exercise prices">3.41</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zIxsO6Lptufi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)">30,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_ztjTBHwKKrCi" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">1.18</span> yrs</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zjujPDLRP5x2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price">3.50</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zRUmSl8r4SU2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)">30,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_ziOgP8wxr8Ha" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">2.18</span> yrs</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zChydIoaTYI" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price">3.50</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_ecustom--ShareBasedCompensationSharesAuthorizedUnderNonOptionOutstandingAndExercisePriceRange_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zR14q4DZbxl5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Range of exercise prices">30.000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zV65h4j9zo6i" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)">683</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zMyqowLEwXoi" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">1.54</span> yrs</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zIqVMW541Xdh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price">30.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zch6Z9aoMQXk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)">683</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zuFvc7CvkT9k" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">2.54</span> yrs</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zVq6JNzLoL4c" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price">30.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_ecustom--ShareBasedCompensationSharesAuthorizedUnderNonOptionOutstandingAndExercisePriceRange_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_z2MowpCRwus1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Range of exercise prices">60.000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zPvuNdmEfNF5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)">53,333</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_z9mNBdbnr55f" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">0.41</span> yrs</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zn3YUagQ1q8c" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price">60.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zeRiw4o4pMce" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)">53,333</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zQivfJBk9Nsd" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">1.41</span> yrs</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_ziuvyG2Aqr0g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price">60.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_ecustom--ShareBasedCompensationSharesAuthorizedUnderNonOptionOutstandingAndExercisePriceRange_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zNmmd7xM2Ytd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Range of exercise prices">120.000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zOenIO4gh5k8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)"><span style="-sec-ix-hidden: xdx2ixbrl1934">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zkoGC7gwQktg" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)"><span style="-sec-ix-hidden: xdx2ixbrl1936">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zxMZLUPHtA6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price"><span style="-sec-ix-hidden: xdx2ixbrl1938">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zmP3GwWfsbcf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)">21,877</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zanVSlPgFfg1" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">0.12</span> yrs</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zdNIxpPKIvy" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price">120.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_989_ecustom--ShareBasedCompensationSharesAuthorizedUnderNonOptionOutstandingAndExercisePriceRange_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_ztYThIsMLZ6b" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Warrants outstanding and exercisable, Range of exercise prices">150.000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zomQT4L0ACx5" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)"><span style="-sec-ix-hidden: xdx2ixbrl1948">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zQtRyZQrYbFa" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)"><span style="-sec-ix-hidden: xdx2ixbrl1950">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zYhMReJba0Zc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price"><span style="-sec-ix-hidden: xdx2ixbrl1952">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zl6X4PPBpYRc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)">13,008</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zHG6ByiWbyzb" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">0.63</span> yrs</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zXNZbRhphL9c" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price">150.00</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember_zoz6x7hHO067" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)">9,174,926</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember_z85w2XN0dLLh" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">3.10</span> yrs</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember_z57nNRGpaFC6" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price">3.60</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember_zS4EtJ6MhIF5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)">9,209,811</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember_zi6RRxPBIPh5" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">4.08</span> yrs</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember_zgkyiJNSdx11" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price">4.10</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_z9WBPXyFKskg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 100000000 100000000 0.00001 0.00001 47419317 45825089 47416658 45822430 357778 1159044 357778 80000 38703 0.81 31349 40000 38703 0.59 22835 40000 25816 1565000 18181820 9090910 3.25 50000000 3180000 46820000 6163198 13000000 400000 12600000 3811 3811 3500 6250 6250 30000 3.41 74000 3.05 3.41 153.96 0.08 0 87720 200000 3860000 34885 3.60 P3Y1M6D <p id="xdx_894_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zHXQppk62et2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following tables set forth common stock purchase warrants outstanding as of December 31, 2022:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B0_zU9CXEIBcIke">SCHEDULE OF WARRANT OUTSTANDING</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number of Warrants</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in shares)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: justify">Outstanding, December 31, 2020</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20210101__20211231_z9JiBALNYYC5" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Number of warrants beginning balance">222,360</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20211231_zQ8k74aTcMU7" style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right" title="Weighted average exercise price beginning balance">89.60</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Warrants granted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_pid_c20210101__20211231_zdwr4a5u2QXj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of warrants granted">9,120,910</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_zrzoPoSP4j5g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price granted">3.30</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Warrants exercised</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_pid_di_c20210101__20211231_zD2b5Bzq72A9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of warrants exercised">(10,063</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_zpWHGsad4xNe" style="font: 10pt Times New Roman, Times, Serif; text-align: right">(1.20</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Warrants canceled/expired</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_pid_di_c20210101__20211231_zOUGHlVSjRNk" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of warrants cancelled/expired">(123,396</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231_z3nL5OwVhMAc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price cancelled/expired">(98.30</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Outstanding, December 31, 2021</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_pid_c20220101__20221231_zJg5uFluVPs3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of warrants ending outstanding">9,209,811</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231_zffXk2Mzueml" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price ending outstanding">4.10</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Warrants expired</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_pid_di_c20220101__20221231_zDXBmXZxedRc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of warrants cancelled/expired">(34,885</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231_zW3uvi9wPTpd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price cancelled/expired">(131.20</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt">Outstanding and exercisable, December 31, 2022</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_pid_c20220101__20221231_zR3woEv8hJWe" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of warrants ending outstanding">9,174,926</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20221231_z0VwFhJUgWab" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price ending outstanding">3.60</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 222360 89.60 9120910 3.30 10063 -1.20 123396 -98.30 9209811 4.10 34885 -131.20 9174926 3.60 <p id="xdx_896_ecustom--ScheduleOfWarrantOutstandingExercisePriceTableTextBlock_z0hfTX4xMhI2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span id="xdx_8BA_zUdRLfQXxUyd">SCHEDULE OF WARRANT OUTSTANDING EXERCISE PRICE</span></b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="20" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Common stock issuable upon exercise of warrants outstanding and exercisable</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="10" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the year ending</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="8" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the year ending</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="8" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31, 2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Range of Exercise Prices</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Warrants Outstanding and Exercisable (in shares)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average Remaining Contractual Life (years)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted Average Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants Outstanding and Exercisable</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(in shares)</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average Remaining Exercisable Contractual Life (years)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted Average Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98D_ecustom--ShareBasedCompensationSharesAuthorizedUnderNonOptionOutstandingAndExercisePriceRange_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zeQfY47F5cY6" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Warrants outstanding and exercisable, Range of exercise prices">3.25</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zEfT5I3qpZJ8" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Warrants Outstanding and Exercisable (in shares)">9,090,910</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_z0jIMREikuv3" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">3.11</span> yrs</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_984_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zG8V9tfW3Rv8" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price">3.30</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zfgZ7IBFTrUj" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Warrants Outstanding and Exercisable (in shares)">9,090,910</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span id="xdx_901_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zzvZTXDW0N9c" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">4.11</span> yrs</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_983_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeOneMember_zk4NU69JvOAk" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price">3.30</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_ecustom--ShareBasedCompensationSharesAuthorizedUnderNonOptionOutstandingAndExercisePriceRange_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zhYMaNf1otq4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Range of exercise prices">3.41</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zIxsO6Lptufi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)">30,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_ztjTBHwKKrCi" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">1.18</span> yrs</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zjujPDLRP5x2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price">3.50</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zRUmSl8r4SU2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)">30,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_ziOgP8wxr8Ha" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">2.18</span> yrs</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeTwoMember_zChydIoaTYI" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price">3.50</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_ecustom--ShareBasedCompensationSharesAuthorizedUnderNonOptionOutstandingAndExercisePriceRange_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zR14q4DZbxl5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Range of exercise prices">30.000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zV65h4j9zo6i" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)">683</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zMyqowLEwXoi" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">1.54</span> yrs</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zIqVMW541Xdh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price">30.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zch6Z9aoMQXk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)">683</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zuFvc7CvkT9k" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">2.54</span> yrs</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeThreeMember_zVq6JNzLoL4c" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price">30.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_ecustom--ShareBasedCompensationSharesAuthorizedUnderNonOptionOutstandingAndExercisePriceRange_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_z2MowpCRwus1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Range of exercise prices">60.000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zPvuNdmEfNF5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)">53,333</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_z9mNBdbnr55f" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">0.41</span> yrs</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zn3YUagQ1q8c" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price">60.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zeRiw4o4pMce" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)">53,333</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_zQivfJBk9Nsd" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">1.41</span> yrs</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFourMember_ziuvyG2Aqr0g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price">60.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_ecustom--ShareBasedCompensationSharesAuthorizedUnderNonOptionOutstandingAndExercisePriceRange_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zNmmd7xM2Ytd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Range of exercise prices">120.000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zOenIO4gh5k8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)"><span style="-sec-ix-hidden: xdx2ixbrl1934">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zkoGC7gwQktg" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)"><span style="-sec-ix-hidden: xdx2ixbrl1936">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zxMZLUPHtA6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price"><span style="-sec-ix-hidden: xdx2ixbrl1938">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zmP3GwWfsbcf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)">21,877</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zanVSlPgFfg1" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">0.12</span> yrs</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeFiveMember_zdNIxpPKIvy" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price">120.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">$</td><td id="xdx_989_ecustom--ShareBasedCompensationSharesAuthorizedUnderNonOptionOutstandingAndExercisePriceRange_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_ztYThIsMLZ6b" style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: right" title="Warrants outstanding and exercisable, Range of exercise prices">150.000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zomQT4L0ACx5" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)"><span style="-sec-ix-hidden: xdx2ixbrl1948">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zQtRyZQrYbFa" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)"><span style="-sec-ix-hidden: xdx2ixbrl1950">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zYhMReJba0Zc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price"><span style="-sec-ix-hidden: xdx2ixbrl1952">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zl6X4PPBpYRc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)">13,008</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zHG6ByiWbyzb" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">0.63</span> yrs</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__custom--ExercisePriceRangeSixMember_zXNZbRhphL9c" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price">150.00</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember_zoz6x7hHO067" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)">9,174,926</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember_z85w2XN0dLLh" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">3.10</span> yrs</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember_z57nNRGpaFC6" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price">3.60</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember_zS4EtJ6MhIF5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants Outstanding and Exercisable (in shares)">9,209,811</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember_zi6RRxPBIPh5" title="Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)">4.08</span> yrs</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_ecustom--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1_iI_pid_c20211231__us-gaap--StatementEquityComponentsAxis__custom--WarrantsMember_zgkyiJNSdx11" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Warrants outstanding and exercisable, Weighted Average Exercise Price">4.10</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 3.25 9090910 P3Y1M9D 3.30 9090910 P4Y1M9D 3.30 3.41 30000 P1Y2M4D 3.50 30000 P2Y2M4D 3.50 30.000 683 P1Y6M14D 30.00 683 P2Y6M14D 30.00 60.000 53333 P0Y4M28D 60.00 53333 P1Y4M28D 60.00 120.000 21877 P0Y1M13D 120.00 150.000 13008 P0Y7M17D 150.00 9174926 P3Y1M6D 3.60 9209811 P4Y29D 4.10 <p id="xdx_809_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zI5YdPoiOVSa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 16 — <span id="xdx_828_zq7n0X0XSBzf">STOCK-BASED COMPENSATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Equity Incentive Plans:</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s stock option plans provide options to purchase shares of common stock to officers, directors, other key employees, and consultants. The purchase price may be paid in cash or “net settled” in the Company’s common stock shares. In a net settlement of an option, the Company does not require payment of the exercise price from the holder but reduces the number of shares of common stock issued upon the exercise of the stock option by the smallest amount of whole shares that have an aggregate fair market value equal to or over the aggregate exercise price for the option shares covered by the option exercised. Options generally vest over three years from the grant date and expire ten years from the grant date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has four plans under which they awarded share-based compensation grants of options to individual directors, employees, and advisors of the Company: the 2013 Stock Option Plan, the 2015 Incentive Compensation Plan, the 2016 Incentive Compensation Plan, and the 2017 Incentive Compensation Plan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective April 30, 2018, the Board of Directors, by unanimous written consent, approved the immediate vesting of all remaining options for terminated employees as part of the cost curtailment measures on April 30, 2018, and June 25, 2018.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 31, 2020, the board of directors of the Company approved an amendment (the “Amendment”) to the Company’s 2013 Long-Term Stock Incentive Plan (the “Plan”), effective January 1, 2021. The Amendment removed a provision that no participant may receive more than 25% of the total shares awarded in any year under the Plan and incorporated specific immaterial clarifying changes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_ecustom--ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivitiesTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zAr1QdciWUqb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">The following table illustrates various plan data under the amended Long-Term Stock Incentive Plan (the “Plan”):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zP9HVAIKUkIh">SCHEDULE OF STOCK OPTION PLANS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the years ended</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Stock-based compensation expense</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensation_pp0p0_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zjC5g3EaG5if" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Stock-based compensation expense">1,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensation_pp0p0_c20210101__20211231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zRkTkNZFxqug" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Stock-based compensation expense">27,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Remaining expense of stock-based compensation</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_ecustom--RemainingStockCompensationExpenses_pp0p0_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zcaJKUh5kJt9" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Remaining expense of stock-based compensation"><span style="-sec-ix-hidden: xdx2ixbrl1980">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_982_ecustom--RemainingStockCompensationExpenses_pp0p0_c20210101__20211231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zQMNcJ8Q70f9" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Remaining expense of stock-based compensation">1,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Remaining amortization period</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--AmortizationPeriod_dtY_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_z1WPrzrIvWC9" title="Remaining amortization period">0.0</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--AmortizationPeriod_dtY_c20210101__20211231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zuRK05pbzRz4" title="Remaining amortization period">0.3</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Weighted average remaining contractual life – options outstanding and exercisable</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingAndExercisableRemainingContractualTerm2_pid_dtY_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zj0nWDFOM0sj" title="Outstanding and exercisable term">4.5</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingAndExercisableRemainingContractualTerm2_pid_dtY_c20210101__20211231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zHBXqj0BaUtj" title="Outstanding and exercisable term">5.5</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Intrinsic value per share</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_ecustom--IntrinsicValuePerShare_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zy1EXay3EUDa" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intrinsic value per share"><span style="-sec-ix-hidden: xdx2ixbrl1992">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_ecustom--IntrinsicValuePerShare_c20210101__20211231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_z15bvd62nFE4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intrinsic value per share"><span style="-sec-ix-hidden: xdx2ixbrl1994">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Range of exercise prices</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--ShareBasedCompensationSharesAuthorizedUnderNonOptionExercisePriceRange_pid_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zgxWDYUeYm1g" title="Range of exercise prices">6.96</span> to $<span id="xdx_90D_ecustom--ShareBasedCompensationSharesAuthorizedUnderNonOptionExercisePriceRange_pid_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zni9iq255rng" title="Range of exercise prices">97.20</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--ShareBasedCompensationSharesAuthorizedUnderNonOptionExercisePriceRange_pid_c20210101__20211231__srt--RangeAxis__srt--MinimumMember__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zZuqmgK0cV25" title="Range of exercise prices">6.96</span> to $<span id="xdx_908_ecustom--ShareBasedCompensationSharesAuthorizedUnderNonOptionExercisePriceRange_pid_c20210101__20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zw2ZOrJ6AwLf" title="Range of exercise prices">1,173.60</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Quantity:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning balance-January 1<sup>st</sup>, outstanding options</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zpLddiaDwdI1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options beginning balance">49,925</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20210101__20211231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zOtULBKFPx4f" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options beginning balance">56,399</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Stock options forfeited</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zWHehmWQA6rh" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Stock options forfeited">(4,916</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20210101__20211231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zGQdKlZetJ82" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Stock options forfeited">(6,474</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, outstanding options</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zYJqwadzInbh" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, ending outstanding">45,009</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20210101__20211231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zr1J7HLWRdv5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, ending outstanding">49,925</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, exercisable options</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zzsYgvyFxHVi" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options exercisable">45,009</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20210101__20211231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_z9cJVjXijvYg" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options exercisable">48,703</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Weighted Averages:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning balance-January 1<sup>st</sup>, outstanding options</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_z7dwmRwviLJb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding beginning balance">88.04</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20211231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zkpflURSnajc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding beginning balance">89.79</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Stock options forfeited</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zJKEH7qTvel2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Stock options forfeited">(96.70</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20210101__20211231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zvdjd9nvBuI2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Stock options forfeited">(84.13</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, outstanding options</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zjz1hRKxV5K5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending balance">87.80</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20210101__20211231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zIwVyoUnnRHi" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending balance">88.04</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, exercisable options</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zlXYced5psX7" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable balance">87.80</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20210101__20211231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zx6TY1h6M084" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable balance">89.80</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A3_zyjJs6HJr4yi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 16 — STOCK-BASED COMPENSATION (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Time-vested stock options:</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock_hus-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zcAepRcp7fWj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with their employment agreement(s), the Company granted the following ten-year, non-statutory time-vested option inducement awards under the NASDAQ Listing Rule 5653(c)(4) outside of the Company’s existing equity compensation plans (all subject to continued employment):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_z2PENWSfOWJ3" style="display: none">SCHEDULE OF STOCK OPTION PLANS FOR VESTED OPTION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Recipient</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Date of Grant</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Options Granted</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Exercise Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Vesting Commencement Date</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Expiration Date</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">25% Vesting</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">75% Remaining Vesting</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: left">●Carleton M. Miller — CEO</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardGrantDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zLEXrzGWAeoc" title="Grant date">1/22/20</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zyX4J21200Of" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right" title="Options granted">359,247</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_pid_c20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zf5m6IKX7iE8" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right" title="Exercise price">1.71</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: center"><span id="xdx_901_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zElnzUc5phS5" title="Vesting commencement date">1/22/20</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: center"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zEd6NivLqKMc" title="Expiration date">1/22/30</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zSlj8FBDN3ai" title="25% Vesting">1/22/21</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: left"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zxXyTMKARvzb" title="75% Remaining Vesting">36 equal monthly payments</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">●Michael Bond — CFO</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardGrantDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_z4kE0j0TBYg9" title="Options grant date">2/27/20</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zS9e3BK3rUWg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options granted">135,168</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_pid_c20221231__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zacccaagWlr9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.96</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zIvlqNDOwedb" title="Vesting commencement date">4/1/20</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zZIrD9EFFMDb" title="Expiration date">4/1/30</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zJxZ9mKoVNM8" title="25% Vesting">4/1/21</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zmz217EvnGLj" title="75% Remaining Vesting">36 equal monthly payments</span></td></tr> </table> <p id="xdx_8AD_zQ1IQ7vkbB7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_hus-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zW9HIv3lHME1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> In determining the time-vested options award’s grant-date fair value, the following assumptions were used:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zPBWwoYNQQPg" style="display: none">SCHEDULE OF SHARE-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Expected term (years)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Expected dividend yield</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Risk-free interest rate</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Volatility</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Exercise Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 35%; text-align: justify">● Carleton M. Miller — CEO</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_znbDxrAKMbrf" title="Expected term (years)">6.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zBdHEimF3xgk" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Expected dividend yield"><span style="-sec-ix-hidden: xdx2ixbrl2070">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zNOlGJV0nRgf" title="Risk-free interest rate">1.57</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zZQRgcyCkaVi" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Volatility">153.0</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--SharePrice_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zSRaY9D4UWX3" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Exercise price">1.71</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">● Michael Bond — CFO</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zCtNd0KpHEPg" title="Expected term (years)">6.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zgLjdmQEJy0f" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Expected dividend yield"><span style="-sec-ix-hidden: xdx2ixbrl2080">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_ztwxxl8PpM9f" title="Risk-free interest rate">0.62</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_ztA3oglEU9S8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Volatility">155.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--SharePrice_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_z072sdSVul28" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.96</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> <p id="xdx_8AC_zD85YlZ9Uxnb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note: no time-vested option awards were granted during the year ended December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_ecustom--ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivitiesTableTextBlock_hus-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zEiB3v7NiqP6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates various plan data under time-based stock option awards:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_zM4s40X7gcee" style="display: none">SCHEDULE OF STOCK OPTION PLANS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20220101__20221231_zz0n7qm5VXMi" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20210101__20211231_zljbJwuEzAL4" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the years ended</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40D_eus-gaap--ShareBasedCompensation_pp0p0_hus-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zGuQ3j3QxrZ5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Stock-based compensation expense</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">179,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">113,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_406_ecustom--RemainingStockCompensationExpenses_pp0p0_hus-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_z3Vb7e1iSZyh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Remaining expense of stock-based compensation</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">319,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">498,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Remaining amortization period</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--AmortizationPeriod_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zYJnNrbOHdTg" title="Remaining amortization period">1.1</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--AmortizationPeriod_dtY_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zSOF72FAcNra" title="Remaining amortization period">2.1</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Weighted average remaining contractual life – options outstanding and exercisable</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zUx0qQtHaxdj" title="Weighted average remaining contractual life - options exercisable">7.1</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zKyQ93HIFqri" title="Weighted average remaining contractual life - options exercisable">8.1</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_403_ecustom--IntrinsicValuePerShare_pid_hus-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zBrNd2vdiFGe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Intrinsic value per share</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2104">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">.38</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Range of exercise prices</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember__srt--RangeAxis__srt--MinimumMember_z07ckKTvcW62" title="Range of exercise prices">0.96</span> to $<span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember__srt--RangeAxis__srt--MaximumMember_zLGdaIUdEyk3" title="Range of exercise prices">1.71</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember__srt--RangeAxis__srt--MinimumMember_zwPPEbfoo5X3" title="Range of exercise prices">0.96</span> to $<span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember__srt--RangeAxis__srt--MaximumMember_zyz5HAigKh4k" title="Range of exercise prices">1.71</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Quantity:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning balance-January 1<sup>st</sup>, outstanding </span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zn7Ib8aC2xQe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options beginning balance">494,415</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zZUl5lFKPfzg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options beginning balance">494,415</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Granted, canceled, expired</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zKRc4CHgYa0h" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Stock options forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2119">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zrTjY1TAIRe6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Stock options forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2121">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, outstanding </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zsQ6deAhMuHg" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, ending outstanding">494,415</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zNriFaZBtbWi" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, ending outstanding">494,415</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, exercisable </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zA9an7fOWpp8" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options exercisable">360,515</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zvXebULdkDg" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options exercisable">236,915</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Weighted Averages:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning balance-January 1<sup>st</sup>, outstanding </span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zdQ6uWekIzwb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding beginning balance">1.01</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zanOwnfcgZb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding beginning balance">1.24</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Granted, canceled, expired</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zkGNip3VdmE7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Stock options forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2135">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zZJs4bUBYN7g" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Stock options forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2137">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, outstanding </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_z1VghjCnHpof" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending balance">0.60</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zvI6GRGiArM5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending balance">1.01</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, exercisable </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zPfviNFGDGYg" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable balance">0.80</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zPP0P2Dzvw75" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable balance">0.48</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_zu8kJ8vXlUCk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 16 — STOCK-BASED COMPENSATION (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Performance-based stock options:</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock_hus-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zAQPpoXJtbj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with their employment agreement, the Company granted the following ten-year, non-statutory performance-based stock option inducement award under the NASDAQ Listing Rule 5653(c)(4) outside of the Company’s existing equity compensation plans that will vest in <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNUT0NLLUJBU0VEIENPTVBFTlNBVElPTiAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zus8Sgy6xI9f" title="Award vesting description">three equal tranches</span> upon attainment of applicable performance conditions for each tranche (all subject to continued employment):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zg4Ui0UUhtHl" style="display: none">SCHEDULE OF STOCK OPTION PLANS FOR VESTED OPTION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">Date of</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">Options</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">Exercise</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="5" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Options Vesting Dates</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Options Vesting Schedule</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Recipient</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Grant</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Granted</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Commencement</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Expiration</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Tranche 1</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Tranche 2</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Tranche 3</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; width: 10%"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 9%"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Carleton M. Miller — CEO</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardGrantDate_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zxUod6Z8JMU4" title="Grant date">1/22/20</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformancebasedstockOptionMember_z5PCTAhetnCg" style="font: 10pt Times New Roman, Times, Serif; text-align: right">250,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_pid_c20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedStockOptionMember_zITRQyAVzwqi" style="font: 10pt Times New Roman, Times, Serif; text-align: right">1.71</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedStockOptionMember_zXuqowpP5Zu2">1/22/20</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedStockOptionMember_zhA9YTxco9qc">1/22/30</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">*<span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20220101__20221231__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedStockOptionMember_fKg_____zqhvusKPUNjh" title="options vesting">83,334</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">**<span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20220101__20221231__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheTwoMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedStockOptionMember_fKio___zuxplIO4EJMf">83,333</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">***<span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20220101__20221231__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheThreeMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedStockOptionMember_fKioq_zb3poyRAcB1c">83,333</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Applicable performance conditions:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span id="xdx_F0A_zLLIeprNmuK5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"><span id="xdx_F1A_zlui5At95W08" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBQTEFOUyBGT1IgVkVTVEVEIE9QVElPTiAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_c20220101__20221231__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zD6SE8dvFnx4" title="Vesting rights description">Shares will vest upon the Company’s attainment, on or before the fifth (5th) anniversary of the Vesting Commencement Date, of Cumulative EBITDA of more than $6,000,000 accumulated over four consecutive fiscal quarters</span>.</span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span id="xdx_F08_z7cYG5U9dBFj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td><td style="text-align: justify"><span id="xdx_F1E_zPtsiUJjeczh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBQTEFOUyBGT1IgVkVTVEVEIE9QVElPTiAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_c20220101__20221231__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheTwoMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zt0J1iZclSig">Shares will vest upon the Company’s attainment, on or before the fifth (5th) anniversary of the Vesting Commencement Date, of Cumulative EBITDA of more than $15,000,000 accumulated over four consecutive fiscal quarters</span>.</span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span id="xdx_F05_z8O9xNJugPS" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">***</span></td><td style="text-align: justify"><span id="xdx_F13_zf3UELok7ef9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBQTEFOUyBGT1IgVkVTVEVEIE9QVElPTiAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_c20220101__20221231__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheThreeMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_z1Qjr7mwEFAe">Shares will vest upon the Company’s attainment, on or before the fifth (5th) anniversary of the Vesting Commencement Date, of Cumulative EBITDA of more than $23,000,000 accumulated over four consecutive fiscal quarters</span>.</span></td> </tr></table> <p id="xdx_8A2_zZd40Uyq0x9b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89E_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_hus-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zhpjk1oWCGM5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In determining the time-vested options award’s grant-date fair value, the following assumptions were used:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zcpFN0OVxeS6" style="display: none">SCHEDULE OF SHARE-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Expected term (years)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Expected dividend yield</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Risk-free interest rate</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Volatility</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Exercise Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 35%; text-align: justify">For the year ended December 31, 2020:</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"/><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"/><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">● Carleton M. Miller — CEO</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zMuIiEnLi8ul">6.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zq54ZteJJrT6" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2170">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zc0GVTeFEYEa" style="font: 10pt Times New Roman, Times, Serif; text-align: right">1.57</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zLtt6vl3Gtj5" style="font: 10pt Times New Roman, Times, Serif; text-align: right">153.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_982_eus-gaap--SharePrice_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_z3XmZqyh9OK9" style="font: 10pt Times New Roman, Times, Serif; text-align: right">1.71</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> <p id="xdx_8A6_za7eX8KDx5n4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note: no time-vested option awards were granted during the year ended December 31, 2022</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 16 — STOCK-BASED COMPENSATION (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">Performance-based stock options (continued):</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_ecustom--ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivitiesTableTextBlock_hus-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zoravF1xkrw2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates various plan data under performance-based stock option awards:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zqcaLYAWFAPj" style="display: none">SCHEDULE OF STOCK OPTION PLANS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20220101__20221231_zzupFDawSKbl" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20210101__20211231_zPyMQoIcnbP8" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the years ended</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_406_eus-gaap--ShareBasedCompensation_hus-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zQt6NPfU6Ere" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock-based compensation expense</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2177">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2178">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_409_ecustom--RemainingStockCompensationExpenses_hus-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zWvezxAczFV2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Remaining expense of stock-based compensation</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">414,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">414,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Remaining amortization period</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--AmortizationPeriod_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zI4ANWNnnuwc" title="Remaining amortization period">2.1</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--AmortizationPeriod_dtY_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zevT9TC6pb03">3.1</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Weighted average remaining contractual life – options outstanding and exercisable</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zCYVpEpneFVk" title="Weighted average remaining contractual life - options exercisable">7.1</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zh1AlxUiRmS7" title="Weighted average remaining contractual life - options exercisable">8.1</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_409_ecustom--IntrinsicValuePerShare_pid_hus-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zUBMEh87Fxii" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Intrinsic value per share</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2190">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.<span style="-sec-ix-hidden: xdx2ixbrl2191">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Range of exercise prices</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zbazTF3FN8Gg">1.71</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zZ9MTHo2bt1a">1.71</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Quantity:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning balance-January 1<sup>st</sup>, outstanding </span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zAj6VRmkVbz2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options beginning balance">250,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zfN1U5BqfLu3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options beginning balance">250,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Granted, canceled, expired</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zqY9c97NGPo2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Stock options forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2199">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_z0LPs8rlOlBi" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Stock options forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2201">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, outstanding </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_z4D4z4JVhLvl" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, ending outstanding">250,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zRkc9p7uQ614" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, ending outstanding">250,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, exercisable </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_z12IMs8gx8N9" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options exercisable"><span style="-sec-ix-hidden: xdx2ixbrl2207">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zIjZ9FjsuFli" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options exercisable"><span style="-sec-ix-hidden: xdx2ixbrl2209">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Weighted Averages:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning balance-January 1<sup>st</sup>, outstanding </span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zzwRJcYGSYE7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding beginning balance">1.65</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zDliMq9hKqxh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding beginning balance">1.65</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Granted, canceled, expired</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_z8ffHnXrC9rf" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Stock options forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2215">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zenhQNX6JHAg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Stock options forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2217">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, outstanding </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zVN5o9DfTzJ" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending balance">1.65</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zj4XMQpvPhdl" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending balance">1.65</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, exercisable </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zMhB0t59QGAc" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable balance"><span style="-sec-ix-hidden: xdx2ixbrl2223">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zd7xdgKZH2Ak" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable balance"><span style="-sec-ix-hidden: xdx2ixbrl2225">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A4_zsvUTgqSaTG8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The probability of achieving any required metrics for vesting is inconclusive, and no options are exercisable as of December 31, 2022. When the Company determines that the remaining performance metrics’ achievement becomes probable, the Company will record a cumulative catch-up stock-based compensation amount. We will record any unrecognized costs over the remaining requisite service period of the awards.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 16 — STOCK-BASED COMPENSATION (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Restricted Stock Units</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Restricted stock awards — time-based:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_eus-gaap--ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock_hus-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zjMg3YgGDxX9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company granted the following awards under the amended Plan for restricted stock units (“RSUs”) subject to continued employment:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zueM0yUAupk9" style="display: none">SCHEDULE OF STOCK OPTION PLANS FOR VESTED OPTION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Grant</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="5" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Initial RSUs Vesting</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="5" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Remaining RSUs Vesting</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Recipient</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Date</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Units</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Exercise Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Date</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Units</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Units</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Terms</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: left">Carleton M. Miller — CEO</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z0RIAc11ik19" title="Grant date">3/3/21</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zOgfDAySigCb" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right" title="Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period">598,665</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_pid_c20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zE8UEJoZGBR4" title="Share-based Compensation Arrangement by Share-based Payment Award, Per Share Weighted Average Price of Shares Purchased">3.60</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: center"><span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zUdTPP6hf5Kl" title="Vested date">3/3/22</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_pid_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zIwkEv9rft63" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right" title="Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period">199,555</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingRemainingContractualUnits_pid_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z5BGQtNHpgib" style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right" title="Vested Remaning contractual term">399,110</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: center"><span id="xdx_900_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingRemainingContractualTerms_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zQqMHy9FdwIi" title="Vesting contractual term">24 equal monthly periods</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Michel Bais — Managing Director</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zbUDdnyrw7A2" title="Grant date">8/17/21</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20220101__20221231__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zS5eg4HObaT1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period">200,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_pid_c20221231__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zSfM4n5vfm55" title="Share-based Compensation Arrangement by Share-based Payment Award, Per Share Weighted Average Price of Shares Purchased">1.89</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z8IVAM41CkSi" title="Vested date">8/17/22</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_pid_c20220101__20221231__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z5cSQBrNSAEb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingRemainingContractualUnits_pid_c20220101__20221231__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zTVyKy7xhC7g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Remaning contractual term">150,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingRemainingContractualTerms_c20220101__20221231__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zPTiftuRRAx9" title="Vesting contractual term">36 equal monthly periods</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Ronnie Hamilton — VP Global Operations</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__custom--VpGlobalOperationsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zpG268IBv7Q9" title="Grant date">1/12/22</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20220101__20221231__srt--TitleOfIndividualAxis__custom--VpGlobalOperationsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zD3PJjxniPs3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period">200,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_pid_c20221231__srt--TitleOfIndividualAxis__custom--VpGlobalOperationsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zKmUAlt7rMxa" title="Share-based Compensation Arrangement by Share-based Payment Award, Per Share Weighted Average Price of Shares Purchased">1.10</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__custom--VpGlobalOperationsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zFqefOCy2Iyf" title="Vested date">1/12/23</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_pid_c20220101__20221231__srt--TitleOfIndividualAxis__custom--VpGlobalOperationsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zAG7v93csBUa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period">66,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingRemainingContractualUnits_pid_c20220101__20221231__srt--TitleOfIndividualAxis__custom--VpGlobalOperationsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zjyKu7VQ8kx4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Remaning contractual term">134,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingRemainingContractualTerms_c20220101__20221231__srt--TitleOfIndividualAxis__custom--VpGlobalOperationsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zqyPxzIrRhk8" title="Vesting contractual term">24 equal monthly periods</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Group of 22 Employees</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__custom--GroupOfTwentyTwoEmployeesMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zeHNxRyPdxN8" title="Grant date">2/17/22</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20220101__20221231__srt--TitleOfIndividualAxis__custom--GroupOfTwentyTwoEmployeesMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zSnUaoAOmVl8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period">515,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_pid_c20221231__srt--TitleOfIndividualAxis__custom--GroupOfTwentyTwoEmployeesMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zqzmG4sA8NBi" title="Share-based Compensation Arrangement by Share-based Payment Award, Per Share Weighted Average Price of Shares Purchased">0.98</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__custom--GroupOfTwentyTwoEmployeesMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zGp8odvsGmPf" title="Vested date">2/17/23</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_pid_c20220101__20221231__srt--TitleOfIndividualAxis__custom--GroupOfTwentyTwoEmployeesMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zDbJG6jrh3we" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period">169,950</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingRemainingContractualUnits_pid_c20220101__20221231__srt--TitleOfIndividualAxis__custom--GroupOfTwentyTwoEmployeesMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zgaO0my1ej5i" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Remaning contractual term">345,050</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingRemainingContractualTerms_c20220101__20221231__srt--TitleOfIndividualAxis__custom--GroupOfTwentyTwoEmployeesMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zW03OAcazB3b" title="Vesting contractual term">24 equal monthly periods</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Carleton M. Miller — CEO</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__custom--CarletonMMillerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zKM1hNqegyCc" title="Grant date">2/16/22</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20220101__20221231__srt--TitleOfIndividualAxis__custom--CarletonMMillerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_znu6isVjdeff" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period">1,033,076</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_pid_c20221231__srt--TitleOfIndividualAxis__custom--CarletonMMillerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z8RQQcFzSw6j" title="Share-based Compensation Arrangement by Share-based Payment Award, Per Share Weighted Average Price of Shares Purchased">1.05</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__custom--CarletonMMillerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zHY4KuZ5k3Lg" title="Vested date">2/16/23</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_pid_c20220101__20221231__srt--TitleOfIndividualAxis__custom--CarletonMMillerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zOoqJgxSN7s7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period">258,269</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingRemainingContractualUnits_pid_c20220101__20221231__srt--TitleOfIndividualAxis__custom--CarletonMMillerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zGr3E9tdKlzl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Remaning contractual term">774,807</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_905_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingRemainingContractualTerms_c20220101__20221231__srt--TitleOfIndividualAxis__custom--CarletonMMillerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_ziacbuKGm1dc" title="Vesting contractual term">36 equal monthly periods</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Mike Bond — CFO</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MikeBondMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zJ2Y89Hh69Ek" title="Grant date">2/16/22</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MikeBondMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zytndDa63m41" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Grant, Units">392,985</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_pid_c20221231__srt--TitleOfIndividualAxis__custom--MikeBondMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zFW12DzMT3Kl" title="Options, Exercise Price">1.05</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MikeBondMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z0LKDNtZP4F8" title="Initial RSUs Vesting, Vested Date">2/16/23</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_pid_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MikeBondMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zOINk4cSv1f6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Initial RSUs Vesting, Vested Units">98,256</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingRemainingContractualUnits_pid_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MikeBondMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zbfDQohIeA2h" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Remaining RSUs Vesting, Units">294,739</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingRemainingContractualTerms_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MikeBondMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zDet0uob0z17" title="Remaining RSUs Vesting, Term">36 equal monthly periods</span></td></tr> </table> <p id="xdx_8A2_zwZjfBGdBcE" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_ecustom--ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivitiesTableTextBlock_hus-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zL8VGuVp0F9c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates various plan data under time-based restricted stock awards:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zXucCbOMJuha" style="display: none">SCHEDULE OF STOCK OPTION PLANS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20220101__20221231_zDGRklZRFtag" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20210101__20211231_zS61tzaAOvj4" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the years ended</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40B_eus-gaap--ShareBasedCompensation_pp0p0_hus-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zxH5Mk6u1rZj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Stock-based compensation expense</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">1,385,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2316">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_406_ecustom--RemainingStockCompensationExpenses_pp0p0_hus-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zRbmBk0TJDI5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Remaining expense of stock-based compensation</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">3,248,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">2,533,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Remaining amortization period</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_908_ecustom--AmortizationPeriod_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zE4BlfOoGNse" title="Remaining amortization period">2.3</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--AmortizationPeriod_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zQRK2ut9486f" title="Remaining amortization period">3.5</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Weighted average remaining contractual life – options outstanding and exercisable</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingAndExercisableWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zwim45hjgLH1" title="Weighted average remaining contractual life options outstanding and exercisable">2.5</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingAndExercisableWeightedAverageRemainingContractualTerms_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z7K5sZGeIbyj" title="Weighted average remaining contractual life options outstanding and exercisable">2.5</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_402_ecustom--IntrinsicValuePerShare_hus-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z6qqNFd15ic5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Intrinsic value per share</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2329">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2330">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Range of exercise prices</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--RangeAxis__srt--MinimumMember_zQ6Fs6Z7wOAd" title="Range of exercise prices, Lower">0.98</span> to $<span id="xdx_909_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--RangeAxis__srt--MaximumMember_ziYEnEhGXFn" title="Range of exercise prices, upper">3.60</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--RangeAxis__srt--MinimumMember_zkXn0j2hpYMd" title="Range of exercise prices, Lower">1.89</span> to $<span id="xdx_902_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--RangeAxis__srt--MaximumMember_z84Tc7VNlmjc" title="Range of exercise prices, upper">3.60</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Quantity:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning balance-January 1<sup>st</sup>, outstanding </span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zCwhsN0NTVDk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options beginning balance">798,665</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zjbBRhqNs58f" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl2342">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Granted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zjzIWmnI2MLg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Stock options granted">2,141,061</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zm5kCDVfHOo2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Stock options granted">798,665</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Forfeited</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zIMiKxo3zjE3" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Stock options forfeited">(125,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zEkWAtbLysTc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Stock options forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2350">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, outstanding </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z5j1TcFkFrYa" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, ending outstanding">2,814,726</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z1Ve0mDBzsv1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, ending outstanding">798,665</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, exercisable </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z3OuJ4LUv7Je" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options exercisable">415,885</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zZNZhCm3Wm6j" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options exercisable"><span style="-sec-ix-hidden: xdx2ixbrl2358">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Weighted Averages:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning balance-January 1<sup>st</sup>, outstanding </span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zkitrCm27K4e" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding beginning balance">3.17</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z6UPVz4PDULf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl2362">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Granted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zWmPTkCH7eUa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Stock options granted">1.04</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zT8jWseTIxm4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Stock options granted">3.17</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Forfeited</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zHON6TLoZAif" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Stock options forfeited">(.98</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z50cGQSbkfs9" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Stock options forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2370">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, outstanding </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zNKLmNr9BX41" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending balance">1.20</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zl0znnFUWKza" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending balance">3.17</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, exercisable </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zS8nXykKvdzf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable balance">3.30</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zRKPPxplz3J" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable balance"><span style="-sec-ix-hidden: xdx2ixbrl2378">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A6_zDXLozQzpRTc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 16 — STOCK-BASED COMPENSATION (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Restricted Stock Units (continued)</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Restricted stock awards — performance-based:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company granted the following awards under the amended Plan for restricted stock units (“RSUs”) subject to performance vesting conditions and continued employment:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock_zqhD6C2sWYZh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span id="xdx_8B0_zG9czoE0zVeg" style="display: none">SCHEDULE OF STOCK OPTION PLANS FOR VESTED OPTION</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Grant</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Units Vesting Schedule</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Recipient</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Date</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Units</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Exercise Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Tranche 1</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Tranche 2</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Tranche 3</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: left">Carleton M. Miller — CEO</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zdNMYnZHKAMe" title="Grant date">3/3/21</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zqbaKXWpQZB3" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award">896,665</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_pid_c20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zutxI8lc5DId" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Exercise Price">3.60</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20220101__20221231__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zmuu1Znh6D6j" title="Units vesting schedule, tranche one">299,555</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20220101__20221231__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheTwoMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zi5MB3s7zXeg" title="Units vesting schedule, tranche two">299,555</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20220101__20221231__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheThreeMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zzBu0x8C1sF8" title="Units vesting schedule, tranche three">299,555</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Michael Bond — CFO</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zab7CYBwI8z7" title="Grant date">12/31/20</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_z4cm7ryh9oi4" style="font: 10pt Times New Roman, Times, Serif; text-align: right">368,715</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_pid_c20221231__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zXBfmpEJ9fJh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price">1.32</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20220101__20221231__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_z5UqzvYmkc99">122,905</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20220101__20221231__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheTwoMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zdXRoPO6TdO5" title="Units vesting schedule, tranche two">122,905</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20220101__20221231__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheThreeMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zjTeD8FHsI25" title="Units vesting schedule, tranche three">122,905</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note: The above performance-based restricted stock units met all three revenue thresholds in the last quarter of 2021, and the Company recognized stock-based compensation expense accordingly for the year ending December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Grant</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Units Vesting Schedule</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Recipient</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Date</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Units</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Exercise Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Tranche 1</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Tranche 2</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Tranche 3</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: left">Carleton M. Miller — CEO</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardGrantDate_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zdyWvNMxBqe2" title="Grant date">2/16/22</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20210101__20211231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z7ZvTGpFOIv6" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Grant units">1,033,076</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_pid_c20211231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z4dgeASnuD3h" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Exercise Price">1.05</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right">*<span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20210101__20211231__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_fKg_____zQWu1QvimG51" title="Units vesting schedule, tranche one">344,359</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right">**<span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20210101__20211231__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheTwoMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_fKio___zboju83iVmf2" title="Units vesting schedule, tranche two">344,359</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right">***<span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20210101__20211231__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheThreeMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_fKioq_zqi1ww72bZU4" title="Units vesting schedule, tranche three">344,359</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Michael Bond — CFO</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardGrantDate_c20210101__20211231__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z2JCXfoZspM" title="Grant date">2/16/22</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20210101__20211231__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z2prYq9E4LG3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Grant units">392,985</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_pid_c20211231__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zLwAzvRrcQ9k" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price">1.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">*<span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20210101__20211231__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_fKg_____zacoOJQONfUj" title="Units vesting schedule, tranche one">130,995</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">**<span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20210101__20211231__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheTwoMember__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockUnitsMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_fKio___z4j6bBZbvYbd" title="Units vesting schedule, tranche two">130,995</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">***<span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20210101__20211231__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheThreeMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_fKioq_zRyWAuMYV5b6" title="Units vesting schedule, tranche three">130,994</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F04_zrpCVLCpjopf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F17_zE1ZtrNKsGp9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBQTEFOUyBGT1IgVkVTVEVEIE9QVElPTiAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zasf1nwiQqz2">RSUs will vest upon the Company’s attainment, on or before December 31, 2026, of revenue of more than $35,575,000 accumulated over four consecutive fiscal quarters.</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F0B_z93byLgUZkda" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1F_z2bB0zxMLSM5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBQTEFOUyBGT1IgVkVTVEVEIE9QVElPTiAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheTwoMember_zTqbGPyXcl06">RSUs will vest upon the Company’s attainment, on or before December 31, 2026, of revenue of more than $37,353,000 accumulated over four consecutive fiscal quarters</span>.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F07_ztxQ22cXlqEh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">***</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F10_zTrI3oNg4ACh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBQTEFOUyBGT1IgVkVTVEVEIE9QVElPTiAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheThreeMember_z3RXdQj0zf9a">RSUs will vest upon the Company’s attainment, on or before December 31, 2026, of revenue of more than $39,220,000 accumulated over four consecutive fiscal quarters</span>.</span></td></tr> </table> <p id="xdx_8AD_zeZKKPbJeERi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note: the determination of revenue for any fiscal period shall be made based on the Company’s revenues on a consolidated basis for each such fiscal period if the employee remains in continuous employment with the Company through the date the Compensation Committee certifies the revenue for such fiscal period and authorizes the issuance of the underlying shares of common stock to the employee according to his award agreement. Except as provided in each employment agreement, if an individual ceases to be an employee of the Company before any vesting date, the remaining portion of the total number of shares unvested is forfeited. The probability of achieving any required metrics for vesting is inconclusive, and no awards are exercisable as of December 31, 2022. When the Company determines that the remaining performance metrics’ achievement becomes probable, the Company will record a cumulative catch-up stock-based compensation amount. We will record any unrecognized costs over the remaining requisite service period of the awards.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 16 — STOCK-BASED COMPENSATION (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Restricted Stock Units (continued)</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Restricted stock awards — performance-based (continued):</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89E_ecustom--ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivitiesTableTextBlock_zKGPYGc4VJp2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates various plan data under performance-based restricted stock awards:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zXOho4coNab6" style="display: none">SCHEDULE OF STOCK OPTION PLANS</span><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20220101__20221231_zISVI6Y34y25" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20210101__20211231_zYrEWVoCeUd1" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the years ended</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_402_eus-gaap--ShareBasedCompensation_pp0p0_hus-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zXpPkHkpmDc3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left; padding-bottom: 2.5pt">Stock-based compensation expense</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2436">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">3,722,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--RemainingStockCompensationExpenses_pp0p0_hus-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zvacMcMYlIah" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Remaining expense of stock-based compensation</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,498,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2440">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Remaining amortization period</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--AmortizationPeriod_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z1J0JHo7Zi5e" title="Remaining amortization period">2.8</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--AmortizationPeriod_dtY_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zRLDXnf7W761" title="Remaining amortization period">0.0</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Weighted average remaining contractual life – options outstanding and exercisable</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingAndExercisableWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zSTxnC4BQVae" title="Weighted average remaining contractual life options outstanding and exercisable">2.8</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingAndExercisableWeightedAverageRemainingContractualTerms_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zOciKVrra1O4" title="Weighted average remaining contractual life options outstanding and exercisable">4.0</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_407_ecustom--IntrinsicValuePerShare_pid_hus-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_ziTcenoLglNj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Intrinsic value per share</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2450">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1.18</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Range of exercise prices</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_z6lNWDRnJn9k" title="RSUs range of exercise prices">1.05</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90F_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__srt--RangeAxis__srt--MinimumMember_zf7NsyxfoUB1" title="RSUs range of exercise prices, lower limit">1.32</span> to <span id="xdx_902_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__srt--RangeAxis__srt--MaximumMember_zQUfjtOm1xH9" title="RSUs range of exercise prices, upper limit">3.60</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Quantity:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning balance-January 1<sup>st</sup>, outstanding </span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zmZwd9vqxCyh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options RSUs, outstanding, beginning balance">1,267,380</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zehaupQXUrqk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options RSUs, outstanding, beginning balance">368,715</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Granted, canceled, expired</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zUNd7cFyjjxa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Restricted stock units granted">1,426,062</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_z0R9vO4EK5I4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Restricted stock units granted">898,665</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zc8TgFNq3cp" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Restricted stock units exercised outstanding">(1,267,380</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised_iN_pid_di_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zlIWETvxjwg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Restricted stock units exercised outstanding"><span style="-sec-ix-hidden: xdx2ixbrl2469">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, outstanding </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zZotTjT732I6" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options RSUs outstanding ending balance">1,426,062</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zqMaFU1Zlhb6" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options RSUs outstanding ending balance">1,267,380</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, exercisable </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_z1KgesMW175e" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options exercisable"><span style="-sec-ix-hidden: xdx2ixbrl2475">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zqaie64orrp1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options exercisable">1,267,380</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Weighted Averages:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning balance-January 1<sup>st</sup>, outstanding </span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zUQBQYQFRcE5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of weighted-averages exercise price exercisable beginning balance">2.90</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zpFxAIJV1uVc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of weighted-averages exercise price exercisable beginning balance">1.32</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Granted, canceled, expired</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_z3MCjnATdKka" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price Restricted stock units , granted">1.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zFN3zkzgy851" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price Restricted stock units , granted">3.60</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageOutstanding_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zvjV30P15Igd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price Restricted stock units exercised outstanding">(2.90</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageOutstanding_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zObT9iUNhyPj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price Restricted stock units exercised outstanding"><span style="-sec-ix-hidden: xdx2ixbrl2489">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, outstanding </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisableWeightedAverageGrantDateFairValue_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zBhq4eB87h65" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price RSUs, exercisable, ending balance">1.10</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisableWeightedAverageGrantDateFairValue_iE_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zidTTNCZz2wb" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price RSUs, exercisable, ending balance">2.90</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, exercisable </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zAkJpTQgpJre" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable balance"><span style="-sec-ix-hidden: xdx2ixbrl2495">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zMavKA3AjGj6" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable balance">2.90</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zUAbPeloMYNi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89C_ecustom--ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivitiesTableTextBlock_hus-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zAr1QdciWUqb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt">The following table illustrates various plan data under the amended Long-Term Stock Incentive Plan (the “Plan”):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_zP9HVAIKUkIh">SCHEDULE OF STOCK OPTION PLANS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the years ended</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Stock-based compensation expense</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensation_pp0p0_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zjC5g3EaG5if" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Stock-based compensation expense">1,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensation_pp0p0_c20210101__20211231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zRkTkNZFxqug" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Stock-based compensation expense">27,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Remaining expense of stock-based compensation</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_ecustom--RemainingStockCompensationExpenses_pp0p0_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zcaJKUh5kJt9" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Remaining expense of stock-based compensation"><span style="-sec-ix-hidden: xdx2ixbrl1980">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_982_ecustom--RemainingStockCompensationExpenses_pp0p0_c20210101__20211231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zQMNcJ8Q70f9" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Remaining expense of stock-based compensation">1,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Remaining amortization period</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--AmortizationPeriod_dtY_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_z1WPrzrIvWC9" title="Remaining amortization period">0.0</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--AmortizationPeriod_dtY_c20210101__20211231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zuRK05pbzRz4" title="Remaining amortization period">0.3</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Weighted average remaining contractual life – options outstanding and exercisable</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingAndExercisableRemainingContractualTerm2_pid_dtY_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zj0nWDFOM0sj" title="Outstanding and exercisable term">4.5</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingAndExercisableRemainingContractualTerm2_pid_dtY_c20210101__20211231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zHBXqj0BaUtj" title="Outstanding and exercisable term">5.5</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Intrinsic value per share</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_ecustom--IntrinsicValuePerShare_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zy1EXay3EUDa" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intrinsic value per share"><span style="-sec-ix-hidden: xdx2ixbrl1992">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_ecustom--IntrinsicValuePerShare_c20210101__20211231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_z15bvd62nFE4" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Intrinsic value per share"><span style="-sec-ix-hidden: xdx2ixbrl1994">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Range of exercise prices</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--ShareBasedCompensationSharesAuthorizedUnderNonOptionExercisePriceRange_pid_c20220101__20221231__srt--RangeAxis__srt--MinimumMember__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zgxWDYUeYm1g" title="Range of exercise prices">6.96</span> to $<span id="xdx_90D_ecustom--ShareBasedCompensationSharesAuthorizedUnderNonOptionExercisePriceRange_pid_c20220101__20221231__srt--RangeAxis__srt--MaximumMember__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zni9iq255rng" title="Range of exercise prices">97.20</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--ShareBasedCompensationSharesAuthorizedUnderNonOptionExercisePriceRange_pid_c20210101__20211231__srt--RangeAxis__srt--MinimumMember__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zZuqmgK0cV25" title="Range of exercise prices">6.96</span> to $<span id="xdx_908_ecustom--ShareBasedCompensationSharesAuthorizedUnderNonOptionExercisePriceRange_pid_c20210101__20211231__srt--RangeAxis__srt--MaximumMember__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zw2ZOrJ6AwLf" title="Range of exercise prices">1,173.60</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Quantity:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning balance-January 1<sup>st</sup>, outstanding options</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zpLddiaDwdI1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options beginning balance">49,925</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20210101__20211231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zOtULBKFPx4f" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options beginning balance">56,399</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Stock options forfeited</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zWHehmWQA6rh" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Stock options forfeited">(4,916</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20210101__20211231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zGQdKlZetJ82" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Stock options forfeited">(6,474</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, outstanding options</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zYJqwadzInbh" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, ending outstanding">45,009</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20210101__20211231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zr1J7HLWRdv5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, ending outstanding">49,925</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, exercisable options</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zzsYgvyFxHVi" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options exercisable">45,009</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20210101__20211231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_z9cJVjXijvYg" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options exercisable">48,703</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Weighted Averages:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning balance-January 1<sup>st</sup>, outstanding options</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_z7dwmRwviLJb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding beginning balance">88.04</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20211231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zkpflURSnajc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding beginning balance">89.79</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Stock options forfeited</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zJKEH7qTvel2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Stock options forfeited">(96.70</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20210101__20211231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zvdjd9nvBuI2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Stock options forfeited">(84.13</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, outstanding options</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zjz1hRKxV5K5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending balance">87.80</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20210101__20211231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zIwVyoUnnRHi" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending balance">88.04</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, exercisable options</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zlXYced5psX7" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable balance">87.80</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20210101__20211231__us-gaap--PlanNameAxis__custom--TwoThousandThirteenLongTermStockIncentivePlanMember_zx6TY1h6M084" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable balance">89.80</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1000 27000 1000 P0Y P0Y3M18D P4Y6M P5Y6M 6.96 97.20 6.96 1173.60 49925 56399 4916 6474 45009 49925 45009 48703 88.04 89.79 96.70 84.13 87.80 88.04 87.80 89.80 <p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock_hus-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zcAepRcp7fWj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with their employment agreement(s), the Company granted the following ten-year, non-statutory time-vested option inducement awards under the NASDAQ Listing Rule 5653(c)(4) outside of the Company’s existing equity compensation plans (all subject to continued employment):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_z2PENWSfOWJ3" style="display: none">SCHEDULE OF STOCK OPTION PLANS FOR VESTED OPTION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Recipient</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Date of Grant</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Options Granted</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Exercise Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Vesting Commencement Date</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Expiration Date</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">25% Vesting</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">75% Remaining Vesting</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 13%; text-align: left">●Carleton M. Miller — CEO</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardGrantDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zLEXrzGWAeoc" title="Grant date">1/22/20</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zyX4J21200Of" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right" title="Options granted">359,247</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_pid_c20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zf5m6IKX7iE8" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right" title="Exercise price">1.71</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: center"><span id="xdx_901_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zElnzUc5phS5" title="Vesting commencement date">1/22/20</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: center"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zEd6NivLqKMc" title="Expiration date">1/22/30</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zSlj8FBDN3ai" title="25% Vesting">1/22/21</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: left"><span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zxXyTMKARvzb" title="75% Remaining Vesting">36 equal monthly payments</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">●Michael Bond — CFO</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardGrantDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_z4kE0j0TBYg9" title="Options grant date">2/27/20</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zS9e3BK3rUWg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Options granted">135,168</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_pid_c20221231__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zacccaagWlr9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.96</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zIvlqNDOwedb" title="Vesting commencement date">4/1/20</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zZIrD9EFFMDb" title="Expiration date">4/1/30</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zJxZ9mKoVNM8" title="25% Vesting">4/1/21</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zmz217EvnGLj" title="75% Remaining Vesting">36 equal monthly payments</span></td></tr> </table> 2020-01-22 359247 1.71 2020-01-22 2030-01-22 2021-01-22 36 equal monthly payments 2020-02-27 135168 0.96 2020-04-01 2030-04-01 2021-04-01 36 equal monthly payments <p id="xdx_89A_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_hus-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zW9HIv3lHME1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> In determining the time-vested options award’s grant-date fair value, the following assumptions were used:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zPBWwoYNQQPg" style="display: none">SCHEDULE OF SHARE-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Expected term (years)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Expected dividend yield</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Risk-free interest rate</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Volatility</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Exercise Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 35%; text-align: justify">● Carleton M. Miller — CEO</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_znbDxrAKMbrf" title="Expected term (years)">6.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zBdHEimF3xgk" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Expected dividend yield"><span style="-sec-ix-hidden: xdx2ixbrl2070">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zNOlGJV0nRgf" title="Risk-free interest rate">1.57</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zZQRgcyCkaVi" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Volatility">153.0</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--SharePrice_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zSRaY9D4UWX3" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Exercise price">1.71</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">● Michael Bond — CFO</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zCtNd0KpHEPg" title="Expected term (years)">6.3</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_dp_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_zgLjdmQEJy0f" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Expected dividend yield"><span style="-sec-ix-hidden: xdx2ixbrl2080">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_ztwxxl8PpM9f" title="Risk-free interest rate">0.62</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_ztA3oglEU9S8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Volatility">155.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--SharePrice_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_z072sdSVul28" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise price">0.96</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> P6Y6M 0.0157 1.530 1.71 P6Y3M18D 0.0062 1.550 0.96 <p id="xdx_89A_ecustom--ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivitiesTableTextBlock_hus-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zEiB3v7NiqP6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates various plan data under time-based stock option awards:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B6_zM4s40X7gcee" style="display: none">SCHEDULE OF STOCK OPTION PLANS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20220101__20221231_zz0n7qm5VXMi" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_497_20210101__20211231_zljbJwuEzAL4" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the years ended</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40D_eus-gaap--ShareBasedCompensation_pp0p0_hus-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zGuQ3j3QxrZ5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Stock-based compensation expense</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">179,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">113,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_406_ecustom--RemainingStockCompensationExpenses_pp0p0_hus-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_z3Vb7e1iSZyh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Remaining expense of stock-based compensation</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">319,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">498,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Remaining amortization period</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--AmortizationPeriod_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zYJnNrbOHdTg" title="Remaining amortization period">1.1</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--AmortizationPeriod_dtY_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zSOF72FAcNra" title="Remaining amortization period">2.1</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Weighted average remaining contractual life – options outstanding and exercisable</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zUx0qQtHaxdj" title="Weighted average remaining contractual life - options exercisable">7.1</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zKyQ93HIFqri" title="Weighted average remaining contractual life - options exercisable">8.1</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_403_ecustom--IntrinsicValuePerShare_pid_hus-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zBrNd2vdiFGe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Intrinsic value per share</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2104">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">.38</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Range of exercise prices</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember__srt--RangeAxis__srt--MinimumMember_z07ckKTvcW62" title="Range of exercise prices">0.96</span> to $<span id="xdx_90C_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember__srt--RangeAxis__srt--MaximumMember_zLGdaIUdEyk3" title="Range of exercise prices">1.71</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember__srt--RangeAxis__srt--MinimumMember_zwPPEbfoo5X3" title="Range of exercise prices">0.96</span> to $<span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember__srt--RangeAxis__srt--MaximumMember_zyz5HAigKh4k" title="Range of exercise prices">1.71</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Quantity:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning balance-January 1<sup>st</sup>, outstanding </span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zn7Ib8aC2xQe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options beginning balance">494,415</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zZUl5lFKPfzg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options beginning balance">494,415</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Granted, canceled, expired</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zKRc4CHgYa0h" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Stock options forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2119">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zrTjY1TAIRe6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Stock options forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2121">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, outstanding </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zsQ6deAhMuHg" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, ending outstanding">494,415</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zNriFaZBtbWi" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, ending outstanding">494,415</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, exercisable </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zA9an7fOWpp8" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options exercisable">360,515</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zvXebULdkDg" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options exercisable">236,915</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Weighted Averages:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning balance-January 1<sup>st</sup>, outstanding </span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zdQ6uWekIzwb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding beginning balance">1.01</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zanOwnfcgZb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding beginning balance">1.24</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Granted, canceled, expired</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zkGNip3VdmE7" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Stock options forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2135">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zZJs4bUBYN7g" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Stock options forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2137">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, outstanding </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_z1VghjCnHpof" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending balance">0.60</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zvI6GRGiArM5" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending balance">1.01</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, exercisable </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zPfviNFGDGYg" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable balance">0.80</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--TimeVestedOptionMember_zPP0P2Dzvw75" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable balance">0.48</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 179000 113000 319000 498000 P1Y1M6D P2Y1M6D P7Y1M6D P8Y1M6D 0.38 0.96 1.71 0.96 1.71 494415 494415 494415 494415 360515 236915 1.01 1.24 0.60 1.01 0.80 0.48 <p id="xdx_899_eus-gaap--ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock_hus-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zAQPpoXJtbj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with their employment agreement, the Company granted the following ten-year, non-statutory performance-based stock option inducement award under the NASDAQ Listing Rule 5653(c)(4) outside of the Company’s existing equity compensation plans that will vest in <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNUT0NLLUJBU0VEIENPTVBFTlNBVElPTiAoRGV0YWlscyBOYXJyYXRpdmUpAA__" id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zus8Sgy6xI9f" title="Award vesting description">three equal tranches</span> upon attainment of applicable performance conditions for each tranche (all subject to continued employment):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zg4Ui0UUhtHl" style="display: none">SCHEDULE OF STOCK OPTION PLANS FOR VESTED OPTION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">Date of</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">Options</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center">Exercise</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="5" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Options Vesting Dates</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Options Vesting Schedule</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Recipient</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Grant</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Granted</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Commencement</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Expiration</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Tranche 1</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Tranche 2</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Tranche 3</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; width: 10%"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 9%"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Carleton M. Miller — CEO</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardGrantDate_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zxUod6Z8JMU4" title="Grant date">1/22/20</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformancebasedstockOptionMember_z5PCTAhetnCg" style="font: 10pt Times New Roman, Times, Serif; text-align: right">250,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_pid_c20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedStockOptionMember_zITRQyAVzwqi" style="font: 10pt Times New Roman, Times, Serif; text-align: right">1.71</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> <span id="xdx_902_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedStockOptionMember_zXuqowpP5Zu2">1/22/20</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedStockOptionMember_zhA9YTxco9qc">1/22/30</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">*<span id="xdx_90D_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20220101__20221231__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedStockOptionMember_fKg_____zqhvusKPUNjh" title="options vesting">83,334</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">**<span id="xdx_904_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20220101__20221231__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheTwoMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedStockOptionMember_fKio___zuxplIO4EJMf">83,333</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">***<span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20220101__20221231__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheThreeMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedStockOptionMember_fKioq_zb3poyRAcB1c">83,333</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Applicable performance conditions:</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span id="xdx_F0A_zLLIeprNmuK5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td><td style="text-align: justify"><span id="xdx_F1A_zlui5At95W08" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBQTEFOUyBGT1IgVkVTVEVEIE9QVElPTiAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_c20220101__20221231__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zD6SE8dvFnx4" title="Vesting rights description">Shares will vest upon the Company’s attainment, on or before the fifth (5th) anniversary of the Vesting Commencement Date, of Cumulative EBITDA of more than $6,000,000 accumulated over four consecutive fiscal quarters</span>.</span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span id="xdx_F08_z7cYG5U9dBFj" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td><td style="text-align: justify"><span id="xdx_F1E_zPtsiUJjeczh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBQTEFOUyBGT1IgVkVTVEVEIE9QVElPTiAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_c20220101__20221231__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheTwoMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zt0J1iZclSig">Shares will vest upon the Company’s attainment, on or before the fifth (5th) anniversary of the Vesting Commencement Date, of Cumulative EBITDA of more than $15,000,000 accumulated over four consecutive fiscal quarters</span>.</span></td> </tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 15pt; text-align: right"><span id="xdx_F05_z8O9xNJugPS" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">***</span></td><td style="text-align: justify"><span id="xdx_F13_zf3UELok7ef9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBQTEFOUyBGT1IgVkVTVEVEIE9QVElPTiAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_c20220101__20221231__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheThreeMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_z1Qjr7mwEFAe">Shares will vest upon the Company’s attainment, on or before the fifth (5th) anniversary of the Vesting Commencement Date, of Cumulative EBITDA of more than $23,000,000 accumulated over four consecutive fiscal quarters</span>.</span></td> </tr></table> three equal tranches 2020-01-22 250000 1.71 2020-01-22 2030-01-22 83334 83333 83333 Shares will vest upon the Company’s attainment, on or before the fifth (5th) anniversary of the Vesting Commencement Date, of Cumulative EBITDA of more than $6,000,000 accumulated over four consecutive fiscal quarters Shares will vest upon the Company’s attainment, on or before the fifth (5th) anniversary of the Vesting Commencement Date, of Cumulative EBITDA of more than $15,000,000 accumulated over four consecutive fiscal quarters Shares will vest upon the Company’s attainment, on or before the fifth (5th) anniversary of the Vesting Commencement Date, of Cumulative EBITDA of more than $23,000,000 accumulated over four consecutive fiscal quarters <p id="xdx_89E_eus-gaap--ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_hus-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zhpjk1oWCGM5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In determining the time-vested options award’s grant-date fair value, the following assumptions were used:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zcpFN0OVxeS6" style="display: none">SCHEDULE OF SHARE-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Expected term (years)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Expected dividend yield</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Risk-free interest rate</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Volatility</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Exercise Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 35%; text-align: justify">For the year ended December 31, 2020:</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"/><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"/><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">● Carleton M. Miller — CEO</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zMuIiEnLi8ul">6.5</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zq54ZteJJrT6" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2170">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zc0GVTeFEYEa" style="font: 10pt Times New Roman, Times, Serif; text-align: right">1.57</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_pid_dp_uPure_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zLtt6vl3Gtj5" style="font: 10pt Times New Roman, Times, Serif; text-align: right">153.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_982_eus-gaap--SharePrice_iI_pid_c20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_z3XmZqyh9OK9" style="font: 10pt Times New Roman, Times, Serif; text-align: right">1.71</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> P6Y6M 0.0157 1.530 1.71 <p id="xdx_89C_ecustom--ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivitiesTableTextBlock_hus-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zoravF1xkrw2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates various plan data under performance-based stock option awards:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zqcaLYAWFAPj" style="display: none">SCHEDULE OF STOCK OPTION PLANS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20220101__20221231_zzupFDawSKbl" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20210101__20211231_zPyMQoIcnbP8" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the years ended</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_406_eus-gaap--ShareBasedCompensation_hus-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zQt6NPfU6Ere" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock-based compensation expense</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2177">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2178">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_409_ecustom--RemainingStockCompensationExpenses_hus-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zWvezxAczFV2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Remaining expense of stock-based compensation</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">414,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">414,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Remaining amortization period</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_ecustom--AmortizationPeriod_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zI4ANWNnnuwc" title="Remaining amortization period">2.1</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--AmortizationPeriod_dtY_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zevT9TC6pb03">3.1</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Weighted average remaining contractual life – options outstanding and exercisable</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zCYVpEpneFVk" title="Weighted average remaining contractual life - options exercisable">7.1</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zh1AlxUiRmS7" title="Weighted average remaining contractual life - options exercisable">8.1</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_409_ecustom--IntrinsicValuePerShare_pid_hus-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zUBMEh87Fxii" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Intrinsic value per share</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2190">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.<span style="-sec-ix-hidden: xdx2ixbrl2191">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Range of exercise prices</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zbazTF3FN8Gg">1.71</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zZ9MTHo2bt1a">1.71</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Quantity:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning balance-January 1<sup>st</sup>, outstanding </span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zAj6VRmkVbz2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options beginning balance">250,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zfN1U5BqfLu3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options beginning balance">250,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Granted, canceled, expired</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zqY9c97NGPo2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Stock options forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2199">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_z0LPs8rlOlBi" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Stock options forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2201">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, outstanding </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_z4D4z4JVhLvl" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, ending outstanding">250,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zRkc9p7uQ614" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, ending outstanding">250,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, exercisable </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_z12IMs8gx8N9" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options exercisable"><span style="-sec-ix-hidden: xdx2ixbrl2207">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zIjZ9FjsuFli" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options exercisable"><span style="-sec-ix-hidden: xdx2ixbrl2209">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Weighted Averages:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning balance-January 1<sup>st</sup>, outstanding </span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zzwRJcYGSYE7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding beginning balance">1.65</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zDliMq9hKqxh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding beginning balance">1.65</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Granted, canceled, expired</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_z8ffHnXrC9rf" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Stock options forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2215">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zenhQNX6JHAg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Stock options forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2217">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, outstanding </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zVN5o9DfTzJ" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending balance">1.65</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zj4XMQpvPhdl" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending balance">1.65</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, exercisable </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zMhB0t59QGAc" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable balance"><span style="-sec-ix-hidden: xdx2ixbrl2223">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zd7xdgKZH2Ak" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable balance"><span style="-sec-ix-hidden: xdx2ixbrl2225">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 414000000 414000000 P2Y1M6D P3Y1M6D P7Y1M6D P8Y1M6D 1.71 1.71 250000 250000 250000 250000 1.65 1.65 1.65 1.65 <p id="xdx_89B_eus-gaap--ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock_hus-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zjMg3YgGDxX9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company granted the following awards under the amended Plan for restricted stock units (“RSUs”) subject to continued employment:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zueM0yUAupk9" style="display: none">SCHEDULE OF STOCK OPTION PLANS FOR VESTED OPTION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Grant</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="5" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Initial RSUs Vesting</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="5" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Remaining RSUs Vesting</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Recipient</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Date</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Units</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Exercise Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Date</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Units</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Units</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Terms</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: left">Carleton M. Miller — CEO</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z0RIAc11ik19" title="Grant date">3/3/21</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zOgfDAySigCb" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right" title="Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period">598,665</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right"><span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_pid_c20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zE8UEJoZGBR4" title="Share-based Compensation Arrangement by Share-based Payment Award, Per Share Weighted Average Price of Shares Purchased">3.60</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: center"><span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zUdTPP6hf5Kl" title="Vested date">3/3/22</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_pid_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zIwkEv9rft63" style="font: 10pt Times New Roman, Times, Serif; width: 7%; text-align: right" title="Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period">199,555</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingRemainingContractualUnits_pid_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z5BGQtNHpgib" style="font: 10pt Times New Roman, Times, Serif; width: 8%; text-align: right" title="Vested Remaning contractual term">399,110</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: center"><span id="xdx_900_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingRemainingContractualTerms_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zQqMHy9FdwIi" title="Vesting contractual term">24 equal monthly periods</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Michel Bais — Managing Director</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zbUDdnyrw7A2" title="Grant date">8/17/21</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20220101__20221231__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zS5eg4HObaT1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period">200,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_pid_c20221231__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zSfM4n5vfm55" title="Share-based Compensation Arrangement by Share-based Payment Award, Per Share Weighted Average Price of Shares Purchased">1.89</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z8IVAM41CkSi" title="Vested date">8/17/22</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_pid_c20220101__20221231__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z5cSQBrNSAEb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period">50,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingRemainingContractualUnits_pid_c20220101__20221231__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zTVyKy7xhC7g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Remaning contractual term">150,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingRemainingContractualTerms_c20220101__20221231__srt--TitleOfIndividualAxis__srt--DirectorMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zPTiftuRRAx9" title="Vesting contractual term">36 equal monthly periods</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Ronnie Hamilton — VP Global Operations</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__custom--VpGlobalOperationsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zpG268IBv7Q9" title="Grant date">1/12/22</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20220101__20221231__srt--TitleOfIndividualAxis__custom--VpGlobalOperationsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zD3PJjxniPs3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period">200,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_pid_c20221231__srt--TitleOfIndividualAxis__custom--VpGlobalOperationsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zKmUAlt7rMxa" title="Share-based Compensation Arrangement by Share-based Payment Award, Per Share Weighted Average Price of Shares Purchased">1.10</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__custom--VpGlobalOperationsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zFqefOCy2Iyf" title="Vested date">1/12/23</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_pid_c20220101__20221231__srt--TitleOfIndividualAxis__custom--VpGlobalOperationsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zAG7v93csBUa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period">66,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingRemainingContractualUnits_pid_c20220101__20221231__srt--TitleOfIndividualAxis__custom--VpGlobalOperationsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zjyKu7VQ8kx4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Remaning contractual term">134,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_901_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingRemainingContractualTerms_c20220101__20221231__srt--TitleOfIndividualAxis__custom--VpGlobalOperationsMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zqyPxzIrRhk8" title="Vesting contractual term">24 equal monthly periods</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Group of 22 Employees</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__custom--GroupOfTwentyTwoEmployeesMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zeHNxRyPdxN8" title="Grant date">2/17/22</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20220101__20221231__srt--TitleOfIndividualAxis__custom--GroupOfTwentyTwoEmployeesMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zSnUaoAOmVl8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period">515,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_pid_c20221231__srt--TitleOfIndividualAxis__custom--GroupOfTwentyTwoEmployeesMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zqzmG4sA8NBi" title="Share-based Compensation Arrangement by Share-based Payment Award, Per Share Weighted Average Price of Shares Purchased">0.98</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__custom--GroupOfTwentyTwoEmployeesMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zGp8odvsGmPf" title="Vested date">2/17/23</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_pid_c20220101__20221231__srt--TitleOfIndividualAxis__custom--GroupOfTwentyTwoEmployeesMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zDbJG6jrh3we" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period">169,950</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingRemainingContractualUnits_pid_c20220101__20221231__srt--TitleOfIndividualAxis__custom--GroupOfTwentyTwoEmployeesMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zgaO0my1ej5i" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Remaning contractual term">345,050</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingRemainingContractualTerms_c20220101__20221231__srt--TitleOfIndividualAxis__custom--GroupOfTwentyTwoEmployeesMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zW03OAcazB3b" title="Vesting contractual term">24 equal monthly periods</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Carleton M. Miller — CEO</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__custom--CarletonMMillerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zKM1hNqegyCc" title="Grant date">2/16/22</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20220101__20221231__srt--TitleOfIndividualAxis__custom--CarletonMMillerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_znu6isVjdeff" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period">1,033,076</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_pid_c20221231__srt--TitleOfIndividualAxis__custom--CarletonMMillerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z8RQQcFzSw6j" title="Share-based Compensation Arrangement by Share-based Payment Award, Per Share Weighted Average Price of Shares Purchased">1.05</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__custom--CarletonMMillerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zHY4KuZ5k3Lg" title="Vested date">2/16/23</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_pid_c20220101__20221231__srt--TitleOfIndividualAxis__custom--CarletonMMillerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zOoqJgxSN7s7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period">258,269</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingRemainingContractualUnits_pid_c20220101__20221231__srt--TitleOfIndividualAxis__custom--CarletonMMillerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zGr3E9tdKlzl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Vested Remaning contractual term">774,807</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_905_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingRemainingContractualTerms_c20220101__20221231__srt--TitleOfIndividualAxis__custom--CarletonMMillerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_ziacbuKGm1dc" title="Vesting contractual term">36 equal monthly periods</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Mike Bond — CFO</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MikeBondMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zJ2Y89Hh69Ek" title="Grant date">2/16/22</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MikeBondMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zytndDa63m41" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Grant, Units">392,985</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_pid_c20221231__srt--TitleOfIndividualAxis__custom--MikeBondMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zFW12DzMT3Kl" title="Options, Exercise Price">1.05</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_908_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MikeBondMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z0LKDNtZP4F8" title="Initial RSUs Vesting, Vested Date">2/16/23</span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_pid_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MikeBondMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zOINk4cSv1f6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Initial RSUs Vesting, Vested Units">98,256</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingRemainingContractualUnits_pid_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MikeBondMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zbfDQohIeA2h" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Remaining RSUs Vesting, Units">294,739</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_90F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingRemainingContractualTerms_c20220101__20221231__srt--TitleOfIndividualAxis__custom--MikeBondMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zDet0uob0z17" title="Remaining RSUs Vesting, Term">36 equal monthly periods</span></td></tr> </table> 2021-03-03 598665 3.60 2022-03-03 199555 399110 24 equal monthly periods 2021-08-17 200000 1.89 2022-08-17 50000 150000 36 equal monthly periods 2022-01-12 200000 1.10 2023-01-12 66000 134000 24 equal monthly periods 2022-02-17 515000 0.98 2023-02-17 169950 345050 24 equal monthly periods 2022-02-16 1033076 1.05 2023-02-16 258269 774807 36 equal monthly periods 2022-02-16 392985 1.05 2023-02-16 98256 294739 36 equal monthly periods <p id="xdx_899_ecustom--ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivitiesTableTextBlock_hus-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zL8VGuVp0F9c" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates various plan data under time-based restricted stock awards:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BD_zXucCbOMJuha" style="display: none">SCHEDULE OF STOCK OPTION PLANS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20220101__20221231_zDGRklZRFtag" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49A_20210101__20211231_zS61tzaAOvj4" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the years ended</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40B_eus-gaap--ShareBasedCompensation_pp0p0_hus-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zxH5Mk6u1rZj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Stock-based compensation expense</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">1,385,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2316">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_406_ecustom--RemainingStockCompensationExpenses_pp0p0_hus-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zRbmBk0TJDI5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Remaining expense of stock-based compensation</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">3,248,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">2,533,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Remaining amortization period</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_908_ecustom--AmortizationPeriod_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zE4BlfOoGNse" title="Remaining amortization period">2.3</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--AmortizationPeriod_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zQRK2ut9486f" title="Remaining amortization period">3.5</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Weighted average remaining contractual life – options outstanding and exercisable</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingAndExercisableWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zwim45hjgLH1" title="Weighted average remaining contractual life options outstanding and exercisable">2.5</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingAndExercisableWeightedAverageRemainingContractualTerms_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z7K5sZGeIbyj" title="Weighted average remaining contractual life options outstanding and exercisable">2.5</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_402_ecustom--IntrinsicValuePerShare_hus-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z6qqNFd15ic5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Intrinsic value per share</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2329">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2330">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Range of exercise prices</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--RangeAxis__srt--MinimumMember_zQ6Fs6Z7wOAd" title="Range of exercise prices, Lower">0.98</span> to $<span id="xdx_909_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--RangeAxis__srt--MaximumMember_ziYEnEhGXFn" title="Range of exercise prices, upper">3.60</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--RangeAxis__srt--MinimumMember_zkXn0j2hpYMd" title="Range of exercise prices, Lower">1.89</span> to $<span id="xdx_902_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePriceRangeUpperRangeLimit_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--RangeAxis__srt--MaximumMember_z84Tc7VNlmjc" title="Range of exercise prices, upper">3.60</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Quantity:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning balance-January 1<sup>st</sup>, outstanding </span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zCwhsN0NTVDk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options beginning balance">798,665</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zjbBRhqNs58f" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl2342">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Granted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zjzIWmnI2MLg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Stock options granted">2,141,061</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zm5kCDVfHOo2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Stock options granted">798,665</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Forfeited</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zIMiKxo3zjE3" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Stock options forfeited">(125,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_iN_pid_di_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zEkWAtbLysTc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, Stock options forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2350">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, outstanding </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z5j1TcFkFrYa" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, ending outstanding">2,814,726</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z1Ve0mDBzsv1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options, ending outstanding">798,665</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, exercisable </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z3OuJ4LUv7Je" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options exercisable">415,885</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zZNZhCm3Wm6j" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options exercisable"><span style="-sec-ix-hidden: xdx2ixbrl2358">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Weighted Averages:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning balance-January 1<sup>st</sup>, outstanding </span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zkitrCm27K4e" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding beginning balance">3.17</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z6UPVz4PDULf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl2362">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Granted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zWmPTkCH7eUa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Stock options granted">1.04</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zT8jWseTIxm4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Stock options granted">3.17</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Forfeited</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zHON6TLoZAif" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Stock options forfeited">(.98</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_iN_pid_di_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z50cGQSbkfs9" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, Stock options forfeited"><span style="-sec-ix-hidden: xdx2ixbrl2370">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, outstanding </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zNKLmNr9BX41" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending balance">1.20</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zl0znnFUWKza" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, outstanding ending balance">3.17</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, exercisable </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zS8nXykKvdzf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable balance">3.30</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zRKPPxplz3J" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable balance"><span style="-sec-ix-hidden: xdx2ixbrl2378">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1385000 3248000 2533000 P2Y3M18D P3Y6M P2Y6M P2Y6M 0.98 3.60 1.89 3.60 798665 2141061 798665 125000 2814726 798665 415885 3.17 1.04 3.17 0.98 1.20 3.17 3.30 <p id="xdx_891_eus-gaap--ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock_zqhD6C2sWYZh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span><span id="xdx_8B0_zG9czoE0zVeg" style="display: none">SCHEDULE OF STOCK OPTION PLANS FOR VESTED OPTION</span></span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Grant</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Units Vesting Schedule</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Recipient</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Date</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Units</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Exercise Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Tranche 1</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Tranche 2</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Tranche 3</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: left">Carleton M. Miller — CEO</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zdNMYnZHKAMe" title="Grant date">3/3/21</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zqbaKXWpQZB3" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award">896,665</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_pid_c20221231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zutxI8lc5DId" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Exercise Price">3.60</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20220101__20221231__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zmuu1Znh6D6j" title="Units vesting schedule, tranche one">299,555</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span id="xdx_903_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20220101__20221231__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheTwoMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zi5MB3s7zXeg" title="Units vesting schedule, tranche two">299,555</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span id="xdx_90E_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20220101__20221231__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheThreeMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zzBu0x8C1sF8" title="Units vesting schedule, tranche three">299,555</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Michael Bond — CFO</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInDate_dd_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zab7CYBwI8z7" title="Grant date">12/31/20</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20220101__20221231__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_z4cm7ryh9oi4" style="font: 10pt Times New Roman, Times, Serif; text-align: right">368,715</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_pid_c20221231__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zXBfmpEJ9fJh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price">1.32</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20220101__20221231__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_z5UqzvYmkc99">122,905</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20220101__20221231__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheTwoMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zdXRoPO6TdO5" title="Units vesting schedule, tranche two">122,905</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20220101__20221231__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheThreeMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zjTeD8FHsI25" title="Units vesting schedule, tranche three">122,905</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Note: The above performance-based restricted stock units met all three revenue thresholds in the last quarter of 2021, and the Company recognized stock-based compensation expense accordingly for the year ending December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Grant</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Units Vesting Schedule</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Recipient</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Date</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Units</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Exercise Price</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Tranche 1</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Tranche 2</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Tranche 3</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 40%; text-align: left">Carleton M. Miller — CEO</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardGrantDate_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zdyWvNMxBqe2" title="Grant date">2/16/22</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20210101__20211231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z7ZvTGpFOIv6" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Grant units">1,033,076</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_pid_c20211231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z4dgeASnuD3h" style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right" title="Exercise Price">1.05</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right">*<span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20210101__20211231__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_fKg_____zQWu1QvimG51" title="Units vesting schedule, tranche one">344,359</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right">**<span id="xdx_90A_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20210101__20211231__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheTwoMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_fKio___zboju83iVmf2" title="Units vesting schedule, tranche two">344,359</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 6%; text-align: right">***<span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20210101__20211231__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheThreeMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_fKioq_zqi1ww72bZU4" title="Units vesting schedule, tranche three">344,359</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Michael Bond — CFO</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardGrantDate_c20210101__20211231__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z2JCXfoZspM" title="Grant date">2/16/22</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward_pid_c20210101__20211231__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_z2prYq9E4LG3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Grant units">392,985</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased_iI_pid_c20211231__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_zLwAzvRrcQ9k" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Exercise Price">1.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">*<span id="xdx_902_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20210101__20211231__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_fKg_____zacoOJQONfUj" title="Units vesting schedule, tranche one">130,995</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">**<span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20210101__20211231__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheTwoMember__us-gaap--AwardTypeAxis__custom--PerformanceBasedRestrictedStockUnitsMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_fKio___z4j6bBZbvYbd" title="Units vesting schedule, tranche two">130,995</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">***<span id="xdx_90C_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber_pid_c20210101__20211231__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheThreeMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember_fKioq_zRyWAuMYV5b6" title="Units vesting schedule, tranche three">130,994</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span id="xdx_F04_zrpCVLCpjopf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F17_zE1ZtrNKsGp9" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBQTEFOUyBGT1IgVkVTVEVEIE9QVElPTiAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_902_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheOneMember_zasf1nwiQqz2">RSUs will vest upon the Company’s attainment, on or before December 31, 2026, of revenue of more than $35,575,000 accumulated over four consecutive fiscal quarters.</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F0B_z93byLgUZkda" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1F_z2bB0zxMLSM5" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBQTEFOUyBGT1IgVkVTVEVEIE9QVElPTiAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheTwoMember_zTqbGPyXcl06">RSUs will vest upon the Company’s attainment, on or before December 31, 2026, of revenue of more than $37,353,000 accumulated over four consecutive fiscal quarters</span>.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_F07_ztxQ22cXlqEh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">***</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F10_zTrI3oNg4ACh" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIFNUT0NLIE9QVElPTiBQTEFOUyBGT1IgVkVTVEVEIE9QVElPTiAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockUnitsRSUMember__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember__us-gaap--VestingAxis__us-gaap--ShareBasedCompensationAwardTrancheThreeMember_z3RXdQj0zf9a">RSUs will vest upon the Company’s attainment, on or before December 31, 2026, of revenue of more than $39,220,000 accumulated over four consecutive fiscal quarters</span>.</span></td></tr> </table> 2021-03-03 896665 3.60 299555 299555 299555 2020-12-31 368715 1.32 122905 122905 122905 2022-02-16 1033076 1.05 344359 344359 344359 2022-02-16 392985 1.05 130995 130995 130994 RSUs will vest upon the Company’s attainment, on or before December 31, 2026, of revenue of more than $35,575,000 accumulated over four consecutive fiscal quarters. RSUs will vest upon the Company’s attainment, on or before December 31, 2026, of revenue of more than $37,353,000 accumulated over four consecutive fiscal quarters RSUs will vest upon the Company’s attainment, on or before December 31, 2026, of revenue of more than $39,220,000 accumulated over four consecutive fiscal quarters <p id="xdx_89E_ecustom--ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivitiesTableTextBlock_zKGPYGc4VJp2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table illustrates various plan data under performance-based restricted stock awards:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zXOho4coNab6" style="display: none">SCHEDULE OF STOCK OPTION PLANS</span><b> </b></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49B_20220101__20221231_zISVI6Y34y25" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_498_20210101__20211231_zYrEWVoCeUd1" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the years ended</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_402_eus-gaap--ShareBasedCompensation_pp0p0_hus-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zXpPkHkpmDc3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left; padding-bottom: 2.5pt">Stock-based compensation expense</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2436">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">3,722,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--RemainingStockCompensationExpenses_pp0p0_hus-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zvacMcMYlIah" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Remaining expense of stock-based compensation</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,498,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2440">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Remaining amortization period</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--AmortizationPeriod_dtY_c20220101__20221231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_z1J0JHo7Zi5e" title="Remaining amortization period">2.8</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--AmortizationPeriod_dtY_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_zRLDXnf7W761" title="Remaining amortization period">0.0</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Weighted average remaining contractual life – options outstanding and exercisable</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingAndExercisableWeightedAverageRemainingContractualTerms_dtY_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zSTxnC4BQVae" title="Weighted average remaining contractual life options outstanding and exercisable">2.8</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingAndExercisableWeightedAverageRemainingContractualTerms_dtY_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zOciKVrra1O4" title="Weighted average remaining contractual life options outstanding and exercisable">4.0</span> years</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_407_ecustom--IntrinsicValuePerShare_pid_hus-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember_ziTcenoLglNj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Intrinsic value per share</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2450">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1.18</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Range of exercise prices</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_z6lNWDRnJn9k" title="RSUs range of exercise prices">1.05</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$<span id="xdx_90F_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__srt--RangeAxis__srt--MinimumMember_zf7NsyxfoUB1" title="RSUs range of exercise prices, lower limit">1.32</span> to <span id="xdx_902_ecustom--ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePriceRangeLowerRangeLimit_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember__srt--RangeAxis__srt--MaximumMember_zQUfjtOm1xH9" title="RSUs range of exercise prices, upper limit">3.60</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Quantity:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning balance-January 1<sup>st</sup>, outstanding </span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zmZwd9vqxCyh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options RSUs, outstanding, beginning balance">1,267,380</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iS_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zehaupQXUrqk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options RSUs, outstanding, beginning balance">368,715</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Granted, canceled, expired</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zUNd7cFyjjxa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Restricted stock units granted">1,426,062</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_z0R9vO4EK5I4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Restricted stock units granted">898,665</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised_iN_pid_di_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zc8TgFNq3cp" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Restricted stock units exercised outstanding">(1,267,380</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised_iN_pid_di_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zlIWETvxjwg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Restricted stock units exercised outstanding"><span style="-sec-ix-hidden: xdx2ixbrl2469">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, outstanding </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zZotTjT732I6" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options RSUs outstanding ending balance">1,426,062</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_iE_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zqMaFU1Zlhb6" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options RSUs outstanding ending balance">1,267,380</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, exercisable </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_z1KgesMW175e" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options exercisable"><span style="-sec-ix-hidden: xdx2ixbrl2475">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_iE_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zqaie64orrp1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of options exercisable">1,267,380</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Weighted Averages:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning balance-January 1<sup>st</sup>, outstanding </span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zUQBQYQFRcE5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of weighted-averages exercise price exercisable beginning balance">2.90</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_iS_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zpFxAIJV1uVc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of weighted-averages exercise price exercisable beginning balance">1.32</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Granted, canceled, expired</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_z3MCjnATdKka" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price Restricted stock units , granted">1.05</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zFN3zkzgy851" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price Restricted stock units , granted">3.60</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; padding-bottom: 1.5pt">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageOutstanding_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zvjV30P15Igd" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price Restricted stock units exercised outstanding">(2.90</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageOutstanding_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zObT9iUNhyPj" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price Restricted stock units exercised outstanding"><span style="-sec-ix-hidden: xdx2ixbrl2489">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, outstanding </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisableWeightedAverageGrantDateFairValue_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zBhq4eB87h65" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price RSUs, exercisable, ending balance">1.10</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisableWeightedAverageGrantDateFairValue_iE_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zidTTNCZz2wb" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price RSUs, exercisable, ending balance">2.90</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending balance-December 31<sup>st</sup>, exercisable </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20220101__20221231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zAkJpTQgpJre" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable balance"><span style="-sec-ix-hidden: xdx2ixbrl2495">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iE_pid_c20210101__20211231__us-gaap--AwardTypeAxis__us-gaap--RestrictedStockMember__us-gaap--StatementEquityComponentsAxis__custom--PerformanceBasedOptionMember_zMavKA3AjGj6" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted average exercise price, exercisable balance">2.90</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 3722000 1498000 P2Y9M18D P0Y P2Y9M18D P4Y 1.18 1.05 1.32 3.60 1267380 368715 1426062 898665 1267380 1426062 1267380 1267380 2.90 1.32 1.05 3.60 -2.90 1.10 2.90 2.90 <p id="xdx_809_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zz0sqRnAaouj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 17 — <span id="xdx_824_zcAQp2ImNrl4">COMMITMENTS AND CONTINGENCIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Pension:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company may make a matching contribution to its employees’ 401(k) plan. Vislink also has a Group Personal Plan in our U.K. Subsidiary, investing funds with Royal London. U.K. employees are entitled to join the Plan to which the Company contributes varying amounts subject to status. Additionally, the Company operates a stakeholder pension scheme in the U.K.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--DefinedContributionPlanDisclosuresTableTextBlock_zEWf3NcKKbC" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below represents the Company’s matching contributions as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_zG30s914uiA3" style="display: none">SCHEDULE OF MATCHING CONTRIBUTIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the year ended</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left; padding-bottom: 2.5pt">Company matching contributions - Group Personal Pension Plan, U.K.</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--DefinedContributionPlanCostRecognized_pp0p0_c20220101__20221231__us-gaap--PlanNameAxis__custom--GroupPersonalPensionPlanUKMember_zynkMCmt1Td7" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Company matching contributions">166,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--DefinedContributionPlanCostRecognized_pp0p0_c20210101__20211231__us-gaap--PlanNameAxis__custom--GroupPersonalPensionPlanUKMember_zbfHv5lddH49" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Company matching contributions">169,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_zlkDbGs3J8Tg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Nasdaq Compliance:</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As previously reported, on May 20, 2022, Vislink Technologies, Inc. (the “Company”) received notice from the Nasdaq Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company of its noncompliance with Nasdaq Listing Rule 5550(a)(2) (the “Rule”) by failing to maintain a minimum bid price for its common stock on the Nasdaq Capital Market of at least $<span id="xdx_903_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220520_zZRnHDmDXK68" title="Common stock per share value">1.00</span> per share for 30 consecutive business days. The Company received a grace period of 180 days, or until November 16, 2022, to regain compliance with the minimum bid price requirement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 10, 2022, the Company submitted a request to Nasdaq for an additional 180-day grace period, or until May 15, 2023, to regain compliance with the minimum bid price requirement. On November 17, 2022, the Company received a letter from Nasdaq advising that the Company had been granted an additional 180-day grace period extension until May 15, 2023, to regain compliance with the minimum bid price requirement and all other applicable requirements for initial listing on the Nasdaq Capital Market except for the minimum bid price requirement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 11, 2023, the Company held a special meeting of stockholders (the “Special Meeting”) whereby stockholders voted and approved a proposal to authorize the Board of Directors of the Company (the “Board”), in its discretion but before the one-year anniversary of the date of the Special Meeting, to implement an amendment to the Company’s certificate of incorporation to effect a reverse stock split (the “Reverse Stock Split”) of all of the outstanding shares of Common Stock, par value $<span id="xdx_902_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20230111__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zNZyRjs5dGD2" title="Common stock per share value">0.00001</span> per share (“Common Stock”), of the Company, at a ratio in the range of <span id="xdx_90E_eus-gaap--StockholdersEquityReverseStockSplit_c20230110__20230110__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zW3gtYg788l3" title="Reverse split">1-for-2</span> to <span id="xdx_90E_eus-gaap--StockholdersEquityReverseStockSplit_c20230111__20230111__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zCstyYGr4Ck9" title="Reverse split">1-for-50</span>. The Company intends to monitor the closing bid price of its common stock and may, if appropriate, consider available options to regain compliance with the Rule, including initiating the Reverse Stock Split.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There can be no assurance that the Reverse Split will result in a sustained increase in the per share market price for the Common Stock for the minimum period necessary to permit the Company to be timely regain compliance with the Rule. There can be no assurance that the Company will be able to regain compliance with the Rule or otherwise be in compliance with other Nasdaq Listing Rules during this additional 180-day extension period. If the Company does not regain compliance within the allotted compliance period, Nasdaq will provide notice that the common stock will be subject to delisting. The Company would then be entitled to appeal that determination to a Nasdaq hearings panel.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Nasdaq notice has no immediate impact on the listing of the Company’s common stock, which will continue to be listed and traded on The Nasdaq Capital Market under the symbol “VISL,” subject to the Company’s compliance with the other continued listing requirements of The Nasdaq Capital Market</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--DefinedContributionPlanDisclosuresTableTextBlock_zEWf3NcKKbC" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below represents the Company’s matching contributions as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_zG30s914uiA3" style="display: none">SCHEDULE OF MATCHING CONTRIBUTIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the year ended</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left; padding-bottom: 2.5pt">Company matching contributions - Group Personal Pension Plan, U.K.</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--DefinedContributionPlanCostRecognized_pp0p0_c20220101__20221231__us-gaap--PlanNameAxis__custom--GroupPersonalPensionPlanUKMember_zynkMCmt1Td7" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Company matching contributions">166,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--DefinedContributionPlanCostRecognized_pp0p0_c20210101__20211231__us-gaap--PlanNameAxis__custom--GroupPersonalPensionPlanUKMember_zbfHv5lddH49" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Company matching contributions">169,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 166000 169000 1.00 0.00001 1-for-2 1-for-50 <p id="xdx_800_eus-gaap--ConcentrationRiskDisclosureTextBlock_z4D9zjoUt0Ij" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 18 — <span id="xdx_825_zOOSk3NXnJ2i">CONCENTRATIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Customer concentration risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2022, the Company recorded sales to a single customer of $<span id="xdx_90F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__srt--MajorCustomersAxis__custom--SingleCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z5OiDCC75GBl">3,436,000</span> (<span id="xdx_909_ecustom--ConcentrationRiskThresholdPercentage_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--SingleCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z6CVZ5L4yrq1">12</span>%), in excess of 10% of the Company’s total sales. For the year ended December 31, 2021, the Company recorded sales to a single customer of $<span id="xdx_905_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__srt--MajorCustomersAxis__custom--SingleCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z6xYSlrG8w81">8,511,000</span> (<span id="xdx_90B_ecustom--ConcentrationRiskThresholdPercentage_pid_dp_uPure_c20210101__20211231__srt--MajorCustomersAxis__custom--SingleCustomerMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z4VLX4TOjib5">25</span>%) in excess of 10% of the Company’s total sales.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 31, 2022, and 2021, the Company recorded accounts receivable of approximately $<span id="xdx_90F_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SingleCustomerMember_zyR9C0y8qY0g" title="Accounts receivable">1,138,000</span> (<span id="xdx_900_ecustom--ConcentrationRiskThresholdPercentage_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SingleCustomerMember_z6UrhRDCtwF2">19</span>%) and $<span id="xdx_904_eus-gaap--AccountsReceivableNet_iI_pp0p0_c20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--SingleCustomerMember_z1jl8G0r5xD9" title="Accounts receivable">4,204,000</span> (<span id="xdx_905_ecustom--ConcentrationRiskThresholdPercentage_pid_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z6P56T2PBL5k">46</span>%), </span>respectively, to a single customer in excess of 10% of the Company’s total consolidated accounts receivable.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline">Vendor concentration risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the years ended December 31, 2022, and 2021, there were no individual vendor inventory purchases in excess of 10% of the Company’s consolidated inventory purchases, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 31, 2022, and 2021, the Company recorded one vendor balance of approximately $<span id="xdx_90D_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_pn4n6_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneVendorMember_zrJvNwXsjLE2" title="Accounts payable">0.27</span> million (<span id="xdx_90C_ecustom--ConcentrationRiskThresholdPercentage_pid_dp_uPure_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneVendorMember_zj8CHdnuZUAi">10</span>%) and $-<span id="xdx_903_eus-gaap--AccountsPayableCurrentAndNoncurrent_iI_pn4n6_c20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember__srt--MajorCustomersAxis__custom--OneVendorMember_zzOaEjSHXtOl" title="Accounts payable">0</span>-, respectively, in excess of 10% of the Company’s total consolidated accounts payable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 3436000 0.12 8511000 0.25 1138000 0.19 4204000 0.46 270000 0.10 0 <p id="xdx_801_eus-gaap--RevenueFromContractWithCustomerTextBlock_zKQAtN6eksVb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 19 – <span id="xdx_821_zjuS0aDoAP9c">REVENUE</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--DisaggregationOfRevenueTableTextBlock_zoldlceZ4be4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has one operating segment, and the decision-making group is the senior executive management team. The Company disaggregated revenue by primary geographical markets and revenue sources in the following tables:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zM0kZU3qHeJ6" style="display: none">SCHEDULE OF DISAGGREGATION OF REVENUE</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the years ended</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Primary geographical markets:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 68%; text-align: justify">North America</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_znwBjJZBuvCc" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Revenue, net">12,037,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_z6BzlDXap9de" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Revenue, net">18,050,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">South America</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__srt--StatementGeographicalAxis__srt--SouthAmericaMember_zr6rLU4eulq5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">182,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__srt--StatementGeographicalAxis__srt--SouthAmericaMember_zMBCDvKgYCu8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">361,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Europe</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zX6Dy0AhbBK6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">9,229,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zUXS38eZrLf7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">11,389,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Asia</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__srt--StatementGeographicalAxis__srt--AsiaMember_z4JACU2qZxC1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">1,851,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__srt--StatementGeographicalAxis__srt--AsiaMember_zYsrbvNYm9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">1,975,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Rest of World</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__srt--StatementGeographicalAxis__custom--RestOfWorldMember_z6yaWZW2JL1d" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">5,103,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__srt--StatementGeographicalAxis__custom--RestOfWorldMember_zqYXSTQdtIX3" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">2,107,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231_zbuSnS0PfGDf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">28,402,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231_zrS5Q7CVjEF1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">33,882,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Primary revenue source:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Equipment sales</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__custom--EquipmentSalesMember_zTwYjBROXKca" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">25,667,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__custom--EquipmentSalesMember_zxSBsKwPH4i2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">31,733,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Installation, integration, and repairs</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__custom--InstallationIntegrationAndRepairsMember_zTvez3A2Sdj1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">1,450,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__custom--InstallationIntegrationAndRepairsMember_zudRMt5dyRWa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">1,082,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Warranties</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__custom--WarrantiesMember_zV0p1sF3N8Ib" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">1,014,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__custom--WarrantiesMember_zcurXPwgVTu8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">743,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Other (See Note 20)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__custom--OtherMember_zuD7F7zCEWVk" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">271,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__custom--OtherMember_zSagYFM9rbBi" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">324,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3p0_c20220101__20221231_zkZzbLvt4gW1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">28,402,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3p0_c20210101__20211231_zEOA058HKLFf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">33,882,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Long-Lived Assets:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">United States</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--NoncurrentAssets_iI_pp0p0_c20221231__srt--StatementGeographicalAxis__country--US_zLW7FHeSUsl7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Long-Lived Assets">1,970,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--NoncurrentAssets_iI_pp0p0_c20211231__srt--StatementGeographicalAxis__country--US_zKeMKBHPJkfi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Long-Lived Assets">2,410,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Netherlands</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--NoncurrentAssets_iI_pp0p0_c20221231__srt--StatementGeographicalAxis__country--NL_zSpg5U3nLtYl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Long-Lived Assets">27,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--NoncurrentAssets_iI_pp0p0_c20211231__srt--StatementGeographicalAxis__country--NL_zaMDoozBDOE" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Long-Lived Assets"><span style="-sec-ix-hidden: xdx2ixbrl2586">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">United Kingdom</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--NoncurrentAssets_iI_pp0p0_c20221231__srt--StatementGeographicalAxis__country--GB_zwzo5pxHPPA1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Long-Lived Assets">4,912,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--NoncurrentAssets_iI_pp0p0_c20211231__srt--StatementGeographicalAxis__country--GB_z2CI4YduesZ3" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Long-Lived Assets">14,257,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_eus-gaap--NoncurrentAssets_iI_pp0p0_c20221231_zZCmAiZz4Qnb" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Long-Lived Assets">6,909,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_eus-gaap--NoncurrentAssets_iI_pp0p0_c20211231_zwEViWphroW7" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Long-Lived Assets">16,667,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A8_zDd6T7f9eS6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--DisaggregationOfRevenueTableTextBlock_zoldlceZ4be4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has one operating segment, and the decision-making group is the senior executive management team. The Company disaggregated revenue by primary geographical markets and revenue sources in the following tables:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zM0kZU3qHeJ6" style="display: none">SCHEDULE OF DISAGGREGATION OF REVENUE</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the years ended</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Primary geographical markets:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 68%; text-align: justify">North America</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_znwBjJZBuvCc" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Revenue, net">12,037,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_986_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__srt--StatementGeographicalAxis__srt--NorthAmericaMember_z6BzlDXap9de" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Revenue, net">18,050,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">South America</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__srt--StatementGeographicalAxis__srt--SouthAmericaMember_zr6rLU4eulq5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">182,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__srt--StatementGeographicalAxis__srt--SouthAmericaMember_zMBCDvKgYCu8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">361,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Europe</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__srt--StatementGeographicalAxis__srt--EuropeMember_zX6Dy0AhbBK6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">9,229,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__srt--StatementGeographicalAxis__srt--EuropeMember_zUXS38eZrLf7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">11,389,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Asia</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__srt--StatementGeographicalAxis__srt--AsiaMember_z4JACU2qZxC1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">1,851,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__srt--StatementGeographicalAxis__srt--AsiaMember_zYsrbvNYm9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">1,975,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Rest of World</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__srt--StatementGeographicalAxis__custom--RestOfWorldMember_z6yaWZW2JL1d" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">5,103,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__srt--StatementGeographicalAxis__custom--RestOfWorldMember_zqYXSTQdtIX3" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">2,107,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231_zbuSnS0PfGDf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">28,402,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231_zrS5Q7CVjEF1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">33,882,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Primary revenue source:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Equipment sales</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__custom--EquipmentSalesMember_zTwYjBROXKca" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">25,667,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__custom--EquipmentSalesMember_zxSBsKwPH4i2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">31,733,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Installation, integration, and repairs</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__custom--InstallationIntegrationAndRepairsMember_zTvez3A2Sdj1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">1,450,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__custom--InstallationIntegrationAndRepairsMember_zudRMt5dyRWa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">1,082,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Warranties</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__custom--WarrantiesMember_zV0p1sF3N8Ib" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">1,014,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__custom--WarrantiesMember_zcurXPwgVTu8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">743,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">Other (See Note 20)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20220101__20221231__us-gaap--IncomeStatementLocationAxis__custom--OtherMember_zuD7F7zCEWVk" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">271,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pp0p0_c20210101__20211231__us-gaap--IncomeStatementLocationAxis__custom--OtherMember_zSagYFM9rbBi" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">324,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3p0_c20220101__20221231_zkZzbLvt4gW1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">28,402,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_pn3p0_c20210101__20211231_zEOA058HKLFf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenue, net">33,882,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Long-Lived Assets:</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">United States</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--NoncurrentAssets_iI_pp0p0_c20221231__srt--StatementGeographicalAxis__country--US_zLW7FHeSUsl7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Long-Lived Assets">1,970,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--NoncurrentAssets_iI_pp0p0_c20211231__srt--StatementGeographicalAxis__country--US_zKeMKBHPJkfi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Long-Lived Assets">2,410,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify">Netherlands</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--NoncurrentAssets_iI_pp0p0_c20221231__srt--StatementGeographicalAxis__country--NL_zSpg5U3nLtYl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Long-Lived Assets">27,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--NoncurrentAssets_iI_pp0p0_c20211231__srt--StatementGeographicalAxis__country--NL_zaMDoozBDOE" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Long-Lived Assets"><span style="-sec-ix-hidden: xdx2ixbrl2586">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: justify; padding-bottom: 1.5pt">United Kingdom</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--NoncurrentAssets_iI_pp0p0_c20221231__srt--StatementGeographicalAxis__country--GB_zwzo5pxHPPA1" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Long-Lived Assets">4,912,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--NoncurrentAssets_iI_pp0p0_c20211231__srt--StatementGeographicalAxis__country--GB_z2CI4YduesZ3" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Long-Lived Assets">14,257,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_eus-gaap--NoncurrentAssets_iI_pp0p0_c20221231_zZCmAiZz4Qnb" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Long-Lived Assets">6,909,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_eus-gaap--NoncurrentAssets_iI_pp0p0_c20211231_zwEViWphroW7" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Long-Lived Assets">16,667,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 12037000 18050000 182000 361000 9229000 11389000 1851000 1975000 5103000 2107000 28402000 33882000 25667000 31733000 1450000 1082000 1014000 743000 271000 324000 28402000 33882000 1970000 2410000 27000 4912000 14257000 6909000 16667000 <p id="xdx_800_ecustom--RebatesTextBlock_z3Feg4kGjUo3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 20 — <span id="xdx_82B_zg1yP9cwJ9Hj">REBATES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amounts generated in Note 18 as part of the Primary revenue source “other” resulted from rebates issued to the Company’s filing appropriate governmental forms related to the research costs incurred by our U.K. subsidiary in prior fiscal years. The Company expects to continue filing applicable rebate forms for the 2022 fiscal year but can provide no assurances that such rebates will be available in future financial periods at similar levels or at all.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_80A_ecustom--GainOnSettlementOfDebtTextBlock_zpAo1rtqEtDl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 21 — <span id="xdx_82E_ziQlEC1Y2f7k">GAINS ON SETTLEMENT OF DEBT</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/> <p id="xdx_890_ecustom--GainOnSettlementOfDebtTableTextBlock_zvSJhV1ZfKPj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The following table represents the Company’s gains on settlement of debt for the years ending December 31, 2022 and 2021:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span id="xdx_8B9_z3mvgpMJyCM9" style="display: none">SCHEDULE OF GAINS ON SETTLEMENT OF DEBT</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td id="xdx_493_20220101__20221231_zzez81WG12Ye" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td id="xdx_496_20210101__20211231_zZKo9SWAIRa2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the Years Ended</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--GainsLossesOnExtinguishmentOfDebt_pp0p0_hsrt--TitleOfIndividualAxis__custom--VendorMember_zFUsxfuCJfLd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: justify">On March 10, 2021, the Company negotiated a vendor accounts payable balance of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_909_eus-gaap--AccountsPayableCurrent_iI_pp0p0_c20210310__srt--TitleOfIndividualAxis__custom--VendorMember_zC060X3iqUu5" title="Accounts payable">494,000</span> with a remittance settlement of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_905_ecustom--RemittanceSettlement_pp0p0_c20210310__20210310__srt--TitleOfIndividualAxis__custom--VendorMember_zUaHPKSx1TGi" title="Remittance settlement">300,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2602">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">194,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--GainsLossesOnExtinguishmentOfDebt_pp0p0_hus-gaap--TypeOfArrangementAxis__custom--PayrollProtectionProgramMember_zkMUoinUBLc1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">On July 26, 2021, the Payroll Protection Program (“PPP”) loan of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90A_eus-gaap--ExtinguishmentOfDebtGainLossNetOfTax_pp0p0_c20210726__20210726__us-gaap--TypeOfArrangementAxis__custom--PayrollProtectionProgramMember_zRUJoyUms8sh" title="Payroll protection program loan">1,168,000</span> received on April 10, 2020, was forgiven. Under ASC 405-20, the Company recorded the transaction as a gain on settlement of debt</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2609">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,168,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--GainsLossesOnExtinguishmentOfDebt_pp0p0_hus-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zUwMT5r27bkl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">On May 4, 2022, and July 19, 2022, the Company issued <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20220504__20220504__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zMfBtuMlW9Qj" title="Shares of common stock issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20220719__20220719__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zUoFXHnrTJtb" title="Shares of common stock issued">38,703</span></span> shares of common stock on each date with an accumulated value of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_pp0p0_c20220504__20220504__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zYgb9RPjqTh8" title="Common stock accumulated value"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_pp0p0_c20220719__20220719__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zxTqrr1cEpbc" title="Common stock accumulated value">54,184</span></span> in satisfaction of an amount payable of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90C_eus-gaap--AccountsPayableCurrent_iI_pp0p0_c20220719__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zzKwgjgXI0d" title="Amount payable"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_900_eus-gaap--AccountsPayableCurrent_iI_pp0p0_c20220504__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zusRiqMuNTIk" title="Amount payable">80,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">25,816</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2615">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--GainsLossesOnExtinguishmentOfDebt_pp0p0_hus-gaap--TypeOfArrangementAxis__custom--DividendsPayableMember_zA80Cso44l9a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt">On November 21, 2022, the Company settled the dividends payable in the amount of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90B_eus-gaap--DividendsPayableCurrentAndNoncurrent_iI_pp0p0_c20221121_zymhlRJQiw05" title="Dividends payable amount">19,916</span> by issuing <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20221121__20221121__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zsHUpyZnuMx1" title="Preferred stock shares issued">47,419</span> Series A Preferred shares with a zero carrying value</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">19,916</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2630">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--GainsLossesOnExtinguishmentOfDebt_pp0p0_zFRfOQTpNFod" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">GAINS ON SETTLEMENT OF DEBT</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">45,732</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,362,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_zEGc8oQGXqMc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_890_ecustom--GainOnSettlementOfDebtTableTextBlock_zvSJhV1ZfKPj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">The following table represents the Company’s gains on settlement of debt for the years ending December 31, 2022 and 2021:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span id="xdx_8B9_z3mvgpMJyCM9" style="display: none">SCHEDULE OF GAINS ON SETTLEMENT OF DEBT</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td id="xdx_493_20220101__20221231_zzez81WG12Ye" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td id="xdx_496_20210101__20211231_zZKo9SWAIRa2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the Years Ended</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--GainsLossesOnExtinguishmentOfDebt_pp0p0_hsrt--TitleOfIndividualAxis__custom--VendorMember_zFUsxfuCJfLd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: justify">On March 10, 2021, the Company negotiated a vendor accounts payable balance of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_909_eus-gaap--AccountsPayableCurrent_iI_pp0p0_c20210310__srt--TitleOfIndividualAxis__custom--VendorMember_zC060X3iqUu5" title="Accounts payable">494,000</span> with a remittance settlement of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_905_ecustom--RemittanceSettlement_pp0p0_c20210310__20210310__srt--TitleOfIndividualAxis__custom--VendorMember_zUaHPKSx1TGi" title="Remittance settlement">300,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2602">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">194,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--GainsLossesOnExtinguishmentOfDebt_pp0p0_hus-gaap--TypeOfArrangementAxis__custom--PayrollProtectionProgramMember_zkMUoinUBLc1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">On July 26, 2021, the Payroll Protection Program (“PPP”) loan of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90A_eus-gaap--ExtinguishmentOfDebtGainLossNetOfTax_pp0p0_c20210726__20210726__us-gaap--TypeOfArrangementAxis__custom--PayrollProtectionProgramMember_zRUJoyUms8sh" title="Payroll protection program loan">1,168,000</span> received on April 10, 2020, was forgiven. Under ASC 405-20, the Company recorded the transaction as a gain on settlement of debt</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2609">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,168,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--GainsLossesOnExtinguishmentOfDebt_pp0p0_hus-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementMember_zUwMT5r27bkl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">On May 4, 2022, and July 19, 2022, the Company issued <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20220504__20220504__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zMfBtuMlW9Qj" title="Shares of common stock issued"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_pid_c20220719__20220719__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zUoFXHnrTJtb" title="Shares of common stock issued">38,703</span></span> shares of common stock on each date with an accumulated value of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_pp0p0_c20220504__20220504__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zYgb9RPjqTh8" title="Common stock accumulated value"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_pp0p0_c20220719__20220719__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zxTqrr1cEpbc" title="Common stock accumulated value">54,184</span></span> in satisfaction of an amount payable of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90C_eus-gaap--AccountsPayableCurrent_iI_pp0p0_c20220719__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zzKwgjgXI0d" title="Amount payable"><span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_900_eus-gaap--AccountsPayableCurrent_iI_pp0p0_c20220504__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zusRiqMuNTIk" title="Amount payable">80,000</span></span></td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">25,816</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2615">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--GainsLossesOnExtinguishmentOfDebt_pp0p0_hus-gaap--TypeOfArrangementAxis__custom--DividendsPayableMember_zA80Cso44l9a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt">On November 21, 2022, the Company settled the dividends payable in the amount of $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90B_eus-gaap--DividendsPayableCurrentAndNoncurrent_iI_pp0p0_c20221121_zymhlRJQiw05" title="Dividends payable amount">19,916</span> by issuing <span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNDSEVEVUxFIE9GIEdBSU5TIE9OIFNFVFRMRU1FTlQgT0YgREVCVCAoRGV0YWlscykgKFBhcmVudGhldGljYWwpAA__" id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20221121__20221121__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zsHUpyZnuMx1" title="Preferred stock shares issued">47,419</span> Series A Preferred shares with a zero carrying value</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">19,916</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2630">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--GainsLossesOnExtinguishmentOfDebt_pp0p0_zFRfOQTpNFod" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">GAINS ON SETTLEMENT OF DEBT</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">45,732</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,362,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 494000 300000 194000 1168000 1168000 38703 38703 54184 54184 80000 80000 25816 19916 47419 19916 45732 1362000 <p id="xdx_80E_eus-gaap--IncomeTaxDisclosureTextBlock_zwvJccuja5tf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 22— <span id="xdx_827_zrqJeJkoIEJd">INCOME TAXES</span> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zJjROsm0qpg2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The provision (benefit) for income taxes consists of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B3_z2LMJlMPncX9" style="display: none">SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20220101__20221231_zXpYNg0gz4Hg" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20210101__20211231_zQ3tRoFWA1Db" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the Years Ended</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40D_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_iB_zFzUav2MTgql" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Current tax provision</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--CurrentFederalTaxExpenseBenefit_pp0p0_maCITEBzz2Y_z3oPhDrMiiii" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Federal</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2646">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2647">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_pp0p0_maCITEBzz2Y_zep2H94Oo2D3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 68%">State</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">7,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_pp0p0_mtCITEBzz2Y_maITEBzKpW_zKTf2t5aQMHk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Current income tax expense, total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">7,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_iB_pp0p0_zxlYkwNapyml" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Deferred tax provision (benefit)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_pp0p0_maDITEBzvPA_z8f78xMUuWq3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Federal</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(532,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(503,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_pp0p0_maDITEBzvPA_zTDDK82Ql1b8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">State</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(427,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,025,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_pp0p0_maDITEBzvPA_zlVE1zWlA2Ce" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Foreign</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(978,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(2,052,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_iN_pp0p0_di_msDITEBzvPA_zrDUHds70Y7c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Change in the valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,722,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,530,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredIncomeTaxExpenseBenefit_iT_pp0p0_maITEBzKpW_mtDITEBzvPA_zxfs5RTXLkuf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Total deferred tax provision (benefit)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(215,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2671">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzKpW_zdJ3qjAMf1Qf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Income tax provision</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(190,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">7,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AE_zYP5eRQKmMHb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zeIX62mcGjMf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A reconciliation of the statutory tax rate to the effective tax rate is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_8BB_zXeer0cVPUli" style="display: none">SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20220101__20221231_zwrgKr72mcS" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20210101__20211231_zExl3ahJ9SUd" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the Years Ended</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_404_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_z3T4OxD2CDZ7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Statutory federal income tax rate</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">21.00</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">21.00</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr> <tr id="xdx_409_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_zcpj9Jkm68a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">State and local taxes, net of federal benefit</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.30</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(6.27</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_iN_pid_dpi_uPure_zSFPAuneAIq4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Permanent differences</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5.28</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(9.12</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_400_ecustom--EffectiveIncomeTaxRateReconciliationExecutiveCompensationTaxBenefitPercent_pid_dp_uPure_zfg5tYAeqnml" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Executive compensation</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(2.26</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2688">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_pid_dp_uPure_z1cmZVdp5dEa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Equity compensation</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(11.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2691">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_405_ecustom--EffectiveIncomeTaxRateReconciliationProvisionToReturn_pid_dp_uPure_zsPQlffHUBxl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Provision to return</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(0.03</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_404_ecustom--EffectiveIncomeTaxRateReconciliationTaxContingenciesDtaAdjustmentForStateNol_pid_dp_uPure_zYivibsl3cO" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">DTA adjustment for state NOL</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_iN_pid_dpi_uPure_zI0ArOxlGqV8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Foreign Rate Differential</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(1.27</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(1.96</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_pid_dp_uPure_z5GBny41suY4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Change rate</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2.66</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(5.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_zXMWpjUPmrC1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(13.27</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1.46</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_zXw4QDdP61xh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Effective tax rate</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1.37</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.04</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)%</td></tr> </table> <p id="xdx_8A4_zY3CPv3UqCs6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the provisions of ASC 740, the Company may recognize the benefits of uncertain tax positions when it is more likely than not that the merits of the position(s) will be sustained upon audit by the relevant tax authorities. No uncertain tax positions were taken or expected on a tax return that would be determined to be an unrecognized tax benefit recorded on the Company’s financial statements for the years ended December 31, 2022, or 2021. The Company does not expect its unrecognized tax benefit position to change during the next twelve months</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 22 — INCOME TAXES (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred income taxes reflect the tax effects of temporary differences between the carrying amounts of assets and liabilities for financial accounting purposes and the amounts used for income tax reporting. Significant components of the Company’s deferred tax assets are as follows:</span></p> <p id="xdx_895_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zI5gKEaUn8tc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B1_z97sKoYR07Yl" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" id="xdx_49C_20221231_z8qxvr3dI842" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" id="xdx_49D_20211231_zrJXnjmH6e72" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the Years Ended</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Deferred Tax Assets</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_iI_pp0p0_maDTAGz8gr_z3ZyZruHmXnc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 68%; text-align: left">Federal R&amp;D credit</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">3,007,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">3,007,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsInventory_iI_pp0p0_maDTAGz8gr_zFrraz2BQsMk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Inventory</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">576,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">457,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_iI_pp0p0_maDTAGz8gr_zXUlJkxeBK32" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Allowance for bad debt</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">72,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">76,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_iI_pp0p0_maDTAGz8gr_zdiwK1losLPl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Compensation related</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">298,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions_iI_pp0p0_maDTAGz8gr_zsaP9J2Mzk96" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Pension</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">72,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">39,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_iI_pp0p0_maDTAGz8gr_z3dv40Lgw1da" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Other accruals</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">16,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_iI_pp0p0_maDTAGz8gr_zIJhzyrdvGdj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">State net operating losses</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4,779,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4,644,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iI_pp0p0_maDTAGz8gr_zzTVU0t5C9pi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Federal net operating losses</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">44,821,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">43,045,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DeferredTaxAssetInterestCarryforward_iI_pp0p0_maDTAGz8gr_zSUMG2s20Tfg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Interest disallowance</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,151,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">82,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_pp0p0_maDTAGz8gr_zEMts5FNEnVi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Stock options</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7,172,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7,621,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0_maDTAGz8gr_zS3Fy4TGwnQi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Other</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">296,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,097,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTAGz8gr_zwAiiRQOkgK5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Valuation Allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(61,731,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(60,048,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGz8gr_zOxKAFQNakwf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total Deferred Tax Assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">229,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">334,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Deferred Tax Liabilities</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_iNI_pp0p0_di_maDTLzIya_zJDpmTBQj7y6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Property and Equipment</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(90,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(47,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_iNI_pp0p0_di_maDTLzIya_zQHuDwSjcRNc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Intangibles</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(870,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,230,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxLiabilitiesPrepaidExpenses_iNI_pp0p0_di_maDTLzIya_zM40BmKw8Ro5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Prepaid Expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(33,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(35,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--DeferredIncomeTaxLiabilities_iNTI_pp0p0_di_mtDTLzIya_zXeRLjXYVQyg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Total Deferred Tax Liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(993,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,312,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--DeferredTaxLiabilities_iNI_pp0p0_di_zyCmvROOtCT2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net Deferred Tax Liability</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(764,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(978,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p id="xdx_8A7_zoTHtLXHLNsk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2022, the Company has federal net operating losses (“NOL”) of approximately $<span id="xdx_902_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20211231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember_zZ3FkVdvZAnb" title="Operating loss carryforwards">183.0</span> million that will expire beginning in 2027. The Company has federal NOLs of approximately $<span id="xdx_90E_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20201231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--DomesticCountryMember__us-gaap--TypeOfArrangementAxis__custom--CarriedForwardIndefinitelyMember_zoe2YhCgd1nf" title="Operating loss carryforwards">26.3</span> million that may be carried forward indefinitely. The Company also has state NOL carryforwards of $<span id="xdx_908_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20201231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--StateAndLocalJurisdictionMember_zL1yZ0mIZaK1" title="Operating loss carryforwards">158.6</span> million, which will expire beginning in 2027. Besides, the Company has foreign NOL carryforwards of approximately $<span id="xdx_902_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20201231__us-gaap--IncomeTaxAuthorityAxis__us-gaap--ForeignCountryMember_zJ0NdboN7199" title="Operating loss carryforwards">26.1</span> million that generally do not expire except under certain circumstances. The Company also has research and development credits of approximately $<span id="xdx_907_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwardsResearch_iI_pn6n6_c20201231_z1uOnmL0kbn3" title="Deferred tax assets, tax credit carryforwards, research">3.0</span> million, which will begin to <span id="xdx_909_ecustom--OperatingLossCarryforwardsExpirationDescription_c20220101__20221231" title="Operating loss carryforwards, expiration description">expire in 2027</span>. The years that remain open for review by taxing authorities are 2019 to 2022 for Federal, Foreign, and State Income Tax returns.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Realizing the NOL carryforwards and other temporary deferred tax differences is contingent on future taxable earnings. The Company’s deferred tax assets were reviewed for expected utilization using a “more likely than not” approach by assessing the available positive and negative evidence surrounding its recoverability. Accordingly, a valuation allowance has been recorded against the Company’s deferred tax assets, as it was determined, based on past and present losses, that it was “more likely than not” that the Company’s deferred tax assets would not be realized. The valuation allowance was increased to the full carrying amount of the Company’s deferred tax assets. In future years, if the deferred tax assets are determined by management to be “more likely than not” to be realized, the recognized tax benefits relating to the reversal of the valuation allowance will be recorded. The Company will continue to assess and evaluate strategies that enable the deferred tax asset, or portion thereof, to be utilized. It will reduce the valuation allowance appropriately when it is determined that the “more likely than not” criteria are satisfied.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The net operating loss carryovers may be subject to annual limitations under Internal Revenue Code Section 382 and similar state provisions should there be a greater than 50% ownership change as determined under the applicable income tax regulations. The limitation amount would be determined based on the company’s value immediately before the ownership change, and subsequent ownership changes could further impact the annual limitation amount. An ownership change under Section 382 may have occurred in the past or could happen in the future, such that the NOLs available for utilization could be significantly limited. The Company plans to perform a Section 382 analysis in the future.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 22 — INCOME TAXES (continued)</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective for tax years beginning after December 31, 2017, <span id="xdx_905_ecustom--EffectiveForTaxYearsDescription_c20220101__20221231_zf50Cbscdf34" title="Effective for tax years, description">the Tax Act includes a participation exemption system of taxation, which generally provides for 100% dividends received deduction on certain qualifying dividend distributions received by U.S. C-corporation shareholders from their 10% or more owned foreign subsidiaries. As a result of this new participation exemption system, it is generally anticipated that the Company should not be subject to additional U.S. federal income taxation on its future receipt of actual dividend income (instead of deemed inclusion amounts under specific anti-deferral rules) from its foreign subsidiary.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For tax years beginning after December 31, 2017, the Tax Act introduced a new limitation on the deduction of interest expense whereby current-year interest deductions are limited (among other restrictions) to 30% of adjusted taxable income, with various modifications and exceptions. The Company does incur interest expenses and evaluates each year the impact, if any, of the new limitation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has not provided for deferred taxes and foreign withholding taxes on the excess of the financial reporting basis over the tax basis in our investments in foreign subsidiaries that are nearly permanent in duration. In general, it is the Company’s practice and intention to reinvest our foreign subsidiary’s earnings in those operations. Generally, our foreign subsidiary’s earnings have become subject to U.S. taxation based on specific U.S. tax law provisions, such as the recently enacted territorial transition tax under section 965 and under certain other circumstances. Due to the complexities of the provisions introduced with the Tax Act, and the underlying assumptions that would have to be made, it is not practicable to estimate the amount of tax provision required to account for these foreign undistributed earnings. The Company will account for any additional expense or deduction in the year it is claimed. The Company will continue to review each year whether this treatment is appropriate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company did not identify any material uncertain tax positions and is not under any income tax examinations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>VISLINK TECHNOLOGIES, INC. AND SUBSIDIARIES</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zJjROsm0qpg2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The provision (benefit) for income taxes consists of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B3_z2LMJlMPncX9" style="display: none">SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT)</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49F_20220101__20221231_zXpYNg0gz4Hg" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49E_20210101__20211231_zQ3tRoFWA1Db" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the Years Ended</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40D_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefitAbstract_iB_zFzUav2MTgql" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Current tax provision</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--CurrentFederalTaxExpenseBenefit_pp0p0_maCITEBzz2Y_z3oPhDrMiiii" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Federal</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2646">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2647">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_pp0p0_maCITEBzz2Y_zep2H94Oo2D3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 68%">State</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">7,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--CurrentIncomeTaxExpenseBenefit_iT_pp0p0_mtCITEBzz2Y_maITEBzKpW_zKTf2t5aQMHk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Current income tax expense, total</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">25,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">7,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefitAbstract_iB_pp0p0_zxlYkwNapyml" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Deferred tax provision (benefit)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_pp0p0_maDITEBzvPA_z8f78xMUuWq3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Federal</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(532,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(503,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_pp0p0_maDITEBzvPA_zTDDK82Ql1b8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">State</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(427,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,025,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredForeignIncomeTaxExpenseBenefit_pp0p0_maDITEBzvPA_zlVE1zWlA2Ce" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Foreign</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(978,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(2,052,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_iN_pp0p0_di_msDITEBzvPA_zrDUHds70Y7c" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Change in the valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,722,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1,530,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredIncomeTaxExpenseBenefit_iT_pp0p0_maITEBzKpW_mtDITEBzvPA_zxfs5RTXLkuf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left">Total deferred tax provision (benefit)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(215,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2671">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--IncomeTaxExpenseBenefit_iT_pp0p0_mtITEBzKpW_zdJ3qjAMf1Qf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Income tax provision</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(190,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">7,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 25000 7000 25000 7000 -532000 -503000 -427000 1025000 -978000 -2052000 -1722000 -1530000 -215000 -190000 7000 <p id="xdx_89C_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zeIX62mcGjMf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A reconciliation of the statutory tax rate to the effective tax rate is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span id="xdx_8BB_zXeer0cVPUli" style="display: none">SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20220101__20221231_zwrgKr72mcS" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20210101__20211231_zExl3ahJ9SUd" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the Years Ended</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_404_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_z3T4OxD2CDZ7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Statutory federal income tax rate</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">21.00</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">21.00</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr> <tr id="xdx_409_eus-gaap--EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_pid_dp_uPure_zcpj9Jkm68a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">State and local taxes, net of federal benefit</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.30</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(6.27</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_40D_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_iN_pid_dpi_uPure_zSFPAuneAIq4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Permanent differences</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5.28</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(9.12</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_400_ecustom--EffectiveIncomeTaxRateReconciliationExecutiveCompensationTaxBenefitPercent_pid_dp_uPure_zfg5tYAeqnml" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Executive compensation</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(2.26</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2688">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent_pid_dp_uPure_z1cmZVdp5dEa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Equity compensation</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(11.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2691">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_405_ecustom--EffectiveIncomeTaxRateReconciliationProvisionToReturn_pid_dp_uPure_zsPQlffHUBxl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Provision to return</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(0.03</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_404_ecustom--EffectiveIncomeTaxRateReconciliationTaxContingenciesDtaAdjustmentForStateNol_pid_dp_uPure_zYivibsl3cO" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">DTA adjustment for state NOL</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(0.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings_iN_pid_dpi_uPure_zI0ArOxlGqV8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Foreign Rate Differential</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(1.27</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(1.96</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate_pid_dp_uPure_z5GBny41suY4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Change rate</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2.66</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(5.06</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_401_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_pid_dp_uPure_zXMWpjUPmrC1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(13.27</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">1.46</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_pid_dp_uPure_zXw4QDdP61xh" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Effective tax rate</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1.37</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.04</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)%</td></tr> </table> 0.2100 0.2100 0.0030 -0.0627 -0.0528 0.0912 -0.0226 -0.1106 0.0000 -0.0003 0.0000 -0.0006 0.0127 0.0196 0.0266 -0.0506 -0.1327 0.0146 0.0137 -0.0004 <p id="xdx_895_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zI5gKEaUn8tc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8B1_z97sKoYR07Yl" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" id="xdx_49C_20221231_z8qxvr3dI842" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" id="xdx_49D_20211231_zrJXnjmH6e72" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="6" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">For the Years Ended</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2022</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Deferred Tax Assets</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsTaxCreditCarryforwards_iI_pp0p0_maDTAGz8gr_z3ZyZruHmXnc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 68%; text-align: left">Federal R&amp;D credit</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">3,007,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">3,007,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsInventory_iI_pp0p0_maDTAGz8gr_zFrraz2BQsMk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Inventory</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">576,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">457,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_iI_pp0p0_maDTAGz8gr_zXUlJkxeBK32" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Allowance for bad debt</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">72,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">76,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_iI_pp0p0_maDTAGz8gr_zdiwK1losLPl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Compensation related</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">298,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions_iI_pp0p0_maDTAGz8gr_zsaP9J2Mzk96" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Pension</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">72,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">39,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_iI_pp0p0_maDTAGz8gr_z3dv40Lgw1da" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Other accruals</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">16,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_iI_pp0p0_maDTAGz8gr_zIJhzyrdvGdj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">State net operating losses</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4,779,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">4,644,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iI_pp0p0_maDTAGz8gr_zzTVU0t5C9pi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Federal net operating losses</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">44,821,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">43,045,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DeferredTaxAssetInterestCarryforward_iI_pp0p0_maDTAGz8gr_zSUMG2s20Tfg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Interest disallowance</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,151,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">82,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_pp0p0_maDTAGz8gr_zEMts5FNEnVi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Stock options</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7,172,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">7,621,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--DeferredTaxAssetsOther_iI_pp0p0_maDTAGz8gr_zS3Fy4TGwnQi" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Other</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">296,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,097,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTAGz8gr_zwAiiRQOkgK5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Valuation Allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(61,731,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(60,048,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGz8gr_zOxKAFQNakwf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total Deferred Tax Assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">229,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">334,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Deferred Tax Liabilities</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--DeferredTaxLiabilitiesPropertyPlantAndEquipment_iNI_pp0p0_di_maDTLzIya_zJDpmTBQj7y6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Property and Equipment</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(90,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(47,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_iNI_pp0p0_di_maDTLzIya_zQHuDwSjcRNc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Intangibles</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(870,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(1,230,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--DeferredTaxLiabilitiesPrepaidExpenses_iNI_pp0p0_di_maDTLzIya_zM40BmKw8Ro5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Prepaid Expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(33,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(35,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40A_eus-gaap--DeferredIncomeTaxLiabilities_iNTI_pp0p0_di_mtDTLzIya_zXeRLjXYVQyg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Total Deferred Tax Liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(993,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(1,312,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--DeferredTaxLiabilities_iNI_pp0p0_di_zyCmvROOtCT2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net Deferred Tax Liability</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(764,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">(978,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> 3007000 3007000 576000 457000 72000 76000 7000 298000 72000 39000 7000 16000 4779000 4644000 44821000 43045000 1151000 82000 7172000 7621000 296000 1097000 61731000 60048000 229000 334000 90000 47000 870000 1230000 33000 35000 993000 1312000 764000 978000 183000000.0 26300000 158600000 26100000 3000000.0 expire in 2027 the Tax Act includes a participation exemption system of taxation, which generally provides for 100% dividends received deduction on certain qualifying dividend distributions received by U.S. C-corporation shareholders from their 10% or more owned foreign subsidiaries. As a result of this new participation exemption system, it is generally anticipated that the Company should not be subject to additional U.S. federal income taxation on its future receipt of actual dividend income (instead of deemed inclusion amounts under specific anti-deferral rules) from its foreign subsidiary. <p id="xdx_80F_eus-gaap--SubsequentEventsTextBlock_zH9FumkywxB5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 23 — <span id="xdx_826_zkhgo4bS7HHe">SUBSEQUENT EVENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under ASC 855-10, the Company has analyzed its operations subsequent to December 31, 2022, and has determined that it does not have any other material subsequent events to disclose in these financial statements except for the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 27, 2023, the Company announced that it is entering into an agreed separation with Michael Bond, the Chief Financial Officer (“CFO”), to be effective on or about March 31, 2023. Effective at the close of business on March 31, 2023, Paul Norridge will become the Company’s new CFO.</span></p> Shares will vest upon the Company’s attainment, on or before the fifth (5th) anniversary of the Vesting Commencement Date, of Cumulative EBITDA of more than $6,000,000 accumulated over four consecutive fiscal quarters. Shares will vest upon the Company’s attainment, on or before the fifth (5th) anniversary of the Vesting Commencement Date, of Cumulative EBITDA of more than $15,000,000 accumulated over four consecutive fiscal quarters. Shares will vest upon the Company’s attainment, on or before the fifth (5th) anniversary of the Vesting Commencement Date, of Cumulative EBITDA of more than $23,000,000 accumulated over four consecutive fiscal quarters. RSUs will vest upon the Company’s attainment, on or before December 31, 2026, of revenue of more than $35,575,000 accumulated over four consecutive fiscal quarters. RSUs will vest upon the Company’s attainment, on or before December 31, 2026, of revenue of more than $37,353,000 accumulated over four consecutive fiscal quarters. RSUs will vest upon the Company’s attainment, on or before December 31, 2026, of revenue of more than $39,220,000 accumulated over four consecutive fiscal quarters. EXCEL 122 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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ŧ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end XML 123 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 124 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 125 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 415 506 1 true 125 0 false 8 false false R1.htm 00000001 - Document - Cover Sheet http://vislink.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://vislink.com/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://vislink.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss Sheet http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss Consolidated Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity Sheet http://vislink.com/role/StatementsOfChangesInStockholdersEquity Consolidated Statements of Changes in Stockholders' Equity Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Cash Flows Sheet http://vislink.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 00000007 - Disclosure - NATURE OF OPERATIONS Sheet http://vislink.com/role/NatureOfOperations NATURE OF OPERATIONS Notes 7 false false R8.htm 00000008 - Disclosure - LIQUIDITY AND FINANCIAL CONDITION Sheet http://vislink.com/role/LiquidityAndFinancialCondition LIQUIDITY AND FINANCIAL CONDITION Notes 8 false false R9.htm 00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://vislink.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 9 false false R10.htm 00000010 - Disclosure - ACQUISITION OF MOBILE VIEWPOINT CORPORATE B.V. Sheet http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v. ACQUISITION OF MOBILE VIEWPOINT CORPORATE B.V. Notes 10 false false R11.htm 00000011 - Disclosure - ACCOUNTS RECEIVABLE Sheet http://vislink.com/role/AccountsReceivable ACCOUNTS RECEIVABLE Notes 11 false false R12.htm 00000012 - Disclosure - INVENTORIES Sheet http://vislink.com/role/Inventories INVENTORIES Notes 12 false false R13.htm 00000013 - Disclosure - PROPERTY AND EQUIPMENT Sheet http://vislink.com/role/PropertyAndEquipment PROPERTY AND EQUIPMENT Notes 13 false false R14.htm 00000014 - Disclosure - GOODWILL Sheet http://vislink.com/role/Goodwill GOODWILL Notes 14 false false R15.htm 00000015 - Disclosure - INTANGIBLE ASSETS Sheet http://vislink.com/role/IntangibleAssets INTANGIBLE ASSETS Notes 15 false false R16.htm 00000016 - Disclosure - ACCRUED EXPENSES Sheet http://vislink.com/role/AccruedExpenses ACCRUED EXPENSES Notes 16 false false R17.htm 00000017 - Disclosure - NOTES PAYABLE Notes http://vislink.com/role/NotesPayable NOTES PAYABLE Notes 17 false false R18.htm 00000018 - Disclosure - LEASES Sheet http://vislink.com/role/Leases LEASES Notes 18 false false R19.htm 00000019 - Disclosure - DERIVATIVE LIABILITIES Sheet http://vislink.com/role/DerivativeLiabilities DERIVATIVE LIABILITIES Notes 19 false false R20.htm 00000020 - Disclosure - PREFERRED SHARES Sheet http://vislink.com/role/PreferredShares PREFERRED SHARES Notes 20 false false R21.htm 00000021 - Disclosure - STOCKHOLDERS??? EQUITY Sheet http://vislink.com/role/StockholdersEquity STOCKHOLDERS??? EQUITY Notes 21 false false R22.htm 00000022 - Disclosure - STOCK-BASED COMPENSATION Sheet http://vislink.com/role/Stock-basedCompensation STOCK-BASED COMPENSATION Notes 22 false false R23.htm 00000023 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://vislink.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 23 false false R24.htm 00000024 - Disclosure - CONCENTRATIONS Sheet http://vislink.com/role/Concentrations CONCENTRATIONS Notes 24 false false R25.htm 00000025 - Disclosure - REVENUE Sheet http://vislink.com/role/Revenue REVENUE Notes 25 false false R26.htm 00000026 - Disclosure - REBATES Sheet http://vislink.com/role/Rebates REBATES Notes 26 false false R27.htm 00000027 - Disclosure - GAINS ON SETTLEMENT OF DEBT Sheet http://vislink.com/role/GainsOnSettlementOfDebt GAINS ON SETTLEMENT OF DEBT Notes 27 false false R28.htm 00000028 - Disclosure - INCOME TAXES Sheet http://vislink.com/role/IncomeTaxes INCOME TAXES Notes 28 false false R29.htm 00000029 - Disclosure - SUBSEQUENT EVENTS Sheet http://vislink.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 29 false false R30.htm 00000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 30 false false R31.htm 00000031 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://vislink.com/role/SummaryOfSignificantAccountingPoliciesTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://vislink.com/role/SummaryOfSignificantAccountingPolicies 31 false false R32.htm 00000032 - Disclosure - ACQUISITION OF MOBILE VIEWPOINT CORPORATE B.V. (Tables) Sheet http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.Tables ACQUISITION OF MOBILE VIEWPOINT CORPORATE B.V. (Tables) Tables http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v. 32 false false R33.htm 00000033 - Disclosure - ACCOUNTS RECEIVABLE (Tables) Sheet http://vislink.com/role/AccountsReceivableTables ACCOUNTS RECEIVABLE (Tables) Tables http://vislink.com/role/AccountsReceivable 33 false false R34.htm 00000034 - Disclosure - INVENTORIES (Tables) Sheet http://vislink.com/role/InventoriesTables INVENTORIES (Tables) Tables http://vislink.com/role/Inventories 34 false false R35.htm 00000035 - Disclosure - PROPERTY AND EQUIPMENT (Tables) Sheet http://vislink.com/role/PropertyAndEquipmentTables PROPERTY AND EQUIPMENT (Tables) Tables http://vislink.com/role/PropertyAndEquipment 35 false false R36.htm 00000036 - Disclosure - GOODWILL (Tables) Sheet http://vislink.com/role/GoodwillTables GOODWILL (Tables) Tables http://vislink.com/role/Goodwill 36 false false R37.htm 00000037 - Disclosure - INTANGIBLE ASSETS (Tables) Sheet http://vislink.com/role/IntangibleAssetsTables INTANGIBLE ASSETS (Tables) Tables http://vislink.com/role/IntangibleAssets 37 false false R38.htm 00000038 - Disclosure - ACCRUED EXPENSES (Tables) Sheet http://vislink.com/role/AccruedExpensesTables ACCRUED EXPENSES (Tables) Tables http://vislink.com/role/AccruedExpenses 38 false false R39.htm 00000039 - Disclosure - NOTES PAYABLE (Tables) Notes http://vislink.com/role/NotesPayableTables NOTES PAYABLE (Tables) Tables http://vislink.com/role/NotesPayable 39 false false R40.htm 00000040 - Disclosure - LEASES (Tables) Sheet http://vislink.com/role/LeasesTables LEASES (Tables) Tables http://vislink.com/role/Leases 40 false false R41.htm 00000041 - Disclosure - DERIVATIVE LIABILITIES (Tables) Sheet http://vislink.com/role/DerivativeLiabilitiesTables DERIVATIVE LIABILITIES (Tables) Tables http://vislink.com/role/DerivativeLiabilities 41 false false R42.htm 00000042 - Disclosure - STOCKHOLDERS??? EQUITY (Tables) Sheet http://vislink.com/role/StockholdersEquityTables STOCKHOLDERS??? EQUITY (Tables) Tables http://vislink.com/role/StockholdersEquity 42 false false R43.htm 00000043 - Disclosure - STOCK-BASED COMPENSATION (Tables) Sheet http://vislink.com/role/Stock-basedCompensationTables STOCK-BASED COMPENSATION (Tables) Tables http://vislink.com/role/Stock-basedCompensation 43 false false R44.htm 00000044 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables) Sheet http://vislink.com/role/CommitmentsAndContingenciesTables COMMITMENTS AND CONTINGENCIES (Tables) Tables http://vislink.com/role/CommitmentsAndContingencies 44 false false R45.htm 00000045 - Disclosure - REVENUE (Tables) Sheet http://vislink.com/role/RevenueTables REVENUE (Tables) Tables http://vislink.com/role/Revenue 45 false false R46.htm 00000046 - Disclosure - GAINS ON SETTLEMENT OF DEBT (Tables) Sheet http://vislink.com/role/GainsOnSettlementOfDebtTables GAINS ON SETTLEMENT OF DEBT (Tables) Tables http://vislink.com/role/GainsOnSettlementOfDebt 46 false false R47.htm 00000047 - Disclosure - INCOME TAXES (Tables) Sheet http://vislink.com/role/IncomeTaxesTables INCOME TAXES (Tables) Tables http://vislink.com/role/IncomeTaxes 47 false false R48.htm 00000048 - Disclosure - LIQUIDITY AND FINANCIAL CONDITION (Details Narrative) Sheet http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative LIQUIDITY AND FINANCIAL CONDITION (Details Narrative) Details http://vislink.com/role/LiquidityAndFinancialCondition 48 false false R49.htm 00000049 - Disclosure - SCHEDULE OF PRODUCT WARRANTY LIABILITY (Details) Sheet http://vislink.com/role/ScheduleOfProductWarrantyLiabilityDetails SCHEDULE OF PRODUCT WARRANTY LIABILITY (Details) Details 49 false false R50.htm 00000050 - Disclosure - SCHEDULE OF ANTI-DILIUTIVE POTENTIAL COMMON STOCK EQUIVALENTS EXCLUDE FROM THE CALCULATION OF LOSS PER SHARE (Details) Sheet http://vislink.com/role/ScheduleOfAnti-diliutivePotentialCommonStockEquivalentsExcludeFromCalculationOfLossPerShareDetails SCHEDULE OF ANTI-DILIUTIVE POTENTIAL COMMON STOCK EQUIVALENTS EXCLUDE FROM THE CALCULATION OF LOSS PER SHARE (Details) Details 50 false false R51.htm 00000051 - Disclosure - SCHEDULE OF FOREIGN EXCHANGE AND CHANGE IN ACCUMULATED COMPREHENSIVE INCOME (Details) Sheet http://vislink.com/role/ScheduleOfForeignExchangeAndChangeInAccumulatedComprehensiveIncomeDetails SCHEDULE OF FOREIGN EXCHANGE AND CHANGE IN ACCUMULATED COMPREHENSIVE INCOME (Details) Details 51 false false R52.htm 00000052 - Disclosure - SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON NON-RECURRING BASIS (Details) Sheet http://vislink.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnNon-recurringBasisDetails SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON NON-RECURRING BASIS (Details) Details 52 false false R53.htm 00000053 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://vislink.com/role/SummaryOfSignificantAccountingPoliciesTables 53 false false R54.htm 00000054 - Disclosure - SCHEDULE OF IDENTIFIABLE ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) Sheet http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails SCHEDULE OF IDENTIFIABLE ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details) Details 54 false false R55.htm 00000055 - Disclosure - SCHEDULE OF ACQUIRED INTANGIBLE WITH THEIR RELATIVE USEFUL LIVES (Details) Sheet http://vislink.com/role/ScheduleOfAcquiredIntangibleWithTheirRelativeUsefulLivesDetails SCHEDULE OF ACQUIRED INTANGIBLE WITH THEIR RELATIVE USEFUL LIVES (Details) Details 55 false false R56.htm 00000056 - Disclosure - SCHEDULE OF UNAUDITED PRO-FORMA COMBINED RESULTS OF OPERATIONS (Details) Sheet http://vislink.com/role/ScheduleOfUnauditedPro-formaCombinedResultsOfOperationsDetails SCHEDULE OF UNAUDITED PRO-FORMA COMBINED RESULTS OF OPERATIONS (Details) Details 56 false false R57.htm 00000057 - Disclosure - ACQUISITION OF MOBILE VIEWPOINT CORPORATE B.V. (Details Narrative) Sheet http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.DetailsNarrative ACQUISITION OF MOBILE VIEWPOINT CORPORATE B.V. (Details Narrative) Details http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.Tables 57 false false R58.htm 00000058 - Disclosure - SCHEDULE OF ACCOUNTS RECEIVABLE (Details) Sheet http://vislink.com/role/ScheduleOfAccountsReceivableDetails SCHEDULE OF ACCOUNTS RECEIVABLE (Details) Details 58 false false R59.htm 00000059 - Disclosure - ACCOUNTS RECEIVABLE (Details Narrative) Sheet http://vislink.com/role/AccountsReceivableDetailsNarrative ACCOUNTS RECEIVABLE (Details Narrative) Details http://vislink.com/role/AccountsReceivableTables 59 false false R60.htm 00000060 - Disclosure - SCHEDULE OF INVENTORIES (Details) Sheet http://vislink.com/role/ScheduleOfInventoriesDetails SCHEDULE OF INVENTORIES (Details) Details 60 false false R61.htm 00000061 - Disclosure - INVENTORIES (Details Narrative) Sheet http://vislink.com/role/InventoriesDetailsNarrative INVENTORIES (Details Narrative) Details http://vislink.com/role/InventoriesTables 61 false false R62.htm 00000062 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details) Sheet http://vislink.com/role/ScheduleOfPropertyAndEquipmentDetails SCHEDULE OF PROPERTY AND EQUIPMENT (Details) Details 62 false false R63.htm 00000063 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative) Sheet http://vislink.com/role/PropertyAndEquipmentDetailsNarrative PROPERTY AND EQUIPMENT (Details Narrative) Details http://vislink.com/role/PropertyAndEquipmentTables 63 false false R64.htm 00000064 - Disclosure - SCHEDULE OF GOODWILL (Details) Sheet http://vislink.com/role/ScheduleOfGoodwillDetails SCHEDULE OF GOODWILL (Details) Details 64 false false R65.htm 00000065 - Disclosure - GOODWILL (Details Narrative) Sheet http://vislink.com/role/GoodwillDetailsNarrative GOODWILL (Details Narrative) Details http://vislink.com/role/GoodwillTables 65 false false R66.htm 00000066 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS (Details) Sheet http://vislink.com/role/ScheduleOfIntangibleAssetsDetails SCHEDULE OF INTANGIBLE ASSETS (Details) Details 66 false false R67.htm 00000067 - Disclosure - SCHEDULE OF CAPITALIZED INTANGIBLE COSTS (Details) Sheet http://vislink.com/role/ScheduleOfCapitalizedIntangibleCostsDetails SCHEDULE OF CAPITALIZED INTANGIBLE COSTS (Details) Details 67 false false R68.htm 00000068 - Disclosure - SCHEDULE OF AMORTIZATION OF INTANGIBLE ASSETS (Details) Sheet http://vislink.com/role/ScheduleOfAmortizationOfIntangibleAssetsDetails SCHEDULE OF AMORTIZATION OF INTANGIBLE ASSETS (Details) Details 68 false false R69.htm 00000069 - Disclosure - SCHEDULE OF ESTIMATED AMORTIZATION EXPENSE FOR INTANGIBLE ASSETS (Details) Sheet http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails SCHEDULE OF ESTIMATED AMORTIZATION EXPENSE FOR INTANGIBLE ASSETS (Details) Details 69 false false R70.htm 00000070 - Disclosure - INTANGIBLE ASSETS (Details Narrative) Sheet http://vislink.com/role/IntangibleAssetsDetailsNarrative INTANGIBLE ASSETS (Details Narrative) Details http://vislink.com/role/IntangibleAssetsTables 70 false false R71.htm 00000071 - Disclosure - SCHEDULE OF ACCRUED EXPENSES (Details) Sheet http://vislink.com/role/ScheduleOfAccruedExpensesDetails SCHEDULE OF ACCRUED EXPENSES (Details) Details 71 false false R72.htm 00000072 - Disclosure - SCHEDULE OF NOTES PAYABLE (Details) Notes http://vislink.com/role/ScheduleOfNotesPayableDetails SCHEDULE OF NOTES PAYABLE (Details) Details 72 false false R73.htm 00000073 - Disclosure - SCHEDULE OF NOTES PAYABLE (Details) (Parenthethical) Notes http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical SCHEDULE OF NOTES PAYABLE (Details) (Parenthethical) Details 73 false false R74.htm 00000074 - Disclosure - SCHEDULE OF OPERATING LEASE DATA (Details) Sheet http://vislink.com/role/ScheduleOfOperatingLeaseDataDetails SCHEDULE OF OPERATING LEASE DATA (Details) Details 74 false false R75.htm 00000075 - Disclosure - SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES (Details) Sheet http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES (Details) Details 75 false false R76.htm 00000076 - Disclosure - SCHEDULE OF LEASE OBLIGATIONS ASSUMED (Details) Sheet http://vislink.com/role/ScheduleOfLeaseObligationsAssumedDetails SCHEDULE OF LEASE OBLIGATIONS ASSUMED (Details) Details 76 false false R77.htm 00000077 - Disclosure - LEASES (Details Narrative) Sheet http://vislink.com/role/LeasesDetailsNarrative LEASES (Details Narrative) Details http://vislink.com/role/LeasesTables 77 false false R78.htm 00000078 - Disclosure - SCHEDULE OF VALUATION AND WARRANTS EXERCISABLE (Details) Sheet http://vislink.com/role/ScheduleOfValuationAndWarrantsExercisableDetails SCHEDULE OF VALUATION AND WARRANTS EXERCISABLE (Details) Details 78 false false R79.htm 00000079 - Disclosure - SCHEDULE OF CHANGES IN FAIR VALUE OF LEVEL 3 FINANCIAL LIABILITIES (Details) Sheet http://vislink.com/role/ScheduleOfChangesInFairValueOfLevel3FinancialLiabilitiesDetails SCHEDULE OF CHANGES IN FAIR VALUE OF LEVEL 3 FINANCIAL LIABILITIES (Details) Details 79 false false R80.htm 00000080 - Disclosure - PREFERRED SHARES (Details Narrative) Sheet http://vislink.com/role/PreferredSharesDetailsNarrative PREFERRED SHARES (Details Narrative) Details http://vislink.com/role/PreferredShares 80 false false R81.htm 00000081 - Disclosure - SCHEDULE OF WARRANT OUTSTANDING (Details) Sheet http://vislink.com/role/ScheduleOfWarrantOutstandingDetails SCHEDULE OF WARRANT OUTSTANDING (Details) Details 81 false false R82.htm 00000082 - Disclosure - SCHEDULE OF WARRANT OUTSTANDING EXERCISE PRICE (Details) Sheet http://vislink.com/role/ScheduleOfWarrantOutstandingExercisePriceDetails SCHEDULE OF WARRANT OUTSTANDING EXERCISE PRICE (Details) Details 82 false false R83.htm 00000083 - Disclosure - STOCKHOLDERS??? EQUITY (Details Narrative) Sheet http://vislink.com/role/StockholdersEquityDetailsNarrative STOCKHOLDERS??? EQUITY (Details Narrative) Details http://vislink.com/role/StockholdersEquityTables 83 false false R84.htm 00000084 - Disclosure - SCHEDULE OF STOCK OPTION PLANS (Details) Sheet http://vislink.com/role/ScheduleOfStockOptionPlansDetails SCHEDULE OF STOCK OPTION PLANS (Details) Details 84 false false R85.htm 00000085 - Disclosure - SCHEDULE OF STOCK OPTION PLANS FOR VESTED OPTION (Details) Sheet http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails SCHEDULE OF STOCK OPTION PLANS FOR VESTED OPTION (Details) Details 85 false false R86.htm 00000086 - Disclosure - SCHEDULE OF SHARE-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS (Details) Sheet http://vislink.com/role/ScheduleOfShare-basedPaymentAwardStockOptionsValuationAssumptionsDetails SCHEDULE OF SHARE-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS (Details) Details 86 false false R87.htm 00000087 - Disclosure - SCHEDULE OF STOCK OPTION PLANS FOR VESTED OPTION (Details) (Parenthetical) Sheet http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetailsParenthetical SCHEDULE OF STOCK OPTION PLANS FOR VESTED OPTION (Details) (Parenthetical) Details 87 false false R88.htm 00000088 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative) Sheet http://vislink.com/role/Stock-basedCompensationDetailsNarrative STOCK-BASED COMPENSATION (Details Narrative) Details http://vislink.com/role/Stock-basedCompensationTables 88 false false R89.htm 00000089 - Disclosure - SCHEDULE OF MATCHING CONTRIBUTIONS (Details) Sheet http://vislink.com/role/ScheduleOfMatchingContributionsDetails SCHEDULE OF MATCHING CONTRIBUTIONS (Details) Details 89 false false R90.htm 00000090 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative) Sheet http://vislink.com/role/CommitmentsAndContingenciesDetailsNarrative COMMITMENTS AND CONTINGENCIES (Details Narrative) Details http://vislink.com/role/CommitmentsAndContingenciesTables 90 false false R91.htm 00000091 - Disclosure - CONCENTRATIONS (Details Narrative) Sheet http://vislink.com/role/ConcentrationsDetailsNarrative CONCENTRATIONS (Details Narrative) Details http://vislink.com/role/Concentrations 91 false false R92.htm 00000092 - Disclosure - SCHEDULE OF DISAGGREGATION OF REVENUE (Details) Sheet http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails SCHEDULE OF DISAGGREGATION OF REVENUE (Details) Details 92 false false R93.htm 00000093 - Disclosure - SCHEDULE OF GAINS ON SETTLEMENT OF DEBT (Details) Sheet http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetails SCHEDULE OF GAINS ON SETTLEMENT OF DEBT (Details) Details 93 false false R94.htm 00000094 - Disclosure - SCHEDULE OF GAINS ON SETTLEMENT OF DEBT (Details) (Parenthetical) Sheet http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical SCHEDULE OF GAINS ON SETTLEMENT OF DEBT (Details) (Parenthetical) Details 94 false false R95.htm 00000095 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT) (Details) Sheet http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT) (Details) Details 95 false false R96.htm 00000096 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details) Sheet http://vislink.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details) Details 96 false false R97.htm 00000097 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) Sheet http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) Details 97 false false R98.htm 00000098 - Disclosure - INCOME TAXES (Details Narrative) Sheet http://vislink.com/role/IncomeTaxesDetailsNarrative INCOME TAXES (Details Narrative) Details http://vislink.com/role/IncomeTaxesTables 98 false false All Reports Book All Reports [dq-0542-Deprecated-Concept] Concept TreasuryStockMember in us-gaap/2022 used in 19 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. form10-k.htm 53, 57, 62, 67, 73, 79, 84, 90, 102, 106, 111, 117, 124, 130, 11573, 11793, 11804, 12002, 12013 [dq-0542-Deprecated-Concept] Concept TreasuryStockShares in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. form10-k.htm 11274 [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 4 fact(s) appearing in ix:hidden were eligible for transformation: VISL:WarrantsAndRightsOutstandingTerms, us-gaap:WarrantsAndRightsOutstandingTerm - form10-k.htm 154, 209, 210, 211 form10-k.htm ex23-1.htm ex31-1.htm ex31-2.htm ex32-1.htm ex32-2.htm ex4-11.htm visl-20221231.xsd visl-20221231_cal.xml visl-20221231_def.xml visl-20221231_lab.xml visl-20221231_pre.xml form10-k_001.jpg form10-k_002.jpg form10-k_003.jpg form10-k_004.jpg form10-k_005.jpg form10-k_006.jpg form10-k_007.jpg form10-k_008.jpg form10-k_009.jpg form10-k_010.jpg http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 128 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form10-k.htm": { "axisCustom": 0, "axisStandard": 27, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 1146, "http://xbrl.sec.gov/dei/2022": 36 }, "contextCount": 415, "dts": { "calculationLink": { "local": [ "visl-20221231_cal.xml" ] }, "definitionLink": { "local": [ "visl-20221231_def.xml" ] }, "inline": { "local": [ "form10-k.htm" ] }, "labelLink": { "local": [ "visl-20221231_lab.xml" ] }, "presentationLink": { "local": [ "visl-20221231_pre.xml" ] }, "schema": { "local": [ "visl-20221231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 799, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 148, "http://vislink.com/20221231": 89, "http://xbrl.sec.gov/dei/2022": 3, "total": 240 }, "keyCustom": 117, "keyStandard": 389, "memberCustom": 64, "memberStandard": 56, "nsprefix": "VISL", "nsuri": "http://vislink.com/20221231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "menuCat": "Cover", "order": "1", "role": "http://vislink.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - ACQUISITION OF MOBILE VIEWPOINT CORPORATE B.V.", "menuCat": "Notes", "order": "10", "role": "http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.", "shortName": "ACQUISITION OF MOBILE VIEWPOINT CORPORATE B.V.", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinancingReceivablesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - ACCOUNTS RECEIVABLE", "menuCat": "Notes", "order": "11", "role": "http://vislink.com/role/AccountsReceivable", "shortName": "ACCOUNTS RECEIVABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FinancingReceivablesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - INVENTORIES", "menuCat": "Notes", "order": "12", "role": "http://vislink.com/role/Inventories", "shortName": "INVENTORIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:InventoryDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - PROPERTY AND EQUIPMENT", "menuCat": "Notes", "order": "13", "role": "http://vislink.com/role/PropertyAndEquipment", "shortName": "PROPERTY AND EQUIPMENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - GOODWILL", "menuCat": "Notes", "order": "14", "role": "http://vislink.com/role/Goodwill", "shortName": "GOODWILL", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:GoodwillDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - INTANGIBLE ASSETS", "menuCat": "Notes", "order": "15", "role": "http://vislink.com/role/IntangibleAssets", "shortName": "INTANGIBLE ASSETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - ACCRUED EXPENSES", "menuCat": "Notes", "order": "16", "role": "http://vislink.com/role/AccruedExpenses", "shortName": "ACCRUED EXPENSES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - NOTES PAYABLE", "menuCat": "Notes", "order": "17", "role": "http://vislink.com/role/NotesPayable", "shortName": "NOTES PAYABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - LEASES", "menuCat": "Notes", "order": "18", "role": "http://vislink.com/role/Leases", "shortName": "LEASES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - DERIVATIVE LIABILITIES", "menuCat": "Notes", "order": "19", "role": "http://vislink.com/role/DerivativeLiabilities", "shortName": "DERIVATIVE LIABILITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Consolidated Balance Sheets", "menuCat": "Statements", "order": "2", "role": "http://vislink.com/role/BalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - PREFERRED SHARES", "menuCat": "Notes", "order": "20", "role": "http://vislink.com/role/PreferredShares", "shortName": "PREFERRED SHARES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - STOCKHOLDERS\u2019 EQUITY", "menuCat": "Notes", "order": "21", "role": "http://vislink.com/role/StockholdersEquity", "shortName": "STOCKHOLDERS\u2019 EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - STOCK-BASED COMPENSATION", "menuCat": "Notes", "order": "22", "role": "http://vislink.com/role/Stock-basedCompensation", "shortName": "STOCK-BASED COMPENSATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - COMMITMENTS AND CONTINGENCIES", "menuCat": "Notes", "order": "23", "role": "http://vislink.com/role/CommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - CONCENTRATIONS", "menuCat": "Notes", "order": "24", "role": "http://vislink.com/role/Concentrations", "shortName": "CONCENTRATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - REVENUE", "menuCat": "Notes", "order": "25", "role": "http://vislink.com/role/Revenue", "shortName": "REVENUE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "VISL:RebatesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - REBATES", "menuCat": "Notes", "order": "26", "role": "http://vislink.com/role/Rebates", "shortName": "REBATES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "VISL:RebatesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "VISL:GainOnSettlementOfDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - GAINS ON SETTLEMENT OF DEBT", "menuCat": "Notes", "order": "27", "role": "http://vislink.com/role/GainsOnSettlementOfDebt", "shortName": "GAINS ON SETTLEMENT OF DEBT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "VISL:GainOnSettlementOfDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - INCOME TAXES", "menuCat": "Notes", "order": "28", "role": "http://vislink.com/role/IncomeTaxes", "shortName": "INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - SUBSEQUENT EVENTS", "menuCat": "Notes", "order": "29", "role": "http://vislink.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)", "menuCat": "Statements", "order": "3", "role": "http://vislink.com/role/BalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:TreasuryStockShares", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationsPolicy", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "menuCat": "Policies", "order": "30", "role": "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationsPolicy", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "us-gaap:GuaranteesIndemnificationsAndWarrantiesPolicies", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "menuCat": "Tables", "order": "31", "role": "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesTables", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:GuaranteesIndemnificationsAndWarrantiesPolicies", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - ACQUISITION OF MOBILE VIEWPOINT CORPORATE B.V. (Tables)", "menuCat": "Tables", "order": "32", "role": "http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.Tables", "shortName": "ACQUISITION OF MOBILE VIEWPOINT CORPORATE B.V. (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "us-gaap:FinancingReceivablesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - ACCOUNTS RECEIVABLE (Tables)", "menuCat": "Tables", "order": "33", "role": "http://vislink.com/role/AccountsReceivableTables", "shortName": "ACCOUNTS RECEIVABLE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FinancingReceivablesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - INVENTORIES (Tables)", "menuCat": "Tables", "order": "34", "role": "http://vislink.com/role/InventoriesTables", "shortName": "INVENTORIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - PROPERTY AND EQUIPMENT (Tables)", "menuCat": "Tables", "order": "35", "role": "http://vislink.com/role/PropertyAndEquipmentTables", "shortName": "PROPERTY AND EQUIPMENT (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "us-gaap:GoodwillDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - GOODWILL (Tables)", "menuCat": "Tables", "order": "36", "role": "http://vislink.com/role/GoodwillTables", "shortName": "GOODWILL (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:GoodwillDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfGoodwillTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - INTANGIBLE ASSETS (Tables)", "menuCat": "Tables", "order": "37", "role": "http://vislink.com/role/IntangibleAssetsTables", "shortName": "INTANGIBLE ASSETS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - ACCRUED EXPENSES (Tables)", "menuCat": "Tables", "order": "38", "role": "http://vislink.com/role/AccruedExpensesTables", "shortName": "ACCRUED EXPENSES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - NOTES PAYABLE (Tables)", "menuCat": "Tables", "order": "39", "role": "http://vislink.com/role/NotesPayableTables", "shortName": "NOTES PAYABLE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Consolidated Statements of Operations and Comprehensive Loss", "menuCat": "Statements", "order": "4", "role": "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss", "shortName": "Consolidated Statements of Operations and Comprehensive Loss", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "lang": null, "name": "us-gaap:LaborAndRelatedExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - LEASES (Tables)", "menuCat": "Tables", "order": "40", "role": "http://vislink.com/role/LeasesTables", "shortName": "LEASES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "VISL:ScheduleOfValuationAndWarrantsExercisableTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000041 - Disclosure - DERIVATIVE LIABILITIES (Tables)", "menuCat": "Tables", "order": "41", "role": "http://vislink.com/role/DerivativeLiabilitiesTables", "shortName": "DERIVATIVE LIABILITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "VISL:ScheduleOfValuationAndWarrantsExercisableTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000042 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Tables)", "menuCat": "Tables", "order": "42", "role": "http://vislink.com/role/StockholdersEquityTables", "shortName": "STOCKHOLDERS\u2019 EQUITY (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "VISL:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000043 - Disclosure - STOCK-BASED COMPENSATION (Tables)", "menuCat": "Tables", "order": "43", "role": "http://vislink.com/role/Stock-basedCompensationTables", "shortName": "STOCK-BASED COMPENSATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "VISL:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000044 - Disclosure - COMMITMENTS AND CONTINGENCIES (Tables)", "menuCat": "Tables", "order": "44", "role": "http://vislink.com/role/CommitmentsAndContingenciesTables", "shortName": "COMMITMENTS AND CONTINGENCIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000045 - Disclosure - REVENUE (Tables)", "menuCat": "Tables", "order": "45", "role": "http://vislink.com/role/RevenueTables", "shortName": "REVENUE (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "VISL:GainOnSettlementOfDebtTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "VISL:GainOnSettlementOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000046 - Disclosure - GAINS ON SETTLEMENT OF DEBT (Tables)", "menuCat": "Tables", "order": "46", "role": "http://vislink.com/role/GainsOnSettlementOfDebtTables", "shortName": "GAINS ON SETTLEMENT OF DEBT (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "VISL:GainOnSettlementOfDebtTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "VISL:GainOnSettlementOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000047 - Disclosure - INCOME TAXES (Tables)", "menuCat": "Tables", "order": "47", "role": "http://vislink.com/role/IncomeTaxesTables", "shortName": "INCOME TAXES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000048 - Disclosure - LIQUIDITY AND FINANCIAL CONDITION (Details Narrative)", "menuCat": "Details", "order": "48", "role": "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative", "shortName": "LIQUIDITY AND FINANCIAL CONDITION (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "VISL:LiquidityAndFinancialConditionTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-5", "lang": null, "name": "VISL:WorkingCapital", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "us-gaap:GuaranteesIndemnificationsAndWarrantiesPolicies", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProductWarrantyAccrual", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000049 - Disclosure - SCHEDULE OF PRODUCT WARRANTY LIABILITY (Details)", "menuCat": "Details", "order": "49", "role": "http://vislink.com/role/ScheduleOfProductWarrantyLiabilityDetails", "shortName": "SCHEDULE OF PRODUCT WARRANTY LIABILITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "us-gaap:GuaranteesIndemnificationsAndWarrantiesPolicies", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31", "decimals": "0", "lang": null, "name": "us-gaap:ProductWarrantyAccrual", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity", "menuCat": "Statements", "order": "5", "role": "http://vislink.com/role/StatementsOfChangesInStockholdersEquity", "shortName": "Consolidated Statements of Changes in Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31_us-gaap_AdditionalPaidInCapitalMember", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000050 - Disclosure - SCHEDULE OF ANTI-DILIUTIVE POTENTIAL COMMON STOCK EQUIVALENTS EXCLUDE FROM THE CALCULATION OF LOSS PER SHARE (Details)", "menuCat": "Details", "order": "50", "role": "http://vislink.com/role/ScheduleOfAnti-diliutivePotentialCommonStockEquivalentsExcludeFromCalculationOfLossPerShareDetails", "shortName": "SCHEDULE OF ANTI-DILIUTIVE POTENTIAL COMMON STOCK EQUIVALENTS EXCLUDE FROM THE CALCULATION OF LOSS PER SHARE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000051 - Disclosure - SCHEDULE OF FOREIGN EXCHANGE AND CHANGE IN ACCUMULATED COMPREHENSIVE INCOME (Details)", "menuCat": "Details", "order": "51", "role": "http://vislink.com/role/ScheduleOfForeignExchangeAndChangeInAccumulatedComprehensiveIncomeDetails", "shortName": "SCHEDULE OF FOREIGN EXCHANGE AND CHANGE IN ACCUMULATED COMPREHENSIVE INCOME (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisTextBlock", "us-gaap:FairValueOfFinancialInstrumentsPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000052 - Disclosure - SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON NON-RECURRING BASIS (Details)", "menuCat": "Details", "order": "52", "role": "http://vislink.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnNon-recurringBasisDetails", "shortName": "SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON NON-RECURRING BASIS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisTextBlock", "us-gaap:FairValueOfFinancialInstrumentsPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ConcentrationRiskCreditRisk", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashFDICInsuredAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000053 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "menuCat": "Details", "order": "53", "role": "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ConcentrationRiskCreditRisk", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashFDICInsuredAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-08-16", "decimals": "0", "first": true, "lang": null, "name": "VISL:BusinessCombinationConsiderationTransferredCash", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000054 - Disclosure - SCHEDULE OF IDENTIFIABLE ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)", "menuCat": "Details", "order": "54", "role": "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails", "shortName": "SCHEDULE OF IDENTIFIABLE ASSETS ACQUIRED AND LIABILITIES ASSUMED (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-08-16", "decimals": "0", "first": true, "lang": null, "name": "VISL:BusinessCombinationConsiderationTransferredCash", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_custom_TradeNameMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000055 - Disclosure - SCHEDULE OF ACQUIRED INTANGIBLE WITH THEIR RELATIVE USEFUL LIVES (Details)", "menuCat": "Details", "order": "55", "role": "http://vislink.com/role/ScheduleOfAcquiredIntangibleWithTheirRelativeUsefulLivesDetails", "shortName": "SCHEDULE OF ACQUIRED INTANGIBLE WITH THEIR RELATIVE USEFUL LIVES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_custom_TradeNameMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-012021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000056 - Disclosure - SCHEDULE OF UNAUDITED PRO-FORMA COMBINED RESULTS OF OPERATIONS (Details)", "menuCat": "Details", "order": "56", "role": "http://vislink.com/role/ScheduleOfUnauditedPro-formaCombinedResultsOfOperationsDetails", "shortName": "SCHEDULE OF UNAUDITED PRO-FORMA COMBINED RESULTS OF OPERATIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-012021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-08-16", "decimals": "-4", "first": true, "lang": null, "name": "VISL:IncreaseInInventory", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000057 - Disclosure - ACQUISITION OF MOBILE VIEWPOINT CORPORATE B.V. (Details Narrative)", "menuCat": "Details", "order": "57", "role": "http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.DetailsNarrative", "shortName": "ACQUISITION OF MOBILE VIEWPOINT CORPORATE B.V. (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-08-16", "decimals": "-4", "first": true, "lang": null, "name": "VISL:IncreaseInInventory", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "us-gaap:FinancingReceivablesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableGrossCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000058 - Disclosure - SCHEDULE OF ACCOUNTS RECEIVABLE (Details)", "menuCat": "Details", "order": "58", "role": "http://vislink.com/role/ScheduleOfAccountsReceivableDetails", "shortName": "SCHEDULE OF ACCOUNTS RECEIVABLE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "us-gaap:FinancingReceivablesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableGrossCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:FinancingReceivablesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProvisionForDoubtfulAccounts", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000059 - Disclosure - ACCOUNTS RECEIVABLE (Details Narrative)", "menuCat": "Details", "order": "59", "role": "http://vislink.com/role/AccountsReceivableDetailsNarrative", "shortName": "ACCOUNTS RECEIVABLE (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Consolidated Statements of Cash Flows", "menuCat": "Statements", "order": "6", "role": "http://vislink.com/role/StatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "lang": null, "name": "VISL:StockIssuanceCommitments", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsAndSupplies", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000060 - Disclosure - SCHEDULE OF INVENTORIES (Details)", "menuCat": "Details", "order": "60", "role": "http://vislink.com/role/ScheduleOfInventoriesDetails", "shortName": "SCHEDULE OF INVENTORIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InventoryRawMaterialsAndSupplies", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:EffectOfLIFOInventoryLiquidationOnIncome", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000061 - Disclosure - INVENTORIES (Details Narrative)", "menuCat": "Details", "order": "61", "role": "http://vislink.com/role/InventoriesDetailsNarrative", "shortName": "INVENTORIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:EffectOfLIFOInventoryLiquidationOnIncome", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R62": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000062 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details)", "menuCat": "Details", "order": "62", "role": "http://vislink.com/role/ScheduleOfPropertyAndEquipmentDetails", "shortName": "SCHEDULE OF PROPERTY AND EQUIPMENT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000063 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)", "menuCat": "Details", "order": "63", "role": "http://vislink.com/role/PropertyAndEquipmentDetailsNarrative", "shortName": "PROPERTY AND EQUIPMENT (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R64": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfGoodwillTextBlock", "us-gaap:GoodwillDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000064 - Disclosure - SCHEDULE OF GOODWILL (Details)", "menuCat": "Details", "order": "64", "role": "http://vislink.com/role/ScheduleOfGoodwillDetails", "shortName": "SCHEDULE OF GOODWILL (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfGoodwillTextBlock", "us-gaap:GoodwillDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-012021-12-31", "decimals": "0", "lang": null, "name": "VISL:GoodwillAdditions", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:GoodwillAndIntangibleAssetsGoodwillPolicy", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-012021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GoodwillImpairmentLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000065 - Disclosure - GOODWILL (Details Narrative)", "menuCat": "Details", "order": "65", "role": "http://vislink.com/role/GoodwillDetailsNarrative", "shortName": "GOODWILL (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R66": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31", "decimals": "0", "first": true, "lang": null, "name": "VISL:BeginningBalanceCostAccumulatedAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000066 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS (Details)", "menuCat": "Details", "order": "66", "role": "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails", "shortName": "SCHEDULE OF INTANGIBLE ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31", "decimals": "0", "first": true, "lang": null, "name": "VISL:BeginningBalanceCostAccumulatedAmortization", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsNet", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000067 - Disclosure - SCHEDULE OF CAPITALIZED INTANGIBLE COSTS (Details)", "menuCat": "Details", "order": "67", "role": "http://vislink.com/role/ScheduleOfCapitalizedIntangibleCostsDetails", "shortName": "SCHEDULE OF CAPITALIZED INTANGIBLE COSTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfImpairedIntangibleAssetsTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31_custom_ProprietaryTechnologyMember", "decimals": "0", "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsNet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000068 - Disclosure - SCHEDULE OF AMORTIZATION OF INTANGIBLE ASSETS (Details)", "menuCat": "Details", "order": "68", "role": "http://vislink.com/role/ScheduleOfAmortizationOfIntangibleAssetsDetails", "shortName": "SCHEDULE OF AMORTIZATION OF INTANGIBLE ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R69": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000069 - Disclosure - SCHEDULE OF ESTIMATED AMORTIZATION EXPENSE FOR INTANGIBLE ASSETS (Details)", "menuCat": "Details", "order": "69", "role": "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails", "shortName": "SCHEDULE OF ESTIMATED AMORTIZATION EXPENSE FOR INTANGIBLE ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - NATURE OF OPERATIONS", "menuCat": "Notes", "order": "7", "role": "http://vislink.com/role/NatureOfOperations", "shortName": "NATURE OF OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000070 - Disclosure - INTANGIBLE ASSETS (Details Narrative)", "menuCat": "Details", "order": "70", "role": "http://vislink.com/role/IntangibleAssetsDetailsNarrative", "shortName": "INTANGIBLE ASSETS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:WorkersCompensationLiabilityCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000071 - Disclosure - SCHEDULE OF ACCRUED EXPENSES (Details)", "menuCat": "Details", "order": "71", "role": "http://vislink.com/role/ScheduleOfAccruedExpensesDetails", "shortName": "SCHEDULE OF ACCRUED EXPENSES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:WorkersCompensationLiabilityCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NotesPayableCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000072 - Disclosure - SCHEDULE OF NOTES PAYABLE (Details)", "menuCat": "Details", "order": "72", "role": "http://vislink.com/role/ScheduleOfNotesPayableDetails", "shortName": "SCHEDULE OF NOTES PAYABLE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31_custom_NotesPayableOneMember", "decimals": "0", "lang": null, "name": "us-gaap:NotesPayableCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:InterestExpenseDebt", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000073 - Disclosure - SCHEDULE OF NOTES PAYABLE (Details) (Parenthethical)", "menuCat": "Details", "order": "73", "role": "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical", "shortName": "SCHEDULE OF NOTES PAYABLE (Details) (Parenthethical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfDebtTableTextBlock", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-04-05_custom_DAndOInsurancePolicyRenewedMember_custom_NotesPayableOneMember", "decimals": "0", "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000074 - Disclosure - SCHEDULE OF OPERATING LEASE DATA (Details)", "menuCat": "Details", "order": "74", "role": "http://vislink.com/role/ScheduleOfOperatingLeaseDataDetails", "shortName": "SCHEDULE OF OPERATING LEASE DATA (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R75": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000075 - Disclosure - SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES (Details)", "menuCat": "Details", "order": "75", "role": "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails", "shortName": "SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000076 - Disclosure - SCHEDULE OF LEASE OBLIGATIONS ASSUMED (Details)", "menuCat": "Details", "order": "76", "role": "http://vislink.com/role/ScheduleOfLeaseObligationsAssumedDetails", "shortName": "SCHEDULE OF LEASE OBLIGATIONS ASSUMED (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "VISL:ScheduleOfLeasesObligationsAssumedTableTextBlock", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31_custom_ColchesterUKWatersideHouseMember", "decimals": "0", "lang": null, "name": "us-gaap:AreaOfLand", "reportCount": 1, "unique": true, "unitRef": "SquareFeet", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "VISL:LesseeOperatingLeaseRemainingLeaseTerms", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000077 - Disclosure - LEASES (Details Narrative)", "menuCat": "Details", "order": "77", "role": "http://vislink.com/role/LeasesDetailsNarrative", "shortName": "LEASES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LesseeOperatingLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "VISL:LesseeOperatingLeaseRemainingLeaseTerms", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "VISL:ScheduleOfValuationAndWarrantsExercisableTableTextBlock", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "VISL:NumberOfSharesUnderlyingWarrants", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000078 - Disclosure - SCHEDULE OF VALUATION AND WARRANTS EXERCISABLE (Details)", "menuCat": "Details", "order": "78", "role": "http://vislink.com/role/ScheduleOfValuationAndWarrantsExercisableDetails", "shortName": "SCHEDULE OF VALUATION AND WARRANTS EXERCISABLE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "VISL:ScheduleOfValuationAndWarrantsExercisableTableTextBlock", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "VISL:NumberOfSharesUnderlyingWarrants", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000079 - Disclosure - SCHEDULE OF CHANGES IN FAIR VALUE OF LEVEL 3 FINANCIAL LIABILITIES (Details)", "menuCat": "Details", "order": "79", "role": "http://vislink.com/role/ScheduleOfChangesInFairValueOfLevel3FinancialLiabilitiesDetails", "shortName": "SCHEDULE OF CHANGES IN FAIR VALUE OF LEVEL 3 FINANCIAL LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "VISL:LiquidityAndFinancialConditionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - LIQUIDITY AND FINANCIAL CONDITION", "menuCat": "Notes", "order": "8", "role": "http://vislink.com/role/LiquidityAndFinancialCondition", "shortName": "LIQUIDITY AND FINANCIAL CONDITION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "VISL:LiquidityAndFinancialConditionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000080 - Disclosure - PREFERRED SHARES (Details Narrative)", "menuCat": "Details", "order": "80", "role": "http://vislink.com/role/PreferredSharesDetailsNarrative", "shortName": "PREFERRED SHARES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PreferredStockTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2013-03-31", "decimals": "-5", "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R81": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000081 - Disclosure - SCHEDULE OF WARRANT OUTSTANDING (Details)", "menuCat": "Details", "order": "81", "role": "http://vislink.com/role/ScheduleOfWarrantOutstandingDetails", "shortName": "SCHEDULE OF WARRANT OUTSTANDING (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "VISL:ScheduleOfWarrantOutstandingExercisePriceTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_custom_WarrantsMember", "decimals": "INF", "first": true, "lang": null, "name": "VISL:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000082 - Disclosure - SCHEDULE OF WARRANT OUTSTANDING EXERCISE PRICE (Details)", "menuCat": "Details", "order": "82", "role": "http://vislink.com/role/ScheduleOfWarrantOutstandingExercisePriceDetails", "shortName": "SCHEDULE OF WARRANT OUTSTANDING EXERCISE PRICE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "VISL:ScheduleOfWarrantOutstandingExercisePriceTableTextBlock", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_custom_WarrantsMember", "decimals": "INF", "first": true, "lang": null, "name": "VISL:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000083 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "menuCat": "Details", "order": "83", "role": "http://vislink.com/role/StockholdersEquityDetailsNarrative", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R84": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensation", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000084 - Disclosure - SCHEDULE OF STOCK OPTION PLANS (Details)", "menuCat": "Details", "order": "84", "role": "http://vislink.com/role/ScheduleOfStockOptionPlansDetails", "shortName": "SCHEDULE OF STOCK OPTION PLANS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "VISL:ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivitiesTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_us-gaap_RestrictedStockUnitsRSUMember", "decimals": "0", "lang": null, "name": "us-gaap:ShareBasedCompensation", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R85": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_custom_PerformanceBasedStockOptionMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000085 - Disclosure - SCHEDULE OF STOCK OPTION PLANS FOR VESTED OPTION (Details)", "menuCat": "Details", "order": "85", "role": "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails", "shortName": "SCHEDULE OF STOCK OPTION PLANS FOR VESTED OPTION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_custom_PerformanceBasedStockOptionMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R86": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_custom_PerformanceBasedOptionMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000086 - Disclosure - SCHEDULE OF SHARE-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS (Details)", "menuCat": "Details", "order": "86", "role": "http://vislink.com/role/ScheduleOfShare-basedPaymentAwardStockOptionsValuationAssumptionsDetails", "shortName": "SCHEDULE OF SHARE-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_custom_PerformanceBasedOptionMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R87": { "firstAnchor": { "ancestors": [ "span", "link:footnote", "span", "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-012021-12-31_us-gaap_RestrictedStockUnitsRSUMember_srt_ChiefExecutiveOfficerMember_us-gaap_ShareBasedCompensationAwardTrancheOneMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights", "reportCount": 1, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000087 - Disclosure - SCHEDULE OF STOCK OPTION PLANS FOR VESTED OPTION (Details) (Parenthetical)", "menuCat": "Details", "order": "87", "role": "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetailsParenthetical", "shortName": "SCHEDULE OF STOCK OPTION PLANS FOR VESTED OPTION (Details) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R88": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_custom_PerformanceBasedOptionMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000088 - Disclosure - STOCK-BASED COMPENSATION (Details Narrative)", "menuCat": "Details", "order": "88", "role": "http://vislink.com/role/Stock-basedCompensationDetailsNarrative", "shortName": "STOCK-BASED COMPENSATION (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_custom_PerformanceBasedOptionMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R89": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_custom_GroupPersonalPensionPlanUKMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DefinedContributionPlanCostRecognized", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000089 - Disclosure - SCHEDULE OF MATCHING CONTRIBUTIONS (Details)", "menuCat": "Details", "order": "89", "role": "http://vislink.com/role/ScheduleOfMatchingContributionsDetails", "shortName": "SCHEDULE OF MATCHING CONTRIBUTIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DefinedContributionPlanDisclosuresTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_custom_GroupPersonalPensionPlanUKMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DefinedContributionPlanCostRecognized", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "menuCat": "Notes", "order": "9", "role": "http://vislink.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R90": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "USDPShares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000090 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details Narrative)", "menuCat": "Details", "order": "90", "role": "http://vislink.com/role/CommitmentsAndContingenciesDetailsNarrative", "shortName": "COMMITMENTS AND CONTINGENCIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2023-01-11_us-gaap_SubsequentEventMember", "decimals": "INF", "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R91": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000091 - Disclosure - CONCENTRATIONS (Details Narrative)", "menuCat": "Details", "order": "91", "role": "http://vislink.com/role/ConcentrationsDetailsNarrative", "shortName": "CONCENTRATIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-012022-12-31_custom_SingleCustomerMember_us-gaap_SalesRevenueNetMember_us-gaap_CustomerConcentrationRiskMember", "decimals": "INF", "lang": null, "name": "VISL:ConcentrationRiskThresholdPercentage", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R92": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000092 - Disclosure - SCHEDULE OF DISAGGREGATION OF REVENUE (Details)", "menuCat": "Details", "order": "92", "role": "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails", "shortName": "SCHEDULE OF DISAGGREGATION OF REVENUE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "lang": null, "name": "us-gaap:NoncurrentAssets", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R93": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "VISL:GainOnSettlementOfDebtTableTextBlock", "VISL:GainOnSettlementOfDebtTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000093 - Disclosure - SCHEDULE OF GAINS ON SETTLEMENT OF DEBT (Details)", "menuCat": "Details", "order": "93", "role": "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetails", "shortName": "SCHEDULE OF GAINS ON SETTLEMENT OF DEBT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "VISL:GainOnSettlementOfDebtTableTextBlock", "VISL:GainOnSettlementOfDebtTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-012021-12-31_custom_PayrollProtectionProgramMember", "decimals": "0", "lang": null, "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R94": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AccountsPayableCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000094 - Disclosure - SCHEDULE OF GAINS ON SETTLEMENT OF DEBT (Details) (Parenthetical)", "menuCat": "Details", "order": "94", "role": "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical", "shortName": "SCHEDULE OF GAINS ON SETTLEMENT OF DEBT (Details) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "VISL:GainOnSettlementOfDebtTableTextBlock", "VISL:GainOnSettlementOfDebtTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-11-21", "decimals": "0", "lang": null, "name": "us-gaap:DividendsPayableCurrentAndNoncurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R95": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CurrentStateAndLocalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000095 - Disclosure - SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT) (Details)", "menuCat": "Details", "order": "95", "role": "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails", "shortName": "SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CurrentStateAndLocalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R96": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000096 - Disclosure - SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details)", "menuCat": "Details", "order": "96", "role": "http://vislink.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails", "shortName": "SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2022-01-01to2022-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R97": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsTaxCreditCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000097 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)", "menuCat": "Details", "order": "97", "role": "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails", "shortName": "SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsTaxCreditCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R98": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000098 - Disclosure - INCOME TAXES (Details Narrative)", "menuCat": "Details", "order": "98", "role": "http://vislink.com/role/IncomeTaxesDetailsNarrative", "shortName": "INCOME TAXES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } } }, "segmentCount": 125, "tag": { "VISL_AbandonmentOfRightofuseOperatingLeasesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Abandonment of Right-of-use Operating Leases [Member]", "label": "Abandonment of Right-of-use Operating Leases [Member]" } } }, "localname": "AbandonmentOfRightofuseOperatingLeasesMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnNon-recurringBasisDetails" ], "xbrltype": "domainItemType" }, "VISL_AccumulatedComprehensiveIncomeUnrealizedLossOnCurrencyTranslationAdjustment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated comprehensive income unrealized loss on currency translation adjustment.", "label": "Accumulated comprehensive income: Unrealized losses on currency translation adjustment" } } }, "localname": "AccumulatedComprehensiveIncomeUnrealizedLossOnCurrencyTranslationAdjustment", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfForeignExchangeAndChangeInAccumulatedComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "VISL_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLifeDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Acquire finite lived intangible assets weighted average useful life description.", "label": "Useful life, description" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLifeDescription", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfAcquiredIntangibleWithTheirRelativeUsefulLivesDetails" ], "xbrltype": "stringItemType" }, "VISL_AdditionscostAccumulatedAmortizations": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Additionscost accumulated amortizations.", "label": "Intangible assets, net Addition" } } }, "localname": "AdditionscostAccumulatedAmortizations", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "VISL_AmortizationPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amortization period.", "label": "Remaining amortization period" } } }, "localname": "AmortizationPeriod", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansDetails" ], "xbrltype": "durationItemType" }, "VISL_AreaOfLandDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area of land description.", "label": "Area of land description" } } }, "localname": "AreaOfLandDescription", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative" ], "xbrltype": "stringItemType" }, "VISL_BeginningBalanceCostAccumulatedAmortization": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Beginning balance cost accumulated amortization.", "label": "BeginningBalanceCostAccumulatedAmortization", "periodStartLabel": "Beginning balance net" } } }, "localname": "BeginningBalanceCostAccumulatedAmortization", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "VISL_BillericaMaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Billerica, MA [Member]", "label": "Billerica, MA [Member]" } } }, "localname": "BillericaMaMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative", "http://vislink.com/role/ScheduleOfLeaseObligationsAssumedDetails" ], "xbrltype": "domainItemType" }, "VISL_BoardCompensationAwardsPreviouslyAccrued": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Board compensation awards previously accrued.", "label": "Board compensation awards previously accrued" } } }, "localname": "BoardCompensationAwardsPreviouslyAccrued", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "VISL_BusinessAcquisitionPercentageOfOutstandingCapitalAcquired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business acquisition percentage of outstanding capital acquired.", "label": "Percentage of outstanding capital acquired" } } }, "localname": "BusinessAcquisitionPercentageOfOutstandingCapitalAcquired", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.DetailsNarrative" ], "xbrltype": "percentItemType" }, "VISL_BusinessCombinationConsiderationPaid": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business combination consideration paid.", "label": "Consideration paid" } } }, "localname": "BusinessCombinationConsiderationPaid", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "VISL_BusinessCombinationConsiderationTransferredCash": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business combination consideration transferred cash.", "label": "BusinessCombinationConsiderationTransferredCash", "verboseLabel": "Cash" } } }, "localname": "BusinessCombinationConsiderationTransferredCash", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "VISL_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredTaxLiabilities": { "auth_ref": [], "calculation": { "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 9.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business combination recognized identifiable assets acquired and liabilities assumed current liabilities deferred tax liabilities.", "label": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredTaxLiabilities", "negatedLabel": "Deferred tax liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredTaxLiabilities", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "VISL_CarletonMMillerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Carleton M. Miller [Member]", "label": "Carleton M. Miller [Member]" } } }, "localname": "CarletonMMillerMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails" ], "xbrltype": "domainItemType" }, "VISL_CarriedForwardIndefinitelyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Carried Forward Indefinitely [Member]", "label": "Hale Capital Partners, LP [Member]" } } }, "localname": "CarriedForwardIndefinitelyMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_CashUsedInAcquisition": { "auth_ref": [], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash used in acquisition.", "label": "CashUsedInAcquisition", "negatedLabel": "Cash used in MVP stock acquisition" } } }, "localname": "CashUsedInAcquisition", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "VISL_ColchesterUKWatersideHouseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Colchester, U.K. - Waterside House [Member]", "label": "Colchester, U.K. - Waterside House [Member]" } } }, "localname": "ColchesterUKWatersideHouseMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfLeaseObligationsAssumedDetails" ], "xbrltype": "domainItemType" }, "VISL_CommonStockIssuedFromExerciseOfWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Common stock issued from exercise of warrants.", "label": "Exercise of common stock warrants" } } }, "localname": "CommonStockIssuedFromExerciseOfWarrants", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "VISL_CommonStockIssuedFromExerciseOfWarrantsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock issued from exercise of warrants shares.", "label": "Exercise of common stock warrants,shares" } } }, "localname": "CommonStockIssuedFromExerciseOfWarrantsShares", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "VISL_CommonStockIssuedInConnectionWithAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock issued in connection with abstract.", "label": "Common stock issued in connection with:" } } }, "localname": "CommonStockIssuedInConnectionWithAbstract", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "VISL_CommonStockIssuedInConnectionWithWarrantsIssuedInSettlementAgreements": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Common stock issued in connection with warrants issued in settlement agreements.", "label": "CommonStockIssuedInConnectionWithWarrantsIssuedInSettlementAgreements", "verboseLabel": "Warrants issued in settlement agreement" } } }, "localname": "CommonStockIssuedInConnectionWithWarrantsIssuedInSettlementAgreements", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "VISL_CommonStockPurchaseWarrantsAndOtherDerivativeFinancialInstrumentsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock purchase warrants and other derivative financial instruments [Policy text block]", "label": "Common Stock Purchase Warrants and Other Derivative Financial Instruments" } } }, "localname": "CommonStockPurchaseWarrantsAndOtherDerivativeFinancialInstrumentsPolicyTextBlock", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "VISL_CommonStockWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common Stock Warrants [Member]", "label": "Common Stock Warrants [Member]" } } }, "localname": "CommonStockWarrantsMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_ConcentrationRiskThresholdPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Concentration Risk Threshold Percentage.", "label": "Concentration risk threshold percentage" } } }, "localname": "ConcentrationRiskThresholdPercentage", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "percentItemType" }, "VISL_ConsultingAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Consulting Agreement [Member]", "label": "Consulting Agreement [Member]" } } }, "localname": "ConsultingAgreementMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetails", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_CustomerOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer One [Member]", "label": "Customer One [Member]" } } }, "localname": "CustomerOneMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_CustomerRelationshipMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer Relationship [Member]", "label": "Customer Relationship [Member]" } } }, "localname": "CustomerRelationshipMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfAcquiredIntangibleWithTheirRelativeUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "VISL_DAndOInsurancePolicyRenewedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "D & O Insurance Policy Renewed [Member]", "label": "D & O Insurance Policy Renewed [Member]" } } }, "localname": "DAndOInsurancePolicyRenewedMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "xbrltype": "domainItemType" }, "VISL_DebtInstrumentDownPayment": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Debt instrument down payment.", "label": "Debt instrument down payment" } } }, "localname": "DebtInstrumentDownPayment", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "xbrltype": "monetaryItemType" }, "VISL_DeferredTaxLiabilties": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax liabilties.", "label": "Deferred tax liabilties associated with MVP acquistion" } } }, "localname": "DeferredTaxLiabilties", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "VISL_DisclosureGainsOnSettlementOfDebtAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Gains On Settlement Of Debt" } } }, "localname": "DisclosureGainsOnSettlementOfDebtAbstract", "nsuri": "http://vislink.com/20221231", "xbrltype": "stringItemType" }, "VISL_DisclosureLeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases", "terseLabel": "Schedule Of Future Minimum Rental Payments For Operating Leases", "verboseLabel": "Schedule Of Operating Lease Data" } } }, "localname": "DisclosureLeasesAbstract", "nsuri": "http://vislink.com/20221231", "xbrltype": "stringItemType" }, "VISL_DisclosureLiquidityAndFinancialConditionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liquidity And Financial Condition" } } }, "localname": "DisclosureLiquidityAndFinancialConditionAbstract", "nsuri": "http://vislink.com/20221231", "xbrltype": "stringItemType" }, "VISL_DisclosureRebatesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Rebates" } } }, "localname": "DisclosureRebatesAbstract", "nsuri": "http://vislink.com/20221231", "xbrltype": "stringItemType" }, "VISL_DividendsPayableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dividends Payable [Member]", "label": "Dividends Payable [Member]" } } }, "localname": "DividendsPayableMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetails" ], "xbrltype": "domainItemType" }, "VISL_DubaiUAEMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dubai, UAE [Member]", "label": "Dubai, UAE [Member]" } } }, "localname": "DubaiUAEMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_DutchDepositGuaranteeScheme": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Dutch deposit guarantee scheme.", "label": "Dutch deposit guarantee scheme" } } }, "localname": "DutchDepositGuaranteeScheme", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "VISL_EffectiveForTaxYearsDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Effective for tax years, description.", "label": "Effective for tax years, description" } } }, "localname": "EffectiveForTaxYearsDescription", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "VISL_EffectiveIncomeTaxRateReconciliationExecutiveCompensationTaxBenefitPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Effective income tax rate reconciliation executive compensation tax benefit percent", "label": "Executive compensation" } } }, "localname": "EffectiveIncomeTaxRateReconciliationExecutiveCompensationTaxBenefitPercent", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "VISL_EffectiveIncomeTaxRateReconciliationProvisionToReturn": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Effective income tax rate reconciliation in respect of provision to return.", "label": "Provision to return" } } }, "localname": "EffectiveIncomeTaxRateReconciliationProvisionToReturn", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "VISL_EffectiveIncomeTaxRateReconciliationTaxContingenciesDtaAdjustmentForStateNol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Effective income tax rate reconciliation tax contingencies DTA adjustment for state NOL.", "label": "DTA adjustment for state NOL" } } }, "localname": "EffectiveIncomeTaxRateReconciliationTaxContingenciesDtaAdjustmentForStateNol", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "VISL_EndingBalanceCostAccumulatedAmortization": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Ending Balance Cost Accumulated Amortization.", "label": "EndingBalanceCostAccumulatedAmortization", "periodEndLabel": "Ending balance net", "periodStartLabel": "Beginning balance net" } } }, "localname": "EndingBalanceCostAccumulatedAmortization", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "VISL_EquipmentSalesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment Sales [Member]", "label": "Equipment Sales [Member]" } } }, "localname": "EquipmentSalesMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "VISL_EuroMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Euro [Member]", "label": "Euro [Member]" } } }, "localname": "EuroMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_EuroToGBPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Euro To GBP [Member]", "label": "Euro To GBP [Member]" } } }, "localname": "EuroToGBPMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_ExcessOfConsiderationPaidOverNetAssetsAcquired": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Excess of consideration paid over net assets acquired.", "label": "Excess of consideration paid over net assets acquired" } } }, "localname": "ExcessOfConsiderationPaidOverNetAssetsAcquired", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "VISL_ExerciseOfCashlessCommonStockWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Exercise of cashless common stock warrants.", "label": "Exercise of cashless common stock warrants" } } }, "localname": "ExerciseOfCashlessCommonStockWarrants", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "VISL_ExerciseOfCashlessCommonStockWarrantsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise of cashless common stock warrants shares.", "label": "Exercise of cashless common stock warrants,shares" } } }, "localname": "ExerciseOfCashlessCommonStockWarrantsShares", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "VISL_ExercisePriceRangeFiveMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Range Five [Member]", "label": "Exercise Price Range Five [Member]" } } }, "localname": "ExercisePriceRangeFiveMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingExercisePriceDetails" ], "xbrltype": "domainItemType" }, "VISL_ExercisePriceRangeFourMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of estimate of range of exercise prices, one including, but not limited to, upper and lower bound amounts, maximum and minimum amounts, and point estimates.", "label": "Exercise Price Range Four [Member]" } } }, "localname": "ExercisePriceRangeFourMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingExercisePriceDetails" ], "xbrltype": "domainItemType" }, "VISL_ExercisePriceRangeOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of estimate of range of exercise prices, one including, but not limited to, upper and lower bound amounts, maximum and minimum amounts, and point estimates.", "label": "Exercise Price Range One [Member]" } } }, "localname": "ExercisePriceRangeOneMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingExercisePriceDetails" ], "xbrltype": "domainItemType" }, "VISL_ExercisePriceRangeSixMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exercise Price Range Six [Member]", "label": "Exercise Price Range Six [Member]" } } }, "localname": "ExercisePriceRangeSixMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingExercisePriceDetails" ], "xbrltype": "domainItemType" }, "VISL_ExercisePriceRangeThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of estimate of range of exercise prices, one including, but not limited to, upper and lower bound amounts, maximum and minimum amounts, and point estimates.", "label": "Exercise Price Range Three [Member]" } } }, "localname": "ExercisePriceRangeThreeMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingExercisePriceDetails" ], "xbrltype": "domainItemType" }, "VISL_ExercisePriceRangeTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of estimate of range of exercise prices, one including, but not limited to, upper and lower bound amounts, maximum and minimum amounts, and point estimates.", "label": "Exercise Price Range Two [Member]" } } }, "localname": "ExercisePriceRangeTwoMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingExercisePriceDetails" ], "xbrltype": "domainItemType" }, "VISL_FebruaryTwoThousandAndTwentyOneFinancingMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "February 2021 Financing [Member]", "label": "February 2021 Financing [Member]" } } }, "localname": "FebruaryTwoThousandAndTwentyOneFinancingMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_GBPMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "GBP [Member]", "label": "GBP [Member]" } } }, "localname": "GBPMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_GBPToUSDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "GBP To USD [Member]", "label": "GBP To USD [Member]" } } }, "localname": "GBPToUSDMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_GainOnSettlementOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gain On Settlement Of Debt [Table Text Block]", "label": "SCHEDULE OF GAINS ON SETTLEMENT OF DEBT" } } }, "localname": "GainOnSettlementOfDebtTableTextBlock", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/GainsOnSettlementOfDebtTables" ], "xbrltype": "textBlockItemType" }, "VISL_GainOnSettlementOfDebtTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Gain On Settlement Of Debt [Text Block]", "label": "GAINS ON SETTLEMENT OF DEBT" } } }, "localname": "GainOnSettlementOfDebtTextBlock", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/GainsOnSettlementOfDebt" ], "xbrltype": "textBlockItemType" }, "VISL_GoodwillAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill", "verboseLabel": "Schedule Of Goodwill" } } }, "localname": "GoodwillAbstract", "nsuri": "http://vislink.com/20221231", "xbrltype": "stringItemType" }, "VISL_GoodwillAdditions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Goodwill additions.", "label": "Goodwill additions" } } }, "localname": "GoodwillAdditions", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "VISL_GoodwillImpairments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Goodwill impairments.", "label": "Goodwill impairment" } } }, "localname": "GoodwillImpairments", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "VISL_GoodwillIntangiblesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Goodwill Intangibles [Member]", "label": "Goodwill Intangibles [Member]" } } }, "localname": "GoodwillIntangiblesMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfAcquiredIntangibleWithTheirRelativeUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "VISL_GrossProceedsFromIssuanceOfCommonStock": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross proceeds from issuance of common stock.", "label": "Proceeds from issuance of offering" } } }, "localname": "GrossProceedsFromIssuanceOfCommonStock", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "VISL_GroupOfTwentyTwoEmployeesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Group of 22 Employees [Member]", "label": "Group of 22 Employees [Member]" } } }, "localname": "GroupOfTwentyTwoEmployeesMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails" ], "xbrltype": "domainItemType" }, "VISL_GroupPersonalPensionPlanUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Group Personal Pension Plan, UK [Member]", "label": "Group Personal Pension Plan, UK [Member]" } } }, "localname": "GroupPersonalPensionPlanUKMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfMatchingContributionsDetails" ], "xbrltype": "domainItemType" }, "VISL_HemelUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Hemel, UK [Member]", "label": "Hemel, UK [Member]" } } }, "localname": "HemelUKMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfLeaseObligationsAssumedDetails" ], "xbrltype": "domainItemType" }, "VISL_ImpairmentAndAbandonmentPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Impairment and Abandonment [Policy text block]", "label": "Impairment and Abandonment" } } }, "localname": "ImpairmentAndAbandonmentPolicyTextBlock", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "VISL_ImpairmentOfRightofuseAssets": { "auth_ref": [], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 5.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Impairment of right of use assets.", "label": "Impairment of right-of-use assets" } } }, "localname": "ImpairmentOfRightofuseAssets", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows", "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "VISL_IncreaseInInventory": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase in inventory.", "label": "Increase of inventory" } } }, "localname": "IncreaseInInventory", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.DetailsNarrative" ], "xbrltype": "monetaryItemType" }, "VISL_IncreasedReciprocalOfInventory": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increased reciprocal of inventory.", "label": "Reciprocal of inventory, increased" } } }, "localname": "IncreasedReciprocalOfInventory", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.DetailsNarrative" ], "xbrltype": "monetaryItemType" }, "VISL_InstallationIntegrationAndRepairsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Installation, Integration and Repairs [Member]", "label": "Installation, Integration and Repairs [Member]" } } }, "localname": "InstallationIntegrationAndRepairsMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "VISL_IntangibleAssetsAccumulatedAmortizationAdditions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Intangible assets accumulated amortization additions.", "label": "Intangible assets accumulated amortization, Additions" } } }, "localname": "IntangibleAssetsAccumulatedAmortizationAdditions", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "VISL_IntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intangible Assets [Member]", "label": "Intangible Assets [Member]" } } }, "localname": "IntangibleAssetsMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.DetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_InternalRateOfReturnMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Internal Rate Of Return [Member]", "label": "Internal Rate Of Return [Member]" } } }, "localname": "InternalRateOfReturnMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.DetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_IntrinsicValuePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intrinsic value per share.", "label": "Intrinsic value per share" } } }, "localname": "IntrinsicValuePerShare", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansDetails" ], "xbrltype": "perShareItemType" }, "VISL_InventoryValuationAdjustments": { "auth_ref": [], "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Inventory valuation adjustments.", "label": "Inventory valuation adjustments" } } }, "localname": "InventoryValuationAdjustments", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "VISL_IssuanceOfCommonStockInConnectionWithAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Issuance of common stock in connection with abstract.", "label": "Issuance of common stock in connection with:" } } }, "localname": "IssuanceOfCommonStockInConnectionWithAbstract", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "stringItemType" }, "VISL_IssuanceOfCommonStockInConnectionWithWarrantsIssuedInSettlementAgreement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of common stock in connection with warrants issued in settlement agreement.", "label": "Warrants issued in settlement agreement" } } }, "localname": "IssuanceOfCommonStockInConnectionWithWarrantsIssuedInSettlementAgreement", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "VISL_IssuanceOfSharesOfSeriesAPreferredStockAsDividendsForCommonStockShareholders": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of shares of Series A Preferred Stock as dividends for common stock shareholders.", "label": "Issuance of shares of Series A Preferred Stock as dividends for common stock shareholders [Default Label]", "verboseLabel": "Issuance of shares of Series A Preferred Stock as dividends for common stock shareholders" } } }, "localname": "IssuanceOfSharesOfSeriesAPreferredStockAsDividendsForCommonStockShareholders", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "VISL_LeaseExpirationDateDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lease expiration date description.", "label": "Lease-End Date" } } }, "localname": "LeaseExpirationDateDescription", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfLeaseObligationsAssumedDetails" ], "xbrltype": "stringItemType" }, "VISL_LesseeOperatingLeaseRemainingLeaseTerms": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Remaining lease term.", "label": "Lease term, description" } } }, "localname": "LesseeOperatingLeaseRemainingLeaseTerms", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative" ], "xbrltype": "stringItemType" }, "VISL_LiquidityAndFinancialConditionTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Liquidity and financial condition [Text block]", "label": "LIQUIDITY AND FINANCIAL CONDITION" } } }, "localname": "LiquidityAndFinancialConditionTextBlock", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/LiquidityAndFinancialCondition" ], "xbrltype": "textBlockItemType" }, "VISL_LossOnLeaseImpairments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "loss on lease impairments.", "label": "loss on lease impairments" } } }, "localname": "LossOnLeaseImpairments", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "VISL_LuttonUKMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lutton, UK [Member]", "label": "Lutton, UK [Member]" } } }, "localname": "LuttonUKMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_MikeBondMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mike Bond [Member]", "label": "Mike Bond [Member]" } } }, "localname": "MikeBondMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails" ], "xbrltype": "domainItemType" }, "VISL_MobileViewpointCorporateBVMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mobile Viewpoint Corporate BV [Member]", "label": "Mobile Viewpoint Corporate BV [Member]" } } }, "localname": "MobileViewpointCorporateBVMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.DetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_MountOliveNJMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Mount Olive, NJ [Member]", "label": "Mount Olive, NJ [Member]" } } }, "localname": "MountOliveNJMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative", "http://vislink.com/role/ScheduleOfLeaseObligationsAssumedDetails" ], "xbrltype": "domainItemType" }, "VISL_NewlyIssuedAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Recently Issued Accounting Pronouncement [Policy Text Block]", "label": "Recently Issued Accounting Pronouncements" } } }, "localname": "NewlyIssuedAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "VISL_NoncashChangesToOperatingLeaseLiabilitiesAccretion": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Less: non-cash changes to operating lease liabilities accretion" } } }, "localname": "NoncashChangesToOperatingLeaseLiabilitiesAccretion", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "VISL_NoncashDisclosuresOfRouAssetsAndOperatingLeaseObligationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non cash disclosures of rou assets and operating lease obligation abstract.", "label": "ROU assets and operating lease obligations recognized (Note 12):" } } }, "localname": "NoncashDisclosuresOfRouAssetsAndOperatingLeaseObligationAbstract", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "VISL_NotesPayableOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Notes Payable One [Member]", "label": "Notes Payable One [Member]" } } }, "localname": "NotesPayableOneMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfNotesPayableDetails", "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "xbrltype": "domainItemType" }, "VISL_NotesPayableTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Notes Payable Two [Member]", "label": "Notes Payable Two [Member]" } } }, "localname": "NotesPayableTwoMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfNotesPayableDetails", "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "xbrltype": "domainItemType" }, "VISL_NumberOfSharesIssuedForExerciseOfWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued for exercise of warrants.", "label": "Number of shares issued for exercise of warrants [Default Label]", "verboseLabel": "Number of shares issued for exercise of warrants" } } }, "localname": "NumberOfSharesIssuedForExerciseOfWarrants", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "VISL_NumberOfSharesUnderlyingWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares underlying the warrants.", "label": "Number of shares underlying the warrants" } } }, "localname": "NumberOfSharesUnderlyingWarrants", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfValuationAndWarrantsExercisableDetails" ], "xbrltype": "sharesItemType" }, "VISL_OneVendorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "One Vendor [Member]", "label": "One Vendor [Member]" } } }, "localname": "OneVendorMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_OperatingImpairments": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating impairments.", "label": "impairments" } } }, "localname": "OperatingImpairments", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "VISL_OperatingLeaseAssetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operating lease asset abstract.", "label": "Less: non-cash changes to operating lease assets amortization" } } }, "localname": "OperatingLeaseAssetAbstract", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "VISL_OperatingLeaseAssetAmortization": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating lease asset amortization.", "label": "OperatingLeaseAssetAmortization", "negatedLabel": "amortization" } } }, "localname": "OperatingLeaseAssetAmortization", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "VISL_OperatingLeaseAssetsRecognized": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating lease assets recognized.", "label": "Operating lease assets recognized" } } }, "localname": "OperatingLeaseAssetsRecognized", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "VISL_OperatingLeaseLiabilitiesRecognized": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating lease liabilities recognized.", "label": "Operating lease liabilities recognized" } } }, "localname": "OperatingLeaseLiabilitiesRecognized", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "VISL_OperatingLeaseRightOfUseAssetAccumulatedAmortization": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating lease accumulated amortization.", "label": "Right of use assets, accumulated depreciation" } } }, "localname": "OperatingLeaseRightOfUseAssetAccumulatedAmortization", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "VISL_OperatingLeasesRightOfUseAssetAccumulatedAmortization": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Right-of-use" } } }, "localname": "OperatingLeasesRightOfUseAssetAccumulatedAmortization", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "VISL_OperatingLossCarryforwardsExpirationDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operating loss carryforwards, expiration description.", "label": "Operating loss carryforwards, expiration description" } } }, "localname": "OperatingLossCarryforwardsExpirationDescription", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "VISL_OtherMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other [Member]", "label": "Other [Member]" } } }, "localname": "OtherMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails", "http://vislink.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnNon-recurringBasisDetails" ], "xbrltype": "domainItemType" }, "VISL_PatentsAndLicensesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Patents and Licenses [Member]", "label": "Patents and Licenses [Member]" } } }, "localname": "PatentsAndLicensesMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/IntangibleAssetsDetailsNarrative", "http://vislink.com/role/ScheduleOfAmortizationOfIntangibleAssetsDetails", "http://vislink.com/role/ScheduleOfCapitalizedIntangibleCostsDetails", "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_PaymentForRentPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Payment for rent percentage.", "label": "Payment for rent percentage" } } }, "localname": "PaymentForRentPercentage", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative" ], "xbrltype": "percentItemType" }, "VISL_PaymentOfIntercompanyIndebtedness": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payment of intercompany indebtness.", "label": "Acquisition payment amount" } } }, "localname": "PaymentOfIntercompanyIndebtedness", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.DetailsNarrative" ], "xbrltype": "monetaryItemType" }, "VISL_PayrollProtectionProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Payroll Protection Program [Member]", "label": "Payroll Protection Program [Member]" } } }, "localname": "PayrollProtectionProgramMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetails", "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical" ], "xbrltype": "domainItemType" }, "VISL_PerformanceBasedOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Performance Based Option [Member]", "label": "Performance Based Option [Member]" } } }, "localname": "PerformanceBasedOptionMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfShare-basedPaymentAwardStockOptionsValuationAssumptionsDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetailsParenthetical", "http://vislink.com/role/Stock-basedCompensationDetailsNarrative", "http://vislink.com/role/Stock-basedCompensationTables" ], "xbrltype": "domainItemType" }, "VISL_PerformanceBasedRestrictedStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Performance Based Restricted Stock Units [Member]", "label": "Performance Based Restricted Stock Units [Member]" } } }, "localname": "PerformanceBasedRestrictedStockUnitsMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails" ], "xbrltype": "domainItemType" }, "VISL_PerformanceBasedStockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Performance Based Stock Option [Member]", "label": "Performance Based Stock Option [Member]" } } }, "localname": "PerformanceBasedStockOptionMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails" ], "xbrltype": "domainItemType" }, "VISL_ProceedsFromOtherConnectionWithEquityFinancing": { "auth_ref": [], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from other connection with equity financing.", "label": "Costs incurred in connection with equity financing" } } }, "localname": "ProceedsFromOtherConnectionWithEquityFinancing", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "VISL_ProductRationalizationProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Product Rationalization Program [Member]", "label": "Product Rationalization Program [Member]" } } }, "localname": "ProductRationalizationProgramMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/InventoriesDetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_ProprietaryTechnologiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Proprietary Technologies [Member]", "label": "Proprietary Technologies [Member]" } } }, "localname": "ProprietaryTechnologiesMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfAcquiredIntangibleWithTheirRelativeUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "VISL_ProprietaryTechnologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Proprietary Technology [Member]", "label": "Proprietary Technology [Member]" } } }, "localname": "ProprietaryTechnologyMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.DetailsNarrative", "http://vislink.com/role/IntangibleAssetsDetailsNarrative", "http://vislink.com/role/ScheduleOfAmortizationOfIntangibleAssetsDetails", "http://vislink.com/role/ScheduleOfCapitalizedIntangibleCostsDetails", "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails", "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "VISL_ROUAssetsAndOperatingLeaseObligationsRecognized": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "ROU assets and operating lease obligations recognized.", "label": "ROU assets and operating lease obligations recognized" } } }, "localname": "ROUAssetsAndOperatingLeaseObligationsRecognized", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "VISL_RebatesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rebates [Text Block]", "label": "REBATES" } } }, "localname": "RebatesTextBlock", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/Rebates" ], "xbrltype": "textBlockItemType" }, "VISL_RecognizationOfOperatingLeaseLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating lease liabilities recognized.", "label": "Operating lease liabilities recognized [Default Label]", "verboseLabel": "Operating lease liabilities recognized" } } }, "localname": "RecognizationOfOperatingLeaseLiabilities", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "VISL_RecoveryOfBadDebt": { "auth_ref": [], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Recovery of bad debt.", "label": "Recovered bad debts", "negatedLabel": "Recovery of bad debt" } } }, "localname": "RecoveryOfBadDebt", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/AccountsReceivableDetailsNarrative", "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "VISL_RedeemablePreferredStockPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redeemable preferred stock [Policy Text Block]", "label": "Redeemable Preferred Stock" } } }, "localname": "RedeemablePreferredStockPolicyTextBlock", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "VISL_RemainingStockCompensationExpenses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Remaining stock compensation expense.", "label": "Remaining expense of stock-based compensation" } } }, "localname": "RemainingStockCompensationExpenses", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansDetails" ], "xbrltype": "monetaryItemType" }, "VISL_RemittanceSettlement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Remittance settlement.", "label": "Remittance settlement" } } }, "localname": "RemittanceSettlement", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical" ], "xbrltype": "monetaryItemType" }, "VISL_RestOfWorldMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rest of World [Member]", "label": "Rest of World [Member]" } } }, "localname": "RestOfWorldMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "VISL_RisksAndUncertaintiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Risks And Uncertainties [Policy Text Block]", "label": "Risks and Uncertainties" } } }, "localname": "RisksAndUncertaintiesPolicyTextBlock", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "VISL_SalesTaxAndValueAddedTaxesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sales tax and value added taxes [Policy text block]", "label": "Sales Tax and Value-Added Taxes" } } }, "localname": "SalesTaxAndValueAddedTaxesPolicyTextBlock", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "VISL_SatisfactionOfAccountsPayableVendorBalance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Satisfaction of accounts payable vendor balance.", "label": "Satisfaction of accounts payable vendor balance" } } }, "localname": "SatisfactionOfAccountsPayableVendorBalance", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "VISL_SatisfactionOfAccountsPayableVendorBalanceShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Satisfaction of accounts payable vendor balance shares.", "label": "Satisfaction of accounts payable vendor balance, shares" } } }, "localname": "SatisfactionOfAccountsPayableVendorBalanceShares", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "VISL_SatisfactionOfWithholdingTaxUponConversionOfRestrictedStockUnits": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Satisfaction of withholding tax upon conversion of restricted stock units.", "label": "Satisfaction of withholding tax upon conversion of restricted stock units" } } }, "localname": "SatisfactionOfWithholdingTaxUponConversionOfRestrictedStockUnits", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "VISL_SatisfactionOfWithholdingTaxUponConversionOfRestrictedStockUnitsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Satisfaction of withholding tax upon conversion of restricted stock units shares.", "label": "Satisfaction of withholding tax upon conversion of restricted stock units, shares" } } }, "localname": "SatisfactionOfWithholdingTaxUponConversionOfRestrictedStockUnitsShares", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "VISL_SatisfactionWithConversionOfRestrictedStockUnits": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Satisfaction with conversion of restricted stock units.", "label": "Satisfaction with the conversion of restricted stock units" } } }, "localname": "SatisfactionWithConversionOfRestrictedStockUnits", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "VISL_SatisfactionWithTheConversionOfRestrictedStockUnitsShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Satisfaction of withholding tax upon conversion.", "label": "Satisfaction with the conversion of restricted stock units, shares" } } }, "localname": "SatisfactionWithTheConversionOfRestrictedStockUnitsShares", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "VISL_ScheduleOfLeasesObligationsAssumedTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Lease Obligations Assumed [Table Text Block]", "label": "SCHEDULE OF LEASE OBLIGATIONS ASSUMED" } } }, "localname": "ScheduleOfLeasesObligationsAssumedTableTextBlock", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "VISL_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of share based compensation employee stock purchase plan activities [Table text block]", "label": "SCHEDULE OF STOCK OPTION PLANS" } } }, "localname": "ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivitiesTableTextBlock", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/Stock-basedCompensationTables" ], "xbrltype": "textBlockItemType" }, "VISL_ScheduleOfValuationAndWarrantsExercisableTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of valuation and warrants exercisable [Table text block]", "label": "SCHEDULE OF VALUATION AND WARRANTS EXERCISABLE" } } }, "localname": "ScheduleOfValuationAndWarrantsExercisableTableTextBlock", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/DerivativeLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "VISL_ScheduleOfWarrantOutstandingExercisePriceTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of warrant outstanding exercise price [Table text block]", "label": "SCHEDULE OF WARRANT OUTSTANDING EXERCISE PRICE" } } }, "localname": "ScheduleOfWarrantOutstandingExercisePriceTableTextBlock", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "VISL_SeriesDConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series D Convertible Preferred Stock [Member]", "label": "Series D Convertible Preferred Stock [Member]" } } }, "localname": "SeriesDConvertiblePreferredStockMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/PreferredSharesDetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_SeriesDPreferredStockAndSeriesEPreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series D Preferred Stock and Series E Preferred Stock [Member]", "label": "Series D Preferred Stock and Series E Preferred Stock [Member]" } } }, "localname": "SeriesDPreferredStockAndSeriesEPreferredStockMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/PreferredSharesDetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_SeriesEConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series E Convertible Preferred Stock [Member]", "label": "Series E Convertible Preferred Stock [Member]" } } }, "localname": "SeriesEConvertiblePreferredStockMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/PreferredSharesDetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_SettlementOfAmountsDueAccountsPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Settlement of amounts due accounts payable.", "label": "Settlement of amounts due accounts payable" } } }, "localname": "SettlementOfAmountsDueAccountsPayable", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "VISL_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award vesting date.", "label": "25% Vesting" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingDate", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails" ], "xbrltype": "dateItemType" }, "VISL_ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Options vesting commencement date.", "label": "Vesting commencement date" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardCommencementDate", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails" ], "xbrltype": "dateItemType" }, "VISL_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award equity instruments other than exercised", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised", "negatedLabel": "Restricted stock units exercised outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercised", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansDetails" ], "xbrltype": "sharesItemType" }, "VISL_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Options grant date.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInDate", "verboseLabel": "Grant date" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInDate", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails" ], "xbrltype": "dateItemType" }, "VISL_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award equity instruments other than options grants in period weighted average outstanding", "label": "Weighted average exercise price Restricted stock units exercised outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageOutstanding", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansDetails" ], "xbrltype": "perShareItemType" }, "VISL_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisableWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted stock units, exercisable weighted average exercise price.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisableWeightedAverageGrantDateFairValue", "periodEndLabel": "Weighted average exercise price RSUs, exercisable, ending balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedExercisableWeightedAverageGrantDateFairValue", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansDetails" ], "xbrltype": "perShareItemType" }, "VISL_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingAndExercisableWeightedAverageRemainingContractualTerms": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award equity instruments other than options outstanding and exercisable weighted average remaining contractual terms.", "label": "Weighted average remaining contractual life options outstanding and exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingAndExercisableWeightedAverageRemainingContractualTerms", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansDetails" ], "xbrltype": "durationItemType" }, "VISL_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vested date.", "label": "Initial RSUs Vesting, Vested Date" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInDate", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails" ], "xbrltype": "dateItemType" }, "VISL_ShareBasedCompensationArrangementByShareBasedPaymentAwardGrantDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award grant date.", "label": "Grant date" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardGrantDate", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails" ], "xbrltype": "dateItemType" }, "VISL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation arrangement by share based payment award non option equity instruments outstanding and exercisable numbers.", "label": "Warrants Outstanding and Exercisable (in shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisableNumbers", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingExercisePriceDetails" ], "xbrltype": "sharesItemType" }, "VISL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableOutstandingWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Exercise Price.", "label": "Weighted average exercise price ending exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableOutstandingWeightedAverageExercisePrice", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "VISL_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Exercise Price.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice", "periodEndLabel": "Weighted average exercise price ending outstanding", "periodStartLabel": "Weighted average exercise price ending outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingDetails" ], "xbrltype": "perShareItemType" }, "VISL_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Exercise Price, exercised.", "label": "Weighted Average Exercise Price, exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingDetails" ], "xbrltype": "perShareItemType" }, "VISL_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Exercise Price, cancelled/expired.", "label": "Weighted average exercise price cancelled/expired" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingDetails" ], "xbrltype": "perShareItemType" }, "VISL_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Exercise Price, granted.", "label": "Weighted average exercise price granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingDetails" ], "xbrltype": "perShareItemType" }, "VISL_ShareBasedCompensationSharesAuthorizedUnderNonOptionExercisePriceRange": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Range of Exercise Prices.", "label": "Range of exercise prices" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderNonOptionExercisePriceRange", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansDetails" ], "xbrltype": "perShareItemType" }, "VISL_ShareBasedCompensationSharesAuthorizedUnderNonOptionOutstandingAndExercisePriceRange": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation shares authorized under non option outstanding and exercise price range.", "label": "Warrants outstanding and exercisable, Range of exercise prices" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderNonOptionOutstandingAndExercisePriceRange", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingExercisePriceDetails" ], "xbrltype": "perShareItemType" }, "VISL_ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePriceRangeLowerRangeLimit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted stock units, exercise price lower limit.", "label": "RSUs range of exercise prices, upper limit" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePriceRangeLowerRangeLimit", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansDetails" ], "xbrltype": "perShareItemType" }, "VISL_ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePriceRangeUpperRangeLimit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted stock units, exercise price upper limit.", "label": "Range of exercise prices, upper" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOtherThanOptionPlansExercisePriceRangeUpperRangeLimit", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansDetails" ], "xbrltype": "perShareItemType" }, "VISL_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingAndExercisableRemainingContractualTerm2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Remaining erercisable price.", "label": "Outstanding and exercisable term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingAndExercisableRemainingContractualTerm2", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansDetails" ], "xbrltype": "durationItemType" }, "VISL_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingRemainingContractualTerms": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Veated Remaning contractual terms.", "label": "Remaining RSUs Vesting, Term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingRemainingContractualTerms", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails" ], "xbrltype": "stringItemType" }, "VISL_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingRemainingContractualUnits": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vested Remaning contractual term", "label": "Remaining RSUs Vesting, Units" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingRemainingContractualUnits", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails" ], "xbrltype": "sharesItemType" }, "VISL_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation shares authorized under stock option plans exercise price range outstanding and exercisable options weighted average exercise price one.", "label": "Warrants outstanding and exercisable, Weighted Average Exercise Price" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageExercisePrice1", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingExercisePriceDetails" ], "xbrltype": "perShareItemType" }, "VISL_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based compensation shares authorized under stock option plans exercise price range outstanding and exercisable options weighted average remaining contractual term two.", "label": "Warrants outstanding and exercisable, Weighted Average Remaining Contractual Life (years)" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingAndExercisableOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingExercisePriceDetails" ], "xbrltype": "durationItemType" }, "VISL_ShippingAndHandlingCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cost incurred during the period in shipping and handling goods and services to customers.", "label": "Shipping and handling costs" } } }, "localname": "ShippingAndHandlingCosts", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "VISL_ShippingAndHandlingCostsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shipping and handling costs [Policy text block]", "label": "Shipping and Handling Costs" } } }, "localname": "ShippingAndHandlingCostsPolicyTextBlock", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "VISL_SingleCustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Single Customer [Member]", "label": "Single Customer [Member]" } } }, "localname": "SingleCustomerMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_SpecificBoardMembersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Specific Board Members [Member]", "label": "Specific Board Members [Member]" } } }, "localname": "SpecificBoardMembersMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_StockIssuanceCommitments": { "auth_ref": [], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Stock issuance commitments.", "label": "StockIssuanceCommitments", "verboseLabel": "Stock issuance commitments" } } }, "localname": "StockIssuanceCommitments", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "VISL_StockIssuanceCommitmentsValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Stock issuance commitments value.", "label": "Stock issuance commitments" } } }, "localname": "StockIssuanceCommitmentsValue", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "VISL_StockIssuedDuringPeriodSharesCommitments": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period shares commitments.", "label": "Stock issuance commitments,shares" } } }, "localname": "StockIssuedDuringPeriodSharesCommitments", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "VISL_StockIssuedDuringPeriodSharesExchangeForPaymentOfOfferingCosts": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period shares exchange for payment of offering costs.", "label": "Underwriting equity raise, net of offering costs,shares" } } }, "localname": "StockIssuedDuringPeriodSharesExchangeForPaymentOfOfferingCosts", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "VISL_StockIssuedDuringPeriodValueExchangeForPaymentOfOfferingCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock issued during period value exchange for payment of offering costs.", "label": "Underwriting equity raises, net of offering costs" } } }, "localname": "StockIssuedDuringPeriodValueExchangeForPaymentOfOfferingCosts", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "VISL_TemporaryEquityRedemptionShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Temporary equity, redemption shares.", "label": "Temporary equity, redemption shares" } } }, "localname": "TemporaryEquityRedemptionShares", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "VISL_TimeVestedOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Time Vested Option [Member]", "label": "Time Vested Option [Member]" } } }, "localname": "TimeVestedOptionMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfShare-basedPaymentAwardStockOptionsValuationAssumptionsDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails", "http://vislink.com/role/Stock-basedCompensationTables" ], "xbrltype": "domainItemType" }, "VISL_TradeNameMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trade name [Member]", "label": "Trade name [Member]" } } }, "localname": "TradeNameMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfAcquiredIntangibleWithTheirRelativeUsefulLivesDetails" ], "xbrltype": "domainItemType" }, "VISL_TradeNamesAndTechnologyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trade Names And Technology [Member]", "label": "Trade Names And Technology [Member]" } } }, "localname": "TradeNamesAndTechnologyMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/IntangibleAssetsDetailsNarrative", "http://vislink.com/role/ScheduleOfAmortizationOfIntangibleAssetsDetails", "http://vislink.com/role/ScheduleOfCapitalizedIntangibleCostsDetails", "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "VISL_TreasuryStockPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Treasury stock [Policy text block]", "label": "Treasury Stock" } } }, "localname": "TreasuryStockPolicyTextBlock", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "VISL_TwoThousandThirteenLongTermStockIncentivePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2013 Long-Term Stock Incentive Plan [Member]", "label": "2013 Long-Term Stock Incentive Plan [Member]" } } }, "localname": "TwoThousandThirteenLongTermStockIncentivePlanMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansDetails", "http://vislink.com/role/Stock-basedCompensationTables" ], "xbrltype": "domainItemType" }, "VISL_VendorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Vendor [Member]", "label": "Vendor [Member]" } } }, "localname": "VendorMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetails", "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical" ], "xbrltype": "domainItemType" }, "VISL_VpGlobalOperationsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "VP Global Operations [Member]", "label": "VP Global Operations [Member]" } } }, "localname": "VpGlobalOperationsMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails" ], "xbrltype": "domainItemType" }, "VISL_WarrantHoldersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant Holders [Member]", "label": "Warrant Holders [Member]" } } }, "localname": "WarrantHoldersMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_WarrantHoldersOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant Holders One [Member]", "label": "Warrant Holders One [Member]" } } }, "localname": "WarrantHoldersOneMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "VISL_WarrantiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warranties [Member]", "label": "Warranties [Member]" } } }, "localname": "WarrantiesMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "VISL_WarrantsAndRightsOutstandingTerms": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants And Rights Outstanding Terms.", "label": "Warrants term" } } }, "localname": "WarrantsAndRightsOutstandingTerms", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "durationItemType" }, "VISL_WarrantsIssuedInSettlementAgreements": { "auth_ref": [], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Warrants issued in settlement agreements.", "label": "WarrantsIssuedInSettlementAgreements", "verboseLabel": "Warrants issued in settlement agreement" } } }, "localname": "WarrantsIssuedInSettlementAgreements", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "VISL_WarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants [Member].", "label": "Warrants [Member]" } } }, "localname": "WarrantsMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingExercisePriceDetails" ], "xbrltype": "domainItemType" }, "VISL_WeightedAverageCostCapitalPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average cost capital percentage.", "label": "Weighted average cost capital percentage" } } }, "localname": "WeightedAverageCostCapitalPercentage", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.DetailsNarrative" ], "xbrltype": "percentItemType" }, "VISL_WorkingCapital": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Working capital.", "label": "Working capital" } } }, "localname": "WorkingCapital", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "VISL_WorkingCapitalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Working Capital [Member]", "label": "Working Capital [Member]" } } }, "localname": "WorkingCapitalMember", "nsuri": "http://vislink.com/20221231", "presentation": [ "http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.DetailsNarrative" ], "xbrltype": "domainItemType" }, "country_GB": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED KINGDOM" } } }, "localname": "GB", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "country_NL": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NETHERLANDS" } } }, "localname": "NL", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "country_SG": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SINGAPORE" } } }, "localname": "SG", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://vislink.com/role/ScheduleOfLeaseObligationsAssumedDetails" ], "xbrltype": "domainItemType" }, "country_US": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "UNITED STATES" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2022", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r725" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r725" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r722", "r724", "r725" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r722", "r724", "r725" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r722", "r724", "r725" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r724" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r722", "r724", "r725" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r723" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r711" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r724" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r724" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r726" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r714" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r717" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r713" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r713" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r730" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r713" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r727" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r725" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r713" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r713" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r713" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r713" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r728" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r724" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r718" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r719" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r712" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r716" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r715" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r720" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r721" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r729" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://vislink.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_AsiaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Asia [Member]" } } }, "localname": "AsiaMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [ "r765" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer [Member]" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://vislink.com/role/ScheduleOfShare-basedPaymentAwardStockOptionsValuationAssumptionsDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetailsParenthetical" ], "xbrltype": "domainItemType" }, "srt_ChiefFinancialOfficerMember": { "auth_ref": [ "r765" ], "lang": { "en-us": { "role": { "label": "Chief Financial Officer [Member]" } } }, "localname": "ChiefFinancialOfficerMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://vislink.com/role/ScheduleOfShare-basedPaymentAwardStockOptionsValuationAssumptionsDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails" ], "xbrltype": "domainItemType" }, "srt_DirectorMember": { "auth_ref": [ "r765" ], "lang": { "en-us": { "role": { "label": "Director [Member]" } } }, "localname": "DirectorMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails" ], "xbrltype": "domainItemType" }, "srt_EuropeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Europe [Member]" } } }, "localname": "EuropeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r333", "r695", "r791", "r857" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r375", "r376", "r377", "r378", "r465", "r625", "r641", "r671", "r672", "r692", "r705", "r710", "r788", "r850", "r851", "r852", "r853", "r854", "r855" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.DetailsNarrative", "http://vislink.com/role/IntangibleAssetsDetailsNarrative", "http://vislink.com/role/ScheduleOfPropertyAndEquipmentDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansDetails", "http://vislink.com/role/ScheduleOfValuationAndWarrantsExercisableDetails", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r375", "r376", "r377", "r378", "r465", "r625", "r641", "r671", "r672", "r692", "r705", "r710", "r788", "r850", "r851", "r852", "r853", "r854", "r855" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://vislink.com/role/IntangibleAssetsDetailsNarrative", "http://vislink.com/role/ScheduleOfPropertyAndEquipmentDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansDetails", "http://vislink.com/role/ScheduleOfValuationAndWarrantsExercisableDetails", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r333", "r695", "r791", "r857" ], "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_NorthAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "North America [Member]" } } }, "localname": "NorthAmericaMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r375", "r376", "r377", "r378", "r457", "r465", "r495", "r496", "r497", "r601", "r625", "r641", "r671", "r672", "r692", "r705", "r710", "r784", "r788", "r851", "r852", "r853", "r854", "r855" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.DetailsNarrative", "http://vislink.com/role/IntangibleAssetsDetailsNarrative", "http://vislink.com/role/ScheduleOfPropertyAndEquipmentDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansDetails", "http://vislink.com/role/ScheduleOfValuationAndWarrantsExercisableDetails", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r375", "r376", "r377", "r378", "r457", "r465", "r495", "r496", "r497", "r601", "r625", "r641", "r671", "r672", "r692", "r705", "r710", "r784", "r788", "r851", "r852", "r853", "r854", "r855" ], "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.DetailsNarrative", "http://vislink.com/role/IntangibleAssetsDetailsNarrative", "http://vislink.com/role/ScheduleOfPropertyAndEquipmentDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansDetails", "http://vislink.com/role/ScheduleOfValuationAndWarrantsExercisableDetails", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_RestatementAdjustmentMember": { "auth_ref": [ "r274", "r275", "r276", "r284", "r285", "r300", "r552", "r553", "r753", "r754", "r755", "r756", "r758", "r761", "r762" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period, Adjustment [Member]" } } }, "localname": "RestatementAdjustmentMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "domainItemType" }, "srt_RestatementAxis": { "auth_ref": [ "r231", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r284", "r285", "r286", "r287", "r288", "r289", "r300", "r343", "r344", "r529", "r551", "r552", "r553", "r554", "r575", "r589", "r590", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r651" ], "lang": { "en-us": { "role": { "label": "Revision of Prior Period [Axis]" } } }, "localname": "RestatementAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "stringItemType" }, "srt_RestatementDomain": { "auth_ref": [ "r231", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r284", "r285", "r286", "r287", "r288", "r289", "r300", "r343", "r344", "r529", "r551", "r552", "r553", "r554", "r575", "r589", "r590", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r651" ], "localname": "RestatementDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioPreviouslyReportedMember": { "auth_ref": [ "r231", "r274", "r276", "r277", "r278", "r279", "r280", "r288", "r300", "r529", "r551", "r552", "r553", "r575", "r642", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r651", "r757", "r758", "r759", "r760", "r761", "r770", "r771", "r832", "r845", "r846" ], "lang": { "en-us": { "role": { "label": "Previously Reported [Member]" } } }, "localname": "ScenarioPreviouslyReportedMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r331", "r332", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r694", "r709", "r791" ], "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative", "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails", "http://vislink.com/role/ScheduleOfLeaseObligationsAssumedDetails" ], "xbrltype": "domainItemType" }, "srt_SouthAmericaMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "South America [Member]" } } }, "localname": "SouthAmericaMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r331", "r332", "r655", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r694", "r709", "r791" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative", "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails", "http://vislink.com/role/ScheduleOfLeaseObligationsAssumedDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r765", "r847" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetails", "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical", "http://vislink.com/role/ScheduleOfShare-basedPaymentAwardStockOptionsValuationAssumptionsDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetailsParenthetical", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetails", "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical", "http://vislink.com/role/ScheduleOfShare-basedPaymentAwardStockOptionsValuationAssumptionsDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetailsParenthetical", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r22" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.", "label": "ACCRUED EXPENSES" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/AccruedExpenses" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r21", "r708" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable", "verboseLabel": "Amount payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheets", "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableCurrentAndNoncurrent": { "auth_ref": [ "r212", "r226" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Accounts Payable", "verboseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableMember": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Obligations incurred and payable to vendors for goods and services received.", "label": "Accounts Payable [Member]" } } }, "localname": "AccountsPayableMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableGrossCurrent": { "auth_ref": [ "r245", "r334", "r335", "r676" ], "calculation": { "http://vislink.com/role/ScheduleOfAccountsReceivableDetails": { "order": 1.0, "parentTag": "us-gaap_AccountsReceivableNetCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable" } } }, "localname": "AccountsReceivableGrossCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r657" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNet": { "auth_ref": [ "r636", "r656" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.", "label": "Accounts Receivable, after Allowance for Credit Loss", "verboseLabel": "Accounts receivable" } } }, "localname": "AccountsReceivableNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r334", "r335" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://vislink.com/role/ScheduleOfAccountsReceivableDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable, net", "totalLabel": "Net accounts receivable" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheets", "http://vislink.com/role/ScheduleOfAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r26" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://vislink.com/role/ScheduleOfAccruedExpensesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued expenses", "totalLabel": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheets", "http://vislink.com/role/ScheduleOfAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedRentCurrent": { "auth_ref": [ "r26", "r677" ], "calculation": { "http://vislink.com/role/ScheduleOfAccruedExpensesDetails": { "order": 4.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for contractual rent under lease arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Rent" } } }, "localname": "AccruedRentCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedSalesCommissionCurrent": { "auth_ref": [ "r26", "r677" ], "calculation": { "http://vislink.com/role/ScheduleOfAccruedExpensesDetails": { "order": 2.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Commissions" } } }, "localname": "AccruedSalesCommissionCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r96", "r238" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingExercisePriceDetails", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r37", "r39", "r40", "r246", "r637", "r647", "r651" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [ "r256", "r257", "r564", "r565", "r566", "r567", "r568", "r570" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingExercisePriceDetails", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r36", "r40", "r176", "r590", "r642", "r643", "r739", "r740", "r741", "r750", "r751", "r752" ], "lang": { "en-us": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Acquired Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r84" ], "lang": { "en-us": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Useful life" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfAcquiredIntangibleWithTheirRelativeUsefulLivesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r13", "r708" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r503", "r504", "r505", "r750", "r751", "r752", "r831" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentForAmortization": { "auth_ref": [ "r57", "r89" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.", "label": "Amortization [Default Label]", "negatedLabel": "Intangible assets, Amortization" } } }, "localname": "AdjustmentForAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r153", "r154", "r467" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "Stock-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "auth_ref": [ "r508" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for advertising cost.", "label": "Advertising Costs" } } }, "localname": "AdvertisingCostsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_AdvertisingExpense": { "auth_ref": [ "r509" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.", "label": "Advertising costs" } } }, "localname": "AdvertisingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r499" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Stock compensation costs" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r247", "r336", "r345" ], "calculation": { "http://vislink.com/role/ScheduleOfAccountsReceivableDetails": { "order": 2.0, "parentTag": "us-gaap_AccountsReceivableNetCurrent", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "negatedLabel": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfAccountsReceivableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r57", "r82", "r89" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization", "negatedLabel": "Intangible assets, net Amortization", "verboseLabel": "Amortization of intangible assets" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfAmortizationOfIntangibleAssetsDetails", "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r299" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Total" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfAnti-diliutivePotentialCommonStockEquivalentsExcludeFromCalculationOfLossPerShareDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": { "auth_ref": [ "r67" ], "lang": { "en-us": { "role": { "documentation": "Information by type of antidilutive security.", "label": "Antidilutive Securities [Axis]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfAnti-diliutivePotentialCommonStockEquivalentsExcludeFromCalculationOfLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfAnti-diliutivePotentialCommonStockEquivalentsExcludeFromCalculationOfLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AntidilutiveSecuritiesNameDomain": { "auth_ref": [ "r67" ], "lang": { "en-us": { "role": { "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented." } } }, "localname": "AntidilutiveSecuritiesNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfAnti-diliutivePotentialCommonStockEquivalentsExcludeFromCalculationOfLossPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AreaOfLand": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area of land held.", "label": "Area of land", "verboseLabel": "Area of Land" } } }, "localname": "AreaOfLand", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative", "http://vislink.com/role/ScheduleOfLeaseObligationsAssumedDetails" ], "xbrltype": "areaItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/IncomeTaxesDetailsNarrative", "http://vislink.com/role/InventoriesDetailsNarrative", "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetails", "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical", "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AssetImpairmentCharges": { "auth_ref": [ "r57", "r93" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.", "label": "Product lines impairing of inventories" } } }, "localname": "AssetImpairmentCharges", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/InventoriesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r206", "r219", "r241", "r270", "r315", "r324", "r328", "r341", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r545", "r547", "r558", "r708", "r786", "r787", "r848" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r233", "r250", "r270", "r341", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r545", "r547", "r558", "r708", "r786", "r787", "r848" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r191" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Total Assets (non-recurring)" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnNon-recurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r470", "r471", "r472", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r494", "r495", "r496", "r497", "r498" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetailsParenthetical", "http://vislink.com/role/Stock-basedCompensationTables", "http://vislink.com/role/StockholdersEquityDetailsNarrative", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BasicEarningsPerShareProForma": { "auth_ref": [ "r0", "r593" ], "lang": { "en-us": { "role": { "documentation": "Pro forma basic earnings per share or earnings per unit, which is commonly presented in initial public offerings based on the terms of the offering.", "label": "Net loss per share" } } }, "localname": "BasicEarningsPerShareProForma", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfUnauditedPro-formaCombinedResultsOfOperationsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r542", "r703", "r704" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.DetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r167", "r168", "r542", "r703", "r704" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.DetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.DetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "auth_ref": [ "r827", "r828" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.", "label": "SCHEDULE OF UNAUDITED PRO-FORMA COMBINED RESULTS OF OPERATIONS" } } }, "localname": "BusinessAcquisitionProFormaInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.Tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": { "auth_ref": [ "r540", "r541" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.", "label": "Net loss allocable to common stockholders" } } }, "localname": "BusinessAcquisitionsProFormaNetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfUnauditedPro-formaCombinedResultsOfOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionsProFormaRevenue": { "auth_ref": [ "r540", "r541" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.", "label": "Revenues, net" } } }, "localname": "BusinessAcquisitionsProFormaRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfUnauditedPro-formaCombinedResultsOfOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAcquisitionRelatedCosts": { "auth_ref": [ "r166" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.", "label": "Acquisition related costs" } } }, "localname": "BusinessCombinationAcquisitionRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.DetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationConsiderationTransferredAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair value of consideration transferred:" } } }, "localname": "BusinessCombinationConsiderationTransferredAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r174", "r543" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "ACQUISITION OF MOBILE VIEWPOINT CORPORATE B.V." } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v." ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "auth_ref": [ "r170" ], "calculation": { "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents", "verboseLabel": "Cash" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets": { "auth_ref": [ "r170" ], "calculation": { "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Prepaid expenses and other assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "auth_ref": [ "r170" ], "calculation": { "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables", "verboseLabel": "Accounts receivable, net" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": { "auth_ref": [ "r170" ], "calculation": { "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 6.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable", "negatedLabel": "Accounts payable" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue": { "auth_ref": [ "r170" ], "calculation": { "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 8.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred revenue expected to be recognized as such within one year or the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Deferred Revenue", "negatedLabel": "Customer deposits and deferred revenue" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesDeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": { "auth_ref": [ "r170" ], "calculation": { "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 7.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other", "negatedLabel": "Accrued expenses" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "auth_ref": [ "r169", "r170" ], "calculation": { "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of inventory recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory", "verboseLabel": "Inventories, net" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet": { "auth_ref": [ "r169", "r170" ], "calculation": { "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized as of the acquisition date for the identifiable assets acquired in excess of (less than) the aggregate liabilities assumed.", "label": "Total identifiable assets acquired", "totalLabel": "Total identifiable net assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Preliminary allocation of the consideration paid in excess of the net assets acquired:" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "auth_ref": [ "r169", "r170" ], "calculation": { "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails": { "order": 5.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment", "verboseLabel": "Property and equipment, net" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": { "auth_ref": [ "r170" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.", "label": "Total intangible assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Recognized amounts of identifiable assets acquired and liabilities assumed:" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationsPolicy": { "auth_ref": [ "r165" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.", "label": "Business Combinations" } } }, "localname": "BusinessCombinationsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Cash": { "auth_ref": [ "r653", "r654", "r708", "r732" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash [Default Label]", "verboseLabel": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAcquiredFromAcquisition": { "auth_ref": [ "r48" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the acquisition of business during the period (for example, cash that was held by the acquired business).", "label": "Cash acquired from MVP for acquisition" } } }, "localname": "CashAcquiredFromAcquisition", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r59", "r236", "r674" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r60" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r53", "r59", "r64" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "Cash, end of the period", "periodStartLabel": "Cash, beginning of the period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r53", "r202" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net (decrease) increase in cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "Cash FDIC insured amount" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashUninsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.", "label": "Cash uninsured amount" } } }, "localname": "CashUninsuredAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r242", "r243", "r244", "r270", "r292", "r293", "r296", "r298", "r303", "r304", "r341", "r379", "r381", "r382", "r383", "r386", "r387", "r416", "r417", "r420", "r424", "r431", "r558", "r673", "r731", "r746", "r763" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical", "http://vislink.com/role/PreferredSharesDetailsNarrative", "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical", "http://vislink.com/role/StatementsOfChangesInStockholdersEquity", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/PreferredSharesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r432" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Warrant exercise price", "verboseLabel": "Warrant exercise price per share" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative", "http://vislink.com/role/ScheduleOfValuationAndWarrantsExercisableDetails", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.", "label": "Number of shares issued for exercise of warrants" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r432" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Warrants to purchase shares of common stock" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/InventoriesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r30", "r213", "r225" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and contingencies (See Note 1)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r99", "r373", "r374", "r658", "r785" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r750", "r751", "r831" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative", "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical", "http://vislink.com/role/StatementsOfChangesInStockholdersEquity", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value", "verboseLabel": "Common stock per share value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical", "http://vislink.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized", "verboseLabel": "Common stock shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r12", "r116" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, shares outstanding", "verboseLabel": "Common stock shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r12", "r708" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock value" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r41", "r252", "r254", "r259", "r632", "r638" ], "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive loss" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Comprehensive loss:" } } }, "localname": "ComprehensiveIncomeNetOfTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_ComputerEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.", "label": "Computer Equipment [Member]" } } }, "localname": "ComputerEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r71", "r72", "r199", "r200", "r333", "r657" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r71", "r72", "r199", "r200", "r333", "r652", "r657" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r71", "r72", "r199", "r200", "r333", "r657", "r858" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r216", "r308" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentrations" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "auth_ref": [ "r77" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date.", "label": "CONCENTRATIONS" } } }, "localname": "ConcentrationRiskDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/Concentrations" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Concentration Risk [Line Items]" } } }, "localname": "ConcentrationRiskLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r71", "r72", "r199", "r200", "r333" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration risk percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTable": { "auth_ref": [ "r69", "r71", "r72", "r73", "r199", "r201", "r657" ], "lang": { "en-us": { "role": { "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.", "label": "Concentration Risk [Table]" } } }, "localname": "ConcentrationRiskTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r71", "r72", "r199", "r200", "r333", "r657" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r175", "r679" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "auth_ref": [ "r434", "r435", "r454" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.", "label": "Customer deposits and deferred revenue" } } }, "localname": "ContractWithCustomerLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r44" ], "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "Costs and Expenses", "totalLabel": "Total cost of revenue and operating expenses" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cost of revenue and operating expenses" } } }, "localname": "CostsAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefitAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current tax provision" } } }, "localname": "CurrentFederalStateAndLocalTaxExpenseBenefitAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "auth_ref": [ "r749", "r823", "r825" ], "calculation": { "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails": { "order": 1.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Federal" } } }, "localname": "CurrentFederalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r164", "r525", "r533", "r749" ], "calculation": { "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails": { "order": 1.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Current Income Tax Expense (Benefit)", "totalLabel": "Current income tax expense, total" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r749", "r823", "r825" ], "calculation": { "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails": { "order": 2.0, "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "State" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r70", "r333" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r173" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.DetailsNarrative", "http://vislink.com/role/ScheduleOfAmortizationOfIntangibleAssetsDetails", "http://vislink.com/role/ScheduleOfCapitalizedIntangibleCostsDetails", "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails", "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r110", "r268", "r393", "r394", "r395", "r396", "r397", "r398", "r399", "r404", "r411", "r412", "r414" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "NOTES PAYABLE" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/NotesPayable" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r4", "r5", "r6", "r207", "r210", "r218", "r273", "r388", "r389", "r390", "r391", "r392", "r394", "r400", "r401", "r402", "r403", "r405", "r406", "r407", "r408", "r409", "r410", "r574", "r687", "r688", "r689", "r690", "r691", "r747" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfNotesPayableDetails", "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r203", "r204", "r388", "r574", "r688", "r689" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt instrument, face amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r28", "r389" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt instrument, interest rate, stated percentage" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r29", "r273", "r388", "r389", "r390", "r391", "r392", "r394", "r400", "r401", "r402", "r403", "r405", "r406", "r407", "r408", "r409", "r410", "r574", "r687", "r688", "r689", "r690", "r691", "r747" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfNotesPayableDetails", "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentPeriodicPaymentInterest": { "auth_ref": [ "r29" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the required periodic payments applied to interest.", "label": "Debt instrument, periodic payment, interest" } } }, "localname": "DebtInstrumentPeriodicPaymentInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]" } } }, "localname": "DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetails", "http://vislink.com/role/ScheduleOfShare-basedPaymentAwardStockOptionsValuationAssumptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredCompensationLiabilityCurrent": { "auth_ref": [ "r130", "r132" ], "calculation": { "http://vislink.com/role/ScheduleOfAccruedExpensesDetails": { "order": 6.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable within one year (or the operating cycle, if longer). Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.", "label": "Deferred Equity" } } }, "localname": "DeferredCompensationLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "auth_ref": [ "r749", "r824", "r825" ], "calculation": { "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Deferred Federal Income Tax Expense (Benefit)", "verboseLabel": "Federal" } } }, "localname": "DeferredFederalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefitAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred tax provision (benefit)" } } }, "localname": "DeferredFederalStateAndLocalTaxExpenseBenefitAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": { "auth_ref": [ "r164", "r749", "r824" ], "calculation": { "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Foreign" } } }, "localname": "DeferredForeignIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r57", "r164", "r526", "r532", "r533", "r749" ], "calculation": { "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails": { "order": 2.0, "parentTag": "us-gaap_IncomeTaxExpenseBenefit", "weight": 1.0 }, "http://vislink.com/role/StatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred tax benefits", "negatedLabel": "Deferred tax benefits", "totalLabel": "Total deferred tax provision (benefit)" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails", "http://vislink.com/role/StatementsOfCashFlows", "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilities": { "auth_ref": [ "r8", "r9", "r208", "r217", "r519" ], "calculation": { "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.", "label": "Deferred Tax Liabilities, Gross", "negatedTotalLabel": "Total Deferred Tax Liabilities" } } }, "localname": "DeferredIncomeTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r512", "r513" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred tax liabilities" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredOfferingCosts": { "auth_ref": [ "r772" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.", "label": "Offering cost" } } }, "localname": "DeferredOfferingCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "auth_ref": [ "r749", "r824", "r825" ], "calculation": { "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Deferred State and Local Income Tax Expense (Benefit)", "verboseLabel": "State" } } }, "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetInterestCarryforward": { "auth_ref": [ "r822" ], "calculation": { "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 9.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible interest carryforward.", "label": "Interest disallowance" } } }, "localname": "DeferredTaxAssetInterestCarryforward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r520" ], "calculation": { "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Gross", "totalLabel": "Total Deferred Tax Assets" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsInventory": { "auth_ref": [ "r162", "r822" ], "calculation": { "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.", "label": "Inventory" } } }, "localname": "DeferredTaxAssetsInventory", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": { "auth_ref": [ "r162", "r822" ], "calculation": { "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 8.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.", "label": "Federal net operating losses" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": { "auth_ref": [ "r162", "r822" ], "calculation": { "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 7.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.", "label": "State net operating losses" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOther": { "auth_ref": [ "r162", "r822" ], "calculation": { "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 11.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.", "label": "Other" } } }, "localname": "DeferredTaxAssetsOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": { "auth_ref": [ "r160", "r162", "r822" ], "calculation": { "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.", "label": "Federal R&D credit" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": { "auth_ref": [ "r160", "r162", "r822" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.", "label": "Deferred tax assets, tax credit carryforwards, research" } } }, "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation": { "auth_ref": [ "r162", "r822" ], "calculation": { "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation.", "label": "Compensation related" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions": { "auth_ref": [ "r822" ], "calculation": { "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from pension benefits.", "label": "Pension" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPensions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "auth_ref": [ "r162", "r822" ], "calculation": { "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 10.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.", "label": "Stock options" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": { "auth_ref": [ "r162", "r822" ], "calculation": { "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.", "label": "Allowance for bad debt" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther": { "auth_ref": [ "r162", "r822" ], "calculation": { "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves and accruals, classified as other.", "label": "Other accruals" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r521" ], "calculation": { "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 12.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Valuation Allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilities": { "auth_ref": [ "r156", "r821" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.", "label": "Deferred Tax Liabilities, Net", "negatedLabel": "Net Deferred Tax Liability" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": { "auth_ref": [ "r162", "r822" ], "calculation": { "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.", "label": "Deferred Tax Liabilities, Intangible Assets", "negatedLabel": "Intangibles" } } }, "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesPrepaidExpenses": { "auth_ref": [], "calculation": { "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax consequences attributable to taxable temporary differences derived from prepaid expenses.", "label": "Deferred Tax Liabilities, Prepaid Expenses", "negatedLabel": "Prepaid Expenses" } } }, "localname": "DeferredTaxLiabilitiesPrepaidExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": { "auth_ref": [ "r162", "r822" ], "calculation": { "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.", "label": "Deferred Tax Liabilities, Property, Plant and Equipment", "negatedLabel": "Property and Equipment" } } }, "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plan Disclosure [Line Items]" } } }, "localname": "DefinedBenefitPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnNon-recurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedContributionPlanCostRecognized": { "auth_ref": [ "r464" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost for defined contribution plan.", "label": "Company matching contributions" } } }, "localname": "DefinedContributionPlanCostRecognized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfMatchingContributionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedContributionPlanDisclosuresTableTextBlock": { "auth_ref": [ "r138" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of defined contribution pension plans or defined contribution other postretirement plans, separately for pension plans and other postretirement benefit plans.", "label": "SCHEDULE OF MATCHING CONTRIBUTIONS" } } }, "localname": "DefinedContributionPlanDisclosuresTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/CommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r57", "r94" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Property and equipment, depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/PropertyAndEquipmentDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r57", "r94" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 7.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Amortization and depreciation", "verboseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows", "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "auth_ref": [ "r830" ], "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.", "label": "Changes in fair value of derivative liabilities" } } }, "localname": "DerivativeGainLossOnDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r182", "r183", "r185", "r186", "r678" ], "lang": { "en-us": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r190", "r549" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "DERIVATIVE LIABILITIES" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/DerivativeLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative [Line Items]" } } }, "localname": "DerivativeLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfValuationAndWarrantsExercisableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeTable": { "auth_ref": [ "r177", "r178", "r179", "r180", "r181", "r184", "r185", "r187", "r188", "r189", "r549" ], "lang": { "en-us": { "role": { "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Derivative [Table]" } } }, "localname": "DerivativeTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfValuationAndWarrantsExercisableDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [ "r453", "r693", "r694", "r695", "r696", "r697", "r698", "r699" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r791" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "SCHEDULE OF DISAGGREGATION OF REVENUE" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/RevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r469", "r500", "r501", "r502", "r507", "r706" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "STOCK-BASED COMPENSATION" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/Stock-basedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DividendsPayableCurrentAndNoncurrent": { "auth_ref": [ "r5", "r7", "r209", "r220" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding.", "label": "Dividends payable amount" } } }, "localname": "DividendsPayableCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_DomesticCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.", "label": "Domestic Tax Authority [Member]" } } }, "localname": "DomesticCountryMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net loss per share attributable to Common Shareholders:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r260", "r279", "r280", "r282", "r283", "r284", "r290", "r292", "r296", "r297", "r298", "r300", "r553", "r554", "r633", "r639", "r682" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Basic and diluted loss per share" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDilutedOtherDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Anti-dilutive potential common stock equivalents excluded from the calculation of loss per share:" } } }, "localname": "EarningsPerShareDilutedOtherDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfAnti-diliutivePotentialCommonStockEquivalentsExcludeFromCalculationOfLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r67", "r68" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Loss Per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r838" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of exchange rate changes on cash" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectOfLIFOInventoryLiquidationOnIncome": { "auth_ref": [ "r357" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The effect of liquidating LIFO (last in first out) inventory layers on income.", "label": "Effect of LIFO Inventory Liquidation on Income", "verboseLabel": "Inventory valuation adjustments" } } }, "localname": "EffectOfLIFOInventoryLiquidationOnIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/InventoriesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r515" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective tax rate" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r271", "r515", "r534" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Statutory federal income tax rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r820", "r826" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.", "label": "Valuation allowance" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate": { "auth_ref": [ "r534", "r820" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates.", "label": "Change rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": { "auth_ref": [ "r820", "r826" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.", "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent", "negatedLabel": "Permanent differences" } } }, "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings": { "auth_ref": [ "r820", "r826" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to the repatriation of foreign earnings.", "label": "Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent", "negatedLabel": "Foreign Rate Differential" } } }, "localname": "EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent": { "auth_ref": [ "r819", "r820" ], "lang": { "en-us": { "role": { "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to expense for award under share-based payment arrangement. Excludes expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.", "label": "Equity compensation" } } }, "localname": "EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": { "auth_ref": [ "r820", "r826" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).", "label": "State and local taxes, net of federal benefit" } } }, "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r116", "r230", "r256", "r257", "r258", "r274", "r275", "r276", "r278", "r285", "r288", "r302", "r342", "r433", "r503", "r504", "r505", "r528", "r529", "r552", "r564", "r565", "r566", "r567", "r568", "r570", "r590", "r642", "r643", "r644" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative", "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical", "http://vislink.com/role/ScheduleOfShare-basedPaymentAwardStockOptionsValuationAssumptionsDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetailsParenthetical", "http://vislink.com/role/ScheduleOfWarrantOutstandingExercisePriceDetails", "http://vislink.com/role/StatementsOfChangesInStockholdersEquity", "http://vislink.com/role/Stock-basedCompensationDetailsNarrative", "http://vislink.com/role/Stock-basedCompensationTables", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ExtinguishmentOfDebtGainLossNetOfTax": { "auth_ref": [ "r108" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The difference between the reacquisition price and the net carrying amount of the extinguished debt recognized currently as a component of income in the period of extinguishment, net of tax.", "label": "Gain on extinguishment debt", "verboseLabel": "Payroll protection program loan" } } }, "localname": "ExtinguishmentOfDebtGainLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisTextBlock": { "auth_ref": [ "r191", "r192", "r193" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets and liabilities by class, including financial instruments measured at fair value that are classified in shareholders' equity, if any, that are measured at fair value on a nonrecurring basis in periods after initial recognition (for example, impaired assets). Disclosures may include, but are not limited to: (a) the fair value measurements recorded and the reasons for the measurements and (b) the level within the fair value hierarchy in which the fair value measurements are categorized in their entirety (levels 1, 2, 3).", "label": "SCHEDULE OF FAIR VALUE, ASSETS AND LIABILITIES MEASURED ON NON-RECURRING BASIS" } } }, "localname": "FairValueAssetsMeasuredOnNonrecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "auth_ref": [ "r194" ], "lang": { "en-us": { "role": { "documentation": "Class of asset." } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.DetailsNarrative", "http://vislink.com/role/ScheduleOfAcquiredIntangibleWithTheirRelativeUsefulLivesDetails", "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueByAssetClassAxis": { "auth_ref": [ "r191", "r196" ], "lang": { "en-us": { "role": { "documentation": "Information by class of asset.", "label": "Asset Class [Axis]" } } }, "localname": "FairValueByAssetClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.DetailsNarrative", "http://vislink.com/role/ScheduleOfAcquiredIntangibleWithTheirRelativeUsefulLivesDetails", "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r402", "r458", "r459", "r460", "r461", "r462", "r463", "r555", "r598", "r599", "r600", "r688", "r689", "r700", "r701", "r702" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnNon-recurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r402", "r458", "r463", "r555", "r598", "r700", "r701", "r702" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnNon-recurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r402", "r458", "r463", "r555", "r599", "r688", "r689", "r700", "r701", "r702" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnNon-recurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r402", "r458", "r459", "r460", "r461", "r462", "r463", "r555", "r600", "r688", "r689", "r700", "r701", "r702" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnNon-recurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease": { "auth_ref": [ "r194" ], "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)", "verboseLabel": "Change in fair value of derivative liabilities" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfChangesInFairValueOfLevel3FinancialLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [ "r194" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfChangesInFairValueOfLevel3FinancialLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r402", "r458", "r459", "r460", "r461", "r462", "r463", "r598", "r599", "r600", "r688", "r689", "r700", "r701", "r702" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnNon-recurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock": { "auth_ref": [ "r194", "r195" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "SCHEDULE OF CHANGES IN FAIR VALUE OF LEVEL 3 FINANCIAL LIABILITIES" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/DerivativeLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r197", "r198" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments and Fair Value Measurements" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r339", "r340", "r346", "r348", "r349", "r350", "r351", "r352", "r353", "r354", "r413", "r429", "r549", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620", "r621", "r622", "r623", "r624", "r685", "r766", "r767", "r768", "r859", "r860", "r861", "r862", "r863", "r864", "r865" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnNon-recurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FinancingReceivablesTextBlock": { "auth_ref": [ "r337", "r338" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for financing receivable.", "label": "ACCOUNTS RECEIVABLE" } } }, "localname": "FinancingReceivablesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/AccountsReceivable" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-lived intangible asset, useful life" } } }, "localname": "FiniteLivedIntangibleAssetUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/IntangibleAssetsDetailsNarrative", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r240", "r368" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "periodEndLabel": "Ending balance, accumulated Amortization", "periodStartLabel": "Beginning balance, accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable": { "auth_ref": [ "r83" ], "lang": { "en-us": { "role": { "documentation": "A table containing detailed characteristics of finite-lived intangible assets acquired during a business combination. Finite-lived intangible assets are assets that have no physical form, but have expected future economic benefit, and are expected to be used over a defined period. Acquired finite-lived intangible assets are disclosed by major class (assets that can be grouped together because they are similar, either by their nature or by their use in operations of the Entity) and in total. Additionally, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period are also disclosed.", "label": "Finite-Lived Intangible Assets Acquired as Part of Business Combination [Table]" } } }, "localname": "FiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": { "auth_ref": [], "calculation": { "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails": { "order": 6.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Thereafter" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r90" ], "calculation": { "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.", "label": "SCHEDULE OF AMORTIZATION OF INTANGIBLE ASSETS" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r90" ], "calculation": { "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails": { "order": 5.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2027" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r90" ], "calculation": { "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails": { "order": 4.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2026" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r90" ], "calculation": { "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails": { "order": 3.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2025" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r90" ], "calculation": { "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r366", "r367", "r368", "r369", "r629", "r630" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.DetailsNarrative", "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r83", "r87" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.DetailsNarrative", "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r88", "r629" ], "calculation": { "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Intangible assets", "totalLabel": "Finite-Lived Intangible Assets, Net, Total" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfCapitalizedIntangibleCostsDetails", "http://vislink.com/role/ScheduleOfEstimatedAmortizationExpenseForIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": { "auth_ref": [ "r629" ], "lang": { "en-us": { "role": { "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-lived intangible assets, remaining amortization period" } } }, "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_ForeignCountryMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile.", "label": "Foreign Tax Authority [Member]" } } }, "localname": "ForeignCountryMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyExchangeRateRemeasurement1": { "auth_ref": [ "r572" ], "lang": { "en-us": { "role": { "documentation": "Foreign exchange rate used to remeasure amounts denominated in a currency other than functional currency into functional currency.", "label": "Foreign currency exchange rate, remeasurement" } } }, "localname": "ForeignCurrencyExchangeRateRemeasurement1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "pureItemType" }, "us-gaap_ForeignCurrencyExchangeRateTranslation1": { "auth_ref": [ "r571", "r572" ], "lang": { "en-us": { "role": { "documentation": "Foreign exchange rate used to translate amounts denominated in functional currency to reporting currency.", "label": "Foreign currency exchange rate, translation", "verboseLabel": "Foreign currency exchange rate" } } }, "localname": "ForeignCurrencyExchangeRateTranslation1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.DetailsNarrative", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "pureItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r559", "r560", "r561", "r563" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.", "label": "Net foreign exchange transactions: Losses" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfForeignExchangeAndChangeInAccumulatedComprehensiveIncomeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": { "auth_ref": [ "r58", "r836", "r837" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.", "label": "Unrealized gain on currency translation adjustment" } } }, "localname": "ForeignCurrencyTransactionGainLossUnrealized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r573" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency and Other Comprehensive (Gains) Losses" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r57", "r108", "r109" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Gain on settlement of debt", "negatedLabel": "Gain on settlement of debt", "verboseLabel": "GAINS ON SETTLEMENT OF DEBT" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetails", "http://vislink.com/role/StatementsOfCashFlows", "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r45" ], "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 3.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative expenses" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r239", "r359", "r631", "r686", "r708", "r773", "r780" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill [Default Label]", "periodEndLabel": "Ending balance, Goodwill", "periodStartLabel": "Beginning balance, Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfGoodwillDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": { "auth_ref": [ "r364", "r365", "r686" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.", "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]", "verboseLabel": "Goodwill" } } }, "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": { "auth_ref": [ "r85" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.", "label": "Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillDisclosureTextBlock": { "auth_ref": [ "r362", "r363", "r365", "r686" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for goodwill.", "label": "GOODWILL" } } }, "localname": "GoodwillDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/Goodwill" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillImpairmentLoss": { "auth_ref": [ "r57", "r360", "r361", "r364", "r686" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 6.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Impairment of goodwill", "verboseLabel": "Goodwill impairment charges" } } }, "localname": "GoodwillImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/GoodwillDetailsNarrative", "http://vislink.com/role/StatementsOfCashFlows", "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill [Member]" } } }, "localname": "GoodwillMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.DetailsNarrative", "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies": { "auth_ref": [ "r104" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for guarantees, indemnifications and product warranties, and methodologies used in determining the amount of such liabilities.", "label": "Warranty Reserve" } } }, "localname": "GuaranteesIndemnificationsAndWarrantiesPolicies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ImpairmentEffectsOnEarningsPerShareLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Impairment Effects on Earnings Per Share [Line Items]" } } }, "localname": "ImpairmentEffectsOnEarningsPerShareLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfAcquiredIntangibleWithTheirRelativeUsefulLivesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ImpairmentEffectsOnEarningsPerShareTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about the effects of asset impairment charge on per share or per unit basis.", "label": "Impairment Effects on Earnings Per Share [Table]" } } }, "localname": "ImpairmentEffectsOnEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfAcquiredIntangibleWithTheirRelativeUsefulLivesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ImpairmentOfLeasehold": { "auth_ref": [ "r57", "r93" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The adjustment to reduce the value of existing agreements that specify the lessee's rights to use the leased property. This expense is charged when the estimates of future profits generated by the leased property are reduced.", "label": "Depreciation leasehold improvement" } } }, "localname": "ImpairmentOfLeasehold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/PropertyAndEquipmentDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOfLongLivedAssetsToBeDisposedOf": { "auth_ref": [ "r57", "r92" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long-lived assets held for abandonment, exchange or sale.", "label": "Right-of-use operating assets impaired" } } }, "localname": "ImpairmentOfLongLivedAssetsToBeDisposedOf", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r42", "r205", "r214", "r228", "r315", "r323", "r327", "r329", "r634", "r684" ], "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Net loss before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r371", "r372" ], "lang": { "en-us": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [ "r372" ], "lang": { "en-us": { "role": { "documentation": "Location in the income statement." } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxAuthorityAxis": { "auth_ref": [ "r158" ], "lang": { "en-us": { "role": { "documentation": "Information by tax jurisdiction.", "label": "Income Tax Authority [Axis]" } } }, "localname": "IncomeTaxAuthorityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxAuthorityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes." } } }, "localname": "IncomeTaxAuthorityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income taxes", "verboseLabel": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r271", "r516", "r517", "r524", "r530", "r535", "r537", "r538", "r539" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r272", "r287", "r288", "r314", "r514", "r531", "r536", "r640" ], "calculation": { "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "totalLabel": "Income tax provision" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r255", "r510", "r511", "r517", "r518", "r523", "r527" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r56" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "verboseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r56" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r56" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Accrued expenses and interest expense" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "auth_ref": [ "r626", "r744" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 21.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Deferred revenue and customer deposits" } } }, "localname": "IncreaseDecreaseInContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredLiabilities": { "auth_ref": [ "r56" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 22.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change during the period in carrying value for all deferred liabilities due within one year or operating cycle.", "label": "Increase (Decrease) in Deferred Liabilities", "verboseLabel": "Deferred tax liabilities" } } }, "localname": "IncreaseDecreaseInDeferredLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDerivativeLiabilities": { "auth_ref": [ "r744" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the period in the carrying value of derivative instruments reported as liabilities that are due to be disposed of within one year (or the normal operating cycle, if longer).", "label": "Change in fair value of derivative liabilities" } } }, "localname": "IncreaseDecreaseInDerivativeLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent": { "auth_ref": [ "r56" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in intangible assets (for example patents and licenses).", "label": "Customer Relationships" } } }, "localname": "IncreaseDecreaseInIntangibleAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.DetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r56" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventory" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in assets and liabilities" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "auth_ref": [ "r744", "r842" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 20.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in obligation for operating lease.", "label": "Operating lease liabilities" } } }, "localname": "IncreaseDecreaseInOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r56" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefinitelivedIntangibleAssetsAcquired": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in assets, excluding financial assets and goodwill, lacking physical substance with an indefinite life, from an acquisition.", "label": "Intangible assets, Additions" } } }, "localname": "IndefinitelivedIntangibleAssetsAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r370" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "INTANGIBLE ASSETS" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/IntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsGrossExcludingGoodwill": { "auth_ref": [ "r239" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.", "label": "Intangible Assets, Gross (Excluding Goodwill)", "periodEndLabel": "Ending balance cost", "periodStartLabel": "Beginning balance cost" } } }, "localname": "IntangibleAssetsGrossExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r81", "r86" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseDebt": { "auth_ref": [ "r47", "r408", "r415", "r690", "r691" ], "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.", "label": "Interest expense", "negatedLabel": "Interest expense, net" } } }, "localname": "InterestExpenseDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical", "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r263", "r265", "r266" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Cash paid during the period for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "localname": "InventoryDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_InventoryDisclosureTextBlock": { "auth_ref": [ "r358" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.", "label": "INVENTORIES" } } }, "localname": "InventoryDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/Inventories" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryFinishedGoods": { "auth_ref": [ "r735" ], "calculation": { "http://vislink.com/role/ScheduleOfInventoriesDetails": { "order": 3.0, "parentTag": "us-gaap_InventoryGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer.", "label": "Finished goods" } } }, "localname": "InventoryFinishedGoods", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryGross": { "auth_ref": [ "r737" ], "calculation": { "http://vislink.com/role/ScheduleOfInventoriesDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "Inventory, Gross", "totalLabel": "Sub-total inventories" } } }, "localname": "InventoryGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryLIFOReserveEffectOnIncomeNet": { "auth_ref": [], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The difference between the change in the inventory reserve representing the cumulative difference in cost between the first in, first out and the last in, first out inventory valuation methods and any LIFO decrement which have been reflected in the statement of income during the period.", "label": "Inventory, LIFO Reserve, Effect on Income, Net", "verboseLabel": "Inventory valuation adjustments" } } }, "localname": "InventoryLIFOReserveEffectOnIncomeNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r249", "r675", "r708" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 }, "http://vislink.com/role/ScheduleOfInventoriesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventories, net", "totalLabel": "Total inventories, net" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheets", "http://vislink.com/role/ScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryPolicyTextBlock": { "auth_ref": [ "r235", "r248", "r301", "r355", "r356", "r358", "r627", "r680" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.", "label": "Inventories" } } }, "localname": "InventoryPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_InventoryRawMaterialsAndSupplies": { "auth_ref": [ "r737" ], "calculation": { "http://vislink.com/role/ScheduleOfInventoriesDetails": { "order": 1.0, "parentTag": "us-gaap_InventoryGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Gross amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed.", "label": "Raw materials" } } }, "localname": "InventoryRawMaterialsAndSupplies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryValuationReserves": { "auth_ref": [ "r80", "r737" ], "calculation": { "http://vislink.com/role/ScheduleOfInventoriesDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of valuation reserve for inventory.", "label": "Inventory Valuation Reserves", "negatedLabel": "Less reserve for slow-moving and excess inventory" } } }, "localname": "InventoryValuationReserves", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcess": { "auth_ref": [ "r736" ], "calculation": { "http://vislink.com/role/ScheduleOfInventoriesDetails": { "order": 2.0, "parentTag": "us-gaap_InventoryGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.", "label": "Work-in-process" } } }, "localname": "InventoryWorkInProcess", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfInventoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LaborAndRelatedExpense": { "auth_ref": [ "r742" ], "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.", "label": "Cost of components and personnel" } } }, "localname": "LaborAndRelatedExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCost": { "auth_ref": [ "r586", "r707" ], "calculation": { "http://vislink.com/role/ScheduleOfOperatingLeaseDataDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease cost recognized by lessee for lease contract.", "label": "Lease, Cost", "totalLabel": "Total lease cost" } } }, "localname": "LeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfOperatingLeaseDataDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r843" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "SCHEDULE OF OPERATING LEASE DATA" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseExpirationDate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date which lease or group of leases is set to expire, in YYYY-MM-DD format.", "label": "Lease expiration" } } }, "localname": "LeaseExpirationDate1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r95" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r579" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Lessee, Leases [Policy Text Block]", "verboseLabel": "Leases" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r844" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "SCHEDULE OF FUTURE MINIMUM RENTAL PAYMENTS FOR OPERATING LEASES" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/LeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r587" ], "calculation": { "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Approximate Future Payments", "totalLabel": "Total lease payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails", "http://vislink.com/role/ScheduleOfLeaseObligationsAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": { "auth_ref": [ "r587" ], "calculation": { "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "order": 6.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five", "verboseLabel": "Thereafter" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r587" ], "calculation": { "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "verboseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": { "auth_ref": [ "r587" ], "calculation": { "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "order": 5.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five", "verboseLabel": "2027" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r587" ], "calculation": { "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "order": 4.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four", "verboseLabel": "2026" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r587" ], "calculation": { "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "order": 3.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three", "verboseLabel": "2025" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r587" ], "calculation": { "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "verboseLabel": "2024" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r587" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Less: imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseOptionToTerminate": { "auth_ref": [ "r580" ], "lang": { "en-us": { "role": { "documentation": "Description of terms and conditions of option to terminate lessee's operating lease. Includes, but is not limited to, information about option recognized as part of right-of-use asset and lease liability.", "label": "Lease maturity description" } } }, "localname": "LesseeOperatingLeaseOptionToTerminate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeasesTextBlock": { "auth_ref": [ "r588" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.", "label": "LEASES" } } }, "localname": "LesseeOperatingLeasesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/Leases" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r25", "r270", "r341", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r546", "r547", "r548", "r558", "r683", "r786", "r848", "r849" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r17", "r211", "r223", "r708", "r748", "r769", "r835" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r27", "r234", "r270", "r341", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r546", "r547", "r548", "r558", "r708", "r786", "r848", "r849" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosure": { "auth_ref": [ "r191" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial and nonfinancial obligations.", "label": "Total Liabilities" } } }, "localname": "LiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnNon-recurringBasisDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MeasurementInputExercisePriceMember": { "auth_ref": [ "r833" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using agreed upon price for exchange of underlying asset.", "label": "Measurement Input, Exercise Price [Member]" } } }, "localname": "MeasurementInputExercisePriceMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfValuationAndWarrantsExercisableDetails", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedDividendRateMember": { "auth_ref": [ "r833" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.", "label": "Measurement Input, Expected Dividend Rate [Member]" } } }, "localname": "MeasurementInputExpectedDividendRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfValuationAndWarrantsExercisableDetails", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputPriceVolatilityMember": { "auth_ref": [ "r833" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.", "label": "Measurement Input, Price Volatility [Member]" } } }, "localname": "MeasurementInputPriceVolatilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfValuationAndWarrantsExercisableDetails", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "auth_ref": [ "r833" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.", "label": "Measurement Input, Risk Free Interest Rate [Member]" } } }, "localname": "MeasurementInputRiskFreeInterestRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfValuationAndWarrantsExercisableDetails", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputSharePriceMember": { "auth_ref": [ "r833" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using share price of saleable stock.", "label": "Measurement Input, Share Price [Member]" } } }, "localname": "MeasurementInputSharePriceMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfValuationAndWarrantsExercisableDetails", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r556" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfValuationAndWarrantsExercisableDetails", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability." } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfValuationAndWarrantsExercisableDetails", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r305", "r311" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "NATURE OF OPERATIONS" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/NatureOfOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r264" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash (used) provided in financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows (used in) provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r264" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r53", "r55", "r58" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "negatedLabel": "Net cash provided by used in operating activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative", "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r43", "r58", "r215", "r227", "r232", "r251", "r253", "r258", "r270", "r277", "r279", "r280", "r282", "r283", "r287", "r288", "r294", "r315", "r323", "r327", "r329", "r341", "r379", "r380", "r381", "r382", "r383", "r384", "r385", "r386", "r387", "r554", "r558", "r684", "r786" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net loss", "totalLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows", "http://vislink.com/role/StatementsOfChangesInStockholdersEquity", "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r279", "r280", "r282", "r283", "r290", "r291", "r295", "r298", "r315", "r323", "r327", "r329", "r684" ], "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net loss attributable to common shareholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental disclosure of non-cash information:" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NoncurrentAssets": { "auth_ref": [ "r332" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.", "label": "Long-Lived Assets" } } }, "localname": "NoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r46" ], "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other income" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other income (expenses)" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_NotesIssued1": { "auth_ref": [ "r61", "r62", "r63" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of notes issued in noncash investing and financing activities.", "label": "Notes payable recognized on D & O Insurance policy (Note 11)" } } }, "localname": "NotesIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayable": { "auth_ref": [ "r6", "r210", "r221" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer.", "label": "Notes Payable" } } }, "localname": "NotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableCurrent": { "auth_ref": [ "r24" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.", "label": "Notes payable" } } }, "localname": "NotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheets", "http://vislink.com/role/ScheduleOfNotesPayableDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r315", "r323", "r327", "r329", "r684" ], "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "negatedLabel": "Operating income loss", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative", "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r581", "r707" ], "calculation": { "http://vislink.com/role/ScheduleOfOperatingLeaseDataDetails": { "order": 1.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating lease cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfOperatingLeaseDataDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseImpairmentLoss": { "auth_ref": [ "r841" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from impairment of right-of-use asset from operating lease.", "label": "Loss on impairment of right-of-use assets", "verboseLabel": "Loss on impairment of Right Of Use Asset" } } }, "localname": "OperatingLeaseImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r577" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Present value of lease liabilities", "verboseLabel": "Operating lease liability" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative", "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r577" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating lease obligations, current", "terseLabel": "Current operating lease liabilities", "verboseLabel": "Less: Current lease liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheets", "http://vislink.com/role/LeasesDetailsNarrative", "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r577" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating lease obligations, net of current portion", "terseLabel": "Non-current operating lease liabilities", "verboseLabel": "Non-current lease liabilities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheets", "http://vislink.com/role/LeasesDetailsNarrative", "http://vislink.com/role/ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r578", "r583" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Cash flows from operating leases" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfOperatingLeaseDataDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r576" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Right of use assets, operating leases", "verboseLabel": "Right of Use Assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheets", "http://vislink.com/role/LeasesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": { "auth_ref": [ "r745" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense for right-of-use asset from operating lease.", "label": "Amortization of right-of-use assets, operating assets" } } }, "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r585", "r707" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Weighted-average discount rate-operating leases", "verboseLabel": "Weighted-average discount rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative", "http://vislink.com/role/ScheduleOfOperatingLeaseDataDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r584", "r707" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Weighted-average remaining lease term-operating leases", "verboseLabel": "Weighted-average remaining term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative", "http://vislink.com/role/ScheduleOfOperatingLeaseDataDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r160" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating loss carryforwards" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwardsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Operating Loss Carryforwards [Line Items]" } } }, "localname": "OperatingLossCarryforwardsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingLossCarryforwardsTable": { "auth_ref": [ "r161" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.", "label": "Operating Loss Carryforwards [Table]" } } }, "localname": "OperatingLossCarryforwardsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "auth_ref": [ "r26" ], "calculation": { "http://vislink.com/role/ScheduleOfAccruedExpensesDetails": { "order": 5.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.", "label": "Accrued expenses other" } } }, "localname": "OtherAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax": { "auth_ref": [ "r35", "r38", "r562", "r569" ], "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit), after reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax", "negatedLabel": "Unrealized gain (loss) on currency translation adjustment" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIntangibleAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intangible assets classified as other.", "label": "Other Intangible Assets [Member]" } } }, "localname": "OtherIntangibleAssetsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNonoperatingIncome": { "auth_ref": [ "r262" ], "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income related to nonoperating activities, classified as other.", "label": "Other income" } } }, "localname": "OtherNonoperatingIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PaymentsForRent": { "auth_ref": [ "r54" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash payments to lessor's for use of assets under operating leases.", "label": "Payment for rent" } } }, "localname": "PaymentsForRent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/LeasesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r49", "r544" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Purchase price" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.DetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r50" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Cash used for property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r792", "r793", "r794", "r795", "r796", "r797", "r798", "r799", "r800", "r801", "r802", "r803", "r804", "r805", "r806", "r807", "r808", "r809", "r810", "r811", "r812", "r813", "r814", "r815", "r816", "r817" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfMatchingContributionsDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansDetails", "http://vislink.com/role/Stock-basedCompensationTables" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r792", "r793", "r794", "r795", "r796", "r797", "r798", "r799", "r800", "r801", "r802", "r803", "r804", "r805", "r806", "r807", "r808", "r809", "r810", "r811", "r812", "r813", "r814", "r815", "r816", "r817" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfMatchingContributionsDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansDetails", "http://vislink.com/role/Stock-basedCompensationTables" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockNoParValue": { "auth_ref": [ "r11", "r789" ], "lang": { "en-us": { "role": { "documentation": "Face amount per share of no-par value preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock par value" } } }, "localname": "PreferredStockNoParValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/PreferredSharesDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r11", "r416" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock, par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical", "http://vislink.com/role/PreferredSharesDetailsNarrative", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockRedemptionTerms": { "auth_ref": [ "r115", "r117" ], "lang": { "en-us": { "role": { "documentation": "The redemption terms of preferred stock of an entity that has priority over common stock in the distribution of dividends and in the event of liquidation of the entity. The redemption features of this capital stock are solely within the control of the issuer.", "label": "Preferred stock redemption terms, description" } } }, "localname": "PreferredStockRedemptionTerms", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/PreferredSharesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PreferredStockShareSubscriptions": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "The number of nonredeemable preferred stock (shares) (or preferred stock redeemable solely at the option of the issuer) allocated to investors to buy shares of a new issue of preferred stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.", "label": "Preferred stock unissued" } } }, "localname": "PreferredStockShareSubscriptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/PreferredSharesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock, shares authorized", "verboseLabel": "Preferred stock shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical", "http://vislink.com/role/PreferredSharesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockTextBlock": { "auth_ref": [ "r128" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.", "label": "PREFERRED SHARES" } } }, "localname": "PreferredStockTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/PreferredShares" ], "xbrltype": "textBlockItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r11", "r708" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock, $0.00001 par value per share: 10,000,000 shares authorized on December 31, 2022, and 2021, respectively" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockVotingRights": { "auth_ref": [ "r11", "r117" ], "lang": { "en-us": { "role": { "documentation": "Description of voting rights of nonredeemable preferred stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.", "label": "Preferred stock voting discription", "verboseLabel": "Preferred stock voting rights" } } }, "localname": "PreferredStockVotingRights", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/PreferredSharesDetailsNarrative", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r738" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid expenses and other current assets", "verboseLabel": "Decrease in prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.DetailsNarrative", "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r51" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Proceeds from public offering", "verboseLabel": "Net proceeds from offering cost" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r51" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from issuance of common stock" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromOtherEquity": { "auth_ref": [ "r51" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from the issuance of equity classified as other.", "label": "Proceeds received from equity financings" } } }, "localname": "ProceedsFromOtherEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromWarrantExercises": { "auth_ref": [ "r743" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.", "label": "Proceeds from the exercise of common stock warrants", "verboseLabel": "Proceeds from exercise of warrants" } } }, "localname": "ProceedsFromWarrantExercises", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ProductWarrantyAccrual": { "auth_ref": [ "r105", "r106", "r212" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.", "label": "Standard and Extended Product Warranty Accrual", "periodEndLabel": "Warranty reserve, ending", "periodStartLabel": "Warranty reserve, beginning" } } }, "localname": "ProductWarrantyAccrual", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfProductWarrantyLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualClassifiedCurrent": { "auth_ref": [ "r26", "r100", "r101" ], "calculation": { "http://vislink.com/role/ScheduleOfAccruedExpensesDetails": { "order": 3.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Warranty" } } }, "localname": "ProductWarrantyAccrualClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualPayments": { "auth_ref": [ "r102" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.", "label": "Standard and Extended Product Warranty Accrual, Decrease for Payments", "negatedLabel": "Warranty claims settled and true-up of accrual" } } }, "localname": "ProductWarrantyAccrualPayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfProductWarrantyLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductWarrantyAccrualWarrantiesIssued": { "auth_ref": [ "r103" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in the standard and extended product warranty accrual from warranties issued.", "label": "Warranty reserve expense" } } }, "localname": "ProductWarrantyAccrualWarrantiesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfProductWarrantyLiabilityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r97" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/IntangibleAssetsDetailsNarrative", "http://vislink.com/role/ScheduleOfAmortizationOfIntangibleAssetsDetails", "http://vislink.com/role/ScheduleOfCapitalizedIntangibleCostsDetails", "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails", "http://vislink.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r98", "r659", "r660", "r661" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "PROPERTY AND EQUIPMENT" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/PropertyAndEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r95", "r237" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, gross" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfAmortizationOfIntangibleAssetsDetails", "http://vislink.com/role/ScheduleOfCapitalizedIntangibleCostsDetails", "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails", "http://vislink.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r97", "r224", "r635", "r708" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheets", "http://vislink.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r97", "r659", "r660" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r97" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "SCHEDULE OF PROPERTY AND EQUIPMENT" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/PropertyAndEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r95" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/IntangibleAssetsDetailsNarrative", "http://vislink.com/role/ScheduleOfAmortizationOfIntangibleAssetsDetails", "http://vislink.com/role/ScheduleOfCapitalizedIntangibleCostsDetails", "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails", "http://vislink.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentUsefulLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.", "label": "Estimated useful life" } } }, "localname": "PropertyPlantAndEquipmentUsefulLife", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfPropertyAndEquipmentDetails", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r261", "r347" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Provision for bad debt", "verboseLabel": "Bad debt expense" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/AccountsReceivableDetailsNarrative", "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Receivables [Abstract]" } } }, "localname": "ReceivablesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": { "auth_ref": [ "r78" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.", "label": "Accounts Receivable and Allowance for Doubtful Accounts" } } }, "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RedeemablePreferredStockDividends": { "auth_ref": [ "r66", "r116", "r123" ], "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Dividends paid to preferred stock holders that is redeemable solely at the option of the issuer.", "label": "Redeemable Preferred Stock Dividends", "negatedLabel": "Dividends" } } }, "localname": "RedeemablePreferredStockDividends", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfMediumTermNotes": { "auth_ref": [ "r52" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to pay off borrowing used to receive debt funding on a regular basis with maturities ranging from 5-10 years.", "label": "Repayments of Medium-term Notes", "negatedLabel": "Principal payments made on D & O notes payable" } } }, "localname": "RepaymentsOfMediumTermNotes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "auth_ref": [ "r52" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.", "label": "Services liabilities" } } }, "localname": "RepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r155", "r229", "r856" ], "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 4.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "auth_ref": [ "r155" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.", "label": "Research and Development Expenses" } } }, "localname": "ResearchAndDevelopmentExpensePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r67" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansDetails", "http://vislink.com/role/Stock-basedCompensationTables" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockUnitsRSUMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.", "label": "Restricted Stock Units (RSUs) [Member]" } } }, "localname": "RestrictedStockUnitsRSUMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetailsParenthetical", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r14", "r123", "r222", "r646", "r651", "r708" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit", "negatedLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheets", "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r230", "r274", "r275", "r276", "r278", "r285", "r288", "r342", "r503", "r504", "r505", "r528", "r529", "r552", "r642", "r644" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r312", "r313", "r322", "r325", "r326", "r330", "r331", "r333", "r452", "r453", "r628" ], "calculation": { "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue, net", "terseLabel": "Revenue from Contract with Customer, Excluding Assessed Tax", "verboseLabel": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative", "http://vislink.com/role/ScheduleOfDisaggregationOfRevenueDetails", "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": { "auth_ref": [ "r444", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r456", "r681" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue from contract with customer.", "label": "Revenue Recognition" } } }, "localname": "RevenueFromContractWithCustomerPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r436", "r437", "r438", "r439", "r440", "r441", "r442", "r443", "r455", "r456" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "REVENUE" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/Revenue" ], "xbrltype": "textBlockItemType" }, "us-gaap_RisksAndUncertaintiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Risks and Uncertainties [Abstract]" } } }, "localname": "RisksAndUncertaintiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r333", "r764" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": { "auth_ref": [ "r34" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.", "label": "SCHEDULE OF ACCOUNTS RECEIVABLE" } } }, "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/AccountsReceivableTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accrued liabilities.", "label": "SCHEDULE OF ACCRUED EXPENSES" } } }, "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/AccruedExpensesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r40", "r839", "r840" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "SCHEDULE OF FOREIGN EXCHANGE AND CHANGE IN ACCUMULATED COMPREHENSIVE INCOME" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": { "auth_ref": [ "r67" ], "lang": { "en-us": { "role": { "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.", "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfAnti-diliutivePotentialCommonStockEquivalentsExcludeFromCalculationOfLossPerShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": { "auth_ref": [ "r67" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.", "label": "SCHEDULE OF ANTI-DILIUTIVE POTENTIAL COMMON STOCK EQUIVALENTS EXCLUDE FROM THE CALCULATION OF LOSS PER SHARE" } } }, "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r167", "r168", "r542" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.DetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r829" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/InventoriesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r163" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (BENEFIT)" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "SCHEDULE OF NOTES PAYABLE" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/NotesPayableTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable": { "auth_ref": [ "r129", "r131" ], "lang": { "en-us": { "role": { "documentation": "Schedule, table or text reflecting arrangements that are not equity-based payments, or pension and other postretirement benefits, with individual employees. The arrangements (for example, profit sharing, deferred bonuses or certain split-dollar life insurance arrangements) are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts at designated future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period and the carrying amount as of the balance sheet date of the related liability.", "label": "Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]" } } }, "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetails", "http://vislink.com/role/ScheduleOfShare-basedPaymentAwardStockOptionsValuationAssumptionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r159" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "auth_ref": [ "r133", "r134", "r135", "r136", "r137" ], "lang": { "en-us": { "role": { "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Defined Benefit Plans Disclosures [Table]" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnNon-recurringBasisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r157" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "SCHEDULE OF EFFECTIVE INCOME TAX RATE RECONCILIATION" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock": { "auth_ref": [ "r83" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of finite-lived intangible assets acquired as part of a business combination or through an asset purchase, by major class and in total, including the value of the asset acquired, any significant residual value (the expected value of the asset at the end of its useful life) and the weighted-average amortization period.", "label": "SCHEDULE OF ACQUIRED INTANGIBLE WITH THEIR RELATIVE USEFUL LIVES" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.Tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r83", "r87", "r629" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r83", "r87" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "SCHEDULE OF INTANGIBLE ASSETS" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfGoodwillTextBlock": { "auth_ref": [ "r686", "r773", "r774", "r775", "r776", "r777", "r778", "r779", "r780", "r781", "r782", "r783" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.", "label": "SCHEDULE OF GOODWILL" } } }, "localname": "ScheduleOfGoodwillTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/GoodwillTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfImpairedIntangibleAssetsTextBlock": { "auth_ref": [ "r91" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of impaired intangible assets excluding goodwill. This may include a description of the facts and circumstances leading to the recording of impairment charges of intangible assets in the period, the amount of the impairment charges, the methods of determining fair value of the associated assets, the caption in the income statement in which the impairment losses are aggregated, and the segment in which the impaired intangible assets are reported.", "label": "SCHEDULE OF CAPITALIZED INTANGIBLE COSTS" } } }, "localname": "ScheduleOfImpairedIntangibleAssetsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "auth_ref": [ "r1", "r18", "r19", "r20" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.", "label": "SCHEDULE OF INVENTORIES" } } }, "localname": "ScheduleOfInventoryCurrentTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/InventoriesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": { "auth_ref": [ "r107" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.", "label": "SCHEDULE OF PRODUCT WARRANTY LIABILITY" } } }, "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r97" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfAmortizationOfIntangibleAssetsDetails", "http://vislink.com/role/ScheduleOfCapitalizedIntangibleCostsDetails", "http://vislink.com/role/ScheduleOfIntangibleAssetsDetails", "http://vislink.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r171" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "SCHEDULE OF IDENTIFIABLE ASSETS ACQUIRED AND LIABILITIES ASSUMED" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.Tables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock": { "auth_ref": [ "r147" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "SCHEDULE OF STOCK OPTION PLANS FOR VESTED OPTION" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/Stock-basedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r466", "r468", "r470", "r471", "r472", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r494", "r495", "r496", "r497", "r498" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfMatchingContributionsDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetailsParenthetical", "http://vislink.com/role/Stock-basedCompensationTables" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "auth_ref": [ "r150" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.", "label": "SCHEDULE OF SHARE-BASED PAYMENT AWARD, STOCK OPTIONS, VALUATION ASSUMPTIONS" } } }, "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/Stock-basedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShortTermDebtTable": { "auth_ref": [ "r23" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.", "label": "Schedule of Short-Term Debt [Table]" } } }, "localname": "ScheduleOfShortTermDebtTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfNotesPayableDetails", "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r111", "r113", "r114", "r117", "r118", "r119", "r120", "r121", "r122", "r123", "r242", "r243", "r244", "r303", "r416", "r417", "r418", "r420", "r424", "r429", "r431", "r692", "r731", "r746" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/PreferredSharesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r127", "r139" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "SCHEDULE OF WARRANT OUTSTANDING" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StockholdersEquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r87" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "SCHEDULE OF ESTIMATED AMORTIZATION EXPENSE FOR INTANGIBLE ASSETS" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r316", "r317", "r318", "r319", "r320", "r321", "r331" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Segment Reporting" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [ "r733", "r734", "r790" ], "lang": { "en-us": { "role": { "documentation": "Series A preferred stock.", "label": "Series A Preferred Stock [Member]" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical", "http://vislink.com/role/PreferredSharesDetailsNarrative", "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical", "http://vislink.com/role/StatementsOfChangesInStockholdersEquity", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesBPreferredStockMember": { "auth_ref": [ "r733", "r734", "r790" ], "lang": { "en-us": { "role": { "documentation": "Series B preferred stock.", "label": "Series B Preferred Stock [Member]" } } }, "localname": "SeriesBPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/PreferredSharesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesDPreferredStockMember": { "auth_ref": [ "r733", "r734", "r790" ], "lang": { "en-us": { "role": { "documentation": "Series D preferred stock.", "label": "Series D Preferred Stock [Member]" } } }, "localname": "SeriesDPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/PreferredSharesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesEPreferredStockMember": { "auth_ref": [ "r733", "r734", "r790" ], "lang": { "en-us": { "role": { "documentation": "Series E preferred stock.", "label": "Series E Preferred Stock [Member]" } } }, "localname": "SeriesEPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/PreferredSharesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r56" ], "calculation": { "http://vislink.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Stock-based compensation expense", "verboseLabel": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansDetails", "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights": { "auth_ref": [ "r141" ], "lang": { "en-us": { "role": { "documentation": "Description of service or performance condition required to be met for earning right to award under share-based payment arrangement. Includes, but is not limited to, combination of market, performance or service condition.", "label": "75% Remaining Vesting", "verboseLabel": "Vesting rights description" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetailsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "auth_ref": [ "r485" ], "lang": { "en-us": { "role": { "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Restricted stock options, granted", "terseLabel": "Grant, Units", "verboseLabel": "Restricted stock units granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r485" ], "lang": { "en-us": { "role": { "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).", "label": "Weighted average exercise price Restricted stock units , granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "auth_ref": [ "r482", "r483" ], "lang": { "en-us": { "role": { "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number", "periodEndLabel": "Number of options RSUs outstanding ending balance", "periodStartLabel": "Number of options RSUs, outstanding, beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [ "r482", "r483" ], "lang": { "en-us": { "role": { "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value", "periodStartLabel": "Number of weighted-averages exercise price exercisable beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms": { "auth_ref": [ "r147" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted average remaining contractual life" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "auth_ref": [ "r486" ], "lang": { "en-us": { "role": { "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.", "label": "Initial RSUs Vesting, Vested Units" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate": { "auth_ref": [ "r793" ], "lang": { "en-us": { "role": { "documentation": "Date the equity-based award expires, in YYYY-MM-DD format.", "label": "Expiration date" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails" ], "xbrltype": "dateItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r496" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Expected dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfShare-basedPaymentAwardStockOptionsValuationAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r495" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfShare-basedPaymentAwardStockOptionsValuationAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r497" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Risk-free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfShare-basedPaymentAwardStockOptionsValuationAssumptionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfMatchingContributionsDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetailsParenthetical", "http://vislink.com/role/Stock-basedCompensationTables" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": { "auth_ref": [ "r145" ], "lang": { "en-us": { "role": { "documentation": "Number of non-option equity instruments exercised by participants.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised", "negatedLabel": "Number of warrants exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures": { "auth_ref": [ "r146" ], "lang": { "en-us": { "role": { "documentation": "Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event.", "label": "Number of warrants cancelled/expired", "negatedLabel": "Number of warrants cancelled/expired" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingDetails", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": { "auth_ref": [ "r144" ], "lang": { "en-us": { "role": { "documentation": "Net number of non-option equity instruments granted to participants.", "label": "Number of warrants granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "auth_ref": [ "r142", "r143" ], "lang": { "en-us": { "role": { "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number", "periodEndLabel": "Number of warrants ending outstanding", "periodStartLabel": "Number of warrants ending outstanding" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "auth_ref": [ "r476" ], "lang": { "en-us": { "role": { "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number", "periodEndLabel": "Number of options exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "auth_ref": [ "r476" ], "lang": { "en-us": { "role": { "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price", "periodEndLabel": "Weighted average exercise price, exercisable balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "auth_ref": [ "r798" ], "lang": { "en-us": { "role": { "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period", "negatedLabel": "Number of options, Stock options forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r798" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price of options that were either forfeited or expired.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price", "negatedLabel": "Weighted average exercise price, Stock options forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r478" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Number of options, Stock options granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r474", "r475" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Number of options, ending outstanding", "periodStartLabel": "Number of options beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r474", "r475" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Weighted average exercise price, outstanding ending balance", "periodStartLabel": "Weighted average exercise price, outstanding beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased": { "auth_ref": [ "r152" ], "lang": { "en-us": { "role": { "documentation": "Per share weighted-average price paid for shares purchased on open market for issuance under share-based payment arrangement.", "label": "Exercise Price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward": { "auth_ref": [ "r818" ], "lang": { "en-us": { "role": { "documentation": "Number of shares purchased for issuance under share-based payment arrangement.", "label": "Grant units" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward": { "auth_ref": [ "r140" ], "lang": { "en-us": { "role": { "documentation": "Description of terms of award under share-based payment arrangement.", "label": "Award vesting description" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardTermsOfAward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r470", "r471", "r472", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r488", "r489", "r490", "r491", "r494", "r495", "r496", "r497", "r498" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetailsParenthetical", "http://vislink.com/role/Stock-basedCompensationTables", "http://vislink.com/role/StockholdersEquityDetailsNarrative", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r479" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price", "verboseLabel": "Range of exercise prices" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r478" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Weighted average exercise price, Stock options granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationAwardTrancheOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.", "label": "Share-Based Payment Arrangement, Tranche One [Member]" } } }, "localname": "ShareBasedCompensationAwardTrancheOneMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetailsParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationAwardTrancheThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.", "label": "Share-Based Payment Arrangement, Tranche Three [Member]" } } }, "localname": "ShareBasedCompensationAwardTrancheThreeMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetailsParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.", "label": "Share-Based Payment Arrangement, Tranche Two [Member]" } } }, "localname": "ShareBasedCompensationAwardTrancheTwoMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetailsParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r473", "r492", "r493", "r494", "r495", "r498", "r506", "r507" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Stock-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis": { "auth_ref": [ "r149" ], "lang": { "en-us": { "role": { "documentation": "Information by range of option prices pertaining to options granted.", "label": "Exercise Price Range [Axis]" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingExercisePriceDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain": { "auth_ref": [ "r151" ], "lang": { "en-us": { "role": { "documentation": "Supplementary information on outstanding and exercisable share awards as of the balance sheet date which stratifies outstanding options by ranges of exercise prices." } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfWarrantOutstandingExercisePriceDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Exercise price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfShare-basedPaymentAwardStockOptionsValuationAssumptionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares for which recognition of cost was accelerated for award under share-based payment arrangement.", "label": "Units vesting schedule, tranche three" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r494" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Expected term (years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfShare-basedPaymentAwardStockOptionsValuationAssumptionsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r148" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term of exercisable stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted average remaining contractual life - options exercisable" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Share issued price per share", "verboseLabel": "Shares issued price per share" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/PreferredSharesDetailsNarrative", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance, shares", "periodStartLabel": "Balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.", "label": "Shares attributable to withholding tax" } } }, "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermDebtLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Short-Term Debt [Line Items]" } } }, "localname": "ShortTermDebtLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfNotesPayableDetails", "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermLeaseCost": { "auth_ref": [ "r582", "r707" ], "calculation": { "http://vislink.com/role/ScheduleOfOperatingLeaseDataDetails": { "order": 2.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.", "label": "Short-term lease cost" } } }, "localname": "ShortTermLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfOperatingLeaseDataDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r65", "r267" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StateAndLocalJurisdictionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.", "label": "State and Local Jurisdiction [Member]" } } }, "localname": "StateAndLocalJurisdictionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r242", "r243", "r244", "r270", "r292", "r293", "r296", "r298", "r303", "r304", "r341", "r379", "r381", "r382", "r383", "r386", "r387", "r416", "r417", "r420", "r424", "r431", "r558", "r673", "r731", "r746", "r763" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical", "http://vislink.com/role/PreferredSharesDetailsNarrative", "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical", "http://vislink.com/role/StatementsOfChangesInStockholdersEquity", "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r33", "r116", "r230", "r256", "r257", "r258", "r274", "r275", "r276", "r278", "r285", "r288", "r302", "r342", "r433", "r503", "r504", "r505", "r528", "r529", "r552", "r564", "r565", "r566", "r567", "r568", "r570", "r590", "r642", "r643", "r644" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative", "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical", "http://vislink.com/role/ScheduleOfShare-basedPaymentAwardStockOptionsValuationAssumptionsDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetailsParenthetical", "http://vislink.com/role/ScheduleOfWarrantOutstandingExercisePriceDetails", "http://vislink.com/role/StatementsOfChangesInStockholdersEquity", "http://vislink.com/role/Stock-basedCompensationDetailsNarrative", "http://vislink.com/role/Stock-basedCompensationTables", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical", "http://vislink.com/role/LeasesDetailsNarrative", "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical", "http://vislink.com/role/ScheduleOfLeaseObligationsAssumedDetails", "http://vislink.com/role/StatementsOfChangesInStockholdersEquity", "http://vislink.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r274", "r275", "r276", "r302", "r628" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical", "http://vislink.com/role/LeasesDetailsNarrative", "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical", "http://vislink.com/role/ScheduleOfLeaseObligationsAssumedDetails", "http://vislink.com/role/StatementsOfChangesInStockholdersEquity", "http://vislink.com/role/Stock-basedCompensationDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r32", "r116", "r117", "r123", "r405" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Shares of common stock issued" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Stock issued during period for services, shares" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r11", "r12", "r116", "r123" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Issuance of shares of Series A Preferred Stock as dividends for common stock shareholders, shares", "terseLabel": "Issuance of common stock share", "verboseLabel": "Issuance of common stock shares" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative", "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical", "http://vislink.com/role/StatementsOfChangesInStockholdersEquity", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r33", "r116", "r123" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Common stock accumulated value" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Stock issued during period for services, value+" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r11", "r12", "r116", "r123" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Issuance of shares of Series A Preferred Stock as dividends for common stock shareholders", "terseLabel": "Issuance of common stock share value", "verboseLabel": "Common stock value" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative", "http://vislink.com/role/StatementsOfChangesInStockholdersEquity", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockOptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).", "label": "Equity Option [Member]" } } }, "localname": "StockOptionMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfAnti-diliutivePotentialCommonStockEquivalentsExcludeFromCalculationOfLossPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r12", "r15", "r16", "r79", "r708", "r748", "r769", "r835" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total stockholders\u2019 equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheets", "http://vislink.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 equity" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r128", "r269", "r417", "r419", "r420", "r421", "r422", "r423", "r424", "r425", "r426", "r427", "r428", "r430", "r433", "r550" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityReverseStockSplit": { "auth_ref": [ "r124" ], "lang": { "en-us": { "role": { "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.", "label": "Reverse split" } } }, "localname": "StockholdersEquityReverseStockSplit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/CommitmentsAndContingenciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r571", "r592" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative", "http://vislink.com/role/PreferredSharesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r571", "r592" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r571", "r592" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative", "http://vislink.com/role/PreferredSharesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r571", "r592" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/CommitmentsAndContingenciesDetailsNarrative", "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative", "http://vislink.com/role/PreferredSharesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for reporting subsequent events.", "label": "Subsequent Events" } } }, "localname": "SubsequentEventsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r591", "r594" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental disclosure of cash payments:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_SupplierConcentrationRiskMember": { "auth_ref": [ "r70" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services.", "label": "Supplier Concentration Risk [Member]" } } }, "localname": "SupplierConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ConcentrationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "auth_ref": [ "r379", "r381", "r382", "r383", "r386", "r387" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Series A Preferred stock, $0.00001 par value per share: 47,500 and -0- shares authorized on December 31, 2022, and 2021, respectively; 47,419 and -0- shares issued and outstanding on December 31, 2022, and 2021, respectively at a redemption value equal to $0.10 in cash for each ten thousand (10,000) whole shares." } } }, "localname": "TemporaryEquityCarryingAmountAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityParOrStatedValuePerShare": { "auth_ref": [ "r3", "r112" ], "lang": { "en-us": { "role": { "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.", "label": "Temporary equity, par value" } } }, "localname": "TemporaryEquityParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_TemporaryEquityRedemptionPricePerShare": { "auth_ref": [ "r3", "r112" ], "lang": { "en-us": { "role": { "documentation": "Amount to be paid per share that is classified as temporary equity by entity upon redemption. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary equity, redemption value per share" } } }, "localname": "TemporaryEquityRedemptionPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_TemporaryEquitySharesAuthorized": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary equity, shares authorized" } } }, "localname": "TemporaryEquitySharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquitySharesIssued": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary equity, shares issued" } } }, "localname": "TemporaryEquitySharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquitySharesOutstanding": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary equity, shares outstanding" } } }, "localname": "TemporaryEquitySharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TradeNamesMember": { "auth_ref": [ "r172" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trade Names [Member]" } } }, "localname": "TradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/AcquisitionOfMobileViewpointCorporateB.v.DetailsNarrative", "http://vislink.com/role/ScheduleOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r339", "r340", "r413", "r429", "r549", "r595", "r596", "r597", "r598", "r599", "r600", "r601", "r602", "r603", "r604", "r605", "r606", "r607", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620", "r621", "r622", "r623", "r624", "r766", "r767", "r768", "r859", "r860", "r861", "r862", "r863", "r864", "r865" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnNon-recurringBasisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockMember": { "auth_ref": [ "r31", "r125" ], "lang": { "en-us": { "role": { "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.", "label": "Treasury Stock [Member]" } } }, "localname": "TreasuryStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_TreasuryStockShares": { "auth_ref": [ "r31", "r125" ], "lang": { "en-us": { "role": { "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.", "label": "Treasury stock, shares" } } }, "localname": "TreasuryStockShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TreasuryStockValue": { "auth_ref": [ "r31", "r125", "r126" ], "calculation": { "http://vislink.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.", "label": "Treasury Stock, Value", "negatedLabel": "Treasury stock, at cost \u2013 2,659 shares as of December 31, 2022, and 2021, respectively" } } }, "localname": "TreasuryStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r829" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/IncomeTaxesDetailsNarrative", "http://vislink.com/role/InventoriesDetailsNarrative", "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetails", "http://vislink.com/role/ScheduleOfGainsOnSettlementOfDebtDetailsParenthetical", "http://vislink.com/role/ScheduleOfNotesPayableDetailsParenthethical", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r74", "r75", "r76", "r306", "r307", "r309", "r310" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [ "r522" ], "calculation": { "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount", "negatedLabel": "Change in the valuation allowance" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfComponentsOfIncomeTaxExpenseBenefitDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_VestingAxis": { "auth_ref": [ "r792", "r793", "r794", "r795", "r796", "r797", "r798", "r799", "r800", "r801", "r802", "r803", "r804", "r805", "r806", "r807", "r808", "r809", "r810", "r811", "r812", "r813", "r814", "r815", "r816", "r817" ], "lang": { "en-us": { "role": { "documentation": "Information by vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Axis]" } } }, "localname": "VestingAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetailsParenthetical" ], "xbrltype": "stringItemType" }, "us-gaap_VestingDomain": { "auth_ref": [ "r792", "r793", "r794", "r795", "r796", "r797", "r798", "r799", "r800", "r801", "r802", "r803", "r804", "r805", "r806", "r807", "r808", "r809", "r810", "r811", "r812", "r813", "r814", "r815", "r816", "r817" ], "lang": { "en-us": { "role": { "documentation": "Vesting schedule of award under share-based payment arrangement." } } }, "localname": "VestingDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetails", "http://vislink.com/role/ScheduleOfStockOptionPlansForVestedOptionDetailsParenthetical" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfAnti-diliutivePotentialCommonStockEquivalentsExcludeFromCalculationOfLossPerShareDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstanding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.", "label": "Warrants outstanding" } } }, "localname": "WarrantsAndRightsOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": { "auth_ref": [ "r557" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.", "label": "Warrants measurement input", "verboseLabel": "Expected dividend yield" } } }, "localname": "WarrantsAndRightsOutstandingMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfValuationAndWarrantsExercisableDetails", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "decimalItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r834" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrant term", "verboseLabel": "Warrant life (years)" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/LiquidityAndFinancialConditionDetailsNarrative", "http://vislink.com/role/ScheduleOfValuationAndWarrantsExercisableDetails", "http://vislink.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberBasicSharesOutstandingAdjustmentProForma": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Adjustment to the weighted average number of basic shares outstanding to convert this to a pro forma presentation.", "label": "Weighted average number of shares outstanding" } } }, "localname": "WeightedAverageNumberBasicSharesOutstandingAdjustmentProForma", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfUnauditedPro-formaCombinedResultsOfOperationsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r290", "r298" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Basic and Diluted" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average number of shares outstanding:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_WorkersCompensationLiabilityCurrent": { "auth_ref": [ "r26" ], "calculation": { "http://vislink.com/role/ScheduleOfAccruedExpensesDetails": { "order": 1.0, "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Compensation" } } }, "localname": "WorkersCompensationLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://vislink.com/role/ScheduleOfAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" } }, "unitCount": 8 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 1.B.2)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=126898705&loc=d3e5934-122674", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907644&loc=d3e11281-110244", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12524-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(2))", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "((c)(3))", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(5)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21564-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.C)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r128": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org/extlink&oid=6409733&loc=d3e19524-108361", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org/extlink&oid=6409733&loc=d3e19512-108361", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org/extlink&oid=6409875&loc=d3e20028-108363", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(a)-(d)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r174": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "https://asc.fasb.org/topic&trid=2303972", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "https://asc.fasb.org/topic&trid=2229140", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(19)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15)(b)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(5))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.15(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(7)(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(27)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29,30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r311": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r337": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/subtopic&trid=2196772", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r338": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/subtopic&trid=2196816", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.3,4)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.F)", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100079-122729", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r358": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r365": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r370": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144471", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6036836-161870", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130561-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130563-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130564-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130566-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r456": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org/topic&trid=49130388", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "70", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r507": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(a)", "Topic": "720", "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "35", "Subparagraph": "(b)", "Topic": "720", "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r516": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r534": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r539": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(3)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(b)(2)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=126980362&loc=d3e28228-110885", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123602790&loc=d3e30226-110892", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30755-110894", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32262-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6897108&loc=SL6897125-166521", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r573": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "https://asc.fasb.org/topic&trid=2175825", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r588": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/subtopic&trid=77888251", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 1.B.3)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=122134661&loc=d3e463720-122850", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r594": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r600": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r607": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=126938201&loc=d3e55415-109406", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "330", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(5))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(iv)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r65": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942793&loc=d3e3073-115593", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r673": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r711": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r712": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r713": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r714": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r715": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r716": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r717": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r718": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r719": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r720": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r721": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r722": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r723": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r724": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r725": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r726": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r727": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r728": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r729": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r730": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r731": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r732": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r733": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r734": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r735": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r736": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r737": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r738": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r739": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r740": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r741": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r742": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(4))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r743": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r744": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r745": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r746": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r747": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r748": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r749": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r750": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r751": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r752": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r753": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r754": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r755": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r756": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r757": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r758": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r759": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r760": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r761": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r762": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r763": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r764": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r765": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r766": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r767": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r768": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r769": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r77": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r770": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(3)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r771": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)(4)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r772": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.A)", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=122040515&loc=d3e105025-122735", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r773": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r774": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r775": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r776": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r777": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r778": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r779": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5144-111524", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r780": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r781": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r782": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=SL108378252-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r783": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r784": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r785": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r786": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r787": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r788": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r789": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r790": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r791": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r792": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r793": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r794": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r795": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r796": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r797": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r798": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r799": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 5.BB)", "Topic": "330", "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r800": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r801": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r802": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r803": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r804": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r805": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r806": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r807": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r808": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r809": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r810": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r811": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r812": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r813": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r814": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r815": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r816": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r817": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r818": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r819": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "740", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126970579&loc=d3e23163-113944", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r820": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r821": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r822": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r823": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r824": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r825": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r826": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r827": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r828": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(3)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r829": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r830": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r831": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r832": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r833": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r834": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r835": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r836": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=125521441&loc=d3e30690-110894", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r837": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=124440516&loc=d3e30840-110895", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r838": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r839": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r840": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r841": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123399704&loc=SL77918431-209957", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r842": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r843": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r844": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r845": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(01)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r846": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r847": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r848": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r849": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r850": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r851": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r852": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r853": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r854": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r855": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r856": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r857": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r858": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r859": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r860": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r861": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r862": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r863": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r864": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r865": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2611-110228", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2420-110228", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r98": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org/topic&trid=2155823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r99": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" } }, "version": "2.2" } ZIP 129 0001493152-23-010183-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-23-010183-xbrl.zip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�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